ML20100L913: Difference between revisions

From kanterella
Jump to navigation Jump to search
VisualWikitext
StriderTol Bot insert
 
StriderTol Bot change
 
Line 17: Line 17:


=Text=
=Text=
{{#Wiki_filter:. . _ . _ . _ .     . ._  _ _ . . . ~ . _ . . . . _ _ _ _ . . . _ . - . . . _ _  _ . _ . _ _ . . m_. -. - . - - _ . _. -
{{#Wiki_filter:.. _. _. _.
I l-                                                                                                                                   I l
_ _... ~. _.
m_.
I l-I l
l l
l l
l l
l l
l PORC                 YES                                                                                   I l                       SQR                   YES
PORC YES I
;                      NQA                 NO 50.59                 YES RESP.MGk.             NES                                                                                   l l                                                                                                                                  I l
l SQR YES NQA NO 50.59 YES RESP.MGk.
LIMERICK. GENERATING STATION l
NES l
l UNITS 1 AND 2                                     l i
I LIMERICK. GENERATING STATION l
I OFFSITE DOSE CALCULATION MANUAL                                           ;
l UNITS 1 AND 2 i
l                                                            Revision 17 PECO ENERGY COMPANY DOCKET NOS. 50-352 AND 50-353
I OFFSITE DOSE CALCULATION MANUAL l
                                '                                                                                                    l Approval:                 L 4         M Plant Manager
Revision 17 PECO ENERGY COMPANY DOCKET NOS. 50-352 AND 50-353 Approval:
                                                                                                                                      \
L 4
M Plant Manager
\\
t i
t i
R
R


    . . . . . . - . - . .      - . _ . . . . - . . . .  .- . - .    .    . .. . . . . . - ~   .        .-.
.. - ~
4 ODCM Rev. 17     j 11/95     i
4 ODCM Rev. 17 j
,                                                      Table-of Contents Page           j i
11/95 i
Part I - RADIOLOGICAL EFFLUENT CONTROLS 1.0     DEFINITIONS                                                             1 2.0     BASIS FOR EFFLUENT MONITORING CONTROLS                                   6 2.1     METEOROLOGICAL MONITORING INSTRUMENTATION                               6         j 2.2     MAPS DEFINING UNRESTRICTED AREAS AND SITE BOUNDARY FOR RADIOACTIVE GASEOUS AND LIQUID EFFLUENTS                             6 2.3     RADIOACTIVE LIQUID EFFLUENT MONITORING INSTRUMENTATION                   6 2.3.1     Concentration                                                 9 2.3.2     Dose                                                           9 2.3.3     Liquid Radwaste Treatment System                           10 2.4     RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION               10 2.4.1     Dose Rate                                                   10-
Table-of Contents Page j
i Part I - RADIOLOGICAL EFFLUENT CONTROLS 1.0 DEFINITIONS 1
2.0 BASIS FOR EFFLUENT MONITORING CONTROLS 6
2.1 METEOROLOGICAL MONITORING INSTRUMENTATION 6
j 2.2 MAPS DEFINING UNRESTRICTED AREAS AND SITE BOUNDARY FOR RADIOACTIVE GASEOUS AND LIQUID EFFLUENTS 6
2.3 RADIOACTIVE LIQUID EFFLUENT MONITORING INSTRUMENTATION 6
2.3.1 Concentration 9
2.3.2 Dose 9
2.3.3 Liquid Radwaste Treatment System 10 2.4 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION 10 2.4.1 Dose Rate 10-
)
)
2.4.2     Dose - Noble Gases                                         11 2.4.3     Dose - Iodine-131, Iodine-133, Tritium, and                             i Radionuclides in Particulate Form                           12           l 2.4.4     Ventilation Exhaust Treatment System                         12 2.4.5     Venting and Purging                                         13 2.4.6     Total Dose                                                   13         ;
2.4.2 Dose - Noble Gases 11 2.4.3 Dose - Iodine-131, Iodine-133, Tritium, and i
l 2.5     MONITORING PROGRAM                                                     13         ]
Radionuclides in Particulate Form 12 2.4.4 Ventilation Exhaust Treatment System 12 2.4.5 Venting and Purging 13 2.4.6 Total Dose 13 l
2.5.1     Land Use Census                                             14 2.5.2     Interlaboratory Comparison Program                         14 2.6     APPLICABILITY                                                         14 3.0     METEOROLOGICAL MONITORING INSTRUMENTATION CONTROLS                     16           l l 3.1         METEOROLOGICAL MONITORING INSTRUMENTATION                               16 i
2.5 MONITORING PROGRAM 13
]
2.5.1 Land Use Census 14 2.5.2 Interlaboratory Comparison Program 14 2.6 APPLICABILITY 14 3.0 METEOROLOGICAL MONITORING INSTRUMENTATION CONTROLS 16 l 3.1 METEOROLOGICAL MONITORING INSTRUMENTATION 16 i
f
f


1 1
1 1
1 OECM Rev. 17 11/95 Page i
OECM Rev. 17 11/95 Page i
i l 3.2 RADIOACTIVE LIQUID EFFLUENT MONITORING INSTRUMENTATION   20       ,
i l 3.2 RADIOACTIVE LIQUID EFFLUENT MONITORING INSTRUMENTATION 20 3.2.1 Radioactive Effluent Monitoring Instrumentation Controls 21 3.2.2 Concentration 24-
3.2.1 Radioactive Effluent Monitoring Instrumentation Controls                           21 3.2.2 Concentration                                     24-
-l 3.2.3 Dose 28' j
                                                                        -l 3.2.3 Dose                                               28'       I 3.2.4 Liquid Radwaste Treatment System                   29       j 3.3 GASEOUS EFFLUENTS l     3.3.1 Radioactive Gaseous Effluent Monitoring Instrumentation                                   30 3.3.2 SITE BOUNDARY Dose Rate                           35 3.3.3 Dose - Noble Gases                                 39 3.3.4 Dose - Iodine-131, Iodine-133, Tritium, and Radionuclides in Particulate Form                 40 3.3.5 Ventilation Exhaust Treatment System               41 3.3.6 Venting or Purging                                 42 3.3.7 Total Dose                                         43 3.4 RADIOLOGICAL ENVIRONMENTAL MONITORING 3.4.1 Monitoring Program                                 44 3.4.2 Land Use Census                                   57 3.4.3 Interlaboratory Comparison Program                 58 3.5 ANNUAL RADIOLOGICAL ENVIRONMENTAL OPERATING REPORT       59 l 3.6 ANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT               60 3.7 MAJOR CHANGES TO RADIOACTIVE WASTE TREATMENT SYSTEMS     62 l
3.2.4 Liquid Radwaste Treatment System 29 3.3 GASEOUS EFFLUENTS l
11
3.3.1 Radioactive Gaseous Effluent Monitoring Instrumentation 30 3.3.2 SITE BOUNDARY Dose Rate 35 3.3.3 Dose - Noble Gases 39 3.3.4 Dose - Iodine-131, Iodine-133, Tritium, and Radionuclides in Particulate Form 40 3.3.5 Ventilation Exhaust Treatment System 41 3.3.6 Venting or Purging 42 3.3.7 Total Dose 43 3.4 RADIOLOGICAL ENVIRONMENTAL MONITORING 3.4.1 Monitoring Program 44 3.4.2 Land Use Census 57 3.4.3 Interlaboratory Comparison Program 58 3.5 ANNUAL RADIOLOGICAL ENVIRONMENTAL OPERATING REPORT 59 l 3.6 ANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT 60 3.7 MAJOR CHANGES TO RADIOACTIVE WASTE TREATMENT SYSTEMS 62 11


ODCM Rev. 17 11/95 LIMERICK GENERATING STATION OFFSITE DOSE CALCULATION MANUAL TABLE CONTENTS Page             :
ODCM Rev. 17 11/95 LIMERICK GENERATING STATION OFFSITE DOSE CALCULATION MANUAL TABLE CONTENTS Page Part II - CALCULATION METHODOLOGIES 1.0 LIQUID EFFLUENTS 63 1.1 RADIATION MONITORING INSTRUMENTATION AND CONTROLS 63 1.2 LIQUID EFFLUENT MONITOR SETPOINT DETERMINATION 64 1.2.1 Radwaste Discharge Monitor 64 1.2.2 Service Water Radiation Monitor 67 1.2.3 RHR Service Water Monitor 68 1.3 LIQUID EFFLUENT DOSE CALCULATIONS - 10 CFR 50 69 1.3.1 Member of the Public Dose - Liquid Effluents 69 1.4 LIQUID EFFLUENT DOSE PROJECTION 74 2.0 GASEOUS EFFLUENTS 75 2.1 RADIATION MONITORING INSTRUMENTATION AND CONTROLS 75 l 2.2 GASEOUS EFFLUENT MONITOR SETPOINT DETERMINATION 76 2.2.1 North Vent Noble Gas Effluent Monitors 77 2.2.2 South Vent Noble Gas Effluent Monitors 79 2.2.3 Noble Gas Effluent Fractional Contribution 81 2.2.4 Noble Gas Effluent Default Setpoints 82 l
Part II - CALCULATION METHODOLOGIES 1.0     LIQUID EFFLUENTS                                           63 1.1   RADIATION MONITORING INSTRUMENTATION AND CONTROLS           63 1.2     LIQUID EFFLUENT MONITOR SETPOINT DETERMINATION             64 1.2.1   Radwaste Discharge Monitor                         64 1.2.2   Service Water Radiation Monitor                     67 1.2.3   RHR Service Water Monitor                           68 1.3     LIQUID EFFLUENT DOSE CALCULATIONS - 10 CFR 50               69 1.3.1   Member of the Public Dose - Liquid Effluents       69 1.4     LIQUID EFFLUENT DOSE PROJECTION                             74 2.0     GASEOUS EFFLUENTS                                           75 2.1     RADIATION MONITORING INSTRUMENTATION AND CONTROLS           75 l 2.2   GASEOUS EFFLUENT MONITOR SETPOINT DETERMINATION             76 2.2.1   North Vent Noble Gas Effluent Monitors             77 2.2.2   South Vent Noble Gas Effluent Monitors               79 2.2.3   Noble Gas Effluent Fractional Contribution           81 2.2.4   Noble Gas Effluent Default Setpoints                 82 l         2.2.5   WRAM Noble Gas Effluent Monitor                     87 l 2.3     GASEOUS EFFLUENT DOSE EVALUATIONS                           90 l         2.3.1   Site Boundary Dose Rate - Noble Gases               91 2.3.2   Site Boundary Dose Rate - Radiciodine and l                 Particulates                                         93           ;
2.2.5 WRAM Noble Gas Effluent Monitor 87 l 2.3 GASEOUS EFFLUENT DOSE EVALUATIONS 90 l
l        2.3.3   Noble Gas Air Dose                                   94 2.3.4   Radiciodine and Particulate Dose Calculations l                 10 CFR 50                                             95 iii
2.3.1 Site Boundary Dose Rate - Noble Gases 91 2.3.2 Site Boundary Dose Rate - Radiciodine and l
Particulates 93 l
2.3.3 Noble Gas Air Dose 94 2.3.4 Radiciodine and Particulate Dose Calculations l
10 CFR 50 95 iii


i l                                                                                       ODCM Rev. 17 t
i l
11/95 j                                                                                                       Page l   l         2.3.5   Annual Dose Evaluation                                                                 98 I
ODCM Rev. 17 t
l 2.4     GASEOUS EFFLUENT DOSE PROJECTION                                                         101
11/95 j
Page l
l 2.3.5 Annual Dose Evaluation 98 I
l 2.4 GASEOUS EFFLUENT DOSE PROJECTION 101
}~
}~
l 3.0     SPECIAL DOSE ANALYSIS                                                                     102 g  l 3.1     TOTAL DOSES TO MEMBERS OF THE PUBLIC                                                     102 l
l 3.0 SPECIAL DOSE ANALYSIS 102 l 3.1 TOTAL DOSES TO MEMBERS OF THE PUBLIC 102 g
        -3.2 DOSES DUE TO ACTIVITIES INSIDE THE SITE BOUNDARY                                         104
l
,  l 4.O     RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM                                             105 i
-3.2 DOSES DUE TO ACTIVITIES INSIDE THE SITE BOUNDARY 104 l 4.O RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM 105 i
l 4.1     SAMPLING PROGRAM                                                                         105
l 4.1 SAMPLING PROGRAM 105
,  -l 4 2     INTERLABORATORY COMPARISON PROGRAM                                                       105 4
-l 4 2 INTERLABORATORY COMPARISON PROGRAM 105 4
l                                         APPENDICES I
l APPENDICES I
l Appendix A - Technical Specification /ODCM                                                         157 l Appendix B - Radiological Environmental Monitoring                                                 160 Program - Sample Type, Location and Analysis l Appendix C - Requirements for ODCM Revision                                                       173 iv
l Appendix A - Technical Specification /ODCM 157 l Appendix B - Radiological Environmental Monitoring 160 Program - Sample Type, Location and Analysis l Appendix C - Requirements for ODCM Revision 173 iv


ODCM Rev. 17 11/95 LIST OF TABLES I 1.1   Surveillance Frequency Notation I 3.1-1 Meteorological Monitoring Instrumentation I 3.1-2 Meteorological Monitoring Instrumentation Surveillance Requirements I 3.2-1 Radioactive Liquid Effluent Monitoring Instrumentation I 3.2-2 Radioactive Liquid Effluent Monitoring Instrumentation Surveillance Requirements I 3.2-3 Radioactive Liquid Waste Sampling and Analysis Program I 3.3-1 Radioactive Gaseous Effluent Monitoring Instrumentation I 3.3-2 Radioactive Gaseous Effluent Monitoring Instrumentation Surveillance Requirements I 3.3-3 Radioactive Gaseous Waste Sampling and Analysis Program I 3.4-1 Radiological Environmental Monitoring Program I 3.4-2 Reporting Levels for Radioactivity Concentrations In Environmental Samples I 3.4-3 Detection Capabilities For Environmental Sample Analysis II 1.1   Ingestion Individual Dose Factors (Daipj) For Liquid Effluents II 1.2   Assumptions Used In Limerick Effluent Dose Evaluations II 2.1   Dose Factors for Noble Gases II 2.2   Ingestion Individual Dose Factors (DFk,1,n) For Gaseous Effluent II 2.3   Assumptions Used In Limerick Gaseous Effluent Dose Evaluation II 2.4   Nearest Gaseous Effluent Dose Receptor Distances (Meters)
ODCM Rev. 17 11/95 LIST OF TABLES I 1.1 Surveillance Frequency Notation I 3.1-1 Meteorological Monitoring Instrumentation I 3.1-2 Meteorological Monitoring Instrumentation Surveillance Requirements I 3.2-1 Radioactive Liquid Effluent Monitoring Instrumentation I 3.2-2 Radioactive Liquid Effluent Monitoring Instrumentation Surveillance Requirements I 3.2-3 Radioactive Liquid Waste Sampling and Analysis Program I 3.3-1 Radioactive Gaseous Effluent Monitoring Instrumentation I 3.3-2 Radioactive Gaseous Effluent Monitoring Instrumentation Surveillance Requirements I 3.3-3 Radioactive Gaseous Waste Sampling and Analysis Program I 3.4-1 Radiological Environmental Monitoring Program I 3.4-2 Reporting Levels for Radioactivity Concentrations In Environmental Samples I 3.4-3 Detection Capabilities For Environmental Sample Analysis II 1.1 Ingestion Individual Dose Factors (Daipj) For Liquid Effluents II 1.2 Assumptions Used In Limerick Effluent Dose Evaluations II 2.1 Dose Factors for Noble Gases II 2.2 Ingestion Individual Dose Factors (DFk,1,n) For Gaseous Effluent II 2.3 Assumptions Used In Limerick Gaseous Effluent Dose Evaluation II 2.4 Nearest Gaseous Effluent Dose Receptor Distances (Meters)
A.1 Technical Specification /ODCM Matrix B.1 Radiological Environmental Monitoring Program v
A.1 Technical Specification /ODCM Matrix B.1 Radiological Environmental Monitoring Program v


ODCM Rev. 17
ODCM Rev. 17
)                                                                                 11/95 i                                           LIST OF TABLES I 1.1   Surveillance Frequency Notation I 3.1-1 Meteorological Monitoring Instrumentation I 3.1-2 Meteorological Monitoring Instrumentation Surveillance Requirements I 3.2-1 Radioactive Liquid Effluent Monitoring Instrumentation I 3.2-2 Radioactive Liquid Effluent Monitoring Instrumentation Surveillance Requirements I 3.2-3 Radioactive Liquid Waste Sampling and Analysis Program I 3.3-1 Radioactive Gaseous Effluent Monitoring Instrumentation I 3.3-2 Radioactive Gaseous Effluent Monitoring Instrumentation Surveillance Requirements I 3.3-3 Radioactive Gaseous Waste Sampling and Analysis Program I 3.4-1 Radiological Environmental Monitoring Program I 3.4-2 Reporting Levels for Radioactivity Concentrations In Environmental Samples I 3.4-3 Detection Capabilities For Environmental Sample Analysis II 1.1   Ingestion Individual Dose Factors (Daipj) For Liquid Effluents II 1.2   Assumptions Used In Limerick Effluent Dose Evaluations II 2.1   Dose Factors for Noble Gases II 2.2   Ingestion Individual Dose Factors (DFk,1,n) For Gaseous Effluent II 2.3   Assumptions Used In Limerick Gaseous Effluent Dose Evaluation II 2.4   Nearest Gaseous Effluent Dose Receptor Distances (Meters)
)
A.1 Technical Specification /ODCM Matrix B.1 Radiological Environmental Monitoring Program v
11/95 i
LIST OF TABLES I 1.1 Surveillance Frequency Notation I 3.1-1 Meteorological Monitoring Instrumentation I 3.1-2 Meteorological Monitoring Instrumentation Surveillance Requirements I 3.2-1 Radioactive Liquid Effluent Monitoring Instrumentation I 3.2-2 Radioactive Liquid Effluent Monitoring Instrumentation Surveillance Requirements I 3.2-3 Radioactive Liquid Waste Sampling and Analysis Program I 3.3-1 Radioactive Gaseous Effluent Monitoring Instrumentation I 3.3-2 Radioactive Gaseous Effluent Monitoring Instrumentation Surveillance Requirements I 3.3-3 Radioactive Gaseous Waste Sampling and Analysis Program I 3.4-1 Radiological Environmental Monitoring Program I 3.4-2 Reporting Levels for Radioactivity Concentrations In Environmental Samples I 3.4-3 Detection Capabilities For Environmental Sample Analysis II 1.1 Ingestion Individual Dose Factors (Daipj) For Liquid Effluents II 1.2 Assumptions Used In Limerick Effluent Dose Evaluations II 2.1 Dose Factors for Noble Gases II 2.2 Ingestion Individual Dose Factors (DFk,1,n) For Gaseous Effluent II 2.3 Assumptions Used In Limerick Gaseous Effluent Dose Evaluation II 2.4 Nearest Gaseous Effluent Dose Receptor Distances (Meters)
A.1 Technical Specification /ODCM Matrix B.1 Radiological Environmental Monitoring Program v


ODCM Rev. 17 11/95 LIST OF FIGURES I 2.2-la Map Defining Exclusion Areas for Radioactive                 i Gaseous and Liquid Effluents I 2.2-1b Map Defining Low Population Areas for Radioactive Gaseous and Liquid Effluents I 3.1-1   Meteorological Tower Location II 1.3.1-1 LGS Dilution vs River Flow (Outfall)
ODCM Rev. 17 11/95 LIST OF FIGURES I
II 1.3.1-2 LGS Dilution vs Rirer Flow (Citizen's Utility)               ,
2.2-la Map Defining Exclusion Areas for Radioactive i
Gaseous and Liquid Effluents I
2.2-1b Map Defining Low Population Areas for Radioactive Gaseous and Liquid Effluents I
3.1-1 Meteorological Tower Location II 1.3.1-1 LGS Dilution vs River Flow (Outfall)
II 1.3.1-2 LGS Dilution vs Rirer Flow (Citizen's Utility)
II 1.3.1-3 LGS Dilution vs River Flow (Phoenixville)
II 1.3.1-3 LGS Dilution vs River Flow (Phoenixville)
II 1.3.1-4 LGS Dilution vs River Flow-(Philadelphia Suburban)
II 1.3.1-4 LGS Dilution vs River Flow-(Philadelphia Suburban)
II 1.3.1-5 LGS Dilution vs River Flow (Crew Course)                     f II 1-1     Liquid Effluent Flow Diagram II 2-1     Gaseous Effluent Flow Diagram - North Stack II 2-2     Gaseous Effluent Flow Diagram - South Stack II 2-3     Gaseous Effluent Flow Diagram - Hot Maintenance Shop B-1     Environmental Sampling Location on Site or Near the Limerick Generating Station B-2     Aquatic and Terrestrial Environmental Sampling Location at Intermediate Distances from the Limerick Generating Station B-3     Airborne and TLD Environmental Sampling Locations at Intermediate Distances from the Limerick Generating Station B-4     2nvironmental Sampling Locations at Remote Distances from the Limerick Generating Station vi
II 1.3.1-5 LGS Dilution vs River Flow (Crew Course) f II 1-1 Liquid Effluent Flow Diagram II 2-1 Gaseous Effluent Flow Diagram - North Stack II 2-2 Gaseous Effluent Flow Diagram - South Stack II 2-3 Gaseous Effluent Flow Diagram - Hot Maintenance Shop B-1 Environmental Sampling Location on Site or Near the Limerick Generating Station B-2 Aquatic and Terrestrial Environmental Sampling Location at Intermediate Distances from the Limerick Generating Station B-3 Airborne and TLD Environmental Sampling Locations at Intermediate Distances from the Limerick Generating Station B-4 2nvironmental Sampling Locations at Remote Distances from the Limerick Generating Station vi


i l
i i
l l
l PURPOSE The purpose of the Offsite Dose Calculation Manual is to establish methodologies and procedures for calculating doses to individuals in areas at and beyond the SITE BOUNDARY due to radioactive effluents from Limerick Generating Station.
i l
l l
I I
PURPOSE l
The purpose of the Offsite Dose Calculation Manual is to establish   '
methodologies and procedures for calculating doses to individuals in areas at and beyond the SITE BOUNDARY due to radioactive effluents from Limerick Generating Station.


as2-.- 2 ,_M_.. a, - - - -   4 + m ar a.a 4 J a_4&-.J AAA@ L A J.4 h_4_Ju144.4 -,a_4d 5J. A 4.444. n -,_4 AA+__.24ama he. . _m.,_ __ _
as2-.-
l 1
2
,_M_..
a, - - - -
4
+ m ar a.a 4
J a_4&-.J AAA@
L A J.4 h_4_Ju144.4
-,a_4d 5J.
A 4.444.
n
-,_4 AA+__.24ama he.
_m.,_
1
?
?
e 1
e 1
Line 95: Line 127:
PART I RADIOLOGICAL EFFLUENT CONTROLS
PART I RADIOLOGICAL EFFLUENT CONTROLS


l                                                             ODCM Rev. 17 Page 1 l                                                                     11/95 1.0 DEFINITIONS The following terms are taken from LGS Unit 1, Unit 2 Tech Specs.
l ODCM Rev. 17 Page 1 l
1.1     ACTION ACTION shall be that part of a specification which prescribes remedial measures required under designated conditions.
11/95 1.0 DEFINITIONS The following terms are taken from LGS Unit 1, Unit 2 Tech Specs.
1.2     CHANNEL CALIBRATION A CHANNEL CALIBRATION shall be the adjustment, as necessary, of the channel output such that it responds with the necessary range and accuracy to known values of the parameter which the channel monitors. The CHANNEL CALIBRATION shall encompass the entire channel including the sensor and alarm and/or trip functions, and shall include the CHANNEL FUNCTION TEST. The CHANNEL CALIBRATION may be performed by any series of sequential, overlapping or total channel steps such that the entire channel is calibrated.
1.1 ACTION ACTION shall be that part of a specification which prescribes remedial measures required under designated conditions.
1.3     CHANNEL CHECK A CHANNEL CHECK shall be the qualitative assessment of channel behavior during operation by observation. This determination shall include, where possible, comparison of the channel indication and/or status with other indications and/or status derived from independent instrument channels measuring the same parameter.
1.2 CHANNEL CALIBRATION A CHANNEL CALIBRATION shall be the adjustment, as necessary, of the channel output such that it responds with the necessary range and accuracy to known values of the parameter which the channel monitors.
1.4     CHANNEL FUNCTIONAL TEST                                             l A CHANNEL FUNCTIONAL TEST shall be:
The CHANNEL CALIBRATION shall encompass the entire channel including the sensor and alarm and/or trip functions, and shall include the CHANNEL FUNCTION TEST.
: a.      Analog channels - the injection of a simulated signal     I into the channel as close to the sensor as practicable to verify OPERABILITY including alarm and/or trip functions and channel failure trips.
The CHANNEL CALIBRATION may be performed by any series of sequential, overlapping or total channel steps such that the entire channel is calibrated.
: b.     Bistable channels - the injection of a simulated signal into the sensor to verify OPERABILITY including alarm and/or trip functions.
1.3 CHANNEL CHECK A CHANNEL CHECK shall be the qualitative assessment of channel behavior during operation by observation.
This determination shall include, where possible, comparison of the channel indication and/or status with other indications and/or status derived from independent instrument channels measuring the same parameter.
1.4 CHANNEL FUNCTIONAL TEST A CHANNEL FUNCTIONAL TEST shall be:
Analog channels - the injection of a simulated signal a.
into the channel as close to the sensor as practicable to verify OPERABILITY including alarm and/or trip functions and channel failure trips.
b.
Bistable channels - the injection of a simulated signal into the sensor to verify OPERABILITY including alarm and/or trip functions.
The CHANNEL FUNCTIONAL TEST may be performed by any series of sequential, overlapping or total channel steps such that the entire channel is tested.
The CHANNEL FUNCTIONAL TEST may be performed by any series of sequential, overlapping or total channel steps such that the entire channel is tested.
l l


l                                                           ODCM Rev. 17 Page 2 l                                                                   11/95 1.5 CONTINUOUS SAMPLING Per ASTM Standard (1987) Section II (Water and Environmental Technology), Volume 11.03, Article D1356; is defined as" sampling without interruptions throughout an operation or for a predetermined time." A CONTINUOUS SAMPLE is the opposite of a GRAB SAMPLE. The time period involved to secure (shut-down) ventilation or re-establish sampling of the release pathway shall meet the intent of CONTINUOUS SAMPLING.
l ODCM Rev. 17 Page 2 l
Consistent with industry standards, the time allowance shall
11/95 1.5 CONTINUOUS SAMPLING Per ASTM Standard (1987) Section II (Water and Environmental Technology), Volume 11.03, Article D1356; is defined as" sampling without interruptions throughout an operation or for a predetermined time."
,        not exceed 8 hours.
A CONTINUOUS SAMPLE is the opposite of a GRAB SAMPLE.
1.6 DOSE EOUIVALENT I-131 DOSE EQUIVALENT I-131 shall be that concentration of I-131, microcuries per gram, which alone would produce the same thyroid dose as the quantity and isotopic mixture of I-131, I-132, I-133, I-134 and I-135 actually present. The thyroid dose conversion factors used for this calculation shall be those listed in Table III of TID-14844, " Calculation of Distance Factors for Power and Test Reactor Sites."
The time period involved to secure (shut-down) ventilation or re-establish sampling of the release pathway shall meet the intent of CONTINUOUS SAMPLING.
1.7 FREOUENCY NOTATION The FREQUENCY NOTATION specified for the performance of Surveillance Requirements shall correspond to the intervals defined in Table II.1.
Consistent with industry standards, the time allowance shall not exceed 8 hours.
1.8 MEMBER (S) OF THE PUBLIC MEMBER (S) OF THE PUBLIC shall include all persons who are not occupationally associated with the plant. This category does not include employees of the utility, its contractors, or vendors. Also excluded from this category are persons who enter the site to service equipment or to make deliveries.
1.6 DOSE EOUIVALENT I-131 DOSE EQUIVALENT I-131 shall be that concentration of I-131, microcuries per gram, which alone would produce the same thyroid dose as the quantity and isotopic mixture of I-131, I-132, I-133, I-134 and I-135 actually present.
The thyroid dose conversion factors used for this calculation shall be those listed in Table III of TID-14844, " Calculation of Distance Factors for Power and Test Reactor Sites."
1.7 FREOUENCY NOTATION The FREQUENCY NOTATION specified for the performance of Surveillance Requirements shall correspond to the intervals defined in Table II.1.
1.8 MEMBER (S) OF THE PUBLIC MEMBER (S) OF THE PUBLIC shall include all persons who are not occupationally associated with the plant.
This category does not include employees of the utility, its contractors, or vendors.
Also excluded from this category are persons who enter the site to service equipment or to make deliveries.
This category does include persons who use portions of the site for recreational, occupational or other purposes not associated with the plant.
This category does include persons who use portions of the site for recreational, occupational or other purposes not associated with the plant.
1.9 OFFSITE DOSE CALCULATION MANUAL The OFFSITE DOSE CALCULATION MANUAL (ODCM) shall contain the methodology and parameters used in the calculation of offsite doses resulting from radioactive gaseous and liquid effluents, in the calculation of gaseous and liquid effluent monitoring Alarm / Trip Setpoints, and in the conduct of the Radiological Environmental Monitoring Program. The ODCM shall also contain (1) the Radioactive Effluents Controls and Radiological Environmental Monitoring Programs required by Technical Specification 6.8.4 and (2) descriptions of the
1.9 OFFSITE DOSE CALCULATION MANUAL The OFFSITE DOSE CALCULATION MANUAL (ODCM) shall contain the methodology and parameters used in the calculation of offsite doses resulting from radioactive gaseous and liquid effluents, in the calculation of gaseous and liquid effluent monitoring Alarm / Trip Setpoints, and in the conduct of the Radiological Environmental Monitoring Program.
The ODCM shall also contain (1) the Radioactive Effluents Controls and Radiological Environmental Monitoring Programs required by Technical Specification 6.8.4 and (2) descriptions of the


l                                                           ODCM Rev. 17 Pcge 3 l                                                                 11/95 information that should be included in the Annual Radiological Environmental Operating and Annual Radiological Effluent Release Reports required by Technical Specifications 6.9.1.7 and 6.9.1.8.   (3) description of meteorological monitoring controls.
l ODCM Rev. 17 Pcge 3 l
1.10 OPERABLE - OPERABILITY A system, subsystem, train, component or device shall be OPERABLE or have OPERABILITY when it is capable of performing its specified functions (s) and when all necessary attendant 4
11/95 information that should be included in the Annual Radiological Environmental Operating and Annual Radiological Effluent Release Reports required by Technical Specifications 6.9.1.7 and 6.9.1.8.
instrumentation, controls, electrical power, cooling or seal water, lubrication or other auxiliary equipment that are         i required for the system, subsystem, train, component or device to perform its function (s) are also capable of performing their related support function (s).
(3) description of meteorological monitoring controls.
1.11 QPERATIONAL CONDITION - CONDITION An OPERATIONAL CONDITION, i.e., CONDITION, shall be any one inclusive combination of mode switch position and average reactor coolant temperature as defined in the Technical Specifications.             ,
1.10 OPERABLE - OPERABILITY A system, subsystem, train, component or device shall be OPERABLE or have OPERABILITY when it is capable of performing its specified functions (s) and when all necessary attendant instrumentation, controls, electrical power, cooling or seal 4
1.12 PURGE - PURGING PURGE or PURGING shall be the controlled process of discharging air or gas from a confinement to maintain temperature,       ,
water, lubrication or other auxiliary equipment that are i
pressure, humidity, concentration or other operating condition, in such a manner that replacement air or gas is required to     ;
required for the system, subsystem, train, component or device to perform its function (s) are also capable of performing their related support function (s).
purify the confinement.                                         !
1.11 QPERATIONAL CONDITION - CONDITION An OPERATIONAL CONDITION, i.e.,
1.13 RATED THERMAL POWER                                             I I
CONDITION, shall be any one inclusive combination of mode switch position and average reactor coolant temperature as defined in the Technical Specifications.
See current LGS Tech Spec definition.                           l 1.14 REPORTABLE EVENT A REPORTABLE EVENT shall be any of those conditions specified in Section 50.73 of 10 CFR Part 50.
1.12 PURGE - PURGING PURGE or PURGING shall be the controlled process of discharging air or gas from a confinement to maintain temperature, pressure, humidity, concentration or other operating condition, in such a manner that replacement air or gas is required to purify the confinement.
1.15 SITE BOUNDARY The SITE BOUNDARY shall be that line as defined in Figure I2.2-la.
1.13 RATED THERMAL POWER I
I
I See current LGS Tech Spec definition.
1.14 REPORTABLE EVENT A REPORTABLE EVENT shall be any of those conditions specified in Section 50.73 of 10 CFR Part 50.
1.15 SITE BOUNDARY The SITE BOUNDARY shall be that line as defined in Figure I2.2-la.


l                                                           ODCM Rev*. 17 Page 4 l                                                                   11/95 1.16 SOURCE CHECK A SOURCE CHECK'shall be the qualitative assessment of channel response when the channel sensor is exposed to a radioactive source.
l ODCM Rev*. 17 Page 4 l
l 1.17 THERMAL POWER THERMAL POWER shall be the total reactor core heat transfer rate to the reactor coolant.
11/95 1.16 SOURCE CHECK A SOURCE CHECK'shall be the qualitative assessment of channel response when the channel sensor is exposed to a radioactive source.
1.18 UNRESTRICTED AREA An UNRESTRICTED AREA shall be any area at or beyond the SITE BOUNDARY access to which is not controlled by the licensee for     y purposes of protection of individuals from exposure to radiation and radioactive materials, or any are within the SITE BOUNDARY used for residential quarters or for industrial, commercial, institutional, and/or recreational purposes.
1.17 THERMAL POWER THERMAL POWER shall be the total reactor core heat transfer rate to the reactor coolant.
i 1.19 VENTILATION EXHAUST TREATMENT SYSTEM                               '
1.18 UNRESTRICTED AREA An UNRESTRICTED AREA shall be any area at or beyond the SITE BOUNDARY access to which is not controlled by the licensee for y
A VENTILATION EXHAUST TREATMENT SYSTEM shall be any system designed and installed to reduce gaseous radiciodine or             ,
purposes of protection of individuals from exposure to radiation and radioactive materials, or any are within the SITE BOUNDARY used for residential quarters or for industrial, commercial, institutional, and/or recreational purposes.
radioactive material in particulate form in effluents by           i passing ventilation or vent exhaust gases through charcoal absorbers and/or HEPA filters for the purpose of removing iodines or particulates from the gaseous exhaust stream prior to the release to the environment (such a system is not considered to have any effect on noble gas effluents).
i 1.19 VENTILATION EXHAUST TREATMENT SYSTEM A VENTILATION EXHAUST TREATMENT SYSTEM shall be any system designed and installed to reduce gaseous radiciodine or radioactive material in particulate form in effluents by i
passing ventilation or vent exhaust gases through charcoal absorbers and/or HEPA filters for the purpose of removing iodines or particulates from the gaseous exhaust stream prior to the release to the environment (such a system is not considered to have any effect on noble gas effluents).
Engineered Safety Feature (ESP) atmospheric cleanup systems are not considered to be VENTILATION EXHAUST TREATMENT SYSTEM components.
Engineered Safety Feature (ESP) atmospheric cleanup systems are not considered to be VENTILATION EXHAUST TREATMENT SYSTEM components.
1.20 VENTING VENTING shall be the controlled process of discharging air or gas from a confinement to maintain temperature, pressure, humidity, concentration or other operating condition, in such a manner that replacement air or gas is not provided or required during VENTING. Vent, used in system names, does not imply a VENTING process.
1.20 VENTING VENTING shall be the controlled process of discharging air or gas from a confinement to maintain temperature, pressure, humidity, concentration or other operating condition, in such a manner that replacement air or gas is not provided or required during VENTING.
Vent, used in system names, does not imply a VENTING process.


l                                                       ODCM Rev. 17 Page 5 l                                                               11/95 i
l ODCM Rev. 17 Page 5 l
TABLE II.1                               l SURVEILLANCE FREOUENCY NOTATION                     '
11/95 i
NOTATION             FREOUENCY                                       l J
TABLE II.1 l
S (Shift)         At least once per 12 hours.
SURVEILLANCE FREOUENCY NOTATION NOTATION FREOUENCY l
D (Daily)         At least once per 24 hours.               -
J S (Shift)
W (Weekly)         At least once per 7 days.                       l M (Monthly)       At least once per 31 days.
At least once per 12 hours.
Q (Quarterly)     At least once per 92 days.                       ;
D (Daily)
SA (Semi-annual)   At least once per 184 days.
At least once per 24 hours.
A (Annual)         At least once per'366 days.
W (Weekly)
E                 At least once per 18 months (550 days).
At least once per 7 days.
R                 At least once per 24 months (731 days).
M (Monthly)
S/U               Prior to each reactor startup.                 ;
At least once per 31 days.
1 P                 Prior to each radioactive release.
Q (Quarterly)
N.A.               Not applicable.
At least once per 92 days.
SA (Semi-annual)
At least once per 184 days.
A (Annual)
At least once per'366 days.
E At least once per 18 months (550 days).
R At least once per 24 months (731 days).
S/U Prior to each reactor startup.
1 P
Prior to each radioactive release.
N.A.
Not applicable.


l                                                         ODCM Rav. 17 Page 6 l                                                                 11/95 2.0 BASIS FOR EFFLUENT MONITORING CONTROLS l
l ODCM Rav. 17 Page 6 l
2.1 METEOROLOGICAL INSTRUMENTATION The OPERABILITY of the meteorological monitoring instrumentation ensures that sufficient meteorological data is available for estimating potential radiation doses to the public as a result of routine or accidental release of radioactive materials to the atmosphere. This capability is required to evaluate the need for initiating measures to protect the health and safety of the public. This instrumentation is consistent with the recommendations of Regulatory Guide 1.23 "Onsite Meteorological Programs,"
11/95 2.0 BASIS FOR EFFLUENT MONITORING CONTROLS l
2.1 METEOROLOGICAL INSTRUMENTATION The OPERABILITY of the meteorological monitoring instrumentation ensures that sufficient meteorological data is available for estimating potential radiation doses to the public as a result of routine or accidental release of radioactive materials to the atmosphere.
This capability is required to evaluate the need for initiating measures to protect the health and safety of the public.
This instrumentation is consistent with the recommendations of Regulatory Guide 1.23 "Onsite Meteorological Programs,"
February, 1972.
February, 1972.
Site data compiled since January 1972 provide correlation between Elevation 1 (Tower 1) and Elevation 1 (Tower 2), and between Elevation 2 (Tower 1) and Elevation 2 (Tower 2). This correlation serves as justification for the use of the appropriate Tower 2 instrument as a back-up to the Tower 1 l       instrument as shown in Table I3.1-1 and Table I3.1-3.
Site data compiled since January 1972 provide correlation between Elevation 1 (Tower 1) and Elevation 1 (Tower 2), and between Elevation 2 (Tower 1) and Elevation 2 (Tower 2).
This correlation serves as justification for the use of the appropriate Tower 2 instrument as a back-up to the Tower 1 l
instrument as shown in Table I3.1-1 and Table I3.1-3.
2.2 MAPS DEFINING UNRESTRICTED AREAS AND SITE BOUNDARY FOR RADIOACTIVE GASEOUS AND LIOUID EFFLUENTS Information regarding radioactive gaseous and liquid effluents, which will allow identification of structures and release points as well as definition of UNRESTRICTED AREAS within the SITE BOUNDARY that are accessible to MEMBER (S) OF THE PUBLIC, shall be shown in Technical Specifications Figures 5.1.3-la and 5.1.3-1b.
2.2 MAPS DEFINING UNRESTRICTED AREAS AND SITE BOUNDARY FOR RADIOACTIVE GASEOUS AND LIOUID EFFLUENTS Information regarding radioactive gaseous and liquid effluents, which will allow identification of structures and release points as well as definition of UNRESTRICTED AREAS within the SITE BOUNDARY that are accessible to MEMBER (S) OF THE PUBLIC, shall be shown in Technical Specifications Figures 5.1.3-la and 5.1.3-1b.
The exclusion area and low population zone shall be as shown in Figures I2.2-la and I2.2-1b.
The exclusion area and low population zone shall be as shown in Figures I2.2-la and I2.2-1b.
2.3 RADIOACTIVE LIOUID EFFLUENT MONITORING INSTRUMENTATION The radioactive liquid effluent instrumentation is provided to monitor and control, as applicable, the releases of radioactive materials in liquid effluents during actual or potential releases of liquid effluents. The alarm / trip setpoints for these instruments shall be calculated in accordance with the procedures in the ODCM part II to ensure that the alarm / trip will occur prior to exceeding the limits of 10 CFR Part 20.
2.3 RADIOACTIVE LIOUID EFFLUENT MONITORING INSTRUMENTATION The radioactive liquid effluent instrumentation is provided to monitor and control, as applicable, the releases of radioactive materials in liquid effluents during actual or potential releases of liquid effluents.
The alarm / trip setpoints for these instruments shall be calculated in accordance with the procedures in the ODCM part II to ensure that the alarm / trip will occur prior to exceeding the limits of 10 CFR Part 20.
The OPERABILITY and use of this instrumentation is consistent with the requirements of General Design Criteria 60, 63, and 64 of Appendix A to 10 CFR Part 50.
The OPERABILITY and use of this instrumentation is consistent with the requirements of General Design Criteria 60, 63, and 64 of Appendix A to 10 CFR Part 50.


l l                                                                                                                                                        ODCM Rev. 17                 )
l ODCM Rev. 17
Page 7   l l
)
11/95 l l
l Page 7 l
I FIGURE I2.2-la EXCLUSION ZONE
11/95 I
    %, fyLl7;'/t'*
FIGURE I2.2-la EXCLUSION ZONE
~~~ P',,s= r..~e-S,q
%, fyLl7;'/t'*
* L =*s * ^-'"
* L =*s * ^-'"
* e.                         ...        ~~~ P',,s= r. .~e- S ,q                                  , '
* e.
5 g.g*W'_",-                                                                               r%.;-w.h-                                   - -.h'fr-A eh[j- -
g.g*W'_",-
                                                                                                . s                                                          .                      ;
r%.;-w.h- - -.h'fr-5 h
                                                                                                  ,6 ..             ..__  + :.- .
s A e [j- -
                                                                                              -{
,6..
                  . - .                                          a.                                                >l                             . - -            .
+ :.-
                                                                                                                -9. f (;L
>l a.
    '[f-           i<     U-_         -L_                                             -i'           .--                                    . -t :.'            =i--                j
-{
    ~ e-
-9. f (;L
    >          'y                      -Q.,       % g.g
. -t :.'
                                                ' 3,.
=i--
                                                                                                                          ' ' 2 -9 , ~z--.%        -
j
                                                                                                                                                          ~ . . -
'[f-i < U-_ -L_
s anusion
-i'
                                                                                  .J.!Lusou; DAW
-Q., g.g
_5;'$ L, r; N'g) y'1 j,                                                                                                                                         ''(' . ,.
' ' 2, ~z-- -
                                                                                                                                                                        'f mem.as Wz1)',v'f,[.}r.sy*u '* *                                      /
-9
j                                                                                      %
~.. -
u3                nu                      s                      a     :                                                                  lr,               I h /(j.," 6
~ e-
                                          /                                                              f
_5;'$ r; N'g) y'1
                                                                                                                                                                        =
'y
        ~~ \ r &;>:7
' 3,.
                        '                      %$\{"~\ -         '          ~
.J.!Lusou; DAW anusion L,
x -
s
                                                                                                                    . % =. ? c e nw.>s,
''('.,.
                                                                                                                - m ph#                               m=
'f
l
/
                                                                                                                                        =    sins          =amn                        ;
j, j
                        ./
sWz mem.as 1)',v'f,[.}r.sy*u I
gy.g . . } \% t;.y s w'>,,
a lr, u3 nu h /(j.," 6
e s t..pe . 4 w n.
%$\\{"~\\x -
Y'k
/
                                                                                                                                                                            ^
f
                                                                          % ,, (l                               hs                          J 3                                                              _.
. % =. ? c e n
                                                                                                  -Q               w cj,6
=
                                    ~         .        2.+                                                                       r TL % ), u ge;;fy                                          fn g :~..,,-a.
~~ \\ r &;>:7
x c                      T' *Q; .. wo.a.m2
- m ph# m=
                                                                          .*-T                         f,'. n..:
w.>s,
a@45 y.?
~
dno r        !
gy.g.. } \\% t;.y s w e s t. e. 4
ji                                  -
./
= sins =amn
'>,,.p w n.
Y'k 3
%,, (l
- Q w cj,6 J
^
hs
~
2.+
r TL % ), u fn g :~..,,-a.
a@45 T' *Q; ge;;fy dno r
x c
.. wo.a.m2
.*-T f,'. n..:
y.?
j i
').
.. u,
. ~_
J''%
J''%
                                                                                                                      . . u,
k
                                                                                                                                              . ~_  '
/,.;<I
k                                                           -
.r x
l
,..g? ' t-r
        ,                                        / ,.;<I ').         r x
',p
r
% L. ! e: 1,ti! w' u.
                                                                                                                                            .r                                  .
1 r
1 1                .      .                  , ..g? ' t-                     ',p                                       . . ..
J
J                                                                                                                                          !
'y\\ )b \\.-.* \\, r 3
n-
n-1
                    ';                              3                                    -                          % L. o ! e: 1,ti! w' u. .      -                -
\\ a;-
        -                        i M'
.e+ff n o
1
i M'
                                                        'y\ )b           \ a;-\.- .* \, .e+ff                 r                  n y          '-              :-
Wr,a:
Wr,a: :
x:3 )%
                      <~2 a .x:3 )% 'xN'q%                                                                            it;
'xN'q i t ;
        '"'~                    '
y
                                              . %>b            '9         .- ]%,,
' 9 ]%
* Q.'pX* ,. '_[ ;"'in s                                      .y    .
* Q.'pX*,. '_[ ;"'in
qx                  ys                  :-            s
<~2 a.
                                                                                                                                                      .. W I             ,
. %>b
                                                                                                \
'"'~
                                                              ,r m .                                          <>
.. W I s
l A % g % a 8 E O L $S
.y qx ys s
                                  ~
\\
: g.                           ,
l A % g % a 8 E O L $,( w b
                                                                                                                                                                    ,( w b
~
,r m.
g.
S


l                                                                 ODCM Rev. 17 Page 8 l                                                                         11/95 FIGURE I2.2-1b LOW POPULATION ZONE
l ODCM Rev. 17 Page 8 l
                                        %. 462V""WY Q                           ,
11/95 FIGURE I2.2-1b LOW POPULATION ZONE
j ,
%. 462V""WY Q i
i W             1 y                 l
j 1
              >            Y          /[I         e                 }
W
cv       w
..y Y
                        .        ~     -
/[I
wg       xy       (     -
}
                                                            <s s     -
e
-,cv w
~
wg xy
(
<s y e&l' s
c
c
      ,    'O jn-Q  y e&l' Z
?f f E ' 3 l 4 k[ f 5-k
    ?f f E ' 3 l 4 k['ky:ll                         f 5-k        .,2 h
'ky:ll
.,2 jn-Z Q
'O h


l                                                             ODCM Rev. 17 Page 9 l                                                                   11/95 2.3.1 CONCENTRATION This control is provided to ensure that the concentration of radioactive materials released in liquid waste effluents to UNRESTRICTED AREAS will be less than the concentration levels specified in 10 CFR Part 20, Appendix B, Table II, Column 2.
l ODCM Rev. 17 Page 9 l
This limitation provides additional assurance that the levels of radioactive materials in bodies of water in UNRESTRICTED AREAS will result in exposures within (1) the Section II.A design objectives of Appendix I, 10 CFR Part 50, to a MEMBER OF THE PUBLIC, and (2) the limits of 10 CFR 20.1301(e) to the population. The concentration limits for dissolved or entrained noble gases are based upon the assumption that Xe-135 is the controlling radioisotope and its MPC in air was converted to an equivalent concentration in water using the methods described in the International Commission on Radiological Protection (ICRP) Publication 2.
11/95 2.3.1 CONCENTRATION This control is provided to ensure that the concentration of radioactive materials released in liquid waste effluents to UNRESTRICTED AREAS will be less than the concentration levels specified in 10 CFR Part 20, Appendix B, Table II, Column 2.
The required detection capabilities for radioactive materials in liquid waste samples are tabulated in terms of the lower limits of detection (LLDs). Detailed discussion of the LLD, and other detection limits can be found in HASL Procedures Manual, RASL-300 (revised annually), Currie, L.A., " Limits   for Qualitative Detection and Quantitative Determination -
This limitation provides additional assurance that the levels of radioactive materials in bodies of water in UNRESTRICTED AREAS will result in exposures within (1) the Section II.A design objectives of Appendix I, 10 CFR Part 50, to a MEMBER OF THE PUBLIC, and (2) the limits of 10 CFR 20.1301(e) to the population.
The concentration limits for dissolved or entrained noble gases are based upon the assumption that Xe-135 is the controlling radioisotope and its MPC in air was converted to an equivalent concentration in water using the methods described in the International Commission on Radiological Protection (ICRP) Publication 2.
The required detection capabilities for radioactive materials in liquid waste samples are tabulated in terms of the lower limits of detection (LLDs).
Detailed discussion of the LLD, and other detection limits can be found in HASL Procedures Manual, RASL-300 (revised annually), Currie, L.A.,
" Limits for Qualitative Detection and Quantitative Determination -
Application to Radiochemistry," Anal. Chem. 40, 586-93 (1968),
Application to Radiochemistry," Anal. Chem. 40, 586-93 (1968),
and Hartwell, J.K., " Detection Limits for Radioanalvtical Countino Technicues,"     Atlantic Richfield Hanford Comoany       ;
and Hartwell, J.K.,
Reoort ARH-SA-215 (June, 1975).
" Detection Limits for Radioanalvtical Countino Technicues,"
2.3.2 DOSE i
Atlantic Richfield Hanford Comoany Reoort ARH-SA-215 (June, 1975).
This Control is provided to implement the requirements of Sections II.A, III.A, and IV.A of Appendix I, 10 CFR Part 50.
2.3.2 DOSE This Control is provided to implement the requirements of Sections II.A, III.A, and IV.A of Appendix I, 10 CFR Part 50.
The Control implements the guides set forth in Section II.A of Appendix I. The ACTION statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive material in liquid effluents will be kept "as low as reasonably achievable". Also, for fresh water sites with drinking water supplies which can be potentially affected by plant operations, there is reasonable assurance that the operation of the facility will not result in radionuclide concentrations in the finished drinking water that are in excess of the requirements of 40 CFR Part 141. The dose calculation methodology and parameters in the ODCM implement the requirements in Section III.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on models and data, such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underestimated. The equations specified in the ODCM for calculating the doses due to the actual release rates of radioactive materials in liquid effluents are consistent with the methodology provided in Regulatory Guide 1.109,
The Control implements the guides set forth in Section II.A of Appendix I.
        " Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with
The ACTION statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive material in liquid effluents will be kept "as low as reasonably achievable".
Also, for fresh water sites with drinking water supplies which can be potentially affected by plant operations, there is reasonable assurance that the operation of the facility will not result in radionuclide concentrations in the finished drinking water that are in excess of the requirements of 40 CFR Part 141.
The dose calculation methodology and parameters in the ODCM implement the requirements in Section III.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on models and data, such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underestimated.
The equations specified in the ODCM for calculating the doses due to the actual release rates of radioactive materials in liquid effluents are consistent with the methodology provided in Regulatory Guide 1.109,
" Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with


l                                                                 ODCM Rev. 17 Page 10 l'                                                                         11/95 10 CFR Part 50, Appendix   I," Revision 1, October, 1977 and Regulatory Guide 1.113, " Estimating Aquatic Dispersion of Effluents from Accidental and Routine Reactor Releases for the Purpose of Implementing Appendix     I," April, 1977.
l ODCM Rev. 17 Page 10 l'
2.3.3 LIOUID RADWASTE TREATMENT SYSTEM The requirement that the appropriate portions of this system be used when specified provides assurance that the releases of radioactive materials in liquid effluents will be kept "as low as reasonably achievable".     This specification implements the requirements of 10 CFR 50.35a, General Design Criterion 60 of Appendix A to 10 CFR Part 50 and the design objective given in Section II.D of Appendix I to 10 CFR Part 50.       The specified limits governing the use of appropriate portions of the liquid radwaste treatment system were specified as a suitable fraction of the dose design objectives set forth in Section II.A of Appendix I, 10 CFR Part 50, for liquid effluents.
11/95 10 CFR Part 50, Appendix I," Revision 1, October, 1977 and Regulatory Guide 1.113, " Estimating Aquatic Dispersion of Effluents from Accidental and Routine Reactor Releases for the Purpose of Implementing Appendix I," April, 1977.
2.4   RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION The radioactive gaseous effluent instrumentation is provided to monitor and control, as applicable, the releases of radioactive materials in' gaseous effluents during actual or potential releases of gaseous effluents.       The alarm / trip setpoints for these instruments shall be calculated in accordance with the procedures in the ODCM to ensure that the alarm / trip will occur prior to exceeding the limits of 10 CFR Part 20.       The OPERABILITY and use of this instrumentation is consistent with the requirements of General Design Criteria 60, 63, and 64 of Appendix A to 10 CFR Part 50.
2.3.3 LIOUID RADWASTE TREATMENT SYSTEM The requirement that the appropriate portions of this system be used when specified provides assurance that the releases of radioactive materials in liquid effluents will be kept "as low as reasonably achievable".
2.4.1 DOSE RATE This control is provided to ensure that the dose at any time at and beyond the SITE BOUNDARY from gaseous effluents from the site will be within the annual dose limits of 10 CFR Part 20 to UNRESTRICTED AREAS. The annual dose limits are the dose associated with the concentrations of 10 CFR Part 20, Appendix B, Table II, Column I. These limits provide reasonable assurance that radioactive material discharged in gaseous effluents will not result in the exposure of a MEMBER OF THE PUBLIC in an UNRESTRICTED AREA, either within or outside the SITE BOUNDARY, to annual average concentrations exceeding the limits specified in Appendix B, Table II of 10 CFR Part 20 (10 CFR 20.106 (b) (1) ) . For MEMBERS OF THE PUBLIC who may at times be within the SITE BOUNDARY, the occupancy factor for that MEMBER OF THE PUBLIC will usually be sufficiently low to compensate for any increase in the atmospheric diffusion factor for above that for the SITE               '
This specification implements the requirements of 10 CFR 50.35a, General Design Criterion 60 of Appendix A to 10 CFR Part 50 and the design objective given in Section II.D of Appendix I to 10 CFR Part 50.
BOUNDARY. Examples of calculations for such MEMBERS OF THE PUBLIC, with the appropriate occupancy factors, are given in the ODCM. The specified release rate limits restrict, at all       .
The specified limits governing the use of appropriate portions of the liquid radwaste treatment system were specified as a suitable fraction of the dose design objectives set forth in Section II.A of Appendix I, 10 CFR Part 50, for liquid effluents.
times, the corresponding gamma and beta dose rates above               l background to a MEMBER OF THE PUBLIC at or beyond the SITE BOUNDARY to less than or equal to 500 mrems/ year to the total i
2.4 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION The radioactive gaseous effluent instrumentation is provided to monitor and control, as applicable, the releases of radioactive materials in' gaseous effluents during actual or potential releases of gaseous effluents.
The alarm / trip setpoints for these instruments shall be calculated in accordance with the procedures in the ODCM to ensure that the alarm / trip will occur prior to exceeding the limits of 10 CFR Part 20.
The OPERABILITY and use of this instrumentation is consistent with the requirements of General Design Criteria 60, 63, and 64 of Appendix A to 10 CFR Part 50.
2.4.1 DOSE RATE This control is provided to ensure that the dose at any time at and beyond the SITE BOUNDARY from gaseous effluents from the site will be within the annual dose limits of 10 CFR Part 20 to UNRESTRICTED AREAS.
The annual dose limits are the dose associated with the concentrations of 10 CFR Part 20, Appendix B, Table II, Column I.
These limits provide reasonable assurance that radioactive material discharged in gaseous effluents will not result in the exposure of a MEMBER OF THE PUBLIC in an UNRESTRICTED AREA, either within or outside the SITE BOUNDARY, to annual average concentrations exceeding the limits specified in Appendix B, Table II of 10 CFR Part 20 (10 CFR 20.106 (b) (1) ).
For MEMBERS OF THE PUBLIC who may at times be within the SITE BOUNDARY, the occupancy factor for that MEMBER OF THE PUBLIC will usually be sufficiently low to compensate for any increase in the atmospheric diffusion factor for above that for the SITE BOUNDARY.
Examples of calculations for such MEMBERS OF THE PUBLIC, with the appropriate occupancy factors, are given in the ODCM.
The specified release rate limits restrict, at all times, the corresponding gamma and beta dose rates above background to a MEMBER OF THE PUBLIC at or beyond the SITE BOUNDARY to less than or equal to 500 mrems/ year to the total i


l                                                               ODCM Rsv. 17 l Pr.ga 11 l l
l ODCM Rsv. 17 Pr.ga 11 l
11/95 l 1
11/95 body or tc lane insr equal to 3000 mreme/ year to the skin.
body or tc lane insr       equal to 3000 mreme/ year to the skin.   !
These relei.n. rate
These relei.n. rate   'cwne also restrict, at all times, the corresponding thyrcid dove rate above background to a child via the inhalation pathway t     S 3   than or equal to                 .
'cwne also restrict, at all times, the corresponding thyrcid dove rate above background to a child via the inhalation pathway t S 3 than or equal to 1500 mrems/ year.
1500 mrems/ year.                                                   l 1
1 This Control applies to the release of radioactive materials in gaseous effluents from all reactors at the site.
This Control applies to the release of radioactive materials in gaseous effluents from all reactors at the site.
The required detection capability for radioactive materials in l
The required detection capability for radioactive materials in       l gaseous waste samples are tabulated in terms of the lower limits of detection (LLDs). Detailed discussion of the LLD,         ;
gaseous waste samples are tabulated in terms of the lower limits of detection (LLDs).
and other detection limits can be found in HASL Procedures           '
Detailed discussion of the LLD, and other detection limits can be found in HASL Procedures Manual, HASL-300 (revised annually), Currie, L.A.,
Manual, HASL-300 (revised annually), Currie, L.A., " Limits for     ;
" Limits for Qualitative Detection and Quantitative Determination -
Qualitative Detection and Quantitative Determination -               i Application to Radiochemistry," Anal. Chem. 40, 586-93 (1986)       '
i Application to Radiochemistry," Anal. Chem. 40, 586-93 (1986) and Hartwell, J.K.,
and Hartwell, J.K., " Detection Limits for Radioanalvtical Countina Technicues."     Atlantic Richfield Hanford Comoany         ,
" Detection Limits for Radioanalvtical Countina Technicues."
ReDort ARH-SA-215 (June 1975).                                       l I
Atlantic Richfield Hanford Comoany ReDort ARH-SA-215 (June 1975).
2.4.2 DOSE - NOBLE GASES This control is provided to implement the requirements of Sections II.B, III.A, and IV.A of Appendix I,     10 CFR Part 50.
2.4.2 DOSE - NOBLE GASES This control is provided to implement the requirements of Sections II.B, III.A, and IV.A of Appendix I, 10 CFR Part 50.
The control implements the guides set forth in Section II.B of
The control implements the guides set forth in Section II.B of
        . Appendix I. The ACTION statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive material in gaseous effluents will be kept "as low as reasonably achievable". The Surveillance Requirements implement the requirements in Section III.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on appropriate pathways in unlikely to be substantially underestimated. The dose calculation established in the ODCM for calculating the doses due to the actual release rates of radioactive noble gases in gaseous effluents are consistent with the methodology provided in Regulatory Guide 1.109, " Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I,"
. Appendix I.
Revision I,   October 1977 and Regulatory Guide 1.111, " Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routing Releases from Light-Water Cooled Reactors," Revision 1, July 1977 with site specific dispersion curves and deposition methodology. The ODCM equations provided for determining the air doses at an beyond the SITE BOUNDARY are based upon the historical average atmospheric conditions.
The ACTION statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive material in gaseous effluents will be kept "as low as reasonably achievable".
The Surveillance Requirements implement the requirements in Section III.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on appropriate pathways in unlikely to be substantially underestimated.
The dose calculation established in the ODCM for calculating the doses due to the actual release rates of radioactive noble gases in gaseous effluents are consistent with the methodology provided in Regulatory Guide 1.109, " Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I,"
Revision I, October 1977 and Regulatory Guide 1.111, " Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routing Releases from Light-Water Cooled Reactors," Revision 1, July 1977 with site specific dispersion curves and deposition methodology.
The ODCM equations provided for determining the air doses at an beyond the SITE BOUNDARY are based upon the historical average atmospheric conditions.


l l                                                            ODCM Rav. 17 I Page 12 l                                                                   11/95 2.4.3 DOSE - IODINE-131, IODINE-133. TRITIUM, AND RADIONUCLIDES IE PARTICULATE FORM This control is provided to implement the requirements of         i Sections II.C, III.A, and IV.A of Appendix I, 10 CFR Part 50.
l ODCM Rav. 17 Page 12 l
The controls are the guides set forth in Section II.C of Appendix I. The ACTION statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive materials in gaseous effluents will be kept "as low as is reasonably achievable." The ODCM calculational methods specified in the Surveillance Requirements implement the requirements in Section III.A of Appendix I be shown by calculational procedures based on models and data, such that the actual exposure of a MEMBER OF THE         l PUBLIC through appropriate pathways is unlikely to be               '
11/95 2.4.3 DOSE - IODINE-131, IODINE-133. TRITIUM, AND RADIONUCLIDES IE PARTICULATE FORM This control is provided to implement the requirements of Sections II.C, III.A, and IV.A of Appendix I, 10 CFR Part 50.
substantially underestimated. The ODCM calculational methods for calculating the doses due to the actual release rates of the subject materials are consistent with the methodology provided in Regulatory Guide 1.109, Calculation of Annual Doses   ,
The controls are the guides set forth in Section II.C of Appendix I.
to Man from Routine Releases of Reactor Effluents for the         I Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix     l I," Revision I, October 1977 and Regulatory Guide 1.111,
The ACTION statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive materials in gaseous effluents will be kept "as low as is reasonably achievable."
          " Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water-Cooled Reactors," Revision 1, July 1977 with site specific dispersion     '
The ODCM calculational methods specified in the Surveillance Requirements implement the requirements in Section III.A of Appendix I be shown by calculational procedures based on models and data, such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underestimated.
curves and deposition methodology. These equations also provide for determining the actual doses based upon the historical average atmospheric conditions. The release rate specifications for iodine-131, iodine-133, tritium, and radionuclides in particulate form with half-lives greater than 8 days are dependent on the existing radionuclides pathways to man in areas at and beyond the SITE BOUNDARY. The pathways which were examined in the development of these calculations were: (1) individual inhalation of airborne radionuclides, (2) deposition of radionuclides onto green leafy vegetation with subsequent consumption by man, (3) deposition onto grassy areas where milk animals and meat-producing animals graze with consumption of the milk and meat by man, and (4) deposition on the ground with subsequent exposure of man.
The ODCM calculational methods for calculating the doses due to the actual release rates of the subject materials are consistent with the methodology provided in Regulatory Guide 1.109, Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I," Revision I, October 1977 and Regulatory Guide 1.111,
2.4.4 VENTILATION EXHAUST TREATMENT SYSTEM The requirement that the appropriate portions of this system be used, when specified, provides reasonable assurance that the releases of radioactive materials in gaseous effluents will be kept "as low as is reasonably achievable."     This control implements the requirements of 10 CFR 50.36a, General Design Criteria 60 of Appendix A to 10 CFR Part 50, and the design objectives given in Section II.D of Appendix I to 10 CFR Part 50. The specified limits governing the use
" Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water-Cooled Reactors," Revision 1, July 1977 with site specific dispersion curves and deposition methodology.
These equations also provide for determining the actual doses based upon the historical average atmospheric conditions.
The release rate specifications for iodine-131, iodine-133, tritium, and radionuclides in particulate form with half-lives greater than 8 days are dependent on the existing radionuclides pathways to man in areas at and beyond the SITE BOUNDARY.
The pathways which were examined in the development of these calculations were: (1) individual inhalation of airborne radionuclides, (2) deposition of radionuclides onto green leafy vegetation with subsequent consumption by man, (3) deposition onto grassy areas where milk animals and meat-producing animals graze with consumption of the milk and meat by man, and (4) deposition on the ground with subsequent exposure of man.
2.4.4 VENTILATION EXHAUST TREATMENT SYSTEM The requirement that the appropriate portions of this system be used, when specified, provides reasonable assurance that the releases of radioactive materials in gaseous effluents will be kept "as low as is reasonably achievable."
This control implements the requirements of 10 CFR 50.36a, General Design Criteria 60 of Appendix A to 10 CFR Part 50, and the design objectives given in Section II.D of Appendix I to 10 CFR Part 50.
The specified limits governing the use


1 l                                                                   ODCM Rev. 17 Fage 13 l                                                                           11/95 of appropriate portions of the systems were specified as a suitable fraction of the dose design objectives set forth in             i Section II.B and II.C of Appendix I, 10 CFR Part 50, for gaseous effluents.
1 l
2.4.5   VENTING OR PURGING i
ODCM Rev. 17 Fage 13 l
This control provides reasonable assurance that releases from             I drywell purging operations will not exceed the annual dose i
11/95 of appropriate portions of the systems were specified as a suitable fraction of the dose design objectives set forth in i
limits of 10 CFR Part 20 for UNRESTRICTED AREAS.                         l, 2.4.6 TOTAL DOSE i                                                                                   1 This control is provided to meet the cose limitations of 40 CFR Part 190 that have been incorporated into 10 CFR Part 20 by 46 CFR 18525.     The control requires the preparation and 4
Section II.B and II.C of Appendix I, 10 CFR Part 50, for gaseous effluents.
submittal of a Special Report whenever the calculated doses
2.4.5 VENTING OR PURGING i
                                                                                      ]
This control provides reasonable assurance that releases from drywell purging operations will not exceed the annual dose limits of 10 CFR Part 20 for UNRESTRICTED AREAS.
from plant radioactive effluents exceed twice the design                 l objective doses of Appendix I. For sites containing up to four           l reactors, it is highly unlikely that the resultant dose to a MEMBER OF THE PUBLIC will exceed the dose limits of 40 CFR 190 if the individual reacters remain within the reporting requirement level.
l 2.4.6 TOTAL DOSE i
The Special Report will describe a course of action that should result in the limitation of the annual dose to a MEMBER OF THE PUBLIC to within the 40 CFR Part 190 limits. For the purposes of the special Report, it may be assumed that the dose l
1 This control is provided to meet the cose limitations of 40 CFR Part 190 that have been incorporated into 10 CFR Part 20 by 46 CFR 18525.
commitment to the MEMBER OF THE PUBLIC from other uranium fuel cycle sources is negligible, with the exception that dose contributions from other nuclear fuel cycle facilities at the i           same site or within a radius of 5 miles must be considered.           If
The control requires the preparation and submittal of a Special Report whenever the calculated doses
{           the dose to any MEMBER OF THE PUBLIC is estimated to exceed         the   l 4
]
requirements of 40 CFR Part 190, the Special Report with a request for a variance (provided the release condition 2
4 from plant radioactive effluents exceed twice the design objective doses of Appendix I.
resulting in violation of 40 CFR Part 190 have not already been corrected), in accordance with the provisions of 40 CFR 190.11 ar.d 10 CFR 2 0 . 4 0 5 c , is considered to be a timely request and fulfills the requirements of 40 CFR Part 90 until NRC staff             '
For sites containing up to four reactors, it is highly unlikely that the resultant dose to a MEMBER OF THE PUBLIC will exceed the dose limits of 40 CFR 190 if the individual reacters remain within the reporting requirement level.
action is completed. An individual is not considered a MEMBER OF THE PUBLIC during any period in which he/she is engaged in carrying out any operation that is part of the nuclear fuel.
The Special Report will describe a course of action that should result in the limitation of the annual dose to a MEMBER OF THE PUBLIC to within the 40 CFR Part 190 limits.
For the purposes of the special Report, it may be assumed that the dose l
commitment to the MEMBER OF THE PUBLIC from other uranium fuel cycle sources is negligible, with the exception that dose contributions from other nuclear fuel cycle facilities at the i
same site or within a radius of 5 miles must be considered.
If
{
the dose to any MEMBER OF THE PUBLIC is estimated to exceed the 4
requirements of 40 CFR Part 190, the Special Report with a request for a variance (provided the release condition resulting in violation of 40 CFR Part 190 have not already been 2
corrected), in accordance with the provisions of 40 CFR 190.11 ar.d 10 CFR 2 0. 4 0 5 c, is considered to be a timely request and fulfills the requirements of 40 CFR Part 90 until NRC staff action is completed.
An individual is not considered a MEMBER OF THE PUBLIC during any period in which he/she is engaged in carrying out any operation that is part of the nuclear fuel.
cycle.
cycle.
2.5     RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM The Radiological Environmental Monitoring Program (REMP) required by this control provides representative measurements of radiation and of radioactive materials in those exposure pathways and for those radionuclides that lead to the highest potential radiation exposures of MEMBER OF THE PUBLIC resulting from the station operation.     This monitoring program implements Section IV.B.2 of Appendix I to 10 CFR Part 50 and thereby supplements the radiological effluent monitoring program by verifying that the measurable concentrations of radioactive materials and levels of radiation are not higher than expected
2.5 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM The Radiological Environmental Monitoring Program (REMP) required by this control provides representative measurements of radiation and of radioactive materials in those exposure pathways and for those radionuclides that lead to the highest potential radiation exposures of MEMBER OF THE PUBLIC resulting from the station operation.
This monitoring program implements Section IV.B.2 of Appendix I to 10 CFR Part 50 and thereby supplements the radiological effluent monitoring program by verifying that the measurable concentrations of radioactive materials and levels of radiation are not higher than expected


l l                                                                     ODCM Rev. 17 .
l l
Page 14 l l
ODCM Rev. 17 l
11/95 )
Page 14 11/95
on the basis of the effluent measurements and modeling of the               '
)
environmental exposure pathways.
on the basis of the effluent measurements and modeling of the environmental exposure pathways.
The required detection capabilities for environmental sample analyses are tabulated in terms of the lower limits of detection (LLDs). The LLDs required by Table I3.4-3 are                     ,
The required detection capabilities for environmental sample analyses are tabulated in terms of the lower limits of detection (LLDs).
considered optimum for routine environmental measurements in industrial laboratories. It should be recognized that the LLD is defined as'an a oriori (before the fact) limit representing the capability of a measurement system and not an after the fact limit for a particular measurement.
The LLDs required by Table I3.4-3 are considered optimum for routine environmental measurements in industrial laboratories.
Detailed discussion of the LLD, and other detection limits, can be found in HASL Procedures Manual, HASL-300 (revised                       '
It should be recognized that the LLD is defined as'an a oriori (before the fact) limit representing the capability of a measurement system and not an after the fact limit for a particular measurement.
annually); Currie L.A.,           " Limits for Qualitative Detection and Quantitative   Determination Anal. Chein . 40,
Detailed discussion of the LLD, and other detection limits, can be found in HASL Procedures Manual, HASL-300 (revised annually); Currie L.A.,
                                            - Application to Radiochemistry,"
" Limits for Qualitative Detection and Quantitative Determination - Application to Radiochemistry,"
586-93 (1968)     and Hartwell, J.K., " Detection Limits for Radioanalvtical Countina Technicues," Atlantic Richfield Hanford Comoany Reoort ARH-SA-215 (June. 1975) 2.5.1 LAND USE CENSUS                                                             '
Anal. Chein. 40, 586-93 (1968) and Hartwell, J.K.,
This control is provided to ensure that changes in the use of               l areas at and beyond the SITE BOUNDARY are identified and that modifications to the monitoring program are made if required by the results of the census. The best information from the door-to-door survey, aerial survey or consulting with local                       I agricultural authorities or any combination of these methods                 i shall be used. This census satisfies the requirements of Section IV.B.3 of Appendix I to 10 CFR Part 50.             Restricting the census to gardens of greater than 500 square feet provides assurance that significant exposure pathways via leafy vegetables will be identified and monitored since a garden of this size is the minimum required to produce the quantity (26 Kg/ year) of leafy vegetables assumed in Regulatory Guide 1.109 for consumption by a child. To determine this minimum garden                 )
" Detection Limits for Radioanalvtical Countina Technicues,"
size, the following assumptions were used: (1) that 20% of the               '
Atlantic Richfield Hanford Comoany Reoort ARH-SA-215 (June. 1975) 2.5.1 LAND USE CENSUS This control is provided to ensure that changes in the use of l
garden was used for growing broad leafy vegetation (i.e.
areas at and beyond the SITE BOUNDARY are identified and that modifications to the monitoring program are made if required by the results of the census.
The best information from the door-to-door survey, aerial survey or consulting with local agricultural authorities or any combination of these methods i
shall be used.
This census satisfies the requirements of Section IV.B.3 of Appendix I to 10 CFR Part 50.
Restricting the census to gardens of greater than 500 square feet provides assurance that significant exposure pathways via leafy vegetables will be identified and monitored since a garden of this size is the minimum required to produce the quantity (26 Kg/ year) of leafy vegetables assumed in Regulatory Guide 1.109 for consumption by a child.
To determine this minimum garden size, the following assumptions were used: (1) that 20% of the garden was used for growing broad leafy vegetation (i.e.
similar to lettuce and cabbage), and (2) a vegetation yield of 2 kg/ Square meter.
similar to lettuce and cabbage), and (2) a vegetation yield of 2 kg/ Square meter.
2.5.2 INTERLABORATORY COMPARISON PROGRAM The requirement for participation in an Interlaboratory Comparison Program ensures that independent checks on the precision and accuracy of the measurements of radioactive material in environmental sample matrices are performed as part of the quality assurance program for environmental monitoring in order to demonstrate that the results are reasonably valid for the purpose of Section IV.B.2 of Appendix I to 10 CFR Part 50.
2.5.2 INTERLABORATORY COMPARISON PROGRAM The requirement for participation in an Interlaboratory Comparison Program ensures that independent checks on the precision and accuracy of the measurements of radioactive material in environmental sample matrices are performed as part of the quality assurance program for environmental monitoring in order to demonstrate that the results are reasonably valid for the purpose of Section IV.B.2 of Appendix I to 10 CFR Part 50.
2.6   APPLICABILITY #
2.6 APPLICABILITY #
2.6.1 Compliance with the controls contained in the succeeding controls section is required during the OPERATIONAL CONDITIONS
2.6.1 Compliance with the controls contained in the succeeding controls section is required during the OPERATIONAL CONDITIONS


l l                                                               ODCM Rev. 17 Page 15 l                                                                     11/95 or other conditions specified therein; except that upon failure to meet the controls, the associated ACTION requirements shall be met.
l l
2.6.2   Non compliance with a control shall exist when the requirements of the control and associated ACTION requirements are not performed within the specified time intervals. If the control is restored prior to expiration of the specified time intervals, completion of the ACTION requirements is not required.
ODCM Rev. 17 Page 15 l
2.6.3   There are no actions in the ODCM which would require an operational condition change.
11/95 or other conditions specified therein; except that upon failure to meet the controls, the associated ACTION requirements shall be met.
2.6.4   There are no restrictions on changing operating conditions in any of the controls on the ODCM.
2.6.2 Non compliance with a control shall exist when the requirements of the control and associated ACTION requirements are not performed within the specified time intervals.
2.6.5   Surveillance Requirements shall be met during the OPERATIONAL CONDITIONS or other conditions specified for individual controls unless otherwise stated in an individual Surveillance Requirement.
If the control is restored prior to expiration of the specified time intervals, completion of the ACTION requirements is not required.
2.6.6   Each Surveillance Requirement shall be performed within the specified interval with a maximum allowable extension not to exceed 25% of the surveillance interval.
2.6.3 There are no actions in the ODCM which would require an operational condition change.
2.6.7   Failure to perform a Surveillance Requirement within the allowed surveillance interval defined by control 2.6.6, shall l'
2.6.4 There are no restrictions on changing operating conditions in any of the controls on the ODCM.
2.6.5 Surveillance Requirements shall be met during the OPERATIONAL CONDITIONS or other conditions specified for individual controls unless otherwise stated in an individual Surveillance Requirement.
2.6.6 Each Surveillance Requirement shall be performed within the specified interval with a maximum allowable extension not to exceed 25% of the surveillance interval.
2.6.7 Failure to perform a Surveillance Requirement within the allowed surveillance interval defined by control 2.6.6, shall l'
constitute noncompliance with the OPERABILITY requirements for l
constitute noncompliance with the OPERABILITY requirements for l
a control. The time limits of the ACTION requirements are applicable at the time it is identified that a Surveillance                   i Requirement has not been performed. The ACTION requirements may be delayed for up to 24 hours to permit the completion of the surveillance when the allowable outage time limits of the ACTION requirements are less than 24 hours. Surveillance requirements do not have to be performed on inoperable                       l equipment.                                                                   l l
a control.
i
The time limits of the ACTION requirements are applicable at the time it is identified that a Surveillance i
        #      The associated bases from the LGS Technical Specifications applies to this section.
Requirement has not been performed.
The ACTION requirements may be delayed for up to 24 hours to permit the completion of the surveillance when the allowable outage time limits of the ACTION requirements are less than 24 hours.
Surveillance requirements do not have to be performed on inoperable equipment.
l i
The associated bases from the LGS Technical Specifications applies to this section.


l l                                                           ODCM Rav. 17 Page 16 l                                                                 11/95 3.0 METEOROLOGICAL MONITORING INSTRUMENTATION 1
l l
ODCM Rav. 17 Page 16 l
11/95 3.0 METEOROLOGICAL MONITORING INSTRUMENTATION 1
CONTROLS l
CONTROLS l
l   3.1 The metecrological monitoring instrumentation channels shown in l
l 3.1 The metecrological monitoring instrumentation channels shown in l
1 Table I3.1-1 shall be OPERABLE.
Table I3.1-1 shall be OPERABLE.
APPLICABILITY: At all times.
1 APPLICABILITY: At all times.
ACTION:
ACTION:
i l
i l
With less than the minimum required instrumentation channels operable for more than 7 days, prepare and submit a Special Report to the Commission pursuant to LGS Technical Specification 6.9.2 within the next 10 days outlining the cause of the malfunction and the plans for restoring the instrumentation to OPERA 3LE status.
With less than the minimum required instrumentation channels operable for more than 7 days, prepare and submit a Special Report to the Commission pursuant to LGS Technical Specification 6.9.2 within the next 10 days outlining the cause of the malfunction and the plans for restoring the instrumentation to OPERA 3LE status.
l       SURVEILLANCE REOUIREMENTS 1
l SURVEILLANCE REOUIREMENTS 1
3.1-1   Each of the above required meteorological monitoring instrumentation channels shall be demonstrated OPERABLE by the performance of the CHANNEL CHECK and CHANNEL CALIERATION operations at the frequencies shown in Table 13.1-2.
3.1-1 Each of the above required meteorological monitoring instrumentation channels shall be demonstrated OPERABLE by the performance of the CHANNEL CHECK and CHANNEL CALIERATION operations at the frequencies shown in Table 13.1-2.
l
l


_. _._      s ___ .       _ . _ . . . _ . _ _ _ . _ . .___            . _ . . _ _ . . _ _          ..        _
s ___.
l                                                                                                     ODCM Rev. 17 Page 17 l                                                                                                             11/95 TABLE I3.1-1                                             .
l ODCM Rev. 17 Page 17 l
I METEOROLOGICAL MONITORING INSTRUMENTATION                                                   {
11/95 TABLE I3.1-1 METEOROLOGICAL MONITORING INSTRUMENTATION
MINIMUM Tower 1 Tower 2             INSTRUMENT             ;
{
INSTRUMENT                                                     (Primary)   (Backup)           OPERABLE
MINIMUM Tower 1 Tower 2 INSTRUMENT INSTRUMENT (Primary)
                                                                                                                      ]
(Backup)
: 1.         Wind Speed
OPERABLE
: a.           Elevation 1                             30 feet   159 feet               1                 l
]
: b.           Elevation 2                           175 feet   304 feet                 1
1.
: 2.         Wind Direction
Wind Speed a.
: a.           Elevation 1                             30 feet   159 feet               1
Elevation 1 30 feet 159 feet 1
: b.           Elevation 2                           175 feet   304 feet               1                 i
b.
: 3.         Air Temperature Difference (AT)
Elevation 2 175 feet 304 feet 1
: a.           Elevations                             266 feet-   300 feet-26 feet     26 feet                 1 TABLE I3.1-2 METEOROLOGICAL MONITORING INSTRUMENTATION SURVEILLANCE REOUIREMENTS Channel           Channel INSTRUMENT                                                                 Check             CALIBRATION
2.
Wind Direction a.
Elevation 1 30 feet 159 feet 1
b.
Elevation 2 175 feet 304 feet 1
i 3.
Air Temperature Difference (AT) a.
Elevations 266 feet-300 feet-26 feet 26 feet 1
TABLE I3.1-2 METEOROLOGICAL MONITORING INSTRUMENTATION SURVEILLANCE REOUIREMENTS Channel Channel INSTRUMENT Check CALIBRATION
: 1. Wind Speed
: 1. Wind Speed
: a. Elevation 1 (Tower 1 and Tower 2)                                               D           SA
: a. Elevation 1 (Tower 1 and Tower 2)
: b. Elevation 2 (Tower 1 and Tower 2)                                               D           SA l
D SA
: 2. Wind Direction                                                                                                     l
: b. Elevation 2 (Tower 1 and Tower 2)
: a. Elevation 1 (Tower 1 and Tower 2)                                               D           SA
D SA
: b. Elevation 2 (Tower 1 and Tower 2)                                               D           SA
: 2. Wind Direction
: 3. Air Temperature Difference (AT)                                                                                   !
: a. Elevation 1 (Tower 1 and Tower 2)
: a. Elevations               266 - 26 ft (Tower 1)                                 D           SA                 ,
D SA
: b. Elevations 300 - 26 ft (Tower 2)                                               D           SA NOTE:
: b. Elevation 2 (Tower 1 and Tower 2)
The meteorological towers shall be located as shown on Figure I3.1-1. For backup sources of data retrieval, refer to Table I3.1-3.
D SA
: 3. Air Temperature Difference (AT)
: a. Elevations 266 - 26 ft (Tower 1)
D SA
: b. Elevations 300 - 26 ft (Tower 2)
D SA NOTE:
The meteorological towers shall be located as shown on Figure I3.1-1.
For backup sources of data retrieval, refer to Table I3.1-3.


he l                                                                                   ODCM Rev. 17 Page 18 l                                                                                                   11/95                                                                     ,.
he l
TABLE I3.1                                                                                                           -
ODCM Rev. 17 Page 18 l
t METEOROLOGICAL TOWER DATA RETRIEVAL INSTRUMENT             TOWER 1                 TOWER 2                                         DATA LOGGER DATA                                                                   - RM-21A             Channel #
11/95 TABLE I3.1 -
Wind Speed                                                                                           1 (TWR1) l     a. Elev. 1           Strip Chart           Strip Chart                       RM-21A             14 (TWR2)                                                               ;
t METEOROLOGICAL TOWER DATA RETRIEVAL INSTRUMENT TOWER 1 TOWER 2 DATA LOGGER DATA
Wind Speed                                                                                           5 (TWR1)                                                           ,
- RM-21A Channel #
l      b. Elev. 2           Strip Chart           Strip Chart                       RM-21A             21 (TWR2)
Wind Speed 1 (TWR1) l
Wind Dir.                                                                                           0 (TWR1) l     a. Elev. 1           Strip Chart           Strip Chart                       RM-21A             13 (TWR2)
: a. Elev. 1 Strip Chart Strip Chart RM-21A 14 (TWR2)
Wind Dir.                                                                                       4 (TWR1) l     b. Elev. 2           Strip Chart           Strip Chart                       RM-21A             20 (TWR2)
Wind Speed 5 (TWR1) l
DELTA T           Multi-pt Rec         Multi-pt Rec                       RM-21A               7 (TWR1) 23 (TWR2)
: b. Elev. 2 Strip Chart Strip Chart RM-21A 21 (TWR2)
Wind Dir.
0 (TWR1) l a.
Elev. 1 Strip Chart Strip Chart RM-21A 13 (TWR2)
Wind Dir.
4 (TWR1) l
: b. Elev. 2 Strip Chart Strip Chart RM-21A 20 (TWR2)
DELTA T Multi-pt Rec Multi-pt Rec RM-21A 7 (TWR1) 23 (TWR2)
PRIMARY OPTION:
PRIMARY OPTION:
A)     .I_E DATA IS UNAVAILABLE FOR TOWER 1 THEN verify corresponding data available for Tower 2 B)     DATA IS AVAILABLE FROM RM-21, DATA LOGGER OR STRIP CHARTS. THE SOURCES OF DATA IN ORDER OF PREFERENCE ARE THE RM-21, DATA ''OGGER OR STRIP CHARTS.
A)
                                                    .                                                DATA LOGGER AND STRIP CHARTS ARE LOCATED IN THE CONTROL ROOM.
.I_E DATA IS UNAVAILABLE FOR TOWER 1 THEN verify corresponding data available for Tower 2 B)
                                - .,      e_-,           , . . = - ,   n --- ,    - - ~ , - ,       , . , , - + , ~ -, -e,.,-- -
DATA IS AVAILABLE FROM RM-21, DATA LOGGER OR STRIP CHARTS.
THE SOURCES OF DATA IN ORDER OF PREFERENCE ARE THE RM-21, DATA ''OGGER OR STRIP CHARTS.
DATA LOGGER AND STRIP CHARTS ARE LOCATED IN THE CONTROL ROOM.
e_-,
,.. = -,
n
- - ~, -,
,.,, - +, ~ -,
-e,.,--


l                                                                                                                                                                                                 ODCM Rev. 17 Page 19 l                                                                                                                                                                                                               11/95 Ficure I3.1-1 Meteorological Tower Location j
l ODCM Rev. 17 Page 19 l
                              $-d 't               I DiT.'.'.Fi' 1'N MMMTI'M'M         .
11/95 Ficure I3.1-1 Meteorological Tower Location j
                              }y k
$-d 't I DiT.'.'.Fi' 1'N MMMTI'M'M L
                                      =\\
t, \
                                                                    \\ %L!5.X!b.* W. 4 'k'. y % % W*: *-                                            '
EiiEDROLDEICAL ,2:.h ,yI l
L          .
t
t
* i. . ( _-Y =~=~:.
* i..
                                                            ,                 .       .p.-                                                       ~~
Y =~=~:. b.* W. 4 'k'. y % % W*
i a\ w\'                            %,
=\\\\
10 m                  yp,7.c                                                     . .".4    KJ                       ,
\\\\ %L!5.X!
q $ . hf$ I Mif                                  <*'/.!y .c.,                           kD y               'I .lJif.n..e
}y k t, \\
                                                                                                                                                                                        .M' 'M W n. :
,2:.h,yI
[y%p.sh           f\$               i     \
~~
                            "r
( _-
(\                 % M W !-( y' - l                                                               b~'             @9p%
.p.-
                            ]
EiiEDROLDEICAL i
gi ks                          '.          ,,
yp,7.c
. KJ
[y% a w\\q $. hf$ I <*'/.!y c., y lJif.n..e W n. :  
.".4 10 m
\\
p.sh f\\$
i
\\
Mif
. kD 'I..M' 'M
(\\
% M W !-( y' - l b~' @ 9 p %
"r
]
ks gi
* l.
* l.
                                .                      /.w. N                   i TPQMwa.Pe!PWg
/.w. N TPQMwa.Pe!PWg =4 c.$b C W__ h., !
: s. c.$b                                                                               s
                                                                                                                                                                                                        =4            ~
l CC          W__ h., !
q                v        's                s,      \      e, d 220KY
                                                                                                                                                                                    ~
l ;
l ;
                                                                            . -          1
's i
                                    . j ,j \,
s.
                                                                            )\h.SUiliAT10N.g-0 iY (yh   $ *h f. '                                         ' * '
s
l
~
                                        -    !      \k               ~ \\ \               ,,i. hN-           __                  :::s::-
\\
6               r       r +,   w,th.
e, d 220KY C
ar              o      .x               n=_-ary
q v
: w(         r.,..
s,
: 5.                     * 'g . , \                                                               !<,,
)\\h.SUiliAT10N.g-0 $ *
* IfE"" 9~ l 'm.                                   -
(yh h f. '
5j .~
1
us                                         -          -
~
                                                                                          =I=a:.VY.- . -x-                                                              w        ,1              .                  ,o:
. j,j \\,
G *s ' . L.*:l:S. .i Ms                                                             . F $ '.E _
iY
\\ k
~ \\\\ \\,,i. hN-
:::s::-
6 r
r
+, a r
.x n=_-ary
: w(
w,th.
o 5.
* 'g.
, \\ =I=a Y.-.
-x-w
,1
,o:
r.,..
IfE"" 9~ l 'm.
5j.~
us G *s '. L.*:l:S..i Ms V
. F $ '.E _
* _f-~'l,
* _f-~'l,
                                                                                                                                                                                                                      '2             I A.,. (
'2 A.,. (
                                  .                                    I 01.0G A 1                                       ,' .
I 01.0G A 1 TOI!n #2 I
_.            .
Z yf'.*:5<*. # g:.K.--
* TOI!n #2                       I                         - -         -
                                                                                                                                                                        ,M '
500KY
500KY
                                                                                                                                                                                        -: !UESTATION y,is,,''Q.
,M
                                                                                                      \
'*' y,is,,''Q.
yf l.1
f l.
                                                                                                        \
\\
                                                                                                        \_.                       Z yf' .*:5<*                          . fs.
!UESTATION y
                                                                                                                                                                                              . # g:.:: <.K.--
1
\\
\\_.
. fs.
yg[p,/, s-%Ag. g h*-==_
' l.&.*/ s \\*w/<.
V
V
                                                                                                                                                                **&                ./                       's yg[p,/, s-%Ag. g                                                            h*-==_                            ' l .&.*/ s \*w/<. <-
./
m'.                          . i.                                    .            \                                      1. i.;.Q '-@ s.Qh
's
                                                      -. .Q.                     \,.                                                             cz. e..2 r-r.
: 1. i.;.Q '-@ s.Qh (i ) f,t -
(iI,)= f,t                  -
m'.
3
. i.
                                                                                                                                                .,4.
\\
3.;              --
- Q.
                                                                                                                                                        - > c.u.
\\,.
: s. a.                                                     . . -. M.
2 cz.
r, yx-                          .-            -
3.; r-r.
                                                                                                    ~                     x..        _    .                      . .{.      . .
a.
yx-
.. -. M. = x..
.,4. c.u.
3 I,
- >.{.
e..
r,
~
s.


l l
l l
l                                                                                       ODCM Rev. 17 Page 20 l                                                                                                     11/95 ,
l ODCM Rev. 17 Page 20 l
l 3.2               RADIOACTIVE LIOUID EFFLUENT MONITORING INSTRUMENTATION CONTROLS I
11/95 3.2 RADIOACTIVE LIOUID EFFLUENT MONITORING INSTRUMENTATION CONTROLS 3.2.1 The radioactive liquid effluent monitoring instrumentation channels shown in Table I3.2-1 shall be OPERABLE with their alarm / trip setpoints set to ensure that Control I3.2.2 is not exceeded.. The alarm /setpoints* of these channels shall be determined and adjusted in accordance with the methodology and l
3.2.1             The radioactive liquid effluent monitoring instrumentation channels shown in Table I3.2-1 shall be OPERABLE with their alarm / trip setpoints set to ensure that Control I3.2.2 is not exceeded. . The alarm /setpoints* of these channels shall be determined and adjusted in accordance with the methodology and                         l parameters in the ODCM - Part II, Section 1.2.
parameters in the ODCM - Part II, Section 1.2.
APPLICABILITY: At all times.                                                                             ]
APPLICABILITY: At all times.
1 ACTION:
]
: a. With a radioactive liquid effluent monitoring instrumentation channel alarm / trip setpoint less conservative than required by the above control, immediately suspend the release of                             '
ACTION:
radioactive liquid effluents monitored by the affected channel, and declare the channel inoperable,
With a radioactive liquid effluent monitoring instrumentation a.
: b. With less than the minimum number of radioactive liquid effluent monitoring instrumentation channels OPERABLE, take the ACTION shown in Table I3.2-1. Restore the inoperable instrumentation to OPERABLE status within the time specified in the ACTION or e:tplain in the next Annual Radioactive Effluent Release Report why this inoperability was not corrected within the time specified.
channel alarm / trip setpoint less conservative than required by the above control, immediately suspend the release of radioactive liquid effluents monitored by the affected channel, and declare the channel inoperable, b.
With less than the minimum number of radioactive liquid effluent monitoring instrumentation channels OPERABLE, take the ACTION shown in Table I3.2-1.
Restore the inoperable instrumentation to OPERABLE status within the time specified in the ACTION or e:tplain in the next Annual Radioactive Effluent Release Report why this inoperability was not corrected within the time specified.
SURVEILLANCE REOUIREMENTS 3.2.1-1 Each radioactive liquid effluent monitoring instrumentation channel shall be demonstrated OPERABLE by performance of the CHANNEL CHECK, SOURCE CHECK, CHANNEL CALIBRATION and CHANNEL FUNCTIONAL TEST performance at the frequencies shown in Table I3.2-2.
SURVEILLANCE REOUIREMENTS 3.2.1-1 Each radioactive liquid effluent monitoring instrumentation channel shall be demonstrated OPERABLE by performance of the CHANNEL CHECK, SOURCE CHECK, CHANNEL CALIBRATION and CHANNEL FUNCTIONAL TEST performance at the frequencies shown in Table I3.2-2.
* Excluding the flow rate measuring devices which are not determined and adjusted in accordance with the ODCM.
* Excluding the flow rate measuring devices which are not determined and adjusted in accordance with the ODCM.


l-                                                         ODCM Rev. 17 Page 21-l                                                                 11/95 TABLE 13.2-1 RADIOACTIVE LIOUID-EFFLUENT MONITORING INSTRUMENTATION i
l-ODCM Rev. 17 Page 21-l 11/95 TABLE 13.2-1 RADIOACTIVE LIOUID-EFFLUENT MONITORING INSTRUMENTATION i
MINIMUM               i CHANNELS INSTRUMENT                           OPERABLE     ACTION
MINIMUM i
: 1. Gross Radioactivity Monitors Providing Automatic Termination of Release
CHANNELS INSTRUMENT OPERABLE ACTION 1.
: a. Liquid Radwaste Effluent Line                 1         100
Gross Radioactivity Monitors Providing Automatic Termination of Release
: b. A/B RHR' Service Water Effluent Line       1/ loop     101
: a. Liquid Radwaste Effluent Line 1
: 2. Gross Radioactivity Monitors Not Providing Automatic Termination of Release
100
: a. Service' Water Effluent Line                 1         101
: b. A/B RHR' Service Water Effluent Line 1/ loop 101 2.
: 3. Flow Rate Measurement Devices
Gross Radioactivity Monitors Not Providing Automatic Termination of Release
: a. Liquid Radwaste Effluent Line                 1         102
: a. Service' Water Effluent Line 1
: b. Discharge Line                               1         102     l l
101 3.
l l
Flow Rate Measurement Devices
: a. Liquid Radwaste Effluent Line 1
102
: b. Discharge Line 1
102 l
l


  -    -  . - . ~ .    - - - - -            .  .-.            ..            --
. -. ~
l                                                                     ODCM Rav. 17 Page 22 l                                                                               11/95 ACTION STATEMENTS                               i 1
l ODCM Rav. 17 Page 22 l
Action 100-     With less than the Minimum Required Channels operable, effluent releases may continue for up to 14 days provided that prior to initiating a release:
11/95 ACTION STATEMENTS i
: a.           At least two independent samples are analyzed in accordance with Table I3.2-3, and
1 Action 100-With less than the Minimum Required Channels operable, effluent releases may continue for up to 14 days provided that prior to initiating a release:
: b.           At least two technically qualified members of the facility staff independently verify the release       j rate calculations and discharge line valving;         i Otherwise, suspend release of radioactive effluents via this pathway.
a.
Action 101-     With less than the Minimum Required Channels operable, effluent releases via this pathway may continue for up to 30 days provided that, at least once per 8 hours, grab             )
At least two independent samples are analyzed in accordance with Table I3.2-3, and b.
samples are collected and analyzed for radioactivity by             l gamma isotopic analysis (Principal Gamma Emitters, I-131,           i and Dissolved / Entrained Gases) as a Lower Limit of               I Detection as specified in Table I3.2-3 or gross                     l radioactivity (beta and gamma). Gross Beta is analyzed             i at an LLD of at least 1N7 pCi/ml. Gross Gamma is                   !
At least two technically qualified members of the facility staff independently verify the release j
analyzed at an LLD of at least SN7 pCi/ml.                         !
rate calculations and discharge line valving; i
If the A or B RHRSW Process Rad Monitor should become               I I
Otherwise, suspend release of radioactive effluents via this pathway.
inoperable, sampling is required at least once every eight (8) hours at a sample point common with the                   ,
Action 101-With less than the Minimum Required Channels operable, effluent releases via this pathway may continue for up to 30 days provided that, at least once per 8 hours, grab samples are collected and analyzed for radioactivity by gamma isotopic analysis (Principal Gamma Emitters, I-131, i
inoperable A and/or B RHRSW Process Rad Monitor (s)                 l whether or not the respective 1C/2C and/or 1D/2D RHRSW Process Rad Monitors are operable. However, there are no additional sampling requirements when the 1C/2C and/or             j 1D/2D RHRSW Process Rad Monitors are inoperable since               i monitoring requirements are satisfied through the operable A and/or B RHRSW Process Rad Monitors or the inop sampling of those points.                                     ,
and Dissolved / Entrained Gases) as a Lower Limit of Detection as specified in Table I3.2-3 or gross radioactivity (beta and gamma).
1 If a monitor is inoperable but will still continuously sample and annunciate on high activity, i.e. rad monitor bypass switch placed in " Bypass", Chemistry sampling is not required as the continuous monitor sampling complies with the periodic sampling requirement.
Gross Beta is analyzed at an LLD of at least 1N7 pCi/ml.
Action 102-     With less than the Minimum Required Channels operable, effluent releases via this pathway may continue for up to 30 days provided the flow rate is estimated at least once per 4 hours during actual releases.           Pump curves generated in situation may be used to estimate flow.
Gross Gamma is analyzed at an LLD of at least SN7 pCi/ml.
If the A or B RHRSW Process Rad Monitor should become inoperable, sampling is required at least once every eight (8) hours at a sample point common with the inoperable A and/or B RHRSW Process Rad Monitor (s) l whether or not the respective 1C/2C and/or 1D/2D RHRSW Process Rad Monitors are operable.
However, there are no additional sampling requirements when the 1C/2C and/or j
1D/2D RHRSW Process Rad Monitors are inoperable since i
monitoring requirements are satisfied through the operable A and/or B RHRSW Process Rad Monitors or the inop sampling of those points.
If a monitor is inoperable but will still continuously sample and annunciate on high activity, i.e. rad monitor bypass switch placed in " Bypass", Chemistry sampling is not required as the continuous monitor sampling complies with the periodic sampling requirement.
Action 102-With less than the Minimum Required Channels operable, effluent releases via this pathway may continue for up to 30 days provided the flow rate is estimated at least once per 4 hours during actual releases.
Pump curves generated in situation may be used to estimate flow.


l                                                           ODCM Rev. 17 Page 23 l                                                                   11/95 TABLE I3.2-2 RADIOACTIVE LIOUID EFFLUENT MONITORING INSTRUMENTATICN SURVEILLANCE REOUIREMENTS CHANNEL CHANNEL SOURCE     CHANNEL   FUNCTIONAL INSTRUMENT                     CHECK   CHECK   CALIBRATION   TEST
l ODCM Rev. 17 Page 23 l
: 1. Gross Radioactivity Monitors Providing Automatic Termination of Release l    a. Liquid Radwaste Effluent Line             D*     D*       R(3)       Q(1)
11/95 TABLE I3.2-2 RADIOACTIVE LIOUID EFFLUENT MONITORING INSTRUMENTATICN SURVEILLANCE REOUIREMENTS CHANNEL CHANNEL SOURCE CHANNEL FUNCTIONAL INSTRUMENT CHECK CHECK CALIBRATION TEST 1.
: b. RHR Service Water System Effluent Line   D       M         R(3)       Q(1)
Gross Radioactivity Monitors Providing Automatic Termination of Release a.
: 2. Gross Radioactivity Monitored Not Providing Automatic Termination of Release
Liquid Radwaste Effluent Line D*
: a. Service Water System Effluent Line       D       M         R(3)       Q (2 )-
D*
: 3. Flow Rate Measurement Devices
R(3)
: a. Liquid Radwaste Effluent Line             D(4)   N.A.       R           Q
Q(1) l
: b. Discharge Line                           D(4)   N.A.       R           Q l*   Daily when in use
: b. RHR Service Water System Effluent Line D
M R(3)
Q(1) 2.
Gross Radioactivity Monitored Not Providing Automatic Termination of Release a.
Service Water System Effluent Line D
M R(3)
Q (2 )-
3.
Flow Rate Measurement Devices
: a. Liquid Radwaste Effluent Line D(4)
N.A.
R Q
b.
Discharge Line D(4)
N.A.
R Q
l*
Daily when in use


l                                                             ODCM Rev. 17 Page 24   ,
l ODCM Rev. 17 Page 24 l
l                                                                    11/95 I l
11/95 TABLE I3.2-2 (Continued) 1 TABLE NOTATIONS (1)
TABLE I3.2-2 (Continued)                             1 TABLE NOTATIONS (1) The CHANNEL FUNCTIONAL TEST shall also demonstrate that automatic isolation of this pathway and control room alarm annunciation will occur if any of the following conditions exists:
The CHANNEL FUNCTIONAL TEST shall also demonstrate that automatic isolation of this pathway and control room alarm annunciation will occur if any of the following conditions exists:
: 1. Instrument indicates measured levels above the alarm / trip setpoint.
1.
: 2. Circuit failure.
Instrument indicates measured levels above the alarm / trip setpoint.
: 3. Instrument indicates a downscale failure.
2.
(2) The CHANNEL FUNCTIONAL TEST shall also demonstrate that control room alarm annunciation occurs if any of the following conditions exists:
Circuit failure.
: 1. Instrument indicates measured levels above the alarm setpoint.
3.
: 2. Circuit failure.
Instrument indicates a downscale failure.
: 3. Instrument indicates a downscale failure.
(2)
l (3) The initial CHANNEL CALIBRATION shall be performed using reference standards certified by the National Institute of Standards and Technology (NIST) obtained from suppliers that participate in measurement assurance activities with NIST.
The CHANNEL FUNCTIONAL TEST shall also demonstrate that control room alarm annunciation occurs if any of the following conditions exists:
These standards shall permit calibrating the system over its           ,
1.
l intended range of energy and measurements range. For subsequent CHANNEL CALIBRATION, sources that have been                 '
Instrument indicates measured levels above the alarm setpoint.
related to the initial calibration shall be used.                     ]
2.
(4) CHANNEL CHECK shall consist of verifying indication of flow during periods of release. CHANNEL CHECK shall be made at least once per 24 hours on days on which batch releases are made.
Circuit failure.
3.
Instrument indicates a downscale failure.
(3)
The initial CHANNEL CALIBRATION shall be performed using reference standards certified by the National Institute of Standards and Technology (NIST) obtained from suppliers that participate in measurement assurance activities with NIST.
These standards shall permit calibrating the system over its intended range of energy and measurements range.
For subsequent CHANNEL CALIBRATION, sources that have been related to the initial calibration shall be used.
]
(4)
CHANNEL CHECK shall consist of verifying indication of flow during periods of release.
CHANNEL CHECK shall be made at least once per 24 hours on days on which batch releases are made.


t 1
t 1
l                                                               ODCM Rev. 17 Page 25 l                                                                     11/95 CONCENTRATION l   CONTROLS 3.2.2   The concentration.of radioactive material released in liquid effluents to UNRESTRICTED AREAS (see Figure I2.2-la,b) shall be limited to the concentrations specified in           l 10 CFR Part 20, Appendix B, Table II, Column 2 for radionuclides other than dissolved or entrained nobles
l ODCM Rev. 17 Page 25 l
,          gases. For dissolved or entrained noble gases, the concentration shall be limited to 2E-4 microcuries/ml total activity.
11/95 CONCENTRATION l
CONTROLS 3.2.2 The concentration.of radioactive material released in liquid effluents to UNRESTRICTED AREAS (see Figure I2.2-la,b) shall be limited to the concentrations specified in l
10 CFR Part 20, Appendix B, Table II, Column 2 for radionuclides other than dissolved or entrained nobles gases.
For dissolved or entrained noble gases, the concentration shall be limited to 2E-4 microcuries/ml total activity.
APPLICABILITY: At all times.
APPLICABILITY: At all times.
ACTION:
ACTION:
With the concentration of radioactive material released in liquid effluents to UNRESTRICTED AREAS exceeding the above limits, immediately restore the concentration to within the above limits or terminate the release.
With the concentration of radioactive material released in liquid effluents to UNRESTRICTED AREAS exceeding the above limits, immediately restore the concentration to within the above limits or terminate the release.
SURVEILLANCE REOUIREMENTS 3.2.2-1     Radioactive liquid wastes shall be sampled and analyzed according to the sampling and analysis program of Table I3.2-3.
SURVEILLANCE REOUIREMENTS 3.2.2-1 Radioactive liquid wastes shall be sampled and analyzed according to the sampling and analysis program of Table I3.2-3.
3.2.2-2     The results of the radioactivity analyses shall be used in accordance with the methodology and parameters in the ODCM Part II. Section 1.3 to assure that the concentrations at the point of release are maintained within the limits of Control I3.2.2.
3.2.2-2 The results of the radioactivity analyses shall be used in accordance with the methodology and parameters in the ODCM Part II. Section 1.3 to assure that the concentrations at the point of release are maintained within the limits of Control I3.2.2.


l                                                             ODCM Rsv. 17 j Page 26 l
l ODCM Rsv. 17 j
l 1                                                                        11/95 TABLE I3.2-3                                   ,
Page 26 l
I RADIOACTIVE LIOUID WASTE SAMPLING AND ANALYSIS PROGRAM               !
11/95 l
Lower Limit Minimum         Type of     of Detection Liquid Release     Sampling     Analysis       Activity       (LLD)*
1 TABLE I3.2-3 RADIOACTIVE LIOUID WASTE SAMPLING AND ANALYSIS PROGRAM Lower Limit Minimum Type of of Detection Liquid Release Sampling Analysis Activity (LLD)*
Type               Frequency   Frequency       Analysis     (uCi/M1) i A. Batch Waste         P           P       Principal Gamma     SE-7 Release         Each Batch     Each Batch     Emitters Tanksb I-131               1E-6
Type Frequency Frequency Analysis (uCi/M1) i A. Batch Waste P
: 1. Floor or             P           M       Dissolved and       1E-5 Equip. Drain   One Batch /M             Entrained Gases Sample Tanks                             (Gamma Emitters)*
P Principal Gamma SE-7 Release Each Batch Each Batch Emitters Tanksb I-131 1E-6 1.
: 2. Laundry             P           M       H-3                 1E-5 Drain Sample   Each Batch   Composite d Tank                                                                       l Gross Alpha         1E-7 P           Q       Sr-89, Sr-90       SE-8 Each Batch   Composite d Fe-55               1E-6 l
Floor or P
B. Continuous           W           W       Principal Gamma     SE-7 Release
M Dissolved and 1E-5 Equip. Drain One Batch /M Entrained Gases Sample Tanks (Gamma Emitters)*
* Grab Sample               Emitters
2.
* I-131               1E-6
Laundry P
: 1. RHR Service         W           W       Dissolved and       1E-5 Watel System Grab Sample                 Entrained Gases Effluent Linef                           (Gamma Emitters)*
M H-3 1E-5 Drain Sample Each Batch Composited Tank l
: 2. Service Water       W           M       H-3                 1E-5 System         Grab Sample Composite d Effluent Linef Gross Alpha         1E-7 W           Q       Sr-89. Sr-90       SE-8 Grab Sample Composite e Fe-55               1E-6
Gross Alpha 1E-7 P
Q Sr-89, Sr-90 SE-8 Each Batch Composited Fe-55 1E-6 B. Continuous W
W Principal Gamma SE-7 Release
* Grab Sample Emitters
* I-131 1E-6
: 1. RHR Service W
W Dissolved and 1E-5 Watel System Grab Sample Entrained Gases Effluent Linef (Gamma Emitters)*
2.
Service Water W
M H-3 1E-5 System Grab Sample Composited Effluent Linef Gross Alpha 1E-7 W
Q Sr-89. Sr-90 SE-8 Grab Sample Composite e Fe-55 1E-6


1 1
1 1
l                                                                     ODCM Rev. 17 Page 27   I l
l ODCM Rev. 17 Page 27 l
11/95 TABLE I3.2-3 (Continued)
11/95 TABLE I3.2-3 (Continued)
TABLE NOTATIONS a.
TABLE NOTATIONS The LLD is defined as the smallest concentration of radioactive a.
The LLD is defined as the smallest concentration of radioactive material in a sample that will yield a net count, above system                 l background, that will be detected with 95% probability with only 5% probability of falsely concluding that a blank observation represents a "real" signal.
material in a sample that will yield a net count, above system background, that will be detected with 95% probability with only 5% probability of falsely concluding that a blank observation represents a "real" signal.
For a measurement system, which may include radiochemical separation:
For a measurement system, which may include radiochemical separation:
                                                                                    )
(2.71 + 4. 66sg) (1-exp (- AAt ) )
(2.71 + 4. 66sg) (1-exp (- AAt 2) )
2 E
E   V   2.22E6     Y   [exp (-AAt )]
V 2.22E6 Y
1   (AAt 2)
[exp (-AAt )] (AAt )
1 2
(2. 71 + 4. 66 sg)
(2. 71 + 4. 66 sg)
LLD (Grab Samples)=                                                     ,
LLD (Grab Samples)=
E   V     2.22E6   -
E V
Y (exp - AAtz)           j Where:
2.22E6 Y (exp - AAtz) j Where:
LLD is the a criori lower limit of detection as defined above                 {
LLD is the a criori lower limit of detection as defined above
( as microcuries per unit mass or volume),                                   l sg is the standard deviation of the background counting rate or of the counting rate of blank sample as appropriate (as counts per minute),
( as microcuries per unit mass or volume),
l sg is the standard deviation of the background counting rate or of the counting rate of blank sample as appropriate (as counts per minute),
E is the counting efficiency, as counts per disintegration, V is the sample size, in units of mass or volume, 2.22E6 is the number of disintegrations per minute per microcurie, Y is the fractional radiochemical yield, when applicable, A is the radioactive decay constant for the particular radionuclide, and At for the plant effluents is the elapsed time between the end 1
E is the counting efficiency, as counts per disintegration, V is the sample size, in units of mass or volume, 2.22E6 is the number of disintegrations per minute per microcurie, Y is the fractional radiochemical yield, when applicable, A is the radioactive decay constant for the particular radionuclide, and At for the plant effluents is the elapsed time between the end 1
of the sample collection and the time of counting.
of the sample collection and the time of counting.
At for the plant effluents is the elapsed time between the end 2
At for the plant effluents is the elapsed time between the end 2
of the sample collection and the start of sample collection.
of the sample collection and the start of sample collection.
Typical values of E, V, Y,     At and At should be used in calculation.
Typical values of E, V,
1       2 It should be recognized that the LLD is defined as an a priori (before the fact) limit representing the capability of a measurement system and not as an after the fact limit for a particular measurement.
Y, At and At should be used in calculation.
1 2
It should be recognized that the LLD is defined as an a priori (before the fact) limit representing the capability of a measurement system and not as an after the fact limit for a particular measurement.
l
l


__.    -                    =_
=_
l                                                               ODCM Rsv. 17 Page 28 l                                                                     11/95 TABLE I3.2-3 (Continqq, dl I
l ODCM Rsv. 17 Page 28 l
l TABLE NOTATIONS                                 l l
11/95 TABLE I3.2-3 (Continqq, dl I
: b. A batch release is the discharge of liquid wastes of a discrete volume. Prior to sampling for analyses, each batch shall be isolated, and then thoroughly mixed to assure representative sampling.
TABLE NOTATIONS l
: c. The principal gamma emitters for which the LLD specification applies include the following radionuclides:       Mn-54, Fe-59, Co-58, Co-60, Zn-65, Mo-99, Cs-134, Cs-137, Ce-141 and Ce-144.
b.
The dissolved and entrained noble gases (gamma emitters) for which the LLD' specification applies include the following radionuclides: Kr-87, Kr-88, Xe-133, Xe-133m, Xe-135, Xe-135m, Xe138. This list does not mean that only these nuclides are to be considered. Other gamma peaks that are identifiable, together with those of the above nuclides, shall also be analyzed and               ,
A batch release is the discharge of liquid wastes of a discrete volume.
I reported in the Semiannual Radioactive Effluent Release Report pursuant to Control 3.6.
Prior to sampling for analyses, each batch shall be isolated, and then thoroughly mixed to assure representative sampling.
: d. The term " Composite Sample" means a combination of individual samples obtained at regular intervals over a time period. Either the volume of each individual sample is proportional to discharge flow rates, or the sampling interval (for constant volume                 "
The principal gamma emitters for which the LLD specification c.
samples) is proportional to flow rates over the time period used to produce the composite.
applies include the following radionuclides:
: e. A continuous release is the discharge of liquid wastes of nondiscrete volume, from a volume of a system that has an input flow during the continuous release.
Mn-54, Fe-59, Co-58, Co-60, Zn-65, Mo-99, Cs-134, Cs-137, Ce-141 and Ce-144.
: f. Whenever effluent releases are in excess of the monitor's setpoint.
The dissolved and entrained noble gases (gamma emitters) for which the LLD' specification applies include the following radionuclides: Kr-87, Kr-88, Xe-133, Xe-133m, Xe-135, Xe-135m, Xe138.
This list does not mean that only these nuclides are to be considered.
Other gamma peaks that are identifiable, together with those of the above nuclides, shall also be analyzed and reported in the Semiannual Radioactive Effluent Release Report pursuant to Control 3.6.
d.
The term " Composite Sample" means a combination of individual samples obtained at regular intervals over a time period.
Either the volume of each individual sample is proportional to discharge flow rates, or the sampling interval (for constant volume samples) is proportional to flow rates over the time period used to produce the composite.
A continuous release is the discharge of liquid wastes of e.
nondiscrete volume, from a volume of a system that has an input flow during the continuous release.
f.
Whenever effluent releases are in excess of the monitor's setpoint.


l                                                                     ODCM Rev. 17 Page 29 l                                                                           11/95 DOSE r                                                                                               l CONTROLS 1
l ODCM Rev. 17 Page 29 l
3.2.3 The dose or dose commitment to a MEMBER OF THE PUBLIC from                   I radioactive materials in liquid effluents released from the site to UNRESTRICTED AREAS (See Figure I2.2-la) shall be l
11/95 DOSE r
limited:                                                                   I
CONTROLS 3.2.3 The dose or dose commitment to a MEMBER OF THE PUBLIC from radioactive materials in liquid effluents released from the site to UNRESTRICTED AREAS (See Figure I2.2-la) shall be limited:
: a. During any calendar quarter to less than or equal to 3 mrems to the total body and to less than or equal to 10 mrems to any organ, and
During any calendar quarter to less than or equal to a.
: b. During any calendar year to less than or equal to 6 mrems to the total body and to less than or equal to_20 mrems to any organ.
3 mrems to the total body and to less than or equal to 10 mrems to any organ, and b.
APPLICABILITY:     At all times.
During any calendar year to less than or equal to 6 mrems to the total body and to less than or equal to_20 mrems to any organ.
APPLICABILITY:
At all times.
ACTION:
ACTION:
With the calculated dose from the release of radioactive materials in liquid effluents exceeding any of the above limits, prepare and submit to the Commission within 30 days, pursuant to Technical Specification 6.9.2, a Special Report which identifies the cause(s) for exceeding the limit (s) and defines the corrective actions that have been taken to reduce the releases and the proposed corrective actions to be taken to assure that subsequent releases will be in compliance with the above limits. This Special Report shall also include the radiological impact on finished drinking water supplies at the nearest downstream drinking water source.
With the calculated dose from the release of radioactive materials in liquid effluents exceeding any of the above limits, prepare and submit to the Commission within 30 days, pursuant to Technical Specification 6.9.2, a Special Report which identifies the cause(s) for exceeding the limit (s) and defines the corrective actions that have been taken to reduce the releases and the proposed corrective actions to be taken to assure that subsequent releases will be in compliance with the above limits.
SURVEILLANCE REOUIREMENTS 3.2.3-1 Cumulative dose contributions from liquid effluents                 l for the current calendar quarter and the current               I calendar year shall-be determined using ST-0-104-878-0 at least once per 31 days.
This Special Report shall also include the radiological impact on finished drinking water supplies at the nearest downstream drinking water source.
SURVEILLANCE REOUIREMENTS 3.2.3-1 Cumulative dose contributions from liquid effluents for the current calendar quarter and the current I
calendar year shall-be determined using ST-0-104-878-0 at least once per 31 days.


l                                                               ODCM Rev. 17 Page 30 :
l ODCM Rev. 17 Page 30 l
l                                                                    11/95 '
11/95 i
i LIOUID RADWASTE TREATMENT SYSTEM CONTROLS 3.2.4   The liquid radwaste treatment system shall be IN SERVICE and appropriate portions of the system shall be used to reduce the radioactive materials in liquid waste prior to their discharge when the projected doses due to the liquid effluent, from the site, to UNRESTRICTED AREAS (See Figure I2.2-la) would exceed 0.06 mrem to the total body or 0.2 mrem to any organ in a 31-day period.
LIOUID RADWASTE TREATMENT SYSTEM CONTROLS 3.2.4 The liquid radwaste treatment system shall be IN SERVICE and appropriate portions of the system shall be used to reduce the radioactive materials in liquid waste prior to their discharge when the projected doses due to the liquid effluent, from the site, to UNRESTRICTED AREAS (See Figure I2.2-la) would exceed 0.06 mrem to the total body or 0.2 mrem to any organ in a 31-day period.
APPLICABILITY:     At all times.
APPLICABILITY:
ACTION:                                                                   )
At all times.
: a. With radioactive liquid waste being discharged without treatment or in excess of the above limits, pursuant       l to Technical Specification 6.9.2, prepare a Special       l Report which includes the following information-           1 l
ACTION:
: 1. Explanation of what liquid radwaste was being discharged without treatment, identification of     l any inoperable equipment or subsystems, and the reason for the inoperability.                       l
)
: 2. Action (s) taken to restore the inoperable equipment to OPERABLE status, and                   j
a.
: 3. Summary description of action (s) taken to prevent a recurrence.
With radioactive liquid waste being discharged without treatment or in excess of the above limits, pursuant to Technical Specification 6.9.2, prepare a Special Report which includes the following information-1 l
: b. Submit report to Commission within 30 days.
1.
Explanation of what liquid radwaste was being discharged without treatment, identification of any inoperable equipment or subsystems, and the reason for the inoperability.
2.
Action (s) taken to restore the inoperable equipment to OPERABLE status, and j
3.
Summary description of action (s) taken to prevent a recurrence.
b.
Submit report to Commission within 30 days.
SURVEILLANCE REOUIREMENTS 3.2.4-1 Dose due to liquid releases from the site to UNRESTRICTED AREAS shall be projected at least once per 31 days using ST-0-104-878-0.
SURVEILLANCE REOUIREMENTS 3.2.4-1 Dose due to liquid releases from the site to UNRESTRICTED AREAS shall be projected at least once per 31 days using ST-0-104-878-0.


l                                                               ODCM Rev. 17 Page 31 l
l ODCM Rev. 17 Page 31 l
11/95 3.3 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION CONTROLS 3.3.1 The radioactive gaseous effluents monitoring instrumentation channels in Table I3.3-1 shall be OPERABLE with their alarm / trip setpoints set to ensure that the limits of ODCM Control Part I Section 3.3.2 are not exceeded. The alarm / trip setpoints of the applicable channels shall be determined in accordance with the methodology and parameters in the ODCM Part II, Section 2.2.
11/95 3.3 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION CONTROLS 3.3.1 The radioactive gaseous effluents monitoring instrumentation channels in Table I3.3-1 shall be OPERABLE with their alarm / trip setpoints set to ensure that the limits of ODCM Control Part I Section 3.3.2 are not exceeded.
APPLICABILITY:   As shown in Table I3.3-1.
The alarm / trip setpoints of the applicable channels shall be determined in accordance with the methodology and parameters in the ODCM Part II, Section 2.2.
APPLICABILITY:
As shown in Table I3.3-1.
ACTION:
ACTION:
: a.      With a radioactive gaseous effluent monitoring instrumentation channel alarm / trip setpoints less conservative than required by Part II Section 2.2, immediately suspend the release of radioactive gaseous effluents monitored by the affected channel or declare the channel inoperable.
With a radioactive gaseous effluent monitoring a.
: b.       With less than the minimum number of radioactive gaseous effluent monitoring instrumentation channels OPERABLE, take the ACTION shown in Table I3.3-1.
instrumentation channel alarm / trip setpoints less conservative than required by Part II Section 2.2, immediately suspend the release of radioactive gaseous effluents monitored by the affected channel or declare the channel inoperable.
Restore the inoperable instrumentation to OPERABLE status within the time specified in the ACTION. If the inoperable instrumentation is not restored within the time specified in the ACTION statement: create an AR in PIMS to ensure an explanation is written by the responsible System Engineer and is included in AERR by the Effluent Physicist.
b.
With less than the minimum number of radioactive gaseous effluent monitoring instrumentation channels OPERABLE, take the ACTION shown in Table I3.3-1.
Restore the inoperable instrumentation to OPERABLE status within the time specified in the ACTION.
If the inoperable instrumentation is not restored within the time specified in the ACTION statement:
create an AR in PIMS to ensure an explanation is written by the responsible System Engineer and is included in AERR by the Effluent Physicist.
SURVEILLANCE REOUIREMENTS 3.3.1-1 Each radioactive gaseous effluent monitoring instrumentation channel shall be demonstrated OPERABLE by performance of the CHANNEL CHECK, SOURCE CHECK, CHANNEL CALIBRATION AND CHANNEL FUNCTIONAL TEST operations at the frequencies shown in Table I3.3-2.
SURVEILLANCE REOUIREMENTS 3.3.1-1 Each radioactive gaseous effluent monitoring instrumentation channel shall be demonstrated OPERABLE by performance of the CHANNEL CHECK, SOURCE CHECK, CHANNEL CALIBRATION AND CHANNEL FUNCTIONAL TEST operations at the frequencies shown in Table I3.3-2.


l                                                                                                                           ODCM Rev. 17                                                                                                       ;
l ODCM Rev. 17 Page 33 l
Page 33 l                                                                                                                                                     11/95
11/95
                                                                                          . TABLE I3.3-1 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION MINIMUM CHANNELS INSTRUMENT                                                                     OPERABLE                     APPLICABILITY ACTION SOUTH STACK EFFLUENT MONITORING SYSTEM
. TABLE I3.3-1 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION MINIMUM CHANNELS INSTRUMENT OPERABLE APPLICABILITY ACTION SOUTH STACK EFFLUENT MONITORING SYSTEM
: a. Noble Gas Activity Monitor                                                                           1
: a. Noble Gas Activity Monitor 1
* 111
111
: b. Iodine Sampler                                                                                     1
[
* 112
b.
: c. Particulate Sampler                                                                                 1
Iodine Sampler 1
* 112   '
112 c.
: d. Effluent System Flow Rate Monitor                                                                   1
Particulate Sampler 1
* 113
112
: e. Sampler Flow Rate Monitor                                                                           1
: d. Effluent System Flow Rate Monitor 1
* 113 NORTH STACK EFFLUENT MONITORING SYSTEM #                                                                                                                                                                                                       ,
113 e.
: a. Noble Gas Activity Monitor                                                                         1
Sampler Flow Rate Monitor 1
* 114   I f
113 NORTH STACK EFFLUENT MONITORING SYSTEM #
: b. Iodine Sampler                                                                                     1
: a. Noble Gas Activity Monitor 1
* 112
114 I
: c. Particulate Sampler                                                                                 1
f b.
* 112   i
Iodine Sampler 1
: d. Effluent System Flow Rate Monitor                                                                   1
112 c.
* 113
Particulate Sampler 1
: e. Sampler Flow Rate Monitor                                                                           1
112 i
* 113   .
: d. Effluent System Flow Rate Monitor 1
HOT MAINTENANCE SHOP VENTILATION EXHAUST RADIATION MONITOR
113 e.
: a. Iodine Sampler                                                                                     1                                                             **                                                          112   ,
Sampler Flow Rate Monitor 1
: b. Particulate Sampler                                                                               1                                                           **                                                            112
113 HOT MAINTENANCE SHOP VENTILATION EXHAUST RADIATION MONITOR a.
: c. Effluent System Flow Rate' Monitor                                                                 1                                                           **                                                            113   ;
Iodine Sampler 1
l
112
: d. Sampler Flow Rate Monitor                                                                         1                                                           **                                                            113   '
: b. Particulate Sampler 1
.                                                                                                                                                                                                                                                      t
112 l
  # The (A or B) North Stack Normal Range Radiation Monitors OR the Wide Range Accident Monitor (Low Range) may be used to satisfy requirements for the North Stack Effluent Monitoring System.
c.
NOTE:     With regard to Actions 111, 112, 113, and 114; with less than the minimum Required Channels operable for greater than 30 days prepare and submit a Special Report to the Effluent Physicist within the next 10 days outlining the cause of the malfunction and the plans for                                                                                                                                                 !
Effluent System Flow Rate' Monitor 1
restoring the instruments to OPERABLE Status. Sampling shall continue until the minimum channel operability requirement is met.
113
* At all times.                                                                                                                                                                                                                         l
: d. Sampler Flow Rate Monitor 1
          **    During operation of the hot maintenance shop ventilation system.
113 t
_-____._.__.m_ . _ . _ _ . _ _ . . _ _ _ _ _ . _ _ _ . - __ ._m_.e_  -_ . _ _ . _ _ _ _ _ _ _      _ _ . _ _ _ . _ . _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ . . _ _ _ _ _ _ . . . _ . . _ _ _ _ _ . _ . . . .
# The (A or B) North Stack Normal Range Radiation Monitors OR the Wide Range Accident Monitor (Low Range) may be used to satisfy requirements for the North Stack Effluent Monitoring System.
NOTE:
With regard to Actions 111, 112, 113, and 114; with less than the minimum Required Channels operable for greater than 30 days prepare and submit a Special Report to the Effluent Physicist within the next 10 days outlining the cause of the malfunction and the plans for restoring the instruments to OPERABLE Status.
Sampling shall continue until the minimum channel operability requirement is met.
At all times.
l During operation of the hot maintenance shop ventilation system.
.m
. m.e


  .. .  .      .          - .    ~-     - - . . . -    -  ._ . _
~-
l                                                               ODCM Rev. 17 Page 33 l                                                                     11/95 TABLE I3.3-1(Continued)
l ODCM Rev. 17 Page 33 l
TABLE NOTATIONS ACTION STATEMENTS ACTION 111     -
11/95 TABLE I3.3-1(Continued)
With less than the minimum Required Channels (SS Noble Gas)       OPERABLE, effluent releases via this pathway       j may continue for up to 30 days provided grab       i samples are taken per ST-5-026-580
TABLE NOTATIONS ACTION STATEMENTS ACTION 111 With less than the minimum Required Channels (SS Noble Gas)
OPERABLE, effluent releases via this pathway j
may continue for up to 30 days provided grab samples are taken per ST-5-026-580
* at least once per 8 hours and these samples are analyzed for gross activity within 24 hours.
* at least once per 8 hours and these samples are analyzed for gross activity within 24 hours.
ACTION 112* -         With less than the minimum Required Channels (Iodine & Part.)     OPERABLE, effluent releases via this pathway may continue for up to 30 days provided samples are continuously collected with             j auxiliary samp]ing equipment per St-5-076-         )
ACTION 112* -
With less than the minimum Required Channels (Iodine & Part.)
OPERABLE, effluent releases via this pathway may continue for up to 30 days provided samples are continuously collected with j
auxiliary samp]ing equipment per St-5-076-
)
815 *, ST-5-076-820
815 *, ST-5-076-820
* as required in               l Table I3.3-3.                                       j IE the Sample Pump is operable, a particulate       l and iodine sample can be obtained;                 ;
* as required in Table I3.3-3.
AHD the Minimum Channels Operable                   '
j IE the Sample Pump is operable, a particulate and iodine sample can be obtained; AHD the Minimum Channels Operable requirements are satisfied.
requirements are satisfied.
ACTION 113* -
ACTION 113* -         With less than the minimum Required Channels       )
With less than the minimum Required Channels
(Eff. & Smpl.       OPERABLE, effluent releases via NS, SS or HMS       '
)
Flow Rate)             may continue for up to 30 days provided the         ;
(Eff. & Smpl.
flow rate is estimated by adding the nominal       '
OPERABLE, effluent releases via NS, SS or HMS Flow Rate) may continue for up to 30 days provided the flow rate is estimated by adding the nominal flow rates indicated in P&ID M-26 for each in-service fan.
flow rates indicated in P&ID M-26 for each         !
This shall be documented in the MCR operations Shift Log at least once per 4 hours.
in-service fan. This shall be documented in the MCR operations Shift Log at least once per 4 hours.
ACTION 114 With less than the minimum Required Channels (NS Noble Gas)
ACTION 114     -
OPERABLE, effluent releases via this pathway may continue for up to 30 days provided grab samples are taken per ST-5-026-580-0 at least once per 8 hours and these samples are analyzed for gross activity within 24 hours.
With less than the minimum Required Channels (NS Noble Gas)       OPERABLE, effluent releases via this pathway may continue for up to 30 days provided grab samples are taken per ST-5-026-580-0 at least once per 8 hours and these samples are analyzed for gross activity within 24 hours.
The Mechanical Vacuum Pumps may not be operated during this LCO.
The Mechanical Vacuum Pumps may not be operated during this LCO.
If release point is che' Hot Maintenance Shop, Then secure ventilation because no means exist to alternately sample the ventilation.
If release point is che' Hot Maintenance Shop, Then secure ventilation because no means exist to alternately sample the ventilation.


l                                                                                                     ODCM Rev. 17 Page 34 l                                                                                                             11/95 TABLE 13.3-2 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION SURVEILLANCE REOUIREMENTS CHANNEL MODES IN WHICH CHANNEL     SOURCE CHANNEL             FUNCT.                             SURVEILLANCE INSTRUMENT                 CHECK           CHECK CALIBR.           TEST                               IS REQUIRED i
l ODCM Rev. 17 Page 34 l
: 1.                           SOUTH STACK EFFLUENT MONITORING SYSTEM
11/95 TABLE 13.3-2 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION SURVEILLANCE REOUIREMENTS CHANNEL MODES IN WHICH CHANNEL SOURCE CHANNEL FUNCT.
: a. Noble Gas Activity Monitor             D             M   R(2)             Q(1)                                           *
SURVEILLANCE INSTRUMENT CHECK CHECK CALIBR.
: b. Iodine Sampler                     W(3)           N.A. N.A.             N.A.                                             *
TEST IS REQUIRED i
: c. Particulate Sampler                 W(3)           N.A. N.A.           N.A.                                             *
1.
: d. Effluent System Flow Rate Monitor       D         N.A. R               Q                                               *
SOUTH STACK EFFLUENT MONITORING SYSTEM
: e. Sampler Flow Rate Monitor               D         N.A. R               Q                                               *
: a. Noble Gas Activity Monitor D
: 2.                             NORTH STACK EFFLUENT MONITORING SYSTEM #
M R(2)
: a. Noble Gas Activity Monitor             D             M   R(2)           Q (1)                                           *
Q(1) b.
: b. Iodine Sampler                     W(3)           N.A. N.A.           N.A.                                             *
Iodine Sampler W(3)
: c. Particulate Sampler                 W(3)           N.A. N.A.           N.A.
N.A.
: d. Effluent System Flow Rate Monitor       D         N.A. R               Q                                               *
N.A.
: e. Sampler Flow Rate   Monitor           D         N.A. R               Q                                               *
N.A.
: 3.                             HOT MAINTENANCE SHOP VENTILATION EXHAUST RADIATION MONITOR
c.
: a. Iodine Sampler                     W(3)           N.A. N.A.           N.A.                                             **
Particulate Sampler W(3)
: b. Particulate Sampler                 W(3)           N.A. N.A.           N.A.                                             **
N.A.
: c. Effluent System Flow Rate Monitor   D             N.A. R               Q                                               **
N.A.
: d. Sampler Flow Rate Monitor           D             N.A. R               Q                                               **
N.A.
                                                                #                  Wide Range Accident Monitor (WRAM) surveillance is specified in Technical Specification 3.3.7.5.
: d. Effluent System Flow Rate Monitor D
* At all times.
N.A.
l                                                                ** During operation of the hot maintenance shop ventilation exhaust system.
R Q
e.
Sampler Flow Rate Monitor D
N.A.
R Q
2.
NORTH STACK EFFLUENT MONITORING SYSTEM #
: a. Noble Gas Activity Monitor D
M R(2)
Q (1) b.
Iodine Sampler W(3)
N.A.
N.A.
N.A.
c.
Particulate Sampler W(3)
N.A.
N.A.
N.A.
: d. Effluent System Flow Rate Monitor D
N.A.
R Q
e.
Sampler Flow Rate Monitor D
N.A.
R Q
3.
HOT MAINTENANCE SHOP VENTILATION EXHAUST RADIATION MONITOR a.
Iodine Sampler W(3)
N.A.
N.A.
N.A.
b.
Particulate Sampler W(3)
N.A.
N.A.
N.A.
c.
Effluent System Flow Rate Monitor D
N.A.
R Q
: d. Sampler Flow Rate Monitor D
N.A.
R Q
Wide Range Accident Monitor (WRAM) surveillance is specified in Technical Specification 3.3.7.5.
At all times.
l
l
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ . . _ . _ _                      _    _.          --.  - . _ _ . _        __  _ _ _ _ _ _ _ _ _ _ _ __ ~_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ . _
** During operation of the hot maintenance shop ventilation exhaust system.
l
~


I l                                                           ODCM Rev. 17 Page 35 l                                                                 11/95 TABLE I3. 3-2 (Continued)
I l
TABLE NOTATIONS l
ODCM Rev. 17 Page 35 l
(1) The CHANNEL FUNCTIONAL TEST shall also demonstrate that             l control room alarm annunciation occurs if any of the following conditions exists:
11/95 TABLE I3. 3-2 (Continued)
: 1. Instruments indicate measured levels above the               i alarm / trip setpoint.                                       I
TABLE NOTATIONS (1)
: 2. Circuit failure.
The CHANNEL FUNCTIONAL TEST shall also demonstrate that control room alarm annunciation occurs if any of the following conditions exists:
: 3. Instrument indicates a downscale failure.
1.
: 4. Instrument controls not set in operate mode.
Instruments indicate measured levels above the i
(2) The initial CHANNEL CALIBRATION shall be performed using one or more of the reference standards certified by the National Institute of Standards and Testing (NIST) or using standards that have been obtained from suppliers that participate in measurement assurance activities with NIST.
alarm / trip setpoint.
These standards shall permit calibrating the system over its intended range of energy and measurement range. For subsequent CHANNEL CALIBRATION, sources that are traceable to the initial calibration shall be used.
2.
(3) The iodine cartridges and particulate filters will be changed and analyzed at least once per 7 days.
Circuit failure.
3.
Instrument indicates a downscale failure.
4.
Instrument controls not set in operate mode.
(2)
The initial CHANNEL CALIBRATION shall be performed using one or more of the reference standards certified by the National Institute of Standards and Testing (NIST) or using standards that have been obtained from suppliers that participate in measurement assurance activities with NIST.
These standards shall permit calibrating the system over its intended range of energy and measurement range.
For subsequent CHANNEL CALIBRATION, sources that are traceable to the initial calibration shall be used.
(3)
The iodine cartridges and particulate filters will be changed and analyzed at least once per 7 days.


l                                                                                     ODCM Rev. 17 Page 36 l
l ODCM Rev. 17 l
11/95 GASEOUS EFFLUENTS CONTROLS 3.3.2 The dose rate due to radioactive materials released in gaseous effluents from the site to areas at or beyond the SITE BOUNDARY (See Figure I2.2-la) shall be limited to:
Page 36 11/95 GASEOUS EFFLUENTS CONTROLS 3.3.2 The dose rate due to radioactive materials released in gaseous effluents from the site to areas at or beyond the SITE BOUNDARY (See Figure I2.2-la) shall be limited to:
: a.       For noble gases:   less than or equal to 500
a.
                                                              -mrems/yr to the total body and less than or equal to 3000 mrems/yr to the skin, and
For noble gases:
: b.       For iodine-131, iodine-133, tritium, and for all radionuclides in particulate form with half-lives greater than 8 days: less than or equal to 1500 mrems/yr to any organ.   (Inhalation pathways only.)
less than or equal to 500
APPLICABILITY:   At all times.
-mrems/yr to the total body and less than or equal to 3000 mrems/yr to the skin, and b.
For iodine-131, iodine-133, tritium, and for all radionuclides in particulate form with half-lives greater than 8 days: less than or equal to 1500 mrems/yr to any organ.
(Inhalation pathways only.)
APPLICABILITY:
At all times.
ACTION:
ACTION:
With the dose rate (s) exceeding the above limits, immediately restore the release rate to within the above limits.
With the dose rate (s) exceeding the above limits, immediately restore the release rate to within the above limits.
Line 715: Line 1,083:
(
(


l l                                                                     ODCM Rev. 17 l
l l
Paga 37 l                                                                             11/95 TABLE I3.3-3 RADIOACTIVE GASEOUS WASTE SAMPLING AND ANALYSIS PROGRAM Lower Limit Minimum         Type of         of Detection Gaseous Release   Sampling     Analysis         Activity         (LLD)*
ODCM Rev. 17 Paga 37 l
Type             Frequency     Frequency       Analysis         (uCi/M1)
11/95 TABLE I3.3-3 RADIOACTIVE GASEOUS WASTE SAMPLING AND ANALYSIS PROGRAM Lower Limit Minimum Type of of Detection Gaseous Release Sampling Analysis Activity (LLD)*
A. North Stack / Continuous'       Q           Gross Alpha         1E-11 South Stack                 Comp. Part.     Sr-89, Sr-90       1E-11 Sample Mb Grab Smpl.       Mb          Noble Gas           1E-4 H-3                 1E-6 Continuousd       W*
Type Frequency Frequency Analysis (uCi/M1)
Char. Smpl.     I-131               1E-12 I-133               1E-10 Part. Smpl.     Principal Gamma Emitters           1E-11 Continuousd Continuous         Noble Gas Noble Gas       Beta or Gamma       1E-6 Monitor                             (Based on Xe-133)
A. North Stack /
B. Hot Mainten. Continuousd       Q           Gross Alpha         1E-11 Comp. Part.     Sr-89, Sr-90       1E-11 Smp3.
Continuous' Q
Continuousd       W Char. Smpl.     I-131               1E-12 I-133               1E-10 Part. Smpl.     Principal Gamma Emitters           1E-11
Gross Alpha 1E-11 South Stack Comp. Part.
Sr-89, Sr-90 1E-11 Sample b
M b
Grab Smpl.
M Noble Gas 1E-4 H-3 1E-6 Continuousd W*
Char. Smpl.
I-131 1E-12 I-133 1E-10 Part. Smpl.
Principal Gamma Emitters 1E-11 Continuousd Continuous Noble Gas Noble Gas Beta or Gamma 1E-6 Monitor (Based on Xe-133)
B. Hot Mainten.
Continuousd Q
Gross Alpha 1E-11 Comp. Part.
Sr-89, Sr-90 1E-11 Smp3.
Continuousd W
Char. Smpl.
I-131 1E-12 I-133 1E-10 Part. Smpl.
Principal Gamma Emitters 1E-11


  . ._ _.__          _      _ . _    . _      _.      _      _ __        _.m _ _          . _ _ _      -
_.m l
l                                                                                  ODCM Rev. 17 Page 38 l                                                                                               11/95 l
ODCM Rev. 17 Page 38 l
l TABLE 13.3-3 (Continued)                                               j l                                               TABLE NOTATIONS                                                 i
l 11/95 TABLE 13.3-3 (Continued) j l
: a. The LLD is defined, as the smallest concentration of radioactive material in a sample that will yield a net count, above system background, that will be detected with 95%
TABLE NOTATIONS i
a.
The LLD is defined, as the smallest concentration of radioactive material in a sample that will yield a net count, above system background, that will be detected with 95%
probability with only 5% probability of falsely concluding l
probability with only 5% probability of falsely concluding l
l that a blank observation represents a "real" signal. It should be recognized that the LLD is defined as an a oriori (before the fact) limit representing the capability of a measurement system and not as an after the fact limit for a particular measurement.
that a blank observation represents a "real" signal.
For a particular measurement system, (which may include                                       !
It l
radiochemical separation):                                                                   l (2. 71 + 4. 66ss ) (1-exp (- AAt 2) )
should be recognized that the LLD is defined as an a oriori (before the fact) limit representing the capability of a measurement system and not as an after the fact limit for a particular measurement.
For a particular measurement system, (which may include radiochemical separation):
(2. 71 + 4. 66s ) (1-exp (- AAt ) )
s 2
LLD -
LLD -
E*V         2.22E6   Y       [exp (- AAt1 )] (AAta)
E*V 2.22E6 Y
(2.71 + 4.66 s s)
[exp (- AAt )] (AAta) 1 (2.71 + 4.66 s )
LLD (Grab Samples) =
s LLD (Grab Samples) =
E       V-     2.22E6     -
Y (exp - AAtz)
Y (exp - AAtz) b Where:
E V-2.22E6 b
L                 LLD is the a oriori lower limit of detection as defined above                               ;
Where:
!                  (uCi/cc or uCi/mL),
L LLD is the a oriori lower limit of detection as defined above (uCi/cc or uCi/mL),
s s is the standard deviation of the background counting rate                                 I or of the counting rate of blank sample as appropriate (as epm), shall be based on the actual observed variance of the
s is the standard deviation of the background counting rate s
,                  background counting rate or of the counting rate of the blank                                 ,
or of the counting rate of blank sample as appropriate (as epm), shall be based on the actual observed variance of the background counting rate or of the counting rate of the blank samples (as appropriate) rather than on an unverified theoretically predicted variance.
!                  samples (as appropriate) rather than on an unverified                                         !
E is the counting efficiency, as cpdis, j
theoretically predicted variance.
V is the sample size, in units of cc or m1, l
E is the counting efficiency, as cpdis,                                                       j V is the sample size, in units of cc or m1, l                 2.22E6 is the number of dpm/uCi Y is the fractional radiochemical yield, when applicable, 1                 A is the radioactive decay constant for the particular radionuclide, and l                 At1 for the plant effluents is the elapsed time between the l                 end of the sample collection and the time of counting.
2.22E6 is the number of dpm/uCi Y is the fractional radiochemical yield, when applicable, 1
At2 for the plant effluents is the elapsed time between the end of the sample collection and the start of sample collection.
A is the radioactive decay constant for the particular radionuclide, and l
Typical values of E, V,         Y At and Ata should be used in calculation.
At for the plant effluents is the elapsed time between the 1
l end of the sample collection and the time of counting.
At for the plant effluents is the elapsed time between the 2
end of the sample collection and the start of sample collection.
Typical values of E, V, Y At and Ata should be used in calculation.
1
1


i l                                                             ODCM RGv. 17         l Page 39 ;
i l
l                                                                              11/95 TABLE I3.3-3 (Continued)
ODCM RGv. 17 Page 39 l
TABLE NOTATIONS
11/95 TABLE I3.3-3 (Continued)
: b. Sampling and analyses shall also be performed following shutdown, startup, or a THERMAL POWER change exceeding 15% of the RATED THERMAL POWER within a 1-hour period using RT-5-000-876 *. This requirement does not apply if (1) analysis show that the DOSE EQUIVALENT I-131 concentration in the primary coolant has not increased more than a factor of 3; and (2) the main condenser offgas pre-treatment radioactivity monitor shows that effluent activity has not increased more than a factor of 3.
TABLE NOTATIONS b.
l l            c. Samples shall be changed at least once per 7 days and analyses shall be completed within 48 hours after changing, or after l                 removal from sampler. Sampling shall also be performed at least once per 24 hours for at least 7 days following each l
Sampling and analyses shall also be performed following shutdown, startup, or a THERMAL POWER change exceeding 15% of the RATED THERMAL POWER within a 1-hour period using RT-5-000-876 *.
shutdown, startup or THERMAL POWER change exceeding 15% of                   l RATED THERMAL POWER in 1 hour and analyses completed within 48               l l                 hours of changing.     When samples collected for 24 hours are analyzed, the corresponding LLDs may be increased by a factor of 10. This requirement does not apply if (1) analysis shows that the DOSE EQUIVALENT I-131 concentration in the primary coolant has not increased more than a factor of 3; and (2) the noble gas monitor shows that effluent activity has not increased more than a factor of 3.
This requirement does not apply if (1) analysis show that the DOSE EQUIVALENT I-131 concentration in the primary coolant has not increased more than a factor of 3; and (2) the main condenser offgas pre-treatment radioactivity monitor shows that effluent activity has not increased more than a factor of 3.
: d. The ratio of the sample flow rate to the sampled stream flow rate shall be known for the time period covered by each dose                 ;
l Samples shall be changed at least once per 7 days and analyses l
or dose rate calculation made in accordance with Controls                     '
c.
3.3.2, 3.3.3, and 3.3.4.
shall be completed within 48 hours after changing, or after l
: e. The principal gamma emitters for which the LLD specification applies include the following radionuclides: Kr-87, Kr-88, Xe-133, Xe-133m, Xe-135, Xe-135m and Xe-138 for gaseous emissions and Mn-54, Fe-59, Co-58, Co-60, Zn-65, I-131, Cs-124, Cs-137, Ce-141 and Ce-144 for particulate emissions. This list does not mean that only these nuclides are to be considered. Other gamma peaks which are identifiable, together with the above nuclides, shall also be analyzed and reported ia the Annual Radioactive Effluent Release Report, pursuant to Control 3.6
removal from sampler.
: f. Under the provisions of footnote e. above, only noble gases need to be considered.
Sampling shall also be performed at least once per 24 hours for at least 7 days following each shutdown, startup or THERMAL POWER change exceeding 15% of RATED THERMAL POWER in 1 hour and analyses completed within 48 l
: g. Required for the hot maintenance shop ventilation exhaust only during operation of the hot maintenance shop ventilation l
l hours of changing.
When samples collected for 24 hours are analyzed, the corresponding LLDs may be increased by a factor of 10.
This requirement does not apply if (1) analysis shows that the DOSE EQUIVALENT I-131 concentration in the primary coolant has not increased more than a factor of 3; and (2) the noble gas monitor shows that effluent activity has not increased more than a factor of 3.
d.
The ratio of the sample flow rate to the sampled stream flow rate shall be known for the time period covered by each dose or dose rate calculation made in accordance with Controls 3.3.2, 3.3.3, and 3.3.4.
The principal gamma emitters for which the LLD specification e.
applies include the following radionuclides: Kr-87, Kr-88, Xe-133, Xe-133m, Xe-135, Xe-135m and Xe-138 for gaseous emissions and Mn-54, Fe-59, Co-58, Co-60, Zn-65, I-131, Cs-124, Cs-137, Ce-141 and Ce-144 for particulate emissions.
This list does not mean that only these nuclides are to be considered.
Other gamma peaks which are identifiable, together with the above nuclides, shall also be analyzed and reported ia the Annual Radioactive Effluent Release Report, pursuant to Control 3.6 f.
Under the provisions of footnote e. above, only noble gases need to be considered.
g.
Required for the hot maintenance shop ventilation exhaust only during operation of the hot maintenance shop ventilation l
exhaust system.
exhaust system.
l l
l l


1 l                                                               ODCM Rev. 17 Page 40 l                                                                       11/95 DOSE - NOBLE GASES CONTROLS 3.3.3   The air dose due to :2cble gases released in gaseous effluents, from the site to areus at and beyond the SITE BOUNDARY (See Figure I2.2-la) shall be limited to the following:
l ODCM Rev. 17 Page 40 l
: a.       During any calendar quarter:     less than or equal to 10 mrads for gamma radiation and less than or equal to 20 mrads for beta radiation, and
11/95 DOSE - NOBLE GASES CONTROLS 3.3.3 The air dose due to :2cble gases released in gaseous effluents, from the site to areus at and beyond the SITE BOUNDARY (See Figure I2.2-la) shall be limited to the following:
: b.       During any calendar year:     less than or equal to 20 mrads for gamma radiation and less than or equal to 40 mrads for beta radiation.
a.
APPLICABILITY:   At all times.
During any calendar quarter:
less than or equal to 10 mrads for gamma radiation and less than or equal to 20 mrads for beta radiation, and b.
During any calendar year:
less than or equal to 20 mrads for gamma radiation and less than or equal to 40 mrads for beta radiation.
APPLICABILITY:
At all times.
ACTION:
ACTION:
: a.       With the calculated air dose from radioactive noble gases in gaseous effluents exceeding any of the above limits, prepare and submit to the Commission within 30       )
a.
days, pursuant to Technical Specification 6.9.2, a Special Report which identifies the cause(s) for exceeding the limit (s) and defines the corrective actions that have been taken to reduce the releases         l and the proposed corrective actions to be taken to           l assure that subsequent releases will be in compliance with the above limits.
With the calculated air dose from radioactive noble gases in gaseous effluents exceeding any of the above limits, prepare and submit to the Commission within 30
SURVEILLANCE REOUIREMENTS                                                     l l
)
3.3.3-1 Cumulative dose contributions for the current quarter         '
days, pursuant to Technical Specification 6.9.2, a
and current calendar year for noble gases shall be determined using ST-0-104-879-0 and ST-0-104-883-0           I l
Special Report which identifies the cause(s) for exceeding the limit (s) and defines the corrective actions that have been taken to reduce the releases and the proposed corrective actions to be taken to assure that subsequent releases will be in compliance with the above limits.
every 31 days.                                               1
SURVEILLANCE REOUIREMENTS l
l 3.3.3-1 Cumulative dose contributions for the current quarter and current calendar year for noble gases shall be determined using ST-0-104-879-0 and ST-0-104-883-0 every 31 days.


l                                                                     ODCM Rev. 17 Page 41 l                                                                             11/95 DOSE - IODINE - 133. TRITIUM. AND RADIONUCLIDES IN PARTICULATE FORM j CONTROLS 3.3.4         The dose to a MEMBER OF THE PUBLIC from iodine-131, iodine-133, tritium and all radionuclides in particulate form with half-lives greater than 8 days in gaseous effluents released from the site to areas at or beyond the SITE BOUNDARY (See Figure I2.2-la) shall be limited to the following:
l ODCM Rev. 17 Page 41 l
a               a.       During any calendar quarter:     less than or equal to 15 mrems to any organ and,
11/95 DOSE - IODINE - 133. TRITIUM. AND RADIONUCLIDES IN PARTICULATE FORM j
: b.       During any calendar year:     less than or equal to 30 mreme to any organ.
CONTROLS 3.3.4 The dose to a MEMBER OF THE PUBLIC from iodine-131, iodine-133, tritium and all radionuclides in particulate form with half-lives greater than 8 days in gaseous effluents released from the site to areas at or beyond the SITE BOUNDARY (See Figure I2.2-la) shall be limited to the following:
APPLICABILITY:         At all times.
a a.
During any calendar quarter:
less than or equal to 15 mrems to any organ and, b.
During any calendar year:
less than or equal to 30 mreme to any organ.
APPLICABILITY:
At all times.
ACTIOE:
ACTIOE:
: a.       With the calculated dose from the release of iodine-131, iodine-133, tritium and all radionuclides in particulate form with half-lives greater than 8 days in gaseous effluents exceeding any of the above limits, prepare and submit to the Commission within 30 days, pursuant to Technical Specification 6.9.2, a Special Report which identifies the cause(s) for exceeding the limit and defines the corrective actions that have been taken to reduce the releases and the proposed corrective actions to be taken to assure that subsequent releases will be in compliance with the above limits.
a.
SURVEILLANCE REOUIREMENTS 3.3.4-1 Cumulative dose contributions for the current calendar quarter and current calendar year for iodine-131, iodine-133, tritium and radionuclides     1 particulate form with half-lives greater than 8 days shall be determined using ST-0-104-879-0 once per 31 days.
With the calculated dose from the release of iodine-131, iodine-133, tritium and all radionuclides in particulate form with half-lives greater than 8 days in gaseous effluents exceeding any of the above limits, prepare and submit to the Commission within 30 days, pursuant to Technical Specification 6.9.2, a
Special Report which identifies the cause(s) for exceeding the limit and defines the corrective actions that have been taken to reduce the releases and the proposed corrective actions to be taken to assure that subsequent releases will be in compliance with the above limits.
SURVEILLANCE REOUIREMENTS 3.3.4-1 Cumulative dose contributions for the current calendar quarter and current calendar year for iodine-131, iodine-133, tritium and radionuclides 1 particulate form with half-lives greater than 8 days shall be determined using ST-0-104-879-0 once per 31 days.


l                                                                                                             'ODCM Rev. 17 Page 42 l                                                                                                                             11/95 VENTILATION EXHAUST TREATMENT SYSTEM CONTROLS 3.3.5   The VE.' 'ILATION EXHAUST TREATMENT SYSTEM shall be IN SERVICE and appropriate portions of the system shall be used to reduce radioactive material in gaseous waste prior to their discharge when the projected doses due to gaseous effluent releases, from the site to areas at and beyond the SITE BOUNDARY (See Figure I2.2-la) when averaged over 31 days would exceed 0.6 mrem to any organ in a 31-day period.
l
APPLICABILITY:       At all times.
'ODCM Rev. 17 Page 42 l
11/95 VENTILATION EXHAUST TREATMENT SYSTEM CONTROLS 3.3.5 The VE.' 'ILATION EXHAUST TREATMENT SYSTEM shall be IN SERVICE and appropriate portions of the system shall be used to reduce radioactive material in gaseous waste prior to their discharge when the projected doses due to gaseous effluent releases, from the site to areas at and beyond the SITE BOUNDARY (See Figure I2.2-la) when averaged over 31 days would exceed 0.6 mrem to any organ in a 31-day period.
APPLICABILITY:
At all times.
ACTION:
ACTION:
: a. With gaseous waste being discharged without treatment, or in excess of the above limits, prepare and submit to the Commission within 30 days, pursuant to Technical Specification 6.9.2, a Special Report which includes the following information:
a.
: 1. Explanation of why gaseous radwaste was being discharged without treatment, identification of any inoperable equipment or subsystems, and the reason for                                                                       {
With gaseous waste being discharged without treatment, or in excess of the above limits, prepare and submit to the Commission within 30 days, pursuant to Technical Specification 6.9.2, a Special Report which includes the following information:
1.
Explanation of why gaseous radwaste was being discharged without treatment, identification of any inoperable equipment or subsystems, and the reason for
{
the inoperability.
the inoperability.
: 2. Action (s) taken to restore the inoperable equipment to OPERABLE status, and
2.
: 3.     Summary description of action (s) taken to prevent a recurrence.
Action (s) taken to restore the inoperable equipment to OPERABLE status, and 3.
SURVEILLANCE REOTTIREMENTS 3.3.5-1       Doses due to gaseous releases from the site to areas at and beyond the SITE BOUNDARY shall be projected at least once per 31 days using ST-0-104-879-0.
Summary description of action (s) taken to prevent a recurrence.
_      _                                    _  _ ~ _ . _          _            . - _ _ . . _      , _ _ _ _              ,._ _ .
SURVEILLANCE REOTTIREMENTS 3.3.5-1 Doses due to gaseous releases from the site to areas at and beyond the SITE BOUNDARY shall be projected at least once per 31 days using ST-0-104-879-0.
~


i l'                                                                           ODCM Rev. 17 Pags 43 l                                                                                   11/95 VENTING OR PURGING CONTROLS i
i l'
3.3.6           The VENTING or PURGING of the Mark II c7ntainment shall be                         i through the standby gas treatment system.                                         l l
ODCM Rev. 17 Pags 43 l
APPLICABILITY:             Whenever the containment is vented or purged.*                         d ACTION:
11/95 VENTING OR PURGING CONTROLS i
: a. With the requirements of the above specification not                       ;
3.3.6 The VENTING or PURGING of the Mark II c7ntainment shall be i
satisfied, suspend all VENTING and PURGING of the                           '
through the standby gas treatment system.
containment.
l l
SURVEILLANCE REOUIREMENTS 3.3.6-1     The containment shall be determined to be aligned for VENTING or PURGING through the standby gas treatment                   i system within 4 hours prior to start of and at least once per 12 hours during VENTING or PURGING of the containment.
APPLICABILITY:
3.3.6-2     Prior to use of the purge system through the standby gas treatment system assure that:
Whenever the containment is vented or purged.*
: a. Both standby gas treatment system trains are OPERABLE                   l whenever the purge system is in use, and                               I
d ACTION:
: b. Whenever the purge system is in use during OPERATIONAL CONDITION 1 or 2 or 3, only one of the standby gas treatment system trains shall be used to prevent damage to both trains should a LOCA occur (LCO 3.6.5.3 ACTION a applies during this configuration).
a.
Except after Containment is deinerted and purged while the                         i reactor is in OPCON 4 or 5                                                         '
With the requirements of the above specification not satisfied, suspend all VENTING and PURGING of the containment.
QE for the one inch /two inch vent valves to the Reactor                           !
SURVEILLANCE REOUIREMENTS 3.3.6-1 The containment shall be determined to be aligned for VENTING or PURGING through the standby gas treatment i
Enclosure Equipment Compartment Exhaust Filters rhen used for                     l containment pressure control and nitrogen make-up operations.
system within 4 hours prior to start of and at least once per 12 hours during VENTING or PURGING of the containment.
3.3.6-2 Prior to use of the purge system through the standby gas treatment system assure that:
a.
Both standby gas treatment system trains are OPERABLE whenever the purge system is in use, and b.
Whenever the purge system is in use during OPERATIONAL CONDITION 1 or 2 or 3, only one of the standby gas treatment system trains shall be used to prevent damage to both trains should a LOCA occur (LCO 3.6.5.3 ACTION a applies during this configuration).
Except after Containment is deinerted and purged while the i
reactor is in OPCON 4 or 5 QE for the one inch /two inch vent valves to the Reactor Enclosure Equipment Compartment Exhaust Filters rhen used for containment pressure control and nitrogen make-up operations.
l l
l l
i l
i l
l 1
u 4
u 4


I i
i l
l                                                                                      ODCM Rev. 17 Page 44 l
ODCM Rev. 17 l
11/95 RADIOACTIVE EFFLUENTS TOTAL DOSE
Page 44 11/95 RADIOACTIVE EFFLUENTS TOTAL DOSE
{
{
CONTROLS.                                                                                                 '
CONTROLS.
3.3.7   The annual (calendar year) dose or dose commitment to any MEMBER OF THE PUBLIC, due to releases of radioactivity and radiation, from uranium fuel cycle sources shall be limited to                                 ;
3.3.7 The annual (calendar year) dose or dose commitment to any MEMBER OF THE PUBLIC, due to releases of radioactivity and radiation, from uranium fuel cycle sources shall be limited to less than or equal to 25 mrems to the total body or any organ,
l less than or equal to 25 mrems to the total body or any organ, except the thyroid, which shall be limited to less than or                                     )'
)
equal to 75 mrems.
except the thyroid, which shall be limited to less than or equal to 75 mrems.
APPLICABILITY:     At all times.
APPLICABILITY:
At all times.
ACTION:
ACTION:
1
1
: a. With the calculated doses from the release of radioactive                                           j materials in liquid or gaseous effluents exceeding twice the                                       l limits of ODCM Controls I3.2.3.a, I3.2.3.b, I3.3.3.a, I3.3.3.b,                                   !
: a. With the calculated doses from the release of radioactive j
I3.3.4.a or I3.3.4.b, calculations shall be made including direct radiation contributions from the reactor units and from outside storage tanks to determine whether the above limits of ODCM Control 3.3.7 have been exceeded.                 If such is the case, prepare and submit to the Commission within 30 days, pursuant to                                   ,
materials in liquid or gaseous effluents exceeding twice the l
Technical Specification 6.9.2, a Special Report that defines the                                 I corrective action to be taken to reduce subsequent releases to prevent recurrence of exceeding the above limits and includes i'
limits of ODCM Controls I3.2.3.a, I3.2.3.b, I3.3.3.a, I3.3.3.b, I3.3.4.a or I3.3.4.b, calculations shall be made including direct radiation contributions from the reactor units and from outside storage tanks to determine whether the above limits of ODCM Control 3.3.7 have been exceeded.
If such is the case, prepare and submit to the Commission within 30 days, pursuant to Technical Specification 6.9.2, a Special Report that defines the I
corrective action to be taken to reduce subsequent releases to prevent recurrence of exceeding the above limits and includes i
the schedule for achieving conformance with the above limits.
the schedule for achieving conformance with the above limits.
l       This Special Report, as defined in 10 CFR 20.2203, shall include an analysis that estimates the radiation exposure (dose) to a MEMBER OF THE PUBLIC from the uranium fuel cycle sources, including all effluent pathways and direct radiation, for the calendar year that includes the release (s) covered by this report. It shall also describe levels of radiation and concentration of radioactive material involved, and the cause of                                   ;
l This Special Report, as defined in 10 CFR 20.2203, shall include an analysis that estimates the radiation exposure (dose) to a MEMBER OF THE PUBLIC from the uranium fuel cycle sources, including all effluent pathways and direct radiation, for the calendar year that includes the release (s) covered by this report.
the exposure levels or concentrations. If the estimated dose (s)                                   i exceeds the above limits, and if the release condition resulting in violation 40 CFR Part 190 has not already been corrected, Lhe Special Report shall include a request for a variance in accordance with the provisions of 40 CFR Part 190.                   Submittal of the report is considered a timely request, and a variance is granted until staff action on the request is complete.
It shall also describe levels of radiation and concentration of radioactive material involved, and the cause of the exposure levels or concentrations.
If the estimated dose (s) i exceeds the above limits, and if the release condition resulting in violation 40 CFR Part 190 has not already been corrected, Lhe Special Report shall include a request for a variance in accordance with the provisions of 40 CFR Part 190.
Submittal of the report is considered a timely request, and a variance is granted until staff action on the request is complete.
SURVEILLANCE REOUIREMENTS 3.3.7-1 Cumulative dose contributions from liquid and gaseous effluents shall be determined using ST-0-104-878-0, ST-0-104-879-0.
SURVEILLANCE REOUIREMENTS 3.3.7-1 Cumulative dose contributions from liquid and gaseous effluents shall be determined using ST-0-104-878-0, ST-0-104-879-0.
3.3.7-2 If the cumulativa dose contributions exceed the limits defined in 3.3.7a, Cumulative dose contribution from direct radiation from unit operation shall be determined using ST-0-104-878-0, ST-0-104-879-0.
3.3.7-2 If the cumulativa dose contributions exceed the limits defined in 3.3.7a, Cumulative dose contribution from direct radiation from unit operation shall be determined using ST-0-104-878-0, ST-0-104-879-0.


l                                                                               ODCM Rav. 17           j Page 45 l                                                                                             11/95     i l
l ODCM Rav. 17 j
l 3.4 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM (REMP)                                               l CONTROLS 3.4.1 The monitoring program shall be conducted as specified in Table I3.4-1.                                                                                   I APPLICABILITY:   At all times.
Page 45 l
11/95 i
3.4 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM (REMP)
CONTROLS 3.4.1 The monitoring program shall be conducted as specified in Table I3.4-1.
I APPLICABILITY:
At all times.
ACTION:
ACTION:
: a.     With the radiological environmental monitoring program                                   I not.being conducted as specified in Table I3.4-1, prepare and submit to the Commission, in the Annual Radiological Environmental Operating Report per ODCM Control 3.5, a description of the reasons for not' conducting the program as required and the plans for preventing a recurrence,
a.
: b.     With the level of radioactivity as the result of plant effluents in an environmental sampling medium at a specified location exceeding the reporting levels of Table I3.4-2 when averaged over any calendar quarter, prepare and submit to the Commission within 30 days, pursuant to Technical Specification 6.9.2, a Special Report that identifies the cause (s) for exceeding the limit (s) and defines the corrective actions to be taken-                               i to reduce radioactive effluents so that the potential                                   j annual dose to a MEMBER OF THE PUBLIC is less than the calendar year limits of ODCM Controls I3.2.3, I3.3.3 and I3.3.4. When more than one of the radionuclides in Table I3.4-2 are detected in the sampling medium, this report shall be submitted if:
With the radiological environmental monitoring program I
concentration ._CLL         . concentration             (:u .  , ,, u                 ,
not.being conducted as specified in Table I3.4-1, prepare and submit to the Commission, in the Annual Radiological Environmental Operating Report per ODCM Control 3.5, a description of the reasons for not' conducting the program as required and the plans for preventing a recurrence, b.
reporting level (1)           reporting level (2)                                     l When radionuclides other than those in Table I3.4-2 are detected and are the result of plant effluents, this report shall be submitted if the potential annual dose to a MEMBER OF THE PUBLIC is equal to or greater than the calendar year limits of ODCM Controls I3.2.3, I3.3.3 and I3.3.4. This report is not required if the measured level of radioactivity was not the result of plant effluents; however; in such an event, the condition shall be reported and described in the Annual                                           ;
With the level of radioactivity as the result of plant effluents in an environmental sampling medium at a specified location exceeding the reporting levels of Table I3.4-2 when averaged over any calendar quarter, prepare and submit to the Commission within 30 days, pursuant to Technical Specification 6.9.2, a Special Report that identifies the cause (s) for exceeding the limit (s) and defines the corrective actions to be taken-i to reduce radioactive effluents so that the potential j
Radiological Environmental Operating Report.                                           l i
annual dose to a MEMBER OF THE PUBLIC is less than the calendar year limits of ODCM Controls I3.2.3, I3.3.3 and I3.3.4.
i
When more than one of the radionuclides in Table I3.4-2 are detected in the sampling medium, this report shall be submitted if:
                                                                                                .~ .
concentration._CLL concentration
(:u
,,, u reporting level (1) reporting level (2)
When radionuclides other than those in Table I3.4-2 are detected and are the result of plant effluents, this report shall be submitted if the potential annual dose to a MEMBER OF THE PUBLIC is equal to or greater than the calendar year limits of ODCM Controls I3.2.3, I3.3.3 and I3.3.4.
This report is not required if the measured level of radioactivity was not the result of plant effluents; however; in such an event, the condition shall be reported and described in the Annual Radiological Environmental Operating Report.
i i
.~.
I
I


l                                                             ODCM Rev. 17 Page 46 l                                                                     11/95 RADIOLOGICAL ENVIRONMENTAL MONITORIHQ (Continued)                                 ;
l ODCM Rev. 17 Page 46 l
: c. With milk or fresh leafy vegetable samples unavailable from one or more of the sample locations required by Table I3.4-1, identify locations for obtaining                   ,
11/95 RADIOLOGICAL ENVIRONMENTAL MONITORIHQ (Continued)
replacement samples and add them to the radiological             '
With milk or fresh leafy vegetable samples unavailable c.
environmental monitoring program within 30 days. The specific locations from which samples were unavailable may then be deleted from the monitoring program.
from one or more of the sample locations required by Table I3.4-1, identify locations for obtaining replacement samples and add them to the radiological environmental monitoring program within 30 days.
The specific locations from which samples were unavailable may then be deleted from the monitoring program.
Pursuant to Technical Specification 6.14, submit as a part of or concurrent with the Annual Radioactive Effluent Release Report, a complete, legible copy of the entire ODCM, including a revised figure (s) and table for the ODCM reflecting the new location (s).
Pursuant to Technical Specification 6.14, submit as a part of or concurrent with the Annual Radioactive Effluent Release Report, a complete, legible copy of the entire ODCM, including a revised figure (s) and table for the ODCM reflecting the new location (s).
SURVEILLANCE REOUIREMENTS 3.4.1-1 The radiological environmental monitoring samples shall be collected (using ST-0-104-800-0) pursuant to Table I3.4-1 from the specific locations given in the table and figure (s) in the ODCM and shall be analyzed pursuant to the requirements of Table I3,4-1, the detection capabilities required by the Table I3.4-3.               1 1
SURVEILLANCE REOUIREMENTS 3.4.1-1 The radiological environmental monitoring samples shall be collected (using ST-0-104-800-0) pursuant to Table I3.4-1 from the specific locations given in the table and figure (s) in the ODCM and shall be analyzed pursuant to the requirements of Table I3,4-1, the detection capabilities required by the Table I3.4-3.
I
1 I
                                                            .-o- _ .            --        , .m_
.-o-
.m_


l                                                                                                                                                                                     ODCM Rev. 17 Page 47 l                                                                                                                                                                                             11/95 TABLE I3.4-1 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM NUMBER OF REPRESENTATIVE EXPOSURE PATHWAY                                                                                                   SAMPLES AND                                                         SAMPLING AND       TYPE AND FREQUENCY AND/OR SAMPLE                                                                                                   SAMPLE LOCATION"3 C
l ODCM Rev. 17 Page 47 l
COLLECTION FREQ.             OF ANALYSIS
11/95 TABLE I3.4-1 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM NUMBER OF REPRESENTATIVE EXPOSURE PATHWAY SAMPLES AND SAMPLING AND TYPE AND FREQUENCY AND/OR SAMPLE SAMPLE LOCATION"3 COLLECTION FREQ.
: 1. DIRECT RADIATION *)                                                                                   40 routine monitoring stations                                         At least Quarterly         Gamma dose at least either with two or more.dosi-                                                                   _ quarterly.
OF ANALYSIS C
: 1. DIRECT RADIATION *)
40 routine monitoring stations At least Quarterly Gamma dose at least either with two or more.dosi-
_ quarterly.
meters or with one instrument for measuring and recording dose rate continuously placed as follows:
meters or with one instrument for measuring and recording dose rate continuously placed as follows:
(1) An inner ring of stations, one in each meteorological 4
(1) An inner ring of stations, one in each meteorological sector, in the general area of 4
sector, in the general area of the SITE BOUNDARY: (2) An outer l                                                                                                                                 ring of stations, one in each-meteorological sector, in the 3-9 mile range from the site; (3) The balance of the stations placed in special interest areas
the SITE BOUNDARY: (2) An outer l
'l such as population centers, nearby residences, schools and in 4                                                                                                                                  1 or 2 areas to serve as control l                                                                                                                                 stations.
ring of stations, one in each-meteorological sector, in the 3-9 mile range from the site; (3) The balance of the stations placed in special interest areas
'l such as population centers, nearby residences, schools and in 1 or 2 areas to serve as control 4
l stations.
1 i
1 i
l J
l J


l ODCM Rev. 17 Page 48 l                                                                                                       11/95 TABLE I3.4-1 (Continued)
l ODCM Rev. 17 Page 48 l
RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM NUMBER OF REPRESENTATIVE EXPOSURE PATHWAY                                               SAMPLES AND                     SAMPLING AND                                                             TYPE AND FREQUENCY AND/OR SAMPLE                                               SAMPLE LOCATION (*)       COI LECTION FREQ.                                                                   OF ANALYSIS
11/95 TABLE I3.4-1 (Continued)
: 2. AIRBORNE Radiciodine and                                 Samples from 5 locations:               Continuous sampler                                                       Radiciodine canisters:
RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM NUMBER OF REPRESENTATIVE EXPOSURE PATHWAY SAMPLES AND SAMPLING AND TYPE AND FREQUENCY AND/OR SAMPLE SAMPLE LOCATION (*)
Particulates                                     a.3 samples from close to the           operation with sample I-131 analysis 3 SITE BOUNDARY locations (in         collection weekly, or                                                       weekly.
COI LECTION FREQ.
different sectors) of the             more frequently if highest calculated annual             required by dust                                                           Particulate Sampler:
OF ANALYSIS
average ground level x/Q.             loading".                                                                   Gross beta radio activity analysis b.1 sample from the vicinity                                                                                         following filter community having one of the highest calculated annual                                                                                         change:d ground level x/Q.                                                                                                 Gamma isotopic 1 sample from a control loca-                                                                                     analysis
: 2. AIRBORNE Radiciodine and Samples from 5 locations:
* of tion, as for example 15-30 km                                                                                     composite (by distant and in the least pre-                                                                                     location) at least valent wind direction.                                                                                             quarterly
Continuous sampler Radiciodine canisters:
Particulates a.3 samples from close to the operation with sample I-131 analysis 3 SITE BOUNDARY locations (in collection weekly, or weekly.
different sectors) of the more frequently if highest calculated annual required by dust Particulate Sampler:
average ground level x/Q.
loading".
Gross beta radio activity analysis b.1 sample from the vicinity following filter community having one of the highest calculated annual change:d ground level x/Q.
Gamma isotopic 1 sample from a control loca-analysis
* of tion, as for example 15-30 km composite (by distant and in the least pre-location) at least valent wind direction.
quarterly


l                                                                                                                 ODCM Rev. 17 Page 49 l                                                                                                                         11/95 TABLE I3.4-1 (Continued)
l ODCM Rev. 17 Page 49 l
RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM NUMBER OF REPRESENTATIVE EXPOSURE PATHWAY                                                           SAMPLES AND                       SAMPLING AND         TYPE AND FREQUENCY AND/OR SAMPLE                                                           SAMPLE LOCATION (')               COLLECTION FREQ.           OF ANALYSIS 3.WATERBO?NE a . Surf ace'                                                     I sample upstream                       Composite sample Gamma isotopic analysis' 1 sample downstream                     over 1-month         monthly. Composite for period 8             tritium analysis quarterly.
11/95 TABLE I3.4-1 (Continued)
: b. Ground                                                       Samples from 1 or 2 sources             Quarterly.
RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM NUMBER OF REPRESENTATIVE EXPOSURE PATHWAY SAMPLES AND SAMPLING AND TYPE AND FREQUENCY AND/OR SAMPLE SAMPLE LOCATION (')
only if likely to be affectedh
COLLECTION FREQ.
: c. Drinking                                                     1 sample of each on 1 to 3 of           Monthly.             I-131 analysis on each of the nearest water supplies             (Composite)         composite when the dose that could be affected by its                                 calculated for the con-discharge.                                                     sumption of the water is greater than 1 mrem per 1 sample from a control                                       year.1 Composite for gross location                                                       beta and gamma isotopic analysis monthly. Comp-osite for tritium analysis quarterly.
OF ANALYSIS 3.WATERBO?NE a. Surf ace' I sample upstream Composite sample Gamma isotopic analysis' 1 sample downstream over 1-month monthly. Composite for period 8 tritium analysis quarterly.
: d. Sediment from                                                 1 sample from downstream area           Semiannually.         Gamma isotopic analysis' shoreline                                                   with existing or potential                                     semiannually.
: b. Ground Samples from 1 or 2 sources Quarterly.
h only if likely to be affected
: c. Drinking 1 sample of each on 1 to 3 of Monthly.
I-131 analysis on each of the nearest water supplies (Composite) composite when the dose that could be affected by its calculated for the con-discharge.
sumption of the water is greater than 1 mrem per 1 sample from a control year.1 Composite for gross location beta and gamma isotopic analysis monthly.
Comp-osite for tritium analysis quarterly.
: d. Sediment from 1 sample from downstream area Semiannually.
Gamma isotopic analysis' shoreline with existing or potential semiannually.


r i;
r i;
i l                                                                                     ODCM Rev. 17                                                               [
i l
                                                                                                    -Page 50                                                               ,
ODCM Rev. 17
l                                                                                              11/95
[
* TABLE I3.4-1 (Continued)                                                                                                         ,
-Page 50 l
t RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM I
11/95 TABLE I3.4-1 (Continued) t RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM I
NUMBER OF REPRESENTATIVE                                                                                                                           ,
NUMBER OF REPRESENTATIVE EXPOSURE PATHWAY SAMPLES AND SAMPLING AND TYPE AND FREQUENCY AND/OR SAMPLE SAMPLE LOCATION (*)
EXPOSURE PATHWAY           SAMPLES AND                                   SAMPLING AND                       TYPE AND FREQUENCY AND/OR SAMPLE           SAMPLE LOCATION (*)                   COLLECTION FREQ.                                 OF ANALYSIS                                           t
COLLECTION FREQ.
: 4. INGESTION 4     a. Milk         Samples from milking animals                         Semimonthly when                   Gamma isotopic' and I-131 in 3 locations within 5 km                           animals are on                     analysis semimonthly when distance having the highest                         pasture, monthly                     animals are on pasture dose potential. If there are                         at other times.                     (April 1 - Oct. 1):
OF ANALYSIS t
none, then 1 sample from                                                                 monthly at other times.                                   t milking animals in each of                                                                                                                         ;
: 4. INGESTION 4
3 areas between 5 to 8 km                                                                                                                         !
: a. Milk Samples from milking animals Semimonthly when Gamma isotopic' and I-131 in 3 locations within 5 km animals are on analysis semimonthly when distance having the highest pasture, monthly animals are on pasture dose potential.
distance where dose are cal-culated to be greater than 1 mrem per year.'                                                                                                                                   i i sample from milking animals                                                                                                                     ,
If there are at other times.
f at a control location (15-30 km distance) and in the                                                                                                                         ;
(April 1 - Oct. 1):
least wind direction.
none, then 1 sample from monthly at other times.
i
t milking animals in each of 3 areas between 5 to 8 km distance where dose are cal-culated to be greater than i
: b. Fish and     1 sample of two recreationally Sample in season,                                         Gamma isotopic
1 mrem per year.'
* r
i i sample from milking animals at a control location (15-f 30 km distance) and in the least wind direction.
.        Invertebrates important species in vicinity                   or semiannually                         analysis on edible of plant discharge area. 1                       if they are not                       portions.
i r
b.
Fish and 1 sample of two recreationally Sample in season, Gamma isotopic
* Invertebrates important species in vicinity or semiannually analysis on edible of plant discharge area. 1 if they are not portions.
sample of same species in area seasonal.
sample of same species in area seasonal.
* not influenced by plant discharge.
not influenced by plant discharge.
1 I
1 I
t t
t t
_.__m___._ _ . . _ _  _._.____________.____.__&_
,2
_ - - _ -      ,2   -w - _u--          _ __ _ _ - . . _ _ _ _ _ _.
-w u--
m


l ODCM Rev. 17 Page 51 l                                                                                                 11/95 TABLE I3.4-1 (Continueel RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM NUMBER OF REPRESENTATIVE EXPOSURE PATHWAY                                 SAMPLES AND                         SAMPLING AND             TYPE AND FREQUENCY AND/OR SAMPLE                             SAMPLE LOCATION <a)                     COLLECTION FREQ.                 OF ANALYSIS
l ODCM Rev. 17 Page 51 l
: 4. INGESTION (Continued)
11/95 TABLE I3.4-1 (Continueel RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM NUMBER OF REPRESENTATIVE EXPOSURE PATHWAY SAMPLES AND SAMPLING AND TYPE AND FREQUENCY AND/OR SAMPLE SAMPLE LOCATION <a)
: c. Food Products Samples of 3 different kinds of                                 Monthly when avail-           Gamma isotopic' and broad leaf vegetation grown                     able, if milk sampling       I-131 analysis.
COLLECTION FREQ.
nearest each of 2 different                     is not preformed.
OF ANALYSIS
: 4. INGESTION (Continued) c.
Food Products Samples of 3 different kinds of Monthly when avail-Gamma isotopic' and broad leaf vegetation grown able, if milk sampling I-131 analysis.
nearest each of 2 different is not preformed.
offsite locations of highest predicted annual average ground level D/Q if milk sampling is not preformed.
offsite locations of highest predicted annual average ground level D/Q if milk sampling is not preformed.
1 sample of each of the similar Monthly when avail-                           Gamma isotopic' and broad leaf vegetation grown                     able, if milk sampling       I-131 analysis.
1 sample of each of the similar Monthly when avail-Gamma isotopic' and broad leaf vegetation grown able, if milk sampling I-131 analysis.
15-30 km distance in the least                 is not performed.
15-30 km distance in the least is not performed.
prevalent wind direction if milk sampling is not performed.
prevalent wind direction if milk sampling is not performed.


I q
q l
l                                                                              ODCM Rev. 17 Page 52 l                                                                                     11/95 RADIOLOGICAL ENVIRONMENTAL MONITORING TABLE I3.4-1 (Continued)
ODCM Rev. 17 Page 52 l
TABLE NOTATIONS
11/95 RADIOLOGICAL ENVIRONMENTAL MONITORING TABLE I3.4-1 (Continued)
: a.      Specific parameters of distance and direction sector form the centerline of the two reactors and additional description where pertinent, shall be provided for each and every sample location in Table 13.4-1 in a table and figure (s) in the'ODCM. Deviations are permitted from the required sampling schedule if specimens are unobtainable due to hazardous conditions, seasonal unavailability, malfunction of automatic sampling equipment and other legitimate reasons. If specimens are unobtainable due to sampling equipment malfunction, every effort shall be made to                         .
TABLE NOTATIONS Specific parameters of distance and direction sector form the a.
complete corrective action prior to the end of the next sampling period. All deviations from the' sampling schedule shall be documented in the Annual Radiological Environmental Operating Report pursuant to ODCM Control 3.5.               It is recognized that, at times, it may not be possible or practicable to continue to obtain samples of the media of choice at the most desired location or time.         In these instances suitable alternative media               ;
centerline of the two reactors and additional description where pertinent, shall be provided for each and every sample location in Table 13.4-1 in a table and figure (s) in the'ODCM.
and locations may be chosen for the particular pathway-in l
Deviations are permitted from the required sampling schedule if specimens are unobtainable due to hazardous conditions, seasonal unavailability, malfunction of automatic sampling equipment and other legitimate reasons.
question and appropriate substitutions made within 30 days in the                     '
If specimens are unobtainable due to sampling equipment malfunction, every effort shall be made to complete corrective action prior to the end of the next sampling period.
radiological environmental monitoring program. Pursuant to Technical Specification 6.14, submit as a part of or concurrent                       .
All deviations from the' sampling schedule shall be documented in the Annual Radiological Environmental Operating Report pursuant to ODCM Control 3.5.
uith the next Annual Radioactive Uffluent Release Report a                             l complete legible copy.of the ODCM including a revised figure (s)                       I and table for the ODCM reflecting the new location (s).
It is recognized that, at times, it may not be possible or practicable to continue to obtain samples of the media of choice at the most desired location or time.
: b.       One or more instruments, such as a pressurized ion chamber, for                       I measuring and recoding dose rate continuously may be used in place of, or in addition to, integrating dosimeters. For the purpose of this table, a thermoluminescent dosimeter (TLD) is considered to be one phosphor; two or more phosphors in a packet are considered as two or more dosimeters. Film badges shall not                       l be used as dosimeters for measuring direct radiation.
In these instances suitable alternative media and locations may be chosen for the particular pathway-in question and appropriate substitutions made within 30 days in the radiological environmental monitoring program.
: c.       Methodology for recovery of radiciodine shall be described in the ODCM.
Pursuant to Technical Specification 6.14, submit as a part of or concurrent uith the next Annual Radioactive Uffluent Release Report a l
: d.       Airborne particulate sample filters shall be analyzed for gross                       !
complete legible copy.of the ODCM including a revised figure (s) and table for the ODCM reflecting the new location (s).
i beta radioactivity 24 hours or mere after sampling to allow for radon and thoron daughter decay. If gross beta activity is air particulate samples is greater t hat 10 times the yearly mean of control samples, gamma isotopic analysis shall be performed on                         j the individual samples.
b.
: e.       Gamma isotopic analysis means the identification and quantification of gamma-emitting radionuclides that may be attributable to the effluents from the facility.
One or more instruments, such as a pressurized ion chamber, for I
measuring and recoding dose rate continuously may be used in place of, or in addition to, integrating dosimeters.
For the purpose of this table, a thermoluminescent dosimeter (TLD) is considered to be one phosphor; two or more phosphors in a packet are considered as two or more dosimeters.
Film badges shall not be used as dosimeters for measuring direct radiation.
c.
Methodology for recovery of radiciodine shall be described in the ODCM.
d.
Airborne particulate sample filters shall be analyzed for gross i
beta radioactivity 24 hours or mere after sampling to allow for radon and thoron daughter decay.
If gross beta activity is air particulate samples is greater t hat 10 times the yearly mean of control samples, gamma isotopic analysis shall be performed on j
the individual samples.
e.
Gamma isotopic analysis means the identification and quantification of gamma-emitting radionuclides that may be attributable to the effluents from the facility.


l                                                                                 ODCM Rev. 17         I Page 53 l                                                                                       11/95           <
l ODCM Rev. 17 I
: f. The " upstream sample" shall be taken'at a distance beyond significant influence of the discharge. The " downstream sample"                                   J shall be taken in an area beyond but near the mixing zone.
Page 53 l
: g. A composite sample is one in which the quantity (aliquot) of                                           l liquid sampled is proportional to the quantity of flowing liquid and in which the method of sampling employed-results in a                                             ;
11/95 f.
specimen that is representative of the liquid flow. In this                                           J program composite sample aliquots shall be collected at time intervals that are very short (e.g., hourly) relative to the l
The " upstream sample" shall be taken'at a distance beyond significant influence of the discharge.
compositing period (e.g. , monthly) in order to assure obtaining a                                     i representative sample.
The " downstream sample" J
: h. Groundwater samples shall be taken when this source is tapped for                                     I drinking or irrigation purposes in areas where the hydraulic gradient or recharge properties are suitable for contamination.
shall be taken in an area beyond but near the mixing zone.
: i. The dose shall be calculated for the maximum organ and age group, using ST-0-104-878-0.
g.
j l'
A composite sample is one in which the quantity (aliquot) of liquid sampled is proportional to the quantity of flowing liquid and in which the method of sampling employed-results in a specimen that is representative of the liquid flow.
s 4
In this J
program composite sample aliquots shall be collected at time intervals that are very short (e.g.,
hourly) relative to the l
compositing period (e.g., monthly) in order to assure obtaining a i
representative sample.
h.
Groundwater samples shall be taken when this source is tapped for I
drinking or irrigation purposes in areas where the hydraulic gradient or recharge properties are suitable for contamination.
i.
The dose shall be calculated for the maximum organ and age group, using ST-0-104-878-0.
j s
4


l                                                             ODCM Rev. 17 Page 54 l                                                                     11/95 TABLE I3.4-2 REPORTING LEVELS FOR RADIOACTIVITY CONCENTRATIONS IN ENVIRONMENTAL SAMPLES Reoortina Levels AIRBORNE                                 FOOD WATER   PARTICULATE or       FISH       MILK     PRODUCTS ANALYSIS   (pCi/L)   GASES (pCi/m 8)   (pCi/kg, wet) (pCi/L) (pCi/kg, wet)
l ODCM Rev. 17 Page 54 l
H-3       20,000*
11/95 TABLE I3.4-2 REPORTING LEVELS FOR RADIOACTIVITY CONCENTRATIONS IN ENVIRONMENTAL SAMPLES Reoortina Levels AIRBORNE FOOD WATER PARTICULATE or FISH MILK PRODUCTS ANALYSIS (pCi/L)
Mn-54       1,000                       30,000 Fe-59         400                       10,000 Co-58       1,000                       30,000 Co-60         300                       10,000 Zn-65         300                       20,000 Zr-Nb-95       400**
GASES (pCi/m )
I-131           2         0.9                           3         100 Cs-134         30       10               1,000       60       1,000 Cs-137         50       20               2,000       70       2,000 Ba-La-140     200**                                   300
(pCi/kg, wet) (pCi/L) (pCi/kg, wet) 8 H-3 20,000*
* For drinking water samples. This is 40 CFR Part 141 value. If   no drinking pathway exists, a value of 30,000 pCi/L may be used.
Mn-54 1,000 30,000 Fe-59 400 10,000 Co-58 1,000 30,000 Co-60 300 10,000 Zn-65 300 20,000 Zr-Nb-95 400**
I-131 2
0.9 3
100 Cs-134 30 10 1,000 60 1,000 Cs-137 50 20 2,000 70 2,000 Ba-La-140 200**
300
* For drinking water samples.
This is 40 CFR Part 141 value.
If no drinking pathway exists, a value of 30,000 pCi/L may be used.
** Total for parent and daughter.
** Total for parent and daughter.


l                                                                                                             ODCM Rev. 17 Page 55           i l                                                                                                                   11/95           .
l ODCM Rev. 17 Page 55 i
I TABLE I3.4-3                                                                   l DETECTION CAPABILITIES FOR ENVIRONMENTAL SAMPLE ANALYSIS (*)                                                                     i Lower limit of Detection (T.T.n) W M AIRBORNE'                                                     FOOD WATER         PARTICULATE or                         FISH     MILK           PRODUCTS         SEDIMENTS ANALYSIS (pCi/L)         GASES (pCi/m2)                       (pCi/kg, (pCi/L)           (pCi/kg,         (pCi/kg,                       l wet)                         wet)                   dry)                   i Gross Beta           4         0.01 H-3     2,000 l
l 11/95 TABLE I3.4-3 DETECTION CAPABILITIES FOR ENVIRONMENTAL SAMPLE ANALYSIS (*)
l Mn-54               15                                         130 Fe-59               30                                         260 Co-58,60             15                                         130 Zn-65               30                                         260 Zr-95               30 Nb-95               15 I-131               1*       0.07                                       1               60 Cs-134               15         0.05                           130       15               60                     150 Cs-137               18         0.06                           150       18               80                     180 Ba-140               60                                                   60 La-140               15                                                   15 i
i Lower limit of Detection (T.T.n) W M AIRBORNE' FOOD WATER PARTICULATE or FISH MILK PRODUCTS SEDIMENTS ANALYSIS (pCi/L)
I i
GASES (pCi/m )
(pCi/kg, (pCi/L)
(pCi/kg, (pCi/kg, 2
wet) wet) dry) i Gross Beta 4
0.01 H-3 2,000 l
Mn-54 15 130 Fe-59 30 260 Co-58,60 15 130 Zn-65 30 260 Zr-95 30 Nb-95 15 I-131 1*
0.07 1
60 Cs-134 15 0.05 130 15 60 150 Cs-137 18 0.06 150 18 80 180 Ba-140 60 60 La-140 15 15 i
i


l l                                                              ODCM Rsv. 17 l Page 56 l                                                                     11/95 i l
l ODCM Rsv. 17 Page 56 l
l TABLE I3.4-3 (Continued)
11/95 TABLE I3.4-3 (Continued)
TABLE NOTATIONS (a)   This list dose not mean that only these nuclides are to considered. Other peaks that are identifiable at 95% confidence level, together with those of the above nuclides, shall also be analyzed and reported in the Annual Radiological Environmental           ,
TABLE NOTATIONS (a)
Operating report pursuant to ODCM Control 3.5.                           '
This list dose not mean that only these nuclides are to considered.
(b)   Required detection capabilities for thermoluminescent dosimeters used for environmental measurements are given in Regulatory Guide 4.13.
Other peaks that are identifiable at 95% confidence level, together with those of the above nuclides, shall also be analyzed and reported in the Annual Radiological Environmental Operating report pursuant to ODCM Control 3.5.
(c)   The LLD is defined, for purposes of these controls, as the smallest concentration of radioactive material in a sample that will yield a net count (above system background) that will be detected with 95% probability with only 5% probability of falsely concluding that a blank observation represents a "real" signal.
(b)
Required detection capabilities for thermoluminescent dosimeters used for environmental measurements are given in Regulatory Guide 4.13.
(c)
The LLD is defined, for purposes of these controls, as the smallest concentration of radioactive material in a sample that will yield a net count (above system background) that will be detected with 95% probability with only 5% probability of falsely concluding that a blank observation represents a "real" signal.
For a particular measurement system (which may include radiochemical separation):
For a particular measurement system (which may include radiochemical separation):
4.66s s LLD=
4.66ss LLD=
EV     2.22     Y exp (-AAt)                               I Where:                                                                         l LLD is the a priori lower limit of detection as defined above           l (as picocuries per unit mass or volume),
EV 2.22 Y
s s is the standard deviation of the background counting rate or         ,
exp (-AAt)
of the counting rate of blank sample as appropriate (as counts           l per minute),                                                             l E is the counting efficiency (as counts per disintegration),
Where:
1 V is the sample size (in units of mass or volume),                       l 2.22 is the number of disintegrations per minute per picoeurie, Y is the fractional radiochemical yield (when applicable),
l LLD is the a priori lower limit of detection as defined above (as picocuries per unit mass or volume),
s is the standard deviation of the background counting rate or s
of the counting rate of blank sample as appropriate (as counts per minute),
E is the counting efficiency (as counts per disintegration),
V is the sample size (in units of mass or volume),
2.22 is the number of disintegrations per minute per picoeurie, Y is the fractional radiochemical yield (when applicable),
A is the radioactive decay constant for the particular radionuclide, and At for the environmental samples is the elapeed time between sample collection (or end of the sample collection period) and time of counting.
A is the radioactive decay constant for the particular radionuclide, and At for the environmental samples is the elapeed time between sample collection (or end of the sample collection period) and time of counting.
Typical values of E, V, Y, and at should be used in calculation.
Typical values of E, V, Y,
and at should be used in calculation.


l                                                             ODCM Rev.'17 Page 57 l                                                                     11/95 l TABLE I3.4-3 (Continued)
l ODCM Rev.'17 Page 57 l
TABLE NOTATIONS It should be recognized that the LLD is defined as an a oriori (before the fact) limit representing the capability of a measurement system and not as an after the fact limit for a particular measurement. Analyses shall be performed in such a manner that the stated LLDs will be achieved under routine conditions. Occasionally background fluctuations, unavoidably small sample sizes, the presence of interfering nuclides, or other uncontrollable circumstances may render these LLDs unachievable. In such canes, the contributing factors shall be identified and described in the Annual Radiological Environmental Operating Report pursuant to ODCM Control 3.5.
11/95 TABLE I3.4-3 (Continued)
(d)   LLD for drinking water samples.
TABLE NOTATIONS It should be recognized that the LLD is defined as an a oriori (before the fact) limit representing the capability of a measurement system and not as an after the fact limit for a particular measurement.
Analyses shall be performed in such a manner that the stated LLDs will be achieved under routine conditions.
Occasionally background fluctuations, unavoidably small sample sizes, the presence of interfering nuclides, or other uncontrollable circumstances may render these LLDs unachievable.
In such canes, the contributing factors shall be identified and described in the Annual Radiological Environmental Operating Report pursuant to ODCM Control 3.5.
(d)
LLD for drinking water samples.


l                                                             ODCM Rsv. 17 Page 58 l                                                                     11/95 RADIOLOGICAL ENVIRONMENTAL MONITORING 1
l ODCM Rsv. 17 Page 58 l
I LAND USE CENSUS CONTROL l
11/95 RADIOLOGICAL ENVIRONMENTAL MONITORING I
3.4.2 A land use census shall be conducted and shall identify within a           l distance of 8 km (5 miles) the location (in each of the 16                 l meteorological sectors) of the nearest garden
LAND USE CENSUS CONTROL 3.4.2 A land use census shall be conducted and shall identify within a distance of 8 km (5 miles) the location (in each of the 16 meteorological sectors) of the nearest garden
* of greater than           j 50 m2 (500 ft2) producing broad leaf or vegetables.                       j APPLICABILITY:   At all times.
* of greater than j
i ACTION:                                                                           l
50 m2 (500 ft2) producing broad leaf or vegetables.
: a. With a land use census identifying a location (s) which yields a calculation dose or dose commitment greater than the values currently being calculated in ODCM Control 3.3.4.1, identify the new lcration(s) in the next Annual Radioactive Effluent Release Report, pursuant to ODCM Control 3.6.
j APPLICABILITY:
: b. With a land use census identifying a location (s) that yields a calculated dose or dose commitment (via the same exposure pathway) 20% greater than at a location from which samples are currently being obtained in accordance with ODCM Control 3.4.1, add the new         i location (s) to the radiological environmental monitoring program within 30 days. The sampling location (s) , excluding the control station location, having the lowest calculated dose or dose commitment (s) (via the same exposure pathway) may be deleted from this monitoring program after October 31 of the year in which this land use census was conducted. Pursuant to Technical Specification 6.14, submit as a part of or concurrent within the next Annual Radioactive Effluent Release Report a complete, legible copy of the entire ODCM including a revised figure (s) and table (s) for the ODCM reflecting the new location (s).
At all times.
SURVEILLANCE REOUIREMEtTTS 3.4.2-1   The land use census shall be conducted during the growing season at least once per 12 months using that information that will provide the best results, such as by a door-to-door survey, aerial survey, or by consulting local agriculture authorities. The results of the land use census are documented in ST-0-107-991-0 and are included in the Annual Radiological Environmental Operating Report
i ACTION:
                -pursuant to ODCM Control 3.5.
With a land use census identifying a location (s) which yields a a.
Broad leaf vegetation sampling of at least 3 different kinds of vegetation may be performed at the SITE BOUNDARY in each of 2 different direction sectors with the highest predicted D/Os in lieu of the garden census. ODCM Controls for broad leaf vegetation sampling in Table I3.4-1 item 4.c. shall be followed, including analysis of control samples-.
calculation dose or dose commitment greater than the values currently being calculated in ODCM Control 3.3.4.1, identify the new lcration(s) in the next Annual Radioactive Effluent Release Report, pursuant to ODCM Control 3.6.
b.
With a land use census identifying a location (s) that yields a calculated dose or dose commitment (via the same exposure pathway) 20% greater than at a location from which samples are currently i
being obtained in accordance with ODCM Control 3.4.1, add the new location (s) to the radiological environmental monitoring program within 30 days.
The sampling location (s), excluding the control station location, having the lowest calculated dose or dose commitment (s) (via the same exposure pathway) may be deleted from this monitoring program after October 31 of the year in which this land use census was conducted.
Pursuant to Technical Specification 6.14, submit as a part of or concurrent within the next Annual Radioactive Effluent Release Report a complete, legible copy of the entire ODCM including a revised figure (s) and table (s) for the ODCM reflecting the new location (s).
SURVEILLANCE REOUIREMEtTTS 3.4.2-1 The land use census shall be conducted during the growing season at least once per 12 months using that information that will provide the best results, such as by a door-to-door survey, aerial survey, or by consulting local agriculture authorities.
The results of the land use census are documented in ST-0-107-991-0 and are included in the Annual Radiological Environmental Operating Report
-pursuant to ODCM Control 3.5.
Broad leaf vegetation sampling of at least 3 different kinds of vegetation may be performed at the SITE BOUNDARY in each of 2 different direction sectors with the highest predicted D/Os in lieu of the garden census.
ODCM Controls for broad leaf vegetation sampling in Table I3.4-1 item 4.c.
shall be followed, including analysis of control samples-.


.-  .,  .-          . - .  - .- . .    - - - -  ~ . . - - - - . - -  - -        ~-              --  -
~..
l l                                                                        ODCM Rev. 17           l Page 59 l                                                                                   11/95 RADIOLOGICAL ENVIRONMENTAL MONITORING INTERLABORATORY COMPARISON PROGRAM                                                                     j CONTROL 3.4.3   In accordance with LGS Technical Specification 3.12.3, analyses.
~-
l ODCM Rev. 17 Page 59 l
11/95 RADIOLOGICAL ENVIRONMENTAL MONITORING INTERLABORATORY COMPARISON PROGRAM j
CONTROL 3.4.3 In accordance with LGS Technical Specification 3.12.3, analyses.
shall be performed on radioactive materials supplied as part of an Interlaboratory Comparison Program which has been approved by the Commission.
shall be performed on radioactive materials supplied as part of an Interlaboratory Comparison Program which has been approved by the Commission.
APPLICABILITY:       At all times.
APPLICABILITY:
At all times.
ACTION:
ACTION:
With analyses not being performed as required above, report the                             !
With analyses not being performed as required above, report the corrective actions taken to prevent a recurrence to the Commission in the Annual Radiological Environmental Operating Report pursuant to ODCM Control 3.5.
corrective actions taken to prevent a recurrence to the Commission in the Annual Radiological Environmental Operating                               i Report pursuant to ODCM Control 3.5.
SURVEILLANCE REOUIREMENTS l
SURVEILLANCE REOUIREMENTS                                                                             l 3.4.3-1 The Interlaboratory Comparison Program shall be                                     !
3.4.3-1 The Interlaboratory Comparison Program shall be documented in ST-0-104-990-0 and described in the ODCM part II, section 4.2.
documented in ST-0-104-990-0 and described in the ODCM part II, section 4.2. A summary of the results shall be included in the Annual Radiological Environmental                             j Operating Report pursuant to ODCM Control 3.5.
A summary of the results shall be included in the Annual Radiological Environmental j
3
Operating Report pursuant to ODCM Control 3.5.
                      ~.                        .
3 i.
3             ,    r. . , - - ,__4     ._    v
~.
3 r.
,__4 v


l                                                                               ODCM Rev. 17 Page 60 l                                                                                       11/95 ANNUAL RADIOLOGICAL ENVIRONMENTAL OPERATING REPORT
l ODCM Rev. 17 Page 60 l
* l       3.5   Routine Annual Radiological Environmental Operating Report covering l             the operation of Unit 1 and Unit 2 during the previous calendar year shall be submitted prior to May 1 for each year. The initial report was submitted prior to May 1 of the year following initial                                   l criticality (1984). A single report is submitted for a multiple unit station.               The Annual Radiological Environmental Operating Report shall include summaries, interpretations, and an analysis of                         1 trends of the results report period, including a comparison (as appropriate), with preoperational studies, operational controls and previous environmental surveillance reports and an assessment of the observed impacts of the plant operation on the environment. The reports shall also include the results of land use census required by ODCM Control 3.4.2. The Annual Radiological Environmental Operating Report shall include the results of all radiological environmental samples and of all environmental radiation measurements taken during the report period pursuant to the locations specified in the tables and figures in the OFFSITE DOSE CALCULATION MANUAL, as well as summarized and tabulated results of these analyses and measurements in the format of the table in the Radiological Branch Technical Position, Revicion 1, November 1979.
11/95 ANNUAL RADIOLOGICAL ENVIRONMENTAL OPERATING REPORT
In the event that some individual results are not available for l
* l 3.5 Routine Annual Radiological Environmental Operating Report covering l
inclusion with the report, the report shall be submitted noting and                           '
the operation of Unit 1 and Unit 2 during the previous calendar year shall be submitted prior to May 1 for each year.
explaining the reasons for the missing results.                     The missing data shall be submitted as soon as possible in a supplementary report.
The initial report was submitted prior to May 1 of the year following initial l
The report shall also include the following:                     a summary description i
criticality (1984).
of the radiological environmental monitoring program and at least I
A single report is submitted for a multiple unit station.
two legible maps. One map shall cover stations near the SITE BOUNDARY; a second shall include the more detailed distant stations.
The Annual Radiological Environmental Operating Report shall include summaries, interpretations, and an analysis of trends of the results report period, including a comparison (as appropriate), with preoperational studies, operational controls and previous environmental surveillance reports and an assessment of the observed impacts of the plant operation on the environment.
The reports shall also include the results of land use census required by ODCM Control 3.4.2.
The Annual Radiological Environmental Operating Report shall include the results of all radiological environmental samples and of all environmental radiation measurements taken during the report period pursuant to the locations specified in the tables and figures in the OFFSITE DOSE CALCULATION MANUAL, as well as summarized and tabulated results of these analyses and measurements in the format of the table in the Radiological Branch Technical Position, Revicion 1, November 1979.
In the event that some individual results are not available for inclusion with the report, the report shall be submitted noting and explaining the reasons for the missing results.
The missing data shall be submitted as soon as possible in a supplementary report.
i The report shall also include the following:
a summary description of the radiological environmental monitoring program and at least two legible maps.
One map shall cover stations near the SITE BOUNDARY; a second shall include the more detailed distant stations.
Covering all sampling locations keyed to a table giving distances and directions from the centerline of the reactor plant; the results of licensee participation-in the Interlaboratory Comparison Program, required by ODCM Control I3.4.3 discussion of all deviations from the Sampling Schedule of Table I3.4-1; and discussion of all analyses in which the LLD required by Table I3.4-3 was not achievable.
Covering all sampling locations keyed to a table giving distances and directions from the centerline of the reactor plant; the results of licensee participation-in the Interlaboratory Comparison Program, required by ODCM Control I3.4.3 discussion of all deviations from the Sampling Schedule of Table I3.4-1; and discussion of all analyses in which the LLD required by Table I3.4-3 was not achievable.
l l
l I
I l
l l
l l
l l
l l
l


l                                                                 ODCM Rev. 17 Page 61 l                                                                       11/95 ADMINISTRATIVE CONTROLS                                                       .
l ODCM Rev. 17 Page 61 l
3.6   ANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT A Routine Annual Radioactive Effluent Release Report covering the operation of Unit 1 and Unit 2 during the previous 12 months of             l operation shall be submitted within 60 days after January 1 of               I each year. The period of the first report shall begin with the l       date of initial criticality. A recurring action request shall be used to generate the report. A single unit submittal is made for the 2 unit station. The submittal combines those sections that               ;
11/95 ADMINISTRATIVE CONTROLS 3.6 ANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT A Routine Annual Radioactive Effluent Release Report covering the operation of Unit 1 and Unit 2 during the previous 12 months of operation shall be submitted within 60 days after January 1 of I
are common to all units at the station. The Annual Radioactive               1 Effluent Release Report shall include a summary of the quantities of radioactive liquid and gaseous effluents and solid waste released from the facility as outlined in Regulatory Guide 1.21,
each year.
        " Measuring, Evaluation, and Reporting Radioactivity in Solid Wastes and Releases of Radioactive Materials in Liquid and Gaseous Effluents from Light-Water-Cooled Nuclear Power Plants,"
The period of the first report shall begin with the l
Revision 1, June 1974, with data summarized       on a quarterly basis following the format of Appendix B thereof.
date of initial criticality.
A recurring action request shall be used to generate the report.
A single unit submittal is made for the 2 unit station.
The submittal combines those sections that are common to all units at the station.
The Annual Radioactive Effluent Release Report shall include a summary of the quantities of radioactive liquid and gaseous effluents and solid waste released from the facility as outlined in Regulatory Guide 1.21,
" Measuring, Evaluation, and Reporting Radioactivity in Solid Wastes and Releases of Radioactive Materials in Liquid and Gaseous Effluents from Light-Water-Cooled Nuclear Power Plants,"
Revision 1, June 1974, with data summarized on a quarterly basis following the format of Appendix B thereof.
The Annual Radioactive Effluent Release Report to be submitted 60 days after January 1 of each year shall include an annual summary of hourly meteorological data collected over the previous year.
The Annual Radioactive Effluent Release Report to be submitted 60 days after January 1 of each year shall include an annual summary of hourly meteorological data collected over the previous year.
This annual summary may be either in the form of an hour-by-hour listing on magnetic tape of wind speed, wind direction and atmospheric stability, and precipitation (if measured), or in the form of joint frequency distributions of wind speed, wind direction, atmospheric stability.     The licensee has the option of retaining this summary of required meteorological data on site in           ,
This annual summary may be either in the form of an hour-by-hour listing on magnetic tape of wind speed, wind direction and atmospheric stability, and precipitation (if measured), or in the form of joint frequency distributions of wind speed, wind direction, atmospheric stability.
l a file that shall be provided to the NRC upon request.       This same report shall include an assessment of the radiation doses due to the radioactive liquid and gaseous effluents released from both             l units during the previous calendar year. This same report shall             '
The licensee has the option of retaining this summary of required meteorological data on site in a file that shall be provided to the NRC upon request.
also include an assessment of the radiation doses from radioactive liquid and gaseous effluents to MEMBER OF THE PUBLIC due to their activities inside the SITE BOUNDARY (Figures I2.2-la and I2.2-1b) during the report period.       All assumptions used in making these assessments shall be included in these reports. The assessment of radiation doses shall be performed in accordance with the methodology and parameters of the OFFSITE DOSE CALCULATION MANUAL (ODCM).
This same report shall include an assessment of the radiation doses due to the radioactive liquid and gaseous effluents released from both units during the previous calendar year.
This same report shall also include an assessment of the radiation doses from radioactive liquid and gaseous effluents to MEMBER OF THE PUBLIC due to their activities inside the SITE BOUNDARY (Figures I2.2-la and I2.2-1b) during the report period.
All assumptions used in making these assessments shall be included in these reports.
The assessment of radiation doses shall be performed in accordance with the methodology and parameters of the OFFSITE DOSE CALCULATION MANUAL (ODCM).


l                                                                 ODCM Rev. 17 Page 62 l                                                                       11/95 The Annual Radioactive Effluent Release Report to be submitted 60 days after January 1 of each year snall also include an assessment of radiation doses to the hypothetically highest exposed MEMBER OF THE PUBLIC from reactor releases and other nearby uranium fuel cycle sources (including doses from primary effluent pathways and             j direct radiation) for the previous calendar year to show conformance with 40 CFR Part 160, Environmental Radiation Protection Standards for Nuclear Power Operation. Dose contribution from liquid and gaseous effluents is calculated based on Regulatory Guide 1.109, Rev 1, October 1977.
l ODCM Rev. 17 Page 62 l
The Annual Radioactive Effluent Release Reports includes the following information for each type of solid waste (as defined in 10 CFR Part 61) shipped offsite during the report period:               '
11/95 The Annual Radioactive Effluent Release Report to be submitted 60 days after January 1 of each year snall also include an assessment of radiation doses to the hypothetically highest exposed MEMBER OF THE PUBLIC from reactor releases and other nearby uranium fuel cycle sources (including doses from primary effluent pathways and j
: 1. Total volume, activity and estimated total % error for each waste type:
direct radiation) for the previous calendar year to show conformance with 40 CFR Part 160, Environmental Radiation Protection Standards for Nuclear Power Operation.
: a. Spent resins filter sludges, evaporator bottoms, etc.
Dose contribution from liquid and gaseous effluents is calculated based on Regulatory Guide 1.109, Rev 1, October 1977.
: b. Dry compressible waste, contaminated equipment, etc.
The Annual Radioactive Effluent Release Reports includes the following information for each type of solid waste (as defined in 10 CFR Part 61) shipped offsite during the report period:
: c. Irradiated components, control rods, etc.
1.
: d. Others (des: ribe).
Total volume, activity and estimated total % error for each waste type:
: 2. Activity and percentage of each principle radionuclide
a.
(>1%), for each individual waste type as defined in
Spent resins filter sludges, evaporator bottoms, etc.
: 1. (a-d) above.
b.
: 3. The disposition of solid waste shipments (identify the number of shipments, the mode of transport, and the destination).
Dry compressible waste, contaminated equipment, etc.
l
c.
: 4. The disposition of irradiated fuel shipments (identify           {
Irradiated components, control rods, etc.
the number of shipments, the mode of transport, and the         ,
d.
destination.                                                     l The Annual Radioactive Effluent Release Report includes a list and description of unplanned releases from the site to UNRESTRICTED AREAS of radioactive material in gaseous and liquid effluents made during the reporting period.
Others (des: ribe).
2.
Activity and percentage of each principle radionuclide
(>1%), for each individual waste type as defined in 1.
(a-d) above.
3.
The disposition of solid waste shipments (identify the number of shipments, the mode of transport, and the destination).
4.
The disposition of irradiated fuel shipments (identify
{
the number of shipments, the mode of transport, and the destination.
The Annual Radioactive Effluent Release Report includes a list and description of unplanned releases from the site to UNRESTRICTED AREAS of radioactive material in gaseous and liquid effluents made during the reporting period.
The Annual Radioactive Effluent Release Reports includes any changes made during the reporting period to procedure RW-C-100 (formerly the PROCESS CONTROL PROGRAM) and to the ODCM, as well as a listing of new locations for dose calculations and/or environmental monitoring identified by the land use census pursuant to ODCM Control 3.4.2.
The Annual Radioactive Effluent Release Reports includes any changes made during the reporting period to procedure RW-C-100 (formerly the PROCESS CONTROL PROGRAM) and to the ODCM, as well as a listing of new locations for dose calculations and/or environmental monitoring identified by the land use census pursuant to ODCM Control 3.4.2.
The Annual Radioactive Effluent Release Reports includes an explanation as to why the inoperability of liquid or gaseous effluent monitoring instrumentation was not corrected within the time specified in ODCM Controls 3.2.1 or 3.3.1, respectively; and description of the events leading to liquid holdup tanks or gas storage tanks exceeding the Control limits.
The Annual Radioactive Effluent Release Reports includes an explanation as to why the inoperability of liquid or gaseous effluent monitoring instrumentation was not corrected within the time specified in ODCM Controls 3.2.1 or 3.3.1, respectively; and description of the events leading to liquid holdup tanks or gas storage tanks exceeding the Control limits.


l                                                               ODCM Rev. 17 Page 63 l                                                                           11/95 3.7   MAJOR CHANGES TO RADIOACTIVE WASTE TREATMENT SYSTEMS Licensee-initiated major changes to the radioactive waste systems (liquid, gaseous, and solid):
l ODCM Rev. 17 Page 63 l
: a. Shall be reported to thui Commission in the Annual Radioactive Effluent Release Report for the period in which the change was made effective. The discussion of each change shall contain:
11/95 3.7 MAJOR CHANGES TO RADIOACTIVE WASTE TREATMENT SYSTEMS Licensee-initiated major changes to the radioactive waste systems (liquid, gaseous, and solid):
: 1. A summary of the evaluation that led to the determination that the change could be made in accordance with 10 CFR 50.59;
a.
: 2. Sufficient detailed information to totally support the reason for the change without benefit of additional or supplemental information;
Shall be reported to thui Commission in the Annual Radioactive Effluent Release Report for the period in which the change was made effective.
: 3. A detailed description of the equipment, components, and processes involved and the interface with other plant systems;
The discussion of each change shall contain:
: 4. An evaluation of the change which shows the predicted releases of radioactive materials in liquid and gaseous effluents and/or quantity of solid waste that differ from those previously predicted in the license application and amendments thereto;
1.
: 5. An evaluation of the change which shows the expected maximum exposures to individual in the UNRESTRICTED AREA and to the general population that differ from those previously estimated in the license application and amendments thereto;
A summary of the evaluation that led to the determination that the change could be made in accordance with 10 CFR 50.59; 2.
: 6. A comparison of the predicted releases of radioactive materials, in liquid and gaseous effluents and in solid waste, to the actual releases for the period prior to when the changes are to be made;
Sufficient detailed information to totally support the reason for the change without benefit of additional or supplemental information; 3.
: 7. An estimate of the exposure to plant operating personnel as a result of the change; and
A detailed description of the equipment, components, and processes involved and the interface with other plant systems; 4.
: 8. Documentation of the fact that the change was reviewed and found acceptable by the PORC.
An evaluation of the change which shows the predicted releases of radioactive materials in liquid and gaseous effluents and/or quantity of solid waste that differ from those previously predicted in the license application and amendments thereto; 5.
: b. Shall be reviewed and accepted by the PORC prior to implementation.
An evaluation of the change which shows the expected maximum exposures to individual in the UNRESTRICTED AREA and to the general population that differ from those previously estimated in the license application and amendments thereto; 6.
l             c. Shall be documented by a recurring action request.
A comparison of the predicted releases of radioactive materials, in liquid and gaseous effluents and in solid waste, to the actual releases for the period prior to when the changes are to be made; 7.
1 i
An estimate of the exposure to plant operating personnel as a result of the change; and 8.
1 1
Documentation of the fact that the change was reviewed and found acceptable by the PORC.
b.
Shall be reviewed and accepted by the PORC prior to implementation.
l c.
Shall be documented by a recurring action request.
i 1
1


I 1
I 1
i i                                                   i
i i
                                            !>        i l
i i
l PART II CALCULATION METHODOLOGIES l
l PART II CALCULATION METHODOLOGIES l
4 i
4 i
l I
l I
      !                                              4 I                                             l i
4 I
l l
l i
i
l i
                                                -    l 1      1 4
1 4
l l
l l
l 1
l 1
1 I
1 I
i 1
i 1
1 i         4-e
1 i
        ,r   . \
4-e
,r
. \\
l l
l l
I
I


s l                                                                             ODCM Rav. 17 Pege 64 l                                                                                   11/95 ;
s l
i 1.O LIOUID EFFLUENTS 1.1   RADIATION MONITORING ll4STRUMENTATION AND CONTROLS The liquid effluent monitoring instrumentation and                         ;
ODCM Rav. 17 Pege 64 l
controls at Limerick for controlling and monitoring normal                 {
11/95 i
radioactive material releases in accordance with the                       :
1.O LIOUID EFFLUENTS 1.1 RADIATION MONITORING ll4STRUMENTATION AND CONTROLS The liquid effluent monitoring instrumentation and controls at Limerick for controlling and monitoring normal
Limerick Technical Specifications are summarized'as                         l follows-l
{
: 1)   Liquid Radwaste System:     The liquid radwaste discharge             !
radioactive material releases in accordance with the Limerick Technical Specifications are summarized'as follows-1)
monitor (RISH63-0K604) provides an alarm and automatic                 l ial releases from the termination of radioactive liquid radwaste   system as mater!ed requi:       by Technical              j Specification 6.8.4.d.1. Additional design features                   J of the liquid radwaste system which prevent inadvertent releases to the environmcnt include 1) redundant disgharge valves, 2) single discharge line                   ,
Liquid Radwaste System:
with loop seal and siphon breaker to eliminate                         l probability of inadvertent discharges, 3) Low Cooling                 '
The liquid radwaste discharge monitor (RISH63-0K604) provides an alarm and automatic termination of radioactive mater!ed by Technical ial releases from the liquid radwaste system as requi:
Tower Blowdown flow interlock which isolates the                     l radwaste discharge line.                                               l
j Specification 6.8.4.d.1.
: 2)   Service Water System:   The Service Water cischarge monitor (RISH10-1K605 AND RISH10-2K605) provides an                   l alarm upon indication of activity in the service watt.r system as required by Technical Specification 6.8.4.d.1. While the service water system is not a                     l 4                        normai release pathway, the monitor provides an                       i indication of potential problems due to excessive leakage of the heat exchangers. In addition, the service water side of the fuel pool heat exchangers is kept at a higher pressure than the shell side to prevent potential radioactive contamination of the service water.
Additional design features J
: 3)   RHR Service Water System:     The RHR Service Water Radiation (RHRSW) Monitors (RISH12-0K619A, RISH12-OK619B, RISH12-1K619C, RISH12-1K619D, RISH12-2K619C
of the liquid radwaste system which prevent inadvertent releases to the environmcnt include 1) redundant disgharge valves, 2) single discharge line with loop seal and siphon breaker to eliminate probability of inadvertent discharges, 3) Low Cooling Tower Blowdown flow interlock which isolates the radwaste discharge line.
  ?                     AND RISH12-2K619D) provide alarm and automatic termination of radioactive material release from the RHRSW system, as required by Technical Specificati~on                   l 6.8.4.d.1. While the RHRSW system is not a normal                     l rele; ace pathway, the monitors provide indication of potential prohtems due to excessive leakage of the                     !
2)
heat exchangers.
Service Water System:
The Service Water cischarge monitor (RISH10-1K605 AND RISH10-2K605) provides an alarm upon indication of activity in the service watt.r system as required by Technical Specification 6.8.4.d.1.
While the service water system is not a i
normai release pathway, the monitor provides an 4
indication of potential problems due to excessive leakage of the heat exchangers.
In addition, the service water side of the fuel pool heat exchangers is kept at a higher pressure than the shell side to prevent potential radioactive contamination of the service water.
3)
RHR Service Water System:
The RHR Service Water Radiation (RHRSW) Monitors (RISH12-0K619A, RISH12-OK619B, RISH12-1K619C, RISH12-1K619D, RISH12-2K619C
?
AND RISH12-2K619D) provide alarm and automatic termination of radioactive material release from the RHRSW system, as required by Technical Specificati~on 6.8.4.d.1.
While the RHRSW system is not a normal rele; ace pathway, the monitors provide indication of potential prohtems due to excessive leakage of the heat exchangers.
4
4


l                                                         ODCh R2v. 17 Page 65 l                                                                   11/95 1.2 LIOUID EFFLUENT MONITOR SETPOINT DETERMINATION                       j l
l ODCh R2v. 17 Page 65 l
Per the requirements of Technical Specif alarm setpoints shall be established for$/the cation   6.8.4.d.1, liquid l
11/95 1.2 LIOUID EFFLUENT MONITOR SETPOINT DETERMINATION j
effluent monitoring instrumentation to ensure that the-J release concentration limits of Specification 6.8.4.d.2 and 6.8.4.d.3 are met (i.e., the concentration of                   {
Per the requirements of Technical Specif alarm setpoints shall be established for$ cation 6.8.4.d.1,
radioactive material released in liquid effluents to                 '
/the liquid effluent monitoring instrumentation to ensure that the-J release concentration limits of Specification 6.8.4.d.2 and 6.8.4.d.3 are met (i.e.,
UNRESTRICTED AREAS shall be limited to the concentrations specified in 10 CFR 20, Appendix B, Table II, Column 2, for radionuclides and 2.0E-04 pCi/ml for dissolved or entrained noble gases).                               e a
the concentration of
1.2.1     Radwaste Discharce Monitor and Discilarce Flow Rate
{
                  - RISH63-0K604                         "
radioactive material released in liquid effluents to UNRESTRICTED AREAS shall be limited to the concentrations specified in 10 CFR 20, Appendix B, Table II, Column 2, for radionuclides and 2.0E-04 pCi/ml for dissolved or entrained noble gases).
The t tpoint for the liquid radwaste discharge monitor and flow rate element are determined by the following equations. The radwaste discharge monitor high-high alarm / isolation setpoint is evaluated at least monthly based on isotopes detected in the liquid radwaste sample tanks released during the previous month or on any specific sample tank being released (EC g _),         the l               required minimum cooling tower blowdown flow at time of discharge (CTBD), and average liquid radwaste discharge flow (RR). The flow rate determination is calculated for each release and 1
e a
the MPC fraction calculated includes, in the CC.ncentration mix, the most recent results from
1.2.1 Radwaste Discharce Monitor and Discilarce Flow Rate
          ,,      1) the quarterly composite for SR-89, SR-90 and Fe-55, and 2) the monthly composite for H-3, and
- RISH63-0K604 The t tpoint for the liquid radwaste discharge monitor and flow rate element are determined by the following equations.
The radwaste discharge monitor high-high alarm / isolation setpoint is evaluated at least monthly based on isotopes detected in the liquid radwaste sample tanks released during the previous month or on any specific sample tank being released (EC _),
the g
l required minimum cooling tower blowdown flow at time of discharge (CTBD), and average liquid radwaste discharge flow (RR).
The flow rate 1
determination is calculated for each release and the MPC fraction calculated includes, in the CC.ncentration mix, the most recent results from
: 1) the quarterly composite for SR-89, SR-90 and Fe-55, and 2) the monthly composite for H-3, and
: 3) the sample (s) for dissolved and entrained noble gases.
: 3) the sample (s) for dissolved and entrained noble gases.
If the calculated setpoint is less than the
If the calculated setpoint is less than the existing setpoint, t'ge setpoint will be reduced to the next value.
                , existing setpoint, t'ge setpoint will be reduced to the next value. If he calculated setpoint is greater than the existing setpoint, the setpoint may remain at the lower val.2e or increased to the calculated value.
If he calculated setpoint is greater than the existing setpoint, the setpoint may remain at the lower val.2e or increased to the calculated value.
4 The actual setpoint may be reduced to a value less than the calculat?d setpoint at the discretion of Supervision.                                     3 If there were no sample tanks released or no activity detected during the previous month, then the calculation is performed using release data from tl.e most recent month during which isotopes were detected. In addition, if there were no sampl'e t.anks released during the previous month, chemistry supervision may substitute more restrictive values (e.g., tritium) based on the plant sampling data.
4 The actual setpoint may be reduced to a value less than the calculat?d setpoint at the discretion of Supervision.
3 If there were no sample tanks released or no activity detected during the previous month, then the calculation is performed using release data from tl.e most recent month during which isotopes were detected.
In addition, if there were no sampl'e t.anks released during the previous month, chemistry supervision may substitute more restrictive values (e.g.,
tritium) based on the plant sampling data.
f
f
)
)
1
1


                                              . . - . . . . . . - . . - . - . . . - - . --      -- .    . . - - ~ - . - . _
.. - - ~ -. -.
l I
I l
l                                                                                            ODCM Rev. 17:           ,
ODCM Rev. 17:
Paga 66 l                                                                                                           11/95 1.7.1-1     Setooint Determination - RISH63-0K604 The setpoint for the liquid radwaste discharge monitor is determined by the
Paga 66 l
          .                                    following equation:
11/95 1.7.1-1 Setooint Determination - RISH63-0K604 The setpoint for the liquid radwaste discharge monitor is determined by the following equation:
CPM.w3 s                                                                   <
CPM.w3 s l
l 1,, (p) (n) [E (Cme,)/MPCme,)3                             (E Cj,) (M+CTBD)
1,, (p) (n) [E (Cme,)/MPCme,)3 (E Cj,) (M+CTBD)
              *                                                                                  +BKG #3    (1_1)             {
+BKG (1_1)
(n+CTBD)                     (S) (E) (M) [EC ,QNPC ,-]           j   j                               i I
{
4 l
(n+CTBD)
where:
(S) (E) (M) [EC,QNPC,-]
i CPMgm>                       =      Calculated liquid radwaste discharge monitor (RISH63-0K604) count rate attributable to the gamma emitting                               i radionuclide, cpm the sum of the. concentration of the Ici,                        =
i
identified gamma emitting nuclides (pci/ml) ,
#3 j
CTBD                         =      the required minimum cooling tower                               i
j 4
                  )                                         blowdown rate at time of discharge                             .)
l where:
(gpm),                                   ;                    J RR                           =        average liquid radwaste discharge flow.
i CPMgm>
(gpm),               ,                                        l BKGgm3                       =       backgroufdcountrateofliquidradwaste discharge monitor (CPM),
Calculated liquid radwaste discharge
E                           =        the gross detection efficiency of the liquid radwaste discharge monitor (pCi/ml/ cpm), and S                           =        2; margin of safety factor to assure that the release is terminated prior to 10 CFR 20 limits being exceeded.
=
Included in this factor are errors associated with monitor uncertainty, sampling uncertainty, flow rate uncertainty, and the contribution of other release paths (Service Wate; and RHRSW) which are not nortally                                   '
monitor (RISH63-0K604) count rate attributable to the gamma emitting i
contaminaged.
radionuclide, cpm
: Ici, the sum of the. concentration of the
=
identified gamma emitting nuclides (pci/ml),
CTBD the required minimum cooling tower i
=
)
blowdown rate at time of discharge
.)
(gpm),
J RR average liquid radwaste discharge flow.
=
(gpm),
l backgroufdcountrateofliquidradwaste BKGgm3
=
discharge monitor (CPM),
E the gross detection efficiency of the
=
liquid radwaste discharge monitor (pCi/ml/ cpm), and S
2; margin of safety factor to assure
=
that the release is terminated prior to 10 CFR 20 limits being exceeded.
Included in this factor are errors associated with monitor uncertainty, sampling uncertainty, flow rate uncertainty, and the contribution of other release paths (Service Wate; and RHRSW) which are not nortally contaminaged.
1
1
}                       Z (Ci,.n /MPCig . )         =        the effective gamma MPC ratio for the mixture of radionuclides in the liquid radwaste discharge line (unitless).
}
l
Z (C,.n
/MPC.
)
i ig the effective gamma MPC ratio for the
=
mixture of radionuclides in the liquid radwaste discharge line (unitless).


l-                                                                         ODCM Rav. 17 Page 67 l                                                                                 11/95 1
l-ODCM Rav. 17 Page 67 l
where:                                                               4           1 Cipk,                 =      the concentration of each identified gamma emittinyt radionuclide i in the           i liquid effJuent (undiluted) (pci/ml)
11/95 1
MPCt ,.                 =      the MPC value corresponding to radionuclide i from 10 CFR 20 Appendix       i B,' Table II.. Column 2 (dissolved and         r entrained ncble gases MPC = 2.0E"
where:
                                                  'pCi/ml)   (pCi/ml).
4 1
E (Ci tut./MPC iwe.)       =      the effective nongamma MPC ratio for the       ;
: Cipk, the concentration of each identified
mixture of radionuclides in the liquid         !
=
radwaste discharge line (unitless) where:
gamma emittinyt radionuclide i in the i
Ci we,                =    'the concentration of each identified nongamma radionuclide i in the liquid         j effluent (undiluted) (pci/ml)*
liquid effJuent (undiluted) (pci/ml)
MPCa.e.                 -      The MPC value corresponding to radionuclide i form 10 CFR 20, Appendix B, Table II, Colunh 2 (dissolved and entrained noble gases MPC = 2E'' pCi/ml)     ,
MPC,.
the MPC value corresponding to
=
t radionuclide i from 10 CFR 20 Appendix i
B,' Table II.. Column 2 (dissolved and r
entrained ncble gases MPC = 2.0E"
'pCi/ml)
(pCi/ml).
E (Ci ut./MPC we.)
the effective nongamma MPC ratio for the
=
t i
mixture of radionuclides in the liquid radwaste discharge line (unitless) where:
'the concentration of each identified C we,
=
i nongamma radionuclide i in the liquid j
effluent (undiluted) (pci/ml)*
MPCa.e.
The MPC value corresponding to radionuclide i form 10 CFR 20, Appendix B,
Table II, Colunh 2 (dissolved and entrained noble gases MPC = 2E'' pCi/ml)
(pci/ml)
(pci/ml)
                                                                                                  )
)
* NOTE:     The concentration mix must include the n'ost recent sample                 I data for H-3, Sr-89, Sr-90, Fe-55 and gross alpha.
* NOTE:
1.2.1-2 Elpw Rate Determination             i e
The concentration mix must include the n'ost recent sample I
* NOTE: lE the effectivu MPC ratio for the mixture                                       '
data for H-3, Sr-89, Sr-90, Fe-55 and gross alpha.
of radionuclides [E (C i /MPC i Y)] is s1.0, IHEH a flow rate setpoint determination is not required, Ann there is no limit on discharge flow rate.
1.2.1-2 Elpw Rate Determination i
II a flow rate determination is required,                                       ,
e
THEN the setpoint for the liquid radwaste flow rate is                           '
* NOTE: lE the effectivu MPC ratio for the mixture of radionuclides [E (C /MPC Y)] is s1.0, i
determined for each release by the following equation:
i IHEH a flow rate setpoint determination is not required, Ann there is no limit on discharge flow rate.
D FLOW"#M s     (SF) [E (Cj/MPCf ) -1)
II a flow rate determination is required, THEN the setpoint for the liquid radwaste flow rate is determined for each release by the following equation:
(1-2) where:
D FLOW"#M s (1-2)
FLOW umn        -    flow limit for radwaste discharge                             ;
(SF) [E (Cj/MPC ) -1) f where:
line (gpm).
flow limit for radwaste discharge FLOW umn line (gpm).
CTBD             =    required minimum cooling tower blowdown flow for time of release (gpm).                                         i SF               =    2; margin of safety factor to assure that the                 ;
CTBD required minimum cooling tower blowdown flow for
release does not exceed 10 CFR 20 limits.                     ;
=
time of release (gpm).
i SF 2; margin of safety factor to assure that the
=
release does not exceed 10 CFR 20 limits.
l
l
(                   h i
(
h i


l                                                                 ODCM R';v. 17 Prge 68     l l                                                                          11/95     i E (Ci /MPCt ) =
l ODCM R';v. 17 Prge 68 l
the effective MPC ratio for the mixture of radionuclides in the liquid radwaste discharge line (unitless) where:
11/95 i
C1            =
E (C /MPC )
the concentration of each identified radionuclide i in the liquid effluent (undiluted) (pci/ml)*
i t
MPC 1        =
the effective MPC ratio for the mixture of
the MPC value corresponding tq radionuclide i from 10 CFR 20 Appendix B, Table *:1, Cclbmn 2, (dissolved and entrained noble gases MPC = 2E''           l pCi/ml) (pCi/ml) .
=
          *ITOTE : The concentration mix must include tt4 most recent sample data for H-3, Sr-89, Sr-90, Fe-55 and dissolved and entrained noble gases.
radionuclides in the liquid radwaste discharge line (unitless) where:
1.2.2   Service Water Radiation Monitor - RISH10-1K605. -         ;
C the concentration of each identified radionuclide
2K605                                                     '
=
l                      , The Service Water Radiation Monitor maximum high-high setpoint is determined by the following               l l                        equation. The setpoint is evaluated every 24 months to assure that a high background count rate does not prevent adequate monitor sensitivity in order to meet the requirements of Technical               ,
1 i in the liquid effluent (undiluted) (pci/ml)*
Specifications 6.8.4.d.2 and 6.7.4.d.3.                   '
MPC the MPC value corresponding tq radionuclide i from
1.2.2-1     Setpoint Determination l                                     The maximum setpoint for the Service     ,
=
Water Radiation Monitor is determined by a                     the following equation:
1 10 CFR 20 Appendix B, Table *:1, Cclbmn 2, (dissolved and entrained noble gases MPC = 2E''
l                         CPM,, ;=   0.5 (2. 0E- 05pCi/ml) (CF) where:
pCi/ml) (pCi/ml).
l                         CPM,,=     Calculated Maximum Service Water Radiation Monitor (RISH12-1K605, -
*ITOTE : The concentration mix must include tt4 most recent sample data for H-3, Sr-89, Sr-90, Fe-55 and dissolved and entrained noble gases.
1.2.2 Service Water Radiation Monitor - RISH10-1K605. -
2K605 l
The Service Water Radiation Monitor maximum high-high setpoint is determined by the following l
equation.
The setpoint is evaluated every 24 months to assure that a high background count rate does not prevent adequate monitor sensitivity in order to meet the requirements of Technical Specifications 6.8.4.d.2 and 6.7.4.d.3.
1.2.2-1 Setpoint Determination l
The maximum setpoint for the Service Water Radiation Monitor is determined by a
the following equation:
l CPM,, ;=
0.5 (2. 0E- 05pCi/ml) (CF) where:
l CPM,,=
Calculated Maximum Service Water Radiation Monitor (RISH12-1K605, -
2K605) count rate, CPM.
2K605) count rate, CPM.
2.0E-05 pCi/ml = MPC limit for Cs-1'37       .,
2.0E-05 pCi/ml = MPC limit for Cs-1'37 CF=Monitorcalibrationfactor-incpm/pCifml l
CF=Monitorcalibrationfactor-incpm/pCifml l                         0.5 = Safety Factor A
0.5 = Safety Factor A


f l                                                   ODCM RLv' 17         ,
f l
Page 69 l                                                             11/95 1.2.3 EHR Service Water Monitor -RISH12-0K619A. -0K619B.             !
ODCM RLv' 17 Page 69 l
            -1K619C,, -1K619D, -2K619C, -2K619D I
11/95 1.2.3 EHR Service Water Monitor -RISH12-0K619A. -0K619B.
h l           The RHR Service Water Radiation Monitor' maximum               i high-high setpoint is determined by the following             !
-1K619C,, -1K619D, -2K619C, -2K619D h
l          equation. The setpoint is evaluated every 24 months to assure that a high background count does not prevent adequate monitor sensitivity in order to meet the Technical Specifications 6.8.4.d.2 and 6.7.4.d.3.
l The RHR Service Water Radiation Monitor' maximum high-high setpoint is determined by the following l
1.2.3-1   Setpoint Determination The setpoint for the RHR Servic;s Water Radiation Monitor is determined by i.he following equation:
equation.
l           CPMum ,= 0. 5 (2. 0E- 05pCi/ml) (CF) where:
The setpoint is evaluated every 24 months to assure that a high background count does not prevent adequate monitor sensitivity in order to meet the Technical Specifications 6.8.4.d.2 and 6.7.4.d.3.
l           CPMumsw   =
1.2.3-1 Setpoint Determination The setpoint for the RHR Servic;s Water Radiation Monitor is determined by i.he following equation:
Calculated maximumRHR Service Water Radiation Monitor (RISH12-0K619A, -OK619B, -
l CPMum,= 0. 5 (2. 0E- 05pCi/ml) (CF) where:
1K619C, -1K619D, -2K619C,   -
l CPMumsw Calculated maximumRHR Service
2K619D) count rate, CPM.
=
1         2.0E-5pCi/ml   =      MPC limit for Cs-137 i
Water Radiation Monitor (RISH12-0K619A, -OK619B, -
CF  =       Monitor calibration factor -
1K619C, -1K619D, -2K619C, 2K619D) count rate, CPM.
1 2.0E-5pCi/ml MPC limit for Cs-137
=
i Monitor calibration factor -
CF
=
in cpm /pci/ml.
in cpm /pci/ml.
0.5 =       Safety Factor I
0.5 =
Safety Factor I
{
{
l f
f
          +
+
l 1
1 l
l
I
                                                      ---__________-______I


l                                                                 ODCM rov. 17 Pcge 70 l                                                                       11/95 1.3 Licuid Effluent Dose Calculation - 10 CFR 50 1.3.1   Members of the Public Dose ODCM I3.2.3 limits the dose or dose commitment to MEMBERS OF THE PUBLIC from radioactive materials in liquid effluents from Limerick Generating Station to:
l ODCM rov. 17 Pcge 70 l
                          - during any calendar quarter, s 3 mrem to total body slo mrem to any organ
11/95 1.3 Licuid Effluent Dose Calculation - 10 CFR 50 1.3.1 Members of the Public Dose ODCM I3.2.3 limits the dose or dose commitment to MEMBERS OF THE PUBLIC from radioactive materials in liquid effluents from Limerick Generating Station to:
                          - during any calendar year.
- during any calendar quarter, 3 mrem to total body s
s 6 mrem t.o total body s20 mrem t.o total organ.
slo mrem to any organ
1 Per ODCM I3.2.3.1 the cumulative dose contribution from liquid effluents for the current calendar quarter year shall be determined at least once per
- during any calendar year.
* 31 days in accordance with the following calculation methods. These equations are for the three aquatic environment exposure pathways (potable water, fish, shoreline exposure) in the Limerick aquatic environment. Only real pathways are addressed for each receptor. The receptors and associated pathways are listed below. Doses from each real pathway are summed to give dosa at the receptor. The monthly results are accumulated y                    to give the quarterly doses and the quarterly results are accumulated to give the annual doses.
6 mrem t.o total body s
l Raceptor             Dist.                   Pathways Location             (mi)       Potable Water       Fish     Shoreline LGS Outfall           0                               X   a     X Citizen's Utility     2.5             X             X         X     .
s20 mrem t.o total organ.
Phoenixvil?.e Water   9.0             X             X         X Phil. Sub. Water     13.6               X                         X Crew Course         37.8                                         X
1 Per ODCM I3.2.3.1 the cumulative dose contribution from liquid effluents for the current calendar quarter year shall be determined at least once per 31 days in accordance with the following calculation methods.
These equations are for the three aquatic environment exposure pathways (potable water, fish, shoreline exposure) in the Limerick aquatic environment.
Only real pathways are addressed for each receptor.
The receptors and associated pathways are listed below.
Doses from each real pathway are summed to give dosa at the receptor.
The monthly results are accumulated to give the quarterly doses and the quarterly y
results are accumulated to give the annual doses.
l Raceptor Dist.
Pathways Location (mi)
Potable Water Fish Shoreline LGS Outfall 0
X a
X Citizen's Utility 2.5 X
X X
Phoenixvil?.e Water 9.0 X
X X
Phil. Sub. Water 13.6 X
X Crew Course 37.8 X


__        . .          _      _ _ . . , _ _ . - .            .._..._..-__-..m                     . _ . . __-___._.m.
.._..._..-__-..m
__-___._.m.
i
i
      -l                                                                                                     ODCM Rav. 17
-l ODCM Rav. 17
                                                                                                                    'Page 71 l                                                                                                       ,        11/95 1.3.1-1             Potable Water Pathway.
'Page 71 l
1
11/95 1.3.1-1 Potable Water Pathway.
                                            .R ,j = 1 1 0 0 g* EOjD,jpj exp(-Ai (18))             (1-6)
.R,j = 1 1 0 0 g* EOjD,jpj exp(-Ai (18))
1 (1-6)
MF1 p
1.3.1-2' Fish (Aquatic Food) Pathway U ' EOj jf,j,j exp (-Aj (ao )
(1-6)
{
88 R,j = 110 0 B
MF1 p
MF1 p
1.3.1-2'              Fish (Aquatic Food) Pathway R,j = 110 0 U88 ' EOjBjf,j,j exp (-Aj (ao )              (1-6)                          {
Shoreline Deposition Pathway i
MF1 p                                                                  .
1.3.1-3
1.3.1-3             Shoreline Deposition  .
** EOjTj,jpj exp (-Al *p) (1-exp (-Aj <t.vsar+s> ))
Pathway                                    . i A,j = 110, 00 0                          EOjTjD,jpj exp (-Al *p) (1-exp (-Aj <t.vsar+s> ))   (1_7)
(1_7)
A,j = 110, 00 0 D
MF1 p
MF1 p
i I
i I
where:                                                                                                           f t
f where:
B , = equilibrium bioa:ccumulation factor for nuclide I .in 1                                                                                                         ,
t B, = equilibrium bioa:ccumulation factor for nuclide I.in 1
pathway p, expressed as the ratio of.the concentration in                                     l 2      biota, in pCi/kg, to the.radionuclide concentration in                                       l water, in pCi/ liter (liters /kg)                                                           :
pathway p, expressed as the ratio of.the concentration in l
i i
biota, in pCi/kg, to the.radionuclide concentration in l
2 water, in pCi/ liter (liters /kg) i i
I f
I f
i I
i I
i I
i 3
3 i
i l
l 1
1 6
6


l                                                                   ODCM Rev. 17 Paga 72 l-                                                                                   11/95 BIOACCUMULATION FACTORS (pCi/kg/pCi/ liter)
l ODCM Rev. 17 Paga 72 l-11/95 BIOACCUMULATION FACTORS (pCi/kg/pCi/ liter)
FRESHWATER           SALTHATER-ELEMENT                     FISH                 FISH
FRESHWATER SALTHATER-ELEMENT FISH FISH
        .H                     9.0E-1               9.0E-1 C                     4.6E 3               1.8E 3 Na                     1.0E 2               6.7E-2 P                     3. 0E 3'             2.9E 4 Cr                     2. 0E ,2             4.0E 2 Mn                     4.0E 2               5.5E 2 Fe                     1.0E 2               3.0E 3 Co                     5.0E 1               1.0E 2 Ni                     1.0E 2               1.0E 2 (X1                   5.0E 1               6.7E 2 Zn                     2.0E 3               2.0E 3 Br                     4.23 2               1.5E-2 Rb                     2.0E 3               8.3E O Sr                     3.0E 1               2.0E O Y                     2.5E 1               2.5E 1 Zr   ^
.H 9.0E-1 9.0E-1 C
3.3E O               2.0E 2 Nb                     3.0E 4               3.0E 4 Mo                     1.0E 1               1.0E 1                 -
4.6E 3 1.8E 3 Na 1.0E 2 6.7E-2 P
Tc                     1.5E 1               1.0E 1                 .
: 3. 0E 3' 2.9E 4 Cr
Ru                     2.0E 1               3.0E O                 .
: 2. 0E,2 4.0E 2 Mn 4.0E 2 5.5E 2 Fe 1.0E 2 3.0E 3 Co 5.0E 1 1.0E 2 Ni 1.0E 2 1.0E 2 (X1 5.0E 1 6.7E 2 Zn 2.0E 3 2.0E 3 Br 4.23 2 1.5E-2 Rb 2.0E 3 8.3E O Sr 3.0E 1 2.0E O Y
Rh                     1.0E 1               1.0E 1                 -
2.5E 1 2.5E 1 Zr 3.3E O 2.0E 2 Nb
Te                     4.0E 2               1.0E 1                 -
^
I                      1.5E 1               1.0E 1 Cs                     2.0E 3               4.0E l'                 -
3.0E 4 3.0E 4 Mo 1.0E 1 1.0E 1 Tc 1.5E 1 1.0E 1 Ru 2.0E 1 3.0E O Rh 1.0E 1 1.0E 1 Te 4.0E 2 1.0E 1 I
Ba                     4.0E O               1.0E 1                   .
1.5E 1 1.0E 1 Cs 2.0E 3 4.0E l' Ba 4.0E O 1.0E 1 LA 3
LA                 3   2.5E 1               2.5E 1                   ,
2.5E 1 2.5E 1 Ce 1.0E O 1.0E 1 Pr 2.5E 1 2.5E 1 Nd 2.5E 1 2.5E 1
Ce                     1.0E O               1.0E 1 Pr                     2.5E 1               2.5E 1                     ~
~
Nd                     2.5E 1               2.5E 1 W                     1.2E 3               3.0E 1                     -
W 1.2E 3 3.0E 1 Np 1.0E 1
Np                     1.0E 1               ~1.0E 1                       -
~1.0E 1 Ref: 1) U.S.N.R.C Reg. Guide 1.109, Rev.
Ref: 1) U.S.N.R.C Reg. Guide 1.109, Rev. 1, Table A-1                                   '
1, Table A-1
: 2) Letter LTR 881209L001, from R.J. Cle.ck , 0.d N.R.C., to                       -
: 2) Letter LTR 881209L001, from R.J. Cle.ck, 0.d N.R.C., to G.A. Hunger, Philadelphia Electric Co., December 9,
G.A. Hunger, Philadelphia Electric Co., December 9, 1988,                     -
: 1988, transmitting evaluation of Limerick ODCM.
transmitting evaluation of Limerick ODCM.                                     '"
i.
i.
s.
s.


        -      - _. . - , - . . . . . - - - _ _ - - ~ ~ _ -                                           --  --      ..        - . . .
- _.. -, -..... - - - _ _ - - ~ ~ _ -
l-                                                                                                           ODCM rov. 17 Page 73
l-ODCM rov. 17 Page 73 l.
: l.                                                                                                                     11/95 D,ig        =          . dose factor specific to a given~ age group a, radionuclide                                               i i, pathway p, and organ j which can be used to calculate                                               3 radiation dose (1) from an intake of a radionuclide, in mrem /pci, or (2) from exposure to-a given concentration                                                 ;
11/95
of a.radionuclide in sediment, in mrem /hr per pCi/m2 Values are listed by age group in Table 1-1.
. dose factor specific to a given~ age group a, radionuclide D,ig
F            =          waste dilution flow rate of liquid effluent dilution                                                   j flow / number of batches (f t3 /sec) .                                                                 j F4
=
                    =            dilution factor at point of exposure or at point of                                                   l withdrawal of drinking' water (dimensionless).                                                         '
i i, pathway p, and organ j which can be used to calculate 3
Values are graphically liated by receptor location in' Figures 1.3.1-                                             ;
radiation dose (1) from an intake of a radionuclide, in mrem /pci, or (2) from exposure to-a given concentration of a.radionuclide in sediment, in mrem /hr per pCi/m2 Values are listed by age group in Table 1-1.
1 to 1.3.1-5. Value will be based on average monthly                                                   l river flow.                                                                                           !
waste dilution flow rate of liquid effluent dilution j
a
F
                                                                                                                            $            i
=
                                                                                                                            ~
flow / number of batches (f t /sec).
01          =            total release of nuclide 'i' for time period (Ci).                                                   > !
j 3
R,g          =           total dose for calculation time period to organ j of                                                   L individuals of age group a from all nuclides i in pathway b (mrem).
dilution factor at point of exposure or at point of l
Ti          =            radioactive half-life of nuclide 1 (days) .                                                           '
F4
U,           =            usage factor specifying exposure time or intake rate for an individual of age group a associated with pathway p                                                 ;
=
(hr/yr, liters /yr, or kg/yr).                                                                       j Pathway                     Infant                                 Child         Teen                     Adult                       I Fish                         --
withdrawal of drinking' water (dimensionless).
6.9*         16*                       21*                         ;
Values are graphically liated by receptor location in' Figures 1.3.1-1 to 1.3.1-5.
Potable Water (1/yr)                       330*                                   510*         510*                     730*                         [
Value will be based on average monthly l
Shoreline Recreation                                                                                                                               !
river flow.
(hr/yr)                       --
i a
14*          67*                      12*                          !
total release of nuclide 'i' for time period (Ci).
Shoreline                                                                                                                               .
01
Recreation                                                                                                                               i (hr/yr)                       --
~
90 5          600 b                    600 6 r
=
i Ref:       Regulatory Guide 1.109, Rev 1, Table E-5 b
total dose for calculation time period to organ j of L
EROL Table 5.2.A-3 w            = shoreline width factor                                     ,
R,g
=
individuals of age group a from all nuclides i in pathway b (mrem).
radioactive half-life of nuclide 1 (days).
T
=
i U,
usage factor specifying exposure time or intake rate for
=
an individual of age group a associated with pathway p (hr/yr, liters /yr, or kg/yr).
j Pathway Infant Child Teen Adult I
Fish 6.9*
16*
21*
Potable Water (1/yr) 330*
510*
510*
730*
[
Shoreline Recreation 14*
67*
12*
(hr/yr)
Shoreline Recreation i
(hr/yr) 5 b
6 90 600 600 r
i Ref:
Regulatory Guide 1.109, Rev 1, Table E-5 b EROL Table 5.2.A-3 shoreline width factor w
=
(dimensionless) = 0.2.
(dimensionless) = 0.2.
Ref: Regulatory Guide 1.109, Rev.
Ref:
: 1.                                   f 1.752E+5     = time period during which sediment isgexposed to contaminated water                             ,
Regulatory Guide 1.109, Rev.
(hrs) (midpoint of plant                                     !
1.
life = 20 yrs) 11          = radioactive decay constant of                               I nuclide 'i' (hr-2)                                         ] '
f time period during which sediment 1.752E+5
=
isgexposed to contaminated water (hrs) (midpoint of plant life = 20 yrs) radioactive decay constant of I
1
=
1 nuclide 'i' (hr-2)
]
I i
I i


                                                                                                                      -      ... m     _ . . _ . __.
... m i
i l'                                                                                                 ODCM Rav. 17 Paga'74                   j l                                                                                                         . 11/95               l 12         =  delay time for potable water pathway in hours to allow for                                       l nuclide decay during transport                                     ;
l' ODCM Rav. 17 Paga'74 j
through the water purification                                     ;
l
plant and the water distribution system,           Ref:   Regulatory Guide 1.109, Rev. 1, App. A.
. 11/95 12 delay time for potable water
1 24         -  delay time for potable fish                                       ,
=
pathway in hours to allow for                                     i nuclide d.ecay during transport                                   !
pathway in hours to allow for nuclide decay during transport through the water purification plant and the water distribution
through the food chain, as well as                               !
: system, Ref:
during food preparation.
Regulatory Guide 1.109, Rev.
Ref: Regulatory Guide 1.109, Rev.
1, App. A.
1,       App. A.                                                 ;
1 24 delay time for potable fish pathway in hours to allow for i
1100       =    factor to convert from Ci/yr per f t3 /sec to pCi/ liter.
nuclide d.ecay during transport through the food chain, as well as during food preparation.
110,000    =    factor to convert from Ci/yr per                                 i 3
Ref:
ft'/see to pCi/ liter                                             :
Regulatory Guide 1.109, Rev.
and to account for proportionately                                 t
1, App. A.
;                                                                                    constant (100) used in sediment                                 .l
1100 factor to convert from Ci/yr per
                                                                                  . radioactivity model.                                             ;
=
3 f t /sec to pCi/ liter.
factor to convert from Ci/yr per i
110,000
=
ft'/see to pCi/ liter 3
and to account for proportionately t
constant (100) used in sediment
.l radioactivity model.
i l
i l
I l
I l
s
. h*
g I
i b
I
l ODCM Rav. 17 Page 75 l
11/95 1.4 Licuid Effluent Dose Proiections l
ODCM I3.2.4 requires that the liquid radwaste treatment system shall be operab.e and appropriate portions of the systems used l
to reduce the radioactive materials in liquid waste prior to their discharge when the projected doses due to the liquid effluent to UNRESTRICTED AREAS would. exceed:
l l
l l
l s
- 0.06 mrem /31 days to the total body or
g                      . h*
- 0.2 mrem /31 days to any organ.
I i
b I
 
l                                                                                ODCM Rav. 17 Page 75 l                                                                                        11/95 1.4 Licuid Effluent Dose Proiections l                  ODCM I3.2.4 requires that the liquid radwaste treatment system shall be operab.e and appropriate portions of the systems used l                  to reduce the radioactive materials in liquid waste prior to their discharge when the projected doses due to the liquid                                ,
effluent to UNRESTRICTED AREAS would. exceed:
l l                              - 0.06 mrem /31 days to the total body or
                              - 0.2 mrem /31 days to any organ.
The applicable liquid radwaste treatment processing equipment for maintaining radioactive materials releases ALARA are delineated in Figure 1.4-6.
The applicable liquid radwaste treatment processing equipment for maintaining radioactive materials releases ALARA are delineated in Figure 1.4-6.
Dose projections are made at least once per 31-days by the following equations:
Dose projections are made at least once per 31-days by the following equations:
Du,      =  (Da/d)
(Da/d)
* 31 days                       (1-8)
* 31 days (1-8)
D.x,     =   (D x/d)
Du,
* 31 days                     (1-9) where:
=
l Du,      =  the total body dose projection for the current 31-day period (mrem).                               3-t   '
(D x/d)
Da      =  the total body dose projection for the current calendar quarter as determined by equation 1-5,,
* 31 days (1-9)
1-6,         and 1-7 (mrem).
D.x,
D,       [ the maximum organ dose projection for the current 31-day period (mrem) .
=
D.,      =  the maximum organ dose to date for the current                   ,
where:
calendar quarter as determined by equations 1-5,     1-6,     and 1-7 (mrem).
l the total body dose projection for the Du,
d       =  the actual number of days in the current calendar quarter at the end of the release (days).         The minimum time elapsed is seven (7) days.
=
t 31 days =  the number of days of concern
current 31-day period (mrem).
3-t the total body dose projection for the current Da
=
calendar quarter as determined by equation 1-5,,
1-6, and 1-7 (mrem).
D,
[ the maximum organ dose projection for the current 31-day period (mrem).
the maximum organ dose to date for the current D.,
=
calendar quarter as determined by equations 1-5, 1-6, and 1-7 (mrem).
d the actual number of days in the current
=
calendar quarter at the end of the release (days).
The minimum time elapsed is seven (7) days.
t 31 days the number of days of concern
=
v


I l
l l
l                                                                ODCM Rev. 17 Pcge 76 l                                                                       11/95 2.0   GASEOUS EFFLUENTS 2.1 Radiation monitorina instrumentation and Controls The gaseops effluent monitoring instrumentation and controls at Limerick for controlling monitoring radioactive material releases in accordance with the ODCM Part 1 are summarized as follows:
ODCM Rev. 17 Pcge 76 l
: 1) North Vent (Common): The plant gaseous discharges via this vent are monitored by two Particulate, Iodine and Gas (PIG) monitors (RY26-075A and RY26-075B) in parallel and by the Wide Range Accident Monitor (WRAM) (EIX26-076).         The PIGS have reparate Particulate, Iodine, and Gas sampling and monitoring channels but the Station ODCM Controls require only particulate and iodine sampling and noble gas monitoring. The KRAM has extendedtrange (via three channels) noble gas monitoring and particulate and iodine sampling capability.         In addition, the WRAM provides an isolation (Group A) of the large Drywell Purge and Vent valves.
11/95 2.0 GASEOUS EFFLUENTS 2.1 Radiation monitorina instrumentation and Controls The gaseops effluent monitoring instrumentation and controls at Limerick for controlling monitoring radioactive material releases in accordance with the ODCM Part 1 are summarized as follows:
: 2)   south Vent (one ner unit)- The plant gaseous discharges via each South Vent are monitored by two redundant PIG monitors (RY26-285A,B). As is the case of the North Vent, each PIG has separate particulate,i iodine, and gas sampling and monitoring channels but the Station ODCM Part I requires only particulate and iodine sampling with gas monitoring.
1)
: 3) Hot Maintenance Shoo (Common) -       Due to the composition of the radioactive materials in the effluent steam (i.e., very low potential for noble gas), this release point is sampled for particulate and iodine (P&I) monitors (RY26-025).         The P&I monitor has a separate particulate and iodine sampling and monitoring channels but Station ODCM Part I requires only particulate and iodine sampling.
North Vent (Common): The plant gaseous discharges via this vent are monitored by two Particulate, Iodine and Gas (PIG) monitors (RY26-075A and RY26-075B) in parallel and by the Wide Range Accident Monitor (WRAM) (EIX26-076).
: 4) Auxiliary Boilers (Common) - Wacte oil with some amount of radioactive particulate content may be burned in the site auxiliary boilers, as allowed by 10CFR20.2004.       In this case, the exhaust stack of the affected auxiliary boiler will be a release point for radioactive effluents. Doses calculated will be based on the radioactive content of the oil sampled prioi to incineration. The radioactive effluent will be determined by performance of ST-0-104-882-0, summed with other effluents from the site and reported to the commission in the annual effluent report.
The PIGS have reparate Particulate, Iodine, and Gas sampling and monitoring channels but the Station ODCM Controls require only particulate and iodine sampling and noble gas monitoring.
The KRAM has extendedtrange (via three channels) noble gas monitoring and particulate and iodine sampling capability.
In addition, the WRAM provides an isolation (Group A) of the large Drywell Purge and Vent valves.
2) south Vent (one ner unit)- The plant gaseous discharges via each South Vent are monitored by two redundant PIG monitors (RY26-285A,B).
As is the case of the North Vent, each PIG has separate particulate,i iodine, and gas sampling and monitoring channels but the Station ODCM Part I requires only particulate and iodine sampling with gas monitoring.
3)
Hot Maintenance Shoo (Common) -
Due to the composition of the radioactive materials in the effluent steam (i.e., very low potential for noble gas), this release point is sampled for particulate and iodine (P&I) monitors (RY26-025).
The P&I monitor has a separate particulate and iodine sampling and monitoring channels but Station ODCM Part I requires only particulate and iodine sampling.
4)
Auxiliary Boilers (Common) -
Wacte oil with some amount of radioactive particulate content may be burned in the site auxiliary boilers, as allowed by 10CFR20.2004.
In this case, the exhaust stack of the affected auxiliary boiler will be a release point for radioactive effluents.
Doses calculated will be based on the radioactive content of the oil sampled prioi to incineration.
The radioactive effluent will be determined by performance of ST-0-104-882-0, summed with other effluents from the site and reported to the commission in the annual effluent report.


I i
I i
l                                                           ODCM Rev. 17 Page 77 l                                                                 11/95 2.2 GASEOUS EFFLUENT MONITOR SETPOINT DETERMINATION                     l ODCM I3.3.1 requires that an alarm setpoint be established for the noble gas effluent monitoring channels (RY26-075A,B,; RY26-     l 185A,B,; RY26-285A,B,; and RIX26-076) to ensure that the release rate of radioactive materials does not exceed the limits of ODCM 13.3.2.a, which corresponds to a dose rate at         I the SITE BOUNDARY of 500 mrem /yr to the -total body or 3000 mrem /yr to the skin. This specification also states that the dose rates from I-131, I-133, Tritium, and all radionuclides in particulate form with half-lives greater than eight days, shall be limited to a maximum of 1500 mrem /yr to any organ (inhalation pathway only).
l ODCM Rev. 17 Page 77 l
ODCM Part I limits are expressed in terms of dose rate, while the instruments which monitor effluents produce data in units
11/95 2.2 GASEOUS EFFLUENT MONITOR SETPOINT DETERMINATION ODCM I3.3.1 requires that an alarm setpoint be established for the noble gas effluent monitoring channels (RY26-075A,B,; RY26-l 185A,B,; RY26-285A,B,; and RIX26-076) to ensure that the release rate of radioactive materials does not exceed the limits of ODCM 13.3.2.a, which corresponds to a dose rate at I
.,      of concentration or release rate. It is therefore necessary to identify the isotopen and calculate the corresponding release rate which will result in the dose rate limit being reached at the site boundary. This calculation is made more complex by the use of multiple release points at LGS.
the SITE BOUNDARY of 500 mrem /yr to the -total body or 3000 mrem /yr to the skin.
Calculation Bases The alarm setpoint calculation is performed monthly and is based on analytical results of grab samples from the appropriate release point. The concentration of each identified radionuclide in the grab samples is determined, and       ,
This specification also states that the dose rates from I-131, I-133, Tritium, and all radionuclides in particulate form with half-lives greater than eight days, shall be limited to a maximum of 1500 mrem /yr to any organ (inhalation pathway only).
the data are used to perform a setpoint calculation for that         ,
ODCM Part I limits are expressed in terms of dose rate, while the instruments which monitor effluents produce data in units of concentration or release rate. It is therefore necessary to identify the isotopen and calculate the corresponding release rate which will result in the dose rate limit being reached at the site boundary.
nuclide mix and release point.                                       l The highest calculated annual average concentration (X/Q) for an area at or beyond the site boundary (1.1E-05sec/M 3, NE sector) is used in the setpoint calculation.
This calculation is made more complex by the use of multiple release points at LGS.
Maximum flow rates through the North and South vents are used       I in alarm setpoint calculations. This is necessary since flow can vary. By using maximum values, any flow less than the maximum will assure that the monitor will alarm before release rate limits are exceeded.
Calculation Bases The alarm setpoint calculation is performed monthly and is based on analytical results of grab samples from the appropriate release point.
The concentration of each identified radionuclide in the grab samples is determined, and the data are used to perform a setpoint calculation for that nuclide mix and release point.
The highest calculated annual average concentration (X/Q) for an area at or beyond the site boundary (1.1E-05sec/M, NE 3
sector) is used in the setpoint calculation.
Maximum flow rates through the North and South vents are used I
in alarm setpoint calculations.
This is necessary since flow can vary.
By using maximum values, any flow less than the maximum will assure that the monitor will alarm before release rate limits are exceeded.
For each release point the noble gas release which would cause a SITE BOUNDARY total body dose rate of 500 mrem /yr and a skin dose of 3000 mren/yr is determined.
For each release point the noble gas release which would cause a SITE BOUNDARY total body dose rate of 500 mrem /yr and a skin dose of 3000 mren/yr is determined.
The fractional contribution of noble gas is calculated for each release point. The fractional contribution to the whole body and skin dose rates due to noble gases is calculated by taking the product of this fraction and the limiting release rate.     A comparison of this release rate for whole body and skin dose rates due to noble gas release is made to determine if the whole body or skin dose limit will be most restrictive. It is expected that the whole body limit will always be most restrictive, but the comparison is necessary to assure compliance with ODCM I. The sum of the contributions from each release point, independently calculated for iodines and noble gases, will equal the maximum instantaneous release rate allowed from the site.
The fractional contribution of noble gas is calculated for each release point.
The fractional contribution to the whole body and skin dose rates due to noble gases is calculated by taking the product of this fraction and the limiting release rate.
A comparison of this release rate for whole body and skin dose rates due to noble gas release is made to determine if the whole body or skin dose limit will be most restrictive.
It is expected that the whole body limit will always be most restrictive, but the comparison is necessary to assure compliance with ODCM I.
The sum of the contributions from each release point, independently calculated for iodines and noble gases, will equal the maximum instantaneous release rate allowed from the site.


e l                                                             ODCM Rcv. 17 P:ga 78 l                                                                   11/95 The purpose of calculating the release rate which corresponds to the site boundary dose limit is n21 to determine an acceptable release rate, but to determine the maximum release rate which may be exceeded. It is n2n intended that releases will be maintained at or near this limit, and in fact,                 ,
e l
requirements to maintain offsite doses As Low As Reasonably.
ODCM Rcv. 17 P:ga 78 l
11/95 The purpose of calculating the release rate which corresponds to the site boundary dose limit is n21 to determine an acceptable release rate, but to determine the maximum release rate which may be exceeded.
It is n2n intended that releases will be maintained at or near this limit, and in fact, requirements to maintain offsite doses As Low As Reasonably.
Achievable (ALARA) are specified in ODCM 13.3.3 and ODCM I3.3.4.
Achievable (ALARA) are specified in ODCM 13.3.3 and ODCM I3.3.4.
2.2.1   H2Tth Vent Noble Gas Effluent Monitors - RY26-075A-3.
2.2.1 H2Tth Vent Noble Gas Effluent Monitors - RY26-075A-3.
PY26-075B-3, AND RIX26-076-2 The North Vent Noble Gas Effluent monitor high-high setpoint is calculated monthly based on the grab sample resulte performed in accordance with ODCM Table I3.3-3.        .
PY26-075B-3, AND RIX26-076-2 The North Vent Noble Gas Effluent monitor high-high setpoint is calculated monthly based on the grab sample resulte performed in accordance with ODCM Table I3.3-3.
Due to taa incorporation of the ALARA philosophy in the design and operation of the Limerick effluent systems, release point grab samples may not identify any
Due to taa incorporation of the ALARA philosophy in the design and operation of the Limerick effluent systems, release point grab samples may not identify any radionuclides.
                                        ,    radionuclides.     In this situation, chemistry may use the results of the last grab sample which identified radionuclides or use the default setpoint which is based on expected concentration ratios as reported in
In this situation, chemistry may use the results of the last grab sample which identified radionuclides or use the default setpoint which is based on expected concentration ratios as reported in the UFSAR.
                                    .        the UFSAR. If any calculated alarm setpoint is less than the existing monitor setpoint, the setpoint will be reduced to the new value.         If the calculated setpoint value is greater than the existing value, the setpoint may remain at the lower value or increased to the new value.
If any calculated alarm setpoint is less than the existing monitor setpoint, the setpoint will be reduced to the new value.
2.2.1   Setuoint Determination                             I The High-High setpoint is calculated per equation (2-la). The basis for the High-High setpoint is the Unusual Event Emergency Action Level Site P- ,dary Dose Rate of 0.114
If the calculated setpoint value is greater than the existing value, the setpoint may remain at the lower value or increased to the new value.
                                                                                                              ]
2.2.1 Setuoint Determination I
mrem /hr. The Higt , ..;oint for the North Vent Noble gas Efflutnt Monitor is set at or below the lesser of the NVSPsan OR NVSPscsx value. (per equations 2-1 or 2-2)
The High-High setpoint is calculated per equation (2-la).
                                                                                                                \
The basis for the High-High setpoint is the Unusual Event Emergency Action Level Site P-
yygg" ,      [VFa] [500] [E Cml           y
,dary Dose Rate of 0.114
]
mrem /hr.
The Higt,..;oint for the North Vent Noble gas Efflutnt Monitor is set at or below the lesser of the NVSPsan OR NVSPscsx value. (per equations 2-1 or 2-2)
\\
[VFa] [500] [E Cml yygg",
y
[3. 4475E9] E [ (Cm) (Kj) ]
[3. 4475E9] E [ (Cm) (Kj) ]
I NVSP(Hi-Hl)" s [3. 447[500]    [E C*]
I
5E9] E [ (Cm) (Kj)] {2]   (2 -la)
[500] [E C*]
NVSP(Hi-Hl)" s
[3. 447 5E9] E [ (Cm) (Kj)] {2]
(2 -la)
I
I


l l                                                                   ODCM rov. 17 Page 79
l l
      !                                                                            11/95 1
ODCM rov. 17 Page 79 11/95 1
gp" g              [VFul [3000] [ECj,)
[VFul [3000] [ECj,)
[3.4475E9} E [(Cjw) (Lj +1.11Mj )]                       j where:
gp" g
NVSPums     -
[3.4475E9} E [(Cjw) (L +1.11M )]
North Vent High Setpoint - Noble Gas Whole Body (pCi/cc)
j j
NVSPg;s,   =
j where:
North Vent High Setpoint - Noble Gas Skin (pCi/cc)
NVSPums North Vent High Setpoint - Noble Gas Whole Body (pCi/cc)
NVSP (Hi-Hi),y,   =  North Vent High-High Setpoint - Noble Gas whole Body ( Ci/cc).
NVSPg;s, North Vent High Setpoint - Noble Gas Skin (pCi/cc)
VFmm       =
=
Fractional contribution to site boundary noble gas dose rate from the North Vent as calculated in equation 2-7.     (unitless).                           "
NVSP (Hi-Hi),y, North Vent High-High Setpoint - Noble Gas
500         =  Total body dose rate limit (mrem /yr) 3000       =  Skin Dose rate limit (mrem /yr)                           l ICuw        =
=
Total noble gas activity from North Vent grab sample (gCi/cc) 2           =  Multiplication Factor to correspond to Unusual Event       j Emergency Action Level Site Boundary Dose Rate Value       '
whole Body ( Ci/cc).
of 0.114 mrem /hr. (Unitless) 3.4475E9   -  Corhrersion factor l
VFmm Fractional contribution to site boundary noble gas
l (pCl) (cc) m3 ) (pCl) l
=
      = (1.1E-5 sec/m3 ) (1E6 pCi/pCl) (664,000 cfm) (1/60 min /sec) (2. 832E4 cc/fc3)     l 1
dose rate from the North Vent as calculated in equation 2-7.
(2-3) where:
(unitless).
1.1E-5 sec/m 3
500 Total body dose rate limit (mrem /yr)
                                      =  highest annual average X/Cl (NE Sector) 1E6 pCi/pci         =  units conversion 664,000 cfm         =  maximum North Vent flow rate for two unit operation 1/60 min /sec       =  units conversion 2.832E4 cc/ft   8    =  units conversion Cay                 -  concentration of noble gas nuclide i as determined by radioanalysis of North Vent grab sample (pCi/cc)
=
3000 Skin Dose rate limit (mrem /yr)
=
ICuw Total noble gas activity from North Vent grab sample
=
(gCi/cc) 2 Multiplication Factor to correspond to Unusual Event
=
j Emergency Action Level Site Boundary Dose Rate Value of 0.114 mrem /hr.
(Unitless)
Corhrersion factor 3.4475E9 (pCl) (cc) 3 m ) (pCl) l 3
= (1.1E-5 sec/m ) (1E6 pCi/pCl) (664,000 cfm) (1/60 min /sec) (2. 832E4 cc/fc3) l (2-3) where:
3 1.1E-5 sec/m highest annual average X/Cl (NE Sector)
=
1E6 pCi/pci units conversion
=
664,000 cfm maximum North Vent flow rate for two unit
=
operation 1/60 min /sec units conversion
=
8 2.832E4 cc/ft units conversion
=
Cay concentration of noble gas nuclide i as determined by radioanalysis of North Vent grab sample (pCi/cc)


  . , - -  .    - . - _ -        ._- - .        . .-      . - .- ~.- .            .    . _ - . .    --            .
-.- ~.-.
n l                                                                                           ODCM Rov-. 17     i Paga 80     l l                                                                                                   -11/95 i
n l
K- i
ODCM Rov-. 17 i
                                            =    Total body dose conversion factor for noble                             :
Paga 80 l
gas nuclide i (mrem /yr per pCi/m 2 , from Table 2-1).
l
Li                        =    Beta skin dose conversion factor noble gas                             l l                                                 nuclide 1 (mrem /yr per pCim*, per Table 2-1).                         l l                                                                                                                       !
-11/95 i
l               Mo                         =
K-Total body dose conversion factor for noble i
Gamma air dose conversion factor for noble                             {
=
l                                                 gas nuclide i (mrad /yr per 'pci/m*, per -                             l
gas nuclide i (mrem /yr per pCi/m, from 2
!                                                Table,2-1).
Table 2-1).
l 2.2.2         South Vent Noble Gas Effluent Monitors -RY26-185A-3.                                         !'
L Beta skin dose conversion factor noble gas l
RY26185B-3, RY26-285A-3, AND RY26-285B-3 Each unit's South Vent Noble Gas Effluent monitor High                                     )
=
setpoint is calculated monthly based on the grab sample                                     !
i l
results performed in accordance with ODCM I3.3-3.                           Due to         i the incorporation of the ALARA philosophy in the design and                                 i
nuclide 1 (mrem /yr per pCim*, per Table 2-1).
;                            operation of the Limerick effluent systems, release point                                   {
l l
grab samples may not identify any radionuclides.                           With this situation, chemistry may use the results of the grab sample                               '
l Mo Gamma air dose conversion factor for noble
which identified radionuclide or use the default setpoint which is based on expected concentration ratios as reported in the UFSAR.         If any calculated-alarm setpoint is less
{
,                            than the existing monitor setpoint, the setpoint will be                                     !
=
l                            reduced to the new value. If the calculated setpoint value is greater than the existing value, .the setpoint may remain                                 ;
l gas nuclide i (mrad /yr per 'pci/m*, per -
i                            -at the lower value, or increased to the new value.
l Table,2-1).
2.2.2-1     Setpoint determination                                                           I The High setpoint for the South Vent Noble Gas Effluent Monitor is set at the lesser of the SVSP o, and SVSPucsx value.
l 2.2.2 South Vent Noble Gas Effluent Monitors -RY26-185A-3.
i                                  SVSP,o,e and'SVSPsosx are calculated for each unit's South Vent.
RY26185B-3, RY26-285A-3, AND RY26-285B-3 Each unit's South Vent Noble Gas Effluent monitor High
)
setpoint is calculated monthly based on the grab sample results performed in accordance with ODCM I3.3-3.
Due to i
the incorporation of the ALARA philosophy in the design and i
operation of the Limerick effluent systems, release point
{
grab samples may not identify any radionuclides.
With this situation, chemistry may use the results of the grab sample which identified radionuclide or use the default setpoint which is based on expected concentration ratios as reported in the UFSAR.
If any calculated-alarm setpoint is less than the existing monitor setpoint, the setpoint will be l
reduced to the new value.
If the calculated setpoint value is greater than the existing value,.the setpoint may remain i
-at the lower value, or increased to the new value.
2.2.2-1 Setpoint determination The High setpoint for the South Vent Noble Gas Effluent Monitor is set at the lesser of the SVSP o, and SVSPucsx value.
SVSP,o,e and'SVSPsosx are i
calculated for each unit's South Vent.
The High-High setpoint is calculated per equation (2-4a).
The High-High setpoint is calculated per equation (2-4a).
The basis for the High-High setpoint is the.
The basis for the High-High setpoint is the.
Unusual Dose    Rate  Event Emergency of 0.114        mrem /hr.Actidn Level Site Boundary gygg" ,          IVFs =1 (sool [EC,,y)               _,)
Unusual Event Emergency /hr.Actidn Level Site Boundary Dose Rate of 0.114 mrem IVF =1 (sool [EC,,y) s gygg",
[1. 2149E9] E [ (Cj ,y) (K;) ]                                               j
_,)
,                          SVSP(Hi-Hj)" s (1.2149E9] E [(C ,y) (Kj)] [2]                 (2-4a)                             !
[1. 2149E9] E [ (C,y) (K;) ]
f
j j
SVSP(Hi-Hj)" s (1.2149E9] E [(C,y) (Kj)] [2]
(2-4a) f
/
/
i
i


                                                      '                                                                        i ODCM Rov. 17 l
i l
Page 81 l
ODCM Rov. 17 Page 81 l
          'l '                                                                                                           11/95 :
'l '
SVSP" s [1. 2149E9)               E [ ( Cj ,y) (Lj +1.11Nj) 2 (2-5) i where:                                                                                                       l l                     SVSP,,,                 =    South Vent Setpoint - Noble Gas Whole Body                                 [
11/95 SVSP" s (2-5)
L                                                   (pCi/cc)                                                                   !
[1. 2149E9) E [ ( C,y) (Lj +1.11Nj) 2 j
SVSPam,                 =      South Vent Setpoint - Noble Gas Skin (pCi/cc)                             !
i where:
VFnma .                =     Fractional contribution to site L                                                   boundary noble gas dose rate from the Unit's South Vent as calculated in equation 2-8 o.                               ,
l l
2-8a (unitless)                                                           l 500                    =      Total body dose rate limit (mrem /yr)                                     ,
SVSP,,,
3000                    =     Skin dose rate limit (mrem /yr)
South Vent Setpoint - Noble Gas Whole Body
ICum                    =     Total noble gas activity from each unit South Vent grab sample (pCi/cc).                                                 ,
[
2                      =      Multiplication Factor to correspond to                                     ,
=
                                                    . Unusual Event Emergency Action Level Site                                 i '
L (pCi/cc)
: SVSPam, South Vent Setpoint - Noble Gas Skin (pCi/cc)
=
Fractional contribution to site VFnma.
=
L boundary noble gas dose rate from the Unit's South Vent as calculated in equation 2-8 o.
2-8a (unitless) l Total body dose rate limit (mrem /yr) 500
=
Skin dose rate limit (mrem /yr) 3000
=
Total noble gas activity from each unit South ICum
=
Vent grab sample (pCi/cc).
Multiplication Factor to correspond to 2
=
. Unusual Event Emergency Action Level Site i
Boundary Dose Rate Value of 0.114 mrem /hr.
Boundary Dose Rate Value of 0.114 mrem /hr.
(Unitless) 1.2149E9               =     Conversion factor (pci) (cc) l l
(Unitless)
(m3 ) (pCi) ,                                                       {
Conversion factor 1.2149E9
I
=
      = (1.1E-5 sec/m3 ) (1E6pCi/pCi) (234,000 cfm) (1/60 min /sec) (2.83E+4 cc/fc3) (2-6) i where:
(pci) (cc)
l                             1.1E-5 sec/m     3       =      highest annual average X/Q (NE Sector) l                             1E6 pCi/pCi               =      units conversion 234,000 cfm               =      maximum South Vent flow rate 1
(m ) (pCi),
1/60 min /sec             =     units conversion 2.832E4 cc/ft       3      =     units conversion C1 ,y                      =      concentration of noble gas nuclide i determined by radioanalysis of South l                                                               Vent grab sample (pci/cc)
{
Ki                          =    Total body dose conversion factor for
3 l
:                                                              noble gas nuclide i (mrem /yr per pCi/m 3, l                                                               from Table 2-1).
= (1.1E-5 sec/m ) (1E6pCi/pCi) (234,000 cfm) (1/60 min /sec) (2.83E+4 cc/fc3) (2-6) 3 i
where:
l 1.1E-5 sec/m 3
highest annual average X/Q (NE Sector)
=
l 1E6 pCi/pCi units conversion
=
234,000 cfm maximum South Vent flow rate
=
1 1/60 min /sec units conversion
=
3 units conversion 2.832E4 cc/ft
=
concentration of noble gas nuclide i C,y
=
1 determined by radioanalysis of South l
Vent grab sample (pci/cc)
Total body dose conversion factor for K
=
i 3
noble gas nuclide i (mrem /yr per pCi/m,
l from Table 2-1).
l 1
l 1


        ,  l.                                                                                                             ODCM Rev. 17 Pago 82               -'
l.
l                                                                                                                                  11/95             -
ODCM Rev. 17 Pago 82 l
s Li                            =
11/95 s
Beta skin dose conversion factor nable                                                 I gas nuclide i (mrem /yr per pCi/m , per                     2 i
L Beta skin dose conversion factor nable I
Table 2-1).                                                                         !
=
Mi                            =
i gas nuclide i (mrem /yr per pCi/m, per i
Gamma air dose conversion factor for                                                 i noble gas nuclide i (mrad /yr per pCi/m ,                               3 per Table 2-1).
2 Table 2-1).
2'.2.3         Nob'Le Gas Effluent Fractional Contribution                                             ,
M Gamma air dose conversion factor for i
The noble gas effluent fractional contribution-is                                                         ;
=
calculated monthly.if activity in all 3 stacks is i
i noble gas nuclide i (mrad /yr per pCi/m,3 per Table 2-1).
identified using.results of the grab samples                                                             i 3         performed in accordance with ODCM I3.3-3. The                                                           I results of this calculation are used in equations 2-1, 2-2, 2-4, and 2-5. This methodology assumes                                                         )
2'.2.3 Nob'Le Gas Effluent Fractional Contribution The noble gas effluent fractional contribution-is calculated monthly.if activity in all 3 stacks is i
that the total body dose is limiting for noble gas                                                       1 releases.               If equations 2-1, 2-2, 2-4, and 2-5                                               !
identified using.results of the grab samples i
show that the skin dose'is limiting, fractional                                                           ]
3 performed in accordance with ODCM I3.3-3.
skin dose should be substituted for the whole body                                                       '
The I
values used in equations 2-7, 2-8, and 2-8a.                                                             I l
results of this calculation are used in equations 2-1, 2-2, 2-4, and 2-5. This methodology assumes
2.2.3-1           Calculation of VF,m, VF43m,                     and VFasm
)
                                                                        ~
that the total body dose is limiting for noble gas releases.
I"   '
If equations 2-1, 2-2, 2-4, and 2-5 show that the skin dose'is limiting, fractional
                              .VF " = E [ (C ,) (Kj) ] +E [ (Cf3g)                     (K j) ] +E [ (C32g) (Kj) ]
]
(2 -7 )                                  )
skin dose should be substituted for the whole body values used in equations 2-7, 2-8, and 2-8a.
3 l
l 2.2.3-1 Calculation of VF,m, VF m, and VFasm 43
E [Cj ,y) (Kj) ]
.VF " =
1" ,
~
E[(Cgy) (K j) ] +E ( (C32y) (Kj) ] +E [ (C (2-8) j ,y) (Kj) ]
I" (2 -7 )
VF                                                   ###    #
)
am = g-( (c1m) (gs) ) +3 [ (c,,p) (g,) ) +3 [ (eg ,p) (g g) )                           (2-8a) j l
E [ (C,) (Kj) ] +E [ (Cf3g) (K ) ] +E [ (C32g) (Kj) ]
1 I
3 j
I j
E [C,y) (Kj) ]
4 k
j (2-8) 1",
i
E[(Cgy) (K ) ] +E ( (C32y) (Kj) ] +E [ (C,y) (Kj) ]
j j
VF (2-8a) am = g-( (c1m) (gs) ) +3 [ (c,,p) (g,) ) +3 [ (e,p) (g ) )
g g
j 1
j 4
k i


4     4 -              _    _                          ._4-4 l                                                                       ODCM rov. 17 Page 83 l                                                                               11/95 where:
4 4
VFmm        =    fractional contribution to site boundary noble gas total body dose rate from the North Vent (unitless).
._4-4 l
                                =
ODCM rov. 17 Page 83 l
VFuma            fractional contribution to site. boundary noble _ , _.
11/95 where:
gan t'otil"b'o df ~d6se ~ rate ~f rom the Unit 1 South
fractional contribution to site boundary noble VFmm
- -      --      --~
=
Vent (unitless).
gas total body dose rate from the North Vent (unitless).
VFnwa      =    fractional contribution to site boundary noble gas total body dose rate from the Unit 2 South Vent (unitless).
fractional contribution to site. boundary noble _, _.
Can        =    concentration of noble gas nuclide i as determined by radioanalysis of North Vent grab sample (pci/cc)
VFuma
Ki        =    total body dose conversion factor for noble gas radionuclide 1 (mrem /yr per pCi/m')
=
Cun,      =    concentration of noble gas nuclide i as                   '
gan t'otil"b' df ~d6se ~ rate ~f rom the Unit 1 South
determined by radioanalysis of Unit 1 South Vent grab sample (pCi/cc)
--~
Cunt      =    concentration of noble gas nuclide i as determined by radioanalysis of Unit 2 South Vent grab sample (pCi/cc) 2.2.4   Noble Gas Effluent Default Setooint This methodology may be used when grab sample results from either the North Vent or the South Vent do not identify any radionuclides. This methodology is based on expected release concentration ratios as outlined in section 11.3 of the Limerick UFSAR.
o Vent (unitless).
2.2.4-1         North Vent Noble Gas Monitors (RY26-075A-3 and RY26-075B-3). The default High setpoint for the North Vent noble gas effluent monitor is set at or below the NVSPmo value. (per equation 2-9).
fractional contribution to site boundary noble VFnwa
NV5P** s
=
[8. 9 0E-1] [500] [1.15E-6]     (2 -9 )
gas total body dose rate from the Unit 2 South Vent (unitless).
concentration of noble gas nuclide i as Can
=
determined by radioanalysis of North Vent grab sample (pci/cc) total body dose conversion factor for noble gas K
=
i radionuclide 1 (mrem /yr per pCi/m')
concentration of noble gas nuclide i as
: Cun,
=
determined by radioanalysis of Unit 1 South Vent grab sample (pCi/cc) concentration of noble gas nuclide i as Cunt
=
determined by radioanalysis of Unit 2 South Vent grab sample (pCi/cc) 2.2.4 Noble Gas Effluent Default Setooint This methodology may be used when grab sample results from either the North Vent or the South Vent do not identify any radionuclides.
This methodology is based on expected release concentration ratios as outlined in section 11.3 of the Limerick UFSAR.
2.2.4-1 North Vent Noble Gas Monitors (RY26-075A-3 and RY26-075B-3).
The default High setpoint for the North Vent noble gas effluent monitor is set at or below the NVSPmo value.
(per equation 2-9).
[8. 9 0E-1] [500] [1.15E-6]
NV5P** s (2 -9 )
[3. 447 5E9] [4. 3 0E-9]
[3. 447 5E9] [4. 3 0E-9]
NVSPmm s 3.45E-5 pCi/cc The Default High-High setpoint for the North Vent Gas Effluent Monitor is calculated per equation (2-9a).
NVSPmm s 3.45E-5 pCi/cc The Default High-High setpoint for the North Vent Gas Effluent Monitor is calculated per equation (2-9a).
The basis for the Default High-High setpoint is the Unusual Event Emergency Action Level Site Boundary Dose Rate of 0.114 mrem /hr.
The basis for the Default High-High setpoint is the Unusual Event Emergency Action Level Site Boundary Dose Rate of 0.114 mrem /hr.


            . _ _ _ _  - ____ _ _.  .. _ _ _ _ ~. _ .. _ . . - _                        _ . . . _ _ _ _ . , _ _ . _ _ _          .      . _ _ _ _ . _ _
.. _ _ _ _ ~. _.. _.. - _
l                                                                                                                   ODCM Rev. 17 Pag 5 84 l                                                                                                                           11/95
l ODCM Rev. 17 Pag 5 84 l
[500] [1.15E-6]                                       (2-9a) ggrsp(yj _yj)"" s [3.4475E9] [4.30E-9] [2]
11/95
l               NVSP (Hi-Hi)mo s 27.76 E-5 pCi/cc
[500] [1.15E-6]
  .. . ._ _ __            where:                                   -
ggrsp(yj _yj)"" s [3.4475E9] [4.30E-9] [2]
I NVSP,m     =        Default North Vent High Setpoint - Noble                                                                       l l                                     Gas (pCi/cc)                                                                                                 j NVSP(Hi-Hi)mo           =        Default North Vent High-High Setpoint - Noble l                                     Gas (pci/ce) 8.90E-1     =        Default fractignal contribution to site boundary                                                             J noble gas total body dose rate from the North                                                                 }
(2-9a) l NVSP (Hi-Hi)mo s 27.76 E-5 pCi/cc where:
Vent (unitless)
I NVSP,m Default North Vent High Setpoint - Noble
I
=
                                                            ,                4 . 3 0E-9                                                                           i (4 . 3 0E-9 ) + (5 . 31E-10 )                                                                   l 4.30E-9     =
l Gas (pCi/cc) j NVSP(Hi-Hi)mo Default North Vent High-High Setpoint - Noble
Summation of the North Vent concentration of                                                                 i noble gas nuclide i multiplied by the                                                                         !
=
corresponding whole body dose factor.                                                                       ;
l Gas (pci/ce) 8.90E-1 Default fractignal contribution to site boundary J
(pCl) (mrem) (m3)                                                                           l (cc) (yr) (pCl) 5.31E-10 =           Summation of the South Vent (Unit 1 & 2)                                                                   '
=
concentration of noble gas nuclide i multiplied by the corresponding whole body dose factor.
noble gas total body dose rate from the North
(pCl) (mrem) (m3)
}
Vent (unitless) 4. 3 0E-9 i
(4. 3 0E-9 ) + (5. 31E-10 )
4.30E-9 Summation of the North Vent concentration of i
=
noble gas nuclide i multiplied by the corresponding whole body dose factor.
(pCl) (mrem) (m )
l 3
(cc) (yr) (pCl) 5.31E-10 =
Summation of the South Vent (Unit 1 & 2) concentration of noble gas nuclide i multiplied by the corresponding whole body dose factor.
3 (pCl) (mrem) (m )
(cc) (yr) (pci),
(cc) (yr) (pci),
Ref:             a)   Based on expected annual release from UFSAR Table 11.3-1.
Ref:
b)   Based on maximum North Vent flow of 664,000 cfm and South Vent flow of 234,000 cfm for Unit 1 and Unit 2 vents.
a)
c)   ODCM II Table 2-1.
Based on expected annual release from UFSAR Table 11.3-1.
500        =        Total body dose rate limit (mrem /yr) 1
b)
Based on maximum North Vent flow of 664,000 cfm and South Vent flow of 234,000 cfm for Unit 1 and Unit 2 vents.
c)
ODCM II Table 2-1.
Total body dose rate limit (mrem /yr) 500
=
1 m


  . = .. . . ..      . . . - - . - - . - - . . .                    - . .-- - _..~~. - -         ..-. .    - - . -    -~   . . - .
=
i l                                                                                               ODCM Rav. 17                 ,
-..-- - _..~~. - -
Page 85             ;
-~
l                                                                                                            11/95           i 1.15E-6                 =          Total noble gas concentration from North                                     ;
i l
Vent (pCi/cc)                                                               !
ODCM Rav. 17 Page 85 l
t Ref: a)     Based UFSAR Table 11.3-1.                                       i b)     Based on maximum North Vent flow of                             ;
11/95 i
664,000 cfm                                                     !
1.15E-6 Total noble gas concentration from North
2                      =
=
Multiplication Factor to correspond to Unusual                               [
Vent (pCi/cc) t Ref:
Event Emergency Action Level Site Boundary Dose                             ;
a)
Rate Value of 0.114 mrem /hr. (Unitiess)                                     !
Based UFSAR Table 11.3-1.
t 3.4475E9 =                         Conversion factor (pCl) ( cc) '                                                     .
i b)
(m3 ) (pCl) ,                                                     I i
Based on maximum North Vent flow of 664,000 cfm Multiplication Factor to correspond to Unusual
4.30E-9                 =
[
Summation of the North Vent concentration of                                I noble gas nuclide i multiplied by the corresponding whole body dose factor.
2
(pCl) (mrem) (m 3)
=
(cc) (yr) (pCl)             ,
Event Emergency Action Level Site Boundary Dose Rate Value of 0.114 mrem /hr.
i Ref:   a)' Based UFSAR Table 11.3-1.
(Unitiess) t 3.4475E9 =
b)   Based on maximum North Vent flow of 664,000 cfm.
Conversion factor (pCl) ( cc) '
c)   ODCM,II Table 2-1.                                             l 1
3 I
l 4   i.
(m ) (pCl),
i Summation of the North Vent concentration of I
4.30E-9
=
noble gas nuclide i multiplied by the corresponding whole body dose factor.
3 (pCl) (mrem) (m )
(cc) (yr) (pCl) i Ref:
a)' Based UFSAR Table 11.3-1.
b)
Based on maximum North Vent flow of 664,000 cfm.
c)
ODCM,II Table 2-1.
l 1
l 4
i.


l                                                                     ODCM Rev. 17 Page 86 l                                                                           11/95 2.2.4-2   South Vent Noble Gas Monitors (RY26-185A-3, RY26-285A-3, RY26-185B-3, and RY26-285B-3).
l ODCM Rev. 17 Page 86 l
11/95 2.2.4-2 South Vent Noble Gas Monitors (RY26-185A-3, RY26-285A-3, RY26-185B-3, and RY26-285B-3).
The de.#ault High setpoint for each Unit's South Vent noble gas effluent monitor is set at or below the SVSPgm value. (per equation 2-10)
The de.#ault High setpoint for each Unit's South Vent noble gas effluent monitor is set at or below the SVSPgm value. (per equation 2-10)
SVSP,m s  (5.49E-2] [500] [7.14E-8)           (2 -10)
(5.49E-2] [500] [7.14E-8)
[1.2149E9) [2.65E-10) t               !.
SVSP,m s (2 -10)
l              SVSPue s 6.09E-6 pCi/cc The default High-High setpoint'for each units South Vent Noble Gas Effluent Monitor is calculated per equation (2-10a) .
[1.2149E9) [2.65E-10) t l
SVSPue s 6.09E-6 pCi/cc The default High-High setpoint'for each units South Vent Noble Gas Effluent Monitor is calculated per equation (2-10a).
The basis for the default High-High setpoint is the Unusual Event Emergency Action Level Site Boundary Dose Rate of 0.114 mrem /hr.
The basis for the default High-High setpoint is the Unusual Event Emergency Action Level Site Boundary Dose Rate of 0.114 mrem /hr.
[500] [7.14E-8)                (2-10a)
[500] [7.14E-8)
SVSP** s [1.2149E9] [2.65E-10} [2]
SVSP** s [1.2149E9] [2.65E-10} [2]
l           SVSPmm s 2.22E-4pCi/cc where:
(2-10a) l SVSPmm s 2.22E-4pCi/cc where:
SVSPro       =  Default South Vent Setpoint - Noble Gas (pCI/cc)
SVSPro Default South Vent Setpoint - Noble
SVSP(Hi-Hi)mo
=
                    =  Default South Vent Setpoint - Noble Gas (pCI/cc)                                             l l'
Gas (pCI/cc)
5.49E-2     =
SVSP(Hi-Hi)mo Default South Vent Setpoint - Noble
Default fractional contribution to site boundary noble gas total body dose rate from the South Vent (unitless)
=
                        ,            2.65E-10 (4 . 3 0E-9 ) + ( 5. 31E-10 )
Gas (pCI/cc) l l
5.49E-2 Default fractional contribution to site
=
boundary noble gas total body dose rate from the South Vent (unitless) 2.65E-10 (4. 3 0E-9 ) + ( 5. 31E-10 )
where:
where:
2.65E-10    =  Summation of the Unit's South Vent concentration of noble gas nuclide i multiplied by the corresponding whole body dose factor.
Summation of the Unit's South Vent 2.65E-10
(pCi) (mrem) (m 2)
=
(cc) (yr) (pci)     ,
concentration of noble gas nuclide i multiplied by the corresponding whole body dose factor.
4.30E-9      =  Summation of the North Vent concentration of noble gas nuclide i multiplied by the corresponding whole body dose factor.                     !
2 (pCi) (mrem) (m )
(cc) (yr) (pci)
Summation of the North Vent concentration of 4.30E-9
=
noble gas nuclide i multiplied by the corresponding whole body dose factor.


['                                                                                         ODCM Rnv. 17           <
['
Page 87 I                                                                                                       11/95     j (pCl) (mrem) (m3)                                                         !
ODCM Rnv. 17 Page 87 I
(cc) (yr) (pCl)                 ,                                        j i
11/95 j
5,31E-10    =
(pCl) (mrem) (m )
Summation of the South Vent (Unit 1 & 2)                                       !
3 (cc) (yr) (pCl) j i
concentration of noble gas nuclide i                                           !
Summation of the South Vent (Unit 1 & 2) 5,31E-10
multiplied by the. corresponding whole body dose factor.
=
                                                                                  ^
concentration of noble gas nuclide i multiplied by the. corresponding whole body dose factor.
l t
l t
(pCl) (mrem) (m3)                                                         ;
^
(cc) (yr) (pCl)                                                         '
(pCl) (mrem) (m )
Ref:     a)                 Based on expected annual release from UFSAR Table 11.3-1.
3 (cc) (yr) (pCl)
b)                 Based on maximum North Vent flow of 664,000 cfm and South Vent flow of 234,000 cfm for Unit 1 and Unit 2 vents.
Ref:
c)                 ODCM II Table 2-1.                               ;
a)
500         =    Total body dose rate limit (mrem /yr)                                         l 7.14E-8     =    Total noble gas concentration from North Vent                                 r (gCi/cc)                                                                       !
Based on expected annual release from UFSAR Table 11.3-1.
t Ref:     a)                 Based UFSAR Table 11.3-1.                         ;
b)
b)                 Based on maximum North Vent flow of               '
Based on maximum North Vent flow of 664,000 cfm and South Vent flow of 234,000 cfm for Unit 1 and Unit 2 vents.
664,000 cfm.
c)
1.2149E9   =    Conversion factor                                                             .
ODCM II Table 2-1.
(pCl) (cc) '                                                     !
500 Total body dose rate limit (mrem /yr) l
(m3) (pCl) ,
=
Ref:     a)                 ODCM II equation 2-3 2.65E-9     =
7.14E-8 Total noble gas concentration from North Vent
Summation of the North Vent concentration of                                   "
=
r (gCi/cc) t Ref:
a)
Based UFSAR Table 11.3-1.
b)
Based on maximum North Vent flow of 664,000 cfm.
1.2149E9 Conversion factor
=
(pCl) (cc) '
(m3) (pCl),
Ref:
a)
ODCM II equation 2-3 2.65E-9 Summation of the North Vent concentration of
=
noble gas nuclide i multiplied by the corresponding whole body dose factor.
noble gas nuclide i multiplied by the corresponding whole body dose factor.
(pci) (cc) '
(pci) (cc) '
(m3 ) (pCl) .
3 (m ) (pCl).
2           =    Mult!. plication factor to correspond to Unusual Event Emergency Action Level Site Boundary Dose Rate.                     (Unitless) 9                                                                                                         !
2 Mult!. plication factor to correspond to Unusual
4
=
Event Emergency Action Level Site Boundary Dose Rate.
(Unitless) 9 4


l                                               ODCM Rtv. 17 l                                                       Paga 88 l                                                     11/95 Ref: a)   Based UFSAR Table 11.3-1.
l ODCM Rtv. 17 l
b)   Based on maximum North Vent flow of 664,000 cfm.
Paga 88 l
c)   ODCM II Table 2-1.
11/95 Ref:
2.2.5 Wide Rance Accident Monitor Noble Gas Effluent Monitor (RIX-26-076-4)
a)
The Wide Range Accident Monitor (WRAM) noble gas total effluent channel displays the North Vent noble gas release rate. This monitor has Main Control Room Annunciation as well as a group 6A isolation function on the primary containment purge and vent valves. The isolation setpoint value of s2.1 pCi/cc specified in Technical Specification 3.3.2-2 is based on the accident
Based UFSAR Table 11.3-1.
            ' dose limits for containment purge during an accident (Ref: UFSAR Section 1.13). For routine operations the total effluent alert and high setpoints are based upon the methodology of Sections 2.2.5-1 and 2.2.5-2. The setpoint units are in microcuries per second using the two unit maximum North Vent flow rate of 664,000 scfm. The total effluent channel High-High setpoint is set at a value less than or equal to ten times the High setpoint (not to exceed the 2.1 pCi/cc equivalent using the two-unit maximum North Vent flow rate). These values are always more conservative than the Technical Specification       1 Table 3.3.2-2 required value of s 2.lgCi/cc.
b)
If the calculated setpoint value is less than the existing monitor setpoint, the setpoint will be reduced to the new value. If the calculated setpoint is greater than the existing value, the setpoint may remain at the lower value, or increased to the new value.
Based on maximum North Vent flow of 664,000 cfm.
c)
ODCM II Table 2-1.
2.2.5 Wide Rance Accident Monitor Noble Gas Effluent Monitor (RIX-26-076-4)
The Wide Range Accident Monitor (WRAM) noble gas total effluent channel displays the North Vent noble gas release rate.
This monitor has Main Control Room Annunciation as well as a group 6A isolation function on the primary containment purge and vent valves.
The isolation setpoint value of s2.1 pCi/cc specified in Technical Specification 3.3.2-2 is based on the accident
' dose limits for containment purge during an accident (Ref:
UFSAR Section 1.13).
For routine operations the total effluent alert and high setpoints are based upon the methodology of Sections 2.2.5-1 and 2.2.5-2.
The setpoint units are in microcuries per second using the two unit maximum North Vent flow rate of 664,000 scfm.
The total effluent channel High-High setpoint is set at a value less than or equal to ten times the High setpoint (not to exceed the 2.1 pCi/cc equivalent using the two-unit maximum North Vent flow rate).
These values are always more conservative than the Technical Specification 1
Table 3.3.2-2 required value of s 2.lgCi/cc.
If the calculated setpoint value is less than the existing monitor setpoint, the setpoint will be reduced to the new value.
If the calculated setpoint is greater than the existing value, the setpoint may remain at the lower value, or increased to the new value.
5
5


                .-        .- ..        _ - -. -- _- -. _ ~. -.                       . . - - _ _ - _ _ _ .      -  ~
_ - -. -- _- -. _ ~. -.
l
~
: l.                                                                                      ODCM Rev. 17 Page 89 l
l.
11/95 2.2.5-1               Routine Onerations Hiah Setooint                                 i Determination                                                     i For routine operations, the High                                 l setpoint for the WRAM Noble Gas total                           j effluent channel is set at or below the                         1 lesser of the NVSPm , OR NVSPmsx value.
ODCM Rev. 17 l
yygp" g        IVFm] [500] [ECj,]
Page 89 11/95 2.2.5-1 Routine Onerations Hiah Setooint i
[3. 4475E9] E [ ( C           3 ,) (Kj) ]
Determination i
gp"                  [VFa] [3000] [EC ,]           j
For routine operations, the High setpoint for the WRAM Noble Gas total j
[3.447 5E9] E [ (C             3 ,) (Lj + 1.11M j) ]
effluent channel is set at or below the 1
lesser of the NVSPm, OR NVSPmsx value.
IVFm] [500] [ECj,]
yygp" g
[3. 4475E9] E [ ( C,) (Kj) ]
3
[VFa] [3000] [EC,]
j gp"
[3.447 5E9] E [ (C,) (Lj + 1.11M ) ]
3 j
whete:
whete:
NVSPmwa               =          North Vent Setpoint - Noble Gas Whole Bod.y (pci/cc)
NVSPmwa North Vent Setpoint - Noble Gas Whole
NVSPmsx               =          North. Vent Setpoint - Noble Gas                                 )
=
Bod.y (pci/cc)
NVSPmsx North. Vent Setpoint - Noble Gas
)
=
Skin (pCi/cc)
Skin (pCi/cc)
VFwm                   =
VFwm Fractional contribution to site boundary
Fractional contribution to site boundary noble gas dose rate from the North Vent                         i as calculated in equation 2-7.                                   i (unitless).                                                     '
=
500                   -
noble gas dose rate from the North Vent i
Total body dose rate limit (mrem /yr) 3000                   =          Skin Dose rate limit (mrem /yr)
as calculated in equation 2-7.
EC1 w                 =          Total noble gas activity from North Vent                         i grab sample (pci/cc)                                               l 3.4475E9               =
i (unitless).
Conversion factor)
500 Total body dose rate limit (mrem /yr) 3000 Skin Dose rate limit (mrem /yr)
(pCi) (cc)
=
(m3 ) (pCl) .
EC w Total noble gas activity from North Vent i
=(1.1E-5 sec/m 3) (1E6pCi/pCi) (664,000 cfm) (1/60 min /sec) (2.832E4 cc/ft 3) (2 -3 )                                 i l
1
l where:
=
1.1E-5 sec/m 2        =          highest annual average X/Q (NE Sector)                           ;
grab sample (pci/cc) 3.4475E9 Conversion factor)
i 1E6 pCi/gCi           =          units conversion 664,000 cfm           =          maximum North Vent flow rate for two unit operation--
=
1/60 min /sec         =          units conversion                                                   !
(pCi) (cc) 3 (m ) (pCl).
3
=(1.1E-5 sec/m ) (1E6pCi/pCi) (664,000 cfm) (1/60 min /sec) (2.832E4 cc/ft ) (2 -3 )
i 3
where:
2 1.1E-5 sec/m highest annual average X/Q (NE Sector)
=
i 1E6 pCi/gCi units conversion
=
664,000 cfm maximum North Vent flow rate for two
=
unit operation--
1/60 min /sec units conversion
=


l                                                                       ODCM Rev. 17         ,
l ODCM Rev. 17 Pcga-90 l-11/95 2.832E4 cc/ft' units conversion
Pcga-90 l-                                                                                 11/95 2.832E4 cc/ft'     =  units conversion Cuw               =  concentration of noble gas nuclide i as determined by radioanalysis of North Vent grab sample (pCi/cc)
=
Ki                =  Total body dose conversion factor for noble gas nuclide 1 (mrem /yr per pCi/m',
Cuw concentration of noble gas nuclide i as
=
determined by radioanalysis of North Vent grab sample (pCi/cc)
K Total body dose conversion factor for i
=
noble gas nuclide 1 (mrem /yr per pCi/m',
from Table 2-1).
from Table 2-1).
Beta skin dose conversion factor noble Li                =
L Beta skin dose conversion factor noble i
gas nuclide i (mrem /yr per pCi/m , per2 Table 2-1).       ,
=
Mi                =
gas nuclide i (mrem /yr per pCi/m, per 2
Gamma air dose conversion factor for noble gas nuclide 1 (mrad /yr per pCi/m',
Table 2-1).
M Gamma air dose conversion factor for i
=
noble gas nuclide 1 (mrad /yr per pCi/m',
per Table 2-1).
per Table 2-1).
The setpoint values are converted from pCi/cc to pCi/sec using the maximum two-unit North Vent flow rate:
The setpoint values are converted from pCi/cc to pCi/sec using the maximum two-unit North Vent flow rate:
NVSPrew, =
[NVSPm] [3.134E8]
[NVSPm] [3.134E8]               (2-14) i NVSPresx =
(2-14)
[NVSPmsx] [3.134E8]             (2-15) where:
: NVSPrew,
l NVSPuy,           =  WRAM total effluent channel North Vent High Setpoint - Noble Gas Whole Body (pCi/sec) .
=
1 NVSPn:sr           =  WRAM total effluent channel North Vent High Setpoint - Noble Gas Skin (pCi/sec).
i
_ _ -            -j
[NVSPmsx] [3.134E8]
                            - --NVsPyg ---------- a---Ncrtif TreHElliph Setpoint - Noble Gas                 !
(2-15)
Whole Body (pCi/cc).
NVSPresx
NVSP,asx           =  North Vent High Setpoint - Noble Gas                   .
=
where:
l
: NVSPuy, WRAM total effluent channel North Vent
=
High Setpoint - Noble Gas Whole Body (pCi/sec).
NVSPn:sr WRAM total effluent channel North Vent
=
High Setpoint - Noble Gas Skin (pCi/sec).
-j
- --NVsPyg ---------- a---Ncrtif TreHElliph Setpoint - Noble Gas Whole Body (pCi/cc).
NVSP,asx North Vent High Setpoint - Noble Gas
=
Skin (pCi/cc).
Skin (pCi/cc).
                                                                                                            )
3.134E8 Conversion factor (cc/sec).
3.134E8           =
=
Conversion factor (cc/sec).
(664,000 scfm) (1/60 min /sec)
                                                  =   (664,000 scfm) (1/60 min /sec)
=
(2.832E4 cc/f t')
(2.832E4 cc/f t')
(2 -16 )   i i
(2 -16 )
i i


1 l
1 l
l                                                                    ODCM rov. 17 Page 91 l                                                                             11/95y 1 2.2.5-2   Routine Ooerations Hich-Hiah Setooinq                   l Determination For routine operations, the High-High setpoint for the WRAM Noble Gas total effluent channel is set at or below ten times           i the lesser of the routine operations NVSPnwa           ,
ODCM rov. 17 Page 91 l
or NVSPasr value.                                       ;
11/95y 1
NVHPan,        = [NVSPmw,] [10]         (2-17)
2.2.5-2 Routine Ooerations Hich-Hiah Setooinq l
NVHPusx = [NVSPmstl [10]                 (2-18) where:                                                                       !
Determination For routine operations, the High-High setpoint for the WRAM Noble Gas total effluent channel is set at or below ten times i
        .            NVHPnm,             =
the lesser of the routine operations NVSPnwa or NVSPasr value.
WRAM total effluent channel North Vent High-High Setpoint Noble Gas Whole Body       :
[NVSPmw,] [10]
(pCi/sec).
(2-17)
'                    NVHPnsx             =    WRAM total effluent channel North Vent High-High Setpoint Noble Gas Skin (ACi/sec).                                   '
: NVHPan,
i NVSPmw,             =
=
WRAM total effluent channel North Vent Setpoint - Noble Gas Whole Body               ,
NVHPusx = [NVSPmstl [10]
(pCi/sec).                                   ;
(2-18) where:
NVSPmsx               =
: NVHPnm, WRAM total effluent channel North Vent
WRAM total effluent channel North Vent Setpoint - Noble Gas Skin (yCi/sec).         )
=
I 10                   =    nultiplication factor to calculate High       j value (unitless)
High-High Setpoint Noble Gas Whole Body (pCi/sec).
                                                                                              )
NVHPnsx WRAM total effluent channel North Vent
                                                                                              )
=
2.3 Gaseous Effluent Dose Evaluation The Annual gaseous effluent dose evaluations are performed using the computer based RM-21A report processor.                       ;
High-High Setpoint Noble Gas Skin (ACi/sec).
Instantaneous Offsite Dose Calculations are performed with               '
i
the MesoRem Jr Common Dose Model computer program. The follcwing sections describe the computational models, assumptions and bases.           Emergency dose calculations are performed using the MesoRem Jr Common Dose Model computer
: NVSPmw, WRAM total effluent channel North Vent
  ,                    program.
=
* Monthly dose calculations are performed based on limiting sector average annual meteorological dispersion parameters. For the noble gas monthly dose calculation, effluent release data are based on the latest grab sample analysis for radionuclide composition and the hourly average effluent monitor response for total release activity. I?or the iodine and particulate monthly dose
Setpoint - Noble Gas Whole Body (pCi/sec).
      ~
NVSPmsx WRAM total effluent channel North Vent
calculations, the effluent release radionuclide composition and release activity are based on the                       j continuous composite samples for the time period of the dose calculation.
=
The quarterly dose calculations are a summation of the applicable monthly dose results.                                         >
Setpoint - Noble Gas Skin (yCi/sec).
)
I 10 nultiplication factor to calculate High j
=
value (unitless)
)
)
2.3 Gaseous Effluent Dose Evaluation The Annual gaseous effluent dose evaluations are performed using the computer based RM-21A report processor.
Instantaneous Offsite Dose Calculations are performed with the MesoRem Jr Common Dose Model computer program. The follcwing sections describe the computational models, assumptions and bases.
Emergency dose calculations are performed using the MesoRem Jr Common Dose Model computer program.
Monthly dose calculations are performed based on limiting sector average annual meteorological dispersion parameters.
For the noble gas monthly dose calculation, effluent release data are based on the latest grab sample analysis for radionuclide composition and the hourly average effluent monitor response for total release activity.
I?or the iodine and particulate monthly dose calculations, the effluent release radionuclide
~
composition and release activity are based on the j
continuous composite samples for the time period of the dose calculation.
The quarterly dose calculations are a summation of the applicable monthly dose results.


l                                                   ODCM R v. 17 Pega 92 l                                                           11/95 i
l ODCM R v.
The annual dose calculations are based on the actual meteorological conditions concurrent with the effluent releases. Wind direction, temperature lapse rate, ambient temperature,grounglevelwindspeed, and release elevation windspeed are prov:ded for each hour of the year. The           l meteorological dispersion values (X/0,   depleted X/Q, and D/Q) are calculated for each hour and linked with the corresponding release data. The effluent release radionuclide composition and activity are based on the same parameters as the monthly dose analyses.
17 Pega 92 l
2.3.1   Site Boundarv, Dose Rate - Noble Gases ODCM I3.3.2.a limits the dose rate at the SITE BOUNDARY due to noble gas releases to s500 mrem /yr total body and s3000 mrem /yr skin. Radiation       ;
11/95 i
monitor alarm setpoints are established to ensure         l that these release limits are not exceeded.         i     l 2
The annual dose calculations are based on the actual meteorological conditions concurrent with the effluent releases.
Simultaneous releases from the North and South             I Vents are considered in evaluating compliance with         l the release rate limits of ODCM I3.3.2.a following         l any releases exceeding the alarm setpoints.
Wind direction, temperature lapse rate, ambient temperature,grounglevelwindspeed, and release elevation windspeed are prov:ded for each hour of the year.
Monitor indications (readings) are averaged over           ,
The meteorological dispersion values (X/0, depleted X/Q, and D/Q) are calculated for each hour and linked with the corresponding release data.
time periods not to exceed 15 minuies when                 '
The effluent release radionuclide composition and activity are based on the same parameters as the monthly dose analyses.
determining noble gas releare rate based on.
2.3.1 Site Boundarv, Dose Rate - Noble Gases ODCM I3.3.2.a limits the dose rate at the SITE BOUNDARY due to noble gas releases to s500 mrem /yr total body and s3000 mrem /yr skin.
correlation of the monitor leading and moni4cr             ;
Radiation monitor alarm setpoints are established to ensure that these release limits are not exceeded.
sensitivity. The 15-min averaging allows for             i reasonable monitor response to potentially changing radioactive material concentrations and to exclude potential electronic spikes in monitor         l readings that may be unrelated to radioactive             )
i l
material releases. When identified, electronic spiking monitor responses are being excluded from the dose calculation.     ,
2 Simultaneous releases from the North and South Vents are considered in evaluating compliance with the release rate limits of ODCM I3.3.2.a following l
                                        +
any releases exceeding the alarm setpoints.
Monitor indications (readings) are averaged over time periods not to exceed 15 minuies when determining noble gas releare rate based on.
correlation of the monitor leading and moni4cr sensitivity.
The 15-min averaging allows for i
reasonable monitor response to potentially changing radioactive material concentrations and to exclude potential electronic spikes in monitor l
readings that may be unrelated to radioactive material releases.
When identified, electronic spiking monitor responses are being excluded from the dose calculation.
+
NOTE: For administrative purposes, more conservative alarm setpoints than those
NOTE: For administrative purposes, more conservative alarm setpoints than those
                    ' requirsd to meet 10 CFR 20 Dose Rate limits are imposed. However, conditions exceeding these more limiting alarm setpoints do not         ;
' requirsd to meet 10 CFR 20 Dose Rate limits are imposed.
necessarily indicate radioactive material           i release rates exceeding the dose limits of
However, conditions exceeding these more limiting alarm setpoints do not necessarily indicate radioactive material i
      ,              ODCM I3.3.2.a. Provided actual releases do not result in radiation monitor indications exceeding values based on the dose rate limits of ODCM I3.3.2.a, no further analysis are required for demonstrating compliance with the limits of ODCM I3.3.2.a.
release rates exceeding the dose limits of ODCM I3.3.2.a.
Provided actual releases do not result in radiation monitor indications exceeding values based on the dose rate limits of ODCM I3.3.2.a, no further analysis are required for demonstrating compliance with the limits of ODCM I3.3.2.a.
t e
t e


    - . . . -                                .              .. - - -          -.-. . _~                   - . .        . . . ..
-.-.. _~
1 l                                                                       t                     ODCM Rsv. 17-Page 93 f   l                                                                                                             11/95 In the event Of a noble gas effluent release                                             ,
1 l
exceeding the setpoint value specified in ODCM.II l                                         sections 2.2r.1 or-2.2.2, the; site boundary dose rate from the release is calculated using the methodology stated below. This methodology is based on worst sector (NE) annual average meteorological dispersion but, if further refinement is required to meet the requirements of                                         l ODCM I3.3.2.a, actu,1 meteorological data from the.                                       l time period of concern may be used to calculate                                           '
t ODCM Rsv. 17-Page 93 f
actual meteorological dispersion.
l 11/95 In the event Of a noble gas effluent release exceeding the setpoint value specified in ODCM.II l
Dsm= (53. 882) (X/0)     '17(( (F,) (0,)3 + (Fm) (O sn)       + (F SV)     (O fsn)] KjJ             (2-22 f           a                                             f i       ,J=3 i
sections 2.2r.1 or-2.2.2, the; site boundary dose rate from the release is calculated using the methodology stated below.
11 Df,g= (53. 8 82) (X/0) 17                                                           .
This methodology is based on worst sector (NE) annual average meteorological dispersion but, if further refinement is required to meet the requirements of l
                                      '(SF) E [ (F,) (Oj,) + (F SV)   1    (Oj,y) + (Fan)(Osn)lN f        f(1     11) 1*3                                                                     .          ?
ODCM I3.3.2.a, actu,1 meteorological data from the.
(2-23)           I where:         ?
l time period of concern may be used to calculate actual meteorological dispersion.
D,m            =        Total Body ?lume Dose Rate (rem /hr) i Drsx            =
sm= (53. 882) (X/0) '17(( (F,) (0,) + (Fm) (O sn) + (F SV) (O sn)] KjJ (2-22 f
Skin Plume Dose Rate (rem /hr)                                                   l 53.882          =       Units conversion fact >r re:n-m'-pCi-yr-min-cc                 ,
D 3
j
f a
                                                , pCi-br-mrem-m3 -sec-f t       3 X/O             =        1.1E-05 highest annual average relative concentration (NE Sector) (sec/m )             3 Fw              =        North Vent Flow Rate (cfm)                                                       ;
f i
Qin            =       ccncentration of noble gas nuclide i during                                     l
,J=3 i
                                                  . period of release from North Vent (pCi/cc)
11 D,g= (53. 8 82) (X/0) f 17
                      '                                                                                                              i F 1sv          =        Unit 1 South Vent Flow Rate (cfm)
'(SF) E [ (F,) (Oj,) + (F SV) (Oj,y) + (Fan)(Osn)lN (1 11) f f
Qitsy          =       Concentration of noble gas nuclide i during period   of release from Unit 1SouthKent (pCi/cc).
1 1*3
Fasy            =        Unit 2 !iouth Vent Flow Rate (cfm)                                     .
?
Qi2sv          =       Concent. ration of noble gas nuclide r duripg period of release from Unit 2 South Vent
(2-23)
I where:
?
Total Body ?lume Dose Rate (rem /hr)
D,m
=
i Skin Plume Dose Rate (rem /hr) l Drsx
=
Units conversion fact >r 53.882
=
re:n-m'-pCi-yr-min-cc j
3 3
, pCi-br-mrem-m -sec-f t X/O 1.1E-05 highest annual average relative
=
concentration (NE Sector) (sec/m )
3 North Vent Flow Rate (cfm)
Fw
=
ccncentration of noble gas nuclide i during l
Qin
=
. period of release from North Vent (pCi/cc) i (cfm)
Unit 1 South Vent Flow Rate F sv
=
1 Concentration of noble gas nuclide i during Qitsy
=
period of release from Unit 1SouthKent (pCi/cc).
Unit 2 !iouth Vent Flow Rate (cfm)
Fasy
=
Concent. ration of noble gas nuclide r duripg Qi2sv
=
period of release from Unit 2 South Vent


i 4,,                                        l_                                                                                   ODCM Rsv. 17                 )
i l_
i                                                                                                                                         Page 94         <
ODCM Rsv. 17
l                                                                                                        11/95 (pCi/cc).
)
                                                  $      Ki              -        Total body dose factor for noble gas nuclide                             l
4,,
: i.         Values are listed in Table 2-1.                             1 I
i Page 94 l
mrem-m' pci-yr ,
11/95 (pCi/cc).
5                                       ,
Total body dose factor for noble gas nuclide K
                                                                                                                    ?                                       l i
i i.
l Li              -
Values are listed in Table 2-1.
Skin dose factor for the beta contribution                               l for noble gas nuclide 1.             Values are listed                 i in Table 2-1.                                                             !
1 I
mrem-m 3 pCi-yr.
mrem-m' pci-yr,
1.11            =        the average ratio of tissue to air energy                               ;
5
absorption coefficients (mrem / mrad) (Ref:                             ;
?
Regulatory Guide 1.109 Section 2.2)                                       '
i l
SF              =        0.7 is the attenuation factor that accounts                             :
Skin dose factor for the beta contribution l
for the dose reduction due to shielding                                 !'
L i
provided by residential structure (dimensionless) (Ref: Regulatory Guide 1.109 Table E-15).
for noble gas nuclide 1.
Mi              =        Gamma. ail dose factor for noble gas nuclide
Values are listed i
: i.             Values ara listed in Table 2-1.
in Table 2-1.
1 mrad-m                 '
3 mrem-m pCi-yr.
l pCi-yr                 +
the average ratio of tissue to air energy 1.11
l 2.3.2         Site Boundarv Dose Raig Radiciodine and Particulates ODCM I3.3.2.d limits thh dose rate to s1500 mrem /yr to any organ (inhalation pathways only) 'for I-131, I-133, Tritium, and all radionuclides in particulate form with half-lives greater than 8 days An gaseous effluents.
=
absorption coefficients (mrem / mrad) (Ref:
Regulatory Guide 1.109 Section 2.2) 0.7 is the attenuation factor that accounts SF
=
for the dose reduction due to shielding provided by residential structure (dimensionless) (Ref:
Regulatory Guide 1.109 Table E-15).
Gamma. ail dose factor for noble gas nuclide M
=
i i.
Values ara listed in Table 2-1.
1 mrad-m pCi-yr
+
2.3.2 Site Boundarv Dose Raig Radiciodine and Particulates ODCM I3.3.2.d limits thh dose rate to s1500 mrem /yr to any organ (inhalation pathways only) 'for I-131, I-133, Tritium, and all radionuclides in particulate form with half-lives greater than 8 days An gaseous effluents.
Compliance with ODCM I3.3.2.d is determined monthly by performance of ODCM II Section 2.3.4.
Compliance with ODCM I3.3.2.d is determined monthly by performance of ODCM II Section 2.3.4.
Simultaneous releases from the North and South Vents                                     !
Simultaneous releases from the North and South Vents are considered in evaluating compliance with the release rate limits of ODCM I3.3.2.b.
are considered in evaluating compliance with the release rate limits of ODCM I3.3.2.b. Release activity is based upon the results of the continuous composite sampler analysis performed in accordance with ODCM Table I3.3-3.                               ;
Release activity is based upon the results of the continuous composite sampler analysis performed in accordance with ODCM Table I3.3-3.
r
r f,
                                                                                                                                                  ,    f,     i i
i i
1
1


l                                                                                           ODCM Rcv. 17 Page 95
l ODCM Rcv. 17 Page 95
          ]                                                                                                   11/95 This methodology is based on the worst sector (NE)                         ,
]
annua.1 average meteorological dispersion but, if                           ;
11/95 This methodology is based on the worst sector (NE) annua.1 average meteorological dispersion but, if further, refinement is required to meet the limits of ODCM I3.3.2.b, actual meteorological data from the time period of concern may be used to calculate actual meteorological dispersion.
further, refinement is required to meet the limits of ODCM I3.3.2.b, actual meteorological data from the time period of concern may be used to calculate actual                           '
i 2.3.3 Noble Gas Air Doses ODCM I3.3 3 limits the air dose due to noble gases l
              .                          meteorological dispersion.
released in gaseous effluents (from both reactor units) to areas at or beyond the SITE BOUNDARY to:
i 2.3.3           Noble Gas Air Doses ODCM I3.3 3 limits the air dose due to noble gases                         l released in gaseous effluents (from both reactor units) to areas at or beyond the SITE BOUNDARY to:                                 !
s 10 mrad gamma for any quarter s 20 mrad beta for any quarter-s 20 mrad gamma during any calendar year s 40 mrad beta duripg any calendar year As required by ODCM 13.3.3.1 Surveillance Requirement, these doses are calculated at least once per 31 days using the results of the most recent grab samples for isotopic composition performed in accordance with ODCM Table 13.3-3 when release point grab samples'do not identify any radionuclides.
s 10 mrad gamma for any quarter s 20 mrad beta for any quarter-s 20 mrad gamma during any calendar year s 40 mrad beta duripg any calendar year As required by ODCM 13.3.3.1 Surveillance Requirement, these doses are calculated at least once per 31 days                       ,
Total release activity is based upon the hourly average effluent monitor response.
using the results of the most recent grab samples for isotopic composition performed in accordance with ODCM Table 13.3-3 when release point grab samples'do                       ,
As identified, electronic spiking monitor responses are excluded from the release activity analyses.
not identify any radionuclides. Total release activity                     ;
The monthly dose calculation is performed using the most limiting average annual meteorological dispersion values.
            ,                            is based upon the hourly average effluent monitor response. As identified, electronic spiking monitor
The quarterly doses are based on the summation of the applicable monthly results.
  ,                                      responses are excluded from the release activity analyses. The monthly dose calculation is performed                         -
The annual dose calculations are based upon actual release meteorological conditions as described in Section 2.3.5.
using the most limiting average annual meteorological dispersion values. The quarterly doses are based on the summation of the applicable monthly results. The                       '
The monthly dose calculations are performed in accordance with the methodology below.
annual dose calculations are based upon actual release meteorological conditions as described in Section 2.3.5. The monthly dose calculations are performed in accordance with the methodology below.
t D, AIR = (0.114 ) (1.11E-5) (47 2) E [ (F,) (Cj,) + (F,) (C32y)+(Fay) ( C,y) ] M3 (2-24)
t D, AIR = (0.114 ) (1.11E-5) (47 2) E [ (F,) (Cj,) + (F               2 ,) (C32y)+(Fay) ( C3,y) ] M3 (2-24)   'i i
'i 2
t D, AIR = (0.114 ) (1.11E-5) (47 2) E [ (F,) (C         3 ,) + (F13)(C32n)+(Fan) (C12n)] Nj (2-25)
3 i
                              ,                      1                                                               >
t D, AIR = (0.114 ) (1.11E-5) (47 2) E [ (F,) (C,) + (F13)(C32n)+(Fan) (C12n)] Nj (2-25) 3 1
1 where:
1 where:
D,ua              =    Gamma air dose from noble gas releases (rad /hr)
Gamma air dose from noble gas releases (rad /hr)
Duan              =   Beta air dose from noble gas release (rad /hr)
D,ua
O.114             =   Unit h conversion rad-pCi-yr
=
                                                          ,pCi-br-mrad, 1.1E-5           =   Highest average annual relative concentration (NE Sector) (sec/m')
Beta air dose from noble gas release (rad /hr)
* 472               =   Tinits conversion
Duan
=
Unit h conversion O.114
=
rad-pCi-yr
,pCi-br-mrad, Highest average annual relative concentration 1.1E-5
=
(NE Sector) (sec/m')
Tinits conversion 472
=


l I
l I
i   l                                                   ODCM R3v. 17 Pnga 96 l                                                           11/95 t
i l
l l                               min /sec
ODCM R3v. 17 Pnga 96 l
                              .sec-ft',
11/95 t
Fu        =  Average North Vent Flow rate for period of release (cfm)
l l
Can      =  Concentration of noble gas nuclide i from North l
min /sec
Vent effluent (pCi/cc)
.sec-ft',
Fuw      =  Average Unit 1 South Vent flow rate for period of release (qfm) l Cup       =  Concentration of noble gas nuclide i from Unit 1 South Vent effluent (pCi/cc) l      F 2sv    =  Average Unit 2 South Vent 41ow rate for period i
Average North Vent Flow rate for period of Fu
=
release (cfm)
Concentration of noble gas nuclide i from North Can
=
Vent effluent (pCi/cc) l Average Unit 1 South Vent flow rate for period Fuw
=
of release (qfm) l Cup Concentration of noble gas nuclide i from
=
Unit 1 South Vent effluent (pCi/cc)
Average Unit 2 South Vent 41ow rate for period F sv l
=
2 i
of release (cfm)
of release (cfm)
Cusy      =  Concentration of noble gas nuclide i from Unit 2 South Vent effluent (pCi/cc)
Concentration of noble gas nuclide i from Cusy
M1        =    Gamma air dose factor for noble gas nuclide i.
=
Unit 2 South Vent effluent (pCi/cc) 1 Gamma air dose factor for noble gas nuclide i.
M
=
l Values are listed in Table 2-1.
l Values are listed in Table 2-1.
mrad-m2 pCi-yr Ni        =  Beta air dose factor for noble gas nuclide i.
mrad-m2 pCi-yr Beta air dose factor for noble gas nuclide i.
values are listed in Table 2-1.
N
mrad-m'
=
:                                pCi-yr l
i values are listed in Table 2-1.
l l         2.3.4 Radiciodine and Particulate Dose Calculations
mrad-m' pCi-yr l
!                      i ODCM I3.3.4 limits the dose (from both reactor         ,
l l
units) to a MEMBER OF THE PUBLIC from I-131, I-       l l                133, Tritium, and all radionuclides in particulate     1 l                 form with half-lives greater than 8 days in gaseous effluents released to areas at or beyond       1 the SITE BOUNDARY to:                                 1 s 15 mrem to any organ during any calendar quarter                                         .
2.3.4 Radiciodine and Particulate Dose Calculations i
s 30 mrem to any organ during any calendar     j year                                           ;
ODCM I3.3.4 limits the dose (from both reactor units) to a MEMBER OF THE PUBLIC from I-131, I-l 133, Tritium, and all radionuclides in particulate 1
                                                                        ^
l form with half-lives greater than 8 days in gaseous effluents released to areas at or beyond 1
As required by ODCM I3.3.4.1 Surveillance Requirement, these doses are calculated at least once per 31 days using the results of the continuous composite sample analysis performed in     I accordance with ODCM Table I3.3-3. Due to the         l i
the SITE BOUNDARY to:
incorporation of the ALARA philosophy in the l                 design and operation of the Limerick effluent
1 15 mrem to any organ during any calendar s
quarter s 30 mrem to any organ during any calendar j
year As required by ODCM I3.3.4.1 Surveillance
^
Requirement, these doses are calculated at least once per 31 days using the results of the continuous composite sample analysis performed in accordance with ODCM Table I3.3-3.
Due to the incorporation of the ALARA philosophy in the i
l design and operation of the Limerick effluent


l                                                                                     ODCM rov. 17         )
l ODCM rov. 17
)
Page 9'{
Page 9'{
    \                                                                                                 11/9!8 systems, these composite samples may nbt identify any radionuclides. Total release actitity is based upon detectable concentration of the continuous composite samples and average appropriate vent flow during the sampling period.
\\
The monthly dose calculation is performed using the most limiting average annual meteorological dispersion values. The quarterly doses are based on the summation of the applicable monthly results. The annual dose calculations are based upon actual release meteorology as described in Section 2.3.5. The monthly dose calculations are performed in accordance with the methodology below. Total organ dose is obtained by the summation of the organ dose from each pathway for each receptor.
11/9!8 systems, these composite samples may nbt identify any radionuclides.
2.3.4-1       Ground Pathway Daru = (3.6E-6) (47 2) (1. 82E-9 ) E e 35 E [ (F yy
Total release actitity is based upon detectable concentration of the continuous composite samples and average appropriate vent flow during the sampling period.
              ) (Ojyy) + (F 1,y) (Oj2,y) + (F2sv) (042sv) + (Fmy) (Oja,) ] DFy ,y,t,y (T)e    (2-26)
The monthly dose calculation is performed using the most limiting average annual meteorological dispersion values.
  ,ja18 2.3.4-2       Yagg..ation, Meat. Cow Milk, and Goat.- Milk Pathway Dypy = (3. 6 E-6 ) (47 2 ) E         -
The quarterly doses are based on the summation of the applicable monthly results.
  '2                                                   ,
The annual dose calculations are based upon actual release meteorology as described in Section 2.3.5.
E [(Fyy) (Ofuv) + (F   1 ,y) (Ojuy) + (F 2s v) (Of lsv) + (Fw) (Ojmy) ] (1.1E-5) DFy,g,t,y   +
The monthly dose calculations are performed in accordance with the methodology below.
  -I'1                                                                                               (Te)
Total organ dose is obtained by the summation of the organ dose from each pathway for each receptor.
  ' 35 E (F yy
2.3.4-1 Ground Pathway Daru = (3.6E-6) (47 2) (1. 82E-9 ) E e 35 E [ (F ) (Ojyy) + (F,y) (Oj2,y) + (F2sv) (0 sv) + (Fmy) (Oja,) ] DF,y,t,y (T)
            ) (Ojyy) + (F 1,y) (Oj2,y) + (F2sv) I.032sv) + (Fas) (O lms) ) (1. 82E-9 ) DFI ,r,r,n
(2-26) yy 1
  ,1=18                                                                                           .
42 y
(2-27)
e j, a18 2.3.4-2 Yagg..ation, Meat. Cow Milk, and Goat.- Milk Pathway Dypy = (3. 6 E-6 ) (47 2 ) E
'2 E [(Fyy) (O uv) + (F,y) (Ojuy) + (F v) (O lsv) + (Fw) (Ojmy) ] (1.1E-5) DF,g,t,y +
f 1
2s f
y
-I'1 (T )
e
' 35 E (F ) (Ojyy) + (F,y) (Oj2,y) + (F2sv) I.0 sv) + (Fas) (O ms) ) (1. 82E-9 ) DF,r,r,n yy 1
32 l
I
,1=18 (2-27)


l                                                                                             ODCM Rev. 17           i Paga 98 l                                                                                                         11/95 2.3.4-3         Inhalation Pathway                                                       i d
l ODCM Rev. 17 i
i Dyp, = (3.6E-6) (47 2) E                   4 e
Paga 98 l
2 E [ (F,) (0,)3 + (F ,)1 (On,y) + (Fay) (Oj,,y) + (F,) (Ojm)) (1.1E-5) DFg,t,, +
11/95 2.3.4-3 Inhalation Pathway i
(Te)         ,
d i
    ,{ [ (F,) (Oj,) + (F ,y)   1      (0 sv) 42  + (Fasv) (042sv) + (Fm) (Osm)] (1. 0E-5) DFr,1,s.
D, = (3.6E-6) (47 2) E 4
I (2-28)   i where:
yp e
1 DGPAR            =  dose from ground pathway due to release of                               l' particulates and iodines (rem).
2 E [ (F,) (0,) + (F,) (On,y) + (Fay) (Oj,,y) + (F,) (Ojm)) (1.1E-5) DF,t,, +
e Dvra              =  dose from vegetation, meat, cow milk,' and goat                           I milk,-pathways due to releases of particulates, iodines, and tritium (rem)                                               i Dz pu            =  dose from inhalation pathway due to release of                           ,
3 1
            .                                particulates, iodines, and tritium (rem) a 3.6E-6             = units conversion factor                                                  j rem-Ci-sec                                               i
g (T )
                                                                                                        ~
e
,{ [ (F,) (Oj,) + (F,y) (0 sv) + (Fasv) (0 sv) + (Fm) (Osm)] (1. 0E-5) DF,1,s.
1 42 42 r
I (2-28) i where:
1 D
dose from ground pathway due to release of l
=
GPAR particulates and iodines (rem).
e dose from vegetation, meat, cow milk,' and goat I
Dvra
=
milk,-pathways due to releases of particulates, iodines, and tritium (rem) i dose from inhalation pathway due to release of D pu
=
z particulates, iodines, and tritium (rem) a units conversion factor j
3.6E-6
=
rem-Ci-sec i
~
br-mrem-p Ci,
br-mrem-p Ci,
                                                                                                                        )
)
472                =  units conversion factor
units conversion factor 472
                                                                ' fin-cci, sec-ft) 1.82E-9            =  highest average annual deposition (ESE Sector)
=
' fin-cci, sec-ft) highest average annual deposition (ESE Sector) 1.82E-9
=
_1, _
_1, _
ma i
a m
E                  =  summation for each release time period t                       (unitless)
i E
Fu                 =faverageNorthVentflowrateduringrelease (cfm).
summation for each release time period
Qni
=
                                            =  concentration of nuclide I from North Vent effluent (gCi/cc).
t (unitless)
F1,y              =  average Unit 1 South Vent flow rate during
Fu
=faverageNorthVentflowrateduringrelease (cfm).
concentration of nuclide I from North Vent Qn
=
i effluent (gCi/cc).
average Unit 1 South Vent flow rate during F,y
=
1


Il t
Il t
j l                                                       ODCM Rev. 17     '
j l
* Page 99 l                                                               11/95 release (cfm).
ODCM Rev. 17 Page 99 l
Qun         =
11/95 release (cfm).
concentration of nuclide i from Unit 1 South Vent effluent (pCi/cc).
Qun concentration of nuclide i from Unit 1 South
Fan         =  average Unit 2 South Vent flow rate during release (cfm).
=
Qun         =
Vent effluent (pCi/cc).
concentration of nuclide i from Unit 2 South Vent effluent (pCi/cc).
Fan average Unit 2 South Vent flow rate during
F,.         =  average Hot Maintenance Shop flow rate during release (cfm).
=
Qums       =  concentration of nuclide i from Hot Maintenance effluent (pci/cc).
release (cfm).
DFi , x,t,, =  dose factor for organ type k, age group 1, pathway number n; dose factors are based on a computer program which is similar to the NRC program GASPAR results from this program provide input data in the form of a lookup table - values of DFun are provided in Table 2-2.
Qun concentration of nuclide i from Unit 2 South
i           =  isotope number (1 through 35) (3 through 17 are noble gases).
=
  ,K           =  organ type (1 through 8, where total body = 1, GI tract = 2, bone.= 3, liver = 4, kidney = 5, thyroid = 6, lung = 7, skin - 8).
Vent effluent (pCi/cc).
L           =  age group (1 through 4, where adult = 1, teen = 2, child = 3, infant A 4).
F,.
N           =  pathway number (1 through 7).
average Hot Maintenance Shop flow rate during
Te          = time duration of release (hrs).
=
1.1E-5      = highest average annual X/Q (:NE Sector) (sec/m') .
release (cfm).
1.0E-5     =
Qums concentration of nuclide i from Hot Maintenance
highest averag)e annual depleted X/Q (NE Sector) (sec/m .
=
2.3.5 Annual Dose Evaluation ODCM I3.6 requires an Annual Dose evaluation be       ,
effluent (pci/cc).
performed and reported in accordance with Regulatory Guide 1.21 in the Annual Radioactive Effluent Release Report submitted 60 days after the first of each year. This dose evaluation is' processed by the RM-21A. In the event that this computer model is unavailable, this analysis can be performed using the same methodology. The liquid portion of this annt al dose calculation is described in Section 1.3 of ODCM II. The annual gaseous dose calculation uses the same methodology described in Section 2.3.1, 2.3.3, and 2.3.4 with the exception of meteorology; which is based upon
dose factor for organ type k, age group 1, DF, x,t,,
=
i pathway number n; dose factors are based on a computer program which is similar to the NRC program GASPAR results from this program provide input data in the form of a lookup table - values of DFun are provided in Table 2-2.
i isotope number (1 through 35) (3 through 17 are
=
noble gases).
,K organ type (1 through 8, where total body = 1,
=
GI tract = 2, bone.= 3, liver = 4, kidney = 5, thyroid = 6, lung = 7, skin - 8).
L age group (1 through 4, where adult = 1,
=
teen = 2, child = 3, infant A 4).
N pathway number (1 through 7).
=
time duration of release (hrs).
T
=
e highest average annual X/Q (:NE Sector) (sec/m').
1.1E-5
=
highest averag)e annual depleted X/Q (NE 1.0E-5
=
Sector) (sec/m 2.3.5 Annual Dose Evaluation ODCM I3.6 requires an Annual Dose evaluation be performed and reported in accordance with Regulatory Guide 1.21 in the Annual Radioactive Effluent Release Report submitted 60 days after the first of each year.
This dose evaluation is' processed by the RM-21A.
In the event that this computer model is unavailable, this analysis can be performed using the same methodology.
The liquid portion of this annt al dose calculation is described in Section 1.3 of ODCM II.
The annual gaseous dose calculation uses the same methodology described in Section 2.3.1, 2.3.3, and 2.3.4 with the exception of meteorology; which is based upon


l l
l ODCM R;v. 17 Pcga 100 l
l                                                                                  ODCM R;v. 17 Pcga 100 l                                                                                               11/95 actual sector average atmospheric dispersion values using the guidance of Regulatory Guide 1.111 (Section C.lc). Finalized hourly values of wind direction, ground level and release elevation                     ,
11/95 actual sector average atmospheric dispersion values using the guidance of Regulatory Guide 1.111 (Section C.lc).
wind speed, ambient temperature, and temperature                       !
Finalized hourly values of wind direction, ground level and release elevation wind speed, ambient temperature, and temperature lapse rate (for P-G stability class) are provided annually using the instrumentation specified in ODCM I3.1-1.
lapse rate (for P-G stability class) are provided                       !
These values are calculated for each hour and linked to the corresponding hourly averaged effluent release rate.
annually using the instrumentation specified in ODCM I3.1-1. These values are calculated for each hour and linked to the corresponding hourly averaged effluent release rate. Doses are then calculated for each hour at the various receptors                       ;
Doses are then calculated for each hour at the various receptors of interest (depending upon release direction).
of interest (depending upon release direction).                         l Radioactiv3 material release rate is calculated as                     ;
Radioactiv3 material release rate is calculated as described in Sections 2.3.3 and 2.3.4.
described in Sections 2.3.3 and 2.3.4.                 Dose at         i each receptor is accumulated for the year and the maximum dose for plume, inhalation, and ingestion                       )
Dose at i
pathways are reported. The gaseous effluent dose                       j receptors are listed in Table 2-4 and the dose is                       j calculated using the methodology below.                                 '
each receptor is accumulated for the year and the maximum dose for plume, inhalation, and ingestion
2.3.5-1       Plume Pathway 17
)
                                                                                                          )
pathways are reported.
Dptyy4= (3. 6E-6 ) (47 2) E (X/0) E [ (F,y) (Ojyy) + (F ,y) 1  (Oj2,y) + (F2sv) (O ssv)3 f
The gaseous effluent dose j
C      C2=3
receptors are listed in Table 2-4 and the dose is j
[e NJ) *) /"t) (DFja)T)e            (2 -29 )
calculated using the methodology below.
I 2.3.5-2       Ground Pathway 17 p,y"= (3. 6E-6) (472) E (X/0) I (Fyy) (Ojyy) + (F2SV) (Dj2sy) + (DFfu) (T e) c2 3. (Fasv) (Ol ssv) + (Fm) (Ojm) -
2.3.5-1 Plume Pathway 17
(2-30) 2.3.5-3       Vecetation. Meat. Cow Milk. Goat Milk Pathway
)
* Dvna = (3. 6E-6 ) (47 2) E
Dptyy4= (3. 6E-6 ) (47 2) E (X/0) E [ (F,y) (Ojyy) + (F,y) (Oj2,y) + (F2sv) (O ssv)3 1
  '2 E[(Fyy) (Ojyy) + (F 1,y) (Dj2,y) + (F2sv) (01 :sv) + (Fm) (Djm) ) [ (X/De) ) (DFj ,g, t,y)   +
f C
l'1                                                               '                        -
C2=3
[e NJ) *) /"t) (DFja)T)
(2 -29 )
e 2.3.5-2 Ground Pathway 17 (Fyy) (Ojyy) + (F SV) (Dj2sy) +
p,y"= (3. 6E-6) (472) E (X/0) I (DFfu) (T )
2 e
c2 3. (Fasv) (O ssv) + (Fm) (Ojm) -
l (2-30) 2.3.5-3 Vecetation. Meat. Cow Milk. Goat Milk Pathway Dvna = (3. 6E-6 ) (47 2) E
'2 E[(Fyy) (Ojyy) + (F,y) (Dj2,y) + (F2sv) (0 :sv) + (Fm) (Djm) ) [ (X/De) ) (DF,g, t,y)
+
1 j
1 l'1
( T,)
( T,)
35 E [(Fyy) (Ojyy) + (F1 ,y) (012sv) (Fasv) (03 sv) + (Fm) (Dja) ) [D/O] e (DFj ,g,t,y) 1 18                                                                                         ,
35 E [(Fyy) (Ojyy) + (F,y) (0 sv) (Fasv) (0 sv) + (Fm) (Dja) ) [D/O] e (DF,g,t,y) 1 12 3
                                                                                            -(2-31) i
j 1 18
-(2-31) i


m _ . _ _ .          -      . _. _ _ _ _    __        __  . __. ._  . - . .      __              __      -    __
m 8
8                                                                                                                          j 4
j 4
l                                                             l                   ODCM Rcv. 17 Page 101 l'
l l
11/95 2.3.5-4     Veaetation. Meat. Cow Milk. Goat Milk Pathway Dym = (3.6E-6) (472) E
ODCM Rcv. 17 Page 101 l'
            *3 E [ (F,y) (Ojy) + (F1y)(012 n)+(F2y) (0 3,y) + (Fm) (03            )] [(X/De)] (DFJ,r,I,n)   +
11/95 2.3.5-4 Veaetation. Meat. Cow Milk. Goat Milk Pathway Dym = (3.6E-6) (472) E
              ' ss (T)e p            E [(F )yy(Ojy) + (Fzy) (Oj2y) + (Fan) (Olan) + (Fm) (03 m)] [D/Og] (DFj,,,t,y)                           i (2-32) where:                                                                                       !
*3 E [ (F,y) (Ojy) + (F1y)(0 n)+(F2y) (0,y) + (Fm) (0
D,-         =  annual dose from plume pathway (rem)
)] [(X/De)] (DF,r,I,n)
Darm       =  annual dose - from ground pathway (rem)                             ,
+
Dv,m       =  annual dose from vegetation, meat, cow milk, and goat milk pathways (rem)                                         !
12 3
D,m2
3 J
                                                  =  annual dose from inhalation pathway (rem)
(T) e
                                                                                                                            \
' ss E [(F ) (Ojy) + (Fzy) (Oj2y) + (Fan) (O an) + (Fm) (0 m)] [D/Og] (DFj,,,t,y) p i
3.6E-6     =  units conversion factor rem-Ci-sec hr-mrem-p Ci,                                                   \
yy l
l 472         =  units conversion factor r                                                   .
3 (2-32) where:
                                                              ' miri-cc'                                                 '
D,-
sec-ft, 1
annual dose from plume pathway (rem)
E          =  summation for each release time period                               !
=
t               (unit less) .
Darm annual dose - from ground pathway (rem)
(X/Q)e     =  relative concentiration for time period "t" (sec/m3 ) .
=
Fw         =  average North Vent flow rate during release (cfm).
Dv,m annual dose from vegetation, meat, cow milk,
I Qiw          =  concentration of nuclide i from North Vent effluent (pCi/cc) .
=
F2,y       =  average Unit 1 South Vent flow rate during                           i release (cfm).
and goat milk pathways (rem)
Qusy        = ' concentration of nuclide i from Unit 1 South Vent effluent (pCi/cc).
D,m annual dose from inhalation pathway (rem)
Fasv       "  average Unit 2 South Vent flow rate during release (cfm).
=
2
\\
3.6E-6 units conversion factor
=
rem-Ci-sec hr-mrem-p Ci,
\\
l 472 units conversion factor
=
r
' miri-cc' sec-ft, E
summation for each release time period
=
t (unit less).
(X/Q)e relative concentiration for time period "t"
=
3 (sec/m ).
Fw average North Vent flow rate during release
=
(cfm).
concentration of nuclide i from North Vent Qiw
=
effluent (pCi/cc).
F,y average Unit 1 South Vent flow rate during i
=
2 release (cfm).
' concentration of nuclide i from Unit 1 South Qusy
=
Vent effluent (pCi/cc).
Fasv average Unit 2 South Vent flow rate during release (cfm).


l                                                         ODCM Rsv. 17 Pcga 102 l                                                               11/95 Qian             =
l ODCM Rsv. 17 Pcga 102 l
concpntrationofnuclideifromUnit2 South Vent effluent (pCi/cc).
11/95 concpntrationofnuclideifromUnit2 South Qian
Ai             = decay constant of nuclide i (sec'2) .
=
l       dr             = distance to receptor "r".
Vent effluent (pCi/cc).
ue              = average windspeed for time period "t"
Ai decay constant of nuclide i (sec'2).
!                          (m/sec).
=
DFi , x,t,,     = dose factor for organ type k, age group 1, pathway number n; dose factors are based on results of a computer program that is based on and is similar to the NRC program GASPAR;
l dr distance to receptor "r".
;                          results from this program provide input data
=
:                          in the form of a lookup table - values of DFn, are provided in Table 2-2.
average windspeed for time period "t" u
i               = isotope number (1 through 35) (3 through 17 are noble gases).
=
l l       K               = organ type (1 through 8, where total ;
e (m/sec).
l                     3,   body = 1, GI tract = 2, bone = 3, liver = 4, i                         kidney = 5, thyroid = 6, lung = 7, skin =
DF, x,t,,
l                         8).
dose factor for organ type k, age group 1,
L               = age group (1 through 4, where adult = r, l                         teen = 2, child = 3, infant = 4).
=
N               = pathway number (1 through 7).
i pathway number n; dose factors are based on results of a computer program that is based on and is similar to the NRC program GASPAR; results from this program provide input data in the form of a lookup table - values of DFn, are provided in Table 2-2.
Te              =
i isotope number (1 through 35) (3 through 17
=
are noble gases).
l l
K organ type (1 through 8, where total ;
=
l 3,
body = 1, GI tract = 2, bone = 3, liver = 4, i
kidney = 5, thyroid = 6, lung = 7, skin =
l 8).
L age group (1 through 4, where adult = r,
=
l teen = 2, child = 3, infant = 4).
N pathway number (1 through 7).
=
time duration of release (hrs).
time duration of release (hrs).
l F ,s           = average Hot Maintenance Shop flow rate during release (cfm).                           1 Q1ms           = concentration of nucl)de i from Hot Maintenance Shop effluent (pci/cc).
T
(D/Q)e         = deposition concentration for time period "t" 2
=
(1/m),
e l
(X/Qo,pi)     = relative depleted concentration for time period "t" (sec/m 3) .
F,s average Hot Maintenance Shop flow rate
l 2.4   Gaseous Effluent Dose Proiection l           ODCM I3.3.5 requires the VENTILATION EXHAUST TREATMENT         )
=
SYSTEM be used to reduce radioactive material levels prior     l
during release (cfm).
!          to' discharge when pro."ected doses from both units to areas at and beyond the SITI: BOUNDARY would exceed 0.6 mrem to any organ in a 31 day period.                                 I i
1 Q1ms concentration of nucl)de i from Hot
=
Maintenance Shop effluent (pci/cc).
(D/Q)e deposition concentration for time period "t"
=
2 (1/m),
(X/Qo,pi) relative depleted concentration for time
=
3 period "t"
(sec/m ).
l 2.4 Gaseous Effluent Dose Proiection l
ODCM I3.3.5 requires the VENTILATION EXHAUST TREATMENT SYSTEM be used to reduce radioactive material levels prior to' discharge when pro."ected doses from both units to areas at and beyond the SITI: BOUNDARY would exceed 0.6 mrem to any organ in a 31 day period.
i i
i i
l' I                                                                   -
i l'
l l
I l
l


l                                                                   ODCM Rev. 17 Page 103   l V,
l ODCM Rev. 17 Page 103 l
l                                                                            11/95 The applicable gaseous processing systems for maintaining radioactive material releases ALARA are the Gaseous Radwaste Treatment System and Exhaust Treatment System in Figures 2-1 and 2-2.
V, 11/95 The applicable gaseous processing systems for maintaining radioactive material releases ALARA are the Gaseous Radwaste Treatment System and Exhaust Treatment System in Figures 2-1 and 2-2.
A dose projection is performed at least once per 31-days by the following equation:
A dose projection is performed at least once per 31-days by the following equation:
        ,      Dmaxp    = (Dmax/d)   = 31d                               (2-33) where:
(Dmax/d)
Dmaxp   =
Dmaxp 31d (2-33)
maximum organ dose projection for current 31-day period (mrem)
=
Dmax     =
=
an dose to date for current calendar maximum quarter asorg#etermined d             by equation (2-26) (2-27) or (2-28) (mrem).
where:
d       =    number of days remaining in current calendar quarter. The minimum time elapsed is seven (7) days.
Dmaxp maximum organ dose projection for current 31-day
31d      =    the number of days of concein.
=
3.0   Special Dose Analysis 3.1   Total Dose to MEMBERS OF THE PUBLIC ODCM I3.3.7 requires that the annual dose or dose commitment to any MEMBER OF THE PUBLIC, due to releases of radioactivity and radiation, from the uranium fuel cycle shall pe limited to:
period (mrem) maximum org#etermined by equation Dmax an dose to date for current calendar
s ii mrem whole body         or any organ except thyroid '
=
s 75 mrem thyroid ODCM 13.3.7.2 Surveillance Requirement requires that cumulative dose contributions from direct radiation from operations be evaluated when the calculated dose from the             ;
quarter as d (2-26) (2-27) or (2-28) (mrem).
release of radioactive materials in liquid or gaseous effluents exceed twice the limits'of ODCM I3.2.3.a, 3.2.3.b, 3.3.3.a, 3.3.3.b, 3.3.4.a, or 3.3.4Jo.           The direct radiation contribution shall be determined by the methodology described below.         This methodology calculatas     ;
d number of days remaining in current calendar
the direct radiation contribution which then must be added             I to the dose or dose commitment determined in accordance               l with sections ODCM III.3.1, 2.3.3, and 2.3.4 to determine             !
=
total dose from all pathways. This evaluatien of direct radiation contribution is in accordance with i
quarter.
ANSI /ANS 6.6.1-1979 Section 7.         The error using this method is estimated to be approximately 8%.           The following   I evaluation is performed for each receptor of concern.                 !
The minimum time elapsed is seven (7) days.
Dm2 =D w1    - Dx ega   - D rrrt i                              (3-1)
the number of days of concein.
31d
=
3.0 Special Dose Analysis 3.1 Total Dose to MEMBERS OF THE PUBLIC ODCM I3.3.7 requires that the annual dose or dose commitment to any MEMBER OF THE PUBLIC, due to releases of radioactivity and radiation, from the uranium fuel cycle shall pe limited to:
ii mrem whole body or any organ except thyroid '
s 75 mrem thyroid s
ODCM 13.3.7.2 Surveillance Requirement requires that cumulative dose contributions from direct radiation from operations be evaluated when the calculated dose from the release of radioactive materials in liquid or gaseous effluents exceed twice the limits'of ODCM I3.2.3.a, 3.2.3.b, 3.3.3.a, 3.3.3.b, 3.3.4.a, or 3.3.4Jo.
The direct radiation contribution shall be determined by the methodology described below.
This methodology calculatas the direct radiation contribution which then must be added to the dose or dose commitment determined in accordance l
with sections ODCM III.3.1, 2.3.3, and 2.3.4 to determine total dose from all pathways.
This evaluatien of direct radiation contribution is in accordance with i
ANSI /ANS 6.6.1-1979 Section 7.
The error using this method is estimated to be approximately 8%.
The following evaluation is performed for each receptor of concern.
Dm2 =D
- Dx ega - D rrrt (3-1) w1 i


l                                                                   ODCM Rsv. 17 Ptgs 104 l                                                                           11/95 ,
l ODCM Rsv. 17 Ptgs 104 l
where:                                                                   >
11/95 where:
Don   = cumulative dose contribution from direct radiation at receptor 1 (mrem).
Don
NOTE: Due to the statistics of radiation measurements and to the conservation of effluent calculations it is plausible the Don may yield a negative value. In this situation the value for Don shall be reported as zero (0) .
= cumulative dose contribution from direct radiation at receptor 1 (mrem).
D7mo  = total dose at receptor of interest (as evaluated by TLD measurement) (mrem) .
NOTE: Due to the statistics of radiation measurements and to the conservation of effluent calculations it is plausible the D may yield a negative value.
NOTE: If there is not a TLD location at the actual receptor location, a more conservative location will Se used to             ;
In this on situation the value for Don shall be reported as zero (0).
evaluate Total Dose.
D mo
Dan   = mean of the background dose as evaluate:d by TLDs at background sites (mrem).
= total dose at receptor of interest (as 7
Dans = ef fluent contribution to dose (as evaluated in             ;
evaluated by TLD measurement) (mrem).
sections 2.3.3 and 2.3.4.1).                         ~
NOTE: If there is not a TLD location at the actual receptor location, a more conservative location will Se used to evaluate Total Dose.
3.2 Doses Due to Activities Inside the SITE BOUNDARY                   l In accordance with ODCM I3.6, the Annual Radioactive effluent' Release Report submitted within 60 days after             ,
Dan
.                      January 1 of each year shall include an assessment of               i radiation dose from radioactive liquid and gaseous effluents to MEMBERS OF THE PUBLIC due to their                     ,
= mean of the background dose as evaluate:d by TLDs at background sites (mrem).
activities inside the SITE BOUNDARY.                               1 There are three locations within the SITE BOUNDARY that are accessible to MEMBERS OF THE PUBLIC for activities unrelated to the operation of Limerick Station. These locations are:               1) the railroad tracks which run along the river within the SITE BOUNDARY;
Dans = ef fluent contribution to dose (as evaluated in sections 2.3.3 and 2.3.4.1).
: 2) the Limerick Atomic Information Center, on Longview Road next to the 500kv! substation; and 3) Fricks Lock environmental laboratory, operated by RMC Environmental Services, Inc. Of these three locations, the railroad tracks are the closest to the plant confines.           The highest annual dose for the three locations should be determined by calculating dose at the railroad track location.
~
    .e s
3.2 Doses Due to Activities Inside the SITE BOUNDARY l
In accordance with ODCM I3.6, the Annual Radioactive effluent' Release Report submitted within 60 days after January 1 of each year shall include an assessment of radiation dose from radioactive liquid and gaseous effluents to MEMBERS OF THE PUBLIC due to their activities inside the SITE BOUNDARY.
1 There are three locations within the SITE BOUNDARY that are accessible to MEMBERS OF THE PUBLIC for activities unrelated to the operation of Limerick Station.
These locations are:
: 1) the railroad tracks which run along the river within the SITE BOUNDARY;
: 2) the Limerick Atomic Information Center, on Longview Road next to the 500kv! substation; and 3) Fricks Lock environmental laboratory, operated by RMC Environmental Services, Inc.
Of these three locations, the railroad tracks are the closest to the plant confines.
The highest annual dose for the three locations should be determined by calculating dose at the railroad track location.
.e s


l                                                               ODCM R:v. 17 Page 105 l                                                                     11/95 4
l ODCM R:v. 17 Page 105 l
The following methodology is used to evaluate dose at the railroad tracks, Information Center, and Fricks Lock locations. This dose assessment is based on the results of the annual dose evaluation outlined in ODCM Section 2.3.5. The maximum dose calculated will be reported.
11/95 The following methodology is used to evaluate dose at 4 the railroad tracks, Information Center, and Fricks Lock locations.
Drm = Da*           = 0. 25   (3-2) where:
This dose assessment is based on the results of the annual dose evaluation outlined in ODCM Section 2.3.5.
Dpsax       =
The maximum dose calculated will be reported.
Dose to MEMBERS OF THE PUBLIC within the SITE BOUNDARY in Sector"X" (mrem).
Drm = Da*
Dsax         =
= 0. 25 (3-2) where:
Dose'at SITE BOUNDARY in Sector   "X" (mrem).
Dpsax Dose to MEMBERS OF THE PUBLIC within the SITE
X/0,3x       =
=
Relative average annual atmospheric dispersion for year of interest at SITE BOUNDARY in Sector "X" (sec/m),
BOUNDARY in Sector"X" (mrem).
a X/Qu,       =
Dsax Dose'at SITE BOUNDARY in Sector "X"
Relative average annual atmospheric dispersion for year of interest at railroad, Information Center or Fricks Lock for distances listed below in Sector "X" (sec/m 2)
(mrem).
Sector               Distance to Location (m)
=
X/0,3x Relative average annual atmospheric dispersion
=
for year of interest at SITE BOUNDARY in a
Sector "X"
(sec/m),
X/Qu, Relative average annual atmospheric dispersion
=
for year of interest at railroad, Information Center or Fricks Lock for distances listed below in Sector "X"
(sec/m )
2 Sector Distance to Location (m)
Railroad Tracks:
Railroad Tracks:
S                                   300 SSW                                 225 SW                                   225 WSW                                 225 W                                   225 WNW                                 345 NW                                   450 Information Center _;.
S 300 SSW 225 SW 225 WSW 225 W
ESE                                 884 Fricks Lock:
225 WNW 345 NW 450 Information Center _;.
WSW                                 450 0.25    =    maximum occupancy factor for railroad trac [ks, Limerick Atomic Information Center or Fricks Lock Environmental Laboratory (unitless).                                .
ESE 884 Fricks Lock:
WSW 450 maximum occupancy factor for railroad trac [ks, Limerick 0.25
=
Atomic Information Center or Fricks Lock Environmental Laboratory (unitless).
F
F


5 l                                                       ODCM Rev. 17 Pcga 106
5 l
  }                                                             11/95 4.0 Ra iolocical Environmental Monitorina Procram 4.1 Samolina Procram           s The operational phase of the Radiological Environmental Monitoring Program (REMP) is conduct.ed in accordance with the requirements of ODCM I3.4-3.
ODCM Rev. 17 Pcga 106
}
11/95 4.0 Ra iolocical Environmental Monitorina Procram 4.1 Samolina Procram s
The operational phase of the Radiological Environmental Monitoring Program (REMP) is conduct.ed in accordance with the requirements of ODCM I3.4-3.
The objectives of the program are:
The objectives of the program are:
To provide data on measurable levels of radiation and radioactive materials in the' site environs.
To provide data on measurable levels of radiation and radioactive materials in the' site environs.
Line 1,971: Line 3,237:
The sampling requirements (type of samples, collection frequency, and analysis) and sample locations are preisented in Appendix B.
The sampling requirements (type of samples, collection frequency, and analysis) and sample locations are preisented in Appendix B.
4.2 Interlaboratory Comoarison Procram Technical Specification 6.8.4.e.3 requires analyses be performed on radioactive material supplied as part of an Interlaboratory Comparison.
4.2 Interlaboratory Comoarison Procram Technical Specification 6.8.4.e.3 requires analyses be performed on radioactive material supplied as part of an Interlaboratory Comparison.
Participation in an approved Interlaboratory Comparison Program provides a check on the preciseness of measurements of radioactive material in environmental samples. A summary of the Interlaboratory Comparison Program results is provided in the Annual Radiological Environmental Operating Report pursuant to ODCM I3 5.
Participation in an approved Interlaboratory Comparison Program provides a check on the preciseness of measurements of radioactive material in environmental samples.
A summary of the Interlaboratory Comparison Program results is provided in the Annual Radiological Environmental Operating Report pursuant to ODCM I3 5.
i i
i i
i
i
Line 1,981: Line 3,248:
2 1
2 1
i 4
i 4
9 I
9 E
E A
A i
i N
N 9
9 I
l I
l 4
4 t
t                                                                                                    1 4                                                                                                     i 2
4 i
w..
2 w..
1 1
1 1


ODCM Rsv. 17 Paga 107 11/95           ,
ODCM Rsv. 17 Paga 107 11/95 t
t 1
1 i
i t
t l
l                                                                                                                                                                                       !
I i
I i
i l                                                                                    TABLE 1-1                                                                                          ;
INGESTION INDIVIDUAL DOSE FACTORS (D.1,3 )                                                                                      l
,                                                                            For-liquid effluents I
1                                                                                                                                                                                        i i
i                                                                                                                                                                                      i 1                                                                                -
                                                                                                                                                                                        'f
                                                        - Units For All Ingestion Pathways are:
mrem /pCi                                                                                        j l                                                                                              .
t l
l
                                                                                                                                                                                        )
i                                                                                                                                                                                        !
l l                                                                                                                                                                                        I I
i l
i l
J f
TABLE 1-1 INGESTION INDIVIDUAL DOSE FACTORS (D.1,3 )
I I
l For-liquid effluents I
j                                                                                                                                                                                       ,,
1 i
i i
i 1
- Units For All Ingestion Pathways are:
'f mrem /pCi j
l t
l l
)
i l
l I
I i
l J
f I
I j
i
i
                                                                                                                                                                                  - -. I
-. I


l ODCM Rav. 17 ;
l ODCM Rav. 17 Page 108 1
Page 108 1 11/95 Table 1-1 Licuid Dose Factors From Table E-1~. or Reg.. Guide 1.109 Ingestion Dose Factors For Adult:
11/95 Table 1-1 Licuid Dose Factors From Table E-1~. or Reg.. Guide 1.109 Ingestion Dose Factors For Adult:
BONE       LIVER     T. BODY     THYROID KIDNEY   LUNG     GI-LLI H3       0.000E+00 1.050E-07 1.050E-07 1.050E-07'1.050E-07 1.050E-07 1.050E-07 C14     2.840E-06 5.680E-07 5.680E-07 5.680E-07 5.680E-07 5.680E-07 5.680E-07 Nn24     1.700E-06 1.700E-06 1.700E-06 1.700E-06 1.700E-06 1.700E-06 1.700E-06 P32     1.930E-04 1.200E-05 7.460E-06 0.000E+00 0.000E+00 0.000E+00 2.170E-05 Cr51     0.000E+00 0.000E+00 2.660E-09 1.590E-09 5.860E-10 3.530E-09 6.690E-07 Mn54     0.000E+00 4.570E-06 8.720E-07 0.000E+00 1.360E-06 0.000E+00 1.400E-05 Mn56     0.000E+00 1.150E-07 2.040E-08 0.000E+00 1.460E-07 0.000E+00 3.670E-06 Fa55     2.750E-06 1.900E-06 4.430E-07 0.000E+00 0.000E+00 1.060E-06 1.090E-06 Fa59     4.340E-06 1.020E-05 3.910E-06 0.000E+00 0.000E+00 2.850E-06 3.400E-05 CoS8     0.000E+00 7.450E-07 1.670E-06 0.000E+00 0.000E+00 0.000E+00 1.510E-05 Co60     0.000E+00 2.140E-06 4.720E-06 0.000E+00 0.000E+00 0.000E+00 4.020E-05 Ni63     1.300E-04 9.010E-06 4.360E-06 0.000E+00 0.000E+00 0.000E+00 1.880E-06 NiG5     5.280E-07 6.860E-08 3.130E-08 0.000E+00 0.000E+00 0.000E+00 1.740E-06 Cu64     0.000E+00 8.330E-08 3.910E-08 0.000E+00 2.100E-07 0.000E+00 7.100E-06 Zn65     4.840E-06 1.540E-05 6.960E-06 0.000E+00 1.030E-05 0.000E+00 9.700E-06 Zn69     1.030E-08 1.970E-08 1.370E-09 0.000E+00 1.280E-08 0.000E+00 2.960E-09 Br83     0.000E+00 0.000E+00 4.020E-08 0.000E+00 0.000E+00 0.000E+00 5.790E-08 Br84     0.000E+00 0.000E+00 5.210E-08 0.000E+00 0.000E+00 0.000E+00 4.090E-13 Br85     0.000E+00 0.000E+00 2.140E-09 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Rb86     0.000E+00 2.110E-05 9.830E-06 0.000E+00 0.000E+0C 0.000E+00 4.160E-06   '
BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H3 0.000E+00 1.050E-07 1.050E-07 1.050E-07'1.050E-07 1.050E-07 1.050E-07 C14 2.840E-06 5.680E-07 5.680E-07 5.680E-07 5.680E-07 5.680E-07 5.680E-07 Nn24 1.700E-06 1.700E-06 1.700E-06 1.700E-06 1.700E-06 1.700E-06 1.700E-06 P32 1.930E-04 1.200E-05 7.460E-06 0.000E+00 0.000E+00 0.000E+00 2.170E-05 Cr51 0.000E+00 0.000E+00 2.660E-09 1.590E-09 5.860E-10 3.530E-09 6.690E-07 Mn54 0.000E+00 4.570E-06 8.720E-07 0.000E+00 1.360E-06 0.000E+00 1.400E-05 Mn56 0.000E+00 1.150E-07 2.040E-08 0.000E+00 1.460E-07 0.000E+00 3.670E-06 Fa55 2.750E-06 1.900E-06 4.430E-07 0.000E+00 0.000E+00 1.060E-06 1.090E-06 Fa59 4.340E-06 1.020E-05 3.910E-06 0.000E+00 0.000E+00 2.850E-06 3.400E-05 CoS8 0.000E+00 7.450E-07 1.670E-06 0.000E+00 0.000E+00 0.000E+00 1.510E-05 Co60 0.000E+00 2.140E-06 4.720E-06 0.000E+00 0.000E+00 0.000E+00 4.020E-05 Ni63 1.300E-04 9.010E-06 4.360E-06 0.000E+00 0.000E+00 0.000E+00 1.880E-06 NiG5 5.280E-07 6.860E-08 3.130E-08 0.000E+00 0.000E+00 0.000E+00 1.740E-06 Cu64 0.000E+00 8.330E-08 3.910E-08 0.000E+00 2.100E-07 0.000E+00 7.100E-06 Zn65 4.840E-06 1.540E-05 6.960E-06 0.000E+00 1.030E-05 0.000E+00 9.700E-06 Zn69 1.030E-08 1.970E-08 1.370E-09 0.000E+00 1.280E-08 0.000E+00 2.960E-09 Br83 0.000E+00 0.000E+00 4.020E-08 0.000E+00 0.000E+00 0.000E+00 5.790E-08 Br84 0.000E+00 0.000E+00 5.210E-08 0.000E+00 0.000E+00 0.000E+00 4.090E-13 Br85 0.000E+00 0.000E+00 2.140E-09 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Rb86 0.000E+00 2.110E-05 9.830E-06 0.000E+00 0.000E+0C 0.000E+00 4.160E-06 Rb88 0.000E+00 6.050E-08 3.210E-08 0.000E+00 0.000E+00 0.000E+00 8.360E-19 Rb89 0.000E+00 4.010E-08 2.820E-08 0.000E+00 0.000E+00 0.000E+00 2.330E-21 Sr89 3.080E-04 0.000E+00 8.840E-06 0.000E+00 0.000E+00 0.000E+00 4.940E-05 Sr90 7.580E-03 0.000E+00 1.860E-03 0.000E+00 0.000E+00 0.000E+00 2.190E-04 Sr91 5.670E-06 0.000E+00 2.290E-07 0.000E+00 0.000E+00 0.000E+00 2.700E-05 Sr92 2.150E-06 0.'000E+00 9.300E-08 0.000E+00 0.000E+00 0.000E+00 4.260E-05 Y90 9.620E-09 0.000E+00 2.580E-30 0.000E+00 0.000E+00 0.000E+00 1.020E-04 Y91m 9.090E-11 0.000E+00 3.520E-12 0.000E+00 0.000E+00 0.000E+00 2.670E-10 Y91 1.410E-07 0.000E+00 3.770E-09 0.000E+00 0.000E+00 0.000E+00 7.670E-05 Y92 8.450E-10 0.000E+00 2.470E-11 0.000E+00 0.000E+00 0.000E+00 1.480E-05 Y93 2.680E-09 0.000E+00 7.400E-11 0.000E+00 0.000E+00 0.000E+00 8.500E-05 Zr95 3.040E-08 9.750E-09 6.600E-09 0.000E+00 1.530E-08 0.000E+00 3.090E-05 Zr97 1.680E-09 3.390E-10 1.550E-10 0.000E+00 5.120E-10 0.000E+00 1.050E-04 Nb95 6.220E-09 3.460E-09 1.860E-09 0.000E+00 3.420E-09 0.000E+00 2.100E-05 Mo99 0.000E-00 4.310E-06 8.200E-07 0.000E+00 9.760E-06 0.000E+00 9.990E-06 Tc99m 2.470E-10 6.980E-10 8.890E-09 0.000E+00 1.060E-08 3.420E-10 4.130E-07 Tc101 2 540E-10 3.660E-10 3.590E-09 0.000E+00 6.590E-06 1.870E-10 1.100E-21 Rul03 1.850E-07 0.000E+00 7.970E-08 0.000E+00 7.060E-07 0.000E+00 2.160E-05 Rul05 1.540E-08 0.000E+00 6.080E-09 0.000E+00 1.990E-07 0.000E+00 9.420E-06 Rul06 2.750E-06 0.000E+00 3.480E-07 0.000E+00 5.310E-06 0.000E+00 1.780E-04 Ag110m 1.600E-07 1.480E-07 8.790E-08 0.000E+00 2.910E-07 0.000E+00 6.040E-05 Te125m 2.860E-06 9.170E-07 3.590E-07 8.060E-07 1.090E-05 0.000E+00 1.070E-05 Tc127m 6.770E-06 2.420E-06 8.250E-07 1.730E-06 2.750E-05 0.000E+00 2.270E-05 Tc127 1.100E-07 3.950E-08 2.380E-08 8.150E-08 4,480E-07 0.000E+00 8.680E-06 Te129m 1.150E-05 4.290E-06 1.820E-06 3.950E-06 4f800E-05 0.000E+00 5.790E-05 Te129 3.140E-08 1.180E-08 7.650E-09 2.410E-08 1.320E-07 0.000E+00 2.370E-08 i
Rb88     0.000E+00 6.050E-08 3.210E-08 0.000E+00 0.000E+00 0.000E+00 8.360E-19 Rb89     0.000E+00 4.010E-08 2.820E-08 0.000E+00 0.000E+00 0.000E+00 2.330E-21 Sr89     3.080E-04 0.000E+00 8.840E-06 0.000E+00 0.000E+00 0.000E+00 4.940E-05 Sr90     7.580E-03 0.000E+00 1.860E-03 0.000E+00 0.000E+00 0.000E+00 2.190E-04 Sr91     5.670E-06 0.000E+00 2.290E-07 0.000E+00 0.000E+00 0.000E+00 2.700E-05 Sr92     2.150E-06 0.'000E+00 9.300E-08 0.000E+00 0.000E+00 0.000E+00 4.260E-05 Y90     9.620E-09 0.000E+00 2.580E-30 0.000E+00 0.000E+00 0.000E+00 1.020E-04 Y91m     9.090E-11 0.000E+00 3.520E-12 0.000E+00 0.000E+00 0.000E+00 2.670E-10 Y91     1.410E-07 0.000E+00 3.770E-09 0.000E+00 0.000E+00 0.000E+00 7.670E-05 Y92     8.450E-10 0.000E+00 2.470E-11 0.000E+00 0.000E+00 0.000E+00 1.480E-05 Y93     2.680E-09 0.000E+00 7.400E-11 0.000E+00 0.000E+00 0.000E+00 8.500E-05 Zr95     3.040E-08 9.750E-09 6.600E-09 0.000E+00 1.530E-08 0.000E+00 3.090E-05 Zr97     1.680E-09 3.390E-10 1.550E-10 0.000E+00 5.120E-10 0.000E+00 1.050E-04 Nb95     6.220E-09 3.460E-09 1.860E-09 0.000E+00 3.420E-09 0.000E+00 2.100E-05 Mo99     0.000E-00 4.310E-06 8.200E-07 0.000E+00 9.760E-06 0.000E+00 9.990E-06 Tc99m   2.470E-10 6.980E-10 8.890E-09 0.000E+00 1.060E-08 3.420E-10 4.130E-07 Tc101   2 540E-10 3.660E-10 3.590E-09 0.000E+00 6.590E-06 1.870E-10 1.100E-21 Rul03   1.850E-07 0.000E+00 7.970E-08 0.000E+00 7.060E-07 0.000E+00 2.160E-05 Rul05   1.540E-08 0.000E+00 6.080E-09 0.000E+00 1.990E-07 0.000E+00 9.420E-06   I Rul06   2.750E-06 0.000E+00 3.480E-07 0.000E+00 5.310E-06 0.000E+00 1.780E-04 Ag110m 1.600E-07 1.480E-07 8.790E-08 0.000E+00 2.910E-07 0.000E+00 6.040E-05 Te125m 2.860E-06 9.170E-07 3.590E-07 8.060E-07 1.090E-05 0.000E+00 1.070E-05 l
Tc127m 6.770E-06 2.420E-06 8.250E-07 1.730E-06 2.750E-05 0.000E+00 2.270E-05 Tc127   1.100E-07 3.950E-08 2.380E-08 8.150E-08 4,480E-07 0.000E+00 8.680E-06 Te129m   1.150E-05 4.290E-06 1.820E-06 3.950E-06 4f800E-05 0.000E+00 5.790E-05 Te129   3.140E-08 1.180E-08 7.650E-09 2.410E-08 1.320E-07 0.000E+00 2.370E-08   I i
1


5                                         ODCM Rev. 17 Prga 109 11/95 Table 1-1 (Continued)
5 ODCM Rev. 17 Prga 109 11/95 Table 1-1 (Continued)
Licuid Dose Factors From Table E-11 or Reg. Guide 1.109 Ingestion Dose Factors For Adult:
Licuid Dose Factors From Table E-11 or Reg. Guide 1.109 Ingestion Dose Factors For Adult:
* BONE       LIVER   T. BODY   THYROID   KIDNEY   LUNG     GI-LLI l
BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI Ta131m 1.730E-06 8.460E-07 7.050E-07 1.340E-06 8.570E-06 0.000E400 8.400E-05 Ta131 1.970E-08 8.230E-09 6.220E-09 1.620E-08 8.630E-08 0.000E+00 2.790E-09 Ta132 2.520E-06 1.630E-06 3.530E-06 1.800E-06 1.570E-05 0.000E+00 7.710E-05 I130 7.560E-07 2.230E-06 8.800E-07 1.890E-04 3.480E-06 0.000E+00 1.920E-06 I131 4.160E-06 5.950E-06 3.410E-06 1.950E-03 1.020E-05 0.000Ee00 1.570E-06 I132 2.030E-07 5.430E-07 1.900E-07 1.900E-05 8.650E-07 0.000E+00 1.020E-07 I133 1.420E-06 2.470E-06 7.530E-07 3.630E-04 4.319E-06 0.000E+00 2.220E-06 I134 1.060E-07 2.880E-07 1.030E-07 4.990E-06 4.580E-07 0.000E+00 2.510E-10 I135 4.430E-07 1.160E-06 4.280E-07 7.650E-05 1.860E-06 0.000E+00 1.310E-06 C 134 6.220E-05 1.480E-04 1.210E-04 0.000E+00 4.790E-05 1.590E-05 2.590E-06 Cs136 6.510E-06 2.570E-05 1.850E-05 0.000E+00 1.430E-05 1.960E-06 2.920E-06 Ca137 7.970E-05 1.090E-04 7.140E-05 0.000E+00 3.700E-05 1.230E-05 2.110E-06 CJ138 5.520E-08 1.090E-07 5.400E-08 0.000E+00 8.010E-08 7.910E-08 4.650E-13 Bn139 9.700E-08 6.910E-11 2.840E-09 0.000E+00 6.460E-11 3.920E-11 1.720E-07 Bn140 2.030E-05 2.550E-08 1.330E-06 0.000E+00 8.670E-09 1.460E-08 4.190E-05 Bn141 4.710E-08 3.560E-11 1.590E-09 0.000E+00 3.310E-11 2.020E-11 2.220E-17 Bn142 2.130E-08 2.190E-11 1.340E-09 0.000E+00 1.850E-11 1.240E-11 3.000E-26 La140 2.500E- 09 1.260E-09 3.330E-10 0.000E+00 0.000E+00 0.000E+00 9.250E-05 La142 1.280E-10 5.820E-11 1.450E-11 0.000E+00 0.000E+00 0.000E+00 4.250E-07 C0141 9.360E-09 6.330E-09 7.180E-10 0.000E+00 2.940E-09 0.000E+00 2.420E-05 CS143 1.650E-09 1.220E-06 1.350E-10 0.000E+00 5.370E-10 0.000E+00 4.560E-05 C2144 4.880E-07 2.040E-07 2.620E-08 0.000E+00 1.210E-07 0.000E+00 1.650E-04 Pr143 9.200E-09 3.690E-09 4.560E-10 0.000E+00 2.130E-09 0.000E+00 4.030E-05 Pr144 3.010E-11 1.250E-11 1.530E-12 0.000E+00 7.050E-12 0.000E+00 4.330E-18 Nd147 6.290E-09 7.270E-09 4.350E-10 0.000E+00 4.250E-09 0.000E+00 3.490E-05 W187 1.030E-07 8.610E-08 3.010E-08 0.000E+00 0.000E+00 0.000E+00 2.820E-05 Np239 1.190E-09 1.170E-10 6.450E-11 0.000E+00 3.650E-13 0.000E+00 2.400E-05
Ta131m 1.730E-06 8.460E-07 7.050E-07 1.340E-06 8.570E-06 0.000E400 8.400E-05 Ta131   1.970E-08 8.230E-09 6.220E-09 1.620E-08 8.630E-08 0.000E+00 2.790E-09 Ta132   2.520E-06 1.630E-06 3.530E-06 1.800E-06 1.570E-05 0.000E+00 7.710E-05 I130   7.560E-07 2.230E-06 8.800E-07 1.890E-04 3.480E-06 0.000E+00 1.920E-06 I131   4.160E-06 5.950E-06 3.410E-06 1.950E-03 1.020E-05 0.000Ee00 1.570E-06 I132   2.030E-07 5.430E-07 1.900E-07 1.900E-05 8.650E-07 0.000E+00 1.020E-07 I133   1.420E-06 2.470E-06 7.530E-07 3.630E-04 4.319E-06 0.000E+00 2.220E-06 I134   1.060E-07 2.880E-07 1.030E-07 4.990E-06 4.580E-07 0.000E+00 2.510E-10 I135   4.430E-07 1.160E-06 4.280E-07 7.650E-05 1.860E-06 0.000E+00 1.310E-06 C 134   6.220E-05 1.480E-04 1.210E-04 0.000E+00 4.790E-05 1.590E-05 2.590E-06 Cs136   6.510E-06 2.570E-05 1.850E-05 0.000E+00 1.430E-05 1.960E-06 2.920E-06 Ca137   7.970E-05 1.090E-04 7.140E-05 0.000E+00 3.700E-05 1.230E-05 2.110E-06 CJ138   5.520E-08 1.090E-07 5.400E-08 0.000E+00 8.010E-08 7.910E-08 4.650E-13 Bn139   9.700E-08 6.910E-11 2.840E-09 0.000E+00 6.460E-11 3.920E-11 1.720E-07 Bn140   2.030E-05 2.550E-08 1.330E-06 0.000E+00 8.670E-09 1.460E-08 4.190E-05 Bn141   4.710E-08 3.560E-11 1.590E-09 0.000E+00 3.310E-11 2.020E-11 2.220E-17 Bn142   2.130E-08 2.190E-11 1.340E-09 0.000E+00 1.850E-11 1.240E-11 3.000E-26 La140   2.500E- 09 1.260E-09 3.330E-10 0.000E+00 0.000E+00 0.000E+00 9.250E-05 La142   1.280E-10 5.820E-11 1.450E-11 0.000E+00 0.000E+00 0.000E+00 4.250E-07 C0141   9.360E-09 6.330E-09 7.180E-10 0.000E+00 2.940E-09 0.000E+00 2.420E-05 CS143   1.650E-09 1.220E-06 1.350E-10 0.000E+00 5.370E-10 0.000E+00 4.560E-05 C2144   4.880E-07 2.040E-07 2.620E-08 0.000E+00 1.210E-07 0.000E+00 1.650E-04               i Pr143   9.200E-09 3.690E-09 4.560E-10 0.000E+00 2.130E-09 0.000E+00 4.030E-05 Pr144   3.010E-11 1.250E-11 1.530E-12 0.000E+00 7.050E-12 0.000E+00 4.330E-18 Nd147   6.290E-09 7.270E-09 4.350E-10 0.000E+00 4.250E-09 0.000E+00 3.490E-05 W187   1.030E-07 8.610E-08 3.010E-08 0.000E+00 0.000E+00 0.000E+00 2.820E-05 Np239   1.190E-09 1.170E-10 6.450E-11 0.000E+00 3.650E-13 0.000E+00 2.400E-05 1


ODCM RLv. 17 Page 110 11/95 Table 1-1 (Continued)
ODCM RLv. 17 Page 110 11/95 Table 1-1 (Continued)
Licuid Dose Factors                             _      _ _ _ _ _ _ .
Licuid Dose Factors
      'From Table E-12 or Reg. Guide 1.109 Ingestion Dose Factors For Teen:                                             .
'From Table E-12 or Reg. Guide 1.109 Ingestion Dose Factors For Teen:
BONE           LIVER T. BODY   THYROID         F.IDNEY LUNG           GI-LLI H3       0.000E+00 1.060E-07 1.060E-07 1.060E-07 1.060E-07 1.060E-07 1.060E-07 C14       4.060E-06 8.120E-07 8.120E-07 8.120E-07 8.120E-07 8.120E-07 8.120E-07 Nn24     2.300E-06 2.300E-06 2.300E-06 2.300E-06 2.300E-06 2.300E-06 2.300E-06 P32       2.760E-04 1.710E-05 1.070E-05 0.000E+00 0.000E+00 0.000E+00 2.320E-05 Cr51     0.000E+00 0.000E+00 3.600E-09 2.000E-09 7.890E-10 5.140E-09 6.050E-07 Mn54     0.000E+00 5.900E-06 1.170E-06 0.000E+00 1.760E-06 0.000E+00 1.210E-05 Mn56     0.000E+00 1.580E-07 2.810E-08 0.000E+00 2.000E-07 0.000E+00 1.040E-05 F055     3.780E-06 2.680E-06 6.250E-07 0.000E+00 0.000E+00 1.700E-06 1.160E-06                             i Fa59     5.870E-06 1.370E-05 5.290E-06 0.000E+00 0.000E+00 4.320E-06 3.240E-05 CoS8     0.000E+00 9.720E-07 2.240E-06 0.000E+00 0.000E+00 0.000E+00 1.340E-05 Co60     0.000E+00 2.810E-06 6.330E-06 0.000E+00 0.000E+00 0.000E+00 3.660E-05 Ni63     1.770E-04 1.250E-05 6.000E-06 0.000E+00 0.000E+00 0.000E+00 1.990E-06 Ni65     7.490E-07 9.570E-08 4.360E-08 0.000E+00 0.000E+00 0.000E+00 5.190E-06 Cu64     0.000E+00 1.150E-07 5.410E-08 0.000E+00 2.910E-07 0.000E+00 8.920E-06 Zn65     5.760E-06 2.000E-05 9.330E-06 0.000E+00 1.280E-05 0.000E+00 8.470E-06 Zn69     1.470E-08 2.800E-08 1.960E-09 0.000E+00 1.830E-08 0.000E+00 5.160E-08 Br83     0.000E+00 0.000E+00 5.740E-08 0.000E+00 0.000E+03 0.000E+00 0.000E+00 Br84     0.000E+00 0.000E+00 7.220E-08 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Br85     0.000E+00 0.000E+00 3.050E-09 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Rb86     0.000E+00 2.980E-05 1.400E-05 0.000E+00 0.000E+00 0.000E+00 4.410E-06                             !
BONE LIVER T. BODY THYROID F.IDNEY LUNG GI-LLI H3 0.000E+00 1.060E-07 1.060E-07 1.060E-07 1.060E-07 1.060E-07 1.060E-07 C14 4.060E-06 8.120E-07 8.120E-07 8.120E-07 8.120E-07 8.120E-07 8.120E-07 Nn24 2.300E-06 2.300E-06 2.300E-06 2.300E-06 2.300E-06 2.300E-06 2.300E-06 P32 2.760E-04 1.710E-05 1.070E-05 0.000E+00 0.000E+00 0.000E+00 2.320E-05 Cr51 0.000E+00 0.000E+00 3.600E-09 2.000E-09 7.890E-10 5.140E-09 6.050E-07 Mn54 0.000E+00 5.900E-06 1.170E-06 0.000E+00 1.760E-06 0.000E+00 1.210E-05 Mn56 0.000E+00 1.580E-07 2.810E-08 0.000E+00 2.000E-07 0.000E+00 1.040E-05 F055 3.780E-06 2.680E-06 6.250E-07 0.000E+00 0.000E+00 1.700E-06 1.160E-06 i
Rb88     0.000E+00 8.520E-08 4.540E-08 0.000E+00 0.000E+00 0.000E+00 7.300E-15 Rb89     0.000E+00 5.500E-08 3.890E-08 0.000E+00 0.000E+00 0.000E+00 8.430E-17 Sr89     4.400E-04 0.000E+00 1.260E-05 0.000E+00 0.000E+00 0.000E+00 5.240E-05 Sr90     8.300E-03 0.000E+00 2.050E-03 0.000E+00 0.000E+00 0.000E+00 2.330E-04 Sr91     8.070E-06 0.000E+00 3.210E-07 0.000E+00 0.000E+00 0.000E+00 3.660E-05 Sr92     3.050E-06 0.000E+00 1.300E-07 0.000E+00 0.000E+00 0.000E+00 7.770E-05 Y90       1.370E-08 0.000E+00 3.690E-10 0.000E+00 0.000E+00 0.000E+00 1.130E-04 Y91m     1.290E-10 0.000E+00 4.930E-12 0.000E+00 0.000E+00 0.000E+00 6.090E-09 Y91     2.010E-07 0.003E+00 5.390E-09 0.000E+00 0.000E+00 0.000E+00 8.240E-05 Y92       1.210E-09 0.000E+00 3.500E-11 0.000E+00 0.000E+00 0.000E+00 3.320E-05 Y93     3.830E-09 0.000E+00 1.050E-10 0.000E+00 0.000E+00 0.000E+00 1.170E-04 Zr9.5   4.120E-08 1.300E-08 8.940E-09 0.000E+00 1.910E-08 0.000E+00 3.000E-05 Zr9'. 2.370E-09 4.690E-10 2.160E-10 0.000E+00 7.110E-10 0.000E+00 1.270E-04 Nb95     8.220E-09 4.560E-09 2.510E-09 0.000E+00 4.420E-09 0.000E+00 1.950E-05 Mo99     0.000E+00 6.030E-06 1.150E-06 0.000E+00 1.380E-05 0.000E+00 1.080E-05 Tc99m   3.320E-10 9.260E-10 1.200E-08 0.000E+00 1.380E-08 5.140E-10 6.080E-07 Tc101   3.600E-10 5.120E-10 5.030E-09 0.000E+00 9.260E-09 3.120E-10 8.750E-17 Rul03   2.550E-07 0.000E+00 1.090E-07 0.000E+00 8.990E-07 0.000E+00 2.130E-05
Fa59 5.870E-06 1.370E-05 5.290E-06 0.000E+00 0.000E+00 4.320E-06 3.240E-05 CoS8 0.000E+00 9.720E-07 2.240E-06 0.000E+00 0.000E+00 0.000E+00 1.340E-05 Co60 0.000E+00 2.810E-06 6.330E-06 0.000E+00 0.000E+00 0.000E+00 3.660E-05 Ni63 1.770E-04 1.250E-05 6.000E-06 0.000E+00 0.000E+00 0.000E+00 1.990E-06 Ni65 7.490E-07 9.570E-08 4.360E-08 0.000E+00 0.000E+00 0.000E+00 5.190E-06 Cu64 0.000E+00 1.150E-07 5.410E-08 0.000E+00 2.910E-07 0.000E+00 8.920E-06 Zn65 5.760E-06 2.000E-05 9.330E-06 0.000E+00 1.280E-05 0.000E+00 8.470E-06 Zn69 1.470E-08 2.800E-08 1.960E-09 0.000E+00 1.830E-08 0.000E+00 5.160E-08 Br83 0.000E+00 0.000E+00 5.740E-08 0.000E+00 0.000E+03 0.000E+00 0.000E+00 Br84 0.000E+00 0.000E+00 7.220E-08 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Br85 0.000E+00 0.000E+00 3.050E-09 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Rb86 0.000E+00 2.980E-05 1.400E-05 0.000E+00 0.000E+00 0.000E+00 4.410E-06 Rb88 0.000E+00 8.520E-08 4.540E-08 0.000E+00 0.000E+00 0.000E+00 7.300E-15 Rb89 0.000E+00 5.500E-08 3.890E-08 0.000E+00 0.000E+00 0.000E+00 8.430E-17 Sr89 4.400E-04 0.000E+00 1.260E-05 0.000E+00 0.000E+00 0.000E+00 5.240E-05 Sr90 8.300E-03 0.000E+00 2.050E-03 0.000E+00 0.000E+00 0.000E+00 2.330E-04 Sr91 8.070E-06 0.000E+00 3.210E-07 0.000E+00 0.000E+00 0.000E+00 3.660E-05 Sr92 3.050E-06 0.000E+00 1.300E-07 0.000E+00 0.000E+00 0.000E+00 7.770E-05 Y90 1.370E-08 0.000E+00 3.690E-10 0.000E+00 0.000E+00 0.000E+00 1.130E-04 Y91m 1.290E-10 0.000E+00 4.930E-12 0.000E+00 0.000E+00 0.000E+00 6.090E-09 Y91 2.010E-07 0.003E+00 5.390E-09 0.000E+00 0.000E+00 0.000E+00 8.240E-05 Y92 1.210E-09 0.000E+00 3.500E-11 0.000E+00 0.000E+00 0.000E+00 3.320E-05 Y93 3.830E-09 0.000E+00 1.050E-10 0.000E+00 0.000E+00 0.000E+00 1.170E-04 Zr9.5 4.120E-08 1.300E-08 8.940E-09 0.000E+00 1.910E-08 0.000E+00 3.000E-05 Zr9'.
  -Rul05   2.180E-08 0.000E+00 8.460E-09 0.000E+00 2.750E-07 0.000E+00 1.760E-05 Rul06   3.920E-06 0.000E+00 4.940E-07 0.000E+00 7.560E-06 0.000E+00 1.880E-04 Ag110m   2.050E-07 1.940E-07 1.180E-07 0.000E+00 3.700E-07 0.000E+00 5.450E-05 To125m   3.830E-06 1.380E-06 5.120E-07 1.070E-06 0.000E+00 0.000E+00 1.130E-05 Te127m   9.670E-06 3.430E-06 1.150E-06 2.300E-06 3.920E-05 0.000E+00 2.410E-05 c To127 1.580E-07 5.600E-08 3.400E-08 1.090E-07 6.400E-07 0.000E+00 1.220E-05 1
2.370E-09 4.690E-10 2.160E-10 0.000E+00 7.110E-10 0.000E+00 1.270E-04 Nb95 8.220E-09 4.560E-09 2.510E-09 0.000E+00 4.420E-09 0.000E+00 1.950E-05 Mo99 0.000E+00 6.030E-06 1.150E-06 0.000E+00 1.380E-05 0.000E+00 1.080E-05 Tc99m 3.320E-10 9.260E-10 1.200E-08 0.000E+00 1.380E-08 5.140E-10 6.080E-07 Tc101 3.600E-10 5.120E-10 5.030E-09 0.000E+00 9.260E-09 3.120E-10 8.750E-17 Rul03 2.550E-07 0.000E+00 1.090E-07 0.000E+00 8.990E-07 0.000E+00 2.130E-05
{'
-Rul05 2.180E-08 0.000E+00 8.460E-09 0.000E+00 2.750E-07 0.000E+00 1.760E-05 Rul06 3.920E-06 0.000E+00 4.940E-07 0.000E+00 7.560E-06 0.000E+00 1.880E-04 Ag110m 2.050E-07 1.940E-07 1.180E-07 0.000E+00 3.700E-07 0.000E+00 5.450E-05 To125m 3.830E-06 1.380E-06 5.120E-07 1.070E-06 0.000E+00 0.000E+00 1.130E-05 Te127m 9.670E-06 3.430E-06 1.150E-06 2.300E-06 3.920E-05 0.000E+00 2.410E-05 1
Tol29m   1.630E-05 6.050E-06 2.580E-06 5.260E-06 6.820E-05 0.000E+00 6.120E-05 Tol29   4.480E-08 1.670E-08 1.090E-08 3.200E-08 1.880ELO7 0.000E+00 2.450E-07 To131m   2.440E-06 1.170E-06 9.760E-07 1.760E-06 1.220E-03 0.000E+00 9.390E-05 To131   2.790E-08 1.150E-08 8.720E-09 2.150E-08 1.220E-C, 0.000E+00 2.290E-09 Te132 3.490E-06 2.210E-06 2.080E-06 2.330E-06 2.120E-05 0.000E+00 7.000E-05                               I
c To127 1.580E-07 5.600E-08 3.400E-08 1.090E-07 6.400E-07 0.000E+00 1.220E-05
{
Tol29m 1.630E-05 6.050E-06 2.580E-06 5.260E-06 6.820E-05 0.000E+00 6.120E-05 Tol29 4.480E-08 1.670E-08 1.090E-08 3.200E-08 1.880ELO7 0.000E+00 2.450E-07 To131m 2.440E-06 1.170E-06 9.760E-07 1.760E-06 1.220E-03 0.000E+00 9.390E-05 To131 2.790E-08 1.150E-08 8.720E-09 2.150E-08 1.220E-C, 0.000E+00 2.290E-09 Te132 3.490E-06 2.210E-06 2.080E-06 2.330E-06 2.120E-05 0.000E+00 7.000E-05 I


ODCM R;v. 17 Pags ill 11/95 Table 1-1 (Continued)
ODCM R;v. 17 Pags ill 11/95 Table 1-1 (Continued)
Licuid Dose Factors                                       -
Licuid Dose Factors From T&hle E-12 or Reg. Guide 1.109 Ingestion Dose Factors For Teen:
From T&hle E-12 or Reg. Guide 1.109 Ingestion Dose Factors For Teen:
BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI I130 1.030E-06 2.980E-06 1.190E-06 2.430E-04 4.590E-06 0.000E+00 2.290E-06 I131 5.850E-06 8.190E-06 4.400E-06 2.390E-03 1.410E-05 0.000E+00 1.620E-06 I132 2.790E-07 7.300E-07 2.620E-07 2.460E-05 1.150E-06 0.000E+00 3.180E-07 I133 2.010E-06 3.410E-06 1.040E-06 4.760E-04 5.980E-06 0.000E+00 2.580E-06 I134 1.460E-07 3.870E-07 1.390E-07 6.450E-06 6.100E-07 0.000E+00 5.100E-09 I135 6.100E-07 1.570E-06 5.820E-07 1.010E-04 2.480E-06 0.000E+00 1.740E-06 i
BONE       LIVER     T. BODY THYROID   KIDNEY     LUNG     GI-LLI I130   1.030E-06 2.980E-06 1.190E-06 2.430E-04 4.590E-06 0.000E+00 2.290E-06 I131   5.850E-06 8.190E-06 4.400E-06 2.390E-03 1.410E-05 0.000E+00 1.620E-06 I132   2.790E-07 7.300E-07 2.620E-07 2.460E-05 1.150E-06 0.000E+00 3.180E-07 I133   2.010E-06 3.410E-06 1.040E-06 4.760E-04 5.980E-06 0.000E+00 2.580E-06 I134   1.460E-07 3.870E-07 1.390E-07 6.450E-06 6.100E-07 0.000E+00 5.100E-09 I135   6.100E-07 1.570E-06 5.820E-07 1.010E-04 2.480E-06 0.000E+00 1.740E-06     i C3134   8.370E-05 1.970E-04 9.140E-05 0.000E+00 6.260E-05 2.390E-05 2.450E-06 C2136   8.590E-06 3.380E-05 2.270E-05 0.000E+00 1.840E-05 2.900E-06 2.720E-06 Cs137   1.120E-04 1.490E-04 5.190E-05 0.000E+00 5.070E-05 1.970E-05 2.120E-06 Cr138   7.760E-08 1.490E-07 7.450E-08 0.000E+00 1.100E-07 1.280E-08 6.760E-11 Ba139   1.390E-07 9.780E-11 4.050E-09 0.000E+00 9.220E-11 6.740E-11 1.240E-06 Bn140   2.840E-05 3.480E-08 1.830E-06 0.000E+00 1.180E-08 2.340E-08 4.380E-05     ,
C3134 8.370E-05 1.970E-04 9.140E-05 0.000E+00 6.260E-05 2.390E-05 2.450E-06 C2136 8.590E-06 3.380E-05 2.270E-05 0.000E+00 1.840E-05 2.900E-06 2.720E-06 Cs137 1.120E-04 1.490E-04 5.190E-05 0.000E+00 5.070E-05 1.970E-05 2.120E-06 Cr138 7.760E-08 1.490E-07 7.450E-08 0.000E+00 1.100E-07 1.280E-08 6.760E-11 Ba139 1.390E-07 9.780E-11 4.050E-09 0.000E+00 9.220E-11 6.740E-11 1.240E-06 Bn140 2.840E-05 3.480E-08 1.830E-06 0.000E+00 1.180E-08 2.340E-08 4.380E-05 Bn141 6.710E-08 5.010E-11 2.240E-09 0.000E+00 4.650E-11 3.430E-11 1.430E-13 Bn142 2.990E-08 2.990E-11 1.840E-09 0.000E+00 2.530E-11 1.990E-11 9.180E-20 La140 3.480E-09 1.710E-09 4.550E-10 0.000E+00 0.000E+00 0.000E+00 9.820E-05 Ln142 1.790E-10 7.950E-11 1.980E-11 0.000E+00 0.000E+00 0.000E+00 2.420E-06 l
Bn141   6.710E-08 5.010E-11 2.240E-09 0.000E+00 4.650E-11 3.430E-11 1.430E-13     '
Cc141 1.330E-08 S.880E 09 1.020E-09 0.000E+00 4.180E-09 0.000E+00 2.540E-05 Ca143 2.350E-09 1.710E-06 1.910E-10 0.000E+00 7.670E-10 0.000E+00 5.140E-05 Cel44 6.960E-07 2.880E-07 3.740E-08 0.000E+00 1.720E-07 0.000E+00 1.750E-04 Pr143 1.310E-08 5.230E-09 6.520E-10 0.000E+00 3.040E-09 0.000E+00 4.310E-05 t
Bn142   2.990E-08 2.990E-11 1.840E-09 0.000E+00 2.530E-11 1.990E-11 9.180E-20 La140   3.480E-09 1.710E-09 4.550E-10 0.000E+00 0.000E+00 0.000E+00 9.820E-05 Ln142   1.790E-10 7.950E-11 1.980E-11 0.000E+00 0.000E+00 0.000E+00 2.420E-06 Cc141   1.330E-08 S.880El 09 1.020E-09 0.000E+00 4.180E-09 0.000E+00 2.540E-05 Ca143   2.350E-09 1.710E-06 1.910E-10 0.000E+00 7.670E-10 0.000E+00 5.140E-05 Cel44   6.960E-07 2.880E-07 3.740E-08 0.000E+00 1.720E-07 0.000E+00 1.750E-04 Pr143   1.310E-08 5.230E-09 6.520E-10 0.000E+00 3.040E-09 0.000E+00 4.310E-05     t Pr144   4.300E-11 1.760E-11 2.180E-12 0.000E+0C 1.010E-11 0.000E+00 4.740E-14 Nd147   9.380E-09 1.020E-08 6.110E-10 0.000E+00 5.990E-09 0.000E+00 3.680E-05 W187   1.460E-07 1.190E-07 4.170E-08 0.000E+00 0.000E+00 0.000E+00 3.220E-05 Np239   1.760E-09 1.660E-10 9.220E-11 0.000E+00 5.210E-10 0.000E+00 2.670E-05 I
Pr144 4.300E-11 1.760E-11 2.180E-12 0.000E+0C 1.010E-11 0.000E+00 4.740E-14 Nd147 9.380E-09 1.020E-08 6.110E-10 0.000E+00 5.990E-09 0.000E+00 3.680E-05 W187 1.460E-07 1.190E-07 4.170E-08 0.000E+00 0.000E+00 0.000E+00 3.220E-05 Np239 1.760E-09 1.660E-10 9.220E-11 0.000E+00 5.210E-10 0.000E+00 2.670E-05 i
l i


  .      . - - . ~                   -  __ _-            _. -        _    - _ _ _ _ _        ._ _ _ _ _
~
i ODCM Rnv. 17 Page 112 11/95 Table 1-1 (Continued)
i ODCM Rnv. 17 Page 112 11/95 Table 1-1 (Continued)
Liould Dose Factors From. Table E-13 or Reg. Guide 1.109                                                               ,
Liould Dose Factors From. Table E-13 or Reg. Guide 1.109 Ingestion Dose Factors For Child:
Ingestion Dose Factors For Child:                                                                 1 BONE     LIVER-         T. BODY THYROID   KIDNEY           LUNG   GI-LLI         l E3           0.000E+00 2.030E-07 2.030E-07 2.030E-07 2.030E-07 2.030E-07 2.030E-07                   l C14         1.210E-05 2.420E-06 2.420E-06 2.420E-06 2.420E-06 2.420E-06 2.420E-06                   l
1 BONE LIVER-T. BODY THYROID KIDNEY LUNG GI-LLI l
    .N224-         5.800E-06 5.800E-06 5.800E-06 5.800E-06 5.000E-06 5.800E-06 5.800E-06                   !
E3 0.000E+00 2.030E-07 2.030E-07 2.030E-07 2.030E-07 2.030E-07 2.030E-07 l
P32         8.250E-04 3.860E-05 3.180E-05 0.000E+00 0.000E+00 0.000E+00 2.280E-05                   ;
C14 1.210E-05 2.420E-06 2.420E-06 2.420E-06 2.420E-06 2.420E-06 2.420E-06 l
Cr51         0.000E+00 0.000E+00 8.900E-09 4.940E-09 1.350E-09 9.020E-09 4.720E-07                   l 2154         0.000E+00 1.070E-05 2.850E-06 0.000E+00 3.000E-06 0.000E+00 8.980E-06                   i Mn56-       0.000E+00 3.340E-07 7.540E-08 0.000E+00.4.040E-07 0.000E+00 4.840E-05                   ,
.N224-5.800E-06 5.800E-06 5.800E-06 5.800E-06 5.000E-06 5.800E-06 5.800E-06 P32 8.250E-04 3.860E-05 3.180E-05 0.000E+00 0.000E+00 0.000E+00 2.280E-05 Cr51 0.000E+00 0.000E+00 8.900E-09 4.940E-09 1.350E-09 9.020E-09 4.720E-07 l
F455-       1.150E-05 6.100E-06 1.890E-06 0.000E+00 0.000E+00 3.450E-06 1.130E-06 fos 9       1.650E-05 2.670E-05 1.330E-05 0.000E+00 0.000E+00 7.740E-06 2.780E-05                   3 CoS8         0.000E+00 1.800E-06 5.510E-06 0.000E+00 0.000E+00 0.000E+00 1.050E-05'                  '
2154 0.000E+00 1.070E-05 2.850E-06 0.000E+00 3.000E-06 0.000E+00 8.980E-06 i
    'Co60         0.000E+00 5.290E-06 1.560E-05 0.000E+00 0.000E+00 0.000E+00 2.930E-05' NiG3         5.380E-04 2.880E-05 1.830E-05 0.000E+00 0.000E+00 0.000E+00 1.940E-06                   >
Mn56-0.000E+00 3.340E-07 7.540E-08 0.000E+00.4.040E-07 0.000E+00 4.840E-05 F455-1.150E-05 6.100E-06 1.890E-06 0.000E+00 0.000E+00 3.450E-06 1.130E-06 fos 9 1.650E-05 2.670E-05 1.330E-05 0.000E+00 0.000E+00 7.740E-06 2.780E-05 3
Ni65-       2.220E-06 2.090E-07 1.220E-07 0.000E+00 0.000E+00 0.000E+00 2.560E-05                   i Cu64         0.000E+00 2.450E-07 1.480E-07 0.000E+00 5.920E-07 0.000E+00 1.150E       Zn65         1.370E05 3.650E-05 2.270E-05 0.000E+00 2.300E-05 0.000E+00 6.410E-06                   i Zn69         4.380E-08 6.330E-08 5.850E-09 0.000E+00 3.840E-08 0.000E+00 3.990E-06
CoS8 0.000E+00 1.800E-06 5.510E-06 0.000E+00 0.000E+00 0.000E+00 1.050E-05'
* Br83         0.000E+00 0.000E+00 1.710E-07 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Br84         0.000E+00 0.000E+00 1.980E-07 0.000E400 0.000E+00 0.000E+00 0.000E+00                   ;
'Co60 0.000E+00 5.290E-06 1.560E-05 0.000E+00 0.000E+00 0.000E+00 2.930E-05' NiG3 5.380E-04 2.880E-05 1.830E-05 0.000E+00 0.000E+00 0.000E+00 1.940E-06 Ni65-2.220E-06 2.090E-07 1.220E-07 0.000E+00 0.000E+00 0.000E+00 2.560E-05 i
Br85         0.000E+00 0.000E+00 9.120E-09 0.000E+00 0.000E+00 0.000E+00 0.000E+00                   '
Cu64 0.000E+00 2.450E-07 1.480E-07 0.000E+00 5.920E-07 0.000E+00 1.150E Zn65 1.370E05 3.650E-05 2.270E-05 0.000E+00 2.300E-05 0.000E+00 6.410E-06 i
Rb86         0.000E+00 6.700E-05 4.120E-05 0.000E+00 0.000E+00 0.000E+00 4.310E-06 Rb88         0.000E+00 1.900E-07 1.320E-07 0.000E+00 0.000E+00 0.000E+00 9.320E-09                   l Rb89         0.000E+00 1.170E-07 1.040E-07 0.000E+00 0.000E+00 0.000E+00 1.020E-09                   ;
Zn69 4.380E-08 6.330E-08 5.850E-09 0.000E+00 3.840E-08 0.000E+00 3.990E-06 Br83 0.000E+00 0.000E+00 1.710E-07 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Br84 0.000E+00 0.000E+00 1.980E-07 0.000E400 0.000E+00 0.000E+00 0.000E+00 Br85 0.000E+00 0.000E+00 9.120E-09 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Rb86 0.000E+00 6.700E-05 4.120E-05 0.000E+00 0.000E+00 0.000E+00 4.310E-06 Rb88 0.000E+00 1.900E-07 1.320E-07 0.000E+00 0.000E+00 0.000E+00 9.320E-09 l
Sr89         1.320E-03 0.000E+00.3.770E-05 0.000E+00 0.000E+00 0.000E+00 5.110E-05                   !
Rb89 0.000E+00 1.170E-07 1.040E-07 0.000E+00 0.000E+00 0.000E+00 1.020E-09 Sr89 1.320E-03 0.000E+00.3.770E-05 0.000E+00 0.000E+00 0.000E+00 5.110E-05 Sr90 1.700E-02 0.000E+00 4.310E-03 0.000E+00 0.000E+00 0.000E+00 2.290E-04 Sr91 2.400E-05 0.000E+00 9.060E-07 0.000E+00 0.000E+00 0.000E+00 5.300E-05 i
Sr90         1.700E-02 0.000E+00 4.310E-03 0.000E+00 0.000E+00 0.000E+00 2.290E-04                   !
Sr92 9.030E-06 0.000E+00 3.620E-07 0.000E+00 0.000E+00 0.000E+00 1.710E-04 l
Sr91         2.400E-05 0.000E+00 9.060E-07 0.000E+00 0.000E+00 0.000E+00 5.300E-05                   i Sr92         9.030E-06 0.000E+00 3.620E-07 0.000E+00 0.000E+00 0.000E+00 1.710E-04                   l Y90         4.110E-08 0.000E+00 1.100E-09 0.000E+00 0.000E+00 0.000E+00 1.170E-04                   !
Y90 4.110E-08 0.000E+00 1.100E-09 0.000E+00 0.000E+00 0.000E+00 1.170E-04 Y91m 3.820E-10 0.000E+00 1.390E-11 0.000E+00 0.000E+00 0.000E+00 7.480E-07
Y91m         3.820E-10 0.000E+00 1.390E-11 0.000E+00 0.000E+00 0.000E+00 7.480E-07                   [
[
Y91         6.020E-07 0.000E+00 1.610E-08 0.000E+00 0.000E+00.0.000E+00 8.020E-05 Y92         3.600E-09 0.000E+00 1.030E-10 0.000E+00 0.000E+00 0.000E+00 1.040F-04 Y93         1.140E-08 0.000E+00 3.130E-10 0.000E+00 0.000E+00 0.000E+00 1.700E-04                   !
Y91 6.020E-07 0.000E+00 1.610E-08 0.000E+00 0.000E+00.0.000E+00 8.020E-05 Y92 3.600E-09 0.000E+00 1.030E-10 0.000E+00 0.000E+00 0.000E+00 1.040F-04 Y93 1.140E-08 0.000E+00 3.130E-10 0.000E+00 0.000E+00 0.000E+00 1.700E-04 Zr95
Zr95        ;1.160E-07 2.550E-08 2.270E-08 0.000E+00 3.650E-08 0.000E+00 2.660E-05                 I Zr97         6.990E-09 1.010E-09 5.960E-10 0.000E+00 1.450E-09 0.000E+00 1.530E-04                   '
;1.160E-07 2.550E-08 2.270E-08 0.000E+00 3.650E-08 0.000E+00 2.660E-05 I
Nb95         2.250E-08 8.760E-09 6.260E-09 0.000E+00 8.230E-09 0.000E+00 1.620E-05                   i Mo99         0.000E+00 1.330E-05 3.290E-06 0.000E+00 2.840E-05 0.000E+00 1.100E-05 Tc99m       9.230E-10 1.810E-09 3.000E-08 0.000E+00 2.630E-08 9.190E-10 1.030E                 '
Zr97 6.990E-09 1.010E-09 5.960E-10 0.000E+00 1.450E-09 0.000E+00 1.530E-04 Nb95 2.250E-08 8.760E-09 6.260E-09 0.000E+00 8.230E-09 0.000E+00 1.620E-05 i
Tc101       1.07CE-09 1.120E-09   1.420E-08   0.000E+00 1.910E-08 5.920E-10 3.560E-09             .
Mo99 0.000E+00 1.330E-05 3.290E-06 0.000E+00 2.840E-05 0.000E+00 1.100E-05 Tc99m 9.230E-10 1.810E-09 3.000E-08 0.000E+00 2.630E-08 9.190E-10 1.030E '
Rul03       7.310E-07 0.000E+00   2.810E-07   0.000E+00 1.840E-06 0.000E+00 1.890E-05             i Rul05-       6.450E-08 0.000E+00   2.340E-08   0.000E+00 5.670E-07 0.000E+00 4.210E-05             t
Tc101 1.07CE-09 1.120E-09 1.420E-08 0.000E+00 1.910E-08 5.920E-10 3.560E-09 Rul03 7.310E-07 0.000E+00 2.810E-07 0.000E+00 1.840E-06 0.000E+00 1.890E-05 i
    -Rul06       1.170E-05 0.000E+00   1.460E-06   0.000E+00 1.580E-05 0.000E+00 1.820E-04             !
Rul05-6.450E-08 0.000E+00 2.340E-08 0.000E+00 5.670E-07 0.000E+00 4.210E-05 t
Ag110m       5.390E-07 3.640E-07 2.910E-07 0.000E+00 6.780E-07 0.000E+00 4.330E-05                   ;
-Rul06 1.170E-05 0.000E+00 1.460E-06 0.000E+00 1.580E-05 0.000E+00 1.820E-04 Ag110m 5.390E-07 3.640E-07 2.910E-07 0.000E+00 6.780E-07 0.000E+00 4.330E-05 Te125m 1.140E-05 3.090E-06 1.520E-06 3.200E-06 0.000E+00 0.000E+00 1.100E-05 i
Te125m       1.140E-05 3.090E-06   1.520E-06   3.200E-06 0.000E+00 0.000E+00 1.100E-05             i To127m       2.890E-05 7.780E-06   3.430E-06   6.910E-06 8.240E-05 0.000E+00 2.340E-05             ;
To127m 2.890E-05 7.780E-06 3.430E-06 6.910E-06 8.240E-05 0.000E+00 2.340E-05 Te127 4.710E-07 1.270E-07 1.010E-07 3.260E-07 1.340E-06 0.000E+00 1.840E-05
Te127       4.710E-07 1.270E-07   1.010E-07   3.260E-07 1.340E-06 0.000E+00 1.840E-05             {
{
Te129m       4.870E-05 1.360E-05   7.560E-06   1.570E-05 1.430E-04 0.000E+00 5.940E-05             l
Te129m 4.870E-05 1.360E-05 7.560E-06 1.570E-05 1.430E-04 0.000E+00 5.940E-05 l
. Te129       1.340E-07 3.740E-08   3.180E-08   9.560E-08 3.920E-07 0.000E+00 8.340E-06             i To131m       7.200E-06 2.490E-06   2.650E-06   5.120E-06 2.410E-05 0.000E+00 1.010E-04             l Tc131         8.300E-08 2.530E-08   2.470E-08   6.350E-08 2.510E-07 0.000E+00 4.360E-07 Te132         1.010E-05 4.470E-06   5.400E-06   6.510E-06 4.150E-05 0.000E+00 4.500E-05 l
Te129 1.340E-07 3.740E-08 3.180E-08 9.560E-08 3.920E-07 0.000E+00 8.340E-06 i
To131m 7.200E-06 2.490E-06 2.650E-06 5.120E-06 2.410E-05 0.000E+00 1.010E-04 l
Tc131 8.300E-08 2.530E-08 2.470E-08 6.350E-08 2.510E-07 0.000E+00 4.360E-07 Te132 1.010E-05 4.470E-06 5.400E-06 6.510E-06 4.150E-05 0.000E+00 4.500E-05 l
I
I


1 ODCM Rev. 17 Pcg2 113   i 11/95 Table 1-1 (Continued)                               ;
1 ODCM Rev. 17 Pcg2 113 i
a                                                                                   ,
11/95 Table 1-1 (Continued) a Licuid Dose Factorg From Table E-13 or Reg. Guide 1.109 Ingestion Dose Factors For Child:
Licuid Dose Factorg From Table E-13 or Reg. Guide 1.109 Ingestion Dose Factors For Child:
)
BONE     LIVER     T. BODY THYROID
BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI I130 2.920E-06 5.900E-06 3.040E-06 6.500E-04 8.820E-06 0.000E+00 2.760E-06 I131 1.720E-05 1.730E-05 9.830E-06 5.720E-03 2.840E-05 0.000E+00 1.540E-06 I132 8.000E-07 1.470E-06 6.760E-07 6.820E-05 2.250E-06 0.000E+00 1.730E-06 I133 5.920E-06 7.320E-06 2.770E-06 1.360E-03 1.220E-05 0.000E+00 2.950E-06 I134 4.190E-07 7.780E-07 3.580E-07 1.790E-05 1.190E-06 0.000E+00 5.160E-07 I135 1.750E-06 3.150E-06 1.490E-06 2.790E-04 4.830E-06 0.000E+00 2.400E-06 Cc134 2.340E-04 3.840E-04 8.100E-05 0.000E+00 1.190E-04 4.2702-05 2.070E-06 C 136 2.350E-05 6.460E-05 4.180E-05 0.000E+00 3.440E-05 5.130E-06 2.270E-06 C2137 3.270E-04 3.130E-04 4.620E-05 0.000E+00 1.020E-04 3.670E-05 1.960E-06 C2138 2.280E-07 3.170E-07 2.010E-07 0.000E+00 2.230E-07 2.400E-08 1.460E-07
                                                                                      )
)
KIDNEY     LUNG     GI-LLI I130     2.920E-06 5.900E-06 3.040E-06 6.500E-04 8.820E-06 0.000E+00 2.760E-06     !
Bn139 4.140E-07 2.210E-10 1.200E-08 0.000E+00 1.930E-10 1.300E-10 2.390E-05 t
I131     1.720E-05 1.730E-05 9.830E-06 5.720E-03 2.840E-05 0.000E+00 1.540E-06 I132     8.000E-07 1.470E-06 6.760E-07 6.820E-05 2.250E-06 0.000E+00 1.730E-06 I133     5.920E-06 7.320E-06 2.770E-06 1.360E-03 1.220E-05 0.000E+00 2.950E-06 I134     4.190E-07 7.780E-07 3.580E-07 1.790E-05 1.190E-06 0.000E+00 5.160E-07     ,
B2140 8.310E-05 7.280E-08 4.850E-06 0.000E+00 2.370E-08 4.340E-08 4.210E-05 Ba141 2.000E-07 1.120E-10 6.510E-09 0.000E+00 9.690E-11 6.580E-10 1.140E-07 Bn142 8.740E-08 6.290E-11 4.880E-09 0.000E+00 5.090E-11 3.700E-11 1.140E-09 La140 1.010E-08 3.530E-09 1.190E-09 0.000E+00 0.000E+00 0.000E+00 9.840E-05 La142 5.240E-10 1.670E-10 5.230E-11 0.000E+00 0.000E+00 0.000E+00 3.310E-05 Cs141 3.970E-08 1.980E-08 2.940E-09 0.000E+00 8.680E-09 0.000E+00 2.470E-05 Ca143 6.990E-09 3.790E-06 5.490E-10 0.000E+00 1.590E-09 0.000E+00 5.550E-05 C0144 2.080E-06 6.520E-07 1.110E-07 0.000E+00 3.610E-07 0.000E+00 1.700E-04 Pr143 3.930E-08 1.180E-08 1.950E-09 0.000E+00 6.390E-09 0.000E+00 4.240E-05 Pr144 1.290E-10 3.990E-11 6.490E-12 0.000E+00 2.110E-11 0.000E+00 8.590E-08 Nd147 2.790E-08 2.260E-08 1.750E-09 0.000E+00 1.240E-08 0.000E+00 3.580E-05 W187 4.290E-07 2.540E-07 1.140E-07 0.000E+00 0.000E+00 0.000E+00 3.570E-05 Np239 5.250E-09 3.770E-10 2.650E-10 0.000E+00 1.090E-09 0.000E+00 2.790E-05 l
I135     1.750E-06 3.150E-06 1.490E-06 2.790E-04 4.830E-06 0.000E+00 2.400E-06 Cc134   2.340E-04 3.840E-04 8.100E-05 0.000E+00 1.190E-04 4.2702-05 2.070E-06 C 136   2.350E-05 6.460E-05 4.180E-05 0.000E+00 3.440E-05 5.130E-06 2.270E-06 C2137   3.270E-04 3.130E-04 4.620E-05 0.000E+00 1.020E-04 3.670E-05 1.960E-06 C2138   2.280E-07 3.170E-07 2.010E-07 0.000E+00 2.230E-07 2.400E-08 1.460E-07 Bn139                                                                              )
4.140E-07 2.210E-10 1.200E-08 0.000E+00 1.930E-10 1.300E-10 2.390E-05     t B2140   8.310E-05 7.280E-08 4.850E-06 0.000E+00 2.370E-08 4.340E-08 4.210E-05 Ba141   2.000E-07 1.120E-10 6.510E-09 0.000E+00 9.690E-11 6.580E-10 1.140E-07 Bn142   8.740E-08 6.290E-11 4.880E-09 0.000E+00 5.090E-11 3.700E-11 1.140E-09 La140   1.010E-08 3.530E-09 1.190E-09 0.000E+00 0.000E+00 0.000E+00 9.840E-05 La142   5.240E-10 1.670E-10 5.230E-11 0.000E+00 0.000E+00 0.000E+00 3.310E-05
!  Cs141   3.970E-08 1.980E-08 2.940E-09 0.000E+00 8.680E-09 0.000E+00 2.470E-05 Ca143   6.990E-09 3.790E-06 5.490E-10 0.000E+00 1.590E-09 0.000E+00 5.550E-05 C0144   2.080E-06 6.520E-07 1.110E-07 0.000E+00 3.610E-07 0.000E+00 1.700E-04 Pr143   3.930E-08 1.180E-08 1.950E-09 0.000E+00 6.390E-09 0.000E+00 4.240E-05   -
Pr144   1.290E-10 3.990E-11 6.490E-12 0.000E+00 2.110E-11 0.000E+00 8.590E-08 Nd147   2.790E-08 2.260E-08 1.750E-09 0.000E+00 1.240E-08 0.000E+00 3.580E-05 W187     4.290E-07 2.540E-07 1.140E-07 0.000E+00 0.000E+00 0.000E+00 3.570E-05 Np239   5.250E-09 3.770E-10 2.650E-10 0.000E+00 1.090E-09 0.000E+00 2.790E-05 l
j
j


ODCM RGv. 17 I
ODCM RGv. 17 Page 114 11/95 Table 1-1 (Continued)
Page 114 11/95 Table 1-1 (Continued) l Lia'uid Dose Fa.ntors From Table E-14 or Reg. Guide 1.109 l
Lia'uid Dose Fa.ntors From Table E-14 or Reg. Guide 1.109 Ingestion Dose Factors For Infant:
Ingestion Dose Factors For Infant:
)
BONE       LIVER       T. BODY   THYROID   KIDNEY       LUNG     GI-LLI         )
BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H3 0.000E+00 3.080E-07 3.080E-07 3.080E-07 3.080E-07 3.0802-07 3.080E-07 C14 2.370E-05 5.060E-06 5.060E-06 5.060E-06 5.060E-06 5.060E-06 5.060E-06 N224 1.010E-05 1.010E-05 1.010E-05 1.010E-05 1.010E-05 1.010E-05 1.010E-05 P32 1.700E-03 1.000E-04 6.590E-05 0.000E+00 0.000E+00 0.000E+00 2.300E-05 Cr51 0.000E+00 0.000E+00 1.410E-08 9.200E-09 2.010E-09 1.790E-08 4.110E-07 Mn54 0.000E+00 1.990E-05 4.510E-06 0.000E+00 4.410E-06 0.000E+00 7.310E-06 Mn56 0.000E+00 8.180E-07 1.410E-07 0.000E+00 7.030E-07 0.000E+00 7.430E-05 Fa55 1.390E-05 8.980E-06 2.400E-06 0.000E+00 0.000E+00 4.390E-06 1.140E-06 Fs59 3.080E-05 5.380E-05 2.120E-05 0.000E+00 0.000E+00 1.590E-05 2.570E-05 CoS8 0.000E+00 3.600E-06 8.980E-06 0.000E+00 0.000E+00 0.000E+00 8.970E-06 Co60 0.000E+00 1.080E-05 2.550E-05 0.000E+00 0.000E+00 0.000E+00 2.570E-05 Ni63 6.340E-04 3.920E-05 2.200E-05 0.000E+00 0.000E+00 0.000E+00 1.950E-06 Ni65 4.700E-06 5.320E-07 2.420E-07 0.000E+00 0.000E+00 0.000E+00 4.050E-05 CuG4 0.000E+00 6.090E-07 2.820E-07 0.000E+00 1.030E-06 0.000E+00 1.250E-05 Zn65 1.840E-05 6.310E-05 2.910E-05 0.000E+00 3.060E-05 0.000E+00 5.330E-05 i
H3         0.000E+00 3.080E-07 3.080E-07 3.080E-07 3.080E-07 3.0802-07 3.080E-07 C14       2.370E-05 5.060E-06 5.060E-06 5.060E-06 5.060E-06 5.060E-06 5.060E-06 N224       1.010E-05 1.010E-05 1.010E-05 1.010E-05 1.010E-05 1.010E-05 1.010E-05 P32       1.700E-03 1.000E-04 6.590E-05 0.000E+00 0.000E+00 0.000E+00 2.300E-05 Cr51       0.000E+00 0.000E+00 1.410E-08 9.200E-09 2.010E-09 1.790E-08 4.110E-07 Mn54     0.000E+00 1.990E-05 4.510E-06 0.000E+00 4.410E-06 0.000E+00 7.310E-06 Mn56     0.000E+00 8.180E-07 1.410E-07 0.000E+00 7.030E-07 0.000E+00 7.430E-05 Fa55     1.390E-05 8.980E-06 2.400E-06 0.000E+00 0.000E+00 4.390E-06 1.140E-06 Fs59     3.080E-05 5.380E-05 2.120E-05 0.000E+00 0.000E+00 1.590E-05 2.570E-05 CoS8     0.000E+00 3.600E-06 8.980E-06 0.000E+00 0.000E+00 0.000E+00 8.970E-06 Co60       0.000E+00 1.080E-05 2.550E-05 0.000E+00 0.000E+00 0.000E+00 2.570E-05 Ni63     6.340E-04 3.920E-05 2.200E-05 0.000E+00 0.000E+00 0.000E+00 1.950E-06 Ni65     4.700E-06 5.320E-07 2.420E-07 0.000E+00 0.000E+00 0.000E+00 4.050E-05 CuG4       0.000E+00 6.090E-07 2.820E-07 0.000E+00 1.030E-06 0.000E+00 1.250E-05 Zn65     1.840E-05 6.310E-05 2.910E-05 0.000E+00 3.060E-05 0.000E+00 5.330E-05                 i Zn69       9.330E-08 1.680E-07 1.250E-08 0.000E+00 6.980E-08 0.000E+00 1.370E-05 Br83     0.000E+00 0.000E+00 3.630E-07 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Br84       0.000E+00 0.000E+00 3.820E-07 0.000E+00 0.000E+00 0.000E+00 0.000E+0U Br85       0.000E+00 0.000E+00 1.940E-08 0.000E+00 0.000E+00 0.000E+00 0.000E+00                 !
Zn69 9.330E-08 1.680E-07 1.250E-08 0.000E+00 6.980E-08 0.000E+00 1.370E-05 Br83 0.000E+00 0.000E+00 3.630E-07 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Br84 0.000E+00 0.000E+00 3.820E-07 0.000E+00 0.000E+00 0.000E+00 0.000E+0U Br85 0.000E+00 0.000E+00 1.940E-08 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Rb86 0.000E+00 1.700E-04 8.400E-05 0.000E+00 0.000E+00 0.000E+00 4.350E-06 Rb88 0.000E+00 4.980E-07 2.730E-07 0.000E+00 0.000E+00 0.000E+00 4.850E-07 Rb89
Rb86     0.000E+00 1.700E-04 8.400E-05 0.000E+00 0.000E+00 0.000E+00 4.350E-06 Rb88       0.000E+00 4.980E-07 2.730E-07 0.000E+00 0.000E+00 0.000E+00 4.850E-07 Rb89     0. 00 0E+00 2. 86 0E-07 1. 970E-07 0. 000E+00-O:000E+~00-~ ~0~. 000E+00T74 UE;0 8'~ ~~
: 0. 00 0E+00 2. 86 0E-07 1. 970E-07 0. 000E+00-O:000E+~00-~ ~0~. 000E+00T74 UE;0 8'~
Sr89     2.510E-03 0.000E+00 7.200E-05 0.000E+00 0.000E+00 0.000E+00 5.160E-05 Sr90     1.850E-02 0.000E+00 4.710E-03 0.000E+00 0.000E+00 0.000E+00 2.310E-04 Sr91     5.000E-05 0.000E+00 1.810E-06 0.000E+00 0.000E+00 0.000E+00 5.920E-05 Sr92     1.920E-05 0.000E+00 7.130E-07 0.000E+00 0.000E+00 0.000E+00 2.070E-04 Y90       8.690E-08 0.000E+00 2.330E-09 0.000E+00 0.000E+00 0.000E+00 1.200E-04 Y913     8.100E-10 0.000E+00 2.760E-11 0.000E+00 0.000E+00 0.000E+00 2.700E-06 Y91       1.130E-06 0.000E+00 3.010E-08 0.000E+00 0.000E+00 0.000E+00 8.100E-05 Y92       7.650E-09 0.000E+00 2.150E-10 0.000E+00 0.000E+00 0.000E+00 1.460E-04 Y93       2.430E-08 0.000E+00 6.620E-10 0.000E+00 0.000E+00 0.000E+00 1.920E-04 Zr95     2.060E-07 5.020E-08 3.560E-08 0.000E+00 5.410E-08 0.000E+00 2.500E-05 Zr97     1.480E-08 2.540E-09 1.160E-09 0.000E+00 2.560E-09 0.000E+00 1.620E-04 Nb95     4.200E-08 1.730E-06 1.000E-08 0.000E+00 1.240E-08 0.000E+00 1.460E-05 Mo99       0.000E+00 3.400E-05 6.630E-06 0.000E+00 5.080E-05 0.000E+00 1.120E-05                 l Tc99m     1.920E-09 3.960E-09 5.100E-08 0.000E+00 4.260E-08 2.070E-09 1.150E-06                 l Tc101     2.270E-09 2.860E-09 2.830E-08 0.000E+00 3.400E-08 1.560E-09 4.860E-07                 l Rul03     1.480E 06 0.000E+00 4.950E-07 0.000E+00 3.080E-06 0.000E+00 1.800E-05 Rul05     1.360E-07 0.000E+00 4.580E-06 0.000E+00 1.000E-06 0.000E+00 5.410E-05                 l l
~~
Rul06     2.410E-05 0.000E+00 3.010E-06 0.000E+00 2.850E-05 0.000E+00 1.830E-04                 i Ag110m     9.960E-07 7.270E-07 4.810E-07 0.000E+00 1.040E-06 0.000E+00 3.770E-05                 l Te125m   2.330E-05 7.790E-06 3.150E-06 7.840E-06 0.000E+00 0.000E+00 1.110E-05                 '
Sr89 2.510E-03 0.000E+00 7.200E-05 0.000E+00 0.000E+00 0.000E+00 5.160E-05 Sr90 1.850E-02 0.000E+00 4.710E-03 0.000E+00 0.000E+00 0.000E+00 2.310E-04 Sr91 5.000E-05 0.000E+00 1.810E-06 0.000E+00 0.000E+00 0.000E+00 5.920E-05 Sr92 1.920E-05 0.000E+00 7.130E-07 0.000E+00 0.000E+00 0.000E+00 2.070E-04 Y90 8.690E-08 0.000E+00 2.330E-09 0.000E+00 0.000E+00 0.000E+00 1.200E-04 Y913 8.100E-10 0.000E+00 2.760E-11 0.000E+00 0.000E+00 0.000E+00 2.700E-06 Y91 1.130E-06 0.000E+00 3.010E-08 0.000E+00 0.000E+00 0.000E+00 8.100E-05 Y92 7.650E-09 0.000E+00 2.150E-10 0.000E+00 0.000E+00 0.000E+00 1.460E-04 Y93 2.430E-08 0.000E+00 6.620E-10 0.000E+00 0.000E+00 0.000E+00 1.920E-04 Zr95 2.060E-07 5.020E-08 3.560E-08 0.000E+00 5.410E-08 0.000E+00 2.500E-05 Zr97 1.480E-08 2.540E-09 1.160E-09 0.000E+00 2.560E-09 0.000E+00 1.620E-04 Nb95 4.200E-08 1.730E-06 1.000E-08 0.000E+00 1.240E-08 0.000E+00 1.460E-05 Mo99 0.000E+00 3.400E-05 6.630E-06 0.000E+00 5.080E-05 0.000E+00 1.120E-05 Tc99m 1.920E-09 3.960E-09 5.100E-08 0.000E+00 4.260E-08 2.070E-09 1.150E-06 Tc101 2.270E-09 2.860E-09 2.830E-08 0.000E+00 3.400E-08 1.560E-09 4.860E-07 Rul03 1.480E 06 0.000E+00 4.950E-07 0.000E+00 3.080E-06 0.000E+00 1.800E-05 Rul05 1.360E-07 0.000E+00 4.580E-06 0.000E+00 1.000E-06 0.000E+00 5.410E-05 Rul06 2.410E-05 0.000E+00 3.010E-06 0.000E+00 2.850E-05 0.000E+00 1.830E-04 i
Tol27m   5.850E-05 1.940E-05 7.080E-06 1.690E-05 1.440E-04 0.000E+00 2.360E-05 Tc127     1.000E-06 3.350E-07 2.150E-07 8.140E-07 2.440E-06 0.000E+00 2.100E-05 Te129m   1.000E-04 3.430E-05 1.540E-05 3.840E-05 2.500E-04 0.000E+00 5.970E-05 Te129     2.840E-07 9.790E-08 6.630E-08 2.380E-07 7.070E-07 0.000E+00 2.270E-05 Te131m     1.520E-05 6.120E-06 5.050E-06 1.240E-05 4.210E-05 0.000E+00 1.030E-04 Te131     1.760E-07 6.500E-08 4.940E-08 1.570E-07 4.500E-07 0.000E+00 7.110E-06 Te132     2.080E-05 1.030E-05 9.610E-06 1.520E-05 6.440E-05, 0.000E+00 3.810E-05
Ag110m 9.960E-07 7.270E-07 4.810E-07 0.000E+00 1.040E-06 0.000E+00 3.770E-05 Te125m 2.330E-05 7.790E-06 3.150E-06 7.840E-06 0.000E+00 0.000E+00 1.110E-05 Tol27m 5.850E-05 1.940E-05 7.080E-06 1.690E-05 1.440E-04 0.000E+00 2.360E-05 Tc127 1.000E-06 3.350E-07 2.150E-07 8.140E-07 2.440E-06 0.000E+00 2.100E-05 Te129m 1.000E-04 3.430E-05 1.540E-05 3.840E-05 2.500E-04 0.000E+00 5.970E-05 Te129 2.840E-07 9.790E-08 6.630E-08 2.380E-07 7.070E-07 0.000E+00 2.270E-05 Te131m 1.520E-05 6.120E-06 5.050E-06 1.240E-05 4.210E-05 0.000E+00 1.030E-04 Te131 1.760E-07 6.500E-08 4.940E-08 1.570E-07 4.500E-07 0.000E+00 7.110E-06 Te132 2.080E-05 1.030E-05 9.610E-06 1.520E-05 6.440E-05, 0.000E+00 3.810E-05


l ODCM Rav. 17 P:ga 115 l
l ODCM Rav. 17 P:ga 115 l
11/95 Table 1-1 (Continued) i Licuid Dose Factors From Table E-14 or Reg. Guide 1.109 Ingestion Dose Factors For Infant:
11/95 Table 1-1 (Continued) i Licuid Dose Factors From Table E-14 or Reg. Guide 1.109 Ingestion Dose Factors For Infant:
BONE       LIVER     T. BODY THYROID     KIDNEY       LUNG         GI-LLI I130     6.000E-06 1.320E-05 5.300E-06 1.480E-03 1.450E-05 0.000E+00 2.830E-06 l I131     3.590E-05 4.230E-05 1.860E-05 1.390E-02 4.940E-05 0.000E+00 1.510E-06 l I132     1.660E-06 3.370E-06 1.200E-06 1.580E-04 3.760E-06 0.000E+00 2.730E-06 l I133     1.250E-05 1.820E-05 5.330E-06 3.310E-03 2.140E-05 0.000E+00 3.080E-06 I134     8.690E-07 1.780E-06 6.330E-07 4.150E-05 1.990E-06 0.000E+00 1.840E-06 1135     3.640E-06 7.240E-06 2.640E-06 6.490E-04 8.070E-06 0.000E+00 2.620E-06 C3134   3.770E-04 7.030E-04 7.100E-05 0.000E+00 1.810E-04 7.420E-05 1.910E-06 C3136   4.590E-05 1.350E-04 5.040E-05 0.000E+00 5.380E-05 1.100E-05 2.050E-06 C3137   5.220E-04 6.110E-04 4.330E-05 0.000E+00 1.640E-04 6.640E-05 1.910E-06 l C2138   4.810E-07 7.820E-07 3.790E-07 0.000E+00 3.900E-07 6.090E-08 1.250E-06 Ba139   8.810E-07 5.840E-10 2.550E-08 0.000E+00 3.510E-10 3.540E-10 5.580E-05 l
BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI I130 6.000E-06 1.320E-05 5.300E-06 1.480E-03 1.450E-05 0.000E+00 2.830E-06 l
B2140   1.710E-04 1.710E-07 8.810E-06 0.000E+00 4.060E-08 1.050E-07 4.200E-05 B 141   4.250E-07 2.910E-10 1.340E-08 0.000E+00 1.750E-10 1.770E-10 5.190E-06 Bn142   1.840E-07 1.530E-10 9.060E-09 0.000E+00 8.810E-11 9.260E-11 7.590E-07 La140   2.110E-08 8.320E-09 2.140E-09 0.000E+00   0.000E+00 0.000E+00       9.770E-05 La142   1.100E-09 4.040E-10 9.670E-11 0.000E400   0.000E+00 0.000E+00       6.860E-05 Ce141   7.870E-08 4.800E-08 5.650E-09 0.000E+00   1.480E-08 0.000E+00       2.480E-05 Ce143   1.480E-08 9.820E-06 1.120E-09 0.000E+00   2.860E-09   0.000E+00     5.730E-05 Cc144   2.980E-06 1.220E-06 1.670E-07 0.000E+00   4.930E-07 0.000E+00       1.710E-04 Pr143   8.130E-08 3.040E-08 4.030E-09 0.000E+00   1.130E-08   0.000E+00     4.290E-05
I131 3.590E-05 4.230E-05 1.860E-05 1.390E-02 4.940E-05 0.000E+00 1.510E-06 l
!  Pr144   2.740E-10 1.060E-10 1.380E-11 0.000E+00 3.840E-11 0.000E+00 4.930E-06 L .Nd147 -- 5.530E-08 5.680E-08 3.480E-09 0.000E+00 2.190E-08 0.000E+00 3.600E-05 g,ggjg_g     gggggj                                             ~~~    ~  '
I132 1.660E-06 3.370E-06 1.200E-06 1.580E-04 3.760E-06 0.000E+00 2.730E-06 l
                                                    - - OTd6d$id0 "6.~06 ~s+00 3.'690s-05 ~ ~ ~ ~ ~
I133 1.250E-05 1.820E-05 5.330E-06 3.310E-03 2.140E-05 0.000E+00 3.080E-06 I134 8.690E-07 1.780E-06 6.330E-07 4.150E-05 1.990E-06 0.000E+00 1.840E-06 1135 3.640E-06 7.240E-06 2.640E-06 6.490E-04 8.070E-06 0.000E+00 2.620E-06 C3134 3.770E-04 7.030E-04 7.100E-05 0.000E+00 1.810E-04 7.420E-05 1.910E-06 C3136 4.590E-05 1.350E-04 5.040E-05 0.000E+00 5.380E-05 1.100E-05 2.050E-06 C3137 5.220E-04 6.110E-04 4.330E-05 0.000E+00 1.640E-04 6.640E-05 1.910E-06 l
C2138 4.810E-07 7.820E-07 3.790E-07 0.000E+00 3.900E-07 6.090E-08 1.250E-06 Ba139 8.810E-07 5.840E-10 2.550E-08 0.000E+00 3.510E-10 3.540E-10 5.580E-05 l
B2140 1.710E-04 1.710E-07 8.810E-06 0.000E+00 4.060E-08 1.050E-07 4.200E-05 B 141 4.250E-07 2.910E-10 1.340E-08 0.000E+00 1.750E-10 1.770E-10 5.190E-06 Bn142 1.840E-07 1.530E-10 9.060E-09 0.000E+00 8.810E-11 9.260E-11 7.590E-07 La140 2.110E-08 8.320E-09 2.140E-09 0.000E+00 0.000E+00 0.000E+00 9.770E-05 La142 1.100E-09 4.040E-10 9.670E-11 0.000E400 0.000E+00 0.000E+00 6.860E-05 Ce141 7.870E-08 4.800E-08 5.650E-09 0.000E+00 1.480E-08 0.000E+00 2.480E-05 Ce143 1.480E-08 9.820E-06 1.120E-09 0.000E+00 2.860E-09 0.000E+00 5.730E-05 Cc144 2.980E-06 1.220E-06 1.670E-07 0.000E+00 4.930E-07 0.000E+00 1.710E-04 Pr143 8.130E-08 3.040E-08 4.030E-09 0.000E+00 1.130E-08 0.000E+00 4.290E-05 Pr144 2.740E-10 1.060E-10 1.380E-11 0.000E+00 3.840E-11 0.000E+00 4.930E-06 L.Nd147 -- 5.530E-08 5.680E-08 3.480E-09 0.000E+00 2.190E-08 0.000E+00 3.600E-05 g,ggjg_g gggggj
- - OTd6d$id0 "6.~06 ~s+00 3.'690s-05 ~ ~ ~ ~ ~
~~~
~
Np239 1.110E-08 9.930E-10 5.610E-10 0.000E+00 1.980E-09 0.000E+00 2.870E-05 i
Np239 1.110E-08 9.930E-10 5.610E-10 0.000E+00 1.980E-09 0.000E+00 2.870E-05 i
I I
I I


ODCM Rsv. 17 Page 116 11/95 Table 1-2 Assumptions used in Limerick Liquid Effluent Dose Evaluation Ind2X                   Descrintion                             Value 1 Fraction of produce from local garden                       7.600E-01 2 Fraction of leafy veg from local garden                     1.000E+00 3 Soil c..ensity in plow layer (kg/m**2)                       2.400E+02 4 Fraction of activity retained on sprayed vegetation           2.500E-01 5 Shielding factor for residential structures                 7.000E-01 6 Period of buildup of activity in soil (hr)                   1.752E+05 7 Period of pasttre grass exposure to activity (hr)             7.200E+02 8 Period of crop exposure to activity (hr)                     1.440E+03 9 Holding time in animal drinking water pond (hr)             0.000E+00 10 Delsy time for ingestion of grass by animals (hr)             0.000E+00 11 Delay time for ingestion of stored fee by animals (hr)       2.160E+03 12 Delay time for ingestion of leaf veg by man (hr)             2.400E+01 13 Delay time for ingestion of other veg by man (hr)             1.440E+03 14 Transport time milk-man (hr)                                 4.800E+01 15 Time between slaughter and consumption of meat animal (hr)   4.800E+02 16 Grass yield, wet wt (kg/m**2)                                 7.000E-01 17 Other vegetation yield, wet wt (kg/m**2)                     2.000E+00 18 Weathering rate constant for activity on vegetation (1/hr)   2.100E-03 19 Milk cow feed consumption rate (kg/ day wet)                 5.000E+01 20 Goat feed consumption rate (kg/ day wet)                     6.000E+00 21 Beef Cattle feed consumption rate (kg/ day wet)               5.000E+01 22 Milk cow water consumption rate (1/ day)                     6.000E+01
ODCM Rsv. 17 Page 116 11/95 Table 1-2 Assumptions used in Limerick Liquid Effluent Dose Evaluation Ind2X Descrintion Value 1 Fraction of produce from local garden 7.600E-01 2 Fraction of leafy veg from local garden 1.000E+00 3 Soil c..ensity in plow layer (kg/m**2) 2.400E+02 4 Fraction of activity retained on sprayed vegetation 2.500E-01 5 Shielding factor for residential structures 7.000E-01 6 Period of buildup of activity in soil (hr) 1.752E+05 7 Period of pasttre grass exposure to activity (hr) 7.200E+02 8 Period of crop exposure to activity (hr) 1.440E+03 9 Holding time in animal drinking water pond (hr) 0.000E+00 10 Delsy time for ingestion of grass by animals (hr) 0.000E+00 11 Delay time for ingestion of stored fee by animals (hr) 2.160E+03 12 Delay time for ingestion of leaf veg by man (hr) 2.400E+01 13 Delay time for ingestion of other veg by man (hr) 1.440E+03 14 Transport time milk-man (hr) 4.800E+01 15 Time between slaughter and consumption of meat animal (hr) 4.800E+02 16 Grass yield, wet wt (kg/m**2) 7.000E-01 17 Other vegetation yield, wet wt (kg/m**2) 2.000E+00 18 Weathering rate constant for activity on vegetation (1/hr) 2.100E-03 19 Milk cow feed consumption rate (kg/ day wet) 5.000E+01 20 Goat feed consumption rate (kg/ day wet) 6.000E+00 21 Beef Cattle feed consumption rate (kg/ day wet) 5.000E+01 22 Milk cow water consumption rate (1/ day) 6.000E+01
_ 73. Roat water. consumption- rata -(1-/ day) - -  -'  -  -
_ 73. Roat water. consumption-rata -(1-/ day) - -
T.000Ef00~~
T.000Ef00~~
                                                                                    ~
~
24 Beef cattle water consumption rate (1/ day)                   5.000E+01 25 Envtl transit time for water ingestion (hr)                 1.200E+01 26 Envtl transit time for fish ingestion (hr)                 2.400E+01 27 Enytl transit time for invertebrate ingestion (hr)       l 2.400E+01 28 Enytl transit time for shore exposure (hr)                 0.000E+00 29 Water ingestion (1/yr) adult                               7.300E+02           1 30 Water ingestion (1/yr) teen                                 5.100E+02           l 31 Water   ingestion (1/yr) child                               5.100E+02           i 32 Water ingestion (1/yr) infant                               3.300E+02 33 Shore e:;posure (hr/yr) adult                               1.200E+01 34 Shore   exposure (hr/yr) teen                               6.700E+01 35 Shore   exposure (hr/yr) child                               1. 4 0 0E+ 01       !
24 Beef cattle water consumption rate (1/ day) 5.000E+01 25 Envtl transit time for water ingestion (hr) 1.200E+01 26 Envtl transit time for fish ingestion (hr) 2.400E+01 27 Enytl transit time for invertebrate ingestion (hr) l 2.400E+01 28 Enytl transit time for shore exposure (hr) 0.000E+00 29 Water ingestion (1/yr) adult 7.300E+02 30 Water ingestion (1/yr) teen 5.100E+02 31 Water ingestion (1/yr) child 5.100E+02 i
36 Shore exposure (hr/yr) infant                               0.000E+00           1 37 Fresh water sport fish ingestion (kg/yr) adult             2.100E+01 38 Fresh   water sport fish ingestion (kg/yr) teen             1.600E+01 39 Fresh water sport fish ingestion (kg/yr) child             6.900E+00 40 Fresh water sport fish ingestion (kg/yr) infant             0.000E+00           l 41 Fresh water commercial fish ingestion (kg/yr) adult         2.100E+01           i 42 Fresh   water commercial fish ingestion (kg/yr) teen         1.600E401 43 Fresh   water commercial fish ingestion (kg/yr) child       6.900E+00 44 Fresh water commercial fish ingestion (kg/yr) infant       0.000E+00 45 Fresh water invertebrate ingestion (kg/yr) adult           5.000E+00 46 Fresh water invertebrate ingestion (kg/yr) teen             3.800E+00 47 Fresh   water invertebrate ingestion (kg/yr) child           1.700E+00 48 Fresh water invertebrate ingestion (kg/yr) infant           0.000E+00
32 Water ingestion (1/yr) infant 3.300E+02 33 Shore e:;posure (hr/yr) adult 1.200E+01 34 Shore exposure (hr/yr) teen 6.700E+01 35 Shore exposure (hr/yr) child
: 1. 4 0 0E+ 01 36 Shore exposure (hr/yr) infant 0.000E+00 1
37 Fresh water sport fish ingestion (kg/yr) adult 2.100E+01 38 Fresh water sport fish ingestion (kg/yr) teen 1.600E+01 39 Fresh water sport fish ingestion (kg/yr) child 6.900E+00 40 Fresh water sport fish ingestion (kg/yr) infant 0.000E+00 41 Fresh water commercial fish ingestion (kg/yr) adult 2.100E+01 i
42 Fresh water commercial fish ingestion (kg/yr) teen 1.600E401 43 Fresh water commercial fish ingestion (kg/yr) child 6.900E+00 44 Fresh water commercial fish ingestion (kg/yr) infant 0.000E+00 45 Fresh water invertebrate ingestion (kg/yr) adult 5.000E+00 46 Fresh water invertebrate ingestion (kg/yr) teen 3.800E+00 47 Fresh water invertebrate ingestion (kg/yr) child 1.700E+00 48 Fresh water invertebrate ingestion (kg/yr) infant 0.000E+00


_ _  . _ _  m. _ .___              . _ _ _  _ . _ . . _    __. -
m.
ODCM Rsv. 17 Page 117
ODCM Rsv. 17 Page 117 11/95 Table 1-2 Assumptions used in Limerick Liquid Effluent Dose Evaluation Index Descriotion Value 49 Salt Water Sport Fish Ingestion (kg/yr) Adult 2.100E+01 50 Salt Water Sport Fish Incestion (kg/yr) Teen 1.600E+01 51 Salt Water Sport Fish Ingestion (kg/yr) Child 6.900E+00 52 Salt Water Sport Fish Ingestion (kg/yr) Infant 0.000E+00 53 Salt Water Commercial Fish Ingestion (kg/yr) Adult 2.100E+01 54 Salt Water Commercial Fish Ingestion (kg/yr) Teen 1.600E+01 55 Salt Water Commercial Fish Ingestion (kg/yr) Child 6.900E+00 56 Salt Water Commercial Fish Ingestion (kg/yr) Infant 0.000E+00 57 Salt Water Invertebrate Ingestion (kg/yr) Adult 5.000E+00
                                              ,                                              11/95 Table 1-2 Assumptions used in Limerick Liquid Effluent Dose Evaluation Index                               Descriotion                             Value 49     Salt Water Sport Fish         Ingestion (kg/yr) Adult               2.100E+01 50     Salt Water Sport Fish         Incestion (kg/yr) Teen                 1.600E+01 51     Salt Water Sport Fish         Ingestion (kg/yr) Child               6.900E+00 52     Salt Water Sport Fish         Ingestion (kg/yr) Infant               0.000E+00 53   Salt Water Commercial         Fish Ingestion (kg/yr) Adult           2.100E+01 54     Salt Water Commercial Fish Ingestion (kg/yr) Teen                     1.600E+01 55     Salt Water Commercial Fish Ingestion (kg/yr) Child                   6.900E+00 56     Salt Water Commercial Fish Ingestion (kg/yr) Infant                   0.000E+00 57   Salt Water Invertebrate Ingestion (kg/yr) Adult                       5.000E+00           )
)
58   Salt Water Invertebrate Ingestion (kg/yr) Teen                       3.800E+00 59   Salt Water Invertebrate Ingestion (kg/yr) Child                       1.700E+00 60   Salt Water Invertebrate Ingestion (kg/yr) Infant                     0.000E+00 61   Irrigated Leafy Vegetable Ingestion (kg/yr) Adult                     6.400E+01 62   Irrigated Leafy Vegetable Ingestion (kg/yr) Teen                     4.200E+01 63   Irrigated Leafy Vegetable Ingestion (kg/yr) Child                     2.600E+01 64   Irrigated Leafy Vegetable Ingestion (kg/yr) Infant                   0.000E+00           .
58 Salt Water Invertebrate Ingestion (kg/yr) Teen 3.800E+00 59 Salt Water Invertebrate Ingestion (kg/yr) Child 1.700E+00 60 Salt Water Invertebrate Ingestion (kg/yr) Infant 0.000E+00 61 Irrigated Leafy Vegetable Ingestion (kg/yr) Adult 6.400E+01 62 Irrigated Leafy Vegetable Ingestion (kg/yr) Teen 4.200E+01 63 Irrigated Leafy Vegetable Ingestion (kg/yr) Child 2.600E+01 64 Irrigated Leafy Vegetable Ingestion (kg/yr) Infant 0.000E+00 65 Irrigated Other Vegetable Ingestion (kg/yr) Adult 5.200E+02 66 Irrigated Other Vegetable Ingestion,(kg/yr) Teen 6.300E+02 l
65   Irrigated Other Vegetable Ingestion (kg/yr) Adult                     5.200E+02           I 66   Irrigated Other Vegetable Ingestion ,(kg/yr) Teen                     6.300E+02           l 67   Irrigated Other Vegetable Ingestion (kg/yr) Child                     5.200E+02 68   Irrigated Other Vegetable Ingestion (kg/yr) Infant                   0.000E+00 69   Irrigated Root Vegetable Ingestion (kg/yr) Adult                     5.200E+02 70   Irrigated Root Vegetable Ingestion (kg/yr) Teen                       6.300E+02 71   Irrigated'Roo't Vegetable Ingestion (kg/yr) Child                     5.200E+02           {
67 Irrigated Other Vegetable Ingestion (kg/yr) Child 5.200E+02 68 Irrigated Other Vegetable Ingestion (kg/yr) Infant 0.000E+00 69 Irrigated Root Vegetable Ingestion (kg/yr) Adult 5.200E+02 70 Irrigated Root Vegetable Ingestion (kg/yr) Teen 6.300E+02 71 Irrigated'Roo't Vegetable Ingestion (kg/yr) Child 5.200E+02
72   Irrigated Root Vegetable Ingestion (kg/yr) Infant.             __  .0.000E+00          '
{
  --73' -Irrigated Cow Milk Ingest ~1c n ~(1/yr)~ AdulE '                       3.100E+02 74   Irrigated Cow Milk Ingestion (1/yr) Teen                             4.000E+02 75   Irrigated Cow Milk Ingestion (1/yr) Child                             3.300E+02 76   Irrigated Cow Milk Ingestion (1/yr) Infant                           3.300E+02 77   Irrigated Goat Milk Ingestion (1/yr) Adult                           3.100E+02 78   Irrig&ted Goat Milk Ingestion (1/yr) Teen                             4.000E+02 79   Irrigated Goat Milk Ingestion (1/yr) Child                           3.300E+02 80   Irrigated Goat Milk Ingestion (1/yr) Infant                           3.300E+02 81   Irrigated Beef Ingestion (1/yr) Adult                                 1.100E+02 82   Irrigated Beef Ingestion (1/yr) Teen                                 6.500E+01 83   Irrigated Beef Ingestion (1/yr) Child                                 4.100E+01 84   Irrigated Beef Ingestion (1/yr) Infant                               0.000E+00 l
72 Irrigated Root Vegetable Ingestion (kg/yr) Infant.
9
--73' -Irrigated Cow Milk Ingest ~1c n ~(1/yr)~ AdulE '
.0.000E+00 3.100E+02 74 Irrigated Cow Milk Ingestion (1/yr) Teen 4.000E+02 75 Irrigated Cow Milk Ingestion (1/yr) Child 3.300E+02 76 Irrigated Cow Milk Ingestion (1/yr) Infant 3.300E+02 77 Irrigated Goat Milk Ingestion (1/yr) Adult 3.100E+02 78 Irrig&ted Goat Milk Ingestion (1/yr) Teen 4.000E+02 79 Irrigated Goat Milk Ingestion (1/yr) Child 3.300E+02 80 Irrigated Goat Milk Ingestion (1/yr) Infant 3.300E+02 81 Irrigated Beef Ingestion (1/yr) Adult 1.100E+02 82 Irrigated Beef Ingestion (1/yr) Teen 6.500E+01 83 Irrigated Beef Ingestion (1/yr) Child 4.100E+01 84 Irrigated Beef Ingestion (1/yr) Infant 0.000E+00 9


i ODCM Rev. 17   ;
i ODCM Rev. 17 Page 118 11/95 j
Page 118 !
Table 2-1 Dose Factors for Noble Gas l
11/95 j 1
Total Body Beta Skin Gamma Air Beta Air Dose Factor Dose Factor Dose Factor Dose Factor Ki (mrem /yr Li (mrem /yr Mi (mrad.yr Ni (mrad /yr per per per per 3
Table 2-1 Dose Factors for Noble Gas                           ,
3 8
l Total Body   Beta Skin     Gamma Air   Beta Air Dose Factor   Dose Factor   Dose Factor Dose Factor Ki (mrem /yr Li (mrem /yr Mi (mrad.yr Ni (mrad /yr       ;
Ind;x Radionuclide pCi/m )
per           per         per         per           '
pCi/m )
Ind;x Radionuclide pCi/m 3)     pCi/m 3)     pCi/m')   pCi/m )8 3     Ar-41     8.84E-03       2.69E-03     9.30E-03     3.28E-03 4     Kr-83m   7.56E-08       -------
pCi/m')
1.93E-05     2.88E-04 5     Kr-85m   1.17E-03       1.46E-03     1.23E-03     1.97E-03 6     Kr-85     1.61E-05       1.34E-03     1.72C-05     1.953-03 7     Kr-87     5.92E-03       9.73E-03     6.17E-03     1.03E-02 8     Kr-88     1.47E-02       2.37E-03     1.52E-02     2.93E-03 9     Kr-89     1.66E-02       1.01E-02     1.73E-02     1.06E-02 10     Kr-90     1.56E-02       7.29E-03     1.63E-02     7.83E-03 11     Ae-131m   9.15E-05       4.76E-04     1.56E-04     1.11E-03 12     Xe-133m   2.51E-04       9.94E-04     3.27E-04     1.48E-03 13     Xe-133   2.94E-04       3.06E-04     3.53E-04     1.05E-03 14     Xe-135m   3.12E-03       7.11E-04     3.36E-03     7.39E-04 15     Xe-135   1.81E-03       1.86E-03     1.92E-03     2.46E-03 16     Xe-137   1.42E-03       1.22E-02     1.51E-03     1.27E-02 17     Xe-138   8.83E-03       .4.13E-03     9.21E-03     4.75E-03
pCi/m )
3 Ar-41 8.84E-03 2.69E-03 9.30E-03 3.28E-03 4
Kr-83m 7.56E-08 1.93E-05 2.88E-04 5
Kr-85m 1.17E-03 1.46E-03 1.23E-03 1.97E-03 6
Kr-85 1.61E-05 1.34E-03 1.72C-05 1.953-03 7
Kr-87 5.92E-03 9.73E-03 6.17E-03 1.03E-02 8
Kr-88 1.47E-02 2.37E-03 1.52E-02 2.93E-03 9
Kr-89 1.66E-02 1.01E-02 1.73E-02 1.06E-02 10 Kr-90 1.56E-02 7.29E-03 1.63E-02 7.83E-03 11 Ae-131m 9.15E-05 4.76E-04 1.56E-04 1.11E-03 12 Xe-133m 2.51E-04 9.94E-04 3.27E-04 1.48E-03 13 Xe-133 2.94E-04 3.06E-04 3.53E-04 1.05E-03 14 Xe-135m 3.12E-03 7.11E-04 3.36E-03 7.39E-04 15 Xe-135 1.81E-03 1.86E-03 1.92E-03 2.46E-03 16 Xe-137 1.42E-03 1.22E-02 1.51E-03 1.27E-02 17 Xe-138 8.83E-03
.4.13E-03 9.21E-03 4.75E-03


ODCM Rsv. 17 Paga 119 11/95         ,
ODCM Rsv. 17 Paga 119 11/95 I
I    a TABLE 2-2 i
a TABLE 2-2 i
INGESTION INDIVIDUAL DOCE FACTORS (DFx,t,,)                                               l For Gaseous Effluents                                               r t
INGESTION INDIVIDUAL DOCE FACTORS (DFx,t,,)
UNITS FOR AIRBORNE PATHWAYS (Pathway Numbers 1 and 7) are:
l For Gaseous Effluents r
3 mrem-m       /Ci-sec                                             '
t UNITS FOR AIRBORNE PATHWAYS (Pathway Numbers 1 and 7) are:
UNITS FOR ' DEPO'3ITION PATHWAYS                                             .
3 mrem-m /Ci-sec UNITS FOR ' DEPO'3ITION PATHWAYS (Pathway Numbers 2-6) are:
(Pathway Numbers 2-6) are:                                                 ,
2 mrent-m /Ci Pathway No.
mrent-m2 /Ci                                                 !
Pathway
Pathway No.                                 Pathway
'l Plume 2
        'l                                   Plume                                                     !
Ground 3
2                                    Ground 3                                   Vegetable                                                 ;
Vegetable 4
4                                    Meat                                                       !
Meat 5
5                                    Cow Milk                                                   r 6                                   Goat Milk                                                 !
Cow Milk r
7                                    Inhalation                                                 l l
6 Goat Milk 7
l l
Inhalation l
i I


4
4 ODCM R;v-17 Page 1*O J
,                                                                                ODCM R;v- 17 J
11/95 1
Page 1*O 11/95 1
Table 2-2 s
Table 2-2                       s 4
4 INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: H3 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID UJNG SKIN Adalt:
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: H3 For Pathway: Plume T. BODY GI-TRACT       BONE     LIVER     KIDNEY THYROID       UJNG     SKIN Adalt:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.90E+00 0.00E+00 Tacn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.90E+00 0.00E+00 Tacn:
: s. BODY GI-TRACT       BONE     LIVER     KIDNEY THYROID     LUNG     SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT       BONE     LIVER     KIDNEY THYROID       LUNG     SKIN Adult:     6.53E+01 6.53E+01 0.00E+00 6.53E+01 6.53E+01 6.53E+01 6.53E+01 0.00E+00 Tcen:     7.75E+01 7.75E+01 0.00E+00 7.75E+01 7.75E+01 7.75E+01 7.75E+01 0.00E+00 Child:     1.21E+02 1.21E+02 0.00E+00 1.21E+02'1.21E+02 1.21E+02 1.21E+02 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.000,+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT     BONE     LIVER     KIDNEY THYROID     LUNG     SKIN Adult:     7.98E+00 7.98E+00 0.00E+-00 7.98E+00 7.98E+00 7.98E+00 7.98E+00 0.00E+00 TOsn:     4.75E+00 4.76E+00 0.00E+00 4.76E+00 4.76E+00 4.76E+00 4.76E+00 0.00E+00 Child:     5.75E+00 5.75E+00 0.00E+00 5.75E+00 5.75E+00 5.75E+00 5.75E+00 0.00E+00 InfEnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+0C 0.00E,00 0.00E+00 0.00E+00 For Pathway: Cow Milk
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
    .        T. BODY GI-TRACT       BONE     LIVER     KIDNEY THYROID       LUNG     SKIN Adult:     1.88E+01 1.88E+01 0.00E+00 1.88E+01 1.88E+01 1.88E+01 1.88E+01 0.00E+00 Toen:     2.45E+01 2.45E+01 0.00E+00 2.45E+01 2.45E+01 2.45E+01 2.45E+01 0.00E+00 Child:     3.87E+01 3.87E+01 0.00E+00 3.87E+01 3.87E+01 3.87E+01 3.87E+01 0.00E+00 Infcnt: 5.87EA01 5.87E+01 0.00E+00 5.37E+01 5.87E+01 5.87E+01 5.87E+01 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT       BONE     LIVER     KIDNEY THYROID     LUNG     SKIN Adult:     3.83E+01 3.88E+01 0.00E+00 3.83E+01 3.83E+01 3.83E+01 3.83E+01 0.00E+00 Tacn:     4.99E+01 4.99E+01 0.00E+00 4.99E+01 4.99E+02. 4.99E+01 4.99E+01 0.00E+00 Child:     7.89E+01 7.89E+01 0.00E+00 7.89E+01 7.89E+01 7.89E+01 7.89E+01 0.00E+00 Infcnt: 1.20E+02 1.20E+02 0.00E+00 1.20E+02 1.20E+02 1_20E+02 1.20R+02 0.00E+00 For Pathway! Inhalation T. BODY GI-TRACT       BONE     LIVER     KIDNEY THYROID       LUNG     SKIN Adult:     4. 01E+01 4. 01E+ 01 0. 00E+00 4. 01E+01 4. 01E+01 4. 01E+ 01 4. 01E+01 0. 0 0E+0 0 Tecn.:     4. 03E+01 4. 03E+01 0. 00E+00 4. 03E+01 4. 03E+ 01 4. 03E+01 4. 03E+01 0. 00E+00 Child:     3.57E+01 3.57E+01 0.00E+00 3.57E+01 3.57E+01 3.57E+01 3.57E+01 0.0d,E+00 Infant: 2.05E+01 2.05E+01 0.00E+00 2.05E+01 2.05E+01 2.05E+01 2.05E+01 0.00E+00 r
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground
: s. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
6.53E+01 6.53E+01 0.00E+00 6.53E+01 6.53E+01 6.53E+01 6.53E+01 0.00E+00 Tcen:
7.75E+01 7.75E+01 0.00E+00 7.75E+01 7.75E+01 7.75E+01 7.75E+01 0.00E+00 Child:
1.21E+02 1.21E+02 0.00E+00 1.21E+02'1.21E+02 1.21E+02 1.21E+02 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.000,+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
7.98E+00 7.98E+00 0.00E+-00 7.98E+00 7.98E+00 7.98E+00 7.98E+00 0.00E+00 TOsn:
4.75E+00 4.76E+00 0.00E+00 4.76E+00 4.76E+00 4.76E+00 4.76E+00 0.00E+00 Child:
5.75E+00 5.75E+00 0.00E+00 5.75E+00 5.75E+00 5.75E+00 5.75E+00 0.00E+00 InfEnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+0C 0.00E,00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
1.88E+01 1.88E+01 0.00E+00 1.88E+01 1.88E+01 1.88E+01 1.88E+01 0.00E+00 Toen:
2.45E+01 2.45E+01 0.00E+00 2.45E+01 2.45E+01 2.45E+01 2.45E+01 0.00E+00 Child:
3.87E+01 3.87E+01 0.00E+00 3.87E+01 3.87E+01 3.87E+01 3.87E+01 0.00E+00 Infcnt: 5.87EA01 5.87E+01 0.00E+00 5.37E+01 5.87E+01 5.87E+01 5.87E+01 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
3.83E+01 3.88E+01 0.00E+00 3.83E+01 3.83E+01 3.83E+01 3.83E+01 0.00E+00 Tacn:
4.99E+01 4.99E+01 0.00E+00 4.99E+01 4.99E+02. 4.99E+01 4.99E+01 0.00E+00 Child:
7.89E+01 7.89E+01 0.00E+00 7.89E+01 7.89E+01 7.89E+01 7.89E+01 0.00E+00 Infcnt: 1.20E+02 1.20E+02 0.00E+00 1.20E+02 1.20E+02 1_20E+02 1.20R+02 0.00E+00 For Pathway! Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
: 4. 01E+01 4. 01E+ 01 0. 00E+00 4. 01E+01 4. 01E+01 4. 01E+ 01 4. 01E+01 0. 0 0E+0 0 Tecn.:
: 4. 03E+01 4. 03E+01 0. 00E+00 4. 03E+01 4. 03E+ 01 4. 03E+01 4. 03E+01 0. 00E+00 Child:
3.57E+01 3.57E+01 0.00E+00 3.57E+01 3.57E+01 3.57E+01 3.57E+01 0.0d,E+00 Infant: 2.05E+01 2.05E+01 0.00E+00 2.05E+01 2.05E+01 2.05E+01 2.05E+01 0.00E+00 r


    .-      - ~ _ . _ - -     ~ - - . . -      ..      .--      .-  . .      .    .
- ~ _. _ - -
                                                                                                      )
~
ODCM Rav. 17 i Prga 121 11/95 i Table 2-2 (Continued) i INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: C14 For Pathway: Plume                                                                                   i T. BODY GI-TRACT               BONE     LIVER     KIDNEY THYROID       LUNG   SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 P.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                   ,
)
Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                     ;
ODCM Rav. 17 i
-For Pathway: Ground T. BODY GI-TRACT               BONE     LIVER     KIDNEY   THYROID     LUNG     SKIN   l Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                     0.00E+00 0.00E+00 0.00E+00 Tecn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                 0.00E+00 0.00E+00 0.00E+00   i Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                 0.00E&00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable                                                                               i T. BODY GI-TRACT               BONE     LIVER     KIDNEY THYROID       LUNG   SKIN   I Adult: 5.22E+03 5.22E+03 2.61E+04 5.22E+03 5.22E+03 5.22E+03 5.22E+03 0.00E+00 Tacn:     8.79E+03 8.79E+03 4.39E+04 8.79E+03 8.79E+03 8.79E+03 8.79E+03 0.00E+00.                   l Child:     2.14E+04 2.14E+04 1.07E+05 2.14E+04 2.14E+04 2.14E+04 2.14E+04 0.00E+00                   i Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                       l For F.hhway: Meat T. BODY       GI-TRACT         BONE     LIVER     KIDNEY THYROID       LUNG   SKIN Adult:     1.64E+03 1.64E+03 8.22E+03 1.64E+03 1.64E+03 1.64E+03 1.64E+03 0.00E+00 Tcan:     1.39E+03 1.39E+03 6.94E+03 1.39E+03 1.39E+03 1.39E+03 1.39E+03;0.00E+00 Child:     3.61E+03 2.61E+03 1.31E+04 2.61E+03 2.61E+03 2.61E+03 2.61E+03 0.00E+00 Infent: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                     .
Prga 121 11/95 i
For Pathway: Cow Milk T. BODY CI-TRACT               BONE     LIVER     KIDNEY THYROID         LUNG   SKIN Adult: 1.79E+03 1.79E+03 8.97E+03 1.79E+03 1.79E+03 1.79E+03 1.79E+03 0.00E+00 Tecn:     3.31E+03 3.31E-03 1.65E+04 3.31E+03 3.31E+03 3.31E+03 3.31E+03 0.00E+00 Child:     8.13E+03 8.13E-03 4.07E+04 8.13E+03 3.13E+03 8.13E+03 8.13E+03 0.00E+00 Infant: 1.70E+04 1.70E+04 7.97E+04 1.70E+04 1.70E+04 1.70E+04 1.70E+04 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT               BONE     LIVER     KIDNEY THYROID         LUNG   SKIN Adult: 1.79E+03 1.79E+03 8.97E+03 1.79E+03 1.79E+03 1.79E+03 1.79E+03 0.00E+00 Tcon:     3.31E+03 3.31E+03 1.65E+04 3.31E+03 3.31E+03 3.31E+03 3.31E+03 0.00E+00 Child:     8.13E+05 8.13E+03 4.07E+04 8.13E+03 8.13E+03 8.13E+03 8.13E+03 0.00E+00 Infant: 1.70E+04 1.70E+04 7.97E+04 1.70E+04 1.70E+04 1.70E+04 1.70E+04 0.00E+00 t
Table 2-2 (Continued) i INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: C14 For Pathway: Plume i
For Pathway: Inhalation                                                                           b T. BODY GI-TRACT               BONE     LIVER     f.IDNEY THYROID       LUNG   SKIN Adult: 1.08E+02 1.08E+02 5.76E+02 1.08E+02 1.08E+02 1.08E+02 1.08E+02 0.00E+00 Teen:     1.54E+02 1.54E+02 8.24E+02 1.54E+02 1.54E+02 1.54E+02 1.54E+02 0.00E+00 Child:   2.13E+02 2.13E+02 1.14E+03 2.13E+02 2.13E+02 2.13E+02 2.13E+02 0.00E+00 Infant: 1.68E+02 1.t;8E+02 8.39E+02 1.68E+02 1.68E+02 1.68E+02 1.68E+02 0.00E+00
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 P.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
-For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l
Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E&00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable i
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN I
Adult:
5.22E+03 5.22E+03 2.61E+04 5.22E+03 5.22E+03 5.22E+03 5.22E+03 0.00E+00 Tacn:
8.79E+03 8.79E+03 4.39E+04 8.79E+03 8.79E+03 8.79E+03 8.79E+03 0.00E+00.
Child:
2.14E+04 2.14E+04 1.07E+05 2.14E+04 2.14E+04 2.14E+04 2.14E+04 0.00E+00 i
Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For F.hhway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
1.64E+03 1.64E+03 8.22E+03 1.64E+03 1.64E+03 1.64E+03 1.64E+03 0.00E+00 Tcan:
1.39E+03 1.39E+03 6.94E+03 1.39E+03 1.39E+03 1.39E+03 1.39E+03;0.00E+00 Child:
3.61E+03 2.61E+03 1.31E+04 2.61E+03 2.61E+03 2.61E+03 2.61E+03 0.00E+00 Infent: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY CI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
1.79E+03 1.79E+03 8.97E+03 1.79E+03 1.79E+03 1.79E+03 1.79E+03 0.00E+00 Tecn:
3.31E+03 3.31E-03 1.65E+04 3.31E+03 3.31E+03 3.31E+03 3.31E+03 0.00E+00 Child:
8.13E+03 8.13E-03 4.07E+04 8.13E+03 3.13E+03 8.13E+03 8.13E+03 0.00E+00 Infant: 1.70E+04 1.70E+04 7.97E+04 1.70E+04 1.70E+04 1.70E+04 1.70E+04 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
1.79E+03 1.79E+03 8.97E+03 1.79E+03 1.79E+03 1.79E+03 1.79E+03 0.00E+00 Tcon:
3.31E+03 3.31E+03 1.65E+04 3.31E+03 3.31E+03 3.31E+03 3.31E+03 0.00E+00 Child:
8.13E+05 8.13E+03 4.07E+04 8.13E+03 8.13E+03 8.13E+03 8.13E+03 0.00E+00 Infant: 1.70E+04 1.70E+04 7.97E+04 1.70E+04 1.70E+04 1.70E+04 1.70E+04 0.00E+00 t
For Pathway: Inhalation b
T. BODY GI-TRACT BONE LIVER f.IDNEY THYROID LUNG SKIN Adult:
1.08E+02 1.08E+02 5.76E+02 1.08E+02 1.08E+02 1.08E+02 1.08E+02 0.00E+00 Teen:
1.54E+02 1.54E+02 8.24E+02 1.54E+02 1.54E+02 1.54E+02 1.54E+02 0.00E+00 Child:
2.13E+02 2.13E+02 1.14E+03 2.13E+02 2.13E+02 2.13E+02 2.13E+02 0.00E+00 Infant: 1.68E+02 1.t;8E+02 8.39E+02 1.68E+02 1.68E+02 1.68E+02 1.68E+02 0.00E+00


t i
t i
ODCM Rev. 17 Page 122'
ODCM Rev. 17 Page 122' 11/95 Table 2-2 (Continued)
            ,,                                                                          11/95 l
INDIVIDUAL DOSE FACTORS VOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Ar41 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i
I
Adult:
                                  '. . Table 2-2 (Continued)
1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02
INDIVIDUAL DOSE FACTORS VOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Ar41 For Pathway: Plume                                                                                   !
! Tacn:
T. BODY GI-TRACT     BONE   LIVER     KIDNEY THYROID       LUNG   SKIN             i
1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 i
,  Adult:       1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02
Child:
! Tacn:         1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02                 i Child:       1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02               !
1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 Infant:-1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02
Infant:-1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02                     !
! For Pathway: Ground l
! For Pathway: Ground                                                                                   ,
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
l                T. BODY GI-TRACT     BONE   LIVER     KIDNEY THYROID       LUNG   SKIN Adult:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00               '
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan:
Tcan:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
( Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l InfD.nt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.Orn+00 0.00E+00 0.00E+00 0.00E+00 t
( Child:
j i
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l InfD.nt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.Orn+00 0.00E+00 0.00E+00 0.00E+00 j
! For Pathway: Vegetable                                                                             l' T. BODY GI-TRACT     BONE   LIVER     KIDNEY THYROID       LUNG   SKIN Adult:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00               ,
t i
i Tsan:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00               *
! For Pathway: Vegetable l'
: l. Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                     ,
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat                           .,
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tsan:
T. BODY GI-TRACT     BONE . LIVER     KIDNEY THYROID       LUNG   SKIN Adult:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn:       0.00E+00 0.00E+00-0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00               ;
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
InfRnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                   ;
: l. Child:
i For Pathway: Cow Milk                                     ,
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE.
l                T. BODY GI-TRACT     BONE   LIVER     KIDNEY   THYROID      LUNG    SKIN l Adult:       0. 00E+00 0. 00E+00 0. 00E+00 0.00E- 00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00       :
LIVER KIDNEY THYROID LUNG SKIN Adult:
l Tecn:         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00               l l Child:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00h+00 Infant: .0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT     BONE   LIVER     KIDNEY   THYROID     LUNG     SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00               '
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn:
Tocn:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00               '
0.00E+00 0.00E+00-0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
Child: -0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 InfRnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i For Pathway: Cow Milk THYROID LUNG SKIN l
  . Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                 ;
T. BODY GI-TRACT BONE LIVER KIDNEY l Adult:
i For ' Pathway: Inhalation                                                                         !
: 0. 00E+00 0. 00E+00 0. 00E+00 0.00E- 00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00 l Tecn:
T. BODY GI-TRACT     BONE   LIVER     KIDNEY   THYROID     LUNG     SKIN i Adult:         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toon:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
; Child:         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00               i l   Infant: 0.00E+00'O.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                   l l
l Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00h+00 Infant:.0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tocn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: -0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00
. Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
For ' Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toon:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
; Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
l Infant: 0.00E+00'O.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
l l
l l
i
l i


ODCM R;v. 17 Prga 123 11/95 Table 2-2 (Continued)             (
ODCM R;v. 17 Prga 123 11/95 Table 2-2 (Continued)
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Cr51 For Pathway: Plume T. BODY GI-TRACT   BONE   LIVER   KIDNEY THYROID   LUNG       SKIN Adult:     0.00E+00 0 00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TC:n:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 s
(
For Pathway: Ground T. BODY GI-TRACT   BONE   LIVER   KIDNEY THYROID   LUNG,       SKIN Adult:     1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+03 1.43C+05 1.69E+05 TO n:     1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.69E+05 Child:     1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.69E+05 Inftnt: 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+0E 1.43E+05 1.69E+05 For Pathway: Vegetable T. BODY GI-TRACT   BONE   LIVER   KIDNEY THYROID   LUNG       SKIN Adult: 1.06E+03 2.66E+05 0.00E+00 0.00E+00 2.33E+02 6.31E+02 1.40E+03 0.00E+00 Tccn:     1.55E+03 2.61E+05 0.00E+00 0.00E+00 3.40E+02 8.61E+02 2.21E+03 0.00E+00 Child:     3.05E+03 1.62E+05 0.00E+00 0.00E+00 4.63E+02 1.70E+03 3.10E+03 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+0J 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT   BONE   LIVER   KIDNEY THYROID   LUNG     SKIN Adult:     1.29E+02 3.23E+04 0.00E+00 0.00E+00 2.83E+01 7.68E+01 1.71E+02 0.00E+00 TC:n:     1.05E+02 1.73E+04 0.00E+00 0.00E+00 2.25E+01 5.71E+01 1.47E+02 0.00E+00 Child:     1.60E+02 8.50E+03 0.00E+00 0.00E+00 2.43E+01 8.90E+01 1.62E+02 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT   BONE   LIVER   KIDNEY THYROID   LUNG     SKIN Adult: 5.20E+02 1.31E+05 0.00E+00 0.00E+00 1.15E+02 3.11E+02 6.91E+02 0.00E+00 Tcen:     9.09E+02 1.53E+05 0.00E+00 0.00E+00 1.99E+02 5.05E+02 1.30E+03 0.00E+00 Child:     1.85E+03 9.83E+04 0.00E+00 0.00E+00 2.81E+02 1.03E+03 1.88E+03 0.00E+00 Inftnt: 2.94E+03 8.56E+04 0.00E+00 0.00E+00 4.19E+02 1.92E+03 3.73E+03 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT   BONE   LIVER   KIDNEY THYROID   LUNG       SKIN Adult: 6.24E+01 1.57E+04 0.00E+00 0.00E+00 1.38E+01 3.73E+01 8.29E+01 0.00E+00
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Cr51 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
; TcCn:     1.09E+02 1.83E+04 0.00E+00 0.00E+00 2.39E+01 6.06E+01 1.56E+02 0.00E+00 l Child:     2.22E+02 1.18E+04 0.00E+00 0.00E+00 3.37E+01 1.23E+02 2.25E+02 0.00E 00 Infant: 3.52E+02 1.03E+04 0.00E+00 0.00E+00 5.02E+01 2.30E+02 4.47E+02 0.00E+00 l For Pathway: Inhalation
0.00E+00 0 00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TC:n:
!            T. BODY GI-TRACT   BCNE   LIVER   KIDNEY THYROID   LUNG       SKIN Adult:     3.17E+00 1.05E+02 0.00E+00 0.00E+00 7.23E-01 1.89E+00 4.56E+02 0.00E+00 Tecn:     4.29E+00 9.51E+01 0.00E+00 0.00E+00 9.74E-01 2.38E+00 6.64E+02 0.00E+00 Child:   4.89E400 3.44E+01 0.00E+00 0.00E+00 7.71E-01 2.71E+00 5.38E+02 0.00E+00 Infcnt: 2.84E+00 1.13E+01 0.00E+00 0.00E+00 4.19E-01 1.82E+00 4.07E+02 0.00E+00 l
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 s
For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID
: LUNG, SKIN Adult:
1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+03 1.43C+05 1.69E+05 TO n:
1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.69E+05 Child:
1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.69E+05 Inftnt: 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+0E 1.43E+05 1.69E+05 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
1.06E+03 2.66E+05 0.00E+00 0.00E+00 2.33E+02 6.31E+02 1.40E+03 0.00E+00 Tccn:
1.55E+03 2.61E+05 0.00E+00 0.00E+00 3.40E+02 8.61E+02 2.21E+03 0.00E+00 Child:
3.05E+03 1.62E+05 0.00E+00 0.00E+00 4.63E+02 1.70E+03 3.10E+03 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+0J 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
1.29E+02 3.23E+04 0.00E+00 0.00E+00 2.83E+01 7.68E+01 1.71E+02 0.00E+00 TC:n:
1.05E+02 1.73E+04 0.00E+00 0.00E+00 2.25E+01 5.71E+01 1.47E+02 0.00E+00 Child:
1.60E+02 8.50E+03 0.00E+00 0.00E+00 2.43E+01 8.90E+01 1.62E+02 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
5.20E+02 1.31E+05 0.00E+00 0.00E+00 1.15E+02 3.11E+02 6.91E+02 0.00E+00 Tcen:
9.09E+02 1.53E+05 0.00E+00 0.00E+00 1.99E+02 5.05E+02 1.30E+03 0.00E+00 Child:
1.85E+03 9.83E+04 0.00E+00 0.00E+00 2.81E+02 1.03E+03 1.88E+03 0.00E+00 Inftnt: 2.94E+03 8.56E+04 0.00E+00 0.00E+00 4.19E+02 1.92E+03 3.73E+03 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
6.24E+01 1.57E+04 0.00E+00 0.00E+00 1.38E+01 3.73E+01 8.29E+01 0.00E+00 TcCn:
1.09E+02 1.83E+04 0.00E+00 0.00E+00 2.39E+01 6.06E+01 1.56E+02 0.00E+00 l
Child:
2.22E+02 1.18E+04 0.00E+00 0.00E+00 3.37E+01 1.23E+02 2.25E+02 0.00E 00 Infant: 3.52E+02 1.03E+04 0.00E+00 0.00E+00 5.02E+01 2.30E+02 4.47E+02 0.00E+00 l
For Pathway: Inhalation T. BODY GI-TRACT BCNE LIVER KIDNEY THYROID LUNG SKIN Adult:
3.17E+00 1.05E+02 0.00E+00 0.00E+00 7.23E-01 1.89E+00 4.56E+02 0.00E+00 Tecn:
4.29E+00 9.51E+01 0.00E+00 0.00E+00 9.74E-01 2.38E+00 6.64E+02 0.00E+00 Child:
4.89E400 3.44E+01 0.00E+00 0.00E+00 7.71E-01 2.71E+00 5.38E+02 0.00E+00 Infcnt: 2.84E+00 1.13E+01 0.00E+00 0.00E+00 4.19E-01 1.82E+00 4.07E+02 0.00E+00 l
I t
I t
f                                                         f i                                                         !
f f
i


1 ODCM'Rsv. 17 Page 124 11/95 Table 2-2 (Continued)                                       I INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Mn54                           I For Pathway: Plume T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID   LUNG   SKIN             '
1 ODCM'Rsv. 17 Page 124 11/95 Table 2-2 (Continued)
Adult:   0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00           '
I INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Mn54 I
Tacn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
-Child:   0.00E+00 0.00E+00 0.00E+00 0.00Fp00 0.00E+00 0.00E+00 0.00E+00 0.00E+00           r Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E&OO 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground                                                                         !
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn:
T. BODY GI-TRACT   BONE   LIVER   KIDNEY   THYROID   LUNG   SKIN Adult: '4.23E+07 4.23E+07 4.23E+07 4'.23E+07 4.23E+07 4.23E+07 4.23E+07 4.96E+07           i Tstn:     4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.96E+07 Child:   4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.96E+07 Infcnt: 4.23E+07 4.23E+07 4.23E+07 4.23E+01 4.23E+07 4.23E+07 4.23E+07 4.96E+07             ,
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
For Pathway: Vegetable T. BODY GI-TRACT   BONE   LIVER   KIDNEY   THYROID   LUNG   SKIN Adult:   1.61E+06 2.58E+07 0.00E+00 8.43E+06 2.51E+06 0.00E+00 0.00E+00 0.00E+00 Tcan:     2.53E+06 2.61E+07 0.00E+00 1.27E+07 3.80E+06 0.00E+00 0.00E+00 0.00E+00.         -
-Child:
Child:   5.03E+06 1.59E+07 0.00E+C0 1.89E+07 5.30E+06 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Fathway: Meat                                                                             i T. BODY. GI-TRACT   BONE   LIVER   KIDNEY   THYROID   LUNG   SKIN Adult:   3.21E+04 5'.16E+05 0.00E+00 1.68E+05 5.01E+04 0.00E+00 0.00E+00 0.00E+00 Tcen:     2.55E+04 2.63E+05 0.00E+00 1.28E+05 3.83E+04 0.00E+00 0.00E+00 0.00E+00 Child:   3.91E+04 1.23E+05 0.00E+00 1.47E+05 4.12E+04 0.00E+00 0.00E+00 0.00E+00           !
0.00E+00 0.00E+00 0.00E+00 0.00Fp00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 r
Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00             i For Pathway: Cow Milk                                                                       ,
Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E&OO 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: '4.23E+07 4.23E+07 4.23E+07 4'.23E+07 4.23E+07 4.23E+07 4.23E+07 4.96E+07 i
T. BODY GI-TRACT   BONE   LIVER   KIDNEY   THYROID   LUNG   SKIN             '
Tstn:
Adult:   2.94E+04 4.73E+05 0.00E+00 1.54E+05 4.59E+04 0.00E+00 0.00E+00 0.00E+00 Tonn:     5.10E+04 5.27E+05 0.00E+00 2.57E+05 7.67E+04 0.00E+00 0.00E+00 0.00E+00         1 Child:   1.02E+05 3.23E+05 0.00E+00 3.85E+05 1.08E+05 0.00E+00 0.00E+00 0.00E+00 Infant: 1.62E+05 2.63E+05 0.00E+00 7.15E+05 1.59E+05 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT   BONE   LIVER   KIDNEY   THYROID   LUNG   SKIN Adult:   3.53E+03 5.67E+04 0.00E+00 1.85E+04 5.51E+03 0.00E+00 0.00E+00 0.00E+00 Tecn:     6.12E+03 6.33E+04 0.00E+00 3.09E+04 9.20E+03 0.00E+00 0.00E+00 0.00E+00 Child:   1.23E+04 3.87E+04 0.00E+00 4.62E+04 1.29E+04 0.00E+00 0.00E+00 0.00E+00 Infant: 1.95E+04 3.15E+04 0.00E+00 8.58E+04 1.90E+04 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT   BONE   LIVER   KIDNEY   THYROID   LUNG   SKIN Adult: 2.00E+02 2.45E+03 0.00E+00 1.26E+03 3.12E+02 0.00E+00 4.44E+04 0.00E+00 Teen:     2.66E+02 2.12E+03 0.00E+00 1.62E+03 4.03E+02 0.00E+00 6.29E+04 0.00E+00 Child:   3.01E+02 7.26E+02 0.00E+00 1.36E+03 3.18E+02 0.00E+00 5.00E+04 0.00E+00           ;
4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.96E+07 Child:
Infcnt: 1.58E+02 2.24E+02 0.00E+00 8.03E 02t 1.58E+02 0.00E+00 3.17E+04 0.00E+00 i
4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.96E+07 Infcnt: 4.23E+07 4.23E+07 4.23E+07 4.23E+01 4.23E+07 4.23E+07 4.23E+07 4.96E+07 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
1.61E+06 2.58E+07 0.00E+00 8.43E+06 2.51E+06 0.00E+00 0.00E+00 0.00E+00 Tcan:
2.53E+06 2.61E+07 0.00E+00 1.27E+07 3.80E+06 0.00E+00 0.00E+00 0.00E+00.
Child:
5.03E+06 1.59E+07 0.00E+C0 1.89E+07 5.30E+06 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Fathway: Meat i
T. BODY. GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
3.21E+04 5'.16E+05 0.00E+00 1.68E+05 5.01E+04 0.00E+00 0.00E+00 0.00E+00 Tcen:
2.55E+04 2.63E+05 0.00E+00 1.28E+05 3.83E+04 0.00E+00 0.00E+00 0.00E+00 Child:
3.91E+04 1.23E+05 0.00E+00 1.47E+05 4.12E+04 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
2.94E+04 4.73E+05 0.00E+00 1.54E+05 4.59E+04 0.00E+00 0.00E+00 0.00E+00 Tonn:
5.10E+04 5.27E+05 0.00E+00 2.57E+05 7.67E+04 0.00E+00 0.00E+00 0.00E+00 1
Child:
1.02E+05 3.23E+05 0.00E+00 3.85E+05 1.08E+05 0.00E+00 0.00E+00 0.00E+00 Infant: 1.62E+05 2.63E+05 0.00E+00 7.15E+05 1.59E+05 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
3.53E+03 5.67E+04 0.00E+00 1.85E+04 5.51E+03 0.00E+00 0.00E+00 0.00E+00 Tecn:
6.12E+03 6.33E+04 0.00E+00 3.09E+04 9.20E+03 0.00E+00 0.00E+00 0.00E+00 Child:
1.23E+04 3.87E+04 0.00E+00 4.62E+04 1.29E+04 0.00E+00 0.00E+00 0.00E+00 Infant: 1.95E+04 3.15E+04 0.00E+00 8.58E+04 1.90E+04 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
2.00E+02 2.45E+03 0.00E+00 1.26E+03 3.12E+02 0.00E+00 4.44E+04 0.00E+00 Teen:
2.66E+02 2.12E+03 0.00E+00 1.62E+03 4.03E+02 0.00E+00 6.29E+04 0.00E+00 Child:
3.01E+02 7.26E+02 0.00E+00 1.36E+03 3.18E+02 0.00E+00 5.00E+04 0.00E+00 Infcnt: 1.58E+02 2.24E+02 0.00E+00 8.03E 02 1.58E+02 0.00E+00 3.17E+04 0.00E+00 t
i


t               }
t
}
[
[
ODCM R3v. 17
ODCM R3v. 17
                                                                                  ?cga 125 11/95 l
?cga 125 11/95 l
r Table 2-2 (Continued)
r Table 2-2 (Continued)
, INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: CoS8 lFor PEthway: Plume                                                                         i T. BODY GI-TRACT   BONE     LIVER     KIDNEY   THYROID     LUNG     SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
, INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: CoS8 lFor PEthway: Plume i
! Tacn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
! Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00M+00 0.00E+00 0.00E+00 0.00E+00           >
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
For Pathway: Ground T. BODY GI-TRACT   BONE     LIVER     KIDNEY THYROID       LUNG     SKIN   !
! Tacn:
l Adult:     1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07       '
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
;Tacn:       1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 Child:     1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 l Infant: 1.16E+ 07 1.16E+07 1.16E+ 07 1.16E+ 07 1.16E+ 07 1.16E+ :17 1.16E+ 0 7 1.16E+ 0 7 l For Pathway: Vegetable                                                                   i
! Child:
:              T. BODY GI-TRACT   BONE     LIVER     KIDNEY   THYROID     LUNG       SKIN l Adult:     1.76E+06 1.59E+07 0.00E+00 7.85E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00M+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult:
'Tecn:       2.72E+06.1.63E+07 0.00E+00 1.18E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00       =
1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07
l Child: 5.43E+06 1.04E+07 0.00E+00 1.77E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00
;Tacn:
'Infent: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00             l 1
1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 Child:
For Pathway: Meat                                                             '
1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 l Infant: 1.16E+ 07 1.16E+07 1.16E+ 07 1.16E+ 07 1.16E+ 07 1.16E+ :17 1.16E+ 0 7 1.16E+ 0 7 l
T. BODY GI-TRACT   BONE     LIVER     KIDNEY   THYROID     LUNG       SKIN     j l Adult:     7.30E+05 6.60E+06 0.00E+00 3.26E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00       ;
For Pathway: Vegetable i
TcOn:     5.79E+05 3.46E+06 0.00E+00 2.51E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00         !
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult:
Child:     8.98E+05 1.71E+06 0.00E+00 2.93E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00         )
1.76E+06 1.59E+07 0.00E+00 7.85E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00
'Tecn:
2.72E+06.1.63E+07 0.00E+00 1.18E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00
=
l Child:
5.43E+06 1.04E+07 0.00E+00 1.77E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00
'Infent: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1
For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN j
l Adult:
7.30E+05 6.60E+06 0.00E+00 3.26E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TcOn:
5.79E+05 3.46E+06 0.00E+00 2.51E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
8.98E+05 1.71E+06 0.00E+00 2.93E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00
)
lInfcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E*00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
lInfcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E*00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
'For Pothway: Cow Milk               '
'For Pothway: Cow Milk l
l              T. BODY GI-TRACT   BONE     LIVER     KIDNEY YHYROID       LUNG       SKIN
T. BODY GI-TRACT BONE LIVER KIDNEY YHYROID LUNG SKIN
; Adult:     1.89E+05 1.71E+06 0.00E+00 8.42E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 lTecn:       3.27E+05 1.95E+06 0.00E+00 1.42E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00
; Adult:
: Child:     6.63E+05 1.26E+06 0.00E+00 2.17E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00
1.89E+05 1.71E+06 0.00E+00 8.42E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 lTecn:
! Infant: 1.08E+05 1.08E+06 0.00E+00 4.33E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID       LUNG       SKIN l Adult:     2.26E+04 2.05E+05 0.00E+00 1.01E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Toen:     -3.92E+04 2.35E+05 0.00E+00 1.70E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     7.96E+04 1.52E+0E 0.00E+00 2.60E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 1.30E+05 1.30E+05 0.00E+00 5.20E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT   BONE   LIVER     KIDNEY   THYROID     LUNG     SKIN Adult:     6.57E+01 3.37E+03 0.00E+00 5.02E+01 0.00E+00 0.00E+00 2.94E+04 0.00E+00
3.27E+05 1.95E+06 0.00E+00 1.42E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
; Tcan:       8.80E+01 3.02E?O3 0.00E+00 6.57E+01 0.00E+00 0.00E+00 4.26E+04 0.00E+00 Child:     1.00E+02 1.09E+03 0.00E+00 5.62E+01 0.00E+00 0.00E+00 3.51E+04 0.00E+00 Infant: 5.77E+01 3.53E+02 0.00E+00 3.87E+01 0.00E+00 0.00E+00 2.46E+04 0.00E+00
6.63E+05 1.26E+06 0.00E+00 2.17E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00
! Infant: 1.08E+05 1.08E+06 0.00E+00 4.33E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult:
2.26E+04 2.05E+05 0.00E+00 1.01E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Toen:
-3.92E+04 2.35E+05 0.00E+00 1.70E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
7.96E+04 1.52E+0E 0.00E+00 2.60E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 1.30E+05 1.30E+05 0.00E+00 5.20E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
6.57E+01 3.37E+03 0.00E+00 5.02E+01 0.00E+00 0.00E+00 2.94E+04 0.00E+00
; Tcan:
8.80E+01 3.02E?O3 0.00E+00 6.57E+01 0.00E+00 0.00E+00 4.26E+04 0.00E+00 Child:
1.00E+02 1.09E+03 0.00E+00 5.62E+01 0.00E+00 0.00E+00 3.51E+04 0.00E+00 Infant: 5.77E+01 3.53E+02 0.00E+00 3.87E+01 0.00E+00 0.00E+00 2.46E+04 0.00E+00


ODCM R;v. 17' Page 126   ;
ODCM R;v. 17' Page 126 11/95 Table 2-2 (Continued)
11/95   ;
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Fe59 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
Table 2-2 (Continued)
0.00E+0C 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tccn:
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Fe59 For Pathway: Plume T. BODY GI-TRACT     BONE     LIVER   KIDNEY THYROID       LUNG     SKIN Adult: 0.00E+0C 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tccn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0 00E+00 0.00E+00 0.00E+00 Child:   0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.0CE+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT     BONE 4  LIVER   KIDNEY THYROID       LUNG       SKIN Adult:   8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 9.80E+06 Tcen:     8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 9.80E+06 Child:   8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 9.80E+06
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0 00E+00 0.00E+00 0.00E+00 Child:
.nfcnt: 8.34E+06 8.34E+06 E.34E+06 8.34E+06 8.34Et06 8.34E+06 8.34E+06 9.80E+06 For Pathway: Vegetable T. BODY GI-TRACT     BONE     LIVER   KIDNEY   THYROID     LUNG       SKIN Adult:   2.80E @6 2.43E+07 3.11E+06 7.30E+06 0.00E+00 0.00E+00 2.04E+06 0.00E+00 Tcen:     4.28E+p6 2.62E+07 4.75E+06 1.11E+07 0.00E+00 0.00E+00 3.50E+06 0.00E+00 Child:   8.69E+06 1.32E+07 1.08E+07 1.76E+07 0.00E+00 0.00E+00 5.06E+06 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 s
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.0CE+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 4
For Pathway: Meat T . BOD'I GI-TRACT . BONE     LIVER   KIDNEY   THYROID     LUNG       SKIN Adult:   4.29E+06 3.73E+07 4.76E+06 1.12E+07 0.00E+00 0.00E+00 3.12E+06 0.00E+00 Tecn:     3.43E+06 2.10E+07 8.87E+06 8.87E+06 0.00E+00 0.00E+00 2.80E+06 0.00E+00           -
Adult:
Child:   5.43E406 1.14E+07 6.74E+06 1.09E+07 0.00E+00 0.00E+00 3.16E+06 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E'+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT     BONE     LIVER   KIDNEY THYROID       LUNG       SIIN Adult: 4.79E+6b 4.17E+06 5.32E+05 1.25E+06 0.00E+00 0.00E+00 3.49E+05 0.00E+00 Tsen:     8.37E+05 5.12E+06 9.28E+05 2.17E+06 0.00E+00 0.00E+00 6.83E+05 0.00E+00 Child:   1.74E+06 3.63E+06 2.15E+06 3.48E+C6 0.00E+00 0.00E+00 1.01E+06 0.00E+00 Infcnt: 2.77E+06 3.35E+06 4.02E+06 7.02E+06 0.00E+00 0.00E+00 2.07E+06 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT     BONE     LIVER   KIDNEY   THYROID   LUNG       SKIN Adult:   6.23E+03 5.42E+04 6.91E+03 1.63E+04 0.00E+00 0.00E+00 4.54E+03 0.00E+00 Tcan:     1.09E+04 6.66E+04 1.21E+04 2.82E+04 0.00E+00 0.00E+00 8.88E+03 0.00E+00 Child:   2.26E+04 4.71E+04 2.80E+04 4.53E+04 0.00E+00 0.00E+00 1.31E+04 0.00E+00 Infant: 3.60E+04 4.36E+04 5.22E+04 9.12E+04 0.00E+00 0.00E+00 2.70E+04 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT     BONE     LIVER   KIDNEY   THYROID   LUNG       SKIN Adult:   3.35E+02 5.96E+03 3.73E+02 8.80E+02 0.00E+00 0.00E+00 3.22E+04 0.00E+00 Tecn:     4.54E+02 5.66E+03 5.05E+02 1.17E+03 0.00E+00 0.00E+00 4.84E+04 0.00E+00 Child:   5. 29E+02 2.24E+03 6. 56E+02 :1. 06E+03 0. 00E +00 0. 00E+00, 4. 02E+04 0.00E+00. ,
8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 9.80E+06 Tcen:
8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 9.80E+06 Child:
8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 9.80E+06
.nfcnt: 8.34E+06 8.34E+06 E.34E+06 8.34E+06 8.34Et06 8.34E+06 8.34E+06 9.80E+06 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
2.80E @6 2.43E+07 3.11E+06 7.30E+06 0.00E+00 0.00E+00 2.04E+06 0.00E+00 Tcen:
4.28E+p6 2.62E+07 4.75E+06 1.11E+07 0.00E+00 0.00E+00 3.50E+06 0.00E+00 Child:
8.69E+06 1.32E+07 1.08E+07 1.76E+07 0.00E+00 0.00E+00 5.06E+06 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 s
For Pathway: Meat T. BOD'I GI-TRACT. BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
4.29E+06 3.73E+07 4.76E+06 1.12E+07 0.00E+00 0.00E+00 3.12E+06 0.00E+00 Tecn:
3.43E+06 2.10E+07 8.87E+06 8.87E+06 0.00E+00 0.00E+00 2.80E+06 0.00E+00 Child:
5.43E406 1.14E+07 6.74E+06 1.09E+07 0.00E+00 0.00E+00 3.16E+06 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E'+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SIIN Adult:
4.79E+6b 4.17E+06 5.32E+05 1.25E+06 0.00E+00 0.00E+00 3.49E+05 0.00E+00 Tsen:
8.37E+05 5.12E+06 9.28E+05 2.17E+06 0.00E+00 0.00E+00 6.83E+05 0.00E+00 Child:
1.74E+06 3.63E+06 2.15E+06 3.48E+C6 0.00E+00 0.00E+00 1.01E+06 0.00E+00 Infcnt: 2.77E+06 3.35E+06 4.02E+06 7.02E+06 0.00E+00 0.00E+00 2.07E+06 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
6.23E+03 5.42E+04 6.91E+03 1.63E+04 0.00E+00 0.00E+00 4.54E+03 0.00E+00 Tcan:
1.09E+04 6.66E+04 1.21E+04 2.82E+04 0.00E+00 0.00E+00 8.88E+03 0.00E+00 Child:
2.26E+04 4.71E+04 2.80E+04 4.53E+04 0.00E+00 0.00E+00 1.31E+04 0.00E+00 Infant: 3.60E+04 4.36E+04 5.22E+04 9.12E+04 0.00E+00 0.00E+00 2.70E+04 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
3.35E+02 5.96E+03 3.73E+02 8.80E+02 0.00E+00 0.00E+00 3.22E+04 0.00E+00 Tecn:
4.54E+02 5.66E+03 5.05E+02 1.17E+03 0.00E+00 0.00E+00 4.84E+04 0.00E+00 Child:
: 5. 29E+02 2.24E+03 6. 56E+02 :1. 06E+03 0. 00E +00 0. 00E+00, 4. 02E+04 0.00E+00.
Infant: 3.00E+02 7.86E+02 4.30E+02 7.46E+02 0.00E+00 0.00E+00 3.22E+04 0.00E+00 0
Infant: 3.00E+02 7.86E+02 4.30E+02 7.46E+02 0.00E+00 0.00E+00 3.22E+04 0.00E+00 0


ODCM'Rsv. 17             I Paga 127             l l                                                                             11/95 i
ODCM'Rsv. 17 I
Table 2-2 (Continued)                                                 -
Paga 127 l
  -INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOP : Co60 i
l 11/95 i
  'For Pathway: Plume                                                                                       '
Table 2-2 (Continued)
T. BODY GI-TRACT     BONE           LIVER     KIDNEY   THYROID LUNG     SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                     l Tann:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.003+00 0.00E+00 0.00E+00                     !
-INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOP : Co60 i
Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT     BONE           LIVER     KIDNEY   THYROID LUNG     SKIN Adult:     7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 8.34E+08                     '
'For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
Tecn:       7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 8.34E+08 Child:     7.09D+08 7.09E+08 7.09E+08 7.09E+08 7.09E+09 7.09E+08 7.09E+08 8.34E+08                     i Infcnt: 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 8.34E+08 i
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
For Pathway: Vegetable                                                                                   .
Tann:
T. BODY GI-TRACT     BONE           LIVER     KIDNEY THYROID   LUNG     SKIN Adult: 1.02E+07 8.68E+07 0.00E+00 4.62E+06 0.00E+00 3 00E+00 0.00E+00 0.00E+00                           .
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.003+00 0.00E+00 0.00E+00 Child:
Tocn:       1.61E+07 9.29E+07 0.00E+00 7.13E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     3.24E+07 6.08E+07 0.00E+00 1.10E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                         i f
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
For Pathway: Me at                                                                                       !
7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 8.34E+08 Tecn:
T. BODY GI-TRACT     BONE           LIVER     KIDNEY   THYROID L'JNG   SKIH                 1 Adult:     3.11E+06 2.65E+07 0.00E+00 1.41E+06 0.00E+00 0 00E+00 0.00E+00 0.00E+00                       i Tsen:       2.46E+06 1.42E+07 0'.00E+00 1.09E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00                     :
7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 8.34E+08 Child:
Child:      3.83E+06 7.19E+06 0.00E+00 1.30E+06 0.00E+00 0.00E+00 0.00E+00'O 00E+00                       l Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT     BONE           LIVER     KIDNEY   THYROID LUNG     SKIN Adult:     6.78E+05 5.77E+06 0.00E+00 3.07E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tson:       1.17E+06 6.78E+06 0.00E+00 5.21E+05 0.00E+00 0.00F300 0.00E+00 0.00E+00 l   Child:     2.38E+06 4.48E+06 0.00E+00 8.09E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 3.90E+06 3.93E+06 0.00E+00 1.65E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT     BONE           LIVER     KIDNEY THYROID   LUNG     SKIN Adult: 8.13E+04 6.93E+05 0.00E+00 3.69E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00                             i Tecn:       1.41E+05 8.14E+05 0.00E+00 6.25E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     2.86E+05 5.37E+05 0.00E+00 9.70E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1   Infant: 4.68E+05 4.71E+05 0.00E+00 1.98E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I
7.09D+08 7.09E+08 7.09E+08 7.09E+08 7.09E+09 7.09E+08 7.09E+08 8.34E+08 i
For Pathway: Inhalation T. BODY GI-TRACT     BONE           LIVER     KIDNEY   THYROID LUNG     SKIN Adult:     4.69E+02 9.03E+03 0.00E+00 3.65E+02 0.00E+00 0.00E+00 1.89E+05 0.00S+00 Tecn:       6.29E+02 8.22E+03 0.00E+00 4.79E+02 0.00E+00 0.00E+00 2.76E+05 0.00E+00 Child:     7.18E+02 3.05E+03 0.00E+00 4.16E+02 0.00E+00 0.00E+00 2.24E+05 0.00E+00 l   Infant: 3.73E+02 1.01E+03 0.00E+00 3.54E+02 0.00E+00 0.00E+00 1.43E+05 0.00E+00 l
Infcnt: 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 8.34E+08 i
For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
1.02E+07 8.68E+07 0.00E+00 4.62E+06 0.00E+00 3 00E+00 0.00E+00 0.00E+00 Tocn:
1.61E+07 9.29E+07 0.00E+00 7.13E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
3.24E+07 6.08E+07 0.00E+00 1.10E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
f' For Pathway: Me at T. BODY GI-TRACT BONE LIVER KIDNEY THYROID L'JNG SKIH 1
Adult:
3.11E+06 2.65E+07 0.00E+00 1.41E+06 0.00E+00 0 00E+00 0.00E+00 0.00E+00 i
Tsen:
2.46E+06 1.42E+07 0'.00E+00 1.09E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
3.83E+06 7.19E+06 0.00E+00 1.30E+06 0.00E+00 0.00E+00 0.00E+00'O 00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
6.78E+05 5.77E+06 0.00E+00 3.07E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tson:
1.17E+06 6.78E+06 0.00E+00 5.21E+05 0.00E+00 0.00F300 0.00E+00 0.00E+00 l
Child:
2.38E+06 4.48E+06 0.00E+00 8.09E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 3.90E+06 3.93E+06 0.00E+00 1.65E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
8.13E+04 6.93E+05 0.00E+00 3.69E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
Tecn:
1.41E+05 8.14E+05 0.00E+00 6.25E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
2.86E+05 5.37E+05 0.00E+00 9.70E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1
Infant: 4.68E+05 4.71E+05 0.00E+00 1.98E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
4.69E+02 9.03E+03 0.00E+00 3.65E+02 0.00E+00 0.00E+00 1.89E+05 0.00S+00 Tecn:
6.29E+02 8.22E+03 0.00E+00 4.79E+02 0.00E+00 0.00E+00 2.76E+05 0.00E+00 Child:
7.18E+02 3.05E+03 0.00E+00 4.16E+02 0.00E+00 0.00E+00 2.24E+05 0.00E+00 l
Infant: 3.73E+02 1.01E+03 0.00E+00 3.54E+02 0.00E+00 0.00E+00 1.43E+05 0.00E+00 l
l l
l l


k           j ODCM Rnv. 17 Page~128 11/95 Table 2-2 (Continued)
k j
INDIVIDUAL DOSF FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Zn65 For Pathway: Plume
ODCM Rnv. 17 Page~128 11/95 Table 2-2 (Continued)
  ;        T. BODY GI-TRACT     BONE   LIVER     KIDNEY THYROID     LUNG   SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcon:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRLCT     BONE   LIVER     KIDNEY THYROID     LUNG     SKIN Adult:     2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.63E+07 TcAn:     2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.63E+07 Child:     2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.63E+07 Inftnt: 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.63E+07 For Pathway: Vegetable T. BODY GI-TRACT     BONE   LIVER     KIDNEY THYROID     LUNG   SKIN Adult:     1.58E+07 2.20E+07 1.10E+07 3.50E+07 2.34E+07 0.00E+00 0.00E+00 0.00E+00 Tc;n:     2.43E+07 2.25E+07 1.53E+07 5.32E+07 3.40E+07 0.00E+00 0.00E+00 0.00E+00 Child:     4.93E+07 1.39E+07 2.98E+07 7.93E+07 5.00E+07 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 C.00E+00 0.00E+00 For Pathway: Mest         ,
INDIVIDUAL DOSF FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Zn65 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
                                                                                        )
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcon:
T. BODY GI-TRACT     BONE   LIVER     KIDNEY THYROID     LUNG   SKIN   '
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
Adult:     1.08E+07 1.50E+07 7.50E+06 2.39E+07 1.60E+07 0.00E400 0.00E+00 0.00E+00 Tcen:     8.54E+06 7.75E+06 5.27E+06 1.33E+07 1.17E+07 0.00E+00 0.00E+00 0.00E+00 Child:     1.31E+07 3.70E+06 7.91E+06 2.11E+07 1.33E+07 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT     BONE   LIVER     KIDNEY THYROID     LUNG   SKIN   l Adult:     4.15E+07 5.79E+07 2. 89E+07 9.20E+07 6.15E+07 0. 00E+00 0. 00E+00 0. 01)E+00 !
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRLCT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
Tecn:     7.19E+07 6.63E+07 4.44E+07 1.54E+08 9.86E+07 0.00E+00 0.00E+00 0.00E+00 Child:     1.44E+08 4.07E+07 8.71E+07 2.32E+08 1.46E+08 0.00E+00 0.00E+00 0.00E+00 Infcnt: 1.85E+08 3.39E+08 1.17E+08 4.01E+08 1.95E+08 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT     BONE   LIVER     KIDNEY THYROID     LUNG   SKIN Adult:     4.99E+06 6.95E+06 3.47E+06 1.10E+07 7.38E+06 0.00E+00 0.00E+00 0.00E+00 Tctn:     8.63E+06 7.83E+06 5.33E+06 1.83E+07 1.18E+07 0.00E+00 0.00E+00 0.00E+00 Child:     1.73E+07 4.89E+06 1.05E+07 2.78E+07 1.75E+07 0.00E+00 0.00E+00 0.00E+00 Infant: 2.22E+07 4.07E+07 1.40E+07 4.810+07 2.33E+07 0.00E+00 0.00E+00 0.00E+00 For Pa.thway: Inhalation T. BODY GI-TRACT     BONE   LIVER     KIDNEY THYROID     LUNG     SKIN Adult:     1.43E+08 1.69E+03 1.03E+03 3.27E+03 2.19E+03 0.00E+00 0.00E+00 0.00E+00 Tacn:     1.93E+08 1.48E+03 1.22E+03 4.24E+03 2.74E+03 0.00E+00 0.00E+00 0.00E+00 Child:     2.23E+03 5.17E+02 1.35E+03 3.59E+03 2.26E+03 0.00E+00 0.00E+00 0.00E+00 Infant: 9.85E+02 1.63E+03 6.12E+02 1.98E+03 1.03E+03 0.00E+00 0.00E+00 0.00E+00
2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.63E+07 TcAn:
2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.63E+07 Child:
2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.63E+07 Inftnt: 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.63E+07 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
1.58E+07 2.20E+07 1.10E+07 3.50E+07 2.34E+07 0.00E+00 0.00E+00 0.00E+00 Tc;n:
2.43E+07 2.25E+07 1.53E+07 5.32E+07 3.40E+07 0.00E+00 0.00E+00 0.00E+00 Child:
4.93E+07 1.39E+07 2.98E+07 7.93E+07 5.00E+07 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 C.00E+00 0.00E+00 For Pathway: Mest
)
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
1.08E+07 1.50E+07 7.50E+06 2.39E+07 1.60E+07 0.00E400 0.00E+00 0.00E+00 Tcen:
8.54E+06 7.75E+06 5.27E+06 1.33E+07 1.17E+07 0.00E+00 0.00E+00 0.00E+00 Child:
1.31E+07 3.70E+06 7.91E+06 2.11E+07 1.33E+07 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
4.15E+07 5.79E+07 2. 89E+07 9.20E+07 6.15E+07 0. 00E+00 0. 00E+00 0. 01)E+00 Tecn:
7.19E+07 6.63E+07 4.44E+07 1.54E+08 9.86E+07 0.00E+00 0.00E+00 0.00E+00 Child:
1.44E+08 4.07E+07 8.71E+07 2.32E+08 1.46E+08 0.00E+00 0.00E+00 0.00E+00 Infcnt: 1.85E+08 3.39E+08 1.17E+08 4.01E+08 1.95E+08 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
4.99E+06 6.95E+06 3.47E+06 1.10E+07 7.38E+06 0.00E+00 0.00E+00 0.00E+00 Tctn:
8.63E+06 7.83E+06 5.33E+06 1.83E+07 1.18E+07 0.00E+00 0.00E+00 0.00E+00 Child:
1.73E+07 4.89E+06 1.05E+07 2.78E+07 1.75E+07 0.00E+00 0.00E+00 0.00E+00 Infant: 2.22E+07 4.07E+07 1.40E+07 4.810+07 2.33E+07 0.00E+00 0.00E+00 0.00E+00 For Pa.thway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
1.43E+08 1.69E+03 1.03E+03 3.27E+03 2.19E+03 0.00E+00 0.00E+00 0.00E+00 Tacn:
1.93E+08 1.48E+03 1.22E+03 4.24E+03 2.74E+03 0.00E+00 0.00E+00 0.00E+00 Child:
2.23E+03 5.17E+02 1.35E+03 3.59E+03 2.26E+03 0.00E+00 0.00E+00 0.00E+00 Infant: 9.85E+02 1.63E+03 6.12E+02 1.98E+03 1.03E+03 0.00E+00 0.00E+00 0.00E+00


l ODCM R v. 17 Pcga 129 11/95 Table 2-2 (Continued) l INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:       Kr83m For Pathway: Plume T. BODY GI-TRACT   BONE     LIVER   KIDNEY THYROID   LUNG   SKIN
l ODCM R v. 17 Pcga 129 11/95 Table 2-2 (Continued) l INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:
;    Adult:     1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.39E-02 4.75E-01 Torn:     1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.39E-02 4.75E-01 i
Kr83m For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
Child:    1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.39E-02 4.75E-01 Inftnt: 1.69E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.39E-02 4.75E-01 For Pathway: Ground l
1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.39E-02 4.75E-01 Torn:
T. BODY GI-TRACT  BONE      LIVER    KIDNEY THYROID    LUNG    SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tccn:      0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:    0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT    BONE    LIVER    KIDNEY THYROID    LUNG    SKIN Adult:    0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tren:      0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:    0.00E+00 0.00E+00 0.00E+00 0.00E+D0 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT    BONE    LIVER    KIDNEY THYROID    LUNG    SKIN Adult:    0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcon:      0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:    0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+N0 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk                                                              .
1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.39E-02 4.75E-01 i
T. BODY GI-TRACT    BONE    LIVER    KIDNEY THYROID    LUNG    SKIN Adult:    0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
Toon:      0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
    , Child:    0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milc                                                                l T. BODY GI-TRACT    BONE    LIVER    KIDNEY THYROID    LUNG    SKIN l    Adult:    0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcen:      0.00E+00 0.00E+00 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l    Child:    0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00      j For Pathway: Inhalation T. BODY GI-TRACT    BONE    LIVER    KIDNEY THYROID    LUNG    SKIN Adult:    0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen:      0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:    0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I
e
 
ODCM Rcv. 17 Page 130 11/95 i
Table 2-2 (Continued)
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:                                Kr85 For Pathway: Plume i
T. BODY GI-TRACT            BONE      LIVER        KIDNEY THYROID              LUNG    SKIN Adult:
Tacn:
3 . 5 7E- 01 3 . 5 7E- 01 3 . 5 7E!- 01 3 . 5 7E- 01 3 . 57E- 01 3 . 5 7E- 01 9 . 5 0E- 01 4 . 2 9E+ 01 ,
Child:
Child:
3.57E-01 3.57E-01 3 52E'-01 3.57E-01 3.57E-01 3.57E-01 9.50E-01 4.29E+01                               '
1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.39E-02 4.75E-01 Inftnt: 1.69E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.39E-02 4.75E-01 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l
3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.S7E-01 3.57E-01 9.50E-01 4.29E+01 Infent: 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 9.50E-01 4.29E+01 For Pathway: Ground T. BODY GI-TRACT             BONE       LIVER       KIDNEY THYROID             LUNG       SKIN Adult:
Adult:
Tacn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tccn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tren:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+D0 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcon:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+N0 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
Toon:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For PEchway: Vegetable T. BODY GI-TRACT            BONE      LIVER        KIDNEY THYROID              LUNG        SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 T;Cn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milc l
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l
Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcen:
0.00E+00 0.00E+00 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
Child:
Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY    GI-TRACT        BONE      LIVER        KIDNEY      THYROID        LUNG        SKIN Adult:      0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:      0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:      0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt:  4 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT            BONE      LIVER        KIDNEY THYROID              LUNG        SKIN      l Adult:      0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tc n:      0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                                ,
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
Child:      0.00F+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                                l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                                     I For Pathway Goat Milk                                                                                              l T. BODY    GI-TRACT        BONE      LIVER        KIDNEY    THYROID          LUNG        SKIN      '
Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 j
Adult:      0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcen:      0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:      0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant:t 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT             BONE       LIVER       KIDNEY     THYROID         LUNG       SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Taea:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00'0.00E+00 0.00E+00 0.00E+00 i
For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I
e


ODCM Rov. 17 P gs 131
ODCM Rcv. 17 Page 130 11/95 Table 2-2 (Continued)
                                                                            ,                11/95 Table 2-2 (Continued)
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:                   KrG5m For Pathway: Plume T. BODY GI-TRACT       BONE     LIVER     KIDNEY THYROID         LUNG     SKIN Adult:     2.60E+01 2.60E+01 2:60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.66E+01 Tenn:       2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.66E+01 Child:     2. 60E+ 01 2. 60E+01 2. 60E +01 2. 6 0E+ 01 2. 6 0E+01 2. 6 0E+01 2. 6 6E+01 7. 66E+01 Infcnt: 2.60E+01 2.60E&01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.66E+01 For Pathway: Ground T. BODY GI-TRACT       BONE     LIVER     KIDNEY   THYROID       LUNG     SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                     '
Kr85 For Pathway: Plume i
Tc;n:      0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 InfRnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT       BONE     LIVER     KIDNEY THYROID         LUNG     SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT       BONE     LIVER     KIDNEY THYROID         LUNG     SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen:       0.00E+00 0.00E+00 0.70E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                   )
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
For Pat hway: Cow Milk                                                                             l T. BODY GI-TRACT       BONE     LIVER     KIDNEY iTHYROID        LUNG     SKIN     I Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E400 0.00E+00 0.00E+00 TcEn:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT       BONE     LIVER     KI7NEY THYROID         LUNG     SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.0iE+00 0.0dE+00 0.00E+00 0.00E+00 Tenn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+0V Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I
3. 5 7E- 01 3. 5 7E- 01 3. 5 7E!- 01 3. 5 7E- 01 3. 57E- 01 3. 5 7E- 01 9. 5 0E- 01 4. 2 9E+ 01 Tacn:
For Pathway: Inhalation i  T. BODY GI-TRACT       10NE      LIVER     KIDNEY   THYROID   . LUNG       SKIN Adult:     0.00E+00 0.00E+00 0 00E+00 0.00E+00 0.00E+00 0.00E+00 J.00E+00 0.00E+00 Tecn:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
3.57E-01 3.57E-01 3 52E'-01 3.57E-01 3.57E-01 3.57E-01 9.50E-01 4.29E+01 Child:
3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.S7E-01 3.57E-01 9.50E-01 4.29E+01 Infent: 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 9.50E-01 4.29E+01 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For PEchway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 T;Cn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 4
For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tc n:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00F+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway Goat Milk l
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcen:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 t
For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Taea:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00'0.00E+00 0.00E+00 0.00E+00 i


fr          ODCM RGv. 17
ODCM Rov. 17 P gs 131 11/95 Table 2-2 (Continued)
                                                              \*              Page 132 11/95 .
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:
l Table 2-2 (Continued)
KrG5m For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUJFfS -- FOR ISOTOPE:       Kr8'J.
2.60E+01 2.60E+01 2:60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.66E+01 Tenn:
For Pathway: Plume T. BODY GI-TRACT   BONE     LIVER   KIDNEY THYROID     LUNG     SKIN Adult: 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.35E+02 4.60E+02          :
2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.66E+01 Child:
Tcen:      1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.35E+02 4.60E+02      ,
: 2. 60E+ 01 2. 60E+01 2. 60E +01 2. 6 0E+ 01 2. 6 0E+01 2. 6 0E+01 2. 6 6E+01 7. 66E+01 Infcnt: 2.60E+01 2.60E&01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.66E+01 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
Child:     1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.35E+02 4.60E+02 Infant: 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.35E+02 4.60E+02 For Pathway: Ground T. BODY GI-TRACT   BONE     LIVER   KIDNEY THYROID     LUNG     SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00     i 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E&OO 0.00E+00 0.00E+00 0.00E+00 Tcon:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tc;n:
Child:    0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E,00 0.00E+00 0.00E+00 0.00E+00 InfEnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable                                                     -
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
T. BODY GI-TRACT   BONE     LIVER   KIDNEY THYROID     LUNG     SKIN   :
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 InfRnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00'E+00 0.00E+00 Tccn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E400 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00         '
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:
For Pathway: Meat                                                                       ;
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
T. BODY GI-TRACT   BONE     LIVER   KIDNEY THYROID     LUNG     SKIN   2 Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tscn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00     ;
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00         '
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen:
For Pathway: Cow Milk T. BODY GI-TRACT   BONE     LIVER   KIDNEY THYROID      LUNG     SKIN   j Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00     i Tacn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT   BONE     LIVER   KIDNEY THYROIE  g  LUNG     SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00     i Tecn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00       l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation                                                                   !
0.00E+00 0.00E+00 0.70E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
T. BODY GI-TRACT   BONE      LIVER   KIDNEY THYROID     LUNG     SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen:     0.00Et00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:    0.00EE00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00         ,
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
1
)
                                        .f
For Pat hway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY iTHYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E400 0.00E+00 0.00E+00 TcEn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KI7NEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.0iE+00 0.0dE+00 0.00E+00 0.00E+00 Tenn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+0V Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I
For Pathway: Inhalation i
T. BODY GI-TRACT 10NE LIVER KIDNEY THYROID
. LUNG SKIN Adult:
0.00E+00 0.00E+00 0 00E+00 0.00E+00 0.00E+00 0.00E+00 J.00E+00 0.00E+00 Tecn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
 
fr ODCM RGv. 17
\\*
Page 132 11/95 Table 2-2 (Continued)
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUJFfS -- FOR ISOTOPE:
Kr8'J.
For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.35E+02 4.60E+02 Tcen:
1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.35E+02 4.60E+02 Child:
1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.35E+02 4.60E+02 Infant: 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.35E+02 4.60E+02 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
Tcon:
0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E&OO 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E,00 0.00E+00 0.00E+00 0.00E+00 InfEnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00'E+00 0.00E+00 Tccn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E400 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 2
Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tscn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN j
Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
Tacn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROIE LUNG SKIN g
Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
Tecn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen:
0.00Et00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00EE00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
.f


_-  ~.            - - .-. . . _ - - -              .-      -          -- .
~.
ODCM Rsv, 17 Pcg3 133 11/95 Table 2-2 (Continued)
ODCM Rsv, 17 Pcg3 133 11/95 Table 2-2 (Continued)
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:                     Kr88
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:
                                                                                                            \
Kr88
For Pathway: Plume                                                                                         j T. BODY GI-TRACT BONE   LIVER               KIDNEY THYROID     LUNG   SKIN         :
\\
Adult:      3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.27E+02 4.50E+02                       ;
For Pathway: Plume j
Tacn:       3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.27E+02 4.50E+02                       )
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
Child:     3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.27E+02 4.50E+02                       -
3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.27E+02 4.50E+02 Tacn:
T.nfcnt : 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.27E+02 4.50E+02                         '
3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.27E+02 4.50E+02
For Pathway: Ground                                                                                       i T. BODY GI-TRACT       BONE   LIVER               KIDNEY THYROID     LUNG     SKIN       '
)
Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tocn:
Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                       ;
3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.27E+02 4.50E+02 T.nfcnt : 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.27E+02 4.50E+02 For Pathway: Ground i
Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                         '
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable i
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tocn:
T. BODY GI-TRACT       BONE   LIVER               KIDNEY THYROID     LUNG     SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                           *(
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
Toen:     0.00E+00 0.00E+00 0.00E+00.0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable i
* Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                           !
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
For Pathway: Meat                                                                                         i T. BODY   GI-TRACT     BONE   LIVER               KIDNEY THYROID     LUNG     SKIN
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen:
-Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00'O.00E+00 Tsen:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.03E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                           i For Pathway: Cow Milk                                                                                     l T.. BODY GI-TRACT       BONE   LIVER               KIDNEY THYROID     LUNG     SKIN       !
0.00E+00 0.00E+00 0.00E+00.0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.09E+00 0.00E+00 0.00E+00 0.00E+00                           j Teen:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                         1 Child:     0300E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                       l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                           1 For Pathway: Goat Milk T. BODY GI-TRACT       BONE   LIVER               KIDNEY THYROID     LUNG     SKIN Adult; Toen:      0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+000.00E+00     0.00E+000.00E+00 0.00E+000.00E+00 0.00E+000.00p;+00 0.00.+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT       BONE   LIVER               KIDNEY THYROID     LUNG     SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:   0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+0C 0.00E+00 0.00E+00
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat i
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
-Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00'O.00E+00 Tsen:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.03E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
For Pathway: Cow Milk T.. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.09E+00 0.00E+00 0.00E+00 0.00E+00 j
Teen:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0300E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1
For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult; 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00p;+00 Toen:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00.+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+0C 0.00E+00 0.00E+00


                                              ^
^
i l
i ODCM Rev. 17 Page 134 11/95 Table 2-2 (Continued)
ODCM Rev. 17 Page 134 11/95 Table 2-2 (Continued)
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:     Kr89 For Pathway: Plume T. BODY GI-TRACT   BONE     LIVER   KIDNEY THYROID   LUNG   SKIA Adult:     3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.72E+02 7.46E+02 3 Tc;n:     3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.72E+02 7.46E+02   l Child:     3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.72E+02 7.46E+02 Infcnt: 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68U+02 3.72E+02 7.46E+02 For Pathway: Ground T.EODY G1-TRACT     BONE     LIVER   KIDNEY THYROID   LUNG     SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TCOn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0 00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT   BONE     LIVER   KIDNEY THYROID   LUNG     SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00. 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat                                                                   :
Kr89 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIA Adult:
T. BODY GI-TRACT   BONE     LIVER   KIDNEY THYROID   LUNG     SKIN   '
3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.72E+02 7.46E+02 3
Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TCOn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk                           ,
Tc;n:
T. BODY GI-TRACT   BONE     LIVER   KIDNEY THYROID   LUNG     SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcon:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00F+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E.00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt. 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TLACT   BONE     LIVER   KIDNEY THYROID   LUNG     SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 2hild:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '
3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.72E+02 7.46E+02 l
Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT   BONE     LIVER   KIDNEY THYROID   LUNG     SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tsen:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
Child:
i
3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.72E+02 7.46E+02 Infcnt: 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68U+02 3.72E+02 7.46E+02 For Pathway: Ground T.EODY G1-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
                                      .O
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TCOn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0 00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00. 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TCOn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcon:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00F+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E.00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt. 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TLACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 2hild:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tsen:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
.O


      ,  -  . - . .    -.  ..    ..      ,      -          . . - ~ - . .      - -.        .- .          . . .
.. - ~ -..
I i
I i
l                                                                                                                    l ODCM Rcv. 17 i                                                                                               Paga 135 11/95 Table 2-2 (Continued)
l ODCM Rcv. 17 i
!                                                                                                                    l INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:                       Sr89 l   For Pathway: Plume L                 T,. BODY---GI-TRACT- -BONE -L-IVER       KIDNEY THYROID - - LUNG                 SKIN-~~~~       f
Paga 135 11/95 Table 2-2 (Continued) l INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:
! Adult:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toon:. 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                             '
Sr89 l
Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i   Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                                 j l   For Pathway: Ground T. BODY GI-TRACT       BONE   LIVER     KIDNEY THYROID                 LUNG       SKIN           i
For Pathway: Plume f
    -Adult:     6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02
L T,. BODY---GI-TRACT- -BONE -L-IVER KIDNEY THYROID - - LUNG SKIN-~~~~
,    Tosn:     6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02 L Child: 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02                                     i Infcnt: 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02                                 l For Pathway: Vegetable T. BODY GI-TRACT       BONE   LIVER     KIDNEY THYROID                 LUNG       SKIN           l Adult:     7.42E+06 4.14E+07 2.58E+08 0.00E+00 0.30E+00 0.00E+00 0.00E+00 0.00E+00 Tscn:       1.20E+07 5.00E+d7 4.20E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
! Adult:
,    Child:     2.91E+07 3.95B+07 1.02E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                             ,
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toon:.
l    Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                                 l
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
;    For Pathway: Meat
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
,                  T. BODY   GI-TRACT   BONE   LIVER     KIDNEY         THYROID       LUNG       SKIN l   Adult:i 1.68E+05 9.41E+05 5.86E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l   Toen: : 1.42E+05 5. 90E+05 4. 95E+06 0.00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00                           j l    Childr 2.68E+05 3.63E+05 9.37E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                                   l
Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 j
!, Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E;00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                                     '
l For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i
For Pathway: Cow Milk T. BODY GI-TRACT       BONE   LIVER     KIDNEY         THYROID       LUNG       SKIN 8.09E+05 4.52E+06 2.82E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Adult:
-Adult:
Toen:      1.49E+06 6.19E+06 5.20E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     3.67E+06 4.98E+06 1.29E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l     Infant: 7.02E+06 5.03E+06 2.45E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                               ,
6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02 Tosn:
For Pathway: Goat Milk T. BODY GI-TRACT       BONE   LIVER     KIDNEY THYROID                 LUNG       SKIN Adult:     1.70E+06 9.50E+06 5.92E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02 L Child:
Tecn:     3.13E+06 1.30E+07 1.09E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l     Child:     7.72E+06 1.05E+07 2.70E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                             !
6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02 i
l    Infant: 1.47E+07 1.06E407 5.14E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                               i For Pathway: Inhalation                                                                                       i T. BODY GI-TRACT       BONE     LIVER   KIDNEY           THYROID       LUNG       SKIN           i Adult:     2.76E+02 1.11E+04 9.64E+03 0.00E+00 0.00E+00 0.00E+00 4.44E+04 0.00E+00                             l 3.96E+02 1.18E+04 1.38E+04 0.00E+00 0.00E+00 0.00E+00 7.66E+04 0.00E+00 Toon:
Infcnt: 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02 l
:  Child:    5.47E+02 5.30E+03 1.90E+04 0.00E+00 0.00E+00 0.00E+00 6.84E+04 0.00E+00 Infant: 3.62E+02 2.03E+03 1.26E+04 0.00E+00 0.00E+00 0.00E+00 6.44E+04 0.00E+00
For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
                                                                                                .o
7.42E+06 4.14E+07 2.58E+08 0.00E+00 0.30E+00 0.00E+00 0.00E+00 0.00E+00 Tscn:
1.20E+07 5.00E+d7 4.20E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
2.91E+07 3.95B+07 1.02E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l
Adult:i 1.68E+05 9.41E+05 5.86E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
Toen: : 1.42E+05 5. 90E+05 4. 95E+06 0.00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00 j
Childr 2.68E+05 3.63E+05 9.37E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
!, Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E;00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
8.09E+05 4.52E+06 2.82E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen:
1.49E+06 6.19E+06 5.20E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
3.67E+06 4.98E+06 1.29E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
Infant: 7.02E+06 5.03E+06 2.45E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
1.70E+06 9.50E+06 5.92E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:
3.13E+06 1.30E+07 1.09E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
l Child:
7.72E+06 1.05E+07 2.70E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
Infant: 1.47E+07 1.06E407 5.14E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
For Pathway: Inhalation i
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i
Adult:
2.76E+02 1.11E+04 9.64E+03 0.00E+00 0.00E+00 0.00E+00 4.44E+04 0.00E+00 Toon:
3.96E+02 1.18E+04 1.38E+04 0.00E+00 0.00E+00 0.00E+00 7.66E+04 0.00E+00 Child:
5.47E+02 5.30E+03 1.90E+04 0.00E+00 0.00E+00 0.00E+00 6.84E+04 0.00E+00 Infant: 3.62E+02 2.03E+03 1.26E+04 0.00E+00 0.00E+00 0.00E+00 6.44E+04 0.00E+00
.o


j ODCM Rav. 17     i Page.136     !
j ODCM Rav. 17 i
11/95 o
Page.136 11/95 o
Table 2-2 (Continued)                                           !
Table 2-2 (Continued) i INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:
i INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:                         Kr90                     l k
Kr90 k
  . .For Pathway:_ Plume _                                                           . . _    _ . _
..For Pathway:_ Plume _
l
/
/
        .          T. BODY   GI-TRACT.._ _           ___
T. BODY GI-TRACT.._ _ _ _ _
BONE. LIVER     KIDNEY     THYROID     LUNG     SKIN Adult:     3.46E+02.3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E+02 6.33E+02 Tcon:     3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E/02 6.33E+02                             i Child: 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E+02 6.33E+02                                  .
l BONE.
Inftnt:-3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E+02 6.33E+02                                l 1                                              .
LIVER KIDNEY THYROID LUNG SKIN Adult:
For Pathway: Ground                                                                            .
3.46E+02.3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E+02 6.33E+02 Tcon:
j T. BODY GI-TRACT                BONE    LIVER      KIDNEY    THYROID    LUNG      SKIN        ,
3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E/02 6.33E+02 i
    . Adult:    0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                              I Taan: -0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                                  '
    . Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                                  t
: Infant: 0.00E+00 0.00E+00.0.00Et00.0.%00E.+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable i
T. BODY GI-TRACT                BONE    LIVER      KIDNEY THYROID        LUNG      SKIN        :
Adult:    0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                          -
Tacn:      0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                              ,
Child:    0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E'+00 0.00E+00 0.00E+A0 0.00E+00                            i Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                                ;
For' Pathway: Meat                                                                                            I T. BODY GI-TRACT                BONE    LIVER      KIDNEY    THYROID-    LUNG      SKIN:      I Adult:    0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-Tcsn:
Child:
Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                             (
3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E+02 6.33E+02 Inftnt:-3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E+02 6.33E+02 l
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                             l Infent:'0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+30 0.00E+00 0.00E+00 0.00E+00                               l For Pathway: Cow Milk                                                                                           I T. BODY GI-TRACT                 BONE   LIVER     KIDNEY     THYROID     LUNG       SKIN       ;
1 For Pathway: Ground j
Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                             i
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
    'Tecn:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                             i Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                             !
. Adult:
Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT                 BONE   LIVER     KIDNEY ' THYROID       LUNG       SKIN       ,
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I
Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                               ;
Taan:
Tecn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                             ,
-0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
    ' Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                                 !
. Child:
For. Pathway: Inhalation                                                                                       I T. BODY   GI-TRACT               BONE   LIVFR     KIDNEY     THYROID     LUNG       SKIN       {
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 t
Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                             i Tecn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                             ;
: Infant: 0.00E+00 0.00E+00.0.00Et00.0.%00E.+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
Child:     0.00Ea00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 4
For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E'+00 0.00E+00 0.00E+A0 0.00E+00 i
Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For' Pathway: Meat I
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID-LUNG SKIN:
I Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-(
Tcsn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
Infent:'0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+30 0.00E+00 0.00E+00 0.00E+00 l
For Pathway: Cow Milk I
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
'Tecn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY ' THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
' Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For. Pathway: Inhalation I
T. BODY GI-TRACT BONE LIVFR KIDNEY THYROID LUNG SKIN
{
Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
Tecn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00Ea00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 4
I
I


ODCM Rcv. 17 Prga 137 11/95 Table 2-2 (Continued) l INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:     Sr90 For Pathway: Plume T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID   LUNG   SKIN Adult:   0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tocn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1
ODCM Rcv. 17 Prga 137 11/95 Table 2-2 (Continued) l INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:
For Pathway: Ground T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID   LUNG   SKIN Adult:   0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.COE+00 0.00E+00
Sr90 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
: TcOn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pat'h'way: Vegetable T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID   LUNG   SKIN I Adult:     1.38E+10 1.63E+09 5.64E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tscn:     1.79E+10 2.04E+09 7.27E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tocn:
* l Child:     3.09E+10 1.54E+09 1.22E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i For Pathway: Meat T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID   LUNG   SKIN Adult:   4.45E+08 5.24E+07 1.81E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn:     2.90E+08 3.29E+07 1.17E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:   3.84E+08 2.04E+07 1.52E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID   LUNG   SKIN Adult:   1.67E+09 1.97E+08 6.32E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Torn:     2.38E+09 2.70E+08 9.64E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l  Child:   4.13E+09 2.19E+08 1.63E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child:
Infant: 4.51E+09 2.21E+08 1.77E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID   LUNG   SKIN
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
,  Adult:   3.51E+09 4.14E+08 1.43E+10 0.002+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen:     5.00E+09 5.68E+08 2.02E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:   8.67E+09 4.61E+08 3.42E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 9.47E+09 4.65E.08 3.72E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l.For Pathway: Inhalation l             T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID   LUNG   SKIN
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.COE+00 0.00E+00
! Adult:     1.93E+05 2.28E+04 3.14E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen:     2.12E+05 2.42E+04 3.42E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:   2.04E+05 1.09E+04 3.20E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 8.21E+04 4.15E+03 1.30E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
: TcOn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pat'h'way: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN I Adult:
1.38E+10 1.63E+09 5.64E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tscn:
1.79E+10 2.04E+09 7.27E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child:
3.09E+10 1.54E+09 1.22E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
4.45E+08 5.24E+07 1.81E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn:
2.90E+08 3.29E+07 1.17E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
3.84E+08 2.04E+07 1.52E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
1.67E+09 1.97E+08 6.32E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Torn:
2.38E+09 2.70E+08 9.64E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
4.13E+09 2.19E+08 1.63E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
Infant: 4.51E+09 2.21E+08 1.77E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
3.51E+09 4.14E+08 1.43E+10 0.002+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen:
5.00E+09 5.68E+08 2.02E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
8.67E+09 4.61E+08 3.42E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 9.47E+09 4.65E.08 3.72E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l.For Pathway: Inhalation l
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
! Adult:
1.93E+05 2.28E+04 3.14E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen:
2.12E+05 2.42E+04 3.42E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
2.04E+05 1.09E+04 3.20E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 8.21E+04 4.15E+03 1.30E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
1
1


ODCM R2v. 17-Page 138 11/95 Table 2-2 (Continued)
ODCM R2v. 17-Page 138 11/95 Table 2-2 (Continued)
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:     Zr95 For Pathway: Plume T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID   LUNG   SKIN Adult:   0.00E+00 9,00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Torn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:   0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 Infnnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00   ,
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:
For Pathway: Ground T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID   LUNG   SKIN Adult:   7.48Et06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67S+06 '
Zr95 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
Tccn:     7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67E+06 Child:   7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67E+06 Infcnt: 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67E+06 For Pathway: Vegetable T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID   LUNG   SKIN   !
0.00E+00 9,00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Torn:
Adult: 6.46E+03 3.03E+07 2.98E+04 9.55E+03 1.50E+04 0.00E+00 0.00E+00 0.00E+00' Tctn:     1.01E+04 3.37E+07 4.63E+04 1.46E+04 2.15E+04 0.00E+00 0.00E+00 0.00E+00 Child:   2.07E+04 2.43E+07 1.06E+05 2.33E+04 3.33E+04 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat                                                                 ;
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID   LUNG   SKIN Adult:   7.26E+03 3.40E+07 3.34E+04 1.07E+04 1.68E+04 0.00E+00 0.00E+00 0.00E+00 Tcon:     5.81E+03 1.95E+07 2.68E+04 8.45E+03 1.24E+04 0.00E+00 0.00E+00 0.00E+00 Child:   9.30E+03 1.09E+07 4.75E+04 1.05E+04 1.50E+04 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID   LUNG   SKIN Adult:   3.65E+00 1.71E+04 1.68E+01 5.40E+00 8.47E+00 0.00E+00 0.00E+00 0.00E+00 Tacn:     6.39E+00 2.14E+04 2.94E+01 9.29E+00 1.36E+01 0.00E+00 0.00E+00 0.00E+00 Child:   1.34E+01 1.57E+04 6.84E+01 1.50E+01 2.15E+01 0.00E+00 0.00E+00 0.00E+00 Infcnt: 2.10E+01 1.47E+04 1.21E+02 2.96E+01 3.19E+01 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID   LUNG   SKIN Adult:   4.39E-01 2.05E+03 2.02E+00 6.48E-01 1.02E+00 0.00E+00 0.00E+00 0.00E+00 TcOn:     7.66E-01 2.57E+03 3.53E+00 1.11E+00 1.64E+00 0.00E+00 0.00E+00 0.00E+00 Child:   1.61E+00 1.88E+03 8.20E+00 1.80E+00 2.58E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 2.52E+00 1.77E+03 1.46Ee01 3.55E+00 3.83E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID   LUNG   SKIN Adult:   7.38E+02 4.77E+03 3.40E+03 1.09E+03 1.72E+03 0.00E+00 5.60E+04 0.00E+00 Tosn:     9.99E+02 4.72E+03 4.62E+03 1.45E+03 2.14E+03 0.00E+00 8.52E+04 0.00E+00 Child:   1.17E+03 1.94E+03 6.02E+03 1.33E+03 1.892+03 0.00E+00 7.07E+04 0.00E+00   1 Infcnt: 6.44E+02 6.88E+02 3.66E+03 8.83E+02 9.85E+03 0.00E+00 5.55E+04 0.00E+00     i
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 Infnnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
7.48Et06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67S+06 Tccn:
7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67E+06 Child:
7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67E+06 Infcnt: 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67E+06 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
6.46E+03 3.03E+07 2.98E+04 9.55E+03 1.50E+04 0.00E+00 0.00E+00 0.00E+00' Tctn:
1.01E+04 3.37E+07 4.63E+04 1.46E+04 2.15E+04 0.00E+00 0.00E+00 0.00E+00 Child:
2.07E+04 2.43E+07 1.06E+05 2.33E+04 3.33E+04 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
7.26E+03 3.40E+07 3.34E+04 1.07E+04 1.68E+04 0.00E+00 0.00E+00 0.00E+00 Tcon:
5.81E+03 1.95E+07 2.68E+04 8.45E+03 1.24E+04 0.00E+00 0.00E+00 0.00E+00 Child:
9.30E+03 1.09E+07 4.75E+04 1.05E+04 1.50E+04 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
3.65E+00 1.71E+04 1.68E+01 5.40E+00 8.47E+00 0.00E+00 0.00E+00 0.00E+00 Tacn:
6.39E+00 2.14E+04 2.94E+01 9.29E+00 1.36E+01 0.00E+00 0.00E+00 0.00E+00 Child:
1.34E+01 1.57E+04 6.84E+01 1.50E+01 2.15E+01 0.00E+00 0.00E+00 0.00E+00 Infcnt: 2.10E+01 1.47E+04 1.21E+02 2.96E+01 3.19E+01 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
4.39E-01 2.05E+03 2.02E+00 6.48E-01 1.02E+00 0.00E+00 0.00E+00 0.00E+00 TcOn:
7.66E-01 2.57E+03 3.53E+00 1.11E+00 1.64E+00 0.00E+00 0.00E+00 0.00E+00 Child:
1.61E+00 1.88E+03 8.20E+00 1.80E+00 2.58E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 2.52E+00 1.77E+03 1.46Ee01 3.55E+00 3.83E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
7.38E+02 4.77E+03 3.40E+03 1.09E+03 1.72E+03 0.00E+00 5.60E+04 0.00E+00 Tosn:
9.99E+02 4.72E+03 4.62E+03 1.45E+03 2.14E+03 0.00E+00 8.52E+04 0.00E+00 Child:
1.17E+03 1.94E+03 6.02E+03 1.33E+03 1.892+03 0.00E+00 7.07E+04 0.00E+00 1
Infcnt: 6.44E+02 6.88E+02 3.66E+03 8.83E+02 9.85E+03 0.00E+00 5.55E+04 0.00E+00 i


P ODCM Rsv. 17 Paga 139         l
P ODCM Rsv. 17 Paga 139 l
                                                            ,                                                        11/95     ,
11/95 i
i Table 2-2 (Continued) j' INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:                                     Sb124                       I
Table 2-2 (Continued) j' INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:
.        For Pathway: Plume T. BODY   GI-TRACT   BONE   LIVER     KIDNEY THYROID     LUNG           SKIN       !
Sb124 I
Adult:                         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                 i Tcan:                           0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                 l 4 Child:                                 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                 l Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                                       l
For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
! For Pathway: Ground T. BODY   GI-TRACT   BONE   LIVER     KIDNEY THYROID       LUNG           SKIN j Adult:                                 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 4
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
TcOn:                           0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                 )
Tcan:
Child:                         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                                       ,
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
For Pathway: Vegetable                                                                                                 l
4 Child:
,                                        T. BODY GI-TRACT     BONE   LIVER     KIDNEY THYROID       LUNG           SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
! For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN j Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TcOn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 4
)
Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable l
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
' ' Tecn:
' ' Tecn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                 i Child:                         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                 !
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
Child:
: For Pathway: Meat                                                               _
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
l T. BODY   GI-TRACT   BONE   LIVER     KIDNEY THYROID     LUNG           SKIN Adult:                         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                 ,
: For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
i Toen:                                 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                 l
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Toen:
; Child:                                 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                 {
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
; Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                                                 j i
; Child:
j For Pathway: Cow Milk T. BODY GI-TRACT     BONE   LIVER     KIDNEY THYROID       LUNG           SKIN Adult:                         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:                         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:                       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT     BONE   LIVER     KIDNEY THYROID       LUNG           SKIN Adult:                         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:                         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:                       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                 l Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT     BONE   LIVER     KIDNEY THYROID       LUNG           SKIN Adult:                         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:                         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:                       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
{
; Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 j
i j For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00


OD2M Rsv. 17 Page 140 11/95   .
OD2M Rsv. 17 Page 140 11/95 Table 2-2 (Continued)
Table 2-2 (Continued)
INDIVIDUAL DOSE FACTORS FOR C'ASEOUS EFFLUENTS -- FOR ISOTOPE:
INDIVIDUAL DOSE FACTORS FOR C'ASEOUS EFFLUENTS -- FOR ISOTOPE:             Illi For Pathway: Plume                                                                             [
Illi For Pathway: Plume
T. BODY GI-TRACT   BONE       LIVER       KIDNEY THYROID         LUNG   SKIN     ;
[
Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Torn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00             ,
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
Child:   0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00             i Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT   BONE       LIVER       KIDNEY   THYROID     LUNG     SKIN Adult:     2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 3.19E+05             !
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Torn:
Tann:     2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 3.19E+05             !
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
Child:   2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+0h 2.63E+05 3.19E+05             [
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
Infont: 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 3.19E+05               >
Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
For Pathway: Vegetable T. BODY GI-TRACT   BONE       LIVER       KIDNEY   THYROID     LUNG     SKIN     ;
2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 3.19E+05 Tann:
Adk t:     4.43E+05-2.04E+05 5.41E+05 7.74E+05 1.33E+06 2.54E+08 0.00E+00 0.00E+00             '
2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 3.19E+05 Child:
Tecn:     4.02E+05 1.48E+05 5.35E+05 7.48E+05 1.29E+06 2.18E+08 0.00E+00 0.00E+00 Child:   5.83E+05 9.13E+04 1.02E+06 1.03E+06 1.68E+05 3.39Ed08 0.00E+00 0.00E+00             !
2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+0h 2.63E+05 3.19E+05
Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
[
                                                                                                  }
Infont: 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 3.19E+05 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adk t:
For Pathway: Meat T. BODY GI-TRACT   BONE       LIVER       KIDNEY   THYROID     LUNG     SKIN     ;
4.43E+05-2.04E+05 5.41E+05 7.74E+05 1.33E+06 2.54E+08 0.00E+00 0.00E+00 Tecn:
Adult:     8.70E+04 4.01E+04 1.06E+05 1.52E+05 2.60E+05 4.98E+07 0.00E+00 0.00E+00             !
4.02E+05 1.48E+05 5.35E+05 7.48E+05 1.29E+06 2.18E+08 0.00E+00 0.00E+00 Child:
Tosn:     6.64E+04 2.44E+04 8.82E+04 1.24E+05 2.13E+05 3.60E+07 0.00E+00 0.00E+00             !
5.83E+05 9.13E+04 1.02E+06 1.03E+06 1.68E+05 3.39Ed08 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
Child:   9.35E+04 1.46E+04 1.64E+05 1.65E+05 2.70E+05 5.44E+07 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT   BONE       LIVER       KIDNEY   THYROID     LUNG     SKIN Adult:     2.39E+06 1.10E+06 2.92E+06 4.17E+06 7.16E+06 1.37E+09 0.00E+00 0.00E+00 Tonn:     3.98E+06 1.47E+06 5.30E+06 7.42E+06 1.28E+07 2.16E+09 0.00E+00 0.00E+00 Child:   7.34E+06 1.15E+06 1.28E+07 1.29E+07 2.12E+07 4.27E+09 0.00E+00 0.00E+00 Infcnt: 1.39E+07 1.13E+0p 2.68E+07 3.16E+07 3.69E+07 1.04E+10 0.00E+00 0.00E+00               !
}
For Pathway: Goat Milk                                                                         ,
For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
T. BODY GI-TRACT   BONE       LIVER       KIDNEY THYROID       LUNG     SKIN Adult:     2.87E+06 1.32E+06 3.50E+06 5.01E+06 8.59E+06 1.64E+09 0.00E+00 0.00E+00
8.70E+04 4.01E+04 1.06E+05 1.52E+05 2.60E+05 4.98E+07 0.00E+00 0.00E+00 Tosn:
  .Tocn:     4.78E+06 1.76E+06 6.36E+06 8.90E+06 1.53E+07 2.60E+09 0.00E+00 0.00E+00 Child:   8.81E+06 1.38E+06 1.54E+07 1.55E+07 2.55E+07 5.13E+09 0.00E+00 0.00E+00 Infont: 1.67E+07 1.35E+06 3.22E+07 3.79E+07 4.43E+07 1.25E+10 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT   BONE       LIVER       KIDNEY   THYROID     LUNG     SKIN Adult:     6.49E+02 1.99E+02 7.99E+02 1.13E+03 1.94E+03 3.78E+05 0.00E+00 0.00E+00             :
6.64E+04 2.44E+04 8.82E+04 1.24E+05 2.13E+05 3.60E+07 0.00E+00 0.00E+00 Child:
Tecn:      8.37E+02 2.06E+02 1.12E+03 1.56E+03 2.66E+03 4.64E+05 0.00E+00 0.00E+00 Child:   8.64E+02 9.01E+01 1.52E+03 1.52E+03 2.50E+03 5.15E+05 0.00E+00 0.00E+00 Infant: 6.21E+02 3.36E+01 1.20E+03 1.41E+03 1.64E+03 4.70E+04 0.00E+00 0.00E+00
9.35E+04 1.46E+04 1.64E+05 1.65E+05 2.70E+05 5.44E+07 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
2.39E+06 1.10E+06 2.92E+06 4.17E+06 7.16E+06 1.37E+09 0.00E+00 0.00E+00 Tonn:
3.98E+06 1.47E+06 5.30E+06 7.42E+06 1.28E+07 2.16E+09 0.00E+00 0.00E+00 Child:
7.34E+06 1.15E+06 1.28E+07 1.29E+07 2.12E+07 4.27E+09 0.00E+00 0.00E+00 Infcnt: 1.39E+07 1.13E+0p 2.68E+07 3.16E+07 3.69E+07 1.04E+10 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
2.87E+06 1.32E+06 3.50E+06 5.01E+06 8.59E+06 1.64E+09 0.00E+00 0.00E+00
.Tocn:
4.78E+06 1.76E+06 6.36E+06 8.90E+06 1.53E+07 2.60E+09 0.00E+00 0.00E+00 Child:
8.81E+06 1.38E+06 1.54E+07 1.55E+07 2.55E+07 5.13E+09 0.00E+00 0.00E+00 Infont: 1.67E+07 1.35E+06 3.22E+07 3.79E+07 4.43E+07 1.25E+10 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
6.49E+02 1.99E+02 7.99E+02 1.13E+03 1.94E+03 3.78E+05 0.00E+00 0.00E+00 Tecn:
8.37E+02 2.06E+02 1.12E+03 1.56E+03 2.66E+03 4.64E+05 0.00E+00 0.00E+00 Child:
8.64E+02 9.01E+01 1.52E+03 1.52E+03 2.50E+03 5.15E+05 0.00E+00 0.00E+00 Infant: 6.21E+02 3.36E+01 1.20E+03 1.41E+03 1.64E+03 4.70E+04 0.00E+00 0.00E+00


ODCM Rev. 17 Pago 141 l
ODCM Rev. 17 Pago 141 l
11/95 I
11/95 I
Tald e 2-2 (Continued)-
Tald e 2-2 (Continued)-
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:       Xe131m l   For Pathway: l Plume l                 T. BODY GI-TRACT   BONE     LIVER     KIDNEY THYROID   LUNG   SKIN   l l : Adult:     2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.38E+00 1.89E+01   l l Tosn:       2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.38E+00 1.89E+01 l   Child:     2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.38E+00 1.89E+01   j l   Infcnt: 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.38E+00.1.89E+01     i l   For Pathway: Ground T. BODY GI-TRACT   BONE     LIVER     KIDNEY THYROID   LUNG   SKIN
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:
- Adult:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l   Tscn:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l   Child:
Xe131m l
l  Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l   For Pathway: Vegetable                                                               I I
For Pathway: l Plume l
T. BODY GI-TRACT   BONE     LIVER     KIDNEY THYROID   LUNG   SKIN   I Adult:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tssn:       0.00E+00 0.00E+00 0.003+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I Child:       0.00E+00 0.00E+00-0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l
  'Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For. Pathway: Meat                                                                   j T. BODY GI-TRACT   BONE     LIVER     KIDNEY THYROID   LUNG     SKIN !
l : Adult:
Adult:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I Tecn:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1
2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.38E+00 1.89E+01 l
Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00F+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 t
l Tosn:
For Pathway: Cow Milk T. BODY GI-TRACT   BONE     LIVER     KIDNEY THYROID   LUNG     SKIN Adult:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.38E+00 1.89E+01 l
,  Tocn:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00t+00 0.00E+00 0.00E+00 l   Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l   Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
Child:
l   For Pathway: Goat Milk i                 T. BODY GI-TRACT   BONE     LIVER     KIDNEY THYROID   LUNG     SKIN l   Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l   Tecn:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l   For Pathway: Inhalation T. BODY GI-TRACT   BONE     LIVER     KIDNEY THYROID   LUNG     SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '
2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.38E+00 1.89E+01 j
Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
l Infcnt: 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.38E+00.1.89E+01 i
l For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
- Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
Tscn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN I
Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tssn:
0.00E+00 0.00E+00 0.003+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I
Child:
0.00E+00 0.00E+00-0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
'Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For. Pathway: Meat j
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1
Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00F+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 t
For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tocn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00t+00 0.00E+00 0.00E+00 l
Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
l For Pathway: Goat Milk i
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l
Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
Tecn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l


l l
l ODCM Rev. 17 Page 142 11/95 i
l ODCM Rev. 17 Page 142   l 11/95 I i
Table 2-2 (Continued)
Table 2-2 (Continued)
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:     I133 For Pathway: Plume T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID     LUNG SKIN Adult:   0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tc;n:     0.00E+00 D.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:   0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT   BONE   LIVER   KIDNEY THYROID     LUNG   SKIN Adult:   3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04 Torn:     3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04 Child:   3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04 Infant: 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04 For Pathway: Vegetable                                                             '
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:
T. BODY GI-TRACT   BONE   LIVER   KIDNEY THYROID     LUNG   SKIN Adult: 7.07E+03 2.08E+04 1.33E+04 2.32E+04 4.05E+04 3.41E+06 0.00E+00 0.00E+00 Tacn:     6.41E+03 1.59E+04 1.24E+04 2.10E+04 3.69E+04 2.93E+06 0.00E+00 0.00E+00   1 Child:   1.06E+04 1.13E+04 2.26E+04 2.79E+04 4.65E+04 5.19E+06 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat                                                                   l T. BODY GI-TRACT   BONE   LIVER   KIDNEY THYROID     LUNG   SKIN Adult:   2.01E-03 5.93E-03 3.79E-03 6.60E-03 1.15E-02 9.70E-01 0.00E+00 0.00E+00 Tcan:     1.64E-03 4.07E-03 3.17E-03 5.38E-03 9.44E-03 7.52E-01 0.00E+00 0.00E+00 Child:   2.76E-03 2.94E-03 5.90E-03 7.29E-03 1.22E-02 1.35E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT   SONE   LIVER   KIDNEY THYROID     LUNG   SKIN Adult: 2.07E+04 6.12E+04 3.91E+04 6.81E+04 1.19E+05 1.00E+07 0.00E+00 0.00E+00 Tc n:     3.70E+04 9.17E+04 7.15E+04 1.21E+05 2.13E+05 1.69E+07 0.00E+00 0.00E+00 Child:   8.12E+04 8.65E+04 1.7.4E+05 2.15E+05 3.58E+05 3.99E407 0.00E+00 0.00E+00 Infant: 1,56E+05 9.03E+04 3.67E+05 5.34E+05 6.28E+05 9.71E+07 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT   BONE   LIVER   KIDNEY THYROID     LUNG   SKIN   l Adult:   2.49E+04 7.34E+04 4.69E+04 8.17E+04 1.42E+05 1.20E+07 0.00E+00 0.00E+00 Toen:     4.44E+04 1.10E+05 8.57E+04 1.45E+05 2.55E+05 2.03E+07 0.00E+00 0.00E+00 Child:   9.75E+04 1.04E+05 2.08E+05 2.58E+05 4.29E+05 4.79E+07 0.00E+00 0.00E+00 Infant: 1.88E+05 1.08E+05 4.40E+05 6.41E+05 7.53E+05 1.16E+08 0.00E+00 0.00E+00 1
I133 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
For Pathway: Inhalation T. BODY GI-TRACT   BONE   LIVER   KIDNEY THYROID     LUNG   SKIN Adult:   1.43E+02 2.81E+02 2.74E+02 4.69E+02 8.19E+02 6.82E+04 0.00E+00 0.00E+00   l Tecn:     1.97E+02 3.27E+02 3.85E+02 6.49E+02 1.14E+03 9.26E+04 0.00E400 0.00E+00   !
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tc;n:
Child:   2.44E+02 1.74E+02 5.25E+02 6.44E+02 1.07E+03 1.22E+05 0.00E+00 0.00E+00   l Infcnt: 1.78E+02 6.83E+01 4.20E+02 6.06E+02 7.10E+02 1.13E+05 0.00E+00 0.00E+00 l
0.00E+00 D.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
l
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04 Torn:
3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04 Child:
3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04 Infant: 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
7.07E+03 2.08E+04 1.33E+04 2.32E+04 4.05E+04 3.41E+06 0.00E+00 0.00E+00 Tacn:
6.41E+03 1.59E+04 1.24E+04 2.10E+04 3.69E+04 2.93E+06 0.00E+00 0.00E+00 Child:
1.06E+04 1.13E+04 2.26E+04 2.79E+04 4.65E+04 5.19E+06 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
2.01E-03 5.93E-03 3.79E-03 6.60E-03 1.15E-02 9.70E-01 0.00E+00 0.00E+00 Tcan:
1.64E-03 4.07E-03 3.17E-03 5.38E-03 9.44E-03 7.52E-01 0.00E+00 0.00E+00 Child:
2.76E-03 2.94E-03 5.90E-03 7.29E-03 1.22E-02 1.35E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT SONE LIVER KIDNEY THYROID LUNG SKIN Adult:
2.07E+04 6.12E+04 3.91E+04 6.81E+04 1.19E+05 1.00E+07 0.00E+00 0.00E+00 Tc n:
3.70E+04 9.17E+04 7.15E+04 1.21E+05 2.13E+05 1.69E+07 0.00E+00 0.00E+00 Child:
8.12E+04 8.65E+04 1.7.4E+05 2.15E+05 3.58E+05 3.99E407 0.00E+00 0.00E+00 Infant: 1,56E+05 9.03E+04 3.67E+05 5.34E+05 6.28E+05 9.71E+07 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
2.49E+04 7.34E+04 4.69E+04 8.17E+04 1.42E+05 1.20E+07 0.00E+00 0.00E+00 Toen:
4.44E+04 1.10E+05 8.57E+04 1.45E+05 2.55E+05 2.03E+07 0.00E+00 0.00E+00 Child:
9.75E+04 1.04E+05 2.08E+05 2.58E+05 4.29E+05 4.79E+07 0.00E+00 0.00E+00 Infant: 1.88E+05 1.08E+05 4.40E+05 6.41E+05 7.53E+05 1.16E+08 0.00E+00 0.00E+00 1
For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
1.43E+02 2.81E+02 2.74E+02 4.69E+02 8.19E+02 6.82E+04 0.00E+00 0.00E+00 Tecn:
1.97E+02 3.27E+02 3.85E+02 6.49E+02 1.14E+03 9.26E+04 0.00E400 0.00E+00 Child:
2.44E+02 1.74E+02 5.25E+02 6.44E+02 1.07E+03 1.22E+05 0.00E+00 0.00E+00 Infcnt: 1.78E+02 6.83E+01 4.20E+02 6.06E+02 7.10E+02 1.13E+05 0.00E+00 0.00E+00


ODCM Rsv. 17 Prga-143 11/95 Table 2-2 (Continued)
ODCM Rsv. 17 Prga-143 11/95 Table 2-2 (Continued)
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:               Xe133 For Pathway: Plume T. BODY GI-TRACT   BONE         LIVER   KIDNEY THYROID     LUNG. SKIN Adult:         6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01 Tacn:           6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01 Child:         6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01 Infant: 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:
  .For Pathway: Ground                                                                           '
Xe133 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG.
T. BODY GI-TRACT   BONE         LIVER   KIDNEY THYROID     LUNG   SKIN Adult:         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan:         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:         0.00E+00 0.00E+00 0.00*+00G      0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable                                                                       ,
SKIN Adult:
T. BODY GI-TRACT   BONE         LIVER   KIDNEY THYROID     LUNG   SKIN ~
6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01 Tacn:
Adult:         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.~00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT   BONE         LIVER   KIDNEY THYROID     LUNG-   SKIN Adult:         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TOOn:         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT   BONE         LIVER   KIDNEY   THYROID LUNG   SKIN Adult:         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tosn:         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT   BONE         LIVER   KIDNEY THYROID     LUNG   SKIN Adult:         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen:         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT   BONE         LIVER   KIDNEY   THYROID LUNG     SKIN Adult:         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen:         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:         0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01 Child:
6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01 Infant: 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01
.For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00*+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 G
Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ~
Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.~00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG-SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TOOn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tosn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00


              ..    . _  _          ~       . _ _ _ _ _ _ . _ .        ___        __ _ _.
~
ODCM Rev. 17 Page 144 11/95 l
ODCM Rev. 17 Page 144 11/95 Table 2-2 (Continued)
Table 2-2 (Continued)
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:               Xe133m                 )
Xe133m
For Pathway: Plume T. BODY GI-TRACT   BONE   LIVER           KIDNEY   THYROID     LUNG-       SKIN Adult:   5.57E+03 5.57E+00 5.57E+00 5.57E+005.57E+00           5.57E+00 6.03E+00 3.96E+01 Toan:     5.57E+00 5.57E+00 5.57E+00 5.57E+005.57E+00           5.57E+00 6.03E+00 3.96E+01 Child:   5.57E+00 5.57E+00 5.57E+00 5.57E+005.57E+00           5.57E+00 6.03E+00 3.96E+01 Infcnt: 5.57E+00 5.57E+00 5.57E+00 5.57E+005.57E+00             5.57E+00 6.03E+00 3.96E+01 For Pathway: Ground T. BODY GI-TRACT   BONE   LIVER           KIDNEY   THYROID     LUNG         SKIN Adult:   0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Totn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.0CE+00 0.00E+00 Child:   0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                   -
)
Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT   BONE   LIVER           KIDNEY   THYROID     LUNG         SKIN   '
For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG-SKIN Adult:
Adult:   0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-Toen:     0.00E+00 0.00E+00 0.00E+00 0.00E+00'O.00E+00 0.00E+00 0.00E+00 0.00E+00                   1 Child:   0.00E+00 0.00E+00 0.00E+00 0.00E+00'O.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 For Pathway: Meat                                                                                   1 T. BODY GI-TRACT   BONE   LIVER           KIDNEY   THYROID     LUNG         SKIN Adult:   0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                   ,
5.57E+03 5.57E+00 5.57E+00 5.57E+005.57E+00 5.57E+00 6.03E+00 3.96E+01 Toan:
Toen:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:   0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT   BONE   LIVER           KIDNEY   THYROID     LUNG         SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tesn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:   0.00E+00 0.00E+00 0.00E+00 0.00E+00-0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT   BONE   LIVER           KIDNEY   THYROID     LUNG         SKIN Adult:   0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                 -i Tecn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:   0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                   ;
5.57E+00 5.57E+00 5.57E+00 5.57E+005.57E+00 5.57E+00 6.03E+00 3.96E+01 Child:
. Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                     1 For Pathway: Inhalation T. BODY GI-TRACT l
5.57E+00 5.57E+00 5.57E+00 5.57E+005.57E+00 5.57E+00 6.03E+00 3.96E+01 Infcnt: 5.57E+00 5.57E+00 5.57E+00 5.57E+005.57E+00 5.57E+00 6.03E+00 3.96E+01 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
BONE   LIVER           KIDNEY   THYROID     LUNG         SKIN Adult:   0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen:     0.00E+00 0.00E+00 0.00E+00 0.00E+00'O.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:   0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                   ,
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Totn:
Infcut: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.0CE+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-Toen:
0.00E+00 0.00E+00 0.00E+00 0.00E+00'O.00E+00 0.00E+00 0.00E+00 0.00E+00 1
Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00'O.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 For Pathway: Meat 1
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tesn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00-0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
- i Tecn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
. Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen:
0.00E+00 0.00E+00 0.00E+00 0.00E+00'O.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcut: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00


i.
i.
ODCM Rev. 17 Pags 145
ODCM Rev. 17 Pags 145 11/95 Table 2-2 (Continued)
                                                      ,                          11/95 Table 2-2 (Continued)                               ,
INDIVIDUAL DOSE-FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:
INDIVIDUAL DOSE-FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:       Cs134 For Pathway: Plume T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID       LUNG SKIN Adult:     0.00E+00-0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.'00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00'0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: dround
Cs134 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
!              T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID     LUNG SKIN I Adult:     2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.46E+08 Tacn:     2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.46E+08.
0.00E+00-0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan:
Child:     2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.46E+08 Infant: '2.11E+00 2.11E+0 8 2.11E+0 8 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2. 4 6E+0 8 I-ForPathway: Vegetable                                                                 !
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.'00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
!              T. BODY GI-TRACT-   BONE   LIVER     KIDNEY THYROID     . LUNG SKIN     6 i' Adult:     2.50E+08 5.34E+06 1.28E+08 3.05E+08 9.88E+07 0.00E+00 3.28E+07 0.00E+00   '
0.00E+00 0.00E+00 0.00E+00 0.00E+00'0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: dround T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN I Adult:
Tecn:     2.21E+08 5.93E+06 2.03E+08 4.77E+08 1.52E+08 0.00E+00 5.79E+07 0.00E+00 Child:     1.60E+08 4.10E+06 4.63E+08 7.60E+08 2.36E+08 0.00E+00 8.46E+07 0.00E+00 InfEnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID     LUNG SKIN Adult:     2.38E+07 5.10E+05.1.22E+07 2.91E+07 9.43E+06 0.00E+00 3.13E+06 0.00E+00
2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.46E+08 Tacn:
! Tecn:       1.06E+07 2.35E+05 9.74E+06 2.29E+07 7.28E+06 0.00E+00 2.78E+06 0.00E+00 i Child:     5.94E+06 1.52E+05 1.72E+07 2.82E+07 8.73E+06 0.00E+00 3.13E+06 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID     LUNG SKIN     l Adult:     2.05E+08 4.38E+06 1.05E+08 2.50E+08 8.11E+07 0.00E+00 2.69E+07 0.00E+00 l Tecn:       2.00E+08 5.35E+06 1.83E+08 4.30E+08 1.37E+08 0.00E+00 5'.22E+07 0.00E+00 L Child:     1.46E+08 3.73E+06 4.22E+08 6.92E+08 2.14E+08 0.00E+00 7.69E+07 0.00E+00 l
2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.46E+08.
Infant: 1.28E+08 3.44E+06 6.79E+08 1.27E+09 3.26E+08 0.00E+00 1.34E+08 0.00E+00 For-Pathway: Goat Milk T. BODY GI-TRACT   BONE     LIVER   KIDNEY THYROID     LUNG   SKIN
Child:
! Adult:     6.14E+08 1.32E+07 3.16E+08 7.51E+08 2.43E+08 0.00E+00 8.07E+07 0.00E+00 Teen:     5.99E+08 1.61E+07 5.48E+08 1.29E+09 4.10E+08 0.00E+00 1.57E+08 0.00E+00 Child:     4.38E+08 1.12E+07 1.26E+09 2.08E+09 6.43E+08 0.00E+00 2.31E+08 0.00E+00 i  Infant: 3.84E+08 1.03E+07 2.04E+09 3.80E+09 9.78E+08 0.00E+00 4.01E+08 0.00E+00 I
2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.46E+08 Infant: '2.11E+00 2.11E+0 8 2.11E+0 8 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2. 4 6E+0 8 I-ForPathway: Vegetable T. BODY GI-TRACT-BONE LIVER KIDNEY THYROID
For Pathway: Inhalation                                                               i T. BODY GI-TRACT BONE         LIVER   KIDNEY THYROID     LUNG   SKIN     I
. LUNG SKIN 6
i' Adult:
2.50E+08 5.34E+06 1.28E+08 3.05E+08 9.88E+07 0.00E+00 3.28E+07 0.00E+00 Tecn:
2.21E+08 5.93E+06 2.03E+08 4.77E+08 1.52E+08 0.00E+00 5.79E+07 0.00E+00 Child:
1.60E+08 4.10E+06 4.63E+08 7.60E+08 2.36E+08 0.00E+00 8.46E+07 0.00E+00 InfEnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
2.38E+07 5.10E+05.1.22E+07 2.91E+07 9.43E+06 0.00E+00 3.13E+06 0.00E+00
! Tecn:
1.06E+07 2.35E+05 9.74E+06 2.29E+07 7.28E+06 0.00E+00 2.78E+06 0.00E+00 i Child:
5.94E+06 1.52E+05 1.72E+07 2.82E+07 8.73E+06 0.00E+00 3.13E+06 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l
Adult:
2.05E+08 4.38E+06 1.05E+08 2.50E+08 8.11E+07 0.00E+00 2.69E+07 0.00E+00 l Tecn:
2.00E+08 5.35E+06 1.83E+08 4.30E+08 1.37E+08 0.00E+00 5'.22E+07 0.00E+00 L Child:
1.46E+08 3.73E+06 4.22E+08 6.92E+08 2.14E+08 0.00E+00 7.69E+07 0.00E+00 l
Infant: 1.28E+08 3.44E+06 6.79E+08 1.27E+09 3.26E+08 0.00E+00 1.34E+08 0.00E+00 For-Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
! Adult:
6.14E+08 1.32E+07 3.16E+08 7.51E+08 2.43E+08 0.00E+00 8.07E+07 0.00E+00 Teen:
5.99E+08 1.61E+07 5.48E+08 1.29E+09 4.10E+08 0.00E+00 1.57E+08 0.00E+00 Child:
4.38E+08 1.12E+07 1.26E+09 2.08E+09 6.43E+08 0.00E+00 2.31E+08 0.00E+00 Infant: 3.84E+08 1.03E+07 2.04E+09 3.80E+09 9.78E+08 0.00E+00 4.01E+08 0.00E+00 i
I For Pathway: Inhalation i
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
! Adult:
! Adult:
2.31E+04 3.30E+02 1.18E+04 2.69E+04 9.10E+03 0.00E+00 3.09E+03 0.00E+00     ,
2.31E+04 3.30E+02 1.18E+04 2.69E+04 9.10E+03 0.00E+00 3.09E+03 0.00E+00 Tecn:
Tecn:     1.74E+04 3.09E+02 1.59E+04 3.58E+04 1.19E+04 0.00E+00 4.64E+03 0.00E+00     )
1.74E+04 3.09E+02 1.59E+04 3.58E+04 1.19E+04 0.00E+00 4.64E+03 0.00E+00
Child:     7.12E+03 1.22E+02 2.06E+04 3.21E+04 1.05E+04 0.00E+00 3.84E+03 0.00E+00 Infant: 2.36E+03 4.23E+01 1.26E+04 2.23E+04 6.04E+03 0.00E+00 2.53E+03 0.00E+00       I l
)
Child:
7.12E+03 1.22E+02 2.06E+04 3.21E+04 1.05E+04 0.00E+00 3.84E+03 0.00E+00 Infant: 2.36E+03 4.23E+01 1.26E+04 2.23E+04 6.04E+03 0.00E+00 2.53E+03 0.00E+00 I


ODCM Rev. 17 Page 146 11/95 Table 2-2 (Continued)
ODCM Rev. 17 Page 146 11/95 Table 2-2 (Continued)
IPDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:                       Xe135m For Pathway: Plume                                               X                                         l T.BOEY GI-TRACT             BONE     LIVER       KINNEY THYROID         LUNG     SKIN Adult:     6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.95E+01 1.05E+02 Tecn:       6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.95E+01 1.05E+02 Child:     6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.95E+01 1.05E+02 Infant: 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.95E+01 1.05E+p2 For Pathway: Ground T. BODY GI-TRACT           BONE     LIVER       KIDNEY THYROID         LUNG     SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 g Child:     0.00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00
IPDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:
* Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E*00 For Pathway: Vegetable                                                                       -
Xe135m For Pathway: Plume X
T. BODY GI-TRACT           BONE     LIVER       KIDNEY THYROID         LUNG     SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infart: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Fathway: Meat T. BODY GI-TRACT           BONE     LIVER       KIDNEY THYROIDS         LUNG     SKIN Adult:     0.00E+00 0.'00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0. 00E,00 0.00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0.001E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT           BONE     LIVER       KIDNEY THYROID         LUNG     SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                         '
l T.BOEY GI-TRACT BONE LIVER KINNEY THYROID LUNG SKIN Adult:
Tecn:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00S-00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 4
6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.95E+01 1.05E+02 Tecn:
For Pathway: Goat Milk T. BODY GI-TRACT           BONE     LIVER       KIDNEY THYROID         LUNG     SKIN       ;
6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.95E+01 1.05E+02 Child:
Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT           BONE     LIVER       KIDNEY T~IYROID         LUNG     SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E.+00 0.00E+00 Child:     0. 00E +0 0 0. 0 0E+0 0 0. 00E+0 0 0. 0 0E+0 0 0. 00E+00 0. 0 0E+00 0 ' 002'+ 0 0 0. 0 0E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 7
6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.95E+01 1.05E+02 Infant: 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.95E+01 1.05E+p2 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
\
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 g Child:
0.00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00
* Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E*00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infart: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Fathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROIDS LUNG SKIN Adult:
0.00E+00 0.'00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0. 00E,00 0.00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0.001E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00S-00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 4
For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY T~IYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E.+00 0.00E+00 Child:
: 0. 00E +0 0 0. 0 0E+0 0 0. 00E+0 0 0. 0 0E+0 0 0. 00E+00 0. 0 0E+00 0 ' 002'+ 0 0 0. 0 0E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 7
\\


                                                              . . .     = _ .       .        -.
.... _. - 7
                                      ... . _ . - 7  .-
= _.
ODCM Rsv. 17
ODCM Rsv. 17 Page'147
                        ,                                                              Page'147   -
,11/95 Table 2-2 (Continued)
                                                                                          ,11/95 Table 2-2 (Continued)                                             .
INDIVID'UAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:
INDIVID'UAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:               Xe135                   ;
Xe135 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
For Pathway: Plume T. BODY GI-TRACT   BONE     LIVER     KIDNEY       THYROID   LUNG     SKIN         '
4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.0CE+02 TGan:
Adult:     4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.0CE+02 TGan:       4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 Child:     4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 Infant: 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 For Pcthway: Ground                                                                                 ,
4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 Child:
T. BODY GI-TRACT   BONE     LIVER     KIDNEY       THYROID   LUNG       SKIN l Adult:
4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 Infant: 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 For Pcthway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                 ;
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn:
Tacn:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                 i Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0. OE+00 0.00E+00                     ,
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
For Pathyay: Vegetable                                                                               '
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
T. BODY GI-TRACT   BONE     LIVER     KIDNEY       THYROID   LUNG       SKIN Adult:     0.00p+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                 l
Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.
' Tecn:     0.00:3+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                 I
OE+00 0.00E+00 For Pathyay: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
! Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                 ;
0.00p+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT   BONE     LIVER     KIDNEY THYROID           LUNG       SKIN t Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Ch41d:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                     )
I
For Pathway: Cow Milk                                                                               l T. BODY GI-TRACT   BONE     LIVER     KIDNEY THYROID         LUNG       SKIN         l Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
' Tecn:
  -Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant:
0.00:3+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0).00E+00 0.00E+00 0.00E+00
! Child:
,  For Pathway: Goat Milk T. BODY GI-TRACT   BONE     LIVER     KIDNEY       THYROID   LUNG       SKIN l Adult:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l.TGen:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00               '
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation                           "
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 t
l        ~
Tecn:
T. BODY GI-TRACT  BONE      LIVER      KIDNEY      THYROID    LUNG      SKIN
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Ch41d:
! Adult:      0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00         0.00E+00 0.00E+00 0.00E+00
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
! Teen:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00         0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00         0.00E+00 0.00E+00 0.00E+00         i Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                     i i
)
1       -            .  .        .
For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
-Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0).00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l.TGen:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation l
~
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
! Adult:
! Teen:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
i 1


i l
i ODCM Rav. 17 Page 148 11/95 Table 2-2 (Continued)
                                                            ,          ODCM Rav. 17 Page 148 11/95 Table 2-2 (Continued)
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:       Cs136 For Pathway: Plume T. BODY GI-TRACT   BONE     LIVER     KIDNEY THYROID   LUNG   SKIN Adult:     0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tzan:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infrnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT   BONE     LIVER     KIDNEY THYROID   LUNG   SKIN Adult:     4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+06 Tcnn:     4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+05 Child:     4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+06 InfCnt: 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+06 For Pathway: Vegetable T. BODY GI-TRACT   BONE     LIVER   KIDNEY THYROID   LUNG   CKIN Adult:     1.99E+05 3.15E+05 7.01E+05 2.77E+06 1.54E+06 0.00E+00 2.11E+05 9.00E+00 TC:n:     2.14E+06 2.57E+05 8.10E+05 3.19E+06 1.74E+06 0.00E+00 2.74E+05 0.00E+00 Child:     2.88E+06 1.57E+05 1.62E+06 4.46E+06 2.37E+06 0.00E+00 3.54E+05 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT   BONE     LIVER   KIDNEY THYROID   LUNG   SKIN Adult:     6.53E+05 1.03E+05 2.30E+05 9.08E+05 5.05%e05 0.00E+00 6.92E+04 0.00E+00 T cn:     4.74E+05 5.68E+04 1.79E+05 7.05E+05 3.84?&OS 0.00E+00 6.05E+04 0.00E+00 Child:     5.50E+05 2.99E+04 3.'tE+05 8.50E+05 4.53E+05 0.00E+00 6.75E+04 S.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT   BONE     LIVER   KIDNEY THYROID     LUNG   SKIN Adult:     1.43E+07 2.26E+06 5.03E+06 1.99E+07 1.10E+07 0.00E+00 1.51E+06 0.00E+00 T n:       2.26E+37 2.71E+06 8.56E+06 3.37E+07 1.83E+07 0.00E+00 2.89E+06 0.00E+00 Child:     3.44E+07 1.87E+06 1.93E+07 5.31E+07 2.83E+07 0.00E+00 4.22E+06 0.00E+00 Infnnt: 4.14E+07 1.69E+06 3.77E+07 1.11E+08 4.42E+07 0.00E+00 9.05E+06 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRAUT   BONE     LIVER   KIDNEY THYROID   LUNG   SKIN Adult:     4.29E+07 6.77E+06 1.51E+07 5.96E+07 3.31E+07 0.00E+00 4.54E+06 0.00E+00 Tacn:     6.79E+07 8.13E+06 2.57E+07 1.01E+08 5.50E+07 0.00E+00 8.67E+06 0.00E+00 Child:     1.03E+08 5.60E+06 5.80E+07 1.59E+08 8.49E+07 0.00E+00 1.27E+07 0.03E+00 Infant: 1.24E+08 5.06E+06 1.13E+08 3.33E+08 1.33E+08 0.00E+00 2.71E+07 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT   BONE     LIVER   KIDNEY THYROID   LUNG   SKIN Adult:     3.50E+03 3.70E+02 1.24E+03 4.64E+03 2.71E+03 0.00E+00 3.80E+02 0.00E+00 Toen:     4.34E+03 3.45E+02 1.63E+03 6.14E+03 3.50E+03 0.00E+00 5.63E+02 0.00E+00 Child:     3.68E+03 1.33E+02 2.06E+03 5.42E+03 3.03E+03 0.00E+00 4.61E+02 0.00E+00 Infcnt: 1.68E+03 4.53E+01 1.53E+06 4.26E+03 1.79E+03 0.00E+00 3.73E+02 0.00E+00
Cs136 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tzan:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infrnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+06 Tcnn:
4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+05 Child:
4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+06 InfCnt: 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+06 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG CKIN Adult:
1.99E+05 3.15E+05 7.01E+05 2.77E+06 1.54E+06 0.00E+00 2.11E+05 9.00E+00 TC:n:
2.14E+06 2.57E+05 8.10E+05 3.19E+06 1.74E+06 0.00E+00 2.74E+05 0.00E+00 Child:
2.88E+06 1.57E+05 1.62E+06 4.46E+06 2.37E+06 0.00E+00 3.54E+05 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
6.53E+05 1.03E+05 2.30E+05 9.08E+05 5.05%e05 0.00E+00 6.92E+04 0.00E+00 T cn:
4.74E+05 5.68E+04 1.79E+05 7.05E+05 3.84?&OS 0.00E+00 6.05E+04 0.00E+00 Child:
5.50E+05 2.99E+04 3.'tE+05 8.50E+05 4.53E+05 0.00E+00 6.75E+04 S.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
1.43E+07 2.26E+06 5.03E+06 1.99E+07 1.10E+07 0.00E+00 1.51E+06 0.00E+00 T n:
2.26E+37 2.71E+06 8.56E+06 3.37E+07 1.83E+07 0.00E+00 2.89E+06 0.00E+00 Child:
3.44E+07 1.87E+06 1.93E+07 5.31E+07 2.83E+07 0.00E+00 4.22E+06 0.00E+00 Infnnt: 4.14E+07 1.69E+06 3.77E+07 1.11E+08 4.42E+07 0.00E+00 9.05E+06 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRAUT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
4.29E+07 6.77E+06 1.51E+07 5.96E+07 3.31E+07 0.00E+00 4.54E+06 0.00E+00 Tacn:
6.79E+07 8.13E+06 2.57E+07 1.01E+08 5.50E+07 0.00E+00 8.67E+06 0.00E+00 Child:
1.03E+08 5.60E+06 5.80E+07 1.59E+08 8.49E+07 0.00E+00 1.27E+07 0.03E+00 Infant: 1.24E+08 5.06E+06 1.13E+08 3.33E+08 1.33E+08 0.00E+00 2.71E+07 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
3.50E+03 3.70E+02 1.24E+03 4.64E+03 2.71E+03 0.00E+00 3.80E+02 0.00E+00 Toen:
4.34E+03 3.45E+02 1.63E+03 6.14E+03 3.50E+03 0.00E+00 5.63E+02 0.00E+00 Child:
3.68E+03 1.33E+02 2.06E+03 5.42E+03 3.03E+03 0.00E+00 4.61E+02 0.00E+00 Infcnt: 1.68E+03 4.53E+01 1.53E+06 4.26E+03 1.79E+03 0.00E+00 3.73E+02 0.00E+00


ODCM Rev. 17 Pcga 149 11/95 i
ODCM Rev. 17 Pcga 149 11/95 i
Table 2-2 (Continued)
Table 2-2 (Continued)
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:     Cs137 l For Pathway: Plume T. BODY GI-TRACT   BONE,   LIVER     KIDNEY THYROID   LUNG   SKIN l Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:
! Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infent: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l For Pathway: Ground T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID   LUNG   SKIN l Adult:     3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+0S 4.64E+08 i Torn:     3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 4.64E+08 l Child:     3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 4.64E+08   l Infcnt: 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98Et08 4.04E+08 l
Cs137 l
For Pathway: Vegetable T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID   LUNG   SKIN Adult:     1.88E+08 5.56E+06 2.10E+08 2.87E+08 9.75E+07 0.00E+00 3.24E+07 0.00E+00 Tsen:     1.61E+08 6.57E+06 3.47E+08 4.62E+08 1.57E+08 0.00E+00 6.11E+07 0.00E+00 Child:                                                                               )
For Pathway: Plume T. BODY GI-TRACT
1.17E+08 4.97E+06 8.29E+08 7.94E+08 2.59E+08 0.00E+00 9.31E+07 0.00E+00   '
: BONE, LIVER KIDNEY THYROID LUNG SKIN l
l Ir4fcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l For Pathway: Meat T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID   LUNG   SKIN j Adult:     1.63E+07 4.80E+05 1.81E+07 2.48E+07 8.42E+06 0.00EFOO 2.80E+06 0.00E+00 l Teen:     6.98E+06 2.85E+05 1.51E+07 2.00E+07 6.82E+06 0.00E+00 2.65E+06 0.00E+00 l
Adult:
Child:     3.92E+06 3.66E+05 2.77E+07 2.66E+07 8.65E+06 0.00E+00 3.11E+06 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00     i For Pathway: Cow Milk T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID   LUNG   SKIN Adult:     1.38E+08 4.07E+06 1.54E+08 2.10E+08 7.13E+07 0.00E+00 2.37E+07 0.00E+00 Tarn:     1.29E+08 5.27E+06 2.78E+08 3.70E+08 1 36E+08 0.00E+00 4.90E+07 0.00E+00   !
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn:
Child:     9.48E+07 4.02E+06 6.71E+08 6.42E+08 2.09E+08 0.00E+00 7.53E+07 0.00E+00   {
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
Infant: 8.88E+07 3.92E+06 1.07E+09 1.25E+09 3.36E+08 0.00E+00 1.36E+08 0.00E+00 For Pathway: Goat Milk                                                               l i
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infent: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID   LUNG   SKIN l Adult:     4.13E+08 1.22E+07 4.61E+08 6.30E+08 2.14E+08 0.00E+00 7.11E+07 0.00E+00   4 l Tsen:     3.87E+08 1.58E+07 8.35E+08 1.11E+09 3.78E+08 0.00E+00 1.47E+08 0.00E+00
For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l
( Child:     2.84E+08 1.21E+07 2.01Ev09 1.93E+09 6.28E+08 0.00E+00 2.26E+08 0.00E+00 Infcnt: 2.66E+08 1.18E+07 3.21E+09 3.76E+09 1.01E+09 0.00E+00 4.09E+08 0.00E+00 l For Pathway: Inhalation l             T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID   LUNG   SKIN Adult:     1.36E+04 2.66E+02 1.52E+04 1.97E+04 7.05E+03 0.00E+00 2.38E+03 0.00E+00 Tecn:     9.87E+03 2.69E+02 2.13E+04 2.69E+04 9.64E+03 0.00E+00 3.83E+03 0.00E+00 i Child:     4.07E+03 1.15E+02 2.8?E+04 2.622+04 8.95E+03 0.00E+00 3.30E+03 0.00E+00 Infant: 1.44E+03 4.23E+01 1.74E+04 1.94E+04 5.46E+03 0.00E+00 2.26E+03 0.00E+00 l
Adult:
3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+0S 4.64E+08 i
Torn:
3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 4.64E+08 l
Child:
3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 4.64E+08 l
Infcnt: 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98Et08 4.04E+08 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
1.88E+08 5.56E+06 2.10E+08 2.87E+08 9.75E+07 0.00E+00 3.24E+07 0.00E+00 Tsen:
1.61E+08 6.57E+06 3.47E+08 4.62E+08 1.57E+08 0.00E+00 6.11E+07 0.00E+00
)
Child:
1.17E+08 4.97E+06 8.29E+08 7.94E+08 2.59E+08 0.00E+00 9.31E+07 0.00E+00 l
Ir4fcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN j
Adult:
1.63E+07 4.80E+05 1.81E+07 2.48E+07 8.42E+06 0.00EFOO 2.80E+06 0.00E+00 l
Teen:
6.98E+06 2.85E+05 1.51E+07 2.00E+07 6.82E+06 0.00E+00 2.65E+06 0.00E+00 l
Child:
3.92E+06 3.66E+05 2.77E+07 2.66E+07 8.65E+06 0.00E+00 3.11E+06 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
1.38E+08 4.07E+06 1.54E+08 2.10E+08 7.13E+07 0.00E+00 2.37E+07 0.00E+00 Tarn:
1.29E+08 5.27E+06 2.78E+08 3.70E+08 1 36E+08 0.00E+00 4.90E+07 0.00E+00 Child:
9.48E+07 4.02E+06 6.71E+08 6.42E+08 2.09E+08 0.00E+00 7.53E+07 0.00E+00
{
Infant: 8.88E+07 3.92E+06 1.07E+09 1.25E+09 3.36E+08 0.00E+00 1.36E+08 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i
l Adult:
4.13E+08 1.22E+07 4.61E+08 6.30E+08 2.14E+08 0.00E+00 7.11E+07 0.00E+00 4
l Tsen:
3.87E+08 1.58E+07 8.35E+08 1.11E+09 3.78E+08 0.00E+00 1.47E+08 0.00E+00
(
Child:
2.84E+08 1.21E+07 2.01Ev09 1.93E+09 6.28E+08 0.00E+00 2.26E+08 0.00E+00 Infcnt: 2.66E+08 1.18E+07 3.21E+09 3.76E+09 1.01E+09 0.00E+00 4.09E+08 0.00E+00 l
For Pathway: Inhalation l
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
1.36E+04 2.66E+02 1.52E+04 1.97E+04 7.05E+03 0.00E+00 2.38E+03 0.00E+00 Tecn:
9.87E+03 2.69E+02 2.13E+04 2.69E+04 9.64E+03 0.00E+00 3.83E+03 0.00E+00 i
Child:
4.07E+03 1.15E+02 2.8?E+04 2.622+04 8.95E+03 0.00E+00 3.30E+03 0.00E+00 Infant: 1.44E+03 4.23E+01 1.74E+04 1.94E+04 5.46E+03 0.00E+00 2.26E+03 0.00E+00 l
l
l


ODCM Rav. 17 Page 150 11/95 Table 2-2 (Continued)
ODCM Rav. 17 Page 150 11/95 Table 2-2 (Continued)
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:                 Xe137 For Pathway: Plume                                                                                   !
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:
                'T. BODY GI-TRACT       BONE       LIVER     KIDNEY THYROID       LUNG     SKIN
Xe137 For Pathway: Plume
    ' Adult:   3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.54E+01 4.24E+02 TsOn:     3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.54E+01 4.24E+02                   '
'T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
Child:     3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.54E+01 4.24E+02 Infcnt: 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.54E+01 4.24E+02 For Pathway:, Ground T. BODY GI-TRACT       BONE       LIVER     KIDNEY     THYROID   LUNG       SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tctn:     0.00E+00'O.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
' Adult:
For Pathway: Vegetable T. BODY GI-TRACT       BONE       LIVER     KIDNEY     THYROID   LUNG       SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcen:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                   t Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                   i Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat                                                                                     i T. BODY GI-TRACT       BONE       LIVER     KIDNEY THYROID       LUNG       SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk                                     .
3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.54E+01 4.24E+02 TsOn:
l T. BODY GI-TRACT       BONE       LIVER     FIDNEY     THYROID   LUNG       SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tenn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 010DE+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.0CE+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk                                                                               j T. BODY GI-TRACT       BONE       LIVER     KIDNEY     THYROID   LUNG       SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tc0n:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                   ,
3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.54E+01 4.24E+02 Child:
Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation i
3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.54E+01 4.24E+02 Infcnt: 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.54E+01 4.24E+02 For Pathway:, Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
T. BODY GI-TRACT       BONE       LIVER     KIDNEY     THYROID   LUNG     SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 t     Tecn:     'O.00E+00,0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                   '
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tctn:
Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                       '
0.00E+00'O.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
t
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
  /
For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcen:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 t
Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat i
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk l
T. BODY GI-TRACT BONE LIVER FIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tenn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 010DE+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.0CE+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk j
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tc0n:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i
Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 t
Tecn:
'O.00E+00,0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 t
/
a
a


  ,      -      __ -  .        _. -.    - _ .  -.    .- -            ...  . - - =         -.            .  . . _ .
. - - =
ODCM Rev. 17 Paga 151         l 11/95 i
ODCM Rev. 17 Paga 151 l
e Table 2-2 (Continued)                                                     !
11/95 i
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:                               Xe138 For Pathway: Plume                                                                                                   !
e Table 2-2 (Continued)
                ' T. BODY GI-TRACT         BONE       LIVER     KIDNEY       THYROID               LUNG SKIN             '
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:
Adult:     1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02 Tccn:     1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02                                   l Child: 1.96E+02 1.96E+02 1.961+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02                                       l Infant: 1.9pE+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02                                       l i
Xe138 For Pathway: Plume
For Pathway: Ground                                                                                                   l T. BODY GI-TRACT         BONE       LIVER     KIDNEY THYROID                     LUNG   SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                                   i
' T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
    . Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                                     .
1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02 Tccn:
s Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                                     i For Pathway: Vegetable                                                                                               l T. BODY GI-TRACT'       BONE       LIVER     KIDNEY' THYROID                   LUNG   SKIN           :
1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02 l
Adult:    0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                                   !
Child:
Tecn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                                   l Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                                   '
1.96E+02 1.96E+02 1.961+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02 l
Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                                     l l
Infant: 1.9pE+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02 l
For Pathway: Meat l
i For Pathway: Ground l
T. BODY GI-TRACT         BONE     LIVER     KIDNEY       THYROID               LUNG   SKIN             i Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00L+00 0.00E+00 0.00E+00
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
    . Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:
    'For Pathway: Cow Milk T. BODY GI-TRACi         BONE     LIVER     KIDNEY THYROID                     LUNG   SKIb Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.30E+00 For Pathway: Goat Milk T. BODY GI-TRACT         BONE     LIVER     KIDNEY . THYROID                   LUNG   SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                                   I Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT         BONE     LIVER     KIDNEY THYROID                     LUNG   SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen:     0.00E+00 0.00E+00 0.00E+30 0.00E+00 0.00E+00 0.00E+0D 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                                     I
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
. Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 s
Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i
For Pathway: Vegetable l
T. BODY GI-TRACT' BONE LIVER KIDNEY' THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l
l For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i
Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00L+00 0.00E+00 0.00E+00
. Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
'For Pathway: Cow Milk T. BODY GI-TRACi BONE LIVER KIDNEY THYROID LUNG SKIb Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.30E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY. THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I
Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen:
0.00E+00 0.00E+00 0.00E+30 0.00E+00 0.00E+00 0.00E+0D 0.00E+00 0.00E+00 Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00


ODCM Rcv. 17 Page 152   .
ODCM Rcv. 17 Page 152 11/95
11/95   [
[
Table 2-2 (Continued)                                   -
Table 2-2 (Continued)
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:           Ba140             I For Pathway: Plume                                                                         -
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:
T. BODY GI-TRACT   BONE     LIVER     KIDNEY     THYROID     LUNG     SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tscn:       0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Ch'ild: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 InfEnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00             '
Ba140 I
ForPabhway: Ground T. BODY GI-TRACT   BONE     LIVER     KIDNEY     THYROID     LUNG'   SKIN   ,
For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
Adult:     6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 7.16E+05 Tecn:       6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 7.16E+05 Child:       6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 5.27E+05 6.27E+05 7.16E+05       >
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tscn:
Inftnt: 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 7.16E 705            !
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Ch'ild:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 InfEnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ForPabhway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG' SKIN Adult:
6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 7.16E+05 Tecn:
6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 7.16E+05 Child:
6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 5.27E+05 6.27E+05 7.16E+05 Inftnt: 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 7.16E 05 7
(
(
For Pathway: Vegetable T. BODY GI-TRACT   BONE     LIVER     KIDNEY     THYROID     LUNG     SKIN   ,
For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
Adult:     1.36E+05 4.29E+06 2.08E+06 2.62E+03 8.89E+02 0.00E+00 1.50E+03 0.00E+00         '
1.36E+05 4.29E+06 2.08E+06 2.62E+03 8.89E+02 0.00E+00 1.50E+03 0.00E+00 Tecn:
Tecn:       ~1.62E+05 3.88E+06 2.52E+06 3.09E+03 1.05E+03 0.00E+00 2.07E+03 0.00E+00
~1.62E+05 3.88E+06 2.52E+06 3.09E+03 1.05E+03 0.00E+00 2.07E+03 0.00E+00 Child:
* Child:     3.13E+05 2.72E+06 5.36E+06 4.69E+03 1.53E+03 0.00E+00 2.80E+03 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00             ,
3.13E+05 2.72E+06 5.36E+06 4.69E+03 1.53E+03 0.00E+00 2.80E+03 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
For Pathway: Meat T. BODY GI-TRACT   BONE     LIVER     KIDNEY     THYROID     LUNG     SKIN Adult:       3.61E+04 1.13E+06 5.50E+05 6.91E+02 2.35E+02 0.00E+00 3.96E+02 0.00E+00 Tecn:       2.93E+04 7.02E+05 4.55E+05 5.58E+02 1.89E+02 0.0dE+00 3.75E+02 0.00E+00       l Child:     4.90E+04 4.25E+05 8.4GE+05 7.36E+02 2.40E+02 0.00E+00 4.39E+03 0.00E+00         ,
3.61E+04 1.13E+06 5.50E+05 6.91E+02 2.35E+02 0.00E+00 3.96E+02 0.00E+00 Tecn:
Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00             ,
2.93E+04 7.02E+05 4.55E+05 5.58E+02 1.89E+02 0.0dE+00 3.75E+02 0.00E+00 l
For Pathway: Cow Milk T. BODY GI-TRACT   BONE     LIVER     KIDNEY     THYROID     LUNG     SKIN   l Adult:       3.37E+04 1.06E+06 5.35E+05 6.47E+02 2.20E+02 0.00E+00 3.70E+02 0.00E+00       '
Child:
TeAn:       5.99E+04 1.4?E+06 9.29E+05 1.14E+03 3.86E+02 0.00E+00 7.66E+02 0.00E+00 Chi'ld : 1.31E+05 1.14E+06 2.24E+06 1.97E+03 6.40E+02 0.00E+00 1.17E+03 0.00E+00 inf. int : 2.38E+05 1.13E+06 4.62E+06 4.62E+03 1.10E+03 0.00E+00 2.83E+03 0.00E+00 Far Pathway: Goat Milk T. BODY GI-TRACT   BONE     LIVER     KIDNEY     THYROID     LUNG     SKIN Ad alt :     4.05E+03 1.27E+05 6.18E+04 7.76E+01 2.64E+01 0.00E+00 4.44E+01 0.00E+00 Toen:       7.18E+03 1.72E+05 1.12E+05 1.37E+02 4.63E+01 0.00E+00 9.19E+01 0.00E+00       '
4.90E+04 4.25E+05 8.4GE+05 7.36E+02 2.40E+02 0.00E+00 4.39E+03 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l
Child:       1.57E+04 1.36E+05 2.69E+02 2.36E+02 7.68E+01 0.00E+00 1.41E+02 0.00E+00 Inlent: 2.85E+04 1.36E+05 5.54E+05 5.54E+02 1.32E+02 0.00E+00 3.40E+0; 0.00E+00             ,
Adult:
Fo:: Pathway: Inhalation T. BODY GI-TRACT   BONE     LIVER     KIDNEY     THYROID     LUNG     SKIN Adult:       8.14E+01 6.92E+03 1.24E+03 1.55E+00 5.30E-01 0.00E+00 4.03E+04 0.00E+00         r Teen:       1.12E+02 7.29E+03 1.73E+0~ 2.13E+00 7.23E-01 0.00E+00 6.44E+04 0.00E+00       1 Child:       1.37E+02 3.23E+03 2.35E+03 2.05E+00 6.70E-01 0.00E+00 5.52E+04 0.00E+00 Infcnt: 9.19E+01 1.22E+03 1.78E+03 1.78E+00 4.26E-01 0.00E+00 5.06E+04 0.00E+00 I
3.37E+04 1.06E+06 5.35E+05 6.47E+02 2.20E+02 0.00E+00 3.70E+02 0.00E+00 TeAn:
5.99E+04 1.4?E+06 9.29E+05 1.14E+03 3.86E+02 0.00E+00 7.66E+02 0.00E+00 Chi'ld :
1.31E+05 1.14E+06 2.24E+06 1.97E+03 6.40E+02 0.00E+00 1.17E+03 0.00E+00 inf. int : 2.38E+05 1.13E+06 4.62E+06 4.62E+03 1.10E+03 0.00E+00 2.83E+03 0.00E+00 Far Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Ad alt :
4.05E+03 1.27E+05 6.18E+04 7.76E+01 2.64E+01 0.00E+00 4.44E+01 0.00E+00 Toen:
7.18E+03 1.72E+05 1.12E+05 1.37E+02 4.63E+01 0.00E+00 9.19E+01 0.00E+00 Child:
1.57E+04 1.36E+05 2.69E+02 2.36E+02 7.68E+01 0.00E+00 1.41E+02 0.00E+00 Inlent: 2.85E+04 1.36E+05 5.54E+05 5.54E+02 1.32E+02 0.00E+00 3.40E+0; 0.00E+00 Fo:: Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
8.14E+01 6.92E+03 1.24E+03 1.55E+00 5.30E-01 0.00E+00 4.03E+04 0.00E+00 r
Teen:
1.12E+02 7.29E+03 1.73E+0~ 2.13E+00 7.23E-01 0.00E+00 6.44E+04 0.00E+00 1
Child:
1.37E+02 3.23E+03 2.35E+03 2.05E+00 6.70E-01 0.00E+00 5.52E+04 0.00E+00 Infcnt: 9.19E+01 1.22E+03 1.78E+03 1.78E+00 4.26E-01 0.00E+00 5.06E+04 0.00E+00 I
t
t


ODCM Rev. 17 Pegn 153 11/95 Table 2-2 (Continued)                                           !
ODCM Rev. 17 Pegn 153 11/95 Table 2-2 (Continued)
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:           Ce141 L For Pathway: Plume                                                                                 ;
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE:
T. BODY GI-TRACTS BONE       LIVER   KIDNEY     THYROID-     LUNG     SKIN Adult:     0.00E+00 0.00E+0040.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00               !
Ce141 L For Pathway: Plume T. BODY GI-TRACTS BONE LIVER KIDNEY THYROID-LUNG SKIN Adult:
  -Tccn:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Child:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+0'O 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT   BONE     LIVER   KIDNEY     THYROID       LUNG   SKIN Adult:     4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05
0.00E+00 0.00E+0040.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
! -Tccn:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Child:
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+0'O 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05
!.Tcon:
!.Tcon:
4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05 Child:     4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05 l Infcnt: 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05 l For Pathway: Vegetable T. BODY GI-TRACT   BONE     LIVER   KIDNEY     THYROID       LUNG   SKIN
4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05 Child:
! Adult:     3.55E+02 1.20E+07 4.63E+03 3.13E+03 1.45E+03 0.00E+00 0.00E+00 0.00E+00 1Totn:     5.57E+02 1.39E+07 7.26E+03 4.85E403 2.28E+03 0.00E+00 0.00E+00 0.00E+00                 i
4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05 l Infcnt: 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05 l For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
! Child:     1.29E+02 1.08E+07 1.74E+04 8.57E+03 3.80E+03 0.00E+00 0.00E+00 0.00E+00 l Infnnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00                   )
! Adult:
For Pathway: Meat T. BODY GI-TRACT i
3.55E+02 1.20E+07 4.63E+03 3.13E+03 1.45E+03 0.00E+00 0.00E+00 0.00E+00 1Totn:
!                                  BONE    ' LIVER   KIDNEY     THYROID       LUNG   SKIN       -  i l Adult:     1.95E+01 6.56E+05 2.54E+02 1.72E+02 7.97E+01 0.00E+00 0.00E+00 0.00E+00                 l
5.57E+02 1.39E+07 7.26E+03 4.85E403 2.28E+03 0.00E+00 0.00E+00 0.00E+00 i
' Tren:       1.63E+01 4.07E+05 2.13E+02 1.42E+02 6.70E+01 0.00E+00 0.00E+00 0.00E+00                 I l Child:     2.97E+01 2.50E+05 4.01E+02 2.00E+02 8.77E+01 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT   BONE     LIVER   KIDNEY     THYROID       LUNG   SKIN l
! Child:
Adult:     6.71E+00 2.26E+05 8.75E+01 5.92E+01 2.75E+01 0.00E+00 0.00E+00 0.00E+00 Tsen:     1.23E+01 3.06E+05 1.60E+02 1.07E+02 5.04E+01 0.00E+00 0.00E+00 0.00E+00 Child:   2.93E+01 2.46E+05 3.95E+02 1.97E+02 8.64E+01 0.00E+00 0.00E+00 0.00E+00
1.29E+02 1.08E+07 1.74E+04 8.57E+03 3.80E+03 0.00E+00 0.00E+00 0.00E+00 l Infnnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
; Infant: 5.62E+01 2.47E+05 7.83E+02 4.78E+02 1.47E+01 0.00E+00 0.00E+00 0.00E+00 L For Pathway: Goat Milk                                                                             j T. BODY GI-TRACT   BONE     LIVER   KIDNEY     THYROID       LUNG   SKIN         '
)
Adult:     8.06E-01 2.72E+04 1.05E+01 7.10E+00 3.30E+00 0.00E+00 0.00E+00 0.00E+00 Tctn:     1.48E+00 3.68E+04 1.93E+01 1.29E+01 6.05E+00 0.00E+00 0.00E+00 0.00E+00
For Pathway: Meat T. BODY GI-TRACT BONE
  ' Child:   3.51E+00 2.95E+04 4.74E+01 2.37E+01 1.04E+01 0.00E+00 0.00E+00 0.00E+00 Inftnt: 6.75E+00 2.96E+05 9.40E+01 5.73E+01 1.77E+01 0.00E+00 0.00E+00 0.00E+00 For-Pathway: Inhalation T. BODY GI-TRACT   BONE     LIVER   KIDNEY THYROID           LUNG   SKIN Adult:     4.84E+01 3.80E+03 6.31E+02 4.29E+0:2 1.99E+02 0.00E+00 2.46E+05 0.00E+00 Teen:     6.87E+01 4.01E+03 9.00E+02 6.01E+02 2.81E+02 0.00E+00 4.24E+05 0.00E+00 Child: '9.13E+01 1.79E+03 1.24E+03 6.19E+02 2.71E+02 0.00E+00 3.79E+05 0.00E+00                   l Infant: 6.30E+01 6.83E+02 8.79E+02 5.28E+02 1.66E+02 0.00E+00 3.12E+05 0.00E+00 l
' LIVER KIDNEY THYROID LUNG SKIN i
l Adult:
1.95E+01 6.56E+05 2.54E+02 1.72E+02 7.97E+01 0.00E+00 0.00E+00 0.00E+00 I
' Tren:
1.63E+01 4.07E+05 2.13E+02 1.42E+02 6.70E+01 0.00E+00 0.00E+00 0.00E+00 l Child:
2.97E+01 2.50E+05 4.01E+02 2.00E+02 8.77E+01 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
6.71E+00 2.26E+05 8.75E+01 5.92E+01 2.75E+01 0.00E+00 0.00E+00 0.00E+00 l
Tsen:
1.23E+01 3.06E+05 1.60E+02 1.07E+02 5.04E+01 0.00E+00 0.00E+00 0.00E+00 Child:
2.93E+01 2.46E+05 3.95E+02 1.97E+02 8.64E+01 0.00E+00 0.00E+00 0.00E+00
; Infant: 5.62E+01 2.47E+05 7.83E+02 4.78E+02 1.47E+01 0.00E+00 0.00E+00 0.00E+00 L For Pathway: Goat Milk j
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
8.06E-01 2.72E+04 1.05E+01 7.10E+00 3.30E+00 0.00E+00 0.00E+00 0.00E+00 Tctn:
1.48E+00 3.68E+04 1.93E+01 1.29E+01 6.05E+00 0.00E+00 0.00E+00 0.00E+00
' Child:
3.51E+00 2.95E+04 4.74E+01 2.37E+01 1.04E+01 0.00E+00 0.00E+00 0.00E+00 Inftnt: 6.75E+00 2.96E+05 9.40E+01 5.73E+01 1.77E+01 0.00E+00 0.00E+00 0.00E+00 For-Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
4.84E+01 3.80E+03 6.31E+02 4.29E+0:2 1.99E+02 0.00E+00 2.46E+05 0.00E+00 Teen:
6.87E+01 4.01E+03 9.00E+02 6.01E+02 2.81E+02 0.00E+00 4.24E+05 0.00E+00 Child: '9.13E+01 1.79E+03 1.24E+03 6.19E+02 2.71E+02 0.00E+00 3.79E+05 0.00E+00 Infant: 6.30E+01 6.83E+02 8.79E+02 5.28E+02 1.66E+02 0.00E+00 3.12E+05 0.00E+00 l
l
l


4
4 ODCM Rev. 17 Page 154 11/95 Table 2-2 (Continued)
                          ,                                            ODCM Rev. 17 Page 154 11/95 Table 2-2 (Continued)
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Ce144 For Pathway:. Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Ce144 For Pathway:. Plume T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID   LUNG   SKIN Adult:     0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:       0.00E+00 0.00E+00 0.30E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:     0.00E+00 0.00E+00-0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt.: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground i       T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID   LUNG   SKIN Adult: 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.45E+06-lTscn:       2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.45E+06
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn:
. Child     2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.45E+06 Infant: 2.12E+06 2.12E+06 2.12E+06 2.12E+0C 2.12E+06 2.12E+06 2.12E+06.2.45E+06 For Pathway: Vegetable T. BODY GI-TRACT   BONE   L11ER     KIDNEY THYROID   LUNG   SKIN Adult:     4.63E+04 2.91E+08 8.62E+05 3.60E+05 2.14E+05 0.00E+00 0.00E+00 0.00E+00
0.00E+00 0.00E+00 0.30E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child:
'Tasn:       7.73E+04 3.62E+08 1.44E+06 5.95E+05 3.56E+05 0.00E+00 0.00E+00 0.00E+00 Child:     1.87E+05 2.87E+08 3.51E+06 1.10E+06 6.10E+05 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID   LUNG   SKIN
0.00E+00 0.00E+00-0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt.: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground i
-Adult:     1.41E+03 8.90E+06 2.63E+04 1.10E+04 6.53E+03 0.00E+00 0.00E+00 0.00E+00.
T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
Toen: . *1.19E+03 5.58E+06 2.22E+04 9.18E+03 5.43E+03 0.00E+00 0.00E+00 0.00E+00 Child:     2.23E+03 3.42E+06 4.18E+04 1.31E+04 7.26E+03 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT   BONE   LIVER     FIDNEY THYROID   LUNG   SKIN Adult:     3.47E+02 2.18E+06 6.46E+03 2.70E+03 1.60E+03 0.00E+00 0.00E+00 0.00E+00 Totn:       6.39E+02 2.99E+06 1.19E+04 4.92E+03 2.94E+03 0.00E+00 0.00E+00 0.00E+00 child:     1.56E+03 2.40E+06 2.93E+04 9.19E+03 5.09E+03 0.00E+00 0.00E+00 0.00E+00 Infcnt: 2.35E+03 2.41E+06 4.20E+04 1.72E+04 6.95E+03 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID   LUNG   SKIN Adult:     4.16E+01 2.62E+05 7.75E+02 3.24E+02 1.92E+02 0.00E+00 0.00E+00 0.00E+00
2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.45E+06-lTscn:
.Tecn:       7.67E+01 3.59E+05 1.43E+03 5.90E+02 3.53E+02 0.00E+00 0.00E+00 0.00E+00.
2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.45E+06
Child:     1.88E+02 2.88E+05 3.52E+03 1.10E+03 6.11E+02 0.00E+00 0.00E+00 0.00E+00 Infant: 2.82E+02 2.89E+05 5.04E+03 2.06E+03 8.34E+p2 0.00E+00 0.00E+00 0.00E+00
. Child 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.45E+06 Infant: 2.12E+06 2.12E+06 2.12E+06 2.12E+0C 2.12E+06 2.12E+06 2.12E+06.2.45E+06 For Pathway: Vegetable T. BODY GI-TRACT BONE L11ER KIDNEY THYROID LUNG SKIN Adult:
.For Pathway: Inhalation T. BODY GI-TRACT   BONE   LIVER     KIDNEY THYROID   LUNG   SKIN Adult:     5.83E+03 2.59E+04 1.09E+05 4.54E+04 2.69E404 0.00E+002i46E+050.00E+00 Tecn:       8.32E+03 2.74E+04 1.55E+05 6.42E+04 3.83E+04 0.00E+00 4/24E+05.0.00E+00 Child:     1.15E+04 1.23E+04 2.15E+05 6.71E+04 3.72E+04 0.00E+00 3.79E+05 0.00E+00 Infant: 5.59E+03.4.70E+03 1.01E+05 3.84E+04 1.70E+04 0.00E+00 3.12E+05 0.00E+00
4.63E+04 2.91E+08 8.62E+05 3.60E+05 2.14E+05 0.00E+00 0.00E+00 0.00E+00
'Tasn:
7.73E+04 3.62E+08 1.44E+06 5.95E+05 3.56E+05 0.00E+00 0.00E+00 0.00E+00 Child:
1.87E+05 2.87E+08 3.51E+06 1.10E+06 6.10E+05 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
-Adult:
1.41E+03 8.90E+06 2.63E+04 1.10E+04 6.53E+03 0.00E+00 0.00E+00 0.00E+00.
Toen:. *1.19E+03 5.58E+06 2.22E+04 9.18E+03 5.43E+03 0.00E+00 0.00E+00 0.00E+00 Child:
2.23E+03 3.42E+06 4.18E+04 1.31E+04 7.26E+03 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER FIDNEY THYROID LUNG SKIN Adult:
3.47E+02 2.18E+06 6.46E+03 2.70E+03 1.60E+03 0.00E+00 0.00E+00 0.00E+00 Totn:
6.39E+02 2.99E+06 1.19E+04 4.92E+03 2.94E+03 0.00E+00 0.00E+00 0.00E+00 child:
1.56E+03 2.40E+06 2.93E+04 9.19E+03 5.09E+03 0.00E+00 0.00E+00 0.00E+00 Infcnt: 2.35E+03 2.41E+06 4.20E+04 1.72E+04 6.95E+03 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
4.16E+01 2.62E+05 7.75E+02 3.24E+02 1.92E+02 0.00E+00 0.00E+00 0.00E+00
.Tecn:
7.67E+01 3.59E+05 1.43E+03 5.90E+02 3.53E+02 0.00E+00 0.00E+00 0.00E+00.
Child:
1.88E+02 2.88E+05 3.52E+03 1.10E+03 6.11E+02 0.00E+00 0.00E+00 0.00E+00 Infant: 2.82E+02 2.89E+05 5.04E+03 2.06E+03 8.34E+p2 0.00E+00 0.00E+00 0.00E+00
.For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:
5.83E+03 2.59E+04 1.09E+05 4.54E+04 2.69E404 0.00E+002i46E+050.00E+00 Tecn:
8.32E+03 2.74E+04 1.55E+05 6.42E+04 3.83E+04 0.00E+00 4/24E+05.0.00E+00 Child:
1.15E+04 1.23E+04 2.15E+05 6.71E+04 3.72E+04 0.00E+00 3.79E+05 0.00E+00 Infant: 5.59E+03.4.70E+03 1.01E+05 3.84E+04 1.70E+04 0.00E+00 3.12E+05 0.00E+00


i I
i ODCM R v. 17 Pnga 155 11/95 TABLE 2-3 Assumptions Used in Limerick Gaseous Effluent Dose Evaluation Index Description value 1
ODCM R v. 17 Pnga 155 11/95 TABLE 2-3                                     I Assumptions Used in Limerick Gaseous Effluent Dose Evaluation Index         Description                                         value 1   Fraction of produce from local garden                           0.76       :
Fraction of produce from local garden 0.76 2
2  Fraction of leafy vegetable from local garden                   1.00       1 3   Soil density in plow layer (kg/m**2)                         240.0 4   Fraction of deposited particulates retained on vegetation       0.20 5   Fraction of deposited iodines retained on vegetation             1.0 6   Shielding factor of residential structures                       0.7 7   Period of buildup of activity in soil (hr)                 175200.0 8   Period of pasture grass exposure to activity (hr)             720.0 9   Period of crop exposure to activity (hr)                     1440.0 10   Transport time milkman (hr)                                     48.0 11   Delay time for ingestion of grass by animals (hr)               0.0 12   Delay time for ingestion of stored feed by animals (hr)     2160.0 13   Delay time for ingestion of leafy vegetable by man thr)         24.0 14   Delay time for ingestion of other vegetable by man (hr)     1440.0 15   Time between slaughter and consumption of meat animal (hr)   480.0 16   Grass yield, wet wt (kg/m**2)                                   0.7 17   Other vegetation yield, wet wt (kg/m**2)                         2.0 18   Weathering rate constant for activity on veg (1./hr)             0.0021     l 19   Milk cow feed consumption rate (kg/ day wet)                   50.0         l 20   Beef cattle consumption rate (kg/ day wet)                     50.~0 21   Goat feed consumption rate (kg/ day wet)                         6.0 22   Plume exposure adult (hr/yr)                                 8760.0 23   Plume exposure teen (hr/yr)                                 8760.0 24   Plume exposure child (hr/yr)                                 8760.0 25   Plutue exposure infant (hr/yr)                               8760.0 26
Fraction of leafy vegetable from local garden 1.00 3
                                                                                    )
Soil density in plow layer (kg/m**2) 240.0 4
Ground exposure adult (hr/yr)                               8760.0         l 27   Ground exposure teen (hr/yr)                                 8760.0 28 Ground exposure child (hr/yr)                               8760.0         I 29   Ground exposure infant (hr/yr)                               8760.0 30   Inhalation exposure adult (m**3/yr)                         8000.0         ,
Fraction of deposited particulates retained on vegetation 0.20 5
31   Inhalation exposure teen (m**3/yr)                           8000.0         I 32   Inhalation exposure child (m**3/yr)                         3700.0         )
Fraction of deposited iodines retained on vegetation 1.0 6
33   Inhalation exposhre infant (m**3/yr)                         1400.0         i 34   Leafy veg exposure adult (kg/yr)                               64.0 35   Leafy veg exposure teen (kg/yr)                                 42.0 30   Leafy veg exposure child (kg/yr)                               26.0         i 37' Leafy veg exposure infant (kg/yr)                                 0.0 38   Non-leafy veg exposure adult (kg/yr)                         520.0         1 39   Non-leafy veg exposure teen (kg/yr)                           630.0 40   Non-leafy veg exposure child (kg/yr)                           520.0         j 41   Non-leafy veg exposure infant (kg/yr)                             0.0 42   Root veg consumption rate adult (kg/yr)                           0.0 43   Root veg consumption rate teen (kg/yr)                           0.0 i 44   Root veg consumption rate child (kg/yr)                           0.0 s
Shielding factor of residential structures 0.7 7
Period of buildup of activity in soil (hr) 175200.0 8
Period of pasture grass exposure to activity (hr) 720.0 9
Period of crop exposure to activity (hr) 1440.0 10 Transport time milkman (hr) 48.0 11 Delay time for ingestion of grass by animals (hr) 0.0 12 Delay time for ingestion of stored feed by animals (hr) 2160.0 13 Delay time for ingestion of leafy vegetable by man thr) 24.0 14 Delay time for ingestion of other vegetable by man (hr) 1440.0 15 Time between slaughter and consumption of meat animal (hr) 480.0 16 Grass yield, wet wt (kg/m**2) 0.7 17 Other vegetation yield, wet wt (kg/m**2) 2.0 18 Weathering rate constant for activity on veg (1./hr) 0.0021 19 Milk cow feed consumption rate (kg/ day wet) 50.0 20 Beef cattle consumption rate (kg/ day wet) 50.~0 21 Goat feed consumption rate (kg/ day wet) 6.0 22 Plume exposure adult (hr/yr) 8760.0 23 Plume exposure teen (hr/yr) 8760.0 24 Plume exposure child (hr/yr) 8760.0 25 Plutue exposure infant (hr/yr) 8760.0 26 Ground exposure adult (hr/yr) 8760.0 27 Ground exposure teen (hr/yr) 8760.0 28 Ground exposure child (hr/yr) 8760.0 29 Ground exposure infant (hr/yr) 8760.0 30 Inhalation exposure adult (m**3/yr) 8000.0 31 Inhalation exposure teen (m**3/yr) 8000.0 32 Inhalation exposure child (m**3/yr) 3700.0
)
33 Inhalation exposhre infant (m**3/yr) 1400.0 i
34 Leafy veg exposure adult (kg/yr) 64.0 35 Leafy veg exposure teen (kg/yr) 42.0 30 Leafy veg exposure child (kg/yr) 26.0 37' Leafy veg exposure infant (kg/yr) 0.0 38 Non-leafy veg exposure adult (kg/yr) 520.0 39 Non-leafy veg exposure teen (kg/yr) 630.0 40 Non-leafy veg exposure child (kg/yr) 520.0 j
41 Non-leafy veg exposure infant (kg/yr) 0.0 42 Root veg consumption rate adult (kg/yr) 0.0 43 Root veg consumption rate teen (kg/yr) 0.0 i
44 Root veg consumption rate child (kg/yr) 0.0 s


ODCM Rev. 17 Page 156 11/95 TABLE 2-3 (Continued)
ODCM Rev. 17 Page 156 11/95 TABLE 2-3 (Continued)
Assumptions Used in Limerick Gaseous
Assumptions Used in Limerick Gaseous I
* I Effluent Dose Evaluation
Effluent Dose Evaluation
  -Indsx           Description                                                 Value 45   Root veg consumption rate infant 1(kg/yr)                                       0.0 46   Cow milk consumption rate adult (1/yr)                                     310.0 47   Cow milk consumption rate teen (1/yr)                                       400.0 48   Cow milk consumption rate child (1/yr)                                     330.0 49   Cow milk consumption rate infant (1/yr)                                     330.0                 !
-Indsx Description Value 45 Root veg consumption rate infant 1(kg/yr) 0.0 46 Cow milk consumption rate adult (1/yr) 310.0 47 Cow milk consumption rate teen (1/yr) 400.0 48 Cow milk consumption rate child (1/yr) 330.0 49 Cow milk consumption rate infant (1/yr) 330.0 50 Goat milk consumption rate adult (1/yr) 23.0 51 Goat milk consumption rate teen (1/yr) 29.0 52 Goat milk consumption rate child (1/yr) 0.0 53 Goat milk censumption rate infant (1/yr) 0.0 54 Meat consumption rate adult (kg/yr) 110.0 55 Meat consumption rate teen (kg/yr) 65.0 56 Meat consumption rate child (kg/yr) 41.0 l
50   Goat milk consumption rate adult (1/yr)                                     23.0 51   Goat milk consumption rate teen (1/yr)                                       29.0 52   Goat milk consumption rate child (1/yr)                                         0.0 53   Goat milk censumption rate infant (1/yr)                                         0.0               ,
57 Meat consumption rate infant (kg/yr) 0.0 58 Fraction of year mals on pasture 0.75
54   Meat consumption rate adult (kg/yr)                                         110.0 55   Meat consumption rate teen (kg/yr)                                           65.0                 .
'd l59 Fraction of feed frv..z pasture when on pasture 0.39 60 Fraction of year leafy veg grown 0.42.
56   Meat consumption rate child (kg/yr)                                         41.0                 l 57   Meat consumption rate infant (kg/yr)                                             0.0 58   Fraction of year     'd mals on pasture                                         0.75             ,
61 Atmosphere hydrogen concentration (gm/md:* 3 )
l59   Fraction of feed frv..z pasture when on pasture                                 0.39 60   Fraction of year leafy veg grown                                                 0.42.
8.0?
61   Atmosphere hydrogen concentration (gm/md:* 3 )                                   8.0?               l 4
4 t
t i
i 9
9 i
i
[
[
a l
a l
                                                                                                              )
)
I e
e
l
\\
                                                                                                              \
l


ODCM Rev. 17 Pega 157 11/95 TABLE 2-4 Nearest Gaseous Effluent Dose Receptor Distances (Meters)
ODCM Rev. 17 Pega 157 11/95 TABLE 2-4 Nearest Gaseous Effluent Dose Receptor Distances (Meters)
Plume Ground Inhalation     Vegetation     Meat       Cow         Goat Direction   Pathways       Pathway         Pathway   Pathway     Pathway N           965           2574           3414         7562             0 NNE         805           805         4 1585             0             0 NE         1287           2414           1097             0             0 ENE         965           2896           3871             0             0 E           965           1770           1890             0             0 ESE         805           1931           4511         1770         1770 SE         1609           1770           7241             0             0 SSE       1609           1931           7224         7562             0 S         1287           1931           3018         3701             0 SSW       1609           2253           1433         2896             0 SW         965           965           2835         4827             0 WSW       1287           1287           2134         4505             0 W           965           3540           4084             0             0 WNW       1126           1126               0             0             0 NW         2092   ,      2574           6660             0             0 NNW       1448     -
Plume Ground Inhalation Vegetation Meat Cow Goat Direction Pathways Pathway Pathway Pathway Pathway N
1931           6325             0             0 i
965 2574 3414 7562 0
NNE 805 805 4 1585 0
0 NE 1287 2414 1097 0
0 ENE 965 2896 3871 0
0 E
965 1770 1890 0
0 ESE 805 1931 4511 1770 1770 SE 1609 1770 7241 0
0 SSE 1609 1931 7224 7562 0
S 1287 1931 3018 3701 0
SSW 1609 2253 1433 2896 0
SW 965 965 2835 4827 0
WSW 1287 1287 2134 4505 0
W 965 3540 4084 0
0 WNW 1126 1126 0
0 0
NW 2092 2574 6660 0
0 NNW 1448 1931 6325 0
0 i
h
h


Line 2,704: Line 4,728:
l t
l t
4 l
4 l
                                    )
)
i                             e     i 1
i e
\
i 1
\\
I i
I i
1 APPENDIX A                       '
1 APPENDIX A a
>              a 1
1 h
l h
?
        ?
I a
I a
t 4
t 4
Line 2,717: Line 4,741:


l l:
l l:
ODCM Rev. 17           ,
ODCM Rev. 17 Paga 159 11/95 TABLE A-1 Technical Specification /ODCM Matrix ODCM ODCM Technical Section I Equation Soecification*
Paga 159 11/95 TABLE A-1 Technical Specification /ODCM Matrix ODCM                                                 ODCM                     ,
Recuirement Section II i
Technical                                                               Section I                                           Equation Soecification*                                                           Recuirement                                         Section II               i i
i 3.3.7.11 3.2.1 1-1 i
3.3.7.11                                                                         3.2.1                                         1-1                     i 1-2 1-3                     '
1-2 1-3 1-4 3.3.7.12 3.3.1 2-1'(or 2-9) 2-2 (or 2-9) 2 (or 2-10) 2-5 (or 2-10)
1-4 3.3.7.12                                                                         3.3.1                                         2-1'(or 2-9) 2-2 (or 2-9)           '
(
2 (or 2-10) 2-5 (or 2-10)
3.11.1.1 3.2.2-1-1 l
1-2 t
1-3 l
1-4 i
3.11.1.2 3.2.3 1-5 1-6 1-7 3.11.1.3 3.2.4 1-8
(
(
3.11.1.1                                                                        3.2.2-                                        1-1 l
1-9 3.11.2.1 3.3.2 2-2't 2-23 3.'11.2.3 3.3.4 2-26 2-27 2-28 3.11.-2.2 3.3.3 2-24 2-25 3.11.2.4 3.3.5.
!.                                                                                                                                    1-2                    '
2-33 3.11.2.7 3.3.6 2-4 2-5 b'
t 1-3                    l 1-4 i
* Transferred to ODCM via T.S.
3.11.1.2                                                                        3.2.3                                  >
amendment # 48 for Unit 1 and 11 for Unit 2.
1-5 1-6 1-7 3.11.1.3                                                                        3.2.4                                        1-8                    (
~
1-9 3.11.2.1                                                                         3.3.2                                         2-2't 2-23 3.'11.2.3                                                                       3.3.4                                         2-26 2-27                     l 2-28 3.11.-2.2                                                                       3.3.3                                         2-24 2-25 3.11.2.4                                                                         3.3.5.                                       2-33 3.11.2.7                                                                         3.3.6                                       2-4 2-5 b
f I'
* Transferred to ODCM via T.S. amendment # 48 for Unit 1 and 11 for Unit 2.                                               ~
f


ODCM Rsv. 17 i 8
ODCM Rsv. 17 8
Page 160 11/95 TABLE A-1 Technical Specification /ODCM Matrix ODCM                       ODCM Tcchnical                         Section I                 Equation Sp;cification*                   Requirement               Section II 6.9.1.8                             3.6                       1-5 1-6 1-7 2-24 2-25 2-26 2-27 2-28 3.11.4                             3.3.7                     3-1 3.12.1                             3.4.1                     Section II App. B 6.9.1.7                             3.5                       1-5 3.12.3                             3.4.3 1-6 1-7 2-29
Page 160 11/95 TABLE A-1 Technical Specification /ODCM Matrix ODCM ODCM Tcchnical Section I Equation Sp;cification*
                                                            !2-30 2-31 2-32 3-2
Requirement Section II 6.9.1.8 3.6 1-5 1-6 1-7 2-24 2-25 2-26 2-27 2-28 3.11.4 3.3.7 3-1 3.12.1 3.4.1 Section II App. B 6.9.1.7 3.5 1-5 3.12.3 3.4.3 1-6 1-7 2-29
* Transferred to ODCM via T.S. amendment # 48 for Unit 1 and 11 for Unit 2.
!2-30 2-31 2-32 3-2
* Transferred to ODCM via T.S.
amendment # 48 for Unit 1 and 11 for Unit 2.


                                                                                                                                                                                          . . _ - _ . ~ .,
.. _ - _. ~.,
                                                                                                                                                                            -OD0f4.Rav. 17   .
-OD0f4.Rav. 17 I
Pzga 161 l
e 11/95 i
I P
s i
t i
r
'i l
i l
APPENDIX B i
i P
RADIOLOGICAL ENVIRONMENTAL MONITORING ~ PROGRAM -
SAMPLE. TYPE, LOCATION,- AND ANALYSIS i
I
I
:                                                                                                                                                                                Pzga 161                  l e
11/95              !
i I
P
:                                                                                                                                  s i
,                                                                                                                                                                                                          t
                        ,                                                                                    .                                                                                            i r
                                                                                                                                                                                                          'i l
i l
APPENDIX B                                                                                                    i i
P RADIOLOGICAL ENVIRONMENTAL MONITORING ~ PROGRAM -                                                                                                      ;
SAMPLE. TYPE, LOCATION,- AND ANALYSIS                                                                                                      .,
i I
(
(
I k
I k
l I
l I
r
r
                                                                                                                                                                                                          +t I
+t I
I 1
I 1
t i
t ii I
i I
I i
I i
i t'
i t'
i i
i i
* i I
i I
                                                                                                                                                                        ..,                                i s
i s
i
i p.
                        , , . ,    p.   -. r -
-. r 7
                                                                          , . ,              -- , . , - . , _ _ .                  - _ . - - - . ,          . . , , .                                      4 7      _                                                                                                                      -  ..,          .,  --
4


.                                                                                                                                                                                                                  ODCM Rev. 17 Page 162
ODCM Rev. 17 Page 162 11/95 TABLE B-1 ODCM - Limerick Generating Station Radiological Environmental Monitoring Program r
* 11/95 TABLE B-1 ODCM - Limerick Generating Station Radiological Environmental Monitoring Program                                                                                                                                                                                         ,
Pathway Station Code Location Collection Method Analyses I.
r Pathway                                                         Station Code                                                                               Location               Collection Method                                                                                                                                 Analyses I.                           Direct                                                       36S2                                                 3,183       feet N of site       1 set of four (4) TLDs                                                                                                       Gamma dose quarterly Site Boundary                                               3S1                                                   2,301       feet NNE of site     from each location'at SS1                                                   2,350       feet NE of site     least quarterly 7S1                                                   3,099       feet ENE of site 10S3                                                 2,648       feet E of site 11S1                                                 2,017       feet ESE of site                                                                                                                                                                                             '
Direct 36S2 3,183 feet N of site 1 set of four (4) TLDs Gamma dose quarterly Site Boundary 3S1 2,301 feet NNE of site from each location'at SS1 2,350 feet NE of site least quarterly 7S1 3,099 feet ENE of site 10S3 2,648 feet E of site 11S1 2,017 feet ESE of site 13S2 2,149 feet SE of site 14S1 3,319 feet SSE of site 18S2 1,390 feet S of site 21S2 977 feet ~SSW of site 23S2.
13S2                                                 2,149       feet SE of site                                                                                                                                                                                             ,
2,793 feet SW of site 25S2 2,445 feet WSW of site 26S3 2,088 feet W of site 29S1 2,886 feet WNW of site 31S1 1,395 feet NW of site 34S2 3,071 feet NNW of site Intermediate 36D1 18,527 feet N of site Distance 2E1 25,112 feet NNE of site 4E1 25,221 feet NE of site 7El 22,489 feet ENE of site,.
14S1                                                 3,319       feet SSE of site 18S2                                                 1,390       feet S of site                                                                                                                                                                                               ,
10E1 20,826 feet E of site 10F3 29,442 feet ESE of site 13E1 22,772 feet.SE of site 16F1 26,608 feet SSE of site 19D1 18,439 feet-S of site i
21S2                                                   977       feet ~SSW of site
20F1 27,648 feet SSW of site 24D1 20,972 feet SW of site 25D1 21,044 feet WSW of site i
* 23S2.                                                 2,793       feet SW of site 25S2                                                   2,445       feet WSW of site 26S3                                                   2,088       feet W of site                                                                                                                                                                                               :
28D2 20,231 feet W of site 29El 26,110 feet WNW of site 31D2 20,446 feet NW of site
29S1                                                   2,886       feet WNW of site 31S1                                                   1,395       feet NW of site 34S2                                                   3,071       feet NNW of site Intermediate                                               36D1                                                   18,527 feet N of site Distance                                                   2E1                                                   25,112 feet NNE of site 4E1                                                   25,221 feet NE of site 7El                                                   22,489 feet ENE of site ,.                                                                                                                                                                                               ,
10E1                                                   20,826       feet E of site 10F3                                                   29,442       feet ESE of site                                                                                                                                                                                           ,
13E1                                                   22,772       feet.SE of site                                                                                                                                 .
16F1                                                   26,608       feet SSE of site 19D1                                                   18,439       feet-S of site                                                                                                                                                                                             .
i 20F1                                                   27,648       feet SSW of site 24D1                                                   20,972       feet SW of site 25D1                                                   21,044       feet WSW of site                                                                                                                                                                                           i 28D2                                                   20,231       feet W of site 29El                                                   26,110       feet WNW of site 31D2                                                   20,446       feet NW of site


ODCM Rev. 17 Page 163 11/95 TABLE B-1 Page 2 of 4 Pathway                 Station Code     Location             Collection Method             Analyses 34E1   24,243 feet NNW of site Distant
ODCM Rev. 17 Page 163 11/95 TABLE B-1 Page 2 of 4 Pathway Station Code Location Collection Method Analyses 34E1 24,243 feet NNW of site Distant 5H1 C
* 5H1 C   130,742 feet'NE of site and               6C1     11,305 feet NE of site Special           9C1     11,377 feet E of site Interest           13C1     14,980 feet SE of site 15D1     16,877 feet SE of site 17B1     8,462 feet S of site 20D1     16,157 feet SSW of site 31D1     15,853 feet WNW of site II.     Airborne Particulates       10S3     2,648 feet E of site     Approximately 1 cfm     Gross beta analysis 11S1     2,017 feet ESE of site   continuous flow through on each weekly 14S1     3,319 feet SSE of site   glass fiber filter       sample. Gamma 13C1   14,980 feet SE of site   which is collected       spectrometry shall be 22G1 C 93,619 feet SW of site   weekly.                 done when gross beta exceeds ten times the yearly mean of control station value.
130,742 feet'NE of site and 6C1 11,305 feet NE of site Special 9C1 11,377 feet E of site Interest 13C1 14,980 feet SE of site 15D1 16,877 feet SE of site 17B1 8,462 feet S of site 20D1 16,157 feet SSW of site 31D1 15,853 feet WNW of site II.
Airborne Particulates 10S3 2,648 feet E of site Approximately 1 cfm Gross beta analysis 11S1 2,017 feet ESE of site continuous flow through on each weekly 14S1 3,319 feet SSE of site glass fiber filter sample.
Gamma 13C1 14,980 feet SE of site which is collected spectrometry shall be 22G1 C 93,619 feet SW of site weekly.
done when gross beta exceeds ten times the yearly mean of control station value.
Gross beta analysis done =24 hr after sampling to allow for Radon and Thoron daughter decay.
Gross beta analysis done =24 hr after sampling to allow for Radon and Thoron daughter decay.
Gamma Spec on quarterly composite.
Gamma Spec on quarterly composite.


ODCM Rev. 17 Page 164 11/95 TABLE B-1 Page 3 of 4 Pathway       Station Code                                                                                                                                                               Location                   Collection Method                                                                         Analyses Iodine                                     10S3                                                                                       2,648                                           feet E of site           A TEDA impregnated                                         Iodine 131 11S1                                                                                       2,017                                           feet ESE of site         flow-through cartridge 14S1                                                                                       3,319                                           feet SSE of site         is connected to air 13C1                                                                           14,980                                                       feet SE of site         sampler and is 22G1                           C                                               93,619                                                       feet SW of site         collected weekly at site filter change.
ODCM Rev. 17 Page 164 11/95 TABLE B-1 Page 3 of 4 Pathway Station Code Location Collection Method Analyses Iodine 10S3 2,648 feet E of site A TEDA impregnated Iodine 131 11S1 2,017 feet ESE of site flow-through cartridge 14S1 3,319 feet SSE of site is connected to air 13C1 14,980 feet SE of site sampler and is 22G1 C
III. Water Surface                                   24S1                         C                                                           1,058 feet SSW of site                                                     Sample collected from a                                   Gamma isotopic 13B1                                                                                       9,225 feet ESE of site                                                   continuous' water                                         analysis monthly:
93,619 feet SW of site collected weekly at site filter change.
sampler, monthly.                                     In event sampler is                                           H-3 on quarterly inoperable, weekly grab                                   composite samples will be collected until sampler returned to service.
III. Water Surface 24S1 C
Sediment                                   16C4                                                                           11,510 feet ESE of site                                                               A sediment sample is                                       Gamma isotopic taken down stream of                                       analysis each discharge semi-annually                                   sample IV. Incestion Milk                                       10B3                                                                                     5,725                                             feet ESE of site         Sample of fresh milk is                                   Gamma isotopic and 19B1                                                                         10,317                                                         feet SSW of site         collected from each                                       I-131 analyses on 21B1                                                                                     9,263                                             feet SSW of site         farm biweekly when cows                                   each sample 22F1                         C                                               50,569                                                         feet SW of site         are on pasture (April through October),
1,058 feet SSW of site Sample collected from a Gamma isotopic 13B1 9,225 feet ESE of site continuous' water analysis monthly:
sampler, monthly.
In event sampler is H-3 on quarterly inoperable, weekly grab composite samples will be collected until sampler returned to service.
Sediment 16C4 11,510 feet ESE of site A sediment sample is Gamma isotopic taken down stream of analysis each discharge semi-annually sample IV.
Incestion Milk 10B3 5,725 feet ESE of site Sample of fresh milk is Gamma isotopic and 19B1 10,317 feet SSW of site collected from each I-131 analyses on 21B1 9,263 feet SSW of site farm biweekly when cows each sample 22F1 C
50,569 feet SW of site are on pasture (April through October),
monthly at other times.
monthly at other times.


ODCM Rev. 17 Page 165 11/95 TABLE B-1 Page 4 of 4 Pathway         Station Code                                               Location             Collection Method     Analyses Drinking                                         15F7       33,400 feet SSE of site Sample collected from a Gross beta and gamma 15F4       45,514 feet SE of site   continuous water         isotopic monthly, 16C2       14,t34 feet SSE of site sampler monthly. In 28F3   C   30,811 feet WNW of site event sampler in         H-3 on quarterly inoperable, weekly grab composite samples will be collected until sampler returned to service.
ODCM Rev. 17 Page 165 11/95 TABLE B-1 Page 4 of 4 Pathway Station Code Location Collection Method Analyses Drinking 15F7 33,400 feet SSE of site Sample collected from a Gross beta and gamma 15F4 45,514 feet SE of site continuous water isotopic monthly, 16C2 14,t34 feet SSE of site sampler monthly.
Fish                                             16C5       9,251 feet SSE of site Two species of           Gamma isotopic 29C1     C 13,725 feet WNW of site recreationally'*         analyses on edible important fish           portions.
In 28F3 C
(Predator and bottom
30,811 feet WNW of site event sampler in H-3 on quarterly inoperable, weekly grab composite samples will be collected until sampler returned to service.
                                                                                '        feeder) sampled in season or semiannually if not seasonal.
Fish 16C5 9,251 feet SSE of site Two species of Gamma isotopic 29C1 C
Food                                             Two offsite locations of highest   Samples of three (3)     Gamma isotopic Products                                         predicted annual average ground     different kinds of       analysis level D/Q and one location (15-     broad leaf vegetation
13,725 feet WNW of site recreationally'*
                              ..                    30 km distance) in the least       monthly when available prevalent wind direction as         if milk samplings is not determined using the results of     performed.
analyses on edible important fish portions.
(Predator and bottom feeder) sampled in season or semiannually if not seasonal.
Food Two offsite locations of highest Samples of three (3)
Gamma isotopic Products predicted annual average ground different kinds of analysis level D/Q and one location (15-broad leaf vegetation 30 km distance) in the least monthly when available prevalent wind direction as if milk samplings is not determined using the results of performed.
the most recent annual Landuse Survey.
the most recent annual Landuse Survey.
C = Control Location
C = Control Location


r-I l               ODCM R v. 17 Prga 166 11/95 l
r-I l
ODCM R v. 17 Prga 166 11/95 l
l l
l l
l P
l P
l i
l i
I r
I r
1 1                                 I l
1 1
                                  )
I l
)
l i
l i
APPENDIX C i
APPENDIX C i
i l
i l
                                .1 h'
.1 h'
1 i
1 i
l 4
4
(
l l
l l
(                                  !
}
l l  }
i i
i i
a t
a t
I
I


l ODCM Rsv. 17 ;
l ODCM Rsv. 17 Pcga 167 11/95 ODCM Revision Process 1
Pcga 167 11/95 ODCM Revision Process 1
I.
I. REVISION PROCESS                                                           l
REVISION PROCESS l
: a. The preparer shall ensure the ODCM contains program elements           i described in Technical Specifications 6.8.4.d,e and f.                .
a.
: b. All pages affected by the change shall contain revision bars           ,
The preparer shall ensure the ODCM contains program elements i
in the margin indicating the area of the page changes and             '
described in Technical Specifications 6.8.4.d,e and f.
1 the date (month and year) of the change. Revision bars from previous revision;s shall be removed.
b.
i
All pages affected by the change shall contain revision bars in the margin indicating the area of the page changes and 1
: c. The preparer of the proposed change shall assemble an ODCM             ;
the date (month and year) of the change.
revision package. This package should contain:
Revision bars from previous revision;s shall be removed.
: 1. Proposed page changes.                                           ,
i c.
i
The preparer of the proposed change shall assemble an ODCM revision package.
: 2. Sufficient information, appropriate analysis or                   !
This package should contain:
evaluation to suppport the change.                               ]
1.
1
Proposed page changes.
: 3. A determination that the changes will maintain the               !
i 2.
level of effluent control required by 10CFR20.1301, 10CFR20.1302, 40 CFR Part.190, 10CFR50.36a and Appendix         j I to 20CFR Part 50.     -
Sufficient information, appropriate analysis or evaluation to suppport the change.
l
]
: 4. A 10CFR50.59 review prepared in accordance with administrative procedures.        .
3.
: 5. Other documentation as required by administrative                 I procedures.
A determination that the changes will maintain the level of effluent control required by 10CFR20.1301, 10CFR20.1302, 40 CFR Part.190, 10CFR50.36a and Appendix j
II. REVIEW PROCESS                                                               I I
I to 20CFR Part 50.
: a. The preparer shall obtain review of the ODCM revision package utilizing the SQR. process in accordance with administrative procedures 8
l 4.
A 10CFR50.59 review prepared in accordance with administrative procedures.
5.
Other documentation as required by administrative I
procedures.
II.
REVIEW PROCESS I
a.
The preparer shall obtain review of the ODCM revision package utilizing the SQR. process in accordance with administrative procedures 8
This review should include:
This review should include:
: 1. Technical Support Health Physics Supervisor.
1.
: 2. Cross-disciplinary review (i.e. Chem, R/W, Nuclear Eng. '
Technical Support Health Physics Supervisor.
Div. Programs Branch, EP) , if required, and
2.
: 3. Review by the Superintendent - Services Division (responsible Superintendent).
Cross-disciplinary review (i.e. Chem, R/W, Nuclear Eng.
l
Div. Programs Branch, EP), if required, and 3.
: b. Upon satisfactory completion of the SQR and responsible Superintendent reviews the preparer shall obtain PORC approval of the ODCM revision package.                               ]
Review by the Superintendent - Services Division (responsible Superintendent).
III. APPROVAL
b.
: a. Upon satisfactory completion of PORC review and appropriate review / approval forms, the revised ODCM shall be forwarded to the Plant Manager for approval signature on the ODCM cover sheet.
Upon satisfactory completion of the SQR and responsible Superintendent reviews the preparer shall obtain PORC approval of the ODCM revision package.
l
]
III. APPROVAL a.
Upon satisfactory completion of PORC review and appropriate review / approval forms, the revised ODCM shall be forwarded to the Plant Manager for approval signature on the ODCM cover sheet.


ODCM Rev. 17'               I Page 168               l 11/95         j IV.         ISSUANCE
ODCM Rev. 17' Page 168 11/95 j
: 2. The ODCM shall be issued as a complete document.                           Issuing                       f page changes is not permitted.                                                                           l
IV.
: b. The ODCM shall contain a cover sheet indicating the ODCM revision number and a Table of Contents. All pages of the ODCM shall be marked with the revision number and date.
ISSUANCE 2.
* 1 l
The ODCM shall be issued as a complete document.
: c. The preparer chall forward the following to the Document                                                 !
Issuing f
Control Center:
page changes is not permitted.
l b.
The ODCM shall contain a cover sheet indicating the ODCM revision number and a Table of Contents.
All pages of the ODCM shall be marked with the revision number and date.
1 l
c.
The preparer chall forward the following to the Document Control Center:
[
1.
Original ODCM for issuance.
[
[
: 1.       Original ODCM for issuance.                                                                    [
2.
The ODCM revision package.
The ODCM revision package.
: 2.                                                                                                        l
l 3.
: 3.       10 CFR50.59 reviews.                                                                           $
10 CFR50.59 reviews.
: 4.       All appropriate review / approval forms.                                                       t V.           IMPLEMENTATION                                                                                                 j a
4.
: a. Changes to the ODCM shall become effective upon approval of the Plant Manager.                                                                                       ;
All appropriate review / approval forms.
i
t V.
: b. The Effluent Physicist shall ensure that a copy of the                                                   l complete ODCM is submitted to the NRC with the Annual                                                     !
IMPLEMENTATION j
Radioactive Release Report for the period of the report in                                               ;
a a.
which the change to the ODCM was made.                                                                   j i
Changes to the ODCM shall become effective upon approval of the Plant Manager.
i b.
The Effluent Physicist shall ensure that a copy of the l
complete ODCM is submitted to the NRC with the Annual Radioactive Release Report for the period of the report in which the change to the ODCM was made.
j i
i
i
                                                            ~
~
f
f
                                                                                                                                        -r 1
:-r 1
i l
i l
i i
i i
i i
i i
{
{
l                 l l
l l
I
l I


p.
p.
ODCM RI;v.17 Pcg3 169
ODCM RI;v.17 Pcg3 169 11/95 l.
: l.                                                                                    11/95 l
1 l
l 1
l 1
J l
1 J
FIGURES l
l FIGURES l
i l
i l
i I
i I
Line 2,899: Line 4,954:
l t
l t
1 1
1 1
1 i
i 1
1 i
i


    .n LGS DILUTION vs RIVER FLOW                             -
.n LGS DILUTION vs RIVER FLOW STATION (OUTFALL) i 1l+03 l
STATION (OUTFALL) i 1l+03                                                                   l l           D i
l D
L U
i L
I  1[+02 0                                                                                                                     ,i '
U I
N                                                                                                                 ,/
1[+02 0
r /
,i '
F                                                                                                         f A                                                                                                       A C   1[+01                                                                                           f AJ T                                                                                           ,
N
O                                                                                         /
,/
R                                                                                     -
/
tr                                                   ___
r F
1[+01                                                       1[+02                 1[.og                   $[.o4
f A
                                                            ~
A C
FLOW AT POTTSTOWN (CFS)
1[+01 f
Figure 1.3.1-1 I                                                                                                                                                         ODCM, Rev. 17 Page 170     -
AJ T
l                                                                                                                                                                 11/95
O
/
R L
tr 1[+01 1[+02 1[.og
$[.o4 FLOW AT POTTSTOWN (CFS)
~
Figure 1.3.1-1 I
ODCM, Rev. 17 Page 170 i
l 11/95


i.
i.
LGS DILUTION vs RIVER FLOW STATION (CITIZEN'S UTILITY) 1(+04 D
LGS DILUTION vs RIVER FLOW STATION (CITIZEN'S UTILITY) 1(+04 D
I e                                                                                                             a i
I e
!                                                      h    1(+03                                                                     ;;
a i h
;                                                      T.                                                                       /
1(+03 T.
l                                                                 r a
/
:                                                      O                                           -
l r
\
O
N                                   ' '
. a
                                                                                          /
\\
1[+02                     -
N
F                        /
/
A                     /
1[+02 F
/
A
/
l 0
l 0
                                                                          /
/
0   11+01 R
0 11+01 R
1[+01         1l+02                                           1l+03                                       1[+04 FLOW AT POTTSTOWN (CFS)
1[+01 1l+02 1l+03 1[+04 FLOW AT POTTSTOWN (CFS)
Figure.1.3.1-2 l                                                                                                                                                                   ODCM, Rev. 17 Page 171 l                                                                                                                                                                           11/95
Figure.1.3.1-2 l
ODCM, Rev. 17 Page 171 l
11/95


i LGS DILUTION vs RIVER FLOW STATION (PHOENIXVILLE) 1[+03 i
i LGS DILUTION vs RIVER FLOW STATION (PHOENIXVILLE)
;                                                                          D i
I 1[+03 i
,                                                                        L                                                                                                                                           .
D i
U                                                                                                         /                                                   1 I                         1[+02                                                                   '
l L
l                                                                                           ,                                                              ;
U
1                                                                     O                                                                                               /
/
N                                                                                 J
1 I
                                                                                                                                                    }f F                                                                         ,- e i
1[+02 l
A                                                                      /                                                                                         ;
1 O
C                             1[+01                               e               .
/
T                                             ,
N J
i O                                          >
} f
r R                                                                                                                         !
?
I f
F e
l 11+00 1l*01               1(+02                                         1[+03           1[+04               ,                      :
i A
i i
/
FLOW AT POTTSTOWN (CFS)
C 1[+01 e
I
T O
;                                                                                                                                              Figure 1.3.1-3 I
i r
l       l                                                                                                                                                                                          ODCM, Rev. 17 Page 172           - -
R I
l                                                                                                                                                                                                        11/95             .
f l
l.
11+00 l
I                                                                                                                                                                                                                                   I
1l*01 1(+02 1[+03 1[+04 i
i FLOW AT POTTSTOWN (CFS)
I Figure 1.3.1-3 7
I l
l ODCM, Rev. 17 Page 172 l
11/95 l.
I I


t LGS DILUTION vs RIVER FLOW STATION (PHILA. SUBURBAN)
t LGS DILUTION vs RIVER FLOW STATION (PHILA. SUBURBAN)
                  ^
^
I 11+03 D
11+03 I
1 L                                                                                                                   .
D 1
3 U                                                            j T 1[+02                                                     /                                                               i rV O                                                       '
L U
N                                                 ,
3 j
                                            /                                                                                   .
T 1[+02
F                                   i/
/
A 11+01
i rV O
                                  /
N
C f
/
T                     -
F i/
O                  l R               lf 11+00 1[+01           1[+02                           1[+05                     1[+04 FLOW AT POTTSTOWN (CFS)
A
/
C 11+01 f
T O
l R
lf 11+00 1[+01 1[+02 1[+05 1[+04 FLOW AT POTTSTOWN (CFS)
Figure 1.3.1-4 S
Figure 1.3.1-4 S
l                                                                                           ODCM, Rev. 17 Page 173 l                                                                                                                   11/95
l ODCM, Rev. 17 Page 173 l
11/95


c                                                                                                             '
c i
i LGS DILUTION vs RIVER FLOW STATION (CREW COURSE)
LGS DILUTION vs RIVER FLOW STATION (CREW COURSE) 1
                                                                                                                                                                                            'l f                                       1[+03                                                                                                 ,
'l f
\,                               D                               -                                                                                    ,l '
1[+03
g L                                                                                                  /                                                         -
\\,
t U                                                                                         /                                                                           '['
D
T     1g.02                                                                           /
,l '
I                                                                                 /
g
O                                                                                 '
/
D N                                                                         ,/-
t L
                                                                                                          /
U
/
' ['
T 1g.02
/
I
/
O D
N
,/-
/
F
F
                                                                                                        /
/
A                                                               -
A C
                      .          C    '1I'01                                               t T
'1I'01 t '
O R
T O
1[+00 1l+01                                             11+02                   1l+03'                                       1[+04 FLOW AT POTTSTOWN (CFS)
R 1[+00 1l+01 11+02 1l+03' 1[+04 FLOW AT POTTSTOWN (CFS)
Figure 1.3.1-5 .
Figure 1.3.1-5
* NOTE: Dilution factore are reduced by o fautor of 50 to neoount for ette spoolfte usage.
* NOTE: Dilution factore are reduced by o fautor of 50 to neoount for ette spoolfte usage.
ODCM, Rev. 17 l
l ODCM, Rev. 17 Page 174 l
Page 174           -
l                                                                                                       .
11/95
11/95


                                                                                                                                                                                                                  +
+
                                        ->   L.D. TANK FE Laundry                                                                                                                                         G Drein (LD)                                                               !                                            L.D.
-> L.D. TANK FE Laundry G
(RE-
(RE Drein (LD)
_g
L.D.
                                                                                                                                                                                                  ^
^
Suesystem                                                                                                                                                                               I .
Suesystem
p   n                           &      SAMPLE          -
_g SAMPLE I.
TANK             -                                          To Cooiing
p n
                                                                                                                                                                'd                                   Tower
TANK To Cooiing
                                        -)   L.D. TANK           M t)                                                                                                                                 Blowdown Line 10 GPM (Nom.)                               (p,,,,,, p.g ,9 FD From Chem.
'd Tower
Weste Tank                                                                             SAMPLE                   g)
-)
                                            'F
L.D. TANK M t)
                                                                                                          , TANK #1                         ,
Blowdown Line 10 GPM (Nom.)
FD                                 _g      FD                                                       FD         ~
(p,,,,,, p.g,9 FD From Chem.
FD F                       ->  COLLECTION           -Tg                       FILTER                                             D       DEMIN             SAMPLE         g 7
Weste Tank SAMPLE g)
Subsystem                           I                                                                                            I TANK #2                                     y
'F
                                                                      ^               J k                                                                                                             To Condeneste To Weste                                             To Weele
, TANK #1 FD FD FD
                                                                                                                                                                            ~
~
FD                                                                                                                                200 GPM           Storage Tank 4     Studge Tank                                           Studge Tank         - (Nom)
FD
                                        ->      SURGE            --
_g F
TANK               ,,                                                                                        ,
COLLECTION -Tg FILTER D
ED
DEMIN SAMPLE g
                                                                                                                                                            ._)   SAMPLE               I.
7 Subsystem I
G 1r                                                                                                             TANK A
TANK #2 y
                                                                      'P ED                                 _g       ED                                ED Equipment               4    COLLECT 80M                                   FILTER                    b TANK i
I
G                                               DEMIN Drain (ED)
^
Subeystem                                           ,r                                                                                               ED                                                          ,
J k To Condeneste FD To Weste To Weele
4      SAMPLE
~
                                                                  --                            > To Weste                 M To Weste                           TANK B                                                         ,
200 GPM Storage Tank SURGE 4
l                        Studge Tank                           ' Sludge Tank T
Studge Tank Studge Tank
To FDCT                                                                                l     PhilodolpNa Electric Comp.               -
- (Nom)
A
TANK ED
* FE-85-OS3                                         Limerick Generating Station Chem Weste                g CW                       p            J                                         ** Ml8H-93412 OK904                                           Me1&2 (CW)
._)
Subsystem TANK                     (d\/
SAMPLE I.G 1r TANK A
Liquid Efflue.H g
'P ED ED 4
ODCM, Rev. 17 Page 175 g
_g ED b
Equipment COLLECT 80M i G FILTER DEMIN Drain (ED)
TANK ED Subeystem
,r 4
SAMPLE
> To Weste M To Weste TANK B l
Studge Tank
' Sludge Tank T
l PhilodolpNa Electric Comp.
To FDCT
* FE-85-OS3 Limerick Generating Station A
CW J
** Ml8H-93412 OK904 Me1&2 Chem Weste p
g (CW)
TANK (d
Liquid Efflue.H Subsystem
\\/
g ODCM, Rev. 17 Page 175 g
11/95
11/95
                                                                                                                                                                                                  ~
~
- _ _ -    _m-        .--    _ _ _ _-              r a.-*+- - ,-w   =         --    W               .      *y*-r   --
m-r a.-*+-
_n  -w-w   -
,-w
w        ve-- w w
=
W
*y*-r n
-w-w w
ve--
w w


D   -
D I
I he Monhw North Vent                                                                                               Wide unne a s N Elet 4H'                                         7                                                         Range Mid&H%
he Monhw North Vent Wide unne a s N Range Elet 4H' 7
Renee Accident,
Mid&H%
                                                                                                                          /\                                                       rettier,iete mad lodine                             >      Monitor Perseviate, lodine &
: Accident,
continvowe                                O          Fitter                L** Me"We Noble Gee Namel                                                                                                                                                       g Range Monitore                                                                                                                                                       7                             Sample One Monitor           p
/\\
                                                                                                                                              $                                3 (3)                                 Turbine Enclosure Enhevet
rettier,iete Renee mad lodine Monitor L** Me"We O
[                   I
Fitter continvowe Perseviate, lodine &
                                                                                                                                              .000 CFM Turb8no Enclosure Turbine Enclosure Enheust I8I                      '
Noble Gee Namel g
                                                                                                                                                +                       k      ,      (2)               (2)             Equip. Compart Erhouet Mechenleal Vee. Pump Turbine Enclosure
Range Monitore 7
  . Equip. Comport Enhevet (II   III                                                                                               +                       M     '
Sample One Monitor p
(?)                               Bettery Room Exhevet
3 (3)
    **
Turbine Enclosure Enhevet
* P                                                                                                                                                                                                    Steam Pecking Exhauster Steam Pack. Enheuster                                                                                                                                                '    '
[
A                                        Redweste Encl. Exhavet D/W Purge                                                                                                                                                                   Redweste Encl. Equip.
I
(2) [                   '
.000 CFM Turb8no Enclosure
                                                                                                                                                +                                                                         Compartment Exhauster emeeous R.de.e- 1,. ~ ent
+
    ... - ,, . .e Tre., ..e.
(2)
7f      ,,,,                      ,
(2)
unii Cond.neer on ees
Equip. Compart Erhouet I8I Turbine Enclosure Enheust k
                                                                                                                                                                                                          **                        enew Onges Fume Hood Exhnvet Philadelphia Electric Comp.
Mechenleal Vee. Pump Turbine Enclosure (II III
Control Area Enhevet
+
                                                                                                                                                +                                                                    Limerick Generating Station I
M
Y  M       (2)
(?)
Units 1 & 2 Gaseous Effluents Flow Diagram North Stack ODCM, Rev. 17 unit t Chereens system Page 176 -
Bettery Room Exhevet
l    L/
. Equip. Comport Enhevet P
        ,M Exhaust Fan               Vg
Steam Pecking Exhauster A
                                    /
Redweste Encl. Exhavet Steam Pack. Enheuster D/W Purge Redweste Encl. Equip.
                                    /       Filter                                                                             = unii n Chercoal a retem 11/95
(2) [
+
Compartment Exhauster 7f emeeous R.de.e-1,. ~ ent
... -,,..e Tre.,..e.
unii Cond.neer on es e
enew Onges Fume Hood Exhnvet
+
Philadelphia Electric Comp.
Limerick Generating Station Control Area Enhevet Y
M (2)
Units 1 & 2 I
Gaseous Effluents Flow Diagram North Stack ODCM, Rev. 17 unit t Chereens system Page 176 -
,M Exhaust Fan
//
11/95 Vg Filter
= unii n Chercoal a etem r
l L/


or us                    t o                     n F'
orus t
l c                      e        .n pto n                 t n tm 9       E                   er         mte "s
o ne
                                    't t
.n l
r o 'e
F' c
: s.          ma p p im CS ot cg 2
m pto t
t n
n n
emk     775 a     cu                 u         in&       luac    179 q o a a                         t r
mt 9
it 1 f rgto        1/
E er t
EC          cora f
e ot s.
eh E   R x                                     s EeSi
ma C S t
                                                                                                    . 1 E                             et   sDh     ve1 Bni   e n uowu  t   eg e
"s
iG U o o o         Ra h
't r
pk el S eF         P leic       G dr                  M
p 2
                                                                          '      ao              C im l
n o 'e p
D hU l
emk 775 a
P                  O
cu im cg t
                      )
luac 179 u
eds2 a na(
in&
t                                                                                                .
o r
y aGr           a                                                                             _
f r o 1/
lu           o c eet inl t
a a q
r  ibn i
it 1
g A                          }                                          -
gt eh E C c a EeS t
ad ot PloNM
f 1
                    ,.                                              )
E R x or s
                                          )        3,               t s
i ve1 E
i g                (
et sDh Bni e n u eg t
t           s           0 5>     n         u                                   0 V
owu eiG U o o o Ra h
e          o u
el S P
n 0
pk eF leic G
0, M F
M dra o l
4 0Mn.4   0, F i h2 t      .1it 1              4C 3                        4CM 5
C im D
uit 4n o              2 on SUlE.C t           s n         u e         o           0 V           u           0                       0 h1      '1 n            0, M F                     0 M n.
hU P
1 it                                   0,F i 4CM t
O l
ut 4n o          4 3  C
)
      ~ oi n 2       g       g       5 SUlE.C                                                  k'
eds2 na(
                                            ,        3              )
ta y
                                            ,        3               t g         g               (
aGr a
                              ,        i       i               i ed s )2 na(
lu o
t a
i A
lu aGr o        )
}
[         (        (
g c eet inlibn t
c eeti it nl 2
rad ot PloNM
)
3, t
)s g
(
i t
s 0
5>
n u
0 0, M 4 0Mn.4 0
e o
V
.1it 3
F 0, F i u
h2 4C 4CM n
1 5
t t 4n 2
ui on o
.C SUlE t
s n
u e
o 0
0 V
u 0
0, F 0 M n.
M
'1 n h1 it 0,F i 1
tut 4n 4 C 4CM
~
oi o
3 5
n
.C 2
g g
k' SUlE 3
)
3 t
g g
(
i i
i ed s )2 na(
t aGr
[
(
(
ib n rd a oo PloNM
                                                                            )
2
(
(
a lu o
)
c eeti (2
nl it ib n rd oo aPloNM
)
2(
y e
y e
r r
ru r
u o        s o
s o
lo       lc                   t n
o lo lc tn F
F          n                   e g       E              t in ts      r             n tm ots            e r le ua  u   t cu ee ma p p f
n e
eh       eh Rn             iu m  o R xE          E         q EC l       l
E m
g tn in r
t t
ot e r s
s le u cu ma t
p u a ee p
m feh eh iu R x Rn o
E E
qE C l
l


                                                                                .n pio
.n pio mta t
              -                                                                mt ot a  t n
ot n
l                                CS 2      em ua     785 icg&
C S em ua 785 2
r   n   mg  r  179 1/
l icg&
t    i 1 Ea ca t i
mg 179 r
                                                                                                  . 1 se                              ler s sD et   u       ve1 r                             Eni e n ow e       eg n                               e           o   Ra i G U s  e G {l         P y
n Ea 1/
h a                               pk                 ,
rt i 1 i
                        .                      c c                              leic             M         .
t c a 1
dr e
s ler sD et u
la              C D                              i e hi m           D
ve1 s
  ~
e Eni ow eg r
P L             O l
e n e
I mr r
n e
s            e                                       -
U s o Ra i G G {l e
d                                         _
P h
                                                          ,    i n                                       _
a pk y
r                                       .
c leic M
c dr la e C
eD i m D
hi P L O
~
l I
mr i
r s
e d
n r
G
G
                                                            \
\\
                                                      ,          r e                        R E
re R
                                                        /_ i t
/_ i T
t F                         T              ._
E tt F
g                        LI
{@\\
{@   \         a                 ~
LI g
F              _
F a
B                               -
~
a                          V                  ~                     _
B V
a                             _
~
e r
a a
A i
e rA r
r a
iap e
p e
i R
e ro i  R l
r e
int                                             ar e
l o
i dn                                                               N oo                                             n l
int a
                          /M                                               e               A e                                            G                 F t
i r
a no          s                                                 R lui                                                               S c t V                          U t ia ird                                                               A aa                                                               H PR                                                                 X E
dn e
i          r e) 5/       t l l
oo n
i Fi c a
N e
p
A l/M e
                                                      \     gy at
G F
                                                    \
ta n R
o s
lui S
V t
U ct ia A
ird H
aa PR XE i
re) 5/
t l l
a i
c Fi p
\\
gy at
\\
B(
B(
_            .t c s '6
.t s '6 l
_        l n u1     m                 s 2 Ea4   hl f
c n u1 m
c Tr oE xE I
s 2 Ea4 f
0           k Nt        k 0           J Uct as   ca  0 7
hl c
eat RES
Tr xE k
* l        l
oE 0
INt k
0 J
Uct c 0
as a 7
eat RES l
l


  .-.  .___m.   ._ _.__ _      ___ .          ..~ __           ~         .  ..        _ _ .        ._ .-. __
.___m.
ODCM R v. 17             l Page 179       ;
..~ __
11/95
~
                                                                                                                              )
ODCM R v. 17 l
Page 179 11/95
)
I l
j 0
l
'l i
N mw we E
Y
*?
T
=
i g\\
E
.im si
,s o
wm ses
.?,,
/
lvru.,o*
~
r S :'
\\
I l
I l
j 0                            l.
s
                                                                                                  'l                        i N
/
mw                          we                                                .
                                "                                            E
                                                  *?      Y T                    =                                        l
* i g\                      ,,,,
                                        ""'                              .im        E
                                            '."                      si o
                                                                  ,s wm                                                    ses
                                                                .?,,
                                .                      /                    ,,
                                            ~        lvru.
                                                                ,o*  ,,,                .
r S :'                        ..
                                                                                                      \
I                              l s                /
u 9
u 9
i I
i I
l Figure B-1                                                       '
l Figure B-1 Environmental Sampling Locations On Site or Near the Limerick Generating Station 1
Environmental Sampling Locations On Site or                                                                 l Near the Limerick Generating Station                                                       . 1 i
i


l l                                                                                         ODCM R3v. 17 Prga 180 11/95 I
l l
ODCM R3v. 17 Prga 180 11/95 I
J I
J I
9 N               NNE NNW     -
9 N
j 34E1'                     2It I
NNE NNW j
NW     t                                                 NE                            '
34E1' 2It I
                                          '3c3i I
NE NW t
I                    41i                             i 3102
'3c3iI I
                                                                                                          )
41i 3102
                                                  /
/
      \  WNW 2eE                               1 eX1     ENE 1
)
3101                   [         50                                             i N
WNW 2eE 1
f
eX1 ENE
                                            \I!'                                                     .
\\
W     '"'?
3101
l                        \
[
                                                              %'a
50 i
                                                                              . toe 1 E
\\I!'
13C1 l
N f
WSW                                                                        ESE hiot                 -
W
                                            '*k         1501 3
'"'?
2401           ,                                13E1 2001 f,
%'a E
('           '~
l
SSW
\\
                                        !" , \\ .**
. toe 1 13C1 hiot
S SSE f%                                l I
'*k ESE WSW 3
o                                                                             A
1501 2401 13E1 2001
!                                                                                                        4 l
!", \\
('
f%
\\.**
'~
SSW SSE f,
S I
A o
4 l
Figure B-2 Airborne and TLD Environmental Sampling Locations at Intermediate Distances from the Limerick Generating Station
Figure B-2 Airborne and TLD Environmental Sampling Locations at Intermediate Distances from the Limerick Generating Station


ODCM Rev. 17 Paga 181 11/95 1
ODCM Rev. 17 Paga 181 11/95 N
N                         N                  ;
N NNW NNE g
NNW     g                 ,  NNE        q l
q l
NW                                                 NE WNW                                                           ENE
NW NE WNW ENE
                                                ,1 2srs sc.         ,
,1 2srs sc.
W                 1 S
W 1
E     .
E S
isp SI 16c
isp
                                                \ ''                                 ,
\\ ''
                            ,                    Ic2 WSW L/             * \ '# ,
SI 16c Ic2 L/
1 ESE             .
* \\ '#
ten ,
WSW 1
0 22F1                 *
ESE ten 0 22F1 Sw -
        %    Sw -                   l                       ter. y             ,
l ter. y I'
SSW I'               \         f v
\\
f SSW v
i 4
i 4
1 F.igure B-3 Aquatic and Milk Environmental Sampling Locations at Intermediate Distances from the Limeri-k Generating Station
1 F.igure B-3 Aquatic and Milk Environmental Sampling Locations at Intermediate Distances from the Limeri-k Generating Station


l ODCM R&v. 17' Prga 182 11/95
l ODCM R&v. 17' Prga 182 11/95
              -*= =
-*= =
il t
il t
i l       **                            T           %
i l
ce I                           I l    .
T ce I
i i m / ,
I
(           li                       .
/
                      "                            c '
(
t                                      n                            \,       .              s g                                                       i I       -
li i
m l
i c
\\,
t s
n i
g I
-l s
2
2
                                                        -l s
~
        ~
s-2 l
s-           ,        .,
i v)
:            2         l                   i                 v)
N.
N.
l' i               i   s I                           I             '
i i
\
s l'
                          !/ !
I I
3     I N*
! /
l     \           /     / /                         s                   /
3 I
N
\\
l
\\
/
/ /
s
/
i t
i t
Figu~re B-4 1
Figu~re B-4 1
Environmental Sampling Locations at Remote Distances from the Limerick Generating Station
Environmental Sampling Locations at Remote Distances from the Limerick Generating Station


ODCM R;v.16 Page 183 l 4/95 l REFERENCES
ODCM R;v.16 Page 183 4/95 l
: 1. Regulatory Guide 1.109, " Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I,"     Revision 1, U.S. Nuclear Regulatory Commission, Washington, D.C. 20555, October 1977.
REFERENCES 1.
: 2. Regulatory Guide 1.111, " Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water-Cooled Reactors," Revision 1, U.S. Nuclear Regulatory Commission, Washington, D.C. 20555, July 1977.             -
Regulatory Guide 1.109, " Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I," Revision 1, U.S. Nuclear Regulatory Commission, Washington, D.C.
: 3. Regulatory Guide 1.112, " Calculation of Releases of Radioactive Materials in Gaseous and Liquid Effluents from Light-Water-Cooled Power Reactors," U.S. Nuclear Regulatory Commission, Washington, D.C. 20555, April 1976.
: 20555, October 1977.
: 4. Regulatory Guide 1.113, " Estimating Aquatic Dispersion of Effluents from Accidental and Routine Reactor Releases for the Purpose of Implementing Appendix I," Revision 1, U.S. Nuclear Regulatory Commission, Washington, D.C. 20555, April 1977.
2.
: 5. U.S. Nuclear Regulatory Commission, " Calculation of Releases of
Regulatory Guide 1.111, " Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water-Cooled Reactors," Revision 1, U.S. Nuclear Regulatory Commission, Washington, D.C.
      . Radioactive Materials in Gaseous and Liquid Effluents from
20555, July 1977.
      ' Boiling Water Reactors (BWR-GALE Code) , " USNRC Report NUREG-0016, Washington, D.C. 20555, April 1976.
3.
: 6. U.S. Nuclear Regulatory Commission, "X00D00, Program for the Methodological Evaluation of Routine Effluent Releases at Nuclear Power Stations," USNRC Report NUREG-0324, Washington, D.C.     20555, September, 1977.
Regulatory Guide 1.112, " Calculation of Releases of Radioactive Materials in Gaseous and Liquid Effluents from Light-Water-Cooled Power Reactors," U.S. Nuclear Regulatory Commission, Washington, D.C.
: 7. Title 10, " Energy," Chapter I, Code of Federal Reculations; Part, 20, Appendix B, U.S. Government Printing Office, Washington, D.C.
20555, April 1976.
4.
Regulatory Guide 1.113, " Estimating Aquatic Dispersion of Effluents from Accidental and Routine Reactor Releases for the Purpose of Implementing Appendix I," Revision 1, U.S. Nuclear Regulatory Commission, Washington, D.C.
20555, April 1977.
5.
U.S. Nuclear Regulatory Commission, " Calculation of Releases of
. Radioactive Materials in Gaseous and Liquid Effluents from
' Boiling Water Reactors (BWR-GALE Code), " USNRC Report NUREG-0016, Washington, D.C.
20555, April 1976.
6.
U.S. Nuclear Regulatory Commission, "X00D00, Program for the Methodological Evaluation of Routine Effluent Releases at Nuclear Power Stations," USNRC Report NUREG-0324, Washington, D.C.
: 20555, September, 1977.
7.
Title 10, " Energy," Chapter I, Code of Federal Reculations; Part, 20, Appendix B, U.S. Government Printing Office, Washington, D.C.
20402, January 1, 1977.
8.
Title 10, " Energy," Chapter I, Code of Federal Reculations; Part 100, U.S.
Government Printing Office, Washington, D.C.
: 20404, January 1, 1977.
9.
Title 40, " Protection of Environment," Chapter I, Code of Federal Reculations, Part 141, U.S. Government Printing Office, Washington, D.C.
20402, January 1, 1977.
20402, January 1, 1977.
: 8. Title 10, " Energy," Chapter I, Code of Federal Reculations; Part 100, U.S. Government Printing Office, Washington, D.C. 20404, January 1, 1977.
10.
: 9. Title 40, " Protection of Environment," Chapter I, Code of Federal Reculations, Part 141, U.S. Government Printing Office, Washington, D.C. 20402, January 1, 1977.
Regulatory Guide 1.21, " Measuring, Evaluating, and Reporting Radioactivity in Solid Wastes and Releases of Radioactive l
: 10. Regulatory Guide 1.21, " Measuring, Evaluating, and Reporting
Materials in Liquid and Gaseous Effluents from Light-Water-Cooled Nuclear Power Plants," Revision 1, U,.S. Nuclear Regulatory Commission, Washington, D.C. 20555,~ June 1974.
;      Radioactivity in Solid Wastes and Releases of Radioactive l     Materials in Liquid and Gaseous Effluents from Light-Water-Cooled Nuclear Power Plants," Revision 1, U,.S. Nuclear Regulatory Commission, Washington, D.C. 20555,~ June 1974.
l i
l i
i
i


k ODCM R2v.16 Pago 184 4/95 REFERENCES
k ODCM R2v.16 Pago 184 4/95 REFERENCES 11.
: 11. Title 40, " Protection of Environment," Chapter I, Code of Federal Regulations, Part 190, Federal Register, Vol. 42, No. 9, Washington, D.C. 20402, January 13, 1977.
Title 40, " Protection of Environment," Chapter I, Code of Federal Regulations, Part 190, Federal Register, Vol. 42, No.
: 12. U.S. Nuclear Regulatory Commission, "Short Term Diffusion Estimates," Section 2.3.4, Standard Review Plan for the Review of Safety Analysis ReDorts for Nuclear Power P?. ants - LWR Edition, USNRC Report NUREG-75/087, Washington, D.C. 20555, November 1975.
9, Washington, D.C. 20402, January 13, 1977.
: 13. U.S. Nuclear Regulatory Commission, " Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants,"         i USNRC Report NUREG-0133, Washington, D.C. 20555, October 1978.
12.
: 14. Letter From Thomas E. Marley, Director Office of Nuclear Reactor 5
U.S. Nuclear Regulatory Commission, "Short Term Diffusion Estimates," Section 2.3.4, Standard Review Plan for the Review of Safety Analysis ReDorts for Nuclear Power P?. ants - LWR Edition, USNRC Report NUREG-75/087, Washington, D.C.
Regulations, To Thomas E. Tipton Vice President and Director Operations, Nuclear Management and Resources Council, 6/30/93.
20555, November 1975.
: 15. ANSI N42.14-1991 (Revision of ANSI N42.14-1978) " Calibration and   j Use of Germanium Spectrometers For the Measurement of Gamma-Ray       l Emission Rates of Radionuclides", Sect. 6.2.2
13.
: 16. EML Procedures Manual, H.L. Volchok and G. dePlangue, Editors, U.S. Dept. Of Energy (Revised Annually)
U.S. Nuclear Regulatory Commission, " Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants,"
: 17. L.A. Currie, " Limits For Qualitative Detection and Quantitative     ,
i USNRC Report NUREG-0133, Washington, D.C.
Determination - Application to Radiochemistry", Analytical           l Chemistry, Vol. 40, pp. 586-593 (TABLE II), 1968                     j
20555, October 1978.
: 18. NUREG/CR-4007, " Lower Limit of Detection: Definition and Elaboration of a Proposed Position for Radiological Effluent and Environmental Measurements", prepared by NRC by L.A. Currie           l (Chapter II, Sect. D.2; Chapter III, Sect. C.1), September 1984     l
14.
: 19. Tech. Spec. Section 1.24 (Definitions) s
Letter From Thomas E. Marley, Director Office of Nuclear Reactor Regulations, To Thomas E. Tipton Vice President and Director 5
: 20. USNRC Generic Letter, 89-01 2*.2 Tech. Spec. Section 6.14.
Operations, Nuclear Management and Resources Council, 6/30/93.
: 22. Tech. Spec. Section 6.5.1.6m.
15.
: 23. Tech. Spec. Section 6.5.3.
ANSI N42.14-1991 (Revision of ANSI N42.14-1978) " Calibration and j
: 24. Tech. Spec. Section 6.8.4d, e and f.
Use of Germanium Spectrometers For the Measurement of Gamma-Ray Emission Rates of Radionuclides", Sect. 6.2.2 16.
: 25. Tech. Spec. Section 6.9.1.8/ODCM Control I.3.6.
EML Procedures Manual, H.L. Volchok and G.
: 26. Tech. Spec. Section 6.10.3m and n.
dePlangue, Editors, U.S. Dept. Of Energy (Revised Annually) 17.
: 27. UFSAR, Section 11.5.6.
L.A. Currie, " Limits For Qualitative Detection and Quantitative Determination - Application to Radiochemistry", Analytical Chemistry, Vol. 40, pp. 586-593 (TABLE II), 1968 j
18.
NUREG/CR-4007, " Lower Limit of Detection:
Definition and Elaboration of a Proposed Position for Radiological Effluent and Environmental Measurements", prepared by NRC by L.A.
Currie (Chapter II, Sect. D.2; Chapter III, Sect. C.1), September 1984 19.
Tech. Spec. Section 1.24 (Definitions) s 20.
USNRC Generic Letter, 89-01 2*.
Tech. Spec. Section 6.14.
2 22.
Tech. Spec. Section 6.5.1.6m.
23.
Tech. Spec. Section 6.5.3.
24.
Tech. Spec. Section 6.8.4d, e and f.
25.
Tech. Spec. Section 6.9.1.8/ODCM Control I.3.6.
26.
Tech. Spec. Section 6.10.3m and n.
27.
UFSAR, Section 11.5.6.


4 a
4 a
e     5
e 5
    +
+
f i
f i
I i
I i
Line 3,321: Line 5,599:
j i
j i
1 1
1 1
1 1
1 1}}
1 1
1}}

Latest revision as of 05:34, 13 December 2024

Rev 17 to LGS Units 1 & 2 Odcm
ML20100L913
Person / Time
Site: Limerick  
Issue date: 11/30/1995
From: Boyce R
PECO ENERGY CO., (FORMERLY PHILADELPHIA ELECTRIC
To:
Shared Package
ML20100L881 List:
References
PROC-951130, NUDOCS 9603050119
Download: ML20100L913 (197)
v • d • e


Text

{{#Wiki_filter:.. _. _. _. _ _... ~. _. m_. I l-I l l l l l PORC YES I l SQR YES NQA NO 50.59 YES RESP.MGk. NES l I LIMERICK. GENERATING STATION l l UNITS 1 AND 2 i I OFFSITE DOSE CALCULATION MANUAL l Revision 17 PECO ENERGY COMPANY DOCKET NOS. 50-352 AND 50-353 Approval: L 4 M Plant Manager \\ t i R

.. - ~ 4 ODCM Rev. 17 j 11/95 i Table-of Contents Page j i Part I - RADIOLOGICAL EFFLUENT CONTROLS 1.0 DEFINITIONS 1 2.0 BASIS FOR EFFLUENT MONITORING CONTROLS 6 2.1 METEOROLOGICAL MONITORING INSTRUMENTATION 6 j 2.2 MAPS DEFINING UNRESTRICTED AREAS AND SITE BOUNDARY FOR RADIOACTIVE GASEOUS AND LIQUID EFFLUENTS 6 2.3 RADIOACTIVE LIQUID EFFLUENT MONITORING INSTRUMENTATION 6 2.3.1 Concentration 9 2.3.2 Dose 9 2.3.3 Liquid Radwaste Treatment System 10 2.4 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION 10 2.4.1 Dose Rate 10- ) 2.4.2 Dose - Noble Gases 11 2.4.3 Dose - Iodine-131, Iodine-133, Tritium, and i Radionuclides in Particulate Form 12 2.4.4 Ventilation Exhaust Treatment System 12 2.4.5 Venting and Purging 13 2.4.6 Total Dose 13 l 2.5 MONITORING PROGRAM 13 ] 2.5.1 Land Use Census 14 2.5.2 Interlaboratory Comparison Program 14 2.6 APPLICABILITY 14 3.0 METEOROLOGICAL MONITORING INSTRUMENTATION CONTROLS 16 l 3.1 METEOROLOGICAL MONITORING INSTRUMENTATION 16 i f

1 1 OECM Rev. 17 11/95 Page i i l 3.2 RADIOACTIVE LIQUID EFFLUENT MONITORING INSTRUMENTATION 20 3.2.1 Radioactive Effluent Monitoring Instrumentation Controls 21 3.2.2 Concentration 24- -l 3.2.3 Dose 28' j 3.2.4 Liquid Radwaste Treatment System 29 3.3 GASEOUS EFFLUENTS l 3.3.1 Radioactive Gaseous Effluent Monitoring Instrumentation 30 3.3.2 SITE BOUNDARY Dose Rate 35 3.3.3 Dose - Noble Gases 39 3.3.4 Dose - Iodine-131, Iodine-133, Tritium, and Radionuclides in Particulate Form 40 3.3.5 Ventilation Exhaust Treatment System 41 3.3.6 Venting or Purging 42 3.3.7 Total Dose 43 3.4 RADIOLOGICAL ENVIRONMENTAL MONITORING 3.4.1 Monitoring Program 44 3.4.2 Land Use Census 57 3.4.3 Interlaboratory Comparison Program 58 3.5 ANNUAL RADIOLOGICAL ENVIRONMENTAL OPERATING REPORT 59 l 3.6 ANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT 60 3.7 MAJOR CHANGES TO RADIOACTIVE WASTE TREATMENT SYSTEMS 62 11

ODCM Rev. 17 11/95 LIMERICK GENERATING STATION OFFSITE DOSE CALCULATION MANUAL TABLE CONTENTS Page Part II - CALCULATION METHODOLOGIES 1.0 LIQUID EFFLUENTS 63 1.1 RADIATION MONITORING INSTRUMENTATION AND CONTROLS 63 1.2 LIQUID EFFLUENT MONITOR SETPOINT DETERMINATION 64 1.2.1 Radwaste Discharge Monitor 64 1.2.2 Service Water Radiation Monitor 67 1.2.3 RHR Service Water Monitor 68 1.3 LIQUID EFFLUENT DOSE CALCULATIONS - 10 CFR 50 69 1.3.1 Member of the Public Dose - Liquid Effluents 69 1.4 LIQUID EFFLUENT DOSE PROJECTION 74 2.0 GASEOUS EFFLUENTS 75 2.1 RADIATION MONITORING INSTRUMENTATION AND CONTROLS 75 l 2.2 GASEOUS EFFLUENT MONITOR SETPOINT DETERMINATION 76 2.2.1 North Vent Noble Gas Effluent Monitors 77 2.2.2 South Vent Noble Gas Effluent Monitors 79 2.2.3 Noble Gas Effluent Fractional Contribution 81 2.2.4 Noble Gas Effluent Default Setpoints 82 l 2.2.5 WRAM Noble Gas Effluent Monitor 87 l 2.3 GASEOUS EFFLUENT DOSE EVALUATIONS 90 l 2.3.1 Site Boundary Dose Rate - Noble Gases 91 2.3.2 Site Boundary Dose Rate - Radiciodine and l Particulates 93 l 2.3.3 Noble Gas Air Dose 94 2.3.4 Radiciodine and Particulate Dose Calculations l 10 CFR 50 95 iii

i l ODCM Rev. 17 t 11/95 j Page l l 2.3.5 Annual Dose Evaluation 98 I l 2.4 GASEOUS EFFLUENT DOSE PROJECTION 101 }~ l 3.0 SPECIAL DOSE ANALYSIS 102 l 3.1 TOTAL DOSES TO MEMBERS OF THE PUBLIC 102 g l -3.2 DOSES DUE TO ACTIVITIES INSIDE THE SITE BOUNDARY 104 l 4.O RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM 105 i l 4.1 SAMPLING PROGRAM 105 -l 4 2 INTERLABORATORY COMPARISON PROGRAM 105 4 l APPENDICES I l Appendix A - Technical Specification /ODCM 157 l Appendix B - Radiological Environmental Monitoring 160 Program - Sample Type, Location and Analysis l Appendix C - Requirements for ODCM Revision 173 iv

ODCM Rev. 17 11/95 LIST OF TABLES I 1.1 Surveillance Frequency Notation I 3.1-1 Meteorological Monitoring Instrumentation I 3.1-2 Meteorological Monitoring Instrumentation Surveillance Requirements I 3.2-1 Radioactive Liquid Effluent Monitoring Instrumentation I 3.2-2 Radioactive Liquid Effluent Monitoring Instrumentation Surveillance Requirements I 3.2-3 Radioactive Liquid Waste Sampling and Analysis Program I 3.3-1 Radioactive Gaseous Effluent Monitoring Instrumentation I 3.3-2 Radioactive Gaseous Effluent Monitoring Instrumentation Surveillance Requirements I 3.3-3 Radioactive Gaseous Waste Sampling and Analysis Program I 3.4-1 Radiological Environmental Monitoring Program I 3.4-2 Reporting Levels for Radioactivity Concentrations In Environmental Samples I 3.4-3 Detection Capabilities For Environmental Sample Analysis II 1.1 Ingestion Individual Dose Factors (Daipj) For Liquid Effluents II 1.2 Assumptions Used In Limerick Effluent Dose Evaluations II 2.1 Dose Factors for Noble Gases II 2.2 Ingestion Individual Dose Factors (DFk,1,n) For Gaseous Effluent II 2.3 Assumptions Used In Limerick Gaseous Effluent Dose Evaluation II 2.4 Nearest Gaseous Effluent Dose Receptor Distances (Meters) A.1 Technical Specification /ODCM Matrix B.1 Radiological Environmental Monitoring Program v

ODCM Rev. 17 ) 11/95 i LIST OF TABLES I 1.1 Surveillance Frequency Notation I 3.1-1 Meteorological Monitoring Instrumentation I 3.1-2 Meteorological Monitoring Instrumentation Surveillance Requirements I 3.2-1 Radioactive Liquid Effluent Monitoring Instrumentation I 3.2-2 Radioactive Liquid Effluent Monitoring Instrumentation Surveillance Requirements I 3.2-3 Radioactive Liquid Waste Sampling and Analysis Program I 3.3-1 Radioactive Gaseous Effluent Monitoring Instrumentation I 3.3-2 Radioactive Gaseous Effluent Monitoring Instrumentation Surveillance Requirements I 3.3-3 Radioactive Gaseous Waste Sampling and Analysis Program I 3.4-1 Radiological Environmental Monitoring Program I 3.4-2 Reporting Levels for Radioactivity Concentrations In Environmental Samples I 3.4-3 Detection Capabilities For Environmental Sample Analysis II 1.1 Ingestion Individual Dose Factors (Daipj) For Liquid Effluents II 1.2 Assumptions Used In Limerick Effluent Dose Evaluations II 2.1 Dose Factors for Noble Gases II 2.2 Ingestion Individual Dose Factors (DFk,1,n) For Gaseous Effluent II 2.3 Assumptions Used In Limerick Gaseous Effluent Dose Evaluation II 2.4 Nearest Gaseous Effluent Dose Receptor Distances (Meters) A.1 Technical Specification /ODCM Matrix B.1 Radiological Environmental Monitoring Program v

ODCM Rev. 17 11/95 LIST OF FIGURES I 2.2-la Map Defining Exclusion Areas for Radioactive i Gaseous and Liquid Effluents I 2.2-1b Map Defining Low Population Areas for Radioactive Gaseous and Liquid Effluents I 3.1-1 Meteorological Tower Location II 1.3.1-1 LGS Dilution vs River Flow (Outfall) II 1.3.1-2 LGS Dilution vs Rirer Flow (Citizen's Utility) II 1.3.1-3 LGS Dilution vs River Flow (Phoenixville) II 1.3.1-4 LGS Dilution vs River Flow-(Philadelphia Suburban) II 1.3.1-5 LGS Dilution vs River Flow (Crew Course) f II 1-1 Liquid Effluent Flow Diagram II 2-1 Gaseous Effluent Flow Diagram - North Stack II 2-2 Gaseous Effluent Flow Diagram - South Stack II 2-3 Gaseous Effluent Flow Diagram - Hot Maintenance Shop B-1 Environmental Sampling Location on Site or Near the Limerick Generating Station B-2 Aquatic and Terrestrial Environmental Sampling Location at Intermediate Distances from the Limerick Generating Station B-3 Airborne and TLD Environmental Sampling Locations at Intermediate Distances from the Limerick Generating Station B-4 2nvironmental Sampling Locations at Remote Distances from the Limerick Generating Station vi

i i l PURPOSE The purpose of the Offsite Dose Calculation Manual is to establish methodologies and procedures for calculating doses to individuals in areas at and beyond the SITE BOUNDARY due to radioactive effluents from Limerick Generating Station.

as2-.- 2 ,_M_.. a, - - - - 4 + m ar a.a 4 J a_4&-.J AAA@ L A J.4 h_4_Ju144.4 -,a_4d 5J. A 4.444. n -,_4 AA+__.24ama he. _m.,_ 1 ? e 1 + 4 T PART I RADIOLOGICAL EFFLUENT CONTROLS

l ODCM Rev. 17 Page 1 l 11/95 1.0 DEFINITIONS The following terms are taken from LGS Unit 1, Unit 2 Tech Specs. 1.1 ACTION ACTION shall be that part of a specification which prescribes remedial measures required under designated conditions. 1.2 CHANNEL CALIBRATION A CHANNEL CALIBRATION shall be the adjustment, as necessary, of the channel output such that it responds with the necessary range and accuracy to known values of the parameter which the channel monitors. The CHANNEL CALIBRATION shall encompass the entire channel including the sensor and alarm and/or trip functions, and shall include the CHANNEL FUNCTION TEST. The CHANNEL CALIBRATION may be performed by any series of sequential, overlapping or total channel steps such that the entire channel is calibrated. 1.3 CHANNEL CHECK A CHANNEL CHECK shall be the qualitative assessment of channel behavior during operation by observation. This determination shall include, where possible, comparison of the channel indication and/or status with other indications and/or status derived from independent instrument channels measuring the same parameter. 1.4 CHANNEL FUNCTIONAL TEST A CHANNEL FUNCTIONAL TEST shall be: Analog channels - the injection of a simulated signal a. into the channel as close to the sensor as practicable to verify OPERABILITY including alarm and/or trip functions and channel failure trips. b. Bistable channels - the injection of a simulated signal into the sensor to verify OPERABILITY including alarm and/or trip functions. The CHANNEL FUNCTIONAL TEST may be performed by any series of sequential, overlapping or total channel steps such that the entire channel is tested.

l ODCM Rev. 17 Page 2 l 11/95 1.5 CONTINUOUS SAMPLING Per ASTM Standard (1987) Section II (Water and Environmental Technology), Volume 11.03, Article D1356; is defined as" sampling without interruptions throughout an operation or for a predetermined time." A CONTINUOUS SAMPLE is the opposite of a GRAB SAMPLE. The time period involved to secure (shut-down) ventilation or re-establish sampling of the release pathway shall meet the intent of CONTINUOUS SAMPLING. Consistent with industry standards, the time allowance shall not exceed 8 hours. 1.6 DOSE EOUIVALENT I-131 DOSE EQUIVALENT I-131 shall be that concentration of I-131, microcuries per gram, which alone would produce the same thyroid dose as the quantity and isotopic mixture of I-131, I-132, I-133, I-134 and I-135 actually present. The thyroid dose conversion factors used for this calculation shall be those listed in Table III of TID-14844, " Calculation of Distance Factors for Power and Test Reactor Sites." 1.7 FREOUENCY NOTATION The FREQUENCY NOTATION specified for the performance of Surveillance Requirements shall correspond to the intervals defined in Table II.1. 1.8 MEMBER (S) OF THE PUBLIC MEMBER (S) OF THE PUBLIC shall include all persons who are not occupationally associated with the plant. This category does not include employees of the utility, its contractors, or vendors. Also excluded from this category are persons who enter the site to service equipment or to make deliveries. This category does include persons who use portions of the site for recreational, occupational or other purposes not associated with the plant. 1.9 OFFSITE DOSE CALCULATION MANUAL The OFFSITE DOSE CALCULATION MANUAL (ODCM) shall contain the methodology and parameters used in the calculation of offsite doses resulting from radioactive gaseous and liquid effluents, in the calculation of gaseous and liquid effluent monitoring Alarm / Trip Setpoints, and in the conduct of the Radiological Environmental Monitoring Program. The ODCM shall also contain (1) the Radioactive Effluents Controls and Radiological Environmental Monitoring Programs required by Technical Specification 6.8.4 and (2) descriptions of the

l ODCM Rev. 17 Pcge 3 l 11/95 information that should be included in the Annual Radiological Environmental Operating and Annual Radiological Effluent Release Reports required by Technical Specifications 6.9.1.7 and 6.9.1.8. (3) description of meteorological monitoring controls. 1.10 OPERABLE - OPERABILITY A system, subsystem, train, component or device shall be OPERABLE or have OPERABILITY when it is capable of performing its specified functions (s) and when all necessary attendant instrumentation, controls, electrical power, cooling or seal 4 water, lubrication or other auxiliary equipment that are i required for the system, subsystem, train, component or device to perform its function (s) are also capable of performing their related support function (s). 1.11 QPERATIONAL CONDITION - CONDITION An OPERATIONAL CONDITION, i.e., CONDITION, shall be any one inclusive combination of mode switch position and average reactor coolant temperature as defined in the Technical Specifications. 1.12 PURGE - PURGING PURGE or PURGING shall be the controlled process of discharging air or gas from a confinement to maintain temperature, pressure, humidity, concentration or other operating condition, in such a manner that replacement air or gas is required to purify the confinement. 1.13 RATED THERMAL POWER I I See current LGS Tech Spec definition. 1.14 REPORTABLE EVENT A REPORTABLE EVENT shall be any of those conditions specified in Section 50.73 of 10 CFR Part 50. 1.15 SITE BOUNDARY The SITE BOUNDARY shall be that line as defined in Figure I2.2-la.

l ODCM Rev*. 17 Page 4 l 11/95 1.16 SOURCE CHECK A SOURCE CHECK'shall be the qualitative assessment of channel response when the channel sensor is exposed to a radioactive source. 1.17 THERMAL POWER THERMAL POWER shall be the total reactor core heat transfer rate to the reactor coolant. 1.18 UNRESTRICTED AREA An UNRESTRICTED AREA shall be any area at or beyond the SITE BOUNDARY access to which is not controlled by the licensee for y purposes of protection of individuals from exposure to radiation and radioactive materials, or any are within the SITE BOUNDARY used for residential quarters or for industrial, commercial, institutional, and/or recreational purposes. i 1.19 VENTILATION EXHAUST TREATMENT SYSTEM A VENTILATION EXHAUST TREATMENT SYSTEM shall be any system designed and installed to reduce gaseous radiciodine or radioactive material in particulate form in effluents by i passing ventilation or vent exhaust gases through charcoal absorbers and/or HEPA filters for the purpose of removing iodines or particulates from the gaseous exhaust stream prior to the release to the environment (such a system is not considered to have any effect on noble gas effluents). Engineered Safety Feature (ESP) atmospheric cleanup systems are not considered to be VENTILATION EXHAUST TREATMENT SYSTEM components. 1.20 VENTING VENTING shall be the controlled process of discharging air or gas from a confinement to maintain temperature, pressure, humidity, concentration or other operating condition, in such a manner that replacement air or gas is not provided or required during VENTING. Vent, used in system names, does not imply a VENTING process.

l ODCM Rev. 17 Page 5 l 11/95 i TABLE II.1 l SURVEILLANCE FREOUENCY NOTATION NOTATION FREOUENCY l J S (Shift) At least once per 12 hours. D (Daily) At least once per 24 hours. W (Weekly) At least once per 7 days. M (Monthly) At least once per 31 days. Q (Quarterly) At least once per 92 days. SA (Semi-annual) At least once per 184 days. A (Annual) At least once per'366 days. E At least once per 18 months (550 days). R At least once per 24 months (731 days). S/U Prior to each reactor startup. 1 P Prior to each radioactive release. N.A. Not applicable.

l ODCM Rav. 17 Page 6 l 11/95 2.0 BASIS FOR EFFLUENT MONITORING CONTROLS l 2.1 METEOROLOGICAL INSTRUMENTATION The OPERABILITY of the meteorological monitoring instrumentation ensures that sufficient meteorological data is available for estimating potential radiation doses to the public as a result of routine or accidental release of radioactive materials to the atmosphere. This capability is required to evaluate the need for initiating measures to protect the health and safety of the public. This instrumentation is consistent with the recommendations of Regulatory Guide 1.23 "Onsite Meteorological Programs," February, 1972. Site data compiled since January 1972 provide correlation between Elevation 1 (Tower 1) and Elevation 1 (Tower 2), and between Elevation 2 (Tower 1) and Elevation 2 (Tower 2). This correlation serves as justification for the use of the appropriate Tower 2 instrument as a back-up to the Tower 1 l instrument as shown in Table I3.1-1 and Table I3.1-3. 2.2 MAPS DEFINING UNRESTRICTED AREAS AND SITE BOUNDARY FOR RADIOACTIVE GASEOUS AND LIOUID EFFLUENTS Information regarding radioactive gaseous and liquid effluents, which will allow identification of structures and release points as well as definition of UNRESTRICTED AREAS within the SITE BOUNDARY that are accessible to MEMBER (S) OF THE PUBLIC, shall be shown in Technical Specifications Figures 5.1.3-la and 5.1.3-1b. The exclusion area and low population zone shall be as shown in Figures I2.2-la and I2.2-1b. 2.3 RADIOACTIVE LIOUID EFFLUENT MONITORING INSTRUMENTATION The radioactive liquid effluent instrumentation is provided to monitor and control, as applicable, the releases of radioactive materials in liquid effluents during actual or potential releases of liquid effluents. The alarm / trip setpoints for these instruments shall be calculated in accordance with the procedures in the ODCM part II to ensure that the alarm / trip will occur prior to exceeding the limits of 10 CFR Part 20. The OPERABILITY and use of this instrumentation is consistent with the requirements of General Design Criteria 60, 63, and 64 of Appendix A to 10 CFR Part 50.

l ODCM Rev. 17 ) l Page 7 l 11/95 I FIGURE I2.2-la EXCLUSION ZONE ~~~ P',,s= r..~e-S,q %, fyLl7;'/t'*

  • L =*s * ^-'"
  • e.

g.g*W'_",- r%.;-w.h- - -.h'fr-5 h s A e [j- - ,6.. + :.- >l a. -{ -9. f (;L . -t :.' =i-- j '[f-i < U-_ -L_ -i' -Q., g.g ' ' 2, ~z-- - -9 ~.. - ~ e- _5;'$ r; N'g) y'1 'y ' 3,. .J.!Lusou; DAW anusion L, s ('.,. 'f / j, j sWz mem.as 1)',v'f,[.}r.sy*u I a lr, u3 nu h /(j.," 6 %$\\{"~\\x - / f . % =. ? c e n = ~~ \\ r &;>:7 - m ph# m= w.>s, ~ gy.g.. } \\% t;.y s w e s t. e. 4 ./ = sins =amn '>,,.p w n. Y'k 3 %,, (l - Q w cj,6 J ^ hs ~ 2.+ r TL % ), u fn g :~..,,-a. a@45 T' *Q; ge;;fy dno r x c .. wo.a.m2 .*-T f,'. n..: y.? j i '). .. u, . ~_ J% k /,.;<I .r x ,..g? ' t-r ',p % L. ! e: 1,ti! w' u. 1 r J 'y\\ )b \\.-.* \\, r 3 n-1 \\ a;- .e+ff n o i M' Wr,a: x:3 )% 'xN'q i t ; y ' 9 ]%

  • Q.'pX*,. '_[ ;"'in

<~2 a. . %>b '"'~ .. W I s .y qx ys s \\ l A % g % a 8 E O L $,( w b ~ ,r m. g. S

l ODCM Rev. 17 Page 8 l 11/95 FIGURE I2.2-1b LOW POPULATION ZONE %. 462V""WY Q i j 1 W ..y Y /[I } e -,cv w ~ wg xy ( <s y e&l' s c ?f f E ' 3 l 4 k[ f 5-k 'ky:ll .,2 jn-Z Q 'O h

l ODCM Rev. 17 Page 9 l 11/95 2.3.1 CONCENTRATION This control is provided to ensure that the concentration of radioactive materials released in liquid waste effluents to UNRESTRICTED AREAS will be less than the concentration levels specified in 10 CFR Part 20, Appendix B, Table II, Column 2. This limitation provides additional assurance that the levels of radioactive materials in bodies of water in UNRESTRICTED AREAS will result in exposures within (1) the Section II.A design objectives of Appendix I, 10 CFR Part 50, to a MEMBER OF THE PUBLIC, and (2) the limits of 10 CFR 20.1301(e) to the population. The concentration limits for dissolved or entrained noble gases are based upon the assumption that Xe-135 is the controlling radioisotope and its MPC in air was converted to an equivalent concentration in water using the methods described in the International Commission on Radiological Protection (ICRP) Publication 2. The required detection capabilities for radioactive materials in liquid waste samples are tabulated in terms of the lower limits of detection (LLDs). Detailed discussion of the LLD, and other detection limits can be found in HASL Procedures Manual, RASL-300 (revised annually), Currie, L.A., " Limits for Qualitative Detection and Quantitative Determination - Application to Radiochemistry," Anal. Chem. 40, 586-93 (1968), and Hartwell, J.K., " Detection Limits for Radioanalvtical Countino Technicues," Atlantic Richfield Hanford Comoany Reoort ARH-SA-215 (June, 1975). 2.3.2 DOSE This Control is provided to implement the requirements of Sections II.A, III.A, and IV.A of Appendix I, 10 CFR Part 50. The Control implements the guides set forth in Section II.A of Appendix I. The ACTION statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive material in liquid effluents will be kept "as low as reasonably achievable". Also, for fresh water sites with drinking water supplies which can be potentially affected by plant operations, there is reasonable assurance that the operation of the facility will not result in radionuclide concentrations in the finished drinking water that are in excess of the requirements of 40 CFR Part 141. The dose calculation methodology and parameters in the ODCM implement the requirements in Section III.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on models and data, such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underestimated. The equations specified in the ODCM for calculating the doses due to the actual release rates of radioactive materials in liquid effluents are consistent with the methodology provided in Regulatory Guide 1.109, " Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with

l ODCM Rev. 17 Page 10 l' 11/95 10 CFR Part 50, Appendix I," Revision 1, October, 1977 and Regulatory Guide 1.113, " Estimating Aquatic Dispersion of Effluents from Accidental and Routine Reactor Releases for the Purpose of Implementing Appendix I," April, 1977. 2.3.3 LIOUID RADWASTE TREATMENT SYSTEM The requirement that the appropriate portions of this system be used when specified provides assurance that the releases of radioactive materials in liquid effluents will be kept "as low as reasonably achievable". This specification implements the requirements of 10 CFR 50.35a, General Design Criterion 60 of Appendix A to 10 CFR Part 50 and the design objective given in Section II.D of Appendix I to 10 CFR Part 50. The specified limits governing the use of appropriate portions of the liquid radwaste treatment system were specified as a suitable fraction of the dose design objectives set forth in Section II.A of Appendix I, 10 CFR Part 50, for liquid effluents. 2.4 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION The radioactive gaseous effluent instrumentation is provided to monitor and control, as applicable, the releases of radioactive materials in' gaseous effluents during actual or potential releases of gaseous effluents. The alarm / trip setpoints for these instruments shall be calculated in accordance with the procedures in the ODCM to ensure that the alarm / trip will occur prior to exceeding the limits of 10 CFR Part 20. The OPERABILITY and use of this instrumentation is consistent with the requirements of General Design Criteria 60, 63, and 64 of Appendix A to 10 CFR Part 50. 2.4.1 DOSE RATE This control is provided to ensure that the dose at any time at and beyond the SITE BOUNDARY from gaseous effluents from the site will be within the annual dose limits of 10 CFR Part 20 to UNRESTRICTED AREAS. The annual dose limits are the dose associated with the concentrations of 10 CFR Part 20, Appendix B, Table II, Column I. These limits provide reasonable assurance that radioactive material discharged in gaseous effluents will not result in the exposure of a MEMBER OF THE PUBLIC in an UNRESTRICTED AREA, either within or outside the SITE BOUNDARY, to annual average concentrations exceeding the limits specified in Appendix B, Table II of 10 CFR Part 20 (10 CFR 20.106 (b) (1) ). For MEMBERS OF THE PUBLIC who may at times be within the SITE BOUNDARY, the occupancy factor for that MEMBER OF THE PUBLIC will usually be sufficiently low to compensate for any increase in the atmospheric diffusion factor for above that for the SITE BOUNDARY. Examples of calculations for such MEMBERS OF THE PUBLIC, with the appropriate occupancy factors, are given in the ODCM. The specified release rate limits restrict, at all times, the corresponding gamma and beta dose rates above background to a MEMBER OF THE PUBLIC at or beyond the SITE BOUNDARY to less than or equal to 500 mrems/ year to the total i

l ODCM Rsv. 17 Pr.ga 11 l 11/95 body or tc lane insr equal to 3000 mreme/ year to the skin. These relei.n. rate 'cwne also restrict, at all times, the corresponding thyrcid dove rate above background to a child via the inhalation pathway t S 3 than or equal to 1500 mrems/ year. 1 This Control applies to the release of radioactive materials in gaseous effluents from all reactors at the site. The required detection capability for radioactive materials in l gaseous waste samples are tabulated in terms of the lower limits of detection (LLDs). Detailed discussion of the LLD, and other detection limits can be found in HASL Procedures Manual, HASL-300 (revised annually), Currie, L.A., " Limits for Qualitative Detection and Quantitative Determination - i Application to Radiochemistry," Anal. Chem. 40, 586-93 (1986) and Hartwell, J.K., " Detection Limits for Radioanalvtical Countina Technicues." Atlantic Richfield Hanford Comoany ReDort ARH-SA-215 (June 1975). 2.4.2 DOSE - NOBLE GASES This control is provided to implement the requirements of Sections II.B, III.A, and IV.A of Appendix I, 10 CFR Part 50. The control implements the guides set forth in Section II.B of . Appendix I. The ACTION statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive material in gaseous effluents will be kept "as low as reasonably achievable". The Surveillance Requirements implement the requirements in Section III.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on appropriate pathways in unlikely to be substantially underestimated. The dose calculation established in the ODCM for calculating the doses due to the actual release rates of radioactive noble gases in gaseous effluents are consistent with the methodology provided in Regulatory Guide 1.109, " Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I," Revision I, October 1977 and Regulatory Guide 1.111, " Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routing Releases from Light-Water Cooled Reactors," Revision 1, July 1977 with site specific dispersion curves and deposition methodology. The ODCM equations provided for determining the air doses at an beyond the SITE BOUNDARY are based upon the historical average atmospheric conditions.

l ODCM Rav. 17 Page 12 l 11/95 2.4.3 DOSE - IODINE-131, IODINE-133. TRITIUM, AND RADIONUCLIDES IE PARTICULATE FORM This control is provided to implement the requirements of Sections II.C, III.A, and IV.A of Appendix I, 10 CFR Part 50. The controls are the guides set forth in Section II.C of Appendix I. The ACTION statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive materials in gaseous effluents will be kept "as low as is reasonably achievable." The ODCM calculational methods specified in the Surveillance Requirements implement the requirements in Section III.A of Appendix I be shown by calculational procedures based on models and data, such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underestimated. The ODCM calculational methods for calculating the doses due to the actual release rates of the subject materials are consistent with the methodology provided in Regulatory Guide 1.109, Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I," Revision I, October 1977 and Regulatory Guide 1.111, " Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water-Cooled Reactors," Revision 1, July 1977 with site specific dispersion curves and deposition methodology. These equations also provide for determining the actual doses based upon the historical average atmospheric conditions. The release rate specifications for iodine-131, iodine-133, tritium, and radionuclides in particulate form with half-lives greater than 8 days are dependent on the existing radionuclides pathways to man in areas at and beyond the SITE BOUNDARY. The pathways which were examined in the development of these calculations were: (1) individual inhalation of airborne radionuclides, (2) deposition of radionuclides onto green leafy vegetation with subsequent consumption by man, (3) deposition onto grassy areas where milk animals and meat-producing animals graze with consumption of the milk and meat by man, and (4) deposition on the ground with subsequent exposure of man. 2.4.4 VENTILATION EXHAUST TREATMENT SYSTEM The requirement that the appropriate portions of this system be used, when specified, provides reasonable assurance that the releases of radioactive materials in gaseous effluents will be kept "as low as is reasonably achievable." This control implements the requirements of 10 CFR 50.36a, General Design Criteria 60 of Appendix A to 10 CFR Part 50, and the design objectives given in Section II.D of Appendix I to 10 CFR Part 50. The specified limits governing the use

1 l ODCM Rev. 17 Fage 13 l 11/95 of appropriate portions of the systems were specified as a suitable fraction of the dose design objectives set forth in i Section II.B and II.C of Appendix I, 10 CFR Part 50, for gaseous effluents. 2.4.5 VENTING OR PURGING i This control provides reasonable assurance that releases from drywell purging operations will not exceed the annual dose limits of 10 CFR Part 20 for UNRESTRICTED AREAS. l 2.4.6 TOTAL DOSE i 1 This control is provided to meet the cose limitations of 40 CFR Part 190 that have been incorporated into 10 CFR Part 20 by 46 CFR 18525. The control requires the preparation and submittal of a Special Report whenever the calculated doses ] 4 from plant radioactive effluents exceed twice the design objective doses of Appendix I. For sites containing up to four reactors, it is highly unlikely that the resultant dose to a MEMBER OF THE PUBLIC will exceed the dose limits of 40 CFR 190 if the individual reacters remain within the reporting requirement level. The Special Report will describe a course of action that should result in the limitation of the annual dose to a MEMBER OF THE PUBLIC to within the 40 CFR Part 190 limits. For the purposes of the special Report, it may be assumed that the dose l commitment to the MEMBER OF THE PUBLIC from other uranium fuel cycle sources is negligible, with the exception that dose contributions from other nuclear fuel cycle facilities at the i same site or within a radius of 5 miles must be considered. If { the dose to any MEMBER OF THE PUBLIC is estimated to exceed the 4 requirements of 40 CFR Part 190, the Special Report with a request for a variance (provided the release condition resulting in violation of 40 CFR Part 190 have not already been 2 corrected), in accordance with the provisions of 40 CFR 190.11 ar.d 10 CFR 2 0. 4 0 5 c, is considered to be a timely request and fulfills the requirements of 40 CFR Part 90 until NRC staff action is completed. An individual is not considered a MEMBER OF THE PUBLIC during any period in which he/she is engaged in carrying out any operation that is part of the nuclear fuel. cycle. 2.5 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM The Radiological Environmental Monitoring Program (REMP) required by this control provides representative measurements of radiation and of radioactive materials in those exposure pathways and for those radionuclides that lead to the highest potential radiation exposures of MEMBER OF THE PUBLIC resulting from the station operation. This monitoring program implements Section IV.B.2 of Appendix I to 10 CFR Part 50 and thereby supplements the radiological effluent monitoring program by verifying that the measurable concentrations of radioactive materials and levels of radiation are not higher than expected

l l ODCM Rev. 17 l Page 14 11/95 ) on the basis of the effluent measurements and modeling of the environmental exposure pathways. The required detection capabilities for environmental sample analyses are tabulated in terms of the lower limits of detection (LLDs). The LLDs required by Table I3.4-3 are considered optimum for routine environmental measurements in industrial laboratories. It should be recognized that the LLD is defined as'an a oriori (before the fact) limit representing the capability of a measurement system and not an after the fact limit for a particular measurement. Detailed discussion of the LLD, and other detection limits, can be found in HASL Procedures Manual, HASL-300 (revised annually); Currie L.A., " Limits for Qualitative Detection and Quantitative Determination - Application to Radiochemistry," Anal. Chein. 40, 586-93 (1968) and Hartwell, J.K., " Detection Limits for Radioanalvtical Countina Technicues," Atlantic Richfield Hanford Comoany Reoort ARH-SA-215 (June. 1975) 2.5.1 LAND USE CENSUS This control is provided to ensure that changes in the use of l areas at and beyond the SITE BOUNDARY are identified and that modifications to the monitoring program are made if required by the results of the census. The best information from the door-to-door survey, aerial survey or consulting with local agricultural authorities or any combination of these methods i shall be used. This census satisfies the requirements of Section IV.B.3 of Appendix I to 10 CFR Part 50. Restricting the census to gardens of greater than 500 square feet provides assurance that significant exposure pathways via leafy vegetables will be identified and monitored since a garden of this size is the minimum required to produce the quantity (26 Kg/ year) of leafy vegetables assumed in Regulatory Guide 1.109 for consumption by a child. To determine this minimum garden size, the following assumptions were used: (1) that 20% of the garden was used for growing broad leafy vegetation (i.e. similar to lettuce and cabbage), and (2) a vegetation yield of 2 kg/ Square meter. 2.5.2 INTERLABORATORY COMPARISON PROGRAM The requirement for participation in an Interlaboratory Comparison Program ensures that independent checks on the precision and accuracy of the measurements of radioactive material in environmental sample matrices are performed as part of the quality assurance program for environmental monitoring in order to demonstrate that the results are reasonably valid for the purpose of Section IV.B.2 of Appendix I to 10 CFR Part 50. 2.6 APPLICABILITY # 2.6.1 Compliance with the controls contained in the succeeding controls section is required during the OPERATIONAL CONDITIONS

l l ODCM Rev. 17 Page 15 l 11/95 or other conditions specified therein; except that upon failure to meet the controls, the associated ACTION requirements shall be met. 2.6.2 Non compliance with a control shall exist when the requirements of the control and associated ACTION requirements are not performed within the specified time intervals. If the control is restored prior to expiration of the specified time intervals, completion of the ACTION requirements is not required. 2.6.3 There are no actions in the ODCM which would require an operational condition change. 2.6.4 There are no restrictions on changing operating conditions in any of the controls on the ODCM. 2.6.5 Surveillance Requirements shall be met during the OPERATIONAL CONDITIONS or other conditions specified for individual controls unless otherwise stated in an individual Surveillance Requirement. 2.6.6 Each Surveillance Requirement shall be performed within the specified interval with a maximum allowable extension not to exceed 25% of the surveillance interval. 2.6.7 Failure to perform a Surveillance Requirement within the allowed surveillance interval defined by control 2.6.6, shall l' constitute noncompliance with the OPERABILITY requirements for l a control. The time limits of the ACTION requirements are applicable at the time it is identified that a Surveillance i Requirement has not been performed. The ACTION requirements may be delayed for up to 24 hours to permit the completion of the surveillance when the allowable outage time limits of the ACTION requirements are less than 24 hours. Surveillance requirements do not have to be performed on inoperable equipment. l i The associated bases from the LGS Technical Specifications applies to this section.

l l ODCM Rav. 17 Page 16 l 11/95 3.0 METEOROLOGICAL MONITORING INSTRUMENTATION 1 CONTROLS l l 3.1 The metecrological monitoring instrumentation channels shown in l Table I3.1-1 shall be OPERABLE. 1 APPLICABILITY: At all times. ACTION: i l With less than the minimum required instrumentation channels operable for more than 7 days, prepare and submit a Special Report to the Commission pursuant to LGS Technical Specification 6.9.2 within the next 10 days outlining the cause of the malfunction and the plans for restoring the instrumentation to OPERA 3LE status. l SURVEILLANCE REOUIREMENTS 1 3.1-1 Each of the above required meteorological monitoring instrumentation channels shall be demonstrated OPERABLE by the performance of the CHANNEL CHECK and CHANNEL CALIERATION operations at the frequencies shown in Table 13.1-2. l

s ___. l ODCM Rev. 17 Page 17 l 11/95 TABLE I3.1-1 METEOROLOGICAL MONITORING INSTRUMENTATION { MINIMUM Tower 1 Tower 2 INSTRUMENT INSTRUMENT (Primary) (Backup) OPERABLE ] 1. Wind Speed a. Elevation 1 30 feet 159 feet 1 b. Elevation 2 175 feet 304 feet 1 2. Wind Direction a. Elevation 1 30 feet 159 feet 1 b. Elevation 2 175 feet 304 feet 1 i 3. Air Temperature Difference (AT) a. Elevations 266 feet-300 feet-26 feet 26 feet 1 TABLE I3.1-2 METEOROLOGICAL MONITORING INSTRUMENTATION SURVEILLANCE REOUIREMENTS Channel Channel INSTRUMENT Check CALIBRATION

1. Wind Speed
a. Elevation 1 (Tower 1 and Tower 2)

D SA

b. Elevation 2 (Tower 1 and Tower 2)

D SA

2. Wind Direction
a. Elevation 1 (Tower 1 and Tower 2)

D SA

b. Elevation 2 (Tower 1 and Tower 2)

D SA

3. Air Temperature Difference (AT)
a. Elevations 266 - 26 ft (Tower 1)

D SA

b. Elevations 300 - 26 ft (Tower 2)

D SA NOTE: The meteorological towers shall be located as shown on Figure I3.1-1. For backup sources of data retrieval, refer to Table I3.1-3.

he l ODCM Rev. 17 Page 18 l 11/95 TABLE I3.1 - t METEOROLOGICAL TOWER DATA RETRIEVAL INSTRUMENT TOWER 1 TOWER 2 DATA LOGGER DATA - RM-21A Channel # Wind Speed 1 (TWR1) l

a. Elev. 1 Strip Chart Strip Chart RM-21A 14 (TWR2)

Wind Speed 5 (TWR1) l

b. Elev. 2 Strip Chart Strip Chart RM-21A 21 (TWR2)

Wind Dir. 0 (TWR1) l a. Elev. 1 Strip Chart Strip Chart RM-21A 13 (TWR2) Wind Dir. 4 (TWR1) l

b. Elev. 2 Strip Chart Strip Chart RM-21A 20 (TWR2)

DELTA T Multi-pt Rec Multi-pt Rec RM-21A 7 (TWR1) 23 (TWR2) PRIMARY OPTION: A) .I_E DATA IS UNAVAILABLE FOR TOWER 1 THEN verify corresponding data available for Tower 2 B) DATA IS AVAILABLE FROM RM-21, DATA LOGGER OR STRIP CHARTS. THE SOURCES OF DATA IN ORDER OF PREFERENCE ARE THE RM-21, DATA OGGER OR STRIP CHARTS. DATA LOGGER AND STRIP CHARTS ARE LOCATED IN THE CONTROL ROOM. e_-, ,.. = -, n - - ~, -, ,.,, - +, ~ -, -e,.,--

l ODCM Rev. 17 Page 19 l 11/95 Ficure I3.1-1 Meteorological Tower Location j $-d 't I DiT.'.'.Fi' 1'N MMMTI'M'M L t

  • i..

Y =~=~:. b.* W. 4 'k'. y % % W* =\\\\ \\\\ %L!5.X! }y k t, \\ ,2:.h,yI ~~ ( _- .p.- EiiEDROLDEICAL i yp,7.c . KJ [y% a w\\q $. hf$ I <*'/.!y c., y lJif.n..e W n. : .".4 10 m \\ p.sh f\\$ i \\ Mif . kD 'I..M' 'M (\\ % M W !-( y' - l b~' @ 9 p % "r ] ks gi

  • l.

/.w. N TPQMwa.Pe!PWg =4 c.$b C W__ h., ! l ; 's i s. s ~ \\ e, d 220KY C q v s, )\\h.SUiliAT10N.g-0 $ * (yh h f. ' 1 ~ . j,j \\, iY \\ k ~ \\\\ \\,,i. hN-

s::-

6 r r +, a r .x n=_-ary

w(

w,th. o 5.

  • 'g.

, \\ =I=a Y.-. -x-w ,1 ,o: r.,.. IfE"" 9~ l 'm. 5j.~ us G *s '. L.*:l:S..i Ms V . F $ '.E _

  • _f-~'l,

'2 A.,. ( I 01.0G A 1 TOI!n #2 I Z yf'.*:5<*. # g:.K.-- 500KY ,M '*' y,is,,Q. f l. \\ !UESTATION y 1 \\ \\_. . fs. yg[p,/, s-%Ag. g h*-==_ ' l.&.*/ s \\*w/<. V ./ 's

1. i.;.Q '-@ s.Qh (i ) f,t -

m'. . i. \\ - Q. \\,. 2 cz. 3.; r-r. a. yx- .. -. M. = x.. .,4. c.u. 3 I, - >.{. e.. r, ~ s.

l l l ODCM Rev. 17 Page 20 l 11/95 3.2 RADIOACTIVE LIOUID EFFLUENT MONITORING INSTRUMENTATION CONTROLS 3.2.1 The radioactive liquid effluent monitoring instrumentation channels shown in Table I3.2-1 shall be OPERABLE with their alarm / trip setpoints set to ensure that Control I3.2.2 is not exceeded.. The alarm /setpoints* of these channels shall be determined and adjusted in accordance with the methodology and l parameters in the ODCM - Part II, Section 1.2. APPLICABILITY: At all times. ] ACTION: With a radioactive liquid effluent monitoring instrumentation a. channel alarm / trip setpoint less conservative than required by the above control, immediately suspend the release of radioactive liquid effluents monitored by the affected channel, and declare the channel inoperable, b. With less than the minimum number of radioactive liquid effluent monitoring instrumentation channels OPERABLE, take the ACTION shown in Table I3.2-1. Restore the inoperable instrumentation to OPERABLE status within the time specified in the ACTION or e:tplain in the next Annual Radioactive Effluent Release Report why this inoperability was not corrected within the time specified. SURVEILLANCE REOUIREMENTS 3.2.1-1 Each radioactive liquid effluent monitoring instrumentation channel shall be demonstrated OPERABLE by performance of the CHANNEL CHECK, SOURCE CHECK, CHANNEL CALIBRATION and CHANNEL FUNCTIONAL TEST performance at the frequencies shown in Table I3.2-2.

  • Excluding the flow rate measuring devices which are not determined and adjusted in accordance with the ODCM.

l-ODCM Rev. 17 Page 21-l 11/95 TABLE 13.2-1 RADIOACTIVE LIOUID-EFFLUENT MONITORING INSTRUMENTATION i MINIMUM i CHANNELS INSTRUMENT OPERABLE ACTION 1. Gross Radioactivity Monitors Providing Automatic Termination of Release

a. Liquid Radwaste Effluent Line 1

100

b. A/B RHR' Service Water Effluent Line 1/ loop 101 2.

Gross Radioactivity Monitors Not Providing Automatic Termination of Release

a. Service' Water Effluent Line 1

101 3. Flow Rate Measurement Devices

a. Liquid Radwaste Effluent Line 1

102

b. Discharge Line 1

102 l l

. -. ~ l ODCM Rav. 17 Page 22 l 11/95 ACTION STATEMENTS i 1 Action 100-With less than the Minimum Required Channels operable, effluent releases may continue for up to 14 days provided that prior to initiating a release: a. At least two independent samples are analyzed in accordance with Table I3.2-3, and b. At least two technically qualified members of the facility staff independently verify the release j rate calculations and discharge line valving; i Otherwise, suspend release of radioactive effluents via this pathway. Action 101-With less than the Minimum Required Channels operable, effluent releases via this pathway may continue for up to 30 days provided that, at least once per 8 hours, grab samples are collected and analyzed for radioactivity by gamma isotopic analysis (Principal Gamma Emitters, I-131, i and Dissolved / Entrained Gases) as a Lower Limit of Detection as specified in Table I3.2-3 or gross radioactivity (beta and gamma). Gross Beta is analyzed at an LLD of at least 1N7 pCi/ml. Gross Gamma is analyzed at an LLD of at least SN7 pCi/ml. If the A or B RHRSW Process Rad Monitor should become inoperable, sampling is required at least once every eight (8) hours at a sample point common with the inoperable A and/or B RHRSW Process Rad Monitor (s) l whether or not the respective 1C/2C and/or 1D/2D RHRSW Process Rad Monitors are operable. However, there are no additional sampling requirements when the 1C/2C and/or j 1D/2D RHRSW Process Rad Monitors are inoperable since i monitoring requirements are satisfied through the operable A and/or B RHRSW Process Rad Monitors or the inop sampling of those points. If a monitor is inoperable but will still continuously sample and annunciate on high activity, i.e. rad monitor bypass switch placed in " Bypass", Chemistry sampling is not required as the continuous monitor sampling complies with the periodic sampling requirement. Action 102-With less than the Minimum Required Channels operable, effluent releases via this pathway may continue for up to 30 days provided the flow rate is estimated at least once per 4 hours during actual releases. Pump curves generated in situation may be used to estimate flow.

l ODCM Rev. 17 Page 23 l 11/95 TABLE I3.2-2 RADIOACTIVE LIOUID EFFLUENT MONITORING INSTRUMENTATICN SURVEILLANCE REOUIREMENTS CHANNEL CHANNEL SOURCE CHANNEL FUNCTIONAL INSTRUMENT CHECK CHECK CALIBRATION TEST 1. Gross Radioactivity Monitors Providing Automatic Termination of Release a. Liquid Radwaste Effluent Line D* D* R(3) Q(1) l

b. RHR Service Water System Effluent Line D

M R(3) Q(1) 2. Gross Radioactivity Monitored Not Providing Automatic Termination of Release a. Service Water System Effluent Line D M R(3) Q (2 )- 3. Flow Rate Measurement Devices

a. Liquid Radwaste Effluent Line D(4)

N.A. R Q b. Discharge Line D(4) N.A. R Q l* Daily when in use

l ODCM Rev. 17 Page 24 l 11/95 TABLE I3.2-2 (Continued) 1 TABLE NOTATIONS (1) The CHANNEL FUNCTIONAL TEST shall also demonstrate that automatic isolation of this pathway and control room alarm annunciation will occur if any of the following conditions exists: 1. Instrument indicates measured levels above the alarm / trip setpoint. 2. Circuit failure. 3. Instrument indicates a downscale failure. (2) The CHANNEL FUNCTIONAL TEST shall also demonstrate that control room alarm annunciation occurs if any of the following conditions exists: 1. Instrument indicates measured levels above the alarm setpoint. 2. Circuit failure. 3. Instrument indicates a downscale failure. (3) The initial CHANNEL CALIBRATION shall be performed using reference standards certified by the National Institute of Standards and Technology (NIST) obtained from suppliers that participate in measurement assurance activities with NIST. These standards shall permit calibrating the system over its intended range of energy and measurements range. For subsequent CHANNEL CALIBRATION, sources that have been related to the initial calibration shall be used. ] (4) CHANNEL CHECK shall consist of verifying indication of flow during periods of release. CHANNEL CHECK shall be made at least once per 24 hours on days on which batch releases are made.

t 1 l ODCM Rev. 17 Page 25 l 11/95 CONCENTRATION l CONTROLS 3.2.2 The concentration.of radioactive material released in liquid effluents to UNRESTRICTED AREAS (see Figure I2.2-la,b) shall be limited to the concentrations specified in l 10 CFR Part 20, Appendix B, Table II, Column 2 for radionuclides other than dissolved or entrained nobles gases. For dissolved or entrained noble gases, the concentration shall be limited to 2E-4 microcuries/ml total activity. APPLICABILITY: At all times. ACTION: With the concentration of radioactive material released in liquid effluents to UNRESTRICTED AREAS exceeding the above limits, immediately restore the concentration to within the above limits or terminate the release. SURVEILLANCE REOUIREMENTS 3.2.2-1 Radioactive liquid wastes shall be sampled and analyzed according to the sampling and analysis program of Table I3.2-3. 3.2.2-2 The results of the radioactivity analyses shall be used in accordance with the methodology and parameters in the ODCM Part II. Section 1.3 to assure that the concentrations at the point of release are maintained within the limits of Control I3.2.2.

l ODCM Rsv. 17 j Page 26 l 11/95 l 1 TABLE I3.2-3 RADIOACTIVE LIOUID WASTE SAMPLING AND ANALYSIS PROGRAM Lower Limit Minimum Type of of Detection Liquid Release Sampling Analysis Activity (LLD)* Type Frequency Frequency Analysis (uCi/M1) i A. Batch Waste P P Principal Gamma SE-7 Release Each Batch Each Batch Emitters Tanksb I-131 1E-6 1. Floor or P M Dissolved and 1E-5 Equip. Drain One Batch /M Entrained Gases Sample Tanks (Gamma Emitters)* 2. Laundry P M H-3 1E-5 Drain Sample Each Batch Composited Tank l Gross Alpha 1E-7 P Q Sr-89, Sr-90 SE-8 Each Batch Composited Fe-55 1E-6 B. Continuous W W Principal Gamma SE-7 Release

  • Grab Sample Emitters
  • I-131 1E-6
1. RHR Service W

W Dissolved and 1E-5 Watel System Grab Sample Entrained Gases Effluent Linef (Gamma Emitters)* 2. Service Water W M H-3 1E-5 System Grab Sample Composited Effluent Linef Gross Alpha 1E-7 W Q Sr-89. Sr-90 SE-8 Grab Sample Composite e Fe-55 1E-6

1 1 l ODCM Rev. 17 Page 27 l 11/95 TABLE I3.2-3 (Continued) TABLE NOTATIONS The LLD is defined as the smallest concentration of radioactive a. material in a sample that will yield a net count, above system background, that will be detected with 95% probability with only 5% probability of falsely concluding that a blank observation represents a "real" signal. For a measurement system, which may include radiochemical separation: (2.71 + 4. 66sg) (1-exp (- AAt ) ) 2 E V 2.22E6 Y [exp (-AAt )] (AAt ) 1 2 (2. 71 + 4. 66 sg) LLD (Grab Samples)= E V 2.22E6 Y (exp - AAtz) j Where: LLD is the a criori lower limit of detection as defined above ( as microcuries per unit mass or volume), l sg is the standard deviation of the background counting rate or of the counting rate of blank sample as appropriate (as counts per minute), E is the counting efficiency, as counts per disintegration, V is the sample size, in units of mass or volume, 2.22E6 is the number of disintegrations per minute per microcurie, Y is the fractional radiochemical yield, when applicable, A is the radioactive decay constant for the particular radionuclide, and At for the plant effluents is the elapsed time between the end 1 of the sample collection and the time of counting. At for the plant effluents is the elapsed time between the end 2 of the sample collection and the start of sample collection. Typical values of E, V, Y, At and At should be used in calculation. 1 2 It should be recognized that the LLD is defined as an a priori (before the fact) limit representing the capability of a measurement system and not as an after the fact limit for a particular measurement. l

=_ l ODCM Rsv. 17 Page 28 l 11/95 TABLE I3.2-3 (Continqq, dl I TABLE NOTATIONS l b. A batch release is the discharge of liquid wastes of a discrete volume. Prior to sampling for analyses, each batch shall be isolated, and then thoroughly mixed to assure representative sampling. The principal gamma emitters for which the LLD specification c. applies include the following radionuclides: Mn-54, Fe-59, Co-58, Co-60, Zn-65, Mo-99, Cs-134, Cs-137, Ce-141 and Ce-144. The dissolved and entrained noble gases (gamma emitters) for which the LLD' specification applies include the following radionuclides: Kr-87, Kr-88, Xe-133, Xe-133m, Xe-135, Xe-135m, Xe138. This list does not mean that only these nuclides are to be considered. Other gamma peaks that are identifiable, together with those of the above nuclides, shall also be analyzed and reported in the Semiannual Radioactive Effluent Release Report pursuant to Control 3.6. d. The term " Composite Sample" means a combination of individual samples obtained at regular intervals over a time period. Either the volume of each individual sample is proportional to discharge flow rates, or the sampling interval (for constant volume samples) is proportional to flow rates over the time period used to produce the composite. A continuous release is the discharge of liquid wastes of e. nondiscrete volume, from a volume of a system that has an input flow during the continuous release. f. Whenever effluent releases are in excess of the monitor's setpoint.

l ODCM Rev. 17 Page 29 l 11/95 DOSE r CONTROLS 3.2.3 The dose or dose commitment to a MEMBER OF THE PUBLIC from radioactive materials in liquid effluents released from the site to UNRESTRICTED AREAS (See Figure I2.2-la) shall be limited: During any calendar quarter to less than or equal to a. 3 mrems to the total body and to less than or equal to 10 mrems to any organ, and b. During any calendar year to less than or equal to 6 mrems to the total body and to less than or equal to_20 mrems to any organ. APPLICABILITY: At all times. ACTION: With the calculated dose from the release of radioactive materials in liquid effluents exceeding any of the above limits, prepare and submit to the Commission within 30 days, pursuant to Technical Specification 6.9.2, a Special Report which identifies the cause(s) for exceeding the limit (s) and defines the corrective actions that have been taken to reduce the releases and the proposed corrective actions to be taken to assure that subsequent releases will be in compliance with the above limits. This Special Report shall also include the radiological impact on finished drinking water supplies at the nearest downstream drinking water source. SURVEILLANCE REOUIREMENTS 3.2.3-1 Cumulative dose contributions from liquid effluents for the current calendar quarter and the current I calendar year shall-be determined using ST-0-104-878-0 at least once per 31 days.

l ODCM Rev. 17 Page 30 l 11/95 i LIOUID RADWASTE TREATMENT SYSTEM CONTROLS 3.2.4 The liquid radwaste treatment system shall be IN SERVICE and appropriate portions of the system shall be used to reduce the radioactive materials in liquid waste prior to their discharge when the projected doses due to the liquid effluent, from the site, to UNRESTRICTED AREAS (See Figure I2.2-la) would exceed 0.06 mrem to the total body or 0.2 mrem to any organ in a 31-day period. APPLICABILITY: At all times. ACTION: ) a. With radioactive liquid waste being discharged without treatment or in excess of the above limits, pursuant to Technical Specification 6.9.2, prepare a Special Report which includes the following information-1 l 1. Explanation of what liquid radwaste was being discharged without treatment, identification of any inoperable equipment or subsystems, and the reason for the inoperability. 2. Action (s) taken to restore the inoperable equipment to OPERABLE status, and j 3. Summary description of action (s) taken to prevent a recurrence. b. Submit report to Commission within 30 days. SURVEILLANCE REOUIREMENTS 3.2.4-1 Dose due to liquid releases from the site to UNRESTRICTED AREAS shall be projected at least once per 31 days using ST-0-104-878-0.

l ODCM Rev. 17 Page 31 l 11/95 3.3 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION CONTROLS 3.3.1 The radioactive gaseous effluents monitoring instrumentation channels in Table I3.3-1 shall be OPERABLE with their alarm / trip setpoints set to ensure that the limits of ODCM Control Part I Section 3.3.2 are not exceeded. The alarm / trip setpoints of the applicable channels shall be determined in accordance with the methodology and parameters in the ODCM Part II, Section 2.2. APPLICABILITY: As shown in Table I3.3-1. ACTION: With a radioactive gaseous effluent monitoring a. instrumentation channel alarm / trip setpoints less conservative than required by Part II Section 2.2, immediately suspend the release of radioactive gaseous effluents monitored by the affected channel or declare the channel inoperable. b. With less than the minimum number of radioactive gaseous effluent monitoring instrumentation channels OPERABLE, take the ACTION shown in Table I3.3-1. Restore the inoperable instrumentation to OPERABLE status within the time specified in the ACTION. If the inoperable instrumentation is not restored within the time specified in the ACTION statement: create an AR in PIMS to ensure an explanation is written by the responsible System Engineer and is included in AERR by the Effluent Physicist. SURVEILLANCE REOUIREMENTS 3.3.1-1 Each radioactive gaseous effluent monitoring instrumentation channel shall be demonstrated OPERABLE by performance of the CHANNEL CHECK, SOURCE CHECK, CHANNEL CALIBRATION AND CHANNEL FUNCTIONAL TEST operations at the frequencies shown in Table I3.3-2.

l ODCM Rev. 17 Page 33 l 11/95 . TABLE I3.3-1 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION MINIMUM CHANNELS INSTRUMENT OPERABLE APPLICABILITY ACTION SOUTH STACK EFFLUENT MONITORING SYSTEM

a. Noble Gas Activity Monitor 1

111 [ b. Iodine Sampler 1 112 c. Particulate Sampler 1 112

d. Effluent System Flow Rate Monitor 1

113 e. Sampler Flow Rate Monitor 1 113 NORTH STACK EFFLUENT MONITORING SYSTEM #

a. Noble Gas Activity Monitor 1

114 I f b. Iodine Sampler 1 112 c. Particulate Sampler 1 112 i

d. Effluent System Flow Rate Monitor 1

113 e. Sampler Flow Rate Monitor 1 113 HOT MAINTENANCE SHOP VENTILATION EXHAUST RADIATION MONITOR a. Iodine Sampler 1 112

b. Particulate Sampler 1

112 l c. Effluent System Flow Rate' Monitor 1 113

d. Sampler Flow Rate Monitor 1

113 t

  1. The (A or B) North Stack Normal Range Radiation Monitors OR the Wide Range Accident Monitor (Low Range) may be used to satisfy requirements for the North Stack Effluent Monitoring System.

NOTE: With regard to Actions 111, 112, 113, and 114; with less than the minimum Required Channels operable for greater than 30 days prepare and submit a Special Report to the Effluent Physicist within the next 10 days outlining the cause of the malfunction and the plans for restoring the instruments to OPERABLE Status. Sampling shall continue until the minimum channel operability requirement is met. At all times. l During operation of the hot maintenance shop ventilation system. .m . m.e

~- l ODCM Rev. 17 Page 33 l 11/95 TABLE I3.3-1(Continued) TABLE NOTATIONS ACTION STATEMENTS ACTION 111 With less than the minimum Required Channels (SS Noble Gas) OPERABLE, effluent releases via this pathway j may continue for up to 30 days provided grab samples are taken per ST-5-026-580

  • at least once per 8 hours and these samples are analyzed for gross activity within 24 hours.

ACTION 112* - With less than the minimum Required Channels (Iodine & Part.) OPERABLE, effluent releases via this pathway may continue for up to 30 days provided samples are continuously collected with j auxiliary samp]ing equipment per St-5-076- ) 815 *, ST-5-076-820

  • as required in Table I3.3-3.

j IE the Sample Pump is operable, a particulate and iodine sample can be obtained; AHD the Minimum Channels Operable requirements are satisfied. ACTION 113* - With less than the minimum Required Channels ) (Eff. & Smpl. OPERABLE, effluent releases via NS, SS or HMS Flow Rate) may continue for up to 30 days provided the flow rate is estimated by adding the nominal flow rates indicated in P&ID M-26 for each in-service fan. This shall be documented in the MCR operations Shift Log at least once per 4 hours. ACTION 114 With less than the minimum Required Channels (NS Noble Gas) OPERABLE, effluent releases via this pathway may continue for up to 30 days provided grab samples are taken per ST-5-026-580-0 at least once per 8 hours and these samples are analyzed for gross activity within 24 hours. The Mechanical Vacuum Pumps may not be operated during this LCO. If release point is che' Hot Maintenance Shop, Then secure ventilation because no means exist to alternately sample the ventilation.

l ODCM Rev. 17 Page 34 l 11/95 TABLE 13.3-2 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION SURVEILLANCE REOUIREMENTS CHANNEL MODES IN WHICH CHANNEL SOURCE CHANNEL FUNCT. SURVEILLANCE INSTRUMENT CHECK CHECK CALIBR. TEST IS REQUIRED i 1. SOUTH STACK EFFLUENT MONITORING SYSTEM

a. Noble Gas Activity Monitor D

M R(2) Q(1) b. Iodine Sampler W(3) N.A. N.A. N.A. c. Particulate Sampler W(3) N.A. N.A. N.A.

d. Effluent System Flow Rate Monitor D

N.A. R Q e. Sampler Flow Rate Monitor D N.A. R Q 2. NORTH STACK EFFLUENT MONITORING SYSTEM #

a. Noble Gas Activity Monitor D

M R(2) Q (1) b. Iodine Sampler W(3) N.A. N.A. N.A. c. Particulate Sampler W(3) N.A. N.A. N.A.

d. Effluent System Flow Rate Monitor D

N.A. R Q e. Sampler Flow Rate Monitor D N.A. R Q 3. HOT MAINTENANCE SHOP VENTILATION EXHAUST RADIATION MONITOR a. Iodine Sampler W(3) N.A. N.A. N.A. b. Particulate Sampler W(3) N.A. N.A. N.A. c. Effluent System Flow Rate Monitor D N.A. R Q

d. Sampler Flow Rate Monitor D

N.A. R Q Wide Range Accident Monitor (WRAM) surveillance is specified in Technical Specification 3.3.7.5. At all times. l

    • During operation of the hot maintenance shop ventilation exhaust system.

l ~

I l ODCM Rev. 17 Page 35 l 11/95 TABLE I3. 3-2 (Continued) TABLE NOTATIONS (1) The CHANNEL FUNCTIONAL TEST shall also demonstrate that control room alarm annunciation occurs if any of the following conditions exists: 1. Instruments indicate measured levels above the i alarm / trip setpoint. 2. Circuit failure. 3. Instrument indicates a downscale failure. 4. Instrument controls not set in operate mode. (2) The initial CHANNEL CALIBRATION shall be performed using one or more of the reference standards certified by the National Institute of Standards and Testing (NIST) or using standards that have been obtained from suppliers that participate in measurement assurance activities with NIST. These standards shall permit calibrating the system over its intended range of energy and measurement range. For subsequent CHANNEL CALIBRATION, sources that are traceable to the initial calibration shall be used. (3) The iodine cartridges and particulate filters will be changed and analyzed at least once per 7 days.

l ODCM Rev. 17 l Page 36 11/95 GASEOUS EFFLUENTS CONTROLS 3.3.2 The dose rate due to radioactive materials released in gaseous effluents from the site to areas at or beyond the SITE BOUNDARY (See Figure I2.2-la) shall be limited to: a. For noble gases: less than or equal to 500 -mrems/yr to the total body and less than or equal to 3000 mrems/yr to the skin, and b. For iodine-131, iodine-133, tritium, and for all radionuclides in particulate form with half-lives greater than 8 days: less than or equal to 1500 mrems/yr to any organ. (Inhalation pathways only.) APPLICABILITY: At all times. ACTION: With the dose rate (s) exceeding the above limits, immediately restore the release rate to within the above limits. SURVEILLANCE REOUIREMENTS 3.3.2-1 The dose rate due to noble gases in gaseous effluents shall be determined to be within the above limits using ST-0-104-879-0. 3.3.2-2 The dose rate due to iodine-131, iodine-133, tritium, and all radionuclides in particulate form with half-lives greater than 8 days in gaseous effluents shall be determined to be within the above limits using ST-0-104-879-0 by obtaining representative samples and performing analyses in accordance with the sampling and analysis program specified in Table I3.3-3. i (

l l ODCM Rev. 17 Paga 37 l 11/95 TABLE I3.3-3 RADIOACTIVE GASEOUS WASTE SAMPLING AND ANALYSIS PROGRAM Lower Limit Minimum Type of of Detection Gaseous Release Sampling Analysis Activity (LLD)* Type Frequency Frequency Analysis (uCi/M1) A. North Stack / Continuous' Q Gross Alpha 1E-11 South Stack Comp. Part. Sr-89, Sr-90 1E-11 Sample b M b Grab Smpl. M Noble Gas 1E-4 H-3 1E-6 Continuousd W* Char. Smpl. I-131 1E-12 I-133 1E-10 Part. Smpl. Principal Gamma Emitters 1E-11 Continuousd Continuous Noble Gas Noble Gas Beta or Gamma 1E-6 Monitor (Based on Xe-133) B. Hot Mainten. Continuousd Q Gross Alpha 1E-11 Comp. Part. Sr-89, Sr-90 1E-11 Smp3. Continuousd W Char. Smpl. I-131 1E-12 I-133 1E-10 Part. Smpl. Principal Gamma Emitters 1E-11

_.m l ODCM Rev. 17 Page 38 l l 11/95 TABLE 13.3-3 (Continued) j l TABLE NOTATIONS i a. The LLD is defined, as the smallest concentration of radioactive material in a sample that will yield a net count, above system background, that will be detected with 95% probability with only 5% probability of falsely concluding l that a blank observation represents a "real" signal. It l should be recognized that the LLD is defined as an a oriori (before the fact) limit representing the capability of a measurement system and not as an after the fact limit for a particular measurement. For a particular measurement system, (which may include radiochemical separation): (2. 71 + 4. 66s ) (1-exp (- AAt ) ) s 2 LLD - E*V 2.22E6 Y [exp (- AAt )] (AAta) 1 (2.71 + 4.66 s ) s LLD (Grab Samples) = Y (exp - AAtz) E V-2.22E6 b Where: L LLD is the a oriori lower limit of detection as defined above (uCi/cc or uCi/mL), s is the standard deviation of the background counting rate s or of the counting rate of blank sample as appropriate (as epm), shall be based on the actual observed variance of the background counting rate or of the counting rate of the blank samples (as appropriate) rather than on an unverified theoretically predicted variance. E is the counting efficiency, as cpdis, j V is the sample size, in units of cc or m1, l 2.22E6 is the number of dpm/uCi Y is the fractional radiochemical yield, when applicable, 1 A is the radioactive decay constant for the particular radionuclide, and l At for the plant effluents is the elapsed time between the 1 l end of the sample collection and the time of counting. At for the plant effluents is the elapsed time between the 2 end of the sample collection and the start of sample collection. Typical values of E, V, Y At and Ata should be used in calculation. 1

i l ODCM RGv. 17 Page 39 l 11/95 TABLE I3.3-3 (Continued) TABLE NOTATIONS b. Sampling and analyses shall also be performed following shutdown, startup, or a THERMAL POWER change exceeding 15% of the RATED THERMAL POWER within a 1-hour period using RT-5-000-876 *. This requirement does not apply if (1) analysis show that the DOSE EQUIVALENT I-131 concentration in the primary coolant has not increased more than a factor of 3; and (2) the main condenser offgas pre-treatment radioactivity monitor shows that effluent activity has not increased more than a factor of 3. l Samples shall be changed at least once per 7 days and analyses l c. shall be completed within 48 hours after changing, or after l removal from sampler. Sampling shall also be performed at least once per 24 hours for at least 7 days following each shutdown, startup or THERMAL POWER change exceeding 15% of RATED THERMAL POWER in 1 hour and analyses completed within 48 l l hours of changing. When samples collected for 24 hours are analyzed, the corresponding LLDs may be increased by a factor of 10. This requirement does not apply if (1) analysis shows that the DOSE EQUIVALENT I-131 concentration in the primary coolant has not increased more than a factor of 3; and (2) the noble gas monitor shows that effluent activity has not increased more than a factor of 3. d. The ratio of the sample flow rate to the sampled stream flow rate shall be known for the time period covered by each dose or dose rate calculation made in accordance with Controls 3.3.2, 3.3.3, and 3.3.4. The principal gamma emitters for which the LLD specification e. applies include the following radionuclides: Kr-87, Kr-88, Xe-133, Xe-133m, Xe-135, Xe-135m and Xe-138 for gaseous emissions and Mn-54, Fe-59, Co-58, Co-60, Zn-65, I-131, Cs-124, Cs-137, Ce-141 and Ce-144 for particulate emissions. This list does not mean that only these nuclides are to be considered. Other gamma peaks which are identifiable, together with the above nuclides, shall also be analyzed and reported ia the Annual Radioactive Effluent Release Report, pursuant to Control 3.6 f. Under the provisions of footnote e. above, only noble gases need to be considered. g. Required for the hot maintenance shop ventilation exhaust only during operation of the hot maintenance shop ventilation l exhaust system. l l

l ODCM Rev. 17 Page 40 l 11/95 DOSE - NOBLE GASES CONTROLS 3.3.3 The air dose due to :2cble gases released in gaseous effluents, from the site to areus at and beyond the SITE BOUNDARY (See Figure I2.2-la) shall be limited to the following: a. During any calendar quarter: less than or equal to 10 mrads for gamma radiation and less than or equal to 20 mrads for beta radiation, and b. During any calendar year: less than or equal to 20 mrads for gamma radiation and less than or equal to 40 mrads for beta radiation. APPLICABILITY: At all times. ACTION: a. With the calculated air dose from radioactive noble gases in gaseous effluents exceeding any of the above limits, prepare and submit to the Commission within 30 ) days, pursuant to Technical Specification 6.9.2, a Special Report which identifies the cause(s) for exceeding the limit (s) and defines the corrective actions that have been taken to reduce the releases and the proposed corrective actions to be taken to assure that subsequent releases will be in compliance with the above limits. SURVEILLANCE REOUIREMENTS l l 3.3.3-1 Cumulative dose contributions for the current quarter and current calendar year for noble gases shall be determined using ST-0-104-879-0 and ST-0-104-883-0 every 31 days.

l ODCM Rev. 17 Page 41 l 11/95 DOSE - IODINE - 133. TRITIUM. AND RADIONUCLIDES IN PARTICULATE FORM j CONTROLS 3.3.4 The dose to a MEMBER OF THE PUBLIC from iodine-131, iodine-133, tritium and all radionuclides in particulate form with half-lives greater than 8 days in gaseous effluents released from the site to areas at or beyond the SITE BOUNDARY (See Figure I2.2-la) shall be limited to the following: a a. During any calendar quarter: less than or equal to 15 mrems to any organ and, b. During any calendar year: less than or equal to 30 mreme to any organ. APPLICABILITY: At all times. ACTIOE: a. With the calculated dose from the release of iodine-131, iodine-133, tritium and all radionuclides in particulate form with half-lives greater than 8 days in gaseous effluents exceeding any of the above limits, prepare and submit to the Commission within 30 days, pursuant to Technical Specification 6.9.2, a Special Report which identifies the cause(s) for exceeding the limit and defines the corrective actions that have been taken to reduce the releases and the proposed corrective actions to be taken to assure that subsequent releases will be in compliance with the above limits. SURVEILLANCE REOUIREMENTS 3.3.4-1 Cumulative dose contributions for the current calendar quarter and current calendar year for iodine-131, iodine-133, tritium and radionuclides 1 particulate form with half-lives greater than 8 days shall be determined using ST-0-104-879-0 once per 31 days.

l 'ODCM Rev. 17 Page 42 l 11/95 VENTILATION EXHAUST TREATMENT SYSTEM CONTROLS 3.3.5 The VE.' 'ILATION EXHAUST TREATMENT SYSTEM shall be IN SERVICE and appropriate portions of the system shall be used to reduce radioactive material in gaseous waste prior to their discharge when the projected doses due to gaseous effluent releases, from the site to areas at and beyond the SITE BOUNDARY (See Figure I2.2-la) when averaged over 31 days would exceed 0.6 mrem to any organ in a 31-day period. APPLICABILITY: At all times. ACTION: a. With gaseous waste being discharged without treatment, or in excess of the above limits, prepare and submit to the Commission within 30 days, pursuant to Technical Specification 6.9.2, a Special Report which includes the following information: 1. Explanation of why gaseous radwaste was being discharged without treatment, identification of any inoperable equipment or subsystems, and the reason for { the inoperability. 2. Action (s) taken to restore the inoperable equipment to OPERABLE status, and 3. Summary description of action (s) taken to prevent a recurrence. SURVEILLANCE REOTTIREMENTS 3.3.5-1 Doses due to gaseous releases from the site to areas at and beyond the SITE BOUNDARY shall be projected at least once per 31 days using ST-0-104-879-0. ~

i l' ODCM Rev. 17 Pags 43 l 11/95 VENTING OR PURGING CONTROLS i 3.3.6 The VENTING or PURGING of the Mark II c7ntainment shall be i through the standby gas treatment system. l l APPLICABILITY: Whenever the containment is vented or purged.* d ACTION: a. With the requirements of the above specification not satisfied, suspend all VENTING and PURGING of the containment. SURVEILLANCE REOUIREMENTS 3.3.6-1 The containment shall be determined to be aligned for VENTING or PURGING through the standby gas treatment i system within 4 hours prior to start of and at least once per 12 hours during VENTING or PURGING of the containment. 3.3.6-2 Prior to use of the purge system through the standby gas treatment system assure that: a. Both standby gas treatment system trains are OPERABLE whenever the purge system is in use, and b. Whenever the purge system is in use during OPERATIONAL CONDITION 1 or 2 or 3, only one of the standby gas treatment system trains shall be used to prevent damage to both trains should a LOCA occur (LCO 3.6.5.3 ACTION a applies during this configuration). Except after Containment is deinerted and purged while the i reactor is in OPCON 4 or 5 QE for the one inch /two inch vent valves to the Reactor Enclosure Equipment Compartment Exhaust Filters rhen used for containment pressure control and nitrogen make-up operations. l l i l u 4

i l ODCM Rev. 17 l Page 44 11/95 RADIOACTIVE EFFLUENTS TOTAL DOSE { CONTROLS. 3.3.7 The annual (calendar year) dose or dose commitment to any MEMBER OF THE PUBLIC, due to releases of radioactivity and radiation, from uranium fuel cycle sources shall be limited to less than or equal to 25 mrems to the total body or any organ, ) except the thyroid, which shall be limited to less than or equal to 75 mrems. APPLICABILITY: At all times. ACTION: 1

a. With the calculated doses from the release of radioactive j

materials in liquid or gaseous effluents exceeding twice the l limits of ODCM Controls I3.2.3.a, I3.2.3.b, I3.3.3.a, I3.3.3.b, I3.3.4.a or I3.3.4.b, calculations shall be made including direct radiation contributions from the reactor units and from outside storage tanks to determine whether the above limits of ODCM Control 3.3.7 have been exceeded. If such is the case, prepare and submit to the Commission within 30 days, pursuant to Technical Specification 6.9.2, a Special Report that defines the I corrective action to be taken to reduce subsequent releases to prevent recurrence of exceeding the above limits and includes i the schedule for achieving conformance with the above limits. l This Special Report, as defined in 10 CFR 20.2203, shall include an analysis that estimates the radiation exposure (dose) to a MEMBER OF THE PUBLIC from the uranium fuel cycle sources, including all effluent pathways and direct radiation, for the calendar year that includes the release (s) covered by this report. It shall also describe levels of radiation and concentration of radioactive material involved, and the cause of the exposure levels or concentrations. If the estimated dose (s) i exceeds the above limits, and if the release condition resulting in violation 40 CFR Part 190 has not already been corrected, Lhe Special Report shall include a request for a variance in accordance with the provisions of 40 CFR Part 190. Submittal of the report is considered a timely request, and a variance is granted until staff action on the request is complete. SURVEILLANCE REOUIREMENTS 3.3.7-1 Cumulative dose contributions from liquid and gaseous effluents shall be determined using ST-0-104-878-0, ST-0-104-879-0. 3.3.7-2 If the cumulativa dose contributions exceed the limits defined in 3.3.7a, Cumulative dose contribution from direct radiation from unit operation shall be determined using ST-0-104-878-0, ST-0-104-879-0.

l ODCM Rav. 17 j Page 45 l 11/95 i 3.4 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM (REMP) CONTROLS 3.4.1 The monitoring program shall be conducted as specified in Table I3.4-1. I APPLICABILITY: At all times. ACTION: a. With the radiological environmental monitoring program I not.being conducted as specified in Table I3.4-1, prepare and submit to the Commission, in the Annual Radiological Environmental Operating Report per ODCM Control 3.5, a description of the reasons for not' conducting the program as required and the plans for preventing a recurrence, b. With the level of radioactivity as the result of plant effluents in an environmental sampling medium at a specified location exceeding the reporting levels of Table I3.4-2 when averaged over any calendar quarter, prepare and submit to the Commission within 30 days, pursuant to Technical Specification 6.9.2, a Special Report that identifies the cause (s) for exceeding the limit (s) and defines the corrective actions to be taken-i to reduce radioactive effluents so that the potential j annual dose to a MEMBER OF THE PUBLIC is less than the calendar year limits of ODCM Controls I3.2.3, I3.3.3 and I3.3.4. When more than one of the radionuclides in Table I3.4-2 are detected in the sampling medium, this report shall be submitted if: concentration._CLL concentration (:u ,,, u reporting level (1) reporting level (2) When radionuclides other than those in Table I3.4-2 are detected and are the result of plant effluents, this report shall be submitted if the potential annual dose to a MEMBER OF THE PUBLIC is equal to or greater than the calendar year limits of ODCM Controls I3.2.3, I3.3.3 and I3.3.4. This report is not required if the measured level of radioactivity was not the result of plant effluents; however; in such an event, the condition shall be reported and described in the Annual Radiological Environmental Operating Report. i i .~. I

l ODCM Rev. 17 Page 46 l 11/95 RADIOLOGICAL ENVIRONMENTAL MONITORIHQ (Continued) With milk or fresh leafy vegetable samples unavailable c. from one or more of the sample locations required by Table I3.4-1, identify locations for obtaining replacement samples and add them to the radiological environmental monitoring program within 30 days. The specific locations from which samples were unavailable may then be deleted from the monitoring program. Pursuant to Technical Specification 6.14, submit as a part of or concurrent with the Annual Radioactive Effluent Release Report, a complete, legible copy of the entire ODCM, including a revised figure (s) and table for the ODCM reflecting the new location (s). SURVEILLANCE REOUIREMENTS 3.4.1-1 The radiological environmental monitoring samples shall be collected (using ST-0-104-800-0) pursuant to Table I3.4-1 from the specific locations given in the table and figure (s) in the ODCM and shall be analyzed pursuant to the requirements of Table I3,4-1, the detection capabilities required by the Table I3.4-3. 1 I .-o- .m_

l ODCM Rev. 17 Page 47 l 11/95 TABLE I3.4-1 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM NUMBER OF REPRESENTATIVE EXPOSURE PATHWAY SAMPLES AND SAMPLING AND TYPE AND FREQUENCY AND/OR SAMPLE SAMPLE LOCATION"3 COLLECTION FREQ. OF ANALYSIS C

1. DIRECT RADIATION *)

40 routine monitoring stations At least Quarterly Gamma dose at least either with two or more.dosi- _ quarterly. meters or with one instrument for measuring and recording dose rate continuously placed as follows: (1) An inner ring of stations, one in each meteorological sector, in the general area of 4 the SITE BOUNDARY: (2) An outer l ring of stations, one in each-meteorological sector, in the 3-9 mile range from the site; (3) The balance of the stations placed in special interest areas 'l such as population centers, nearby residences, schools and in 1 or 2 areas to serve as control 4 l stations. 1 i l J

l ODCM Rev. 17 Page 48 l 11/95 TABLE I3.4-1 (Continued) RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM NUMBER OF REPRESENTATIVE EXPOSURE PATHWAY SAMPLES AND SAMPLING AND TYPE AND FREQUENCY AND/OR SAMPLE SAMPLE LOCATION (*) COI LECTION FREQ. OF ANALYSIS

2. AIRBORNE Radiciodine and Samples from 5 locations:

Continuous sampler Radiciodine canisters: Particulates a.3 samples from close to the operation with sample I-131 analysis 3 SITE BOUNDARY locations (in collection weekly, or weekly. different sectors) of the more frequently if highest calculated annual required by dust Particulate Sampler: average ground level x/Q. loading". Gross beta radio activity analysis b.1 sample from the vicinity following filter community having one of the highest calculated annual change:d ground level x/Q. Gamma isotopic 1 sample from a control loca-analysis

  • of tion, as for example 15-30 km composite (by distant and in the least pre-location) at least valent wind direction.

quarterly

l ODCM Rev. 17 Page 49 l 11/95 TABLE I3.4-1 (Continued) RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM NUMBER OF REPRESENTATIVE EXPOSURE PATHWAY SAMPLES AND SAMPLING AND TYPE AND FREQUENCY AND/OR SAMPLE SAMPLE LOCATION (') COLLECTION FREQ. OF ANALYSIS 3.WATERBO?NE a. Surf ace' I sample upstream Composite sample Gamma isotopic analysis' 1 sample downstream over 1-month monthly. Composite for period 8 tritium analysis quarterly.

b. Ground Samples from 1 or 2 sources Quarterly.

h only if likely to be affected

c. Drinking 1 sample of each on 1 to 3 of Monthly.

I-131 analysis on each of the nearest water supplies (Composite) composite when the dose that could be affected by its calculated for the con-discharge. sumption of the water is greater than 1 mrem per 1 sample from a control year.1 Composite for gross location beta and gamma isotopic analysis monthly. Comp-osite for tritium analysis quarterly.

d. Sediment from 1 sample from downstream area Semiannually.

Gamma isotopic analysis' shoreline with existing or potential semiannually.

r i; i l ODCM Rev. 17 [ -Page 50 l 11/95 TABLE I3.4-1 (Continued) t RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM I NUMBER OF REPRESENTATIVE EXPOSURE PATHWAY SAMPLES AND SAMPLING AND TYPE AND FREQUENCY AND/OR SAMPLE SAMPLE LOCATION (*) COLLECTION FREQ. OF ANALYSIS t

4. INGESTION 4
a. Milk Samples from milking animals Semimonthly when Gamma isotopic' and I-131 in 3 locations within 5 km animals are on analysis semimonthly when distance having the highest pasture, monthly animals are on pasture dose potential.

If there are at other times. (April 1 - Oct. 1): none, then 1 sample from monthly at other times. t milking animals in each of 3 areas between 5 to 8 km distance where dose are cal-culated to be greater than i 1 mrem per year.' i i sample from milking animals at a control location (15-f 30 km distance) and in the least wind direction. i r b. Fish and 1 sample of two recreationally Sample in season, Gamma isotopic

  • Invertebrates important species in vicinity or semiannually analysis on edible of plant discharge area. 1 if they are not portions.

sample of same species in area seasonal. not influenced by plant discharge. 1 I t t ,2 -w u-- m

l ODCM Rev. 17 Page 51 l 11/95 TABLE I3.4-1 (Continueel RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM NUMBER OF REPRESENTATIVE EXPOSURE PATHWAY SAMPLES AND SAMPLING AND TYPE AND FREQUENCY AND/OR SAMPLE SAMPLE LOCATION <a) COLLECTION FREQ. OF ANALYSIS

4. INGESTION (Continued) c.

Food Products Samples of 3 different kinds of Monthly when avail-Gamma isotopic' and broad leaf vegetation grown able, if milk sampling I-131 analysis. nearest each of 2 different is not preformed. offsite locations of highest predicted annual average ground level D/Q if milk sampling is not preformed. 1 sample of each of the similar Monthly when avail-Gamma isotopic' and broad leaf vegetation grown able, if milk sampling I-131 analysis. 15-30 km distance in the least is not performed. prevalent wind direction if milk sampling is not performed.

q l ODCM Rev. 17 Page 52 l 11/95 RADIOLOGICAL ENVIRONMENTAL MONITORING TABLE I3.4-1 (Continued) TABLE NOTATIONS Specific parameters of distance and direction sector form the a. centerline of the two reactors and additional description where pertinent, shall be provided for each and every sample location in Table 13.4-1 in a table and figure (s) in the'ODCM. Deviations are permitted from the required sampling schedule if specimens are unobtainable due to hazardous conditions, seasonal unavailability, malfunction of automatic sampling equipment and other legitimate reasons. If specimens are unobtainable due to sampling equipment malfunction, every effort shall be made to complete corrective action prior to the end of the next sampling period. All deviations from the' sampling schedule shall be documented in the Annual Radiological Environmental Operating Report pursuant to ODCM Control 3.5. It is recognized that, at times, it may not be possible or practicable to continue to obtain samples of the media of choice at the most desired location or time. In these instances suitable alternative media and locations may be chosen for the particular pathway-in question and appropriate substitutions made within 30 days in the radiological environmental monitoring program. Pursuant to Technical Specification 6.14, submit as a part of or concurrent uith the next Annual Radioactive Uffluent Release Report a l complete legible copy.of the ODCM including a revised figure (s) and table for the ODCM reflecting the new location (s). b. One or more instruments, such as a pressurized ion chamber, for I measuring and recoding dose rate continuously may be used in place of, or in addition to, integrating dosimeters. For the purpose of this table, a thermoluminescent dosimeter (TLD) is considered to be one phosphor; two or more phosphors in a packet are considered as two or more dosimeters. Film badges shall not be used as dosimeters for measuring direct radiation. c. Methodology for recovery of radiciodine shall be described in the ODCM. d. Airborne particulate sample filters shall be analyzed for gross i beta radioactivity 24 hours or mere after sampling to allow for radon and thoron daughter decay. If gross beta activity is air particulate samples is greater t hat 10 times the yearly mean of control samples, gamma isotopic analysis shall be performed on j the individual samples. e. Gamma isotopic analysis means the identification and quantification of gamma-emitting radionuclides that may be attributable to the effluents from the facility.

l ODCM Rev. 17 I Page 53 l 11/95 f. The " upstream sample" shall be taken'at a distance beyond significant influence of the discharge. The " downstream sample" J shall be taken in an area beyond but near the mixing zone. g. A composite sample is one in which the quantity (aliquot) of liquid sampled is proportional to the quantity of flowing liquid and in which the method of sampling employed-results in a specimen that is representative of the liquid flow. In this J program composite sample aliquots shall be collected at time intervals that are very short (e.g., hourly) relative to the l compositing period (e.g., monthly) in order to assure obtaining a i representative sample. h. Groundwater samples shall be taken when this source is tapped for I drinking or irrigation purposes in areas where the hydraulic gradient or recharge properties are suitable for contamination. i. The dose shall be calculated for the maximum organ and age group, using ST-0-104-878-0. j s 4

l ODCM Rev. 17 Page 54 l 11/95 TABLE I3.4-2 REPORTING LEVELS FOR RADIOACTIVITY CONCENTRATIONS IN ENVIRONMENTAL SAMPLES Reoortina Levels AIRBORNE FOOD WATER PARTICULATE or FISH MILK PRODUCTS ANALYSIS (pCi/L) GASES (pCi/m ) (pCi/kg, wet) (pCi/L) (pCi/kg, wet) 8 H-3 20,000* Mn-54 1,000 30,000 Fe-59 400 10,000 Co-58 1,000 30,000 Co-60 300 10,000 Zn-65 300 20,000 Zr-Nb-95 400** I-131 2 0.9 3 100 Cs-134 30 10 1,000 60 1,000 Cs-137 50 20 2,000 70 2,000 Ba-La-140 200** 300

  • For drinking water samples.

This is 40 CFR Part 141 value. If no drinking pathway exists, a value of 30,000 pCi/L may be used.

    • Total for parent and daughter.

l ODCM Rev. 17 Page 55 i l 11/95 TABLE I3.4-3 DETECTION CAPABILITIES FOR ENVIRONMENTAL SAMPLE ANALYSIS (*) i Lower limit of Detection (T.T.n) W M AIRBORNE' FOOD WATER PARTICULATE or FISH MILK PRODUCTS SEDIMENTS ANALYSIS (pCi/L) GASES (pCi/m ) (pCi/kg, (pCi/L) (pCi/kg, (pCi/kg, 2 wet) wet) dry) i Gross Beta 4 0.01 H-3 2,000 l Mn-54 15 130 Fe-59 30 260 Co-58,60 15 130 Zn-65 30 260 Zr-95 30 Nb-95 15 I-131 1* 0.07 1 60 Cs-134 15 0.05 130 15 60 150 Cs-137 18 0.06 150 18 80 180 Ba-140 60 60 La-140 15 15 i i

l ODCM Rsv. 17 Page 56 l 11/95 TABLE I3.4-3 (Continued) TABLE NOTATIONS (a) This list dose not mean that only these nuclides are to considered. Other peaks that are identifiable at 95% confidence level, together with those of the above nuclides, shall also be analyzed and reported in the Annual Radiological Environmental Operating report pursuant to ODCM Control 3.5. (b) Required detection capabilities for thermoluminescent dosimeters used for environmental measurements are given in Regulatory Guide 4.13. (c) The LLD is defined, for purposes of these controls, as the smallest concentration of radioactive material in a sample that will yield a net count (above system background) that will be detected with 95% probability with only 5% probability of falsely concluding that a blank observation represents a "real" signal. For a particular measurement system (which may include radiochemical separation): 4.66ss LLD= EV 2.22 Y exp (-AAt) Where: l LLD is the a priori lower limit of detection as defined above (as picocuries per unit mass or volume), s is the standard deviation of the background counting rate or s of the counting rate of blank sample as appropriate (as counts per minute), E is the counting efficiency (as counts per disintegration), V is the sample size (in units of mass or volume), 2.22 is the number of disintegrations per minute per picoeurie, Y is the fractional radiochemical yield (when applicable), A is the radioactive decay constant for the particular radionuclide, and At for the environmental samples is the elapeed time between sample collection (or end of the sample collection period) and time of counting. Typical values of E, V, Y, and at should be used in calculation.

l ODCM Rev.'17 Page 57 l 11/95 TABLE I3.4-3 (Continued) TABLE NOTATIONS It should be recognized that the LLD is defined as an a oriori (before the fact) limit representing the capability of a measurement system and not as an after the fact limit for a particular measurement. Analyses shall be performed in such a manner that the stated LLDs will be achieved under routine conditions. Occasionally background fluctuations, unavoidably small sample sizes, the presence of interfering nuclides, or other uncontrollable circumstances may render these LLDs unachievable. In such canes, the contributing factors shall be identified and described in the Annual Radiological Environmental Operating Report pursuant to ODCM Control 3.5. (d) LLD for drinking water samples.

l ODCM Rsv. 17 Page 58 l 11/95 RADIOLOGICAL ENVIRONMENTAL MONITORING I LAND USE CENSUS CONTROL 3.4.2 A land use census shall be conducted and shall identify within a distance of 8 km (5 miles) the location (in each of the 16 meteorological sectors) of the nearest garden

  • of greater than j

50 m2 (500 ft2) producing broad leaf or vegetables. j APPLICABILITY: At all times. i ACTION: With a land use census identifying a location (s) which yields a a. calculation dose or dose commitment greater than the values currently being calculated in ODCM Control 3.3.4.1, identify the new lcration(s) in the next Annual Radioactive Effluent Release Report, pursuant to ODCM Control 3.6. b. With a land use census identifying a location (s) that yields a calculated dose or dose commitment (via the same exposure pathway) 20% greater than at a location from which samples are currently i being obtained in accordance with ODCM Control 3.4.1, add the new location (s) to the radiological environmental monitoring program within 30 days. The sampling location (s), excluding the control station location, having the lowest calculated dose or dose commitment (s) (via the same exposure pathway) may be deleted from this monitoring program after October 31 of the year in which this land use census was conducted. Pursuant to Technical Specification 6.14, submit as a part of or concurrent within the next Annual Radioactive Effluent Release Report a complete, legible copy of the entire ODCM including a revised figure (s) and table (s) for the ODCM reflecting the new location (s). SURVEILLANCE REOUIREMEtTTS 3.4.2-1 The land use census shall be conducted during the growing season at least once per 12 months using that information that will provide the best results, such as by a door-to-door survey, aerial survey, or by consulting local agriculture authorities. The results of the land use census are documented in ST-0-107-991-0 and are included in the Annual Radiological Environmental Operating Report -pursuant to ODCM Control 3.5. Broad leaf vegetation sampling of at least 3 different kinds of vegetation may be performed at the SITE BOUNDARY in each of 2 different direction sectors with the highest predicted D/Os in lieu of the garden census. ODCM Controls for broad leaf vegetation sampling in Table I3.4-1 item 4.c. shall be followed, including analysis of control samples-.

~.. ~- l ODCM Rev. 17 Page 59 l 11/95 RADIOLOGICAL ENVIRONMENTAL MONITORING INTERLABORATORY COMPARISON PROGRAM j CONTROL 3.4.3 In accordance with LGS Technical Specification 3.12.3, analyses. shall be performed on radioactive materials supplied as part of an Interlaboratory Comparison Program which has been approved by the Commission. APPLICABILITY: At all times. ACTION: With analyses not being performed as required above, report the corrective actions taken to prevent a recurrence to the Commission in the Annual Radiological Environmental Operating Report pursuant to ODCM Control 3.5. SURVEILLANCE REOUIREMENTS l 3.4.3-1 The Interlaboratory Comparison Program shall be documented in ST-0-104-990-0 and described in the ODCM part II, section 4.2. A summary of the results shall be included in the Annual Radiological Environmental j Operating Report pursuant to ODCM Control 3.5. 3 i. ~. 3 r. ,__4 v

l ODCM Rev. 17 Page 60 l 11/95 ANNUAL RADIOLOGICAL ENVIRONMENTAL OPERATING REPORT

  • l 3.5 Routine Annual Radiological Environmental Operating Report covering l

the operation of Unit 1 and Unit 2 during the previous calendar year shall be submitted prior to May 1 for each year. The initial report was submitted prior to May 1 of the year following initial l criticality (1984). A single report is submitted for a multiple unit station. The Annual Radiological Environmental Operating Report shall include summaries, interpretations, and an analysis of trends of the results report period, including a comparison (as appropriate), with preoperational studies, operational controls and previous environmental surveillance reports and an assessment of the observed impacts of the plant operation on the environment. The reports shall also include the results of land use census required by ODCM Control 3.4.2. The Annual Radiological Environmental Operating Report shall include the results of all radiological environmental samples and of all environmental radiation measurements taken during the report period pursuant to the locations specified in the tables and figures in the OFFSITE DOSE CALCULATION MANUAL, as well as summarized and tabulated results of these analyses and measurements in the format of the table in the Radiological Branch Technical Position, Revicion 1, November 1979. In the event that some individual results are not available for inclusion with the report, the report shall be submitted noting and explaining the reasons for the missing results. The missing data shall be submitted as soon as possible in a supplementary report. i The report shall also include the following: a summary description of the radiological environmental monitoring program and at least two legible maps. One map shall cover stations near the SITE BOUNDARY; a second shall include the more detailed distant stations. Covering all sampling locations keyed to a table giving distances and directions from the centerline of the reactor plant; the results of licensee participation-in the Interlaboratory Comparison Program, required by ODCM Control I3.4.3 discussion of all deviations from the Sampling Schedule of Table I3.4-1; and discussion of all analyses in which the LLD required by Table I3.4-3 was not achievable. l I l l l l l

l ODCM Rev. 17 Page 61 l 11/95 ADMINISTRATIVE CONTROLS 3.6 ANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT A Routine Annual Radioactive Effluent Release Report covering the operation of Unit 1 and Unit 2 during the previous 12 months of operation shall be submitted within 60 days after January 1 of I each year. The period of the first report shall begin with the l date of initial criticality. A recurring action request shall be used to generate the report. A single unit submittal is made for the 2 unit station. The submittal combines those sections that are common to all units at the station. The Annual Radioactive Effluent Release Report shall include a summary of the quantities of radioactive liquid and gaseous effluents and solid waste released from the facility as outlined in Regulatory Guide 1.21, " Measuring, Evaluation, and Reporting Radioactivity in Solid Wastes and Releases of Radioactive Materials in Liquid and Gaseous Effluents from Light-Water-Cooled Nuclear Power Plants," Revision 1, June 1974, with data summarized on a quarterly basis following the format of Appendix B thereof. The Annual Radioactive Effluent Release Report to be submitted 60 days after January 1 of each year shall include an annual summary of hourly meteorological data collected over the previous year. This annual summary may be either in the form of an hour-by-hour listing on magnetic tape of wind speed, wind direction and atmospheric stability, and precipitation (if measured), or in the form of joint frequency distributions of wind speed, wind direction, atmospheric stability. The licensee has the option of retaining this summary of required meteorological data on site in a file that shall be provided to the NRC upon request. This same report shall include an assessment of the radiation doses due to the radioactive liquid and gaseous effluents released from both units during the previous calendar year. This same report shall also include an assessment of the radiation doses from radioactive liquid and gaseous effluents to MEMBER OF THE PUBLIC due to their activities inside the SITE BOUNDARY (Figures I2.2-la and I2.2-1b) during the report period. All assumptions used in making these assessments shall be included in these reports. The assessment of radiation doses shall be performed in accordance with the methodology and parameters of the OFFSITE DOSE CALCULATION MANUAL (ODCM).

l ODCM Rev. 17 Page 62 l 11/95 The Annual Radioactive Effluent Release Report to be submitted 60 days after January 1 of each year snall also include an assessment of radiation doses to the hypothetically highest exposed MEMBER OF THE PUBLIC from reactor releases and other nearby uranium fuel cycle sources (including doses from primary effluent pathways and j direct radiation) for the previous calendar year to show conformance with 40 CFR Part 160, Environmental Radiation Protection Standards for Nuclear Power Operation. Dose contribution from liquid and gaseous effluents is calculated based on Regulatory Guide 1.109, Rev 1, October 1977. The Annual Radioactive Effluent Release Reports includes the following information for each type of solid waste (as defined in 10 CFR Part 61) shipped offsite during the report period: 1. Total volume, activity and estimated total % error for each waste type: a. Spent resins filter sludges, evaporator bottoms, etc. b. Dry compressible waste, contaminated equipment, etc. c. Irradiated components, control rods, etc. d. Others (des: ribe). 2. Activity and percentage of each principle radionuclide (>1%), for each individual waste type as defined in 1. (a-d) above. 3. The disposition of solid waste shipments (identify the number of shipments, the mode of transport, and the destination). 4. The disposition of irradiated fuel shipments (identify { the number of shipments, the mode of transport, and the destination. The Annual Radioactive Effluent Release Report includes a list and description of unplanned releases from the site to UNRESTRICTED AREAS of radioactive material in gaseous and liquid effluents made during the reporting period. The Annual Radioactive Effluent Release Reports includes any changes made during the reporting period to procedure RW-C-100 (formerly the PROCESS CONTROL PROGRAM) and to the ODCM, as well as a listing of new locations for dose calculations and/or environmental monitoring identified by the land use census pursuant to ODCM Control 3.4.2. The Annual Radioactive Effluent Release Reports includes an explanation as to why the inoperability of liquid or gaseous effluent monitoring instrumentation was not corrected within the time specified in ODCM Controls 3.2.1 or 3.3.1, respectively; and description of the events leading to liquid holdup tanks or gas storage tanks exceeding the Control limits.

l ODCM Rev. 17 Page 63 l 11/95 3.7 MAJOR CHANGES TO RADIOACTIVE WASTE TREATMENT SYSTEMS Licensee-initiated major changes to the radioactive waste systems (liquid, gaseous, and solid): a. Shall be reported to thui Commission in the Annual Radioactive Effluent Release Report for the period in which the change was made effective. The discussion of each change shall contain: 1. A summary of the evaluation that led to the determination that the change could be made in accordance with 10 CFR 50.59; 2. Sufficient detailed information to totally support the reason for the change without benefit of additional or supplemental information; 3. A detailed description of the equipment, components, and processes involved and the interface with other plant systems; 4. An evaluation of the change which shows the predicted releases of radioactive materials in liquid and gaseous effluents and/or quantity of solid waste that differ from those previously predicted in the license application and amendments thereto; 5. An evaluation of the change which shows the expected maximum exposures to individual in the UNRESTRICTED AREA and to the general population that differ from those previously estimated in the license application and amendments thereto; 6. A comparison of the predicted releases of radioactive materials, in liquid and gaseous effluents and in solid waste, to the actual releases for the period prior to when the changes are to be made; 7. An estimate of the exposure to plant operating personnel as a result of the change; and 8. Documentation of the fact that the change was reviewed and found acceptable by the PORC. b. Shall be reviewed and accepted by the PORC prior to implementation. l c. Shall be documented by a recurring action request. i 1 1

I 1 i i i i l PART II CALCULATION METHODOLOGIES l 4 i l I 4 I l i l i 1 4 l l l 1 1 I i 1 1 i 4-e ,r . \\ l l I

s l ODCM Rav. 17 Pege 64 l 11/95 i 1.O LIOUID EFFLUENTS 1.1 RADIATION MONITORING ll4STRUMENTATION AND CONTROLS The liquid effluent monitoring instrumentation and controls at Limerick for controlling and monitoring normal { radioactive material releases in accordance with the Limerick Technical Specifications are summarized'as follows-1) Liquid Radwaste System: The liquid radwaste discharge monitor (RISH63-0K604) provides an alarm and automatic termination of radioactive mater!ed by Technical ial releases from the liquid radwaste system as requi: j Specification 6.8.4.d.1. Additional design features J of the liquid radwaste system which prevent inadvertent releases to the environmcnt include 1) redundant disgharge valves, 2) single discharge line with loop seal and siphon breaker to eliminate probability of inadvertent discharges, 3) Low Cooling Tower Blowdown flow interlock which isolates the radwaste discharge line. 2) Service Water System: The Service Water cischarge monitor (RISH10-1K605 AND RISH10-2K605) provides an alarm upon indication of activity in the service watt.r system as required by Technical Specification 6.8.4.d.1. While the service water system is not a i normai release pathway, the monitor provides an 4 indication of potential problems due to excessive leakage of the heat exchangers. In addition, the service water side of the fuel pool heat exchangers is kept at a higher pressure than the shell side to prevent potential radioactive contamination of the service water. 3) RHR Service Water System: The RHR Service Water Radiation (RHRSW) Monitors (RISH12-0K619A, RISH12-OK619B, RISH12-1K619C, RISH12-1K619D, RISH12-2K619C ? AND RISH12-2K619D) provide alarm and automatic termination of radioactive material release from the RHRSW system, as required by Technical Specificati~on 6.8.4.d.1. While the RHRSW system is not a normal rele; ace pathway, the monitors provide indication of potential prohtems due to excessive leakage of the heat exchangers. 4

l ODCh R2v. 17 Page 65 l 11/95 1.2 LIOUID EFFLUENT MONITOR SETPOINT DETERMINATION j Per the requirements of Technical Specif alarm setpoints shall be established for$ cation 6.8.4.d.1, /the liquid effluent monitoring instrumentation to ensure that the-J release concentration limits of Specification 6.8.4.d.2 and 6.8.4.d.3 are met (i.e., the concentration of { radioactive material released in liquid effluents to UNRESTRICTED AREAS shall be limited to the concentrations specified in 10 CFR 20, Appendix B, Table II, Column 2, for radionuclides and 2.0E-04 pCi/ml for dissolved or entrained noble gases). e a 1.2.1 Radwaste Discharce Monitor and Discilarce Flow Rate - RISH63-0K604 The t tpoint for the liquid radwaste discharge monitor and flow rate element are determined by the following equations. The radwaste discharge monitor high-high alarm / isolation setpoint is evaluated at least monthly based on isotopes detected in the liquid radwaste sample tanks released during the previous month or on any specific sample tank being released (EC _), the g l required minimum cooling tower blowdown flow at time of discharge (CTBD), and average liquid radwaste discharge flow (RR). The flow rate 1 determination is calculated for each release and the MPC fraction calculated includes, in the CC.ncentration mix, the most recent results from

1) the quarterly composite for SR-89, SR-90 and Fe-55, and 2) the monthly composite for H-3, and
3) the sample (s) for dissolved and entrained noble gases.

If the calculated setpoint is less than the existing setpoint, t'ge setpoint will be reduced to the next value. If he calculated setpoint is greater than the existing setpoint, the setpoint may remain at the lower val.2e or increased to the calculated value. 4 The actual setpoint may be reduced to a value less than the calculat?d setpoint at the discretion of Supervision. 3 If there were no sample tanks released or no activity detected during the previous month, then the calculation is performed using release data from tl.e most recent month during which isotopes were detected. In addition, if there were no sampl'e t.anks released during the previous month, chemistry supervision may substitute more restrictive values (e.g., tritium) based on the plant sampling data. f ) 1

.. - - ~ -. -. I l ODCM Rev. 17: Paga 66 l 11/95 1.7.1-1 Setooint Determination - RISH63-0K604 The setpoint for the liquid radwaste discharge monitor is determined by the following equation: CPM.w3 s l 1,, (p) (n) [E (Cme,)/MPCme,)3 (E Cj,) (M+CTBD) +BKG (1_1) { (n+CTBD) (S) (E) (M) [EC,QNPC,-] i

  1. 3 j

j 4 l where: i CPMgm> Calculated liquid radwaste discharge = monitor (RISH63-0K604) count rate attributable to the gamma emitting i radionuclide, cpm

Ici, the sum of the. concentration of the

= identified gamma emitting nuclides (pci/ml), CTBD the required minimum cooling tower i = ) blowdown rate at time of discharge .) (gpm), J RR average liquid radwaste discharge flow. = (gpm), l backgroufdcountrateofliquidradwaste BKGgm3 = discharge monitor (CPM), E the gross detection efficiency of the = liquid radwaste discharge monitor (pCi/ml/ cpm), and S 2; margin of safety factor to assure = that the release is terminated prior to 10 CFR 20 limits being exceeded. Included in this factor are errors associated with monitor uncertainty, sampling uncertainty, flow rate uncertainty, and the contribution of other release paths (Service Wate; and RHRSW) which are not nortally contaminaged. 1 } Z (C,.n /MPC. ) i ig the effective gamma MPC ratio for the = mixture of radionuclides in the liquid radwaste discharge line (unitless).

l-ODCM Rav. 17 Page 67 l 11/95 1 where: 4 1

Cipk, the concentration of each identified

= gamma emittinyt radionuclide i in the i liquid effJuent (undiluted) (pci/ml) MPC,. the MPC value corresponding to = t radionuclide i from 10 CFR 20 Appendix i B,' Table II.. Column 2 (dissolved and r entrained ncble gases MPC = 2.0E" 'pCi/ml) (pCi/ml). E (Ci ut./MPC we.) the effective nongamma MPC ratio for the = t i mixture of radionuclides in the liquid radwaste discharge line (unitless) where: 'the concentration of each identified C we, = i nongamma radionuclide i in the liquid j effluent (undiluted) (pci/ml)* MPCa.e. The MPC value corresponding to radionuclide i form 10 CFR 20, Appendix B, Table II, Colunh 2 (dissolved and entrained noble gases MPC = 2E pCi/ml) (pci/ml) )

  • NOTE:

The concentration mix must include the n'ost recent sample I data for H-3, Sr-89, Sr-90, Fe-55 and gross alpha. 1.2.1-2 Elpw Rate Determination i e

  • NOTE: lE the effectivu MPC ratio for the mixture of radionuclides [E (C /MPC Y)] is s1.0, i

i IHEH a flow rate setpoint determination is not required, Ann there is no limit on discharge flow rate. II a flow rate determination is required, THEN the setpoint for the liquid radwaste flow rate is determined for each release by the following equation: D FLOW"#M s (1-2) (SF) [E (Cj/MPC ) -1) f where: flow limit for radwaste discharge FLOW umn line (gpm). CTBD required minimum cooling tower blowdown flow for = time of release (gpm). i SF 2; margin of safety factor to assure that the = release does not exceed 10 CFR 20 limits. l ( h i

l ODCM R';v. 17 Prge 68 l 11/95 i E (C /MPC ) i t the effective MPC ratio for the mixture of = radionuclides in the liquid radwaste discharge line (unitless) where: C the concentration of each identified radionuclide = 1 i in the liquid effluent (undiluted) (pci/ml)* MPC the MPC value corresponding tq radionuclide i from = 1 10 CFR 20 Appendix B, Table *:1, Cclbmn 2, (dissolved and entrained noble gases MPC = 2E pCi/ml) (pCi/ml).

  • ITOTE : The concentration mix must include tt4 most recent sample data for H-3, Sr-89, Sr-90, Fe-55 and dissolved and entrained noble gases.

1.2.2 Service Water Radiation Monitor - RISH10-1K605. - 2K605 l The Service Water Radiation Monitor maximum high-high setpoint is determined by the following l equation. The setpoint is evaluated every 24 months to assure that a high background count rate does not prevent adequate monitor sensitivity in order to meet the requirements of Technical Specifications 6.8.4.d.2 and 6.7.4.d.3. 1.2.2-1 Setpoint Determination l The maximum setpoint for the Service Water Radiation Monitor is determined by a the following equation: l CPM,, ;= 0.5 (2. 0E- 05pCi/ml) (CF) where: l CPM,,= Calculated Maximum Service Water Radiation Monitor (RISH12-1K605, - 2K605) count rate, CPM. 2.0E-05 pCi/ml = MPC limit for Cs-1'37 CF=Monitorcalibrationfactor-incpm/pCifml l 0.5 = Safety Factor A

f l ODCM RLv' 17 Page 69 l 11/95 1.2.3 EHR Service Water Monitor -RISH12-0K619A. -0K619B. -1K619C,, -1K619D, -2K619C, -2K619D h l The RHR Service Water Radiation Monitor' maximum high-high setpoint is determined by the following l equation. The setpoint is evaluated every 24 months to assure that a high background count does not prevent adequate monitor sensitivity in order to meet the Technical Specifications 6.8.4.d.2 and 6.7.4.d.3. 1.2.3-1 Setpoint Determination The setpoint for the RHR Servic;s Water Radiation Monitor is determined by i.he following equation: l CPMum,= 0. 5 (2. 0E- 05pCi/ml) (CF) where: l CPMumsw Calculated maximumRHR Service = Water Radiation Monitor (RISH12-0K619A, -OK619B, - 1K619C, -1K619D, -2K619C, 2K619D) count rate, CPM. 1 2.0E-5pCi/ml MPC limit for Cs-137 = i Monitor calibration factor - CF = in cpm /pci/ml. 0.5 = Safety Factor I { f + 1 l I

l ODCM rov. 17 Pcge 70 l 11/95 1.3 Licuid Effluent Dose Calculation - 10 CFR 50 1.3.1 Members of the Public Dose ODCM I3.2.3 limits the dose or dose commitment to MEMBERS OF THE PUBLIC from radioactive materials in liquid effluents from Limerick Generating Station to: - during any calendar quarter, 3 mrem to total body s slo mrem to any organ - during any calendar year. 6 mrem t.o total body s s20 mrem t.o total organ. 1 Per ODCM I3.2.3.1 the cumulative dose contribution from liquid effluents for the current calendar quarter year shall be determined at least once per 31 days in accordance with the following calculation methods. These equations are for the three aquatic environment exposure pathways (potable water, fish, shoreline exposure) in the Limerick aquatic environment. Only real pathways are addressed for each receptor. The receptors and associated pathways are listed below. Doses from each real pathway are summed to give dosa at the receptor. The monthly results are accumulated to give the quarterly doses and the quarterly y results are accumulated to give the annual doses. l Raceptor Dist. Pathways Location (mi) Potable Water Fish Shoreline LGS Outfall 0 X a X Citizen's Utility 2.5 X X X Phoenixvil?.e Water 9.0 X X X Phil. Sub. Water 13.6 X X Crew Course 37.8 X

.._..._..-__-..m __-___._.m. i -l ODCM Rav. 17 'Page 71 l 11/95 1.3.1-1 Potable Water Pathway. .R,j = 1 1 0 0 g* EOjD,jpj exp(-Ai (18)) 1 (1-6) MF1 p 1.3.1-2' Fish (Aquatic Food) Pathway U ' EOj jf,j,j exp (-Aj (ao ) (1-6) { 88 R,j = 110 0 B MF1 p Shoreline Deposition Pathway i 1.3.1-3

    • EOjTj,jpj exp (-Al *p) (1-exp (-Aj <t.vsar+s> ))

(1_7) A,j = 110, 00 0 D MF1 p i I f where: t B, = equilibrium bioa:ccumulation factor for nuclide I.in 1 pathway p, expressed as the ratio of.the concentration in l biota, in pCi/kg, to the.radionuclide concentration in l 2 water, in pCi/ liter (liters /kg) i i I f i I i 3 i l 1 6

l ODCM Rev. 17 Paga 72 l-11/95 BIOACCUMULATION FACTORS (pCi/kg/pCi/ liter) FRESHWATER SALTHATER-ELEMENT FISH FISH .H 9.0E-1 9.0E-1 C 4.6E 3 1.8E 3 Na 1.0E 2 6.7E-2 P

3. 0E 3' 2.9E 4 Cr
2. 0E,2 4.0E 2 Mn 4.0E 2 5.5E 2 Fe 1.0E 2 3.0E 3 Co 5.0E 1 1.0E 2 Ni 1.0E 2 1.0E 2 (X1 5.0E 1 6.7E 2 Zn 2.0E 3 2.0E 3 Br 4.23 2 1.5E-2 Rb 2.0E 3 8.3E O Sr 3.0E 1 2.0E O Y

2.5E 1 2.5E 1 Zr 3.3E O 2.0E 2 Nb ^ 3.0E 4 3.0E 4 Mo 1.0E 1 1.0E 1 Tc 1.5E 1 1.0E 1 Ru 2.0E 1 3.0E O Rh 1.0E 1 1.0E 1 Te 4.0E 2 1.0E 1 I 1.5E 1 1.0E 1 Cs 2.0E 3 4.0E l' Ba 4.0E O 1.0E 1 LA 3 2.5E 1 2.5E 1 Ce 1.0E O 1.0E 1 Pr 2.5E 1 2.5E 1 Nd 2.5E 1 2.5E 1 ~ W 1.2E 3 3.0E 1 Np 1.0E 1 ~1.0E 1 Ref: 1) U.S.N.R.C Reg. Guide 1.109, Rev. 1, Table A-1

2) Letter LTR 881209L001, from R.J. Cle.ck, 0.d N.R.C., to G.A. Hunger, Philadelphia Electric Co., December 9,
1988, transmitting evaluation of Limerick ODCM.

i. s.

- _.. -, -..... - - - _ _ - - ~ ~ _ - l-ODCM rov. 17 Page 73 l. 11/95 . dose factor specific to a given~ age group a, radionuclide D,ig = i i, pathway p, and organ j which can be used to calculate 3 radiation dose (1) from an intake of a radionuclide, in mrem /pci, or (2) from exposure to-a given concentration of a.radionuclide in sediment, in mrem /hr per pCi/m2 Values are listed by age group in Table 1-1. waste dilution flow rate of liquid effluent dilution j F = flow / number of batches (f t /sec). j 3 dilution factor at point of exposure or at point of l F4 = withdrawal of drinking' water (dimensionless). Values are graphically liated by receptor location in' Figures 1.3.1-1 to 1.3.1-5. Value will be based on average monthly l river flow. i a total release of nuclide 'i' for time period (Ci). 01 ~ = total dose for calculation time period to organ j of L R,g = individuals of age group a from all nuclides i in pathway b (mrem). radioactive half-life of nuclide 1 (days). T = i U, usage factor specifying exposure time or intake rate for = an individual of age group a associated with pathway p (hr/yr, liters /yr, or kg/yr). j Pathway Infant Child Teen Adult I Fish 6.9* 16* 21* Potable Water (1/yr) 330* 510* 510* 730* [ Shoreline Recreation 14* 67* 12* (hr/yr) Shoreline Recreation i (hr/yr) 5 b 6 90 600 600 r i Ref: Regulatory Guide 1.109, Rev 1, Table E-5 b EROL Table 5.2.A-3 shoreline width factor w = (dimensionless) = 0.2. Ref: Regulatory Guide 1.109, Rev. 1. f time period during which sediment 1.752E+5 = isgexposed to contaminated water (hrs) (midpoint of plant life = 20 yrs) radioactive decay constant of I 1 = 1 nuclide 'i' (hr-2) ] I i

... m i l' ODCM Rav. 17 Paga'74 j l . 11/95 12 delay time for potable water = pathway in hours to allow for nuclide decay during transport through the water purification plant and the water distribution

system, Ref:

Regulatory Guide 1.109, Rev. 1, App. A. 1 24 delay time for potable fish pathway in hours to allow for i nuclide d.ecay during transport through the food chain, as well as during food preparation. Ref: Regulatory Guide 1.109, Rev. 1, App. A. 1100 factor to convert from Ci/yr per = 3 f t /sec to pCi/ liter. factor to convert from Ci/yr per i 110,000 = ft'/see to pCi/ liter 3 and to account for proportionately t constant (100) used in sediment .l radioactivity model. i l I l s . h* g I i b I

l ODCM Rav. 17 Page 75 l 11/95 1.4 Licuid Effluent Dose Proiections l ODCM I3.2.4 requires that the liquid radwaste treatment system shall be operab.e and appropriate portions of the systems used l to reduce the radioactive materials in liquid waste prior to their discharge when the projected doses due to the liquid effluent to UNRESTRICTED AREAS would. exceed: l l - 0.06 mrem /31 days to the total body or - 0.2 mrem /31 days to any organ. The applicable liquid radwaste treatment processing equipment for maintaining radioactive materials releases ALARA are delineated in Figure 1.4-6. Dose projections are made at least once per 31-days by the following equations: (Da/d)

  • 31 days (1-8)

Du, = (D x/d)

  • 31 days (1-9)

D.x, = where: l the total body dose projection for the Du, = current 31-day period (mrem). 3-t the total body dose projection for the current Da = calendar quarter as determined by equation 1-5,, 1-6, and 1-7 (mrem). D, [ the maximum organ dose projection for the current 31-day period (mrem). the maximum organ dose to date for the current D., = calendar quarter as determined by equations 1-5, 1-6, and 1-7 (mrem). d the actual number of days in the current = calendar quarter at the end of the release (days). The minimum time elapsed is seven (7) days. t 31 days the number of days of concern = v

l l ODCM Rev. 17 Pcge 76 l 11/95 2.0 GASEOUS EFFLUENTS 2.1 Radiation monitorina instrumentation and Controls The gaseops effluent monitoring instrumentation and controls at Limerick for controlling monitoring radioactive material releases in accordance with the ODCM Part 1 are summarized as follows: 1) North Vent (Common): The plant gaseous discharges via this vent are monitored by two Particulate, Iodine and Gas (PIG) monitors (RY26-075A and RY26-075B) in parallel and by the Wide Range Accident Monitor (WRAM) (EIX26-076). The PIGS have reparate Particulate, Iodine, and Gas sampling and monitoring channels but the Station ODCM Controls require only particulate and iodine sampling and noble gas monitoring. The KRAM has extendedtrange (via three channels) noble gas monitoring and particulate and iodine sampling capability. In addition, the WRAM provides an isolation (Group A) of the large Drywell Purge and Vent valves. 2) south Vent (one ner unit)- The plant gaseous discharges via each South Vent are monitored by two redundant PIG monitors (RY26-285A,B). As is the case of the North Vent, each PIG has separate particulate,i iodine, and gas sampling and monitoring channels but the Station ODCM Part I requires only particulate and iodine sampling with gas monitoring. 3) Hot Maintenance Shoo (Common) - Due to the composition of the radioactive materials in the effluent steam (i.e., very low potential for noble gas), this release point is sampled for particulate and iodine (P&I) monitors (RY26-025). The P&I monitor has a separate particulate and iodine sampling and monitoring channels but Station ODCM Part I requires only particulate and iodine sampling. 4) Auxiliary Boilers (Common) - Wacte oil with some amount of radioactive particulate content may be burned in the site auxiliary boilers, as allowed by 10CFR20.2004. In this case, the exhaust stack of the affected auxiliary boiler will be a release point for radioactive effluents. Doses calculated will be based on the radioactive content of the oil sampled prioi to incineration. The radioactive effluent will be determined by performance of ST-0-104-882-0, summed with other effluents from the site and reported to the commission in the annual effluent report.

I i l ODCM Rev. 17 Page 77 l 11/95 2.2 GASEOUS EFFLUENT MONITOR SETPOINT DETERMINATION ODCM I3.3.1 requires that an alarm setpoint be established for the noble gas effluent monitoring channels (RY26-075A,B,; RY26-l 185A,B,; RY26-285A,B,; and RIX26-076) to ensure that the release rate of radioactive materials does not exceed the limits of ODCM 13.3.2.a, which corresponds to a dose rate at I the SITE BOUNDARY of 500 mrem /yr to the -total body or 3000 mrem /yr to the skin. This specification also states that the dose rates from I-131, I-133, Tritium, and all radionuclides in particulate form with half-lives greater than eight days, shall be limited to a maximum of 1500 mrem /yr to any organ (inhalation pathway only). ODCM Part I limits are expressed in terms of dose rate, while the instruments which monitor effluents produce data in units of concentration or release rate. It is therefore necessary to identify the isotopen and calculate the corresponding release rate which will result in the dose rate limit being reached at the site boundary. This calculation is made more complex by the use of multiple release points at LGS. Calculation Bases The alarm setpoint calculation is performed monthly and is based on analytical results of grab samples from the appropriate release point. The concentration of each identified radionuclide in the grab samples is determined, and the data are used to perform a setpoint calculation for that nuclide mix and release point. The highest calculated annual average concentration (X/Q) for an area at or beyond the site boundary (1.1E-05sec/M, NE 3 sector) is used in the setpoint calculation. Maximum flow rates through the North and South vents are used I in alarm setpoint calculations. This is necessary since flow can vary. By using maximum values, any flow less than the maximum will assure that the monitor will alarm before release rate limits are exceeded. For each release point the noble gas release which would cause a SITE BOUNDARY total body dose rate of 500 mrem /yr and a skin dose of 3000 mren/yr is determined. The fractional contribution of noble gas is calculated for each release point. The fractional contribution to the whole body and skin dose rates due to noble gases is calculated by taking the product of this fraction and the limiting release rate. A comparison of this release rate for whole body and skin dose rates due to noble gas release is made to determine if the whole body or skin dose limit will be most restrictive. It is expected that the whole body limit will always be most restrictive, but the comparison is necessary to assure compliance with ODCM I. The sum of the contributions from each release point, independently calculated for iodines and noble gases, will equal the maximum instantaneous release rate allowed from the site.

e l ODCM Rcv. 17 P:ga 78 l 11/95 The purpose of calculating the release rate which corresponds to the site boundary dose limit is n21 to determine an acceptable release rate, but to determine the maximum release rate which may be exceeded. It is n2n intended that releases will be maintained at or near this limit, and in fact, requirements to maintain offsite doses As Low As Reasonably. Achievable (ALARA) are specified in ODCM 13.3.3 and ODCM I3.3.4. 2.2.1 H2Tth Vent Noble Gas Effluent Monitors - RY26-075A-3. PY26-075B-3, AND RIX26-076-2 The North Vent Noble Gas Effluent monitor high-high setpoint is calculated monthly based on the grab sample resulte performed in accordance with ODCM Table I3.3-3. Due to taa incorporation of the ALARA philosophy in the design and operation of the Limerick effluent systems, release point grab samples may not identify any radionuclides. In this situation, chemistry may use the results of the last grab sample which identified radionuclides or use the default setpoint which is based on expected concentration ratios as reported in the UFSAR. If any calculated alarm setpoint is less than the existing monitor setpoint, the setpoint will be reduced to the new value. If the calculated setpoint value is greater than the existing value, the setpoint may remain at the lower value or increased to the new value. 2.2.1 Setuoint Determination I The High-High setpoint is calculated per equation (2-la). The basis for the High-High setpoint is the Unusual Event Emergency Action Level Site P- ,dary Dose Rate of 0.114 ] mrem /hr. The Higt,..;oint for the North Vent Noble gas Efflutnt Monitor is set at or below the lesser of the NVSPsan OR NVSPscsx value. (per equations 2-1 or 2-2) \\ [VFa] [500] [E Cml yygg", y [3. 4475E9] E [ (Cm) (Kj) ] I [500] [E C*] NVSP(Hi-Hl)" s [3. 447 5E9] E [ (Cm) (Kj)] {2] (2 -la) I

l l ODCM rov. 17 Page 79 11/95 1 [VFul [3000] [ECj,) gp" g [3.4475E9} E [(Cjw) (L +1.11M )] j j j where: NVSPums North Vent High Setpoint - Noble Gas Whole Body (pCi/cc) NVSPg;s, North Vent High Setpoint - Noble Gas Skin (pCi/cc) = NVSP (Hi-Hi),y, North Vent High-High Setpoint - Noble Gas = whole Body ( Ci/cc). VFmm Fractional contribution to site boundary noble gas = dose rate from the North Vent as calculated in equation 2-7. (unitless). 500 Total body dose rate limit (mrem /yr) = 3000 Skin Dose rate limit (mrem /yr) = ICuw Total noble gas activity from North Vent grab sample = (gCi/cc) 2 Multiplication Factor to correspond to Unusual Event = j Emergency Action Level Site Boundary Dose Rate Value of 0.114 mrem /hr. (Unitless) Corhrersion factor 3.4475E9 (pCl) (cc) 3 m ) (pCl) l 3 = (1.1E-5 sec/m ) (1E6 pCi/pCl) (664,000 cfm) (1/60 min /sec) (2. 832E4 cc/fc3) l (2-3) where: 3 1.1E-5 sec/m highest annual average X/Cl (NE Sector) = 1E6 pCi/pci units conversion = 664,000 cfm maximum North Vent flow rate for two unit = operation 1/60 min /sec units conversion = 8 2.832E4 cc/ft units conversion = Cay concentration of noble gas nuclide i as determined by radioanalysis of North Vent grab sample (pCi/cc)

-.- ~.-. n l ODCM Rov-. 17 i Paga 80 l l -11/95 i K-Total body dose conversion factor for noble i = gas nuclide i (mrem /yr per pCi/m, from 2 Table 2-1). L Beta skin dose conversion factor noble gas l = i l nuclide 1 (mrem /yr per pCim*, per Table 2-1). l l l Mo Gamma air dose conversion factor for noble { = l gas nuclide i (mrad /yr per 'pci/m*, per - l Table,2-1). l 2.2.2 South Vent Noble Gas Effluent Monitors -RY26-185A-3. RY26185B-3, RY26-285A-3, AND RY26-285B-3 Each unit's South Vent Noble Gas Effluent monitor High ) setpoint is calculated monthly based on the grab sample results performed in accordance with ODCM I3.3-3. Due to i the incorporation of the ALARA philosophy in the design and i operation of the Limerick effluent systems, release point { grab samples may not identify any radionuclides. With this situation, chemistry may use the results of the grab sample which identified radionuclide or use the default setpoint which is based on expected concentration ratios as reported in the UFSAR. If any calculated-alarm setpoint is less than the existing monitor setpoint, the setpoint will be l reduced to the new value. If the calculated setpoint value is greater than the existing value,.the setpoint may remain i -at the lower value, or increased to the new value. 2.2.2-1 Setpoint determination The High setpoint for the South Vent Noble Gas Effluent Monitor is set at the lesser of the SVSP o, and SVSPucsx value. SVSP,o,e and'SVSPsosx are i calculated for each unit's South Vent. The High-High setpoint is calculated per equation (2-4a). The basis for the High-High setpoint is the. Unusual Event Emergency /hr.Actidn Level Site Boundary Dose Rate of 0.114 mrem IVF =1 (sool [EC,,y) s gygg", _,) [1. 2149E9] E [ (C,y) (K;) ] j j SVSP(Hi-Hj)" s (1.2149E9] E [(C,y) (Kj)] [2] (2-4a) f / i

i l ODCM Rov. 17 Page 81 l 'l ' 11/95 SVSP" s (2-5) [1. 2149E9) E [ ( C,y) (Lj +1.11Nj) 2 j i where: l l SVSP,,, South Vent Setpoint - Noble Gas Whole Body [ = L (pCi/cc)

SVSPam, South Vent Setpoint - Noble Gas Skin (pCi/cc)

= Fractional contribution to site VFnma. = L boundary noble gas dose rate from the Unit's South Vent as calculated in equation 2-8 o. 2-8a (unitless) l Total body dose rate limit (mrem /yr) 500 = Skin dose rate limit (mrem /yr) 3000 = Total noble gas activity from each unit South ICum = Vent grab sample (pCi/cc). Multiplication Factor to correspond to 2 = . Unusual Event Emergency Action Level Site i Boundary Dose Rate Value of 0.114 mrem /hr. (Unitless) Conversion factor 1.2149E9 = (pci) (cc) (m ) (pCi), { 3 l = (1.1E-5 sec/m ) (1E6pCi/pCi) (234,000 cfm) (1/60 min /sec) (2.83E+4 cc/fc3) (2-6) 3 i where: l 1.1E-5 sec/m 3 highest annual average X/Q (NE Sector) = l 1E6 pCi/pCi units conversion = 234,000 cfm maximum South Vent flow rate = 1 1/60 min /sec units conversion = 3 units conversion 2.832E4 cc/ft = concentration of noble gas nuclide i C,y = 1 determined by radioanalysis of South l Vent grab sample (pci/cc) Total body dose conversion factor for K = i 3 noble gas nuclide i (mrem /yr per pCi/m, l from Table 2-1). l 1

l. ODCM Rev. 17 Pago 82 l 11/95 s L Beta skin dose conversion factor nable I = i gas nuclide i (mrem /yr per pCi/m, per i 2 Table 2-1). M Gamma air dose conversion factor for i = i noble gas nuclide i (mrad /yr per pCi/m,3 per Table 2-1). 2'.2.3 Nob'Le Gas Effluent Fractional Contribution The noble gas effluent fractional contribution-is calculated monthly.if activity in all 3 stacks is i identified using.results of the grab samples i 3 performed in accordance with ODCM I3.3-3. The I results of this calculation are used in equations 2-1, 2-2, 2-4, and 2-5. This methodology assumes ) that the total body dose is limiting for noble gas releases. If equations 2-1, 2-2, 2-4, and 2-5 show that the skin dose'is limiting, fractional ] skin dose should be substituted for the whole body values used in equations 2-7, 2-8, and 2-8a. l 2.2.3-1 Calculation of VF,m, VF m, and VFasm 43 .VF " = ~ I" (2 -7 ) ) E [ (C,) (Kj) ] +E [ (Cf3g) (K ) ] +E [ (C32g) (Kj) ] 3 j E [C,y) (Kj) ] j (2-8) 1", E[(Cgy) (K ) ] +E ( (C32y) (Kj) ] +E [ (C,y) (Kj) ] j j VF (2-8a) am = g-( (c1m) (gs) ) +3 [ (c,,p) (g,) ) +3 [ (e,p) (g ) ) g g j 1 j 4 k i

4 4 ._4-4 l ODCM rov. 17 Page 83 l 11/95 where: fractional contribution to site boundary noble VFmm = gas total body dose rate from the North Vent (unitless). fractional contribution to site. boundary noble _, _. VFuma = gan t'otil"b' df ~d6se ~ rate ~f rom the Unit 1 South --~ o Vent (unitless). fractional contribution to site boundary noble VFnwa = gas total body dose rate from the Unit 2 South Vent (unitless). concentration of noble gas nuclide i as Can = determined by radioanalysis of North Vent grab sample (pci/cc) total body dose conversion factor for noble gas K = i radionuclide 1 (mrem /yr per pCi/m') concentration of noble gas nuclide i as

Cun,

= determined by radioanalysis of Unit 1 South Vent grab sample (pCi/cc) concentration of noble gas nuclide i as Cunt = determined by radioanalysis of Unit 2 South Vent grab sample (pCi/cc) 2.2.4 Noble Gas Effluent Default Setooint This methodology may be used when grab sample results from either the North Vent or the South Vent do not identify any radionuclides. This methodology is based on expected release concentration ratios as outlined in section 11.3 of the Limerick UFSAR. 2.2.4-1 North Vent Noble Gas Monitors (RY26-075A-3 and RY26-075B-3). The default High setpoint for the North Vent noble gas effluent monitor is set at or below the NVSPmo value. (per equation 2-9). [8. 9 0E-1] [500] [1.15E-6] NV5P** s (2 -9 ) [3. 447 5E9] [4. 3 0E-9] NVSPmm s 3.45E-5 pCi/cc The Default High-High setpoint for the North Vent Gas Effluent Monitor is calculated per equation (2-9a). The basis for the Default High-High setpoint is the Unusual Event Emergency Action Level Site Boundary Dose Rate of 0.114 mrem /hr.

.. _ _ _ _ ~. _.. _.. - _ l ODCM Rev. 17 Pag 5 84 l 11/95 [500] [1.15E-6] ggrsp(yj _yj)"" s [3.4475E9] [4.30E-9] [2] (2-9a) l NVSP (Hi-Hi)mo s 27.76 E-5 pCi/cc where: I NVSP,m Default North Vent High Setpoint - Noble = l Gas (pCi/cc) j NVSP(Hi-Hi)mo Default North Vent High-High Setpoint - Noble = l Gas (pci/ce) 8.90E-1 Default fractignal contribution to site boundary J = noble gas total body dose rate from the North } Vent (unitless) 4. 3 0E-9 i (4. 3 0E-9 ) + (5. 31E-10 ) 4.30E-9 Summation of the North Vent concentration of i = noble gas nuclide i multiplied by the corresponding whole body dose factor. (pCl) (mrem) (m ) l 3 (cc) (yr) (pCl) 5.31E-10 = Summation of the South Vent (Unit 1 & 2) concentration of noble gas nuclide i multiplied by the corresponding whole body dose factor. 3 (pCl) (mrem) (m ) (cc) (yr) (pci), Ref: a) Based on expected annual release from UFSAR Table 11.3-1. b) Based on maximum North Vent flow of 664,000 cfm and South Vent flow of 234,000 cfm for Unit 1 and Unit 2 vents. c) ODCM II Table 2-1. Total body dose rate limit (mrem /yr) 500 = 1 m

= -..-- - _..~~. - - -~ i l ODCM Rav. 17 Page 85 l 11/95 i 1.15E-6 Total noble gas concentration from North = Vent (pCi/cc) t Ref: a) Based UFSAR Table 11.3-1. i b) Based on maximum North Vent flow of 664,000 cfm Multiplication Factor to correspond to Unusual [ 2 = Event Emergency Action Level Site Boundary Dose Rate Value of 0.114 mrem /hr. (Unitiess) t 3.4475E9 = Conversion factor (pCl) ( cc) ' 3 I (m ) (pCl), i Summation of the North Vent concentration of I 4.30E-9 = noble gas nuclide i multiplied by the corresponding whole body dose factor. 3 (pCl) (mrem) (m ) (cc) (yr) (pCl) i Ref: a)' Based UFSAR Table 11.3-1. b) Based on maximum North Vent flow of 664,000 cfm. c) ODCM,II Table 2-1. l 1 l 4 i.

l ODCM Rev. 17 Page 86 l 11/95 2.2.4-2 South Vent Noble Gas Monitors (RY26-185A-3, RY26-285A-3, RY26-185B-3, and RY26-285B-3). The de.#ault High setpoint for each Unit's South Vent noble gas effluent monitor is set at or below the SVSPgm value. (per equation 2-10) (5.49E-2] [500] [7.14E-8) SVSP,m s (2 -10) [1.2149E9) [2.65E-10) t l SVSPue s 6.09E-6 pCi/cc The default High-High setpoint'for each units South Vent Noble Gas Effluent Monitor is calculated per equation (2-10a). The basis for the default High-High setpoint is the Unusual Event Emergency Action Level Site Boundary Dose Rate of 0.114 mrem /hr. [500] [7.14E-8) SVSP** s [1.2149E9] [2.65E-10} [2] (2-10a) l SVSPmm s 2.22E-4pCi/cc where: SVSPro Default South Vent Setpoint - Noble = Gas (pCI/cc) SVSP(Hi-Hi)mo Default South Vent Setpoint - Noble = Gas (pCI/cc) l l 5.49E-2 Default fractional contribution to site = boundary noble gas total body dose rate from the South Vent (unitless) 2.65E-10 (4. 3 0E-9 ) + ( 5. 31E-10 ) where: Summation of the Unit's South Vent 2.65E-10 = concentration of noble gas nuclide i multiplied by the corresponding whole body dose factor. 2 (pCi) (mrem) (m ) (cc) (yr) (pci) Summation of the North Vent concentration of 4.30E-9 = noble gas nuclide i multiplied by the corresponding whole body dose factor.

[' ODCM Rnv. 17 Page 87 I 11/95 j (pCl) (mrem) (m ) 3 (cc) (yr) (pCl) j i Summation of the South Vent (Unit 1 & 2) 5,31E-10 = concentration of noble gas nuclide i multiplied by the. corresponding whole body dose factor. l t ^ (pCl) (mrem) (m ) 3 (cc) (yr) (pCl) Ref: a) Based on expected annual release from UFSAR Table 11.3-1. b) Based on maximum North Vent flow of 664,000 cfm and South Vent flow of 234,000 cfm for Unit 1 and Unit 2 vents. c) ODCM II Table 2-1. 500 Total body dose rate limit (mrem /yr) l = 7.14E-8 Total noble gas concentration from North Vent = r (gCi/cc) t Ref: a) Based UFSAR Table 11.3-1. b) Based on maximum North Vent flow of 664,000 cfm. 1.2149E9 Conversion factor = (pCl) (cc) ' (m3) (pCl), Ref: a) ODCM II equation 2-3 2.65E-9 Summation of the North Vent concentration of = noble gas nuclide i multiplied by the corresponding whole body dose factor. (pci) (cc) ' 3 (m ) (pCl). 2 Mult!. plication factor to correspond to Unusual = Event Emergency Action Level Site Boundary Dose Rate. (Unitless) 9 4

l ODCM Rtv. 17 l Paga 88 l 11/95 Ref: a) Based UFSAR Table 11.3-1. b) Based on maximum North Vent flow of 664,000 cfm. c) ODCM II Table 2-1. 2.2.5 Wide Rance Accident Monitor Noble Gas Effluent Monitor (RIX-26-076-4) The Wide Range Accident Monitor (WRAM) noble gas total effluent channel displays the North Vent noble gas release rate. This monitor has Main Control Room Annunciation as well as a group 6A isolation function on the primary containment purge and vent valves. The isolation setpoint value of s2.1 pCi/cc specified in Technical Specification 3.3.2-2 is based on the accident ' dose limits for containment purge during an accident (Ref: UFSAR Section 1.13). For routine operations the total effluent alert and high setpoints are based upon the methodology of Sections 2.2.5-1 and 2.2.5-2. The setpoint units are in microcuries per second using the two unit maximum North Vent flow rate of 664,000 scfm. The total effluent channel High-High setpoint is set at a value less than or equal to ten times the High setpoint (not to exceed the 2.1 pCi/cc equivalent using the two-unit maximum North Vent flow rate). These values are always more conservative than the Technical Specification 1 Table 3.3.2-2 required value of s 2.lgCi/cc. If the calculated setpoint value is less than the existing monitor setpoint, the setpoint will be reduced to the new value. If the calculated setpoint is greater than the existing value, the setpoint may remain at the lower value, or increased to the new value. 5

_ - -. -- _- -. _ ~. -. ~ l. ODCM Rev. 17 l Page 89 11/95 2.2.5-1 Routine Onerations Hiah Setooint i Determination i For routine operations, the High setpoint for the WRAM Noble Gas total j effluent channel is set at or below the 1 lesser of the NVSPm, OR NVSPmsx value. IVFm] [500] [ECj,] yygp" g [3. 4475E9] E [ ( C,) (Kj) ] 3 [VFa] [3000] [EC,] j gp" [3.447 5E9] E [ (C,) (Lj + 1.11M ) ] 3 j whete: NVSPmwa North Vent Setpoint - Noble Gas Whole = Bod.y (pci/cc) NVSPmsx North. Vent Setpoint - Noble Gas ) = Skin (pCi/cc) VFwm Fractional contribution to site boundary = noble gas dose rate from the North Vent i as calculated in equation 2-7. i (unitless). 500 Total body dose rate limit (mrem /yr) 3000 Skin Dose rate limit (mrem /yr) = EC w Total noble gas activity from North Vent i 1 = grab sample (pci/cc) 3.4475E9 Conversion factor) = (pCi) (cc) 3 (m ) (pCl). 3 =(1.1E-5 sec/m ) (1E6pCi/pCi) (664,000 cfm) (1/60 min /sec) (2.832E4 cc/ft ) (2 -3 ) i 3 where: 2 1.1E-5 sec/m highest annual average X/Q (NE Sector) = i 1E6 pCi/gCi units conversion = 664,000 cfm maximum North Vent flow rate for two = unit operation-- 1/60 min /sec units conversion =

l ODCM Rev. 17 Pcga-90 l-11/95 2.832E4 cc/ft' units conversion = Cuw concentration of noble gas nuclide i as = determined by radioanalysis of North Vent grab sample (pCi/cc) K Total body dose conversion factor for i = noble gas nuclide 1 (mrem /yr per pCi/m', from Table 2-1). L Beta skin dose conversion factor noble i = gas nuclide i (mrem /yr per pCi/m, per 2 Table 2-1). M Gamma air dose conversion factor for i = noble gas nuclide 1 (mrad /yr per pCi/m', per Table 2-1). The setpoint values are converted from pCi/cc to pCi/sec using the maximum two-unit North Vent flow rate: [NVSPm] [3.134E8] (2-14)

NVSPrew,

= i [NVSPmsx] [3.134E8] (2-15) NVSPresx = where: l

NVSPuy, WRAM total effluent channel North Vent

= High Setpoint - Noble Gas Whole Body (pCi/sec). NVSPn:sr WRAM total effluent channel North Vent = High Setpoint - Noble Gas Skin (pCi/sec). -j - --NVsPyg ---------- a---Ncrtif TreHElliph Setpoint - Noble Gas Whole Body (pCi/cc). NVSP,asx North Vent High Setpoint - Noble Gas = Skin (pCi/cc). 3.134E8 Conversion factor (cc/sec). = (664,000 scfm) (1/60 min /sec) = (2.832E4 cc/f t') (2 -16 ) i i

1 l ODCM rov. 17 Page 91 l 11/95y 1 2.2.5-2 Routine Ooerations Hich-Hiah Setooinq l Determination For routine operations, the High-High setpoint for the WRAM Noble Gas total effluent channel is set at or below ten times i the lesser of the routine operations NVSPnwa or NVSPasr value. [NVSPmw,] [10] (2-17)

NVHPan,

= NVHPusx = [NVSPmstl [10] (2-18) where:

NVHPnm, WRAM total effluent channel North Vent

= High-High Setpoint Noble Gas Whole Body (pCi/sec). NVHPnsx WRAM total effluent channel North Vent = High-High Setpoint Noble Gas Skin (ACi/sec). i

NVSPmw, WRAM total effluent channel North Vent

= Setpoint - Noble Gas Whole Body (pCi/sec). NVSPmsx WRAM total effluent channel North Vent = Setpoint - Noble Gas Skin (yCi/sec). ) I 10 nultiplication factor to calculate High j = value (unitless) ) ) 2.3 Gaseous Effluent Dose Evaluation The Annual gaseous effluent dose evaluations are performed using the computer based RM-21A report processor. Instantaneous Offsite Dose Calculations are performed with the MesoRem Jr Common Dose Model computer program. The follcwing sections describe the computational models, assumptions and bases. Emergency dose calculations are performed using the MesoRem Jr Common Dose Model computer program. Monthly dose calculations are performed based on limiting sector average annual meteorological dispersion parameters. For the noble gas monthly dose calculation, effluent release data are based on the latest grab sample analysis for radionuclide composition and the hourly average effluent monitor response for total release activity. I?or the iodine and particulate monthly dose calculations, the effluent release radionuclide ~ composition and release activity are based on the j continuous composite samples for the time period of the dose calculation. The quarterly dose calculations are a summation of the applicable monthly dose results.

l ODCM R v. 17 Pega 92 l 11/95 i The annual dose calculations are based on the actual meteorological conditions concurrent with the effluent releases. Wind direction, temperature lapse rate, ambient temperature,grounglevelwindspeed, and release elevation windspeed are prov:ded for each hour of the year. The meteorological dispersion values (X/0, depleted X/Q, and D/Q) are calculated for each hour and linked with the corresponding release data. The effluent release radionuclide composition and activity are based on the same parameters as the monthly dose analyses. 2.3.1 Site Boundarv, Dose Rate - Noble Gases ODCM I3.3.2.a limits the dose rate at the SITE BOUNDARY due to noble gas releases to s500 mrem /yr total body and s3000 mrem /yr skin. Radiation monitor alarm setpoints are established to ensure that these release limits are not exceeded. i l 2 Simultaneous releases from the North and South Vents are considered in evaluating compliance with the release rate limits of ODCM I3.3.2.a following l any releases exceeding the alarm setpoints. Monitor indications (readings) are averaged over time periods not to exceed 15 minuies when determining noble gas releare rate based on. correlation of the monitor leading and moni4cr sensitivity. The 15-min averaging allows for i reasonable monitor response to potentially changing radioactive material concentrations and to exclude potential electronic spikes in monitor l readings that may be unrelated to radioactive material releases. When identified, electronic spiking monitor responses are being excluded from the dose calculation. + NOTE: For administrative purposes, more conservative alarm setpoints than those ' requirsd to meet 10 CFR 20 Dose Rate limits are imposed. However, conditions exceeding these more limiting alarm setpoints do not necessarily indicate radioactive material i release rates exceeding the dose limits of ODCM I3.3.2.a. Provided actual releases do not result in radiation monitor indications exceeding values based on the dose rate limits of ODCM I3.3.2.a, no further analysis are required for demonstrating compliance with the limits of ODCM I3.3.2.a. t e

-.-.. _~ 1 l t ODCM Rsv. 17-Page 93 f l 11/95 In the event Of a noble gas effluent release exceeding the setpoint value specified in ODCM.II l sections 2.2r.1 or-2.2.2, the; site boundary dose rate from the release is calculated using the methodology stated below. This methodology is based on worst sector (NE) annual average meteorological dispersion but, if further refinement is required to meet the requirements of l ODCM I3.3.2.a, actu,1 meteorological data from the. l time period of concern may be used to calculate actual meteorological dispersion. sm= (53. 882) (X/0) '17(( (F,) (0,) + (Fm) (O sn) + (F SV) (O sn)] KjJ (2-22 f D 3 f a f i ,J=3 i 11 D,g= (53. 8 82) (X/0) f 17 '(SF) E [ (F,) (Oj,) + (F SV) (Oj,y) + (Fan)(Osn)lN (1 11) f f 1 1*3 ? (2-23) I where: ? Total Body ?lume Dose Rate (rem /hr) D,m = i Skin Plume Dose Rate (rem /hr) l Drsx = Units conversion fact >r 53.882 = re:n-m'-pCi-yr-min-cc j 3 3 , pCi-br-mrem-m -sec-f t X/O 1.1E-05 highest annual average relative = concentration (NE Sector) (sec/m ) 3 North Vent Flow Rate (cfm) Fw = ccncentration of noble gas nuclide i during l Qin = . period of release from North Vent (pCi/cc) i (cfm) Unit 1 South Vent Flow Rate F sv = 1 Concentration of noble gas nuclide i during Qitsy = period of release from Unit 1SouthKent (pCi/cc). Unit 2 !iouth Vent Flow Rate (cfm) Fasy = Concent. ration of noble gas nuclide r duripg Qi2sv = period of release from Unit 2 South Vent

i l_ ODCM Rsv. 17 ) 4,, i Page 94 l 11/95 (pCi/cc). Total body dose factor for noble gas nuclide K i i. Values are listed in Table 2-1. 1 I mrem-m' pci-yr, 5 ? i l Skin dose factor for the beta contribution l L i for noble gas nuclide 1. Values are listed i in Table 2-1. 3 mrem-m pCi-yr. the average ratio of tissue to air energy 1.11 = absorption coefficients (mrem / mrad) (Ref: Regulatory Guide 1.109 Section 2.2) 0.7 is the attenuation factor that accounts SF = for the dose reduction due to shielding provided by residential structure (dimensionless) (Ref: Regulatory Guide 1.109 Table E-15). Gamma. ail dose factor for noble gas nuclide M = i i. Values ara listed in Table 2-1. 1 mrad-m pCi-yr + 2.3.2 Site Boundarv Dose Raig Radiciodine and Particulates ODCM I3.3.2.d limits thh dose rate to s1500 mrem /yr to any organ (inhalation pathways only) 'for I-131, I-133, Tritium, and all radionuclides in particulate form with half-lives greater than 8 days An gaseous effluents. Compliance with ODCM I3.3.2.d is determined monthly by performance of ODCM II Section 2.3.4. Simultaneous releases from the North and South Vents are considered in evaluating compliance with the release rate limits of ODCM I3.3.2.b. Release activity is based upon the results of the continuous composite sampler analysis performed in accordance with ODCM Table I3.3-3. r f, i i 1

l ODCM Rcv. 17 Page 95 ] 11/95 This methodology is based on the worst sector (NE) annua.1 average meteorological dispersion but, if further, refinement is required to meet the limits of ODCM I3.3.2.b, actual meteorological data from the time period of concern may be used to calculate actual meteorological dispersion. i 2.3.3 Noble Gas Air Doses ODCM I3.3 3 limits the air dose due to noble gases l released in gaseous effluents (from both reactor units) to areas at or beyond the SITE BOUNDARY to: s 10 mrad gamma for any quarter s 20 mrad beta for any quarter-s 20 mrad gamma during any calendar year s 40 mrad beta duripg any calendar year As required by ODCM 13.3.3.1 Surveillance Requirement, these doses are calculated at least once per 31 days using the results of the most recent grab samples for isotopic composition performed in accordance with ODCM Table 13.3-3 when release point grab samples'do not identify any radionuclides. Total release activity is based upon the hourly average effluent monitor response. As identified, electronic spiking monitor responses are excluded from the release activity analyses. The monthly dose calculation is performed using the most limiting average annual meteorological dispersion values. The quarterly doses are based on the summation of the applicable monthly results. The annual dose calculations are based upon actual release meteorological conditions as described in Section 2.3.5. The monthly dose calculations are performed in accordance with the methodology below. t D, AIR = (0.114 ) (1.11E-5) (47 2) E [ (F,) (Cj,) + (F,) (C32y)+(Fay) ( C,y) ] M3 (2-24) 'i 2 3 i t D, AIR = (0.114 ) (1.11E-5) (47 2) E [ (F,) (C,) + (F13)(C32n)+(Fan) (C12n)] Nj (2-25) 3 1 1 where: Gamma air dose from noble gas releases (rad /hr) D,ua = Beta air dose from noble gas release (rad /hr) Duan = Unit h conversion O.114 = rad-pCi-yr ,pCi-br-mrad, Highest average annual relative concentration 1.1E-5 = (NE Sector) (sec/m') Tinits conversion 472 =

l I i l ODCM R3v. 17 Pnga 96 l 11/95 t l l min /sec .sec-ft', Average North Vent Flow rate for period of Fu = release (cfm) Concentration of noble gas nuclide i from North Can = Vent effluent (pCi/cc) l Average Unit 1 South Vent flow rate for period Fuw = of release (qfm) l Cup Concentration of noble gas nuclide i from = Unit 1 South Vent effluent (pCi/cc) Average Unit 2 South Vent 41ow rate for period F sv l = 2 i of release (cfm) Concentration of noble gas nuclide i from Cusy = Unit 2 South Vent effluent (pCi/cc) 1 Gamma air dose factor for noble gas nuclide i. M = l Values are listed in Table 2-1. mrad-m2 pCi-yr Beta air dose factor for noble gas nuclide i. N = i values are listed in Table 2-1. mrad-m' pCi-yr l l l 2.3.4 Radiciodine and Particulate Dose Calculations i ODCM I3.3.4 limits the dose (from both reactor units) to a MEMBER OF THE PUBLIC from I-131, I-l 133, Tritium, and all radionuclides in particulate 1 l form with half-lives greater than 8 days in gaseous effluents released to areas at or beyond 1 the SITE BOUNDARY to: 1 15 mrem to any organ during any calendar s quarter s 30 mrem to any organ during any calendar j year As required by ODCM I3.3.4.1 Surveillance ^ Requirement, these doses are calculated at least once per 31 days using the results of the continuous composite sample analysis performed in accordance with ODCM Table I3.3-3. Due to the incorporation of the ALARA philosophy in the i l design and operation of the Limerick effluent

l ODCM rov. 17 ) Page 9'{ \\ 11/9!8 systems, these composite samples may nbt identify any radionuclides. Total release actitity is based upon detectable concentration of the continuous composite samples and average appropriate vent flow during the sampling period. The monthly dose calculation is performed using the most limiting average annual meteorological dispersion values. The quarterly doses are based on the summation of the applicable monthly results. The annual dose calculations are based upon actual release meteorology as described in Section 2.3.5. The monthly dose calculations are performed in accordance with the methodology below. Total organ dose is obtained by the summation of the organ dose from each pathway for each receptor. 2.3.4-1 Ground Pathway Daru = (3.6E-6) (47 2) (1. 82E-9 ) E e 35 E [ (F ) (Ojyy) + (F,y) (Oj2,y) + (F2sv) (0 sv) + (Fmy) (Oja,) ] DF,y,t,y (T) (2-26) yy 1 42 y e j, a18 2.3.4-2 Yagg..ation, Meat. Cow Milk, and Goat.- Milk Pathway Dypy = (3. 6 E-6 ) (47 2 ) E '2 E [(Fyy) (O uv) + (F,y) (Ojuy) + (F v) (O lsv) + (Fw) (Ojmy) ] (1.1E-5) DF,g,t,y + f 1 2s f y -I'1 (T ) e ' 35 E (F ) (Ojyy) + (F,y) (Oj2,y) + (F2sv) I.0 sv) + (Fas) (O ms) ) (1. 82E-9 ) DF,r,r,n yy 1 32 l I ,1=18 (2-27)

l ODCM Rev. 17 i Paga 98 l 11/95 2.3.4-3 Inhalation Pathway i d i D, = (3.6E-6) (47 2) E 4 yp e 2 E [ (F,) (0,) + (F,) (On,y) + (Fay) (Oj,,y) + (F,) (Ojm)) (1.1E-5) DF,t,, + 3 1 g (T ) e ,{ [ (F,) (Oj,) + (F,y) (0 sv) + (Fasv) (0 sv) + (Fm) (Osm)] (1. 0E-5) DF,1,s. 1 42 42 r I (2-28) i where: 1 D dose from ground pathway due to release of l = GPAR particulates and iodines (rem). e dose from vegetation, meat, cow milk,' and goat I Dvra = milk,-pathways due to releases of particulates, iodines, and tritium (rem) i dose from inhalation pathway due to release of D pu = z particulates, iodines, and tritium (rem) a units conversion factor j 3.6E-6 = rem-Ci-sec i ~ br-mrem-p Ci, ) units conversion factor 472 = ' fin-cci, sec-ft) highest average annual deposition (ESE Sector) 1.82E-9 = _1, _ a m i E summation for each release time period = t (unitless) Fu =faverageNorthVentflowrateduringrelease (cfm). concentration of nuclide I from North Vent Qn = i effluent (gCi/cc). average Unit 1 South Vent flow rate during F,y = 1

Il t j l ODCM Rev. 17 Page 99 l 11/95 release (cfm). Qun concentration of nuclide i from Unit 1 South = Vent effluent (pCi/cc). Fan average Unit 2 South Vent flow rate during = release (cfm). Qun concentration of nuclide i from Unit 2 South = Vent effluent (pCi/cc). F,. average Hot Maintenance Shop flow rate during = release (cfm). Qums concentration of nuclide i from Hot Maintenance = effluent (pci/cc). dose factor for organ type k, age group 1, DF, x,t,, = i pathway number n; dose factors are based on a computer program which is similar to the NRC program GASPAR results from this program provide input data in the form of a lookup table - values of DFun are provided in Table 2-2. i isotope number (1 through 35) (3 through 17 are = noble gases). ,K organ type (1 through 8, where total body = 1, = GI tract = 2, bone.= 3, liver = 4, kidney = 5, thyroid = 6, lung = 7, skin - 8). L age group (1 through 4, where adult = 1, = teen = 2, child = 3, infant A 4). N pathway number (1 through 7). = time duration of release (hrs). T = e highest average annual X/Q (:NE Sector) (sec/m'). 1.1E-5 = highest averag)e annual depleted X/Q (NE 1.0E-5 = Sector) (sec/m 2.3.5 Annual Dose Evaluation ODCM I3.6 requires an Annual Dose evaluation be performed and reported in accordance with Regulatory Guide 1.21 in the Annual Radioactive Effluent Release Report submitted 60 days after the first of each year. This dose evaluation is' processed by the RM-21A. In the event that this computer model is unavailable, this analysis can be performed using the same methodology. The liquid portion of this annt al dose calculation is described in Section 1.3 of ODCM II. The annual gaseous dose calculation uses the same methodology described in Section 2.3.1, 2.3.3, and 2.3.4 with the exception of meteorology; which is based upon

l ODCM R;v. 17 Pcga 100 l 11/95 actual sector average atmospheric dispersion values using the guidance of Regulatory Guide 1.111 (Section C.lc). Finalized hourly values of wind direction, ground level and release elevation wind speed, ambient temperature, and temperature lapse rate (for P-G stability class) are provided annually using the instrumentation specified in ODCM I3.1-1. These values are calculated for each hour and linked to the corresponding hourly averaged effluent release rate. Doses are then calculated for each hour at the various receptors of interest (depending upon release direction). Radioactiv3 material release rate is calculated as described in Sections 2.3.3 and 2.3.4. Dose at i each receptor is accumulated for the year and the maximum dose for plume, inhalation, and ingestion ) pathways are reported. The gaseous effluent dose j receptors are listed in Table 2-4 and the dose is j calculated using the methodology below. 2.3.5-1 Plume Pathway 17 ) Dptyy4= (3. 6E-6 ) (47 2) E (X/0) E [ (F,y) (Ojyy) + (F,y) (Oj2,y) + (F2sv) (O ssv)3 1 f C C2=3 [e NJ) *) /"t) (DFja)T) (2 -29 ) e 2.3.5-2 Ground Pathway 17 (Fyy) (Ojyy) + (F SV) (Dj2sy) + p,y"= (3. 6E-6) (472) E (X/0) I (DFfu) (T ) 2 e c2 3. (Fasv) (O ssv) + (Fm) (Ojm) - l (2-30) 2.3.5-3 Vecetation. Meat. Cow Milk. Goat Milk Pathway Dvna = (3. 6E-6 ) (47 2) E '2 E[(Fyy) (Ojyy) + (F,y) (Dj2,y) + (F2sv) (0 :sv) + (Fm) (Djm) ) [ (X/De) ) (DF,g, t,y) + 1 j 1 l'1 ( T,) 35 E [(Fyy) (Ojyy) + (F,y) (0 sv) (Fasv) (0 sv) + (Fm) (Dja) ) [D/O] e (DF,g,t,y) 1 12 3 j 1 18 -(2-31) i

m 8 j 4 l l ODCM Rcv. 17 Page 101 l' 11/95 2.3.5-4 Veaetation. Meat. Cow Milk. Goat Milk Pathway Dym = (3.6E-6) (472) E

  • 3 E [ (F,y) (Ojy) + (F1y)(0 n)+(F2y) (0,y) + (Fm) (0

)] [(X/De)] (DF,r,I,n) + 12 3 3 J (T) e ' ss E [(F ) (Ojy) + (Fzy) (Oj2y) + (Fan) (O an) + (Fm) (0 m)] [D/Og] (DFj,,,t,y) p i yy l 3 (2-32) where: D,- annual dose from plume pathway (rem) = Darm annual dose - from ground pathway (rem) = Dv,m annual dose from vegetation, meat, cow milk, = and goat milk pathways (rem) D,m annual dose from inhalation pathway (rem) = 2 \\ 3.6E-6 units conversion factor = rem-Ci-sec hr-mrem-p Ci, \\ l 472 units conversion factor = r ' miri-cc' sec-ft, E summation for each release time period = t (unit less). (X/Q)e relative concentiration for time period "t" = 3 (sec/m ). Fw average North Vent flow rate during release = (cfm). concentration of nuclide i from North Vent Qiw = effluent (pCi/cc). F,y average Unit 1 South Vent flow rate during i = 2 release (cfm). ' concentration of nuclide i from Unit 1 South Qusy = Vent effluent (pCi/cc). Fasv average Unit 2 South Vent flow rate during release (cfm).

l ODCM Rsv. 17 Pcga 102 l 11/95 concpntrationofnuclideifromUnit2 South Qian = Vent effluent (pCi/cc). Ai decay constant of nuclide i (sec'2). = l dr distance to receptor "r". = average windspeed for time period "t" u = e (m/sec). DF, x,t,, dose factor for organ type k, age group 1, = i pathway number n; dose factors are based on results of a computer program that is based on and is similar to the NRC program GASPAR; results from this program provide input data in the form of a lookup table - values of DFn, are provided in Table 2-2. i isotope number (1 through 35) (3 through 17 = are noble gases). l l K organ type (1 through 8, where total ; = l 3, body = 1, GI tract = 2, bone = 3, liver = 4, i kidney = 5, thyroid = 6, lung = 7, skin = l 8). L age group (1 through 4, where adult = r, = l teen = 2, child = 3, infant = 4). N pathway number (1 through 7). = time duration of release (hrs). T = e l F,s average Hot Maintenance Shop flow rate = during release (cfm). 1 Q1ms concentration of nucl)de i from Hot = Maintenance Shop effluent (pci/cc). (D/Q)e deposition concentration for time period "t" = 2 (1/m), (X/Qo,pi) relative depleted concentration for time = 3 period "t" (sec/m ). l 2.4 Gaseous Effluent Dose Proiection l ODCM I3.3.5 requires the VENTILATION EXHAUST TREATMENT SYSTEM be used to reduce radioactive material levels prior to' discharge when pro."ected doses from both units to areas at and beyond the SITI: BOUNDARY would exceed 0.6 mrem to any organ in a 31 day period. i i i l' I l l

l ODCM Rev. 17 Page 103 l V, 11/95 The applicable gaseous processing systems for maintaining radioactive material releases ALARA are the Gaseous Radwaste Treatment System and Exhaust Treatment System in Figures 2-1 and 2-2. A dose projection is performed at least once per 31-days by the following equation: (Dmax/d) Dmaxp 31d (2-33) = = where: Dmaxp maximum organ dose projection for current 31-day = period (mrem) maximum org#etermined by equation Dmax an dose to date for current calendar = quarter as d (2-26) (2-27) or (2-28) (mrem). d number of days remaining in current calendar = quarter. The minimum time elapsed is seven (7) days. the number of days of concein. 31d = 3.0 Special Dose Analysis 3.1 Total Dose to MEMBERS OF THE PUBLIC ODCM I3.3.7 requires that the annual dose or dose commitment to any MEMBER OF THE PUBLIC, due to releases of radioactivity and radiation, from the uranium fuel cycle shall pe limited to: ii mrem whole body or any organ except thyroid ' s 75 mrem thyroid s ODCM 13.3.7.2 Surveillance Requirement requires that cumulative dose contributions from direct radiation from operations be evaluated when the calculated dose from the release of radioactive materials in liquid or gaseous effluents exceed twice the limits'of ODCM I3.2.3.a, 3.2.3.b, 3.3.3.a, 3.3.3.b, 3.3.4.a, or 3.3.4Jo. The direct radiation contribution shall be determined by the methodology described below. This methodology calculatas the direct radiation contribution which then must be added to the dose or dose commitment determined in accordance l with sections ODCM III.3.1, 2.3.3, and 2.3.4 to determine total dose from all pathways. This evaluatien of direct radiation contribution is in accordance with i ANSI /ANS 6.6.1-1979 Section 7. The error using this method is estimated to be approximately 8%. The following evaluation is performed for each receptor of concern. Dm2 =D - Dx ega - D rrrt (3-1) w1 i

l ODCM Rsv. 17 Ptgs 104 l 11/95 where: Don = cumulative dose contribution from direct radiation at receptor 1 (mrem). NOTE: Due to the statistics of radiation measurements and to the conservation of effluent calculations it is plausible the D may yield a negative value. In this on situation the value for Don shall be reported as zero (0). D mo = total dose at receptor of interest (as 7 evaluated by TLD measurement) (mrem). NOTE: If there is not a TLD location at the actual receptor location, a more conservative location will Se used to evaluate Total Dose. Dan = mean of the background dose as evaluate:d by TLDs at background sites (mrem). Dans = ef fluent contribution to dose (as evaluated in sections 2.3.3 and 2.3.4.1). ~ 3.2 Doses Due to Activities Inside the SITE BOUNDARY l In accordance with ODCM I3.6, the Annual Radioactive effluent' Release Report submitted within 60 days after January 1 of each year shall include an assessment of radiation dose from radioactive liquid and gaseous effluents to MEMBERS OF THE PUBLIC due to their activities inside the SITE BOUNDARY. 1 There are three locations within the SITE BOUNDARY that are accessible to MEMBERS OF THE PUBLIC for activities unrelated to the operation of Limerick Station. These locations are:

1) the railroad tracks which run along the river within the SITE BOUNDARY;
2) the Limerick Atomic Information Center, on Longview Road next to the 500kv! substation; and 3) Fricks Lock environmental laboratory, operated by RMC Environmental Services, Inc.

Of these three locations, the railroad tracks are the closest to the plant confines. The highest annual dose for the three locations should be determined by calculating dose at the railroad track location. .e s

l ODCM R:v. 17 Page 105 l 11/95 The following methodology is used to evaluate dose at 4 the railroad tracks, Information Center, and Fricks Lock locations. This dose assessment is based on the results of the annual dose evaluation outlined in ODCM Section 2.3.5. The maximum dose calculated will be reported. Drm = Da* = 0. 25 (3-2) where: Dpsax Dose to MEMBERS OF THE PUBLIC within the SITE = BOUNDARY in Sector"X" (mrem). Dsax Dose'at SITE BOUNDARY in Sector "X" (mrem). = X/0,3x Relative average annual atmospheric dispersion = for year of interest at SITE BOUNDARY in a Sector "X" (sec/m), X/Qu, Relative average annual atmospheric dispersion = for year of interest at railroad, Information Center or Fricks Lock for distances listed below in Sector "X" (sec/m ) 2 Sector Distance to Location (m) Railroad Tracks: S 300 SSW 225 SW 225 WSW 225 W 225 WNW 345 NW 450 Information Center _;. ESE 884 Fricks Lock: WSW 450 maximum occupancy factor for railroad trac [ks, Limerick 0.25 = Atomic Information Center or Fricks Lock Environmental Laboratory (unitless). F

5 l ODCM Rev. 17 Pcga 106 } 11/95 4.0 Ra iolocical Environmental Monitorina Procram 4.1 Samolina Procram s The operational phase of the Radiological Environmental Monitoring Program (REMP) is conduct.ed in accordance with the requirements of ODCM I3.4-3. The objectives of the program are: To provide data on measurable levels of radiation and radioactive materials in the' site environs. To evaluate the relationship between quantities of radioactive materials released from LGS and resultant radiation doses to individuals from principal pathways of exposure. The sampling requirements (type of samples, collection frequency, and analysis) and sample locations are preisented in Appendix B. 4.2 Interlaboratory Comoarison Procram Technical Specification 6.8.4.e.3 requires analyses be performed on radioactive material supplied as part of an Interlaboratory Comparison. Participation in an approved Interlaboratory Comparison Program provides a check on the preciseness of measurements of radioactive material in environmental samples. A summary of the Interlaboratory Comparison Program results is provided in the Annual Radiological Environmental Operating Report pursuant to ODCM I3 5. i i i

9 i TABLES 4 d 4 l 4 2 1 i 4 9 E A i N 9 l I 4 t 4 i 2 w.. 1 1

ODCM Rsv. 17 Paga 107 11/95 t 1 i t l I i i l TABLE 1-1 INGESTION INDIVIDUAL DOSE FACTORS (D.1,3 ) l For-liquid effluents I 1 i i i i 1 - Units For All Ingestion Pathways are: 'f mrem /pCi j l t l l ) i l l I I i l J f I I j i -. I

l ODCM Rav. 17 Page 108 1 11/95 Table 1-1 Licuid Dose Factors From Table E-1~. or Reg.. Guide 1.109 Ingestion Dose Factors For Adult: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H3 0.000E+00 1.050E-07 1.050E-07 1.050E-07'1.050E-07 1.050E-07 1.050E-07 C14 2.840E-06 5.680E-07 5.680E-07 5.680E-07 5.680E-07 5.680E-07 5.680E-07 Nn24 1.700E-06 1.700E-06 1.700E-06 1.700E-06 1.700E-06 1.700E-06 1.700E-06 P32 1.930E-04 1.200E-05 7.460E-06 0.000E+00 0.000E+00 0.000E+00 2.170E-05 Cr51 0.000E+00 0.000E+00 2.660E-09 1.590E-09 5.860E-10 3.530E-09 6.690E-07 Mn54 0.000E+00 4.570E-06 8.720E-07 0.000E+00 1.360E-06 0.000E+00 1.400E-05 Mn56 0.000E+00 1.150E-07 2.040E-08 0.000E+00 1.460E-07 0.000E+00 3.670E-06 Fa55 2.750E-06 1.900E-06 4.430E-07 0.000E+00 0.000E+00 1.060E-06 1.090E-06 Fa59 4.340E-06 1.020E-05 3.910E-06 0.000E+00 0.000E+00 2.850E-06 3.400E-05 CoS8 0.000E+00 7.450E-07 1.670E-06 0.000E+00 0.000E+00 0.000E+00 1.510E-05 Co60 0.000E+00 2.140E-06 4.720E-06 0.000E+00 0.000E+00 0.000E+00 4.020E-05 Ni63 1.300E-04 9.010E-06 4.360E-06 0.000E+00 0.000E+00 0.000E+00 1.880E-06 NiG5 5.280E-07 6.860E-08 3.130E-08 0.000E+00 0.000E+00 0.000E+00 1.740E-06 Cu64 0.000E+00 8.330E-08 3.910E-08 0.000E+00 2.100E-07 0.000E+00 7.100E-06 Zn65 4.840E-06 1.540E-05 6.960E-06 0.000E+00 1.030E-05 0.000E+00 9.700E-06 Zn69 1.030E-08 1.970E-08 1.370E-09 0.000E+00 1.280E-08 0.000E+00 2.960E-09 Br83 0.000E+00 0.000E+00 4.020E-08 0.000E+00 0.000E+00 0.000E+00 5.790E-08 Br84 0.000E+00 0.000E+00 5.210E-08 0.000E+00 0.000E+00 0.000E+00 4.090E-13 Br85 0.000E+00 0.000E+00 2.140E-09 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Rb86 0.000E+00 2.110E-05 9.830E-06 0.000E+00 0.000E+0C 0.000E+00 4.160E-06 Rb88 0.000E+00 6.050E-08 3.210E-08 0.000E+00 0.000E+00 0.000E+00 8.360E-19 Rb89 0.000E+00 4.010E-08 2.820E-08 0.000E+00 0.000E+00 0.000E+00 2.330E-21 Sr89 3.080E-04 0.000E+00 8.840E-06 0.000E+00 0.000E+00 0.000E+00 4.940E-05 Sr90 7.580E-03 0.000E+00 1.860E-03 0.000E+00 0.000E+00 0.000E+00 2.190E-04 Sr91 5.670E-06 0.000E+00 2.290E-07 0.000E+00 0.000E+00 0.000E+00 2.700E-05 Sr92 2.150E-06 0.'000E+00 9.300E-08 0.000E+00 0.000E+00 0.000E+00 4.260E-05 Y90 9.620E-09 0.000E+00 2.580E-30 0.000E+00 0.000E+00 0.000E+00 1.020E-04 Y91m 9.090E-11 0.000E+00 3.520E-12 0.000E+00 0.000E+00 0.000E+00 2.670E-10 Y91 1.410E-07 0.000E+00 3.770E-09 0.000E+00 0.000E+00 0.000E+00 7.670E-05 Y92 8.450E-10 0.000E+00 2.470E-11 0.000E+00 0.000E+00 0.000E+00 1.480E-05 Y93 2.680E-09 0.000E+00 7.400E-11 0.000E+00 0.000E+00 0.000E+00 8.500E-05 Zr95 3.040E-08 9.750E-09 6.600E-09 0.000E+00 1.530E-08 0.000E+00 3.090E-05 Zr97 1.680E-09 3.390E-10 1.550E-10 0.000E+00 5.120E-10 0.000E+00 1.050E-04 Nb95 6.220E-09 3.460E-09 1.860E-09 0.000E+00 3.420E-09 0.000E+00 2.100E-05 Mo99 0.000E-00 4.310E-06 8.200E-07 0.000E+00 9.760E-06 0.000E+00 9.990E-06 Tc99m 2.470E-10 6.980E-10 8.890E-09 0.000E+00 1.060E-08 3.420E-10 4.130E-07 Tc101 2 540E-10 3.660E-10 3.590E-09 0.000E+00 6.590E-06 1.870E-10 1.100E-21 Rul03 1.850E-07 0.000E+00 7.970E-08 0.000E+00 7.060E-07 0.000E+00 2.160E-05 Rul05 1.540E-08 0.000E+00 6.080E-09 0.000E+00 1.990E-07 0.000E+00 9.420E-06 Rul06 2.750E-06 0.000E+00 3.480E-07 0.000E+00 5.310E-06 0.000E+00 1.780E-04 Ag110m 1.600E-07 1.480E-07 8.790E-08 0.000E+00 2.910E-07 0.000E+00 6.040E-05 Te125m 2.860E-06 9.170E-07 3.590E-07 8.060E-07 1.090E-05 0.000E+00 1.070E-05 Tc127m 6.770E-06 2.420E-06 8.250E-07 1.730E-06 2.750E-05 0.000E+00 2.270E-05 Tc127 1.100E-07 3.950E-08 2.380E-08 8.150E-08 4,480E-07 0.000E+00 8.680E-06 Te129m 1.150E-05 4.290E-06 1.820E-06 3.950E-06 4f800E-05 0.000E+00 5.790E-05 Te129 3.140E-08 1.180E-08 7.650E-09 2.410E-08 1.320E-07 0.000E+00 2.370E-08 i

5 ODCM Rev. 17 Prga 109 11/95 Table 1-1 (Continued) Licuid Dose Factors From Table E-11 or Reg. Guide 1.109 Ingestion Dose Factors For Adult: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI Ta131m 1.730E-06 8.460E-07 7.050E-07 1.340E-06 8.570E-06 0.000E400 8.400E-05 Ta131 1.970E-08 8.230E-09 6.220E-09 1.620E-08 8.630E-08 0.000E+00 2.790E-09 Ta132 2.520E-06 1.630E-06 3.530E-06 1.800E-06 1.570E-05 0.000E+00 7.710E-05 I130 7.560E-07 2.230E-06 8.800E-07 1.890E-04 3.480E-06 0.000E+00 1.920E-06 I131 4.160E-06 5.950E-06 3.410E-06 1.950E-03 1.020E-05 0.000Ee00 1.570E-06 I132 2.030E-07 5.430E-07 1.900E-07 1.900E-05 8.650E-07 0.000E+00 1.020E-07 I133 1.420E-06 2.470E-06 7.530E-07 3.630E-04 4.319E-06 0.000E+00 2.220E-06 I134 1.060E-07 2.880E-07 1.030E-07 4.990E-06 4.580E-07 0.000E+00 2.510E-10 I135 4.430E-07 1.160E-06 4.280E-07 7.650E-05 1.860E-06 0.000E+00 1.310E-06 C 134 6.220E-05 1.480E-04 1.210E-04 0.000E+00 4.790E-05 1.590E-05 2.590E-06 Cs136 6.510E-06 2.570E-05 1.850E-05 0.000E+00 1.430E-05 1.960E-06 2.920E-06 Ca137 7.970E-05 1.090E-04 7.140E-05 0.000E+00 3.700E-05 1.230E-05 2.110E-06 CJ138 5.520E-08 1.090E-07 5.400E-08 0.000E+00 8.010E-08 7.910E-08 4.650E-13 Bn139 9.700E-08 6.910E-11 2.840E-09 0.000E+00 6.460E-11 3.920E-11 1.720E-07 Bn140 2.030E-05 2.550E-08 1.330E-06 0.000E+00 8.670E-09 1.460E-08 4.190E-05 Bn141 4.710E-08 3.560E-11 1.590E-09 0.000E+00 3.310E-11 2.020E-11 2.220E-17 Bn142 2.130E-08 2.190E-11 1.340E-09 0.000E+00 1.850E-11 1.240E-11 3.000E-26 La140 2.500E- 09 1.260E-09 3.330E-10 0.000E+00 0.000E+00 0.000E+00 9.250E-05 La142 1.280E-10 5.820E-11 1.450E-11 0.000E+00 0.000E+00 0.000E+00 4.250E-07 C0141 9.360E-09 6.330E-09 7.180E-10 0.000E+00 2.940E-09 0.000E+00 2.420E-05 CS143 1.650E-09 1.220E-06 1.350E-10 0.000E+00 5.370E-10 0.000E+00 4.560E-05 C2144 4.880E-07 2.040E-07 2.620E-08 0.000E+00 1.210E-07 0.000E+00 1.650E-04 Pr143 9.200E-09 3.690E-09 4.560E-10 0.000E+00 2.130E-09 0.000E+00 4.030E-05 Pr144 3.010E-11 1.250E-11 1.530E-12 0.000E+00 7.050E-12 0.000E+00 4.330E-18 Nd147 6.290E-09 7.270E-09 4.350E-10 0.000E+00 4.250E-09 0.000E+00 3.490E-05 W187 1.030E-07 8.610E-08 3.010E-08 0.000E+00 0.000E+00 0.000E+00 2.820E-05 Np239 1.190E-09 1.170E-10 6.450E-11 0.000E+00 3.650E-13 0.000E+00 2.400E-05

ODCM RLv. 17 Page 110 11/95 Table 1-1 (Continued) Licuid Dose Factors 'From Table E-12 or Reg. Guide 1.109 Ingestion Dose Factors For Teen: BONE LIVER T. BODY THYROID F.IDNEY LUNG GI-LLI H3 0.000E+00 1.060E-07 1.060E-07 1.060E-07 1.060E-07 1.060E-07 1.060E-07 C14 4.060E-06 8.120E-07 8.120E-07 8.120E-07 8.120E-07 8.120E-07 8.120E-07 Nn24 2.300E-06 2.300E-06 2.300E-06 2.300E-06 2.300E-06 2.300E-06 2.300E-06 P32 2.760E-04 1.710E-05 1.070E-05 0.000E+00 0.000E+00 0.000E+00 2.320E-05 Cr51 0.000E+00 0.000E+00 3.600E-09 2.000E-09 7.890E-10 5.140E-09 6.050E-07 Mn54 0.000E+00 5.900E-06 1.170E-06 0.000E+00 1.760E-06 0.000E+00 1.210E-05 Mn56 0.000E+00 1.580E-07 2.810E-08 0.000E+00 2.000E-07 0.000E+00 1.040E-05 F055 3.780E-06 2.680E-06 6.250E-07 0.000E+00 0.000E+00 1.700E-06 1.160E-06 i Fa59 5.870E-06 1.370E-05 5.290E-06 0.000E+00 0.000E+00 4.320E-06 3.240E-05 CoS8 0.000E+00 9.720E-07 2.240E-06 0.000E+00 0.000E+00 0.000E+00 1.340E-05 Co60 0.000E+00 2.810E-06 6.330E-06 0.000E+00 0.000E+00 0.000E+00 3.660E-05 Ni63 1.770E-04 1.250E-05 6.000E-06 0.000E+00 0.000E+00 0.000E+00 1.990E-06 Ni65 7.490E-07 9.570E-08 4.360E-08 0.000E+00 0.000E+00 0.000E+00 5.190E-06 Cu64 0.000E+00 1.150E-07 5.410E-08 0.000E+00 2.910E-07 0.000E+00 8.920E-06 Zn65 5.760E-06 2.000E-05 9.330E-06 0.000E+00 1.280E-05 0.000E+00 8.470E-06 Zn69 1.470E-08 2.800E-08 1.960E-09 0.000E+00 1.830E-08 0.000E+00 5.160E-08 Br83 0.000E+00 0.000E+00 5.740E-08 0.000E+00 0.000E+03 0.000E+00 0.000E+00 Br84 0.000E+00 0.000E+00 7.220E-08 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Br85 0.000E+00 0.000E+00 3.050E-09 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Rb86 0.000E+00 2.980E-05 1.400E-05 0.000E+00 0.000E+00 0.000E+00 4.410E-06 Rb88 0.000E+00 8.520E-08 4.540E-08 0.000E+00 0.000E+00 0.000E+00 7.300E-15 Rb89 0.000E+00 5.500E-08 3.890E-08 0.000E+00 0.000E+00 0.000E+00 8.430E-17 Sr89 4.400E-04 0.000E+00 1.260E-05 0.000E+00 0.000E+00 0.000E+00 5.240E-05 Sr90 8.300E-03 0.000E+00 2.050E-03 0.000E+00 0.000E+00 0.000E+00 2.330E-04 Sr91 8.070E-06 0.000E+00 3.210E-07 0.000E+00 0.000E+00 0.000E+00 3.660E-05 Sr92 3.050E-06 0.000E+00 1.300E-07 0.000E+00 0.000E+00 0.000E+00 7.770E-05 Y90 1.370E-08 0.000E+00 3.690E-10 0.000E+00 0.000E+00 0.000E+00 1.130E-04 Y91m 1.290E-10 0.000E+00 4.930E-12 0.000E+00 0.000E+00 0.000E+00 6.090E-09 Y91 2.010E-07 0.003E+00 5.390E-09 0.000E+00 0.000E+00 0.000E+00 8.240E-05 Y92 1.210E-09 0.000E+00 3.500E-11 0.000E+00 0.000E+00 0.000E+00 3.320E-05 Y93 3.830E-09 0.000E+00 1.050E-10 0.000E+00 0.000E+00 0.000E+00 1.170E-04 Zr9.5 4.120E-08 1.300E-08 8.940E-09 0.000E+00 1.910E-08 0.000E+00 3.000E-05 Zr9'. 2.370E-09 4.690E-10 2.160E-10 0.000E+00 7.110E-10 0.000E+00 1.270E-04 Nb95 8.220E-09 4.560E-09 2.510E-09 0.000E+00 4.420E-09 0.000E+00 1.950E-05 Mo99 0.000E+00 6.030E-06 1.150E-06 0.000E+00 1.380E-05 0.000E+00 1.080E-05 Tc99m 3.320E-10 9.260E-10 1.200E-08 0.000E+00 1.380E-08 5.140E-10 6.080E-07 Tc101 3.600E-10 5.120E-10 5.030E-09 0.000E+00 9.260E-09 3.120E-10 8.750E-17 Rul03 2.550E-07 0.000E+00 1.090E-07 0.000E+00 8.990E-07 0.000E+00 2.130E-05 -Rul05 2.180E-08 0.000E+00 8.460E-09 0.000E+00 2.750E-07 0.000E+00 1.760E-05 Rul06 3.920E-06 0.000E+00 4.940E-07 0.000E+00 7.560E-06 0.000E+00 1.880E-04 Ag110m 2.050E-07 1.940E-07 1.180E-07 0.000E+00 3.700E-07 0.000E+00 5.450E-05 To125m 3.830E-06 1.380E-06 5.120E-07 1.070E-06 0.000E+00 0.000E+00 1.130E-05 Te127m 9.670E-06 3.430E-06 1.150E-06 2.300E-06 3.920E-05 0.000E+00 2.410E-05 1 c To127 1.580E-07 5.600E-08 3.400E-08 1.090E-07 6.400E-07 0.000E+00 1.220E-05 { Tol29m 1.630E-05 6.050E-06 2.580E-06 5.260E-06 6.820E-05 0.000E+00 6.120E-05 Tol29 4.480E-08 1.670E-08 1.090E-08 3.200E-08 1.880ELO7 0.000E+00 2.450E-07 To131m 2.440E-06 1.170E-06 9.760E-07 1.760E-06 1.220E-03 0.000E+00 9.390E-05 To131 2.790E-08 1.150E-08 8.720E-09 2.150E-08 1.220E-C, 0.000E+00 2.290E-09 Te132 3.490E-06 2.210E-06 2.080E-06 2.330E-06 2.120E-05 0.000E+00 7.000E-05 I

ODCM R;v. 17 Pags ill 11/95 Table 1-1 (Continued) Licuid Dose Factors From T&hle E-12 or Reg. Guide 1.109 Ingestion Dose Factors For Teen: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI I130 1.030E-06 2.980E-06 1.190E-06 2.430E-04 4.590E-06 0.000E+00 2.290E-06 I131 5.850E-06 8.190E-06 4.400E-06 2.390E-03 1.410E-05 0.000E+00 1.620E-06 I132 2.790E-07 7.300E-07 2.620E-07 2.460E-05 1.150E-06 0.000E+00 3.180E-07 I133 2.010E-06 3.410E-06 1.040E-06 4.760E-04 5.980E-06 0.000E+00 2.580E-06 I134 1.460E-07 3.870E-07 1.390E-07 6.450E-06 6.100E-07 0.000E+00 5.100E-09 I135 6.100E-07 1.570E-06 5.820E-07 1.010E-04 2.480E-06 0.000E+00 1.740E-06 i C3134 8.370E-05 1.970E-04 9.140E-05 0.000E+00 6.260E-05 2.390E-05 2.450E-06 C2136 8.590E-06 3.380E-05 2.270E-05 0.000E+00 1.840E-05 2.900E-06 2.720E-06 Cs137 1.120E-04 1.490E-04 5.190E-05 0.000E+00 5.070E-05 1.970E-05 2.120E-06 Cr138 7.760E-08 1.490E-07 7.450E-08 0.000E+00 1.100E-07 1.280E-08 6.760E-11 Ba139 1.390E-07 9.780E-11 4.050E-09 0.000E+00 9.220E-11 6.740E-11 1.240E-06 Bn140 2.840E-05 3.480E-08 1.830E-06 0.000E+00 1.180E-08 2.340E-08 4.380E-05 Bn141 6.710E-08 5.010E-11 2.240E-09 0.000E+00 4.650E-11 3.430E-11 1.430E-13 Bn142 2.990E-08 2.990E-11 1.840E-09 0.000E+00 2.530E-11 1.990E-11 9.180E-20 La140 3.480E-09 1.710E-09 4.550E-10 0.000E+00 0.000E+00 0.000E+00 9.820E-05 Ln142 1.790E-10 7.950E-11 1.980E-11 0.000E+00 0.000E+00 0.000E+00 2.420E-06 l Cc141 1.330E-08 S.880E 09 1.020E-09 0.000E+00 4.180E-09 0.000E+00 2.540E-05 Ca143 2.350E-09 1.710E-06 1.910E-10 0.000E+00 7.670E-10 0.000E+00 5.140E-05 Cel44 6.960E-07 2.880E-07 3.740E-08 0.000E+00 1.720E-07 0.000E+00 1.750E-04 Pr143 1.310E-08 5.230E-09 6.520E-10 0.000E+00 3.040E-09 0.000E+00 4.310E-05 t Pr144 4.300E-11 1.760E-11 2.180E-12 0.000E+0C 1.010E-11 0.000E+00 4.740E-14 Nd147 9.380E-09 1.020E-08 6.110E-10 0.000E+00 5.990E-09 0.000E+00 3.680E-05 W187 1.460E-07 1.190E-07 4.170E-08 0.000E+00 0.000E+00 0.000E+00 3.220E-05 Np239 1.760E-09 1.660E-10 9.220E-11 0.000E+00 5.210E-10 0.000E+00 2.670E-05 i

~ i ODCM Rnv. 17 Page 112 11/95 Table 1-1 (Continued) Liould Dose Factors From. Table E-13 or Reg. Guide 1.109 Ingestion Dose Factors For Child: 1 BONE LIVER-T. BODY THYROID KIDNEY LUNG GI-LLI l E3 0.000E+00 2.030E-07 2.030E-07 2.030E-07 2.030E-07 2.030E-07 2.030E-07 l C14 1.210E-05 2.420E-06 2.420E-06 2.420E-06 2.420E-06 2.420E-06 2.420E-06 l .N224-5.800E-06 5.800E-06 5.800E-06 5.800E-06 5.000E-06 5.800E-06 5.800E-06 P32 8.250E-04 3.860E-05 3.180E-05 0.000E+00 0.000E+00 0.000E+00 2.280E-05 Cr51 0.000E+00 0.000E+00 8.900E-09 4.940E-09 1.350E-09 9.020E-09 4.720E-07 l 2154 0.000E+00 1.070E-05 2.850E-06 0.000E+00 3.000E-06 0.000E+00 8.980E-06 i Mn56-0.000E+00 3.340E-07 7.540E-08 0.000E+00.4.040E-07 0.000E+00 4.840E-05 F455-1.150E-05 6.100E-06 1.890E-06 0.000E+00 0.000E+00 3.450E-06 1.130E-06 fos 9 1.650E-05 2.670E-05 1.330E-05 0.000E+00 0.000E+00 7.740E-06 2.780E-05 3 CoS8 0.000E+00 1.800E-06 5.510E-06 0.000E+00 0.000E+00 0.000E+00 1.050E-05' 'Co60 0.000E+00 5.290E-06 1.560E-05 0.000E+00 0.000E+00 0.000E+00 2.930E-05' NiG3 5.380E-04 2.880E-05 1.830E-05 0.000E+00 0.000E+00 0.000E+00 1.940E-06 Ni65-2.220E-06 2.090E-07 1.220E-07 0.000E+00 0.000E+00 0.000E+00 2.560E-05 i Cu64 0.000E+00 2.450E-07 1.480E-07 0.000E+00 5.920E-07 0.000E+00 1.150E Zn65 1.370E05 3.650E-05 2.270E-05 0.000E+00 2.300E-05 0.000E+00 6.410E-06 i Zn69 4.380E-08 6.330E-08 5.850E-09 0.000E+00 3.840E-08 0.000E+00 3.990E-06 Br83 0.000E+00 0.000E+00 1.710E-07 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Br84 0.000E+00 0.000E+00 1.980E-07 0.000E400 0.000E+00 0.000E+00 0.000E+00 Br85 0.000E+00 0.000E+00 9.120E-09 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Rb86 0.000E+00 6.700E-05 4.120E-05 0.000E+00 0.000E+00 0.000E+00 4.310E-06 Rb88 0.000E+00 1.900E-07 1.320E-07 0.000E+00 0.000E+00 0.000E+00 9.320E-09 l Rb89 0.000E+00 1.170E-07 1.040E-07 0.000E+00 0.000E+00 0.000E+00 1.020E-09 Sr89 1.320E-03 0.000E+00.3.770E-05 0.000E+00 0.000E+00 0.000E+00 5.110E-05 Sr90 1.700E-02 0.000E+00 4.310E-03 0.000E+00 0.000E+00 0.000E+00 2.290E-04 Sr91 2.400E-05 0.000E+00 9.060E-07 0.000E+00 0.000E+00 0.000E+00 5.300E-05 i Sr92 9.030E-06 0.000E+00 3.620E-07 0.000E+00 0.000E+00 0.000E+00 1.710E-04 l Y90 4.110E-08 0.000E+00 1.100E-09 0.000E+00 0.000E+00 0.000E+00 1.170E-04 Y91m 3.820E-10 0.000E+00 1.390E-11 0.000E+00 0.000E+00 0.000E+00 7.480E-07 [ Y91 6.020E-07 0.000E+00 1.610E-08 0.000E+00 0.000E+00.0.000E+00 8.020E-05 Y92 3.600E-09 0.000E+00 1.030E-10 0.000E+00 0.000E+00 0.000E+00 1.040F-04 Y93 1.140E-08 0.000E+00 3.130E-10 0.000E+00 0.000E+00 0.000E+00 1.700E-04 Zr95

1.160E-07 2.550E-08 2.270E-08 0.000E+00 3.650E-08 0.000E+00 2.660E-05 I

Zr97 6.990E-09 1.010E-09 5.960E-10 0.000E+00 1.450E-09 0.000E+00 1.530E-04 Nb95 2.250E-08 8.760E-09 6.260E-09 0.000E+00 8.230E-09 0.000E+00 1.620E-05 i Mo99 0.000E+00 1.330E-05 3.290E-06 0.000E+00 2.840E-05 0.000E+00 1.100E-05 Tc99m 9.230E-10 1.810E-09 3.000E-08 0.000E+00 2.630E-08 9.190E-10 1.030E ' Tc101 1.07CE-09 1.120E-09 1.420E-08 0.000E+00 1.910E-08 5.920E-10 3.560E-09 Rul03 7.310E-07 0.000E+00 2.810E-07 0.000E+00 1.840E-06 0.000E+00 1.890E-05 i Rul05-6.450E-08 0.000E+00 2.340E-08 0.000E+00 5.670E-07 0.000E+00 4.210E-05 t -Rul06 1.170E-05 0.000E+00 1.460E-06 0.000E+00 1.580E-05 0.000E+00 1.820E-04 Ag110m 5.390E-07 3.640E-07 2.910E-07 0.000E+00 6.780E-07 0.000E+00 4.330E-05 Te125m 1.140E-05 3.090E-06 1.520E-06 3.200E-06 0.000E+00 0.000E+00 1.100E-05 i To127m 2.890E-05 7.780E-06 3.430E-06 6.910E-06 8.240E-05 0.000E+00 2.340E-05 Te127 4.710E-07 1.270E-07 1.010E-07 3.260E-07 1.340E-06 0.000E+00 1.840E-05 { Te129m 4.870E-05 1.360E-05 7.560E-06 1.570E-05 1.430E-04 0.000E+00 5.940E-05 l Te129 1.340E-07 3.740E-08 3.180E-08 9.560E-08 3.920E-07 0.000E+00 8.340E-06 i To131m 7.200E-06 2.490E-06 2.650E-06 5.120E-06 2.410E-05 0.000E+00 1.010E-04 l Tc131 8.300E-08 2.530E-08 2.470E-08 6.350E-08 2.510E-07 0.000E+00 4.360E-07 Te132 1.010E-05 4.470E-06 5.400E-06 6.510E-06 4.150E-05 0.000E+00 4.500E-05 l I

1 ODCM Rev. 17 Pcg2 113 i 11/95 Table 1-1 (Continued) a Licuid Dose Factorg From Table E-13 or Reg. Guide 1.109 Ingestion Dose Factors For Child: ) BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI I130 2.920E-06 5.900E-06 3.040E-06 6.500E-04 8.820E-06 0.000E+00 2.760E-06 I131 1.720E-05 1.730E-05 9.830E-06 5.720E-03 2.840E-05 0.000E+00 1.540E-06 I132 8.000E-07 1.470E-06 6.760E-07 6.820E-05 2.250E-06 0.000E+00 1.730E-06 I133 5.920E-06 7.320E-06 2.770E-06 1.360E-03 1.220E-05 0.000E+00 2.950E-06 I134 4.190E-07 7.780E-07 3.580E-07 1.790E-05 1.190E-06 0.000E+00 5.160E-07 I135 1.750E-06 3.150E-06 1.490E-06 2.790E-04 4.830E-06 0.000E+00 2.400E-06 Cc134 2.340E-04 3.840E-04 8.100E-05 0.000E+00 1.190E-04 4.2702-05 2.070E-06 C 136 2.350E-05 6.460E-05 4.180E-05 0.000E+00 3.440E-05 5.130E-06 2.270E-06 C2137 3.270E-04 3.130E-04 4.620E-05 0.000E+00 1.020E-04 3.670E-05 1.960E-06 C2138 2.280E-07 3.170E-07 2.010E-07 0.000E+00 2.230E-07 2.400E-08 1.460E-07 ) Bn139 4.140E-07 2.210E-10 1.200E-08 0.000E+00 1.930E-10 1.300E-10 2.390E-05 t B2140 8.310E-05 7.280E-08 4.850E-06 0.000E+00 2.370E-08 4.340E-08 4.210E-05 Ba141 2.000E-07 1.120E-10 6.510E-09 0.000E+00 9.690E-11 6.580E-10 1.140E-07 Bn142 8.740E-08 6.290E-11 4.880E-09 0.000E+00 5.090E-11 3.700E-11 1.140E-09 La140 1.010E-08 3.530E-09 1.190E-09 0.000E+00 0.000E+00 0.000E+00 9.840E-05 La142 5.240E-10 1.670E-10 5.230E-11 0.000E+00 0.000E+00 0.000E+00 3.310E-05 Cs141 3.970E-08 1.980E-08 2.940E-09 0.000E+00 8.680E-09 0.000E+00 2.470E-05 Ca143 6.990E-09 3.790E-06 5.490E-10 0.000E+00 1.590E-09 0.000E+00 5.550E-05 C0144 2.080E-06 6.520E-07 1.110E-07 0.000E+00 3.610E-07 0.000E+00 1.700E-04 Pr143 3.930E-08 1.180E-08 1.950E-09 0.000E+00 6.390E-09 0.000E+00 4.240E-05 Pr144 1.290E-10 3.990E-11 6.490E-12 0.000E+00 2.110E-11 0.000E+00 8.590E-08 Nd147 2.790E-08 2.260E-08 1.750E-09 0.000E+00 1.240E-08 0.000E+00 3.580E-05 W187 4.290E-07 2.540E-07 1.140E-07 0.000E+00 0.000E+00 0.000E+00 3.570E-05 Np239 5.250E-09 3.770E-10 2.650E-10 0.000E+00 1.090E-09 0.000E+00 2.790E-05 l j

ODCM RGv. 17 Page 114 11/95 Table 1-1 (Continued) Lia'uid Dose Fa.ntors From Table E-14 or Reg. Guide 1.109 Ingestion Dose Factors For Infant: ) BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H3 0.000E+00 3.080E-07 3.080E-07 3.080E-07 3.080E-07 3.0802-07 3.080E-07 C14 2.370E-05 5.060E-06 5.060E-06 5.060E-06 5.060E-06 5.060E-06 5.060E-06 N224 1.010E-05 1.010E-05 1.010E-05 1.010E-05 1.010E-05 1.010E-05 1.010E-05 P32 1.700E-03 1.000E-04 6.590E-05 0.000E+00 0.000E+00 0.000E+00 2.300E-05 Cr51 0.000E+00 0.000E+00 1.410E-08 9.200E-09 2.010E-09 1.790E-08 4.110E-07 Mn54 0.000E+00 1.990E-05 4.510E-06 0.000E+00 4.410E-06 0.000E+00 7.310E-06 Mn56 0.000E+00 8.180E-07 1.410E-07 0.000E+00 7.030E-07 0.000E+00 7.430E-05 Fa55 1.390E-05 8.980E-06 2.400E-06 0.000E+00 0.000E+00 4.390E-06 1.140E-06 Fs59 3.080E-05 5.380E-05 2.120E-05 0.000E+00 0.000E+00 1.590E-05 2.570E-05 CoS8 0.000E+00 3.600E-06 8.980E-06 0.000E+00 0.000E+00 0.000E+00 8.970E-06 Co60 0.000E+00 1.080E-05 2.550E-05 0.000E+00 0.000E+00 0.000E+00 2.570E-05 Ni63 6.340E-04 3.920E-05 2.200E-05 0.000E+00 0.000E+00 0.000E+00 1.950E-06 Ni65 4.700E-06 5.320E-07 2.420E-07 0.000E+00 0.000E+00 0.000E+00 4.050E-05 CuG4 0.000E+00 6.090E-07 2.820E-07 0.000E+00 1.030E-06 0.000E+00 1.250E-05 Zn65 1.840E-05 6.310E-05 2.910E-05 0.000E+00 3.060E-05 0.000E+00 5.330E-05 i Zn69 9.330E-08 1.680E-07 1.250E-08 0.000E+00 6.980E-08 0.000E+00 1.370E-05 Br83 0.000E+00 0.000E+00 3.630E-07 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Br84 0.000E+00 0.000E+00 3.820E-07 0.000E+00 0.000E+00 0.000E+00 0.000E+0U Br85 0.000E+00 0.000E+00 1.940E-08 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Rb86 0.000E+00 1.700E-04 8.400E-05 0.000E+00 0.000E+00 0.000E+00 4.350E-06 Rb88 0.000E+00 4.980E-07 2.730E-07 0.000E+00 0.000E+00 0.000E+00 4.850E-07 Rb89

0. 00 0E+00 2. 86 0E-07 1. 970E-07 0. 000E+00-O:000E+~00-~ ~0~. 000E+00T74 UE;0 8'~

~~ Sr89 2.510E-03 0.000E+00 7.200E-05 0.000E+00 0.000E+00 0.000E+00 5.160E-05 Sr90 1.850E-02 0.000E+00 4.710E-03 0.000E+00 0.000E+00 0.000E+00 2.310E-04 Sr91 5.000E-05 0.000E+00 1.810E-06 0.000E+00 0.000E+00 0.000E+00 5.920E-05 Sr92 1.920E-05 0.000E+00 7.130E-07 0.000E+00 0.000E+00 0.000E+00 2.070E-04 Y90 8.690E-08 0.000E+00 2.330E-09 0.000E+00 0.000E+00 0.000E+00 1.200E-04 Y913 8.100E-10 0.000E+00 2.760E-11 0.000E+00 0.000E+00 0.000E+00 2.700E-06 Y91 1.130E-06 0.000E+00 3.010E-08 0.000E+00 0.000E+00 0.000E+00 8.100E-05 Y92 7.650E-09 0.000E+00 2.150E-10 0.000E+00 0.000E+00 0.000E+00 1.460E-04 Y93 2.430E-08 0.000E+00 6.620E-10 0.000E+00 0.000E+00 0.000E+00 1.920E-04 Zr95 2.060E-07 5.020E-08 3.560E-08 0.000E+00 5.410E-08 0.000E+00 2.500E-05 Zr97 1.480E-08 2.540E-09 1.160E-09 0.000E+00 2.560E-09 0.000E+00 1.620E-04 Nb95 4.200E-08 1.730E-06 1.000E-08 0.000E+00 1.240E-08 0.000E+00 1.460E-05 Mo99 0.000E+00 3.400E-05 6.630E-06 0.000E+00 5.080E-05 0.000E+00 1.120E-05 Tc99m 1.920E-09 3.960E-09 5.100E-08 0.000E+00 4.260E-08 2.070E-09 1.150E-06 Tc101 2.270E-09 2.860E-09 2.830E-08 0.000E+00 3.400E-08 1.560E-09 4.860E-07 Rul03 1.480E 06 0.000E+00 4.950E-07 0.000E+00 3.080E-06 0.000E+00 1.800E-05 Rul05 1.360E-07 0.000E+00 4.580E-06 0.000E+00 1.000E-06 0.000E+00 5.410E-05 Rul06 2.410E-05 0.000E+00 3.010E-06 0.000E+00 2.850E-05 0.000E+00 1.830E-04 i Ag110m 9.960E-07 7.270E-07 4.810E-07 0.000E+00 1.040E-06 0.000E+00 3.770E-05 Te125m 2.330E-05 7.790E-06 3.150E-06 7.840E-06 0.000E+00 0.000E+00 1.110E-05 Tol27m 5.850E-05 1.940E-05 7.080E-06 1.690E-05 1.440E-04 0.000E+00 2.360E-05 Tc127 1.000E-06 3.350E-07 2.150E-07 8.140E-07 2.440E-06 0.000E+00 2.100E-05 Te129m 1.000E-04 3.430E-05 1.540E-05 3.840E-05 2.500E-04 0.000E+00 5.970E-05 Te129 2.840E-07 9.790E-08 6.630E-08 2.380E-07 7.070E-07 0.000E+00 2.270E-05 Te131m 1.520E-05 6.120E-06 5.050E-06 1.240E-05 4.210E-05 0.000E+00 1.030E-04 Te131 1.760E-07 6.500E-08 4.940E-08 1.570E-07 4.500E-07 0.000E+00 7.110E-06 Te132 2.080E-05 1.030E-05 9.610E-06 1.520E-05 6.440E-05, 0.000E+00 3.810E-05

l ODCM Rav. 17 P:ga 115 l 11/95 Table 1-1 (Continued) i Licuid Dose Factors From Table E-14 or Reg. Guide 1.109 Ingestion Dose Factors For Infant: BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI I130 6.000E-06 1.320E-05 5.300E-06 1.480E-03 1.450E-05 0.000E+00 2.830E-06 l I131 3.590E-05 4.230E-05 1.860E-05 1.390E-02 4.940E-05 0.000E+00 1.510E-06 l I132 1.660E-06 3.370E-06 1.200E-06 1.580E-04 3.760E-06 0.000E+00 2.730E-06 l I133 1.250E-05 1.820E-05 5.330E-06 3.310E-03 2.140E-05 0.000E+00 3.080E-06 I134 8.690E-07 1.780E-06 6.330E-07 4.150E-05 1.990E-06 0.000E+00 1.840E-06 1135 3.640E-06 7.240E-06 2.640E-06 6.490E-04 8.070E-06 0.000E+00 2.620E-06 C3134 3.770E-04 7.030E-04 7.100E-05 0.000E+00 1.810E-04 7.420E-05 1.910E-06 C3136 4.590E-05 1.350E-04 5.040E-05 0.000E+00 5.380E-05 1.100E-05 2.050E-06 C3137 5.220E-04 6.110E-04 4.330E-05 0.000E+00 1.640E-04 6.640E-05 1.910E-06 l C2138 4.810E-07 7.820E-07 3.790E-07 0.000E+00 3.900E-07 6.090E-08 1.250E-06 Ba139 8.810E-07 5.840E-10 2.550E-08 0.000E+00 3.510E-10 3.540E-10 5.580E-05 l B2140 1.710E-04 1.710E-07 8.810E-06 0.000E+00 4.060E-08 1.050E-07 4.200E-05 B 141 4.250E-07 2.910E-10 1.340E-08 0.000E+00 1.750E-10 1.770E-10 5.190E-06 Bn142 1.840E-07 1.530E-10 9.060E-09 0.000E+00 8.810E-11 9.260E-11 7.590E-07 La140 2.110E-08 8.320E-09 2.140E-09 0.000E+00 0.000E+00 0.000E+00 9.770E-05 La142 1.100E-09 4.040E-10 9.670E-11 0.000E400 0.000E+00 0.000E+00 6.860E-05 Ce141 7.870E-08 4.800E-08 5.650E-09 0.000E+00 1.480E-08 0.000E+00 2.480E-05 Ce143 1.480E-08 9.820E-06 1.120E-09 0.000E+00 2.860E-09 0.000E+00 5.730E-05 Cc144 2.980E-06 1.220E-06 1.670E-07 0.000E+00 4.930E-07 0.000E+00 1.710E-04 Pr143 8.130E-08 3.040E-08 4.030E-09 0.000E+00 1.130E-08 0.000E+00 4.290E-05 Pr144 2.740E-10 1.060E-10 1.380E-11 0.000E+00 3.840E-11 0.000E+00 4.930E-06 L.Nd147 -- 5.530E-08 5.680E-08 3.480E-09 0.000E+00 2.190E-08 0.000E+00 3.600E-05 g,ggjg_g gggggj - - OTd6d$id0 "6.~06 ~s+00 3.'690s-05 ~ ~ ~ ~ ~ ~~~ ~ Np239 1.110E-08 9.930E-10 5.610E-10 0.000E+00 1.980E-09 0.000E+00 2.870E-05 i I I

ODCM Rsv. 17 Page 116 11/95 Table 1-2 Assumptions used in Limerick Liquid Effluent Dose Evaluation Ind2X Descrintion Value 1 Fraction of produce from local garden 7.600E-01 2 Fraction of leafy veg from local garden 1.000E+00 3 Soil c..ensity in plow layer (kg/m**2) 2.400E+02 4 Fraction of activity retained on sprayed vegetation 2.500E-01 5 Shielding factor for residential structures 7.000E-01 6 Period of buildup of activity in soil (hr) 1.752E+05 7 Period of pasttre grass exposure to activity (hr) 7.200E+02 8 Period of crop exposure to activity (hr) 1.440E+03 9 Holding time in animal drinking water pond (hr) 0.000E+00 10 Delsy time for ingestion of grass by animals (hr) 0.000E+00 11 Delay time for ingestion of stored fee by animals (hr) 2.160E+03 12 Delay time for ingestion of leaf veg by man (hr) 2.400E+01 13 Delay time for ingestion of other veg by man (hr) 1.440E+03 14 Transport time milk-man (hr) 4.800E+01 15 Time between slaughter and consumption of meat animal (hr) 4.800E+02 16 Grass yield, wet wt (kg/m**2) 7.000E-01 17 Other vegetation yield, wet wt (kg/m**2) 2.000E+00 18 Weathering rate constant for activity on vegetation (1/hr) 2.100E-03 19 Milk cow feed consumption rate (kg/ day wet) 5.000E+01 20 Goat feed consumption rate (kg/ day wet) 6.000E+00 21 Beef Cattle feed consumption rate (kg/ day wet) 5.000E+01 22 Milk cow water consumption rate (1/ day) 6.000E+01 _ 73. Roat water. consumption-rata -(1-/ day) - - T.000Ef00~~ ~ 24 Beef cattle water consumption rate (1/ day) 5.000E+01 25 Envtl transit time for water ingestion (hr) 1.200E+01 26 Envtl transit time for fish ingestion (hr) 2.400E+01 27 Enytl transit time for invertebrate ingestion (hr) l 2.400E+01 28 Enytl transit time for shore exposure (hr) 0.000E+00 29 Water ingestion (1/yr) adult 7.300E+02 30 Water ingestion (1/yr) teen 5.100E+02 31 Water ingestion (1/yr) child 5.100E+02 i 32 Water ingestion (1/yr) infant 3.300E+02 33 Shore e:;posure (hr/yr) adult 1.200E+01 34 Shore exposure (hr/yr) teen 6.700E+01 35 Shore exposure (hr/yr) child

1. 4 0 0E+ 01 36 Shore exposure (hr/yr) infant 0.000E+00 1

37 Fresh water sport fish ingestion (kg/yr) adult 2.100E+01 38 Fresh water sport fish ingestion (kg/yr) teen 1.600E+01 39 Fresh water sport fish ingestion (kg/yr) child 6.900E+00 40 Fresh water sport fish ingestion (kg/yr) infant 0.000E+00 41 Fresh water commercial fish ingestion (kg/yr) adult 2.100E+01 i 42 Fresh water commercial fish ingestion (kg/yr) teen 1.600E401 43 Fresh water commercial fish ingestion (kg/yr) child 6.900E+00 44 Fresh water commercial fish ingestion (kg/yr) infant 0.000E+00 45 Fresh water invertebrate ingestion (kg/yr) adult 5.000E+00 46 Fresh water invertebrate ingestion (kg/yr) teen 3.800E+00 47 Fresh water invertebrate ingestion (kg/yr) child 1.700E+00 48 Fresh water invertebrate ingestion (kg/yr) infant 0.000E+00

m. ODCM Rsv. 17 Page 117 11/95 Table 1-2 Assumptions used in Limerick Liquid Effluent Dose Evaluation Index Descriotion Value 49 Salt Water Sport Fish Ingestion (kg/yr) Adult 2.100E+01 50 Salt Water Sport Fish Incestion (kg/yr) Teen 1.600E+01 51 Salt Water Sport Fish Ingestion (kg/yr) Child 6.900E+00 52 Salt Water Sport Fish Ingestion (kg/yr) Infant 0.000E+00 53 Salt Water Commercial Fish Ingestion (kg/yr) Adult 2.100E+01 54 Salt Water Commercial Fish Ingestion (kg/yr) Teen 1.600E+01 55 Salt Water Commercial Fish Ingestion (kg/yr) Child 6.900E+00 56 Salt Water Commercial Fish Ingestion (kg/yr) Infant 0.000E+00 57 Salt Water Invertebrate Ingestion (kg/yr) Adult 5.000E+00 ) 58 Salt Water Invertebrate Ingestion (kg/yr) Teen 3.800E+00 59 Salt Water Invertebrate Ingestion (kg/yr) Child 1.700E+00 60 Salt Water Invertebrate Ingestion (kg/yr) Infant 0.000E+00 61 Irrigated Leafy Vegetable Ingestion (kg/yr) Adult 6.400E+01 62 Irrigated Leafy Vegetable Ingestion (kg/yr) Teen 4.200E+01 63 Irrigated Leafy Vegetable Ingestion (kg/yr) Child 2.600E+01 64 Irrigated Leafy Vegetable Ingestion (kg/yr) Infant 0.000E+00 65 Irrigated Other Vegetable Ingestion (kg/yr) Adult 5.200E+02 66 Irrigated Other Vegetable Ingestion,(kg/yr) Teen 6.300E+02 l 67 Irrigated Other Vegetable Ingestion (kg/yr) Child 5.200E+02 68 Irrigated Other Vegetable Ingestion (kg/yr) Infant 0.000E+00 69 Irrigated Root Vegetable Ingestion (kg/yr) Adult 5.200E+02 70 Irrigated Root Vegetable Ingestion (kg/yr) Teen 6.300E+02 71 Irrigated'Roo't Vegetable Ingestion (kg/yr) Child 5.200E+02 { 72 Irrigated Root Vegetable Ingestion (kg/yr) Infant. --73' -Irrigated Cow Milk Ingest ~1c n ~(1/yr)~ AdulE ' .0.000E+00 3.100E+02 74 Irrigated Cow Milk Ingestion (1/yr) Teen 4.000E+02 75 Irrigated Cow Milk Ingestion (1/yr) Child 3.300E+02 76 Irrigated Cow Milk Ingestion (1/yr) Infant 3.300E+02 77 Irrigated Goat Milk Ingestion (1/yr) Adult 3.100E+02 78 Irrig&ted Goat Milk Ingestion (1/yr) Teen 4.000E+02 79 Irrigated Goat Milk Ingestion (1/yr) Child 3.300E+02 80 Irrigated Goat Milk Ingestion (1/yr) Infant 3.300E+02 81 Irrigated Beef Ingestion (1/yr) Adult 1.100E+02 82 Irrigated Beef Ingestion (1/yr) Teen 6.500E+01 83 Irrigated Beef Ingestion (1/yr) Child 4.100E+01 84 Irrigated Beef Ingestion (1/yr) Infant 0.000E+00 9

i ODCM Rev. 17 Page 118 11/95 j Table 2-1 Dose Factors for Noble Gas l Total Body Beta Skin Gamma Air Beta Air Dose Factor Dose Factor Dose Factor Dose Factor Ki (mrem /yr Li (mrem /yr Mi (mrad.yr Ni (mrad /yr per per per per 3 3 8 Ind;x Radionuclide pCi/m ) pCi/m ) pCi/m') pCi/m ) 3 Ar-41 8.84E-03 2.69E-03 9.30E-03 3.28E-03 4 Kr-83m 7.56E-08 1.93E-05 2.88E-04 5 Kr-85m 1.17E-03 1.46E-03 1.23E-03 1.97E-03 6 Kr-85 1.61E-05 1.34E-03 1.72C-05 1.953-03 7 Kr-87 5.92E-03 9.73E-03 6.17E-03 1.03E-02 8 Kr-88 1.47E-02 2.37E-03 1.52E-02 2.93E-03 9 Kr-89 1.66E-02 1.01E-02 1.73E-02 1.06E-02 10 Kr-90 1.56E-02 7.29E-03 1.63E-02 7.83E-03 11 Ae-131m 9.15E-05 4.76E-04 1.56E-04 1.11E-03 12 Xe-133m 2.51E-04 9.94E-04 3.27E-04 1.48E-03 13 Xe-133 2.94E-04 3.06E-04 3.53E-04 1.05E-03 14 Xe-135m 3.12E-03 7.11E-04 3.36E-03 7.39E-04 15 Xe-135 1.81E-03 1.86E-03 1.92E-03 2.46E-03 16 Xe-137 1.42E-03 1.22E-02 1.51E-03 1.27E-02 17 Xe-138 8.83E-03 .4.13E-03 9.21E-03 4.75E-03

ODCM Rsv. 17 Paga 119 11/95 I a TABLE 2-2 i INGESTION INDIVIDUAL DOCE FACTORS (DFx,t,,) l For Gaseous Effluents r t UNITS FOR AIRBORNE PATHWAYS (Pathway Numbers 1 and 7) are: 3 mrem-m /Ci-sec UNITS FOR ' DEPO'3ITION PATHWAYS (Pathway Numbers 2-6) are: 2 mrent-m /Ci Pathway No. Pathway 'l Plume 2 Ground 3 Vegetable 4 Meat 5 Cow Milk r 6 Goat Milk 7 Inhalation l

4 ODCM R;v-17 Page 1*O J 11/95 1 Table 2-2 s 4 INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: H3 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID UJNG SKIN Adalt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.90E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground

s. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:

0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.53E+01 6.53E+01 0.00E+00 6.53E+01 6.53E+01 6.53E+01 6.53E+01 0.00E+00 Tcen: 7.75E+01 7.75E+01 0.00E+00 7.75E+01 7.75E+01 7.75E+01 7.75E+01 0.00E+00 Child: 1.21E+02 1.21E+02 0.00E+00 1.21E+02'1.21E+02 1.21E+02 1.21E+02 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.000,+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.98E+00 7.98E+00 0.00E+-00 7.98E+00 7.98E+00 7.98E+00 7.98E+00 0.00E+00 TOsn: 4.75E+00 4.76E+00 0.00E+00 4.76E+00 4.76E+00 4.76E+00 4.76E+00 0.00E+00 Child: 5.75E+00 5.75E+00 0.00E+00 5.75E+00 5.75E+00 5.75E+00 5.75E+00 0.00E+00 InfEnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+0C 0.00E,00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.88E+01 1.88E+01 0.00E+00 1.88E+01 1.88E+01 1.88E+01 1.88E+01 0.00E+00 Toen: 2.45E+01 2.45E+01 0.00E+00 2.45E+01 2.45E+01 2.45E+01 2.45E+01 0.00E+00 Child: 3.87E+01 3.87E+01 0.00E+00 3.87E+01 3.87E+01 3.87E+01 3.87E+01 0.00E+00 Infcnt: 5.87EA01 5.87E+01 0.00E+00 5.37E+01 5.87E+01 5.87E+01 5.87E+01 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.83E+01 3.88E+01 0.00E+00 3.83E+01 3.83E+01 3.83E+01 3.83E+01 0.00E+00 Tacn: 4.99E+01 4.99E+01 0.00E+00 4.99E+01 4.99E+02. 4.99E+01 4.99E+01 0.00E+00 Child: 7.89E+01 7.89E+01 0.00E+00 7.89E+01 7.89E+01 7.89E+01 7.89E+01 0.00E+00 Infcnt: 1.20E+02 1.20E+02 0.00E+00 1.20E+02 1.20E+02 1_20E+02 1.20R+02 0.00E+00 For Pathway! Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:

4. 01E+01 4. 01E+ 01 0. 00E+00 4. 01E+01 4. 01E+01 4. 01E+ 01 4. 01E+01 0. 0 0E+0 0 Tecn.:
4. 03E+01 4. 03E+01 0. 00E+00 4. 03E+01 4. 03E+ 01 4. 03E+01 4. 03E+01 0. 00E+00 Child:

3.57E+01 3.57E+01 0.00E+00 3.57E+01 3.57E+01 3.57E+01 3.57E+01 0.0d,E+00 Infant: 2.05E+01 2.05E+01 0.00E+00 2.05E+01 2.05E+01 2.05E+01 2.05E+01 0.00E+00 r

- ~ _. _ - - ~ ) ODCM Rav. 17 i Prga 121 11/95 i Table 2-2 (Continued) i INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: C14 For Pathway: Plume i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 P.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 -For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E&00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN I Adult: 5.22E+03 5.22E+03 2.61E+04 5.22E+03 5.22E+03 5.22E+03 5.22E+03 0.00E+00 Tacn: 8.79E+03 8.79E+03 4.39E+04 8.79E+03 8.79E+03 8.79E+03 8.79E+03 0.00E+00. Child: 2.14E+04 2.14E+04 1.07E+05 2.14E+04 2.14E+04 2.14E+04 2.14E+04 0.00E+00 i Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For F.hhway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.64E+03 1.64E+03 8.22E+03 1.64E+03 1.64E+03 1.64E+03 1.64E+03 0.00E+00 Tcan: 1.39E+03 1.39E+03 6.94E+03 1.39E+03 1.39E+03 1.39E+03 1.39E+03;0.00E+00 Child: 3.61E+03 2.61E+03 1.31E+04 2.61E+03 2.61E+03 2.61E+03 2.61E+03 0.00E+00 Infent: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY CI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.79E+03 1.79E+03 8.97E+03 1.79E+03 1.79E+03 1.79E+03 1.79E+03 0.00E+00 Tecn: 3.31E+03 3.31E-03 1.65E+04 3.31E+03 3.31E+03 3.31E+03 3.31E+03 0.00E+00 Child: 8.13E+03 8.13E-03 4.07E+04 8.13E+03 3.13E+03 8.13E+03 8.13E+03 0.00E+00 Infant: 1.70E+04 1.70E+04 7.97E+04 1.70E+04 1.70E+04 1.70E+04 1.70E+04 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.79E+03 1.79E+03 8.97E+03 1.79E+03 1.79E+03 1.79E+03 1.79E+03 0.00E+00 Tcon: 3.31E+03 3.31E+03 1.65E+04 3.31E+03 3.31E+03 3.31E+03 3.31E+03 0.00E+00 Child: 8.13E+05 8.13E+03 4.07E+04 8.13E+03 8.13E+03 8.13E+03 8.13E+03 0.00E+00 Infant: 1.70E+04 1.70E+04 7.97E+04 1.70E+04 1.70E+04 1.70E+04 1.70E+04 0.00E+00 t For Pathway: Inhalation b T. BODY GI-TRACT BONE LIVER f.IDNEY THYROID LUNG SKIN Adult: 1.08E+02 1.08E+02 5.76E+02 1.08E+02 1.08E+02 1.08E+02 1.08E+02 0.00E+00 Teen: 1.54E+02 1.54E+02 8.24E+02 1.54E+02 1.54E+02 1.54E+02 1.54E+02 0.00E+00 Child: 2.13E+02 2.13E+02 1.14E+03 2.13E+02 2.13E+02 2.13E+02 2.13E+02 0.00E+00 Infant: 1.68E+02 1.t;8E+02 8.39E+02 1.68E+02 1.68E+02 1.68E+02 1.68E+02 0.00E+00

t i ODCM Rev. 17 Page 122' 11/95 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS VOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Ar41 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i Adult: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 ! Tacn: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 i Child: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 Infant:-1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 ! For Pathway: Ground l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ( Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l InfD.nt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.Orn+00 0.00E+00 0.00E+00 0.00E+00 j t i ! For Pathway: Vegetable l' T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tsan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i

l. Child:

0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE. LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00-0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 InfRnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i For Pathway: Cow Milk THYROID LUNG SKIN l T. BODY GI-TRACT BONE LIVER KIDNEY l Adult:

0. 00E+00 0. 00E+00 0. 00E+00 0.00E- 00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00 l Tecn:

0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00h+00 Infant:.0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tocn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: -0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 . Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i For ' Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

Child

0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i l Infant: 0.00E+00'O.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l l l l i

ODCM R;v. 17 Prga 123 11/95 Table 2-2 (Continued) ( INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Cr51 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0 00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TC:n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 s For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID

LUNG, SKIN Adult:

1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+03 1.43C+05 1.69E+05 TO n: 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.69E+05 Child: 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.69E+05 Inftnt: 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+0E 1.43E+05 1.69E+05 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.06E+03 2.66E+05 0.00E+00 0.00E+00 2.33E+02 6.31E+02 1.40E+03 0.00E+00 Tccn: 1.55E+03 2.61E+05 0.00E+00 0.00E+00 3.40E+02 8.61E+02 2.21E+03 0.00E+00 Child: 3.05E+03 1.62E+05 0.00E+00 0.00E+00 4.63E+02 1.70E+03 3.10E+03 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+0J 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.29E+02 3.23E+04 0.00E+00 0.00E+00 2.83E+01 7.68E+01 1.71E+02 0.00E+00 TC:n: 1.05E+02 1.73E+04 0.00E+00 0.00E+00 2.25E+01 5.71E+01 1.47E+02 0.00E+00 Child: 1.60E+02 8.50E+03 0.00E+00 0.00E+00 2.43E+01 8.90E+01 1.62E+02 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 5.20E+02 1.31E+05 0.00E+00 0.00E+00 1.15E+02 3.11E+02 6.91E+02 0.00E+00 Tcen: 9.09E+02 1.53E+05 0.00E+00 0.00E+00 1.99E+02 5.05E+02 1.30E+03 0.00E+00 Child: 1.85E+03 9.83E+04 0.00E+00 0.00E+00 2.81E+02 1.03E+03 1.88E+03 0.00E+00 Inftnt: 2.94E+03 8.56E+04 0.00E+00 0.00E+00 4.19E+02 1.92E+03 3.73E+03 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.24E+01 1.57E+04 0.00E+00 0.00E+00 1.38E+01 3.73E+01 8.29E+01 0.00E+00 TcCn: 1.09E+02 1.83E+04 0.00E+00 0.00E+00 2.39E+01 6.06E+01 1.56E+02 0.00E+00 l Child: 2.22E+02 1.18E+04 0.00E+00 0.00E+00 3.37E+01 1.23E+02 2.25E+02 0.00E 00 Infant: 3.52E+02 1.03E+04 0.00E+00 0.00E+00 5.02E+01 2.30E+02 4.47E+02 0.00E+00 l For Pathway: Inhalation T. BODY GI-TRACT BCNE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.17E+00 1.05E+02 0.00E+00 0.00E+00 7.23E-01 1.89E+00 4.56E+02 0.00E+00 Tecn: 4.29E+00 9.51E+01 0.00E+00 0.00E+00 9.74E-01 2.38E+00 6.64E+02 0.00E+00 Child: 4.89E400 3.44E+01 0.00E+00 0.00E+00 7.71E-01 2.71E+00 5.38E+02 0.00E+00 Infcnt: 2.84E+00 1.13E+01 0.00E+00 0.00E+00 4.19E-01 1.82E+00 4.07E+02 0.00E+00 l I t f f i

1 ODCM'Rsv. 17 Page 124 11/95 Table 2-2 (Continued) I INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Mn54 I For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 -Child: 0.00E+00 0.00E+00 0.00E+00 0.00Fp00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 r Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E&OO 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: '4.23E+07 4.23E+07 4.23E+07 4'.23E+07 4.23E+07 4.23E+07 4.23E+07 4.96E+07 i Tstn: 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.96E+07 Child: 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.96E+07 Infcnt: 4.23E+07 4.23E+07 4.23E+07 4.23E+01 4.23E+07 4.23E+07 4.23E+07 4.96E+07 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.61E+06 2.58E+07 0.00E+00 8.43E+06 2.51E+06 0.00E+00 0.00E+00 0.00E+00 Tcan: 2.53E+06 2.61E+07 0.00E+00 1.27E+07 3.80E+06 0.00E+00 0.00E+00 0.00E+00. Child: 5.03E+06 1.59E+07 0.00E+C0 1.89E+07 5.30E+06 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Fathway: Meat i T. BODY. GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.21E+04 5'.16E+05 0.00E+00 1.68E+05 5.01E+04 0.00E+00 0.00E+00 0.00E+00 Tcen: 2.55E+04 2.63E+05 0.00E+00 1.28E+05 3.83E+04 0.00E+00 0.00E+00 0.00E+00 Child: 3.91E+04 1.23E+05 0.00E+00 1.47E+05 4.12E+04 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.94E+04 4.73E+05 0.00E+00 1.54E+05 4.59E+04 0.00E+00 0.00E+00 0.00E+00 Tonn: 5.10E+04 5.27E+05 0.00E+00 2.57E+05 7.67E+04 0.00E+00 0.00E+00 0.00E+00 1 Child: 1.02E+05 3.23E+05 0.00E+00 3.85E+05 1.08E+05 0.00E+00 0.00E+00 0.00E+00 Infant: 1.62E+05 2.63E+05 0.00E+00 7.15E+05 1.59E+05 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.53E+03 5.67E+04 0.00E+00 1.85E+04 5.51E+03 0.00E+00 0.00E+00 0.00E+00 Tecn: 6.12E+03 6.33E+04 0.00E+00 3.09E+04 9.20E+03 0.00E+00 0.00E+00 0.00E+00 Child: 1.23E+04 3.87E+04 0.00E+00 4.62E+04 1.29E+04 0.00E+00 0.00E+00 0.00E+00 Infant: 1.95E+04 3.15E+04 0.00E+00 8.58E+04 1.90E+04 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.00E+02 2.45E+03 0.00E+00 1.26E+03 3.12E+02 0.00E+00 4.44E+04 0.00E+00 Teen: 2.66E+02 2.12E+03 0.00E+00 1.62E+03 4.03E+02 0.00E+00 6.29E+04 0.00E+00 Child: 3.01E+02 7.26E+02 0.00E+00 1.36E+03 3.18E+02 0.00E+00 5.00E+04 0.00E+00 Infcnt: 1.58E+02 2.24E+02 0.00E+00 8.03E 02 1.58E+02 0.00E+00 3.17E+04 0.00E+00 t i

t } [ ODCM R3v. 17 ?cga 125 11/95 l r Table 2-2 (Continued) , INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: CoS8 lFor PEthway: Plume i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ! Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ! Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00M+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07

Tacn

1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 Child: 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 l Infant: 1.16E+ 07 1.16E+07 1.16E+ 07 1.16E+ 07 1.16E+ 07 1.16E+ :17 1.16E+ 0 7 1.16E+ 0 7 l For Pathway: Vegetable i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 1.76E+06 1.59E+07 0.00E+00 7.85E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 'Tecn: 2.72E+06.1.63E+07 0.00E+00 1.18E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 = l Child: 5.43E+06 1.04E+07 0.00E+00 1.77E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 'Infent: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN j l Adult: 7.30E+05 6.60E+06 0.00E+00 3.26E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TcOn: 5.79E+05 3.46E+06 0.00E+00 2.51E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 8.98E+05 1.71E+06 0.00E+00 2.93E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ) lInfcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E*00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 'For Pothway: Cow Milk l T. BODY GI-TRACT BONE LIVER KIDNEY YHYROID LUNG SKIN

Adult

1.89E+05 1.71E+06 0.00E+00 8.42E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 lTecn: 3.27E+05 1.95E+06 0.00E+00 1.42E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 6.63E+05 1.26E+06 0.00E+00 2.17E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ! Infant: 1.08E+05 1.08E+06 0.00E+00 4.33E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 2.26E+04 2.05E+05 0.00E+00 1.01E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Toen: -3.92E+04 2.35E+05 0.00E+00 1.70E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 7.96E+04 1.52E+0E 0.00E+00 2.60E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 1.30E+05 1.30E+05 0.00E+00 5.20E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.57E+01 3.37E+03 0.00E+00 5.02E+01 0.00E+00 0.00E+00 2.94E+04 0.00E+00

Tcan

8.80E+01 3.02E?O3 0.00E+00 6.57E+01 0.00E+00 0.00E+00 4.26E+04 0.00E+00 Child: 1.00E+02 1.09E+03 0.00E+00 5.62E+01 0.00E+00 0.00E+00 3.51E+04 0.00E+00 Infant: 5.77E+01 3.53E+02 0.00E+00 3.87E+01 0.00E+00 0.00E+00 2.46E+04 0.00E+00

ODCM R;v. 17' Page 126 11/95 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Fe59 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+0C 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tccn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0 00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.0CE+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 4 Adult: 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 9.80E+06 Tcen: 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 9.80E+06 Child: 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 9.80E+06 .nfcnt: 8.34E+06 8.34E+06 E.34E+06 8.34E+06 8.34Et06 8.34E+06 8.34E+06 9.80E+06 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.80E @6 2.43E+07 3.11E+06 7.30E+06 0.00E+00 0.00E+00 2.04E+06 0.00E+00 Tcen: 4.28E+p6 2.62E+07 4.75E+06 1.11E+07 0.00E+00 0.00E+00 3.50E+06 0.00E+00 Child: 8.69E+06 1.32E+07 1.08E+07 1.76E+07 0.00E+00 0.00E+00 5.06E+06 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 s For Pathway: Meat T. BOD'I GI-TRACT. BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.29E+06 3.73E+07 4.76E+06 1.12E+07 0.00E+00 0.00E+00 3.12E+06 0.00E+00 Tecn: 3.43E+06 2.10E+07 8.87E+06 8.87E+06 0.00E+00 0.00E+00 2.80E+06 0.00E+00 Child: 5.43E406 1.14E+07 6.74E+06 1.09E+07 0.00E+00 0.00E+00 3.16E+06 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E'+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SIIN Adult: 4.79E+6b 4.17E+06 5.32E+05 1.25E+06 0.00E+00 0.00E+00 3.49E+05 0.00E+00 Tsen: 8.37E+05 5.12E+06 9.28E+05 2.17E+06 0.00E+00 0.00E+00 6.83E+05 0.00E+00 Child: 1.74E+06 3.63E+06 2.15E+06 3.48E+C6 0.00E+00 0.00E+00 1.01E+06 0.00E+00 Infcnt: 2.77E+06 3.35E+06 4.02E+06 7.02E+06 0.00E+00 0.00E+00 2.07E+06 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.23E+03 5.42E+04 6.91E+03 1.63E+04 0.00E+00 0.00E+00 4.54E+03 0.00E+00 Tcan: 1.09E+04 6.66E+04 1.21E+04 2.82E+04 0.00E+00 0.00E+00 8.88E+03 0.00E+00 Child: 2.26E+04 4.71E+04 2.80E+04 4.53E+04 0.00E+00 0.00E+00 1.31E+04 0.00E+00 Infant: 3.60E+04 4.36E+04 5.22E+04 9.12E+04 0.00E+00 0.00E+00 2.70E+04 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.35E+02 5.96E+03 3.73E+02 8.80E+02 0.00E+00 0.00E+00 3.22E+04 0.00E+00 Tecn: 4.54E+02 5.66E+03 5.05E+02 1.17E+03 0.00E+00 0.00E+00 4.84E+04 0.00E+00 Child:

5. 29E+02 2.24E+03 6. 56E+02 :1. 06E+03 0. 00E +00 0. 00E+00, 4. 02E+04 0.00E+00.

Infant: 3.00E+02 7.86E+02 4.30E+02 7.46E+02 0.00E+00 0.00E+00 3.22E+04 0.00E+00 0

ODCM'Rsv. 17 I Paga 127 l l 11/95 i Table 2-2 (Continued) -INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOP : Co60 i 'For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Tann: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.003+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 8.34E+08 Tecn: 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 8.34E+08 Child: 7.09D+08 7.09E+08 7.09E+08 7.09E+08 7.09E+09 7.09E+08 7.09E+08 8.34E+08 i Infcnt: 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 8.34E+08 i For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.02E+07 8.68E+07 0.00E+00 4.62E+06 0.00E+00 3 00E+00 0.00E+00 0.00E+00 Tocn: 1.61E+07 9.29E+07 0.00E+00 7.13E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 3.24E+07 6.08E+07 0.00E+00 1.10E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i f' For Pathway: Me at T. BODY GI-TRACT BONE LIVER KIDNEY THYROID L'JNG SKIH 1 Adult: 3.11E+06 2.65E+07 0.00E+00 1.41E+06 0.00E+00 0 00E+00 0.00E+00 0.00E+00 i Tsen: 2.46E+06 1.42E+07 0'.00E+00 1.09E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 3.83E+06 7.19E+06 0.00E+00 1.30E+06 0.00E+00 0.00E+00 0.00E+00'O 00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.78E+05 5.77E+06 0.00E+00 3.07E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tson: 1.17E+06 6.78E+06 0.00E+00 5.21E+05 0.00E+00 0.00F300 0.00E+00 0.00E+00 l Child: 2.38E+06 4.48E+06 0.00E+00 8.09E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 3.90E+06 3.93E+06 0.00E+00 1.65E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 8.13E+04 6.93E+05 0.00E+00 3.69E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Tecn: 1.41E+05 8.14E+05 0.00E+00 6.25E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 2.86E+05 5.37E+05 0.00E+00 9.70E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 Infant: 4.68E+05 4.71E+05 0.00E+00 1.98E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.69E+02 9.03E+03 0.00E+00 3.65E+02 0.00E+00 0.00E+00 1.89E+05 0.00S+00 Tecn: 6.29E+02 8.22E+03 0.00E+00 4.79E+02 0.00E+00 0.00E+00 2.76E+05 0.00E+00 Child: 7.18E+02 3.05E+03 0.00E+00 4.16E+02 0.00E+00 0.00E+00 2.24E+05 0.00E+00 l Infant: 3.73E+02 1.01E+03 0.00E+00 3.54E+02 0.00E+00 0.00E+00 1.43E+05 0.00E+00 l l l

k j ODCM Rnv. 17 Page~128 11/95 Table 2-2 (Continued) INDIVIDUAL DOSF FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Zn65 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRLCT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.63E+07 TcAn: 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.63E+07 Child: 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.63E+07 Inftnt: 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.63E+07 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.58E+07 2.20E+07 1.10E+07 3.50E+07 2.34E+07 0.00E+00 0.00E+00 0.00E+00 Tc;n: 2.43E+07 2.25E+07 1.53E+07 5.32E+07 3.40E+07 0.00E+00 0.00E+00 0.00E+00 Child: 4.93E+07 1.39E+07 2.98E+07 7.93E+07 5.00E+07 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 C.00E+00 0.00E+00 For Pathway: Mest ) T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.08E+07 1.50E+07 7.50E+06 2.39E+07 1.60E+07 0.00E400 0.00E+00 0.00E+00 Tcen: 8.54E+06 7.75E+06 5.27E+06 1.33E+07 1.17E+07 0.00E+00 0.00E+00 0.00E+00 Child: 1.31E+07 3.70E+06 7.91E+06 2.11E+07 1.33E+07 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.15E+07 5.79E+07 2. 89E+07 9.20E+07 6.15E+07 0. 00E+00 0. 00E+00 0. 01)E+00 Tecn: 7.19E+07 6.63E+07 4.44E+07 1.54E+08 9.86E+07 0.00E+00 0.00E+00 0.00E+00 Child: 1.44E+08 4.07E+07 8.71E+07 2.32E+08 1.46E+08 0.00E+00 0.00E+00 0.00E+00 Infcnt: 1.85E+08 3.39E+08 1.17E+08 4.01E+08 1.95E+08 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.99E+06 6.95E+06 3.47E+06 1.10E+07 7.38E+06 0.00E+00 0.00E+00 0.00E+00 Tctn: 8.63E+06 7.83E+06 5.33E+06 1.83E+07 1.18E+07 0.00E+00 0.00E+00 0.00E+00 Child: 1.73E+07 4.89E+06 1.05E+07 2.78E+07 1.75E+07 0.00E+00 0.00E+00 0.00E+00 Infant: 2.22E+07 4.07E+07 1.40E+07 4.810+07 2.33E+07 0.00E+00 0.00E+00 0.00E+00 For Pa.thway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.43E+08 1.69E+03 1.03E+03 3.27E+03 2.19E+03 0.00E+00 0.00E+00 0.00E+00 Tacn: 1.93E+08 1.48E+03 1.22E+03 4.24E+03 2.74E+03 0.00E+00 0.00E+00 0.00E+00 Child: 2.23E+03 5.17E+02 1.35E+03 3.59E+03 2.26E+03 0.00E+00 0.00E+00 0.00E+00 Infant: 9.85E+02 1.63E+03 6.12E+02 1.98E+03 1.03E+03 0.00E+00 0.00E+00 0.00E+00

l ODCM R v. 17 Pcga 129 11/95 Table 2-2 (Continued) l INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Kr83m For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.39E-02 4.75E-01 Torn: 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.39E-02 4.75E-01 i Child: 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.39E-02 4.75E-01 Inftnt: 1.69E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.39E-02 4.75E-01 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tccn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tren: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+D0 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+N0 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Toon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milc l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcen: 0.00E+00 0.00E+00 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 j For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I e

ODCM Rcv. 17 Page 130 11/95 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Kr85 For Pathway: Plume i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3. 5 7E- 01 3. 5 7E- 01 3. 5 7E!- 01 3. 5 7E- 01 3. 57E- 01 3. 5 7E- 01 9. 5 0E- 01 4. 2 9E+ 01 Tacn: 3.57E-01 3.57E-01 3 52E'-01 3.57E-01 3.57E-01 3.57E-01 9.50E-01 4.29E+01 Child: 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.S7E-01 3.57E-01 9.50E-01 4.29E+01 Infent: 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 9.50E-01 4.29E+01 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For PEchway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 T;Cn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 4 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tc n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00F+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway Goat Milk l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 t For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Taea: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00'0.00E+00 0.00E+00 0.00E+00 i

ODCM Rov. 17 P gs 131 11/95 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: KrG5m For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.60E+01 2.60E+01 2:60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.66E+01 Tenn: 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.66E+01 Child:

2. 60E+ 01 2. 60E+01 2. 60E +01 2. 6 0E+ 01 2. 6 0E+01 2. 6 0E+01 2. 6 6E+01 7. 66E+01 Infcnt: 2.60E+01 2.60E&01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.66E+01 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:

0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tc;n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 InfRnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.70E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ) For Pat hway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY iTHYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E400 0.00E+00 0.00E+00 TcEn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KI7NEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.0iE+00 0.0dE+00 0.00E+00 0.00E+00 Tenn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+0V Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I For Pathway: Inhalation i T. BODY GI-TRACT 10NE LIVER KIDNEY THYROID . LUNG SKIN Adult: 0.00E+00 0.00E+00 0 00E+00 0.00E+00 0.00E+00 0.00E+00 J.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

fr ODCM RGv. 17 \\* Page 132 11/95 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUJFfS -- FOR ISOTOPE: Kr8'J. For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.35E+02 4.60E+02 Tcen: 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.35E+02 4.60E+02 Child: 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.35E+02 4.60E+02 Infant: 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.35E+02 4.60E+02 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Tcon: 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E&OO 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E,00 0.00E+00 0.00E+00 0.00E+00 InfEnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00'E+00 0.00E+00 Tccn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E400 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 2 Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tscn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN j Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROIE LUNG SKIN g Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen: 0.00Et00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00EE00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 .f

~. ODCM Rsv, 17 Pcg3 133 11/95 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Kr88 \\ For Pathway: Plume j T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.27E+02 4.50E+02 Tacn: 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.27E+02 4.50E+02 ) Child: 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.27E+02 4.50E+02 T.nfcnt : 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.27E+02 4.50E+02 For Pathway: Ground i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tocn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00.0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN -Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00'O.00E+00 Tsen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.03E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i For Pathway: Cow Milk T.. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.09E+00 0.00E+00 0.00E+00 0.00E+00 j Teen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0300E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult; 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00p;+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00.+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+0C 0.00E+00 0.00E+00

^ i ODCM Rev. 17 Page 134 11/95 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Kr89 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIA Adult: 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.72E+02 7.46E+02 3 Tc;n: 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.72E+02 7.46E+02 l Child: 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.72E+02 7.46E+02 Infcnt: 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68U+02 3.72E+02 7.46E+02 For Pathway: Ground T.EODY G1-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TCOn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0 00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00. 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TCOn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00F+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E.00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt. 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TLACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 2hild: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tsen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i .O

.. - ~ -.. I i l ODCM Rcv. 17 i Paga 135 11/95 Table 2-2 (Continued) l INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Sr89 l For Pathway: Plume f L T,. BODY---GI-TRACT- -BONE -L-IVER KIDNEY THYROID - - LUNG SKIN-~~~~ ! Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toon:. 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 j l For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i -Adult: 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02 Tosn: 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02 L Child: 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02 i Infcnt: 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02 l For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.42E+06 4.14E+07 2.58E+08 0.00E+00 0.30E+00 0.00E+00 0.00E+00 0.00E+00 Tscn: 1.20E+07 5.00E+d7 4.20E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 2.91E+07 3.95B+07 1.02E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult:i 1.68E+05 9.41E+05 5.86E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Toen: : 1.42E+05 5. 90E+05 4. 95E+06 0.00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00 j Childr 2.68E+05 3.63E+05 9.37E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l !, Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E;00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 8.09E+05 4.52E+06 2.82E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 1.49E+06 6.19E+06 5.20E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 3.67E+06 4.98E+06 1.29E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 7.02E+06 5.03E+06 2.45E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.70E+06 9.50E+06 5.92E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 3.13E+06 1.30E+07 1.09E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l l Child: 7.72E+06 1.05E+07 2.70E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 1.47E+07 1.06E407 5.14E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i For Pathway: Inhalation i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i Adult: 2.76E+02 1.11E+04 9.64E+03 0.00E+00 0.00E+00 0.00E+00 4.44E+04 0.00E+00 Toon: 3.96E+02 1.18E+04 1.38E+04 0.00E+00 0.00E+00 0.00E+00 7.66E+04 0.00E+00 Child: 5.47E+02 5.30E+03 1.90E+04 0.00E+00 0.00E+00 0.00E+00 6.84E+04 0.00E+00 Infant: 3.62E+02 2.03E+03 1.26E+04 0.00E+00 0.00E+00 0.00E+00 6.44E+04 0.00E+00 .o

j ODCM Rav. 17 i Page.136 11/95 o Table 2-2 (Continued) i INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Kr90 k ..For Pathway:_ Plume _ / T. BODY GI-TRACT.._ _ _ _ _ l BONE. LIVER KIDNEY THYROID LUNG SKIN Adult: 3.46E+02.3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E+02 6.33E+02 Tcon: 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E/02 6.33E+02 i Child: 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E+02 6.33E+02 Inftnt:-3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E+02 6.33E+02 l 1 For Pathway: Ground j T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN . Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I Taan: -0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 . Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 t

Infant: 0.00E+00 0.00E+00.0.00Et00.0.%00E.+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i

For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E'+00 0.00E+00 0.00E+A0 0.00E+00 i Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For' Pathway: Meat I T. BODY GI-TRACT BONE LIVER KIDNEY THYROID-LUNG SKIN: I Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-( Tcsn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infent:'0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+30 0.00E+00 0.00E+00 0.00E+00 l For Pathway: Cow Milk I T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i 'Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY ' THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ' Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For. Pathway: Inhalation I T. BODY GI-TRACT BONE LIVFR KIDNEY THYROID LUNG SKIN { Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00Ea00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 4 I

ODCM Rcv. 17 Prga 137 11/95 Table 2-2 (Continued) l INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Sr90 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tocn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.COE+00 0.00E+00

TcOn:

0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E400 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pat'h'way: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN I Adult: 1.38E+10 1.63E+09 5.64E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tscn: 1.79E+10 2.04E+09 7.27E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 3.09E+10 1.54E+09 1.22E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.45E+08 5.24E+07 1.81E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 2.90E+08 3.29E+07 1.17E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 3.84E+08 2.04E+07 1.52E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.67E+09 1.97E+08 6.32E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Torn: 2.38E+09 2.70E+08 9.64E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 4.13E+09 2.19E+08 1.63E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 4.51E+09 2.21E+08 1.77E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.51E+09 4.14E+08 1.43E+10 0.002+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen: 5.00E+09 5.68E+08 2.02E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 8.67E+09 4.61E+08 3.42E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 9.47E+09 4.65E.08 3.72E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l.For Pathway: Inhalation l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ! Adult: 1.93E+05 2.28E+04 3.14E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen: 2.12E+05 2.42E+04 3.42E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 2.04E+05 1.09E+04 3.20E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 8.21E+04 4.15E+03 1.30E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l 1

ODCM R2v. 17-Page 138 11/95 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Zr95 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 9,00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Torn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 Infnnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.48Et06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67S+06 Tccn: 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67E+06 Child: 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67E+06 Infcnt: 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67E+06 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.46E+03 3.03E+07 2.98E+04 9.55E+03 1.50E+04 0.00E+00 0.00E+00 0.00E+00' Tctn: 1.01E+04 3.37E+07 4.63E+04 1.46E+04 2.15E+04 0.00E+00 0.00E+00 0.00E+00 Child: 2.07E+04 2.43E+07 1.06E+05 2.33E+04 3.33E+04 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.26E+03 3.40E+07 3.34E+04 1.07E+04 1.68E+04 0.00E+00 0.00E+00 0.00E+00 Tcon: 5.81E+03 1.95E+07 2.68E+04 8.45E+03 1.24E+04 0.00E+00 0.00E+00 0.00E+00 Child: 9.30E+03 1.09E+07 4.75E+04 1.05E+04 1.50E+04 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.65E+00 1.71E+04 1.68E+01 5.40E+00 8.47E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 6.39E+00 2.14E+04 2.94E+01 9.29E+00 1.36E+01 0.00E+00 0.00E+00 0.00E+00 Child: 1.34E+01 1.57E+04 6.84E+01 1.50E+01 2.15E+01 0.00E+00 0.00E+00 0.00E+00 Infcnt: 2.10E+01 1.47E+04 1.21E+02 2.96E+01 3.19E+01 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.39E-01 2.05E+03 2.02E+00 6.48E-01 1.02E+00 0.00E+00 0.00E+00 0.00E+00 TcOn: 7.66E-01 2.57E+03 3.53E+00 1.11E+00 1.64E+00 0.00E+00 0.00E+00 0.00E+00 Child: 1.61E+00 1.88E+03 8.20E+00 1.80E+00 2.58E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 2.52E+00 1.77E+03 1.46Ee01 3.55E+00 3.83E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.38E+02 4.77E+03 3.40E+03 1.09E+03 1.72E+03 0.00E+00 5.60E+04 0.00E+00 Tosn: 9.99E+02 4.72E+03 4.62E+03 1.45E+03 2.14E+03 0.00E+00 8.52E+04 0.00E+00 Child: 1.17E+03 1.94E+03 6.02E+03 1.33E+03 1.892+03 0.00E+00 7.07E+04 0.00E+00 1 Infcnt: 6.44E+02 6.88E+02 3.66E+03 8.83E+02 9.85E+03 0.00E+00 5.55E+04 0.00E+00 i

P ODCM Rsv. 17 Paga 139 l 11/95 i Table 2-2 (Continued) j' INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Sb124 I For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Tcan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l 4 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l ! For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN j Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TcOn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 4 ) Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ' ' Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:

0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

Child

0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 {

Infcnt
0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 j

i j For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

OD2M Rsv. 17 Page 140 11/95 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR C'ASEOUS EFFLUENTS -- FOR ISOTOPE: Illi For Pathway: Plume [ T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Torn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 3.19E+05 Tann: 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 3.19E+05 Child: 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+0h 2.63E+05 3.19E+05 [ Infont: 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 3.19E+05 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adk t: 4.43E+05-2.04E+05 5.41E+05 7.74E+05 1.33E+06 2.54E+08 0.00E+00 0.00E+00 Tecn: 4.02E+05 1.48E+05 5.35E+05 7.48E+05 1.29E+06 2.18E+08 0.00E+00 0.00E+00 Child: 5.83E+05 9.13E+04 1.02E+06 1.03E+06 1.68E+05 3.39Ed08 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 } For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 8.70E+04 4.01E+04 1.06E+05 1.52E+05 2.60E+05 4.98E+07 0.00E+00 0.00E+00 Tosn: 6.64E+04 2.44E+04 8.82E+04 1.24E+05 2.13E+05 3.60E+07 0.00E+00 0.00E+00 Child: 9.35E+04 1.46E+04 1.64E+05 1.65E+05 2.70E+05 5.44E+07 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.39E+06 1.10E+06 2.92E+06 4.17E+06 7.16E+06 1.37E+09 0.00E+00 0.00E+00 Tonn: 3.98E+06 1.47E+06 5.30E+06 7.42E+06 1.28E+07 2.16E+09 0.00E+00 0.00E+00 Child: 7.34E+06 1.15E+06 1.28E+07 1.29E+07 2.12E+07 4.27E+09 0.00E+00 0.00E+00 Infcnt: 1.39E+07 1.13E+0p 2.68E+07 3.16E+07 3.69E+07 1.04E+10 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.87E+06 1.32E+06 3.50E+06 5.01E+06 8.59E+06 1.64E+09 0.00E+00 0.00E+00 .Tocn: 4.78E+06 1.76E+06 6.36E+06 8.90E+06 1.53E+07 2.60E+09 0.00E+00 0.00E+00 Child: 8.81E+06 1.38E+06 1.54E+07 1.55E+07 2.55E+07 5.13E+09 0.00E+00 0.00E+00 Infont: 1.67E+07 1.35E+06 3.22E+07 3.79E+07 4.43E+07 1.25E+10 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.49E+02 1.99E+02 7.99E+02 1.13E+03 1.94E+03 3.78E+05 0.00E+00 0.00E+00 Tecn: 8.37E+02 2.06E+02 1.12E+03 1.56E+03 2.66E+03 4.64E+05 0.00E+00 0.00E+00 Child: 8.64E+02 9.01E+01 1.52E+03 1.52E+03 2.50E+03 5.15E+05 0.00E+00 0.00E+00 Infant: 6.21E+02 3.36E+01 1.20E+03 1.41E+03 1.64E+03 4.70E+04 0.00E+00 0.00E+00

ODCM Rev. 17 Pago 141 l 11/95 I Tald e 2-2 (Continued)- INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xe131m l For Pathway: l Plume l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l l : Adult: 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.38E+00 1.89E+01 l l Tosn: 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.38E+00 1.89E+01 l Child: 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.38E+00 1.89E+01 j l Infcnt: 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.38E+00.1.89E+01 i l For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN - Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Tscn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN I Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tssn: 0.00E+00 0.00E+00 0.003+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I Child: 0.00E+00 0.00E+00-0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 'Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For. Pathway: Meat j T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00F+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 t For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tocn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00t+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i l For Pathway: Goat Milk i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l

l ODCM Rev. 17 Page 142 11/95 i Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: I133 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tc;n: 0.00E+00 D.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04 Torn: 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04 Child: 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04 Infant: 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.07E+03 2.08E+04 1.33E+04 2.32E+04 4.05E+04 3.41E+06 0.00E+00 0.00E+00 Tacn: 6.41E+03 1.59E+04 1.24E+04 2.10E+04 3.69E+04 2.93E+06 0.00E+00 0.00E+00 Child: 1.06E+04 1.13E+04 2.26E+04 2.79E+04 4.65E+04 5.19E+06 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.01E-03 5.93E-03 3.79E-03 6.60E-03 1.15E-02 9.70E-01 0.00E+00 0.00E+00 Tcan: 1.64E-03 4.07E-03 3.17E-03 5.38E-03 9.44E-03 7.52E-01 0.00E+00 0.00E+00 Child: 2.76E-03 2.94E-03 5.90E-03 7.29E-03 1.22E-02 1.35E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT SONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.07E+04 6.12E+04 3.91E+04 6.81E+04 1.19E+05 1.00E+07 0.00E+00 0.00E+00 Tc n: 3.70E+04 9.17E+04 7.15E+04 1.21E+05 2.13E+05 1.69E+07 0.00E+00 0.00E+00 Child: 8.12E+04 8.65E+04 1.7.4E+05 2.15E+05 3.58E+05 3.99E407 0.00E+00 0.00E+00 Infant: 1,56E+05 9.03E+04 3.67E+05 5.34E+05 6.28E+05 9.71E+07 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.49E+04 7.34E+04 4.69E+04 8.17E+04 1.42E+05 1.20E+07 0.00E+00 0.00E+00 Toen: 4.44E+04 1.10E+05 8.57E+04 1.45E+05 2.55E+05 2.03E+07 0.00E+00 0.00E+00 Child: 9.75E+04 1.04E+05 2.08E+05 2.58E+05 4.29E+05 4.79E+07 0.00E+00 0.00E+00 Infant: 1.88E+05 1.08E+05 4.40E+05 6.41E+05 7.53E+05 1.16E+08 0.00E+00 0.00E+00 1 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.43E+02 2.81E+02 2.74E+02 4.69E+02 8.19E+02 6.82E+04 0.00E+00 0.00E+00 Tecn: 1.97E+02 3.27E+02 3.85E+02 6.49E+02 1.14E+03 9.26E+04 0.00E400 0.00E+00 Child: 2.44E+02 1.74E+02 5.25E+02 6.44E+02 1.07E+03 1.22E+05 0.00E+00 0.00E+00 Infcnt: 1.78E+02 6.83E+01 4.20E+02 6.06E+02 7.10E+02 1.13E+05 0.00E+00 0.00E+00

ODCM Rsv. 17 Prga-143 11/95 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xe133 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG. SKIN Adult: 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01 Tacn: 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01 Child: 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01 Infant: 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01 .For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00*+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 G Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ~ Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.~00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG-SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TOOn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tosn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

~ ODCM Rev. 17 Page 144 11/95 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xe133m ) For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG-SKIN Adult: 5.57E+03 5.57E+00 5.57E+00 5.57E+005.57E+00 5.57E+00 6.03E+00 3.96E+01 Toan: 5.57E+00 5.57E+00 5.57E+00 5.57E+005.57E+00 5.57E+00 6.03E+00 3.96E+01 Child: 5.57E+00 5.57E+00 5.57E+00 5.57E+005.57E+00 5.57E+00 6.03E+00 3.96E+01 Infcnt: 5.57E+00 5.57E+00 5.57E+00 5.57E+005.57E+00 5.57E+00 6.03E+00 3.96E+01 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Totn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.0CE+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00'O.00E+00 0.00E+00 0.00E+00 0.00E+00 1 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00'O.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00E+00 For Pathway: Meat 1 T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tesn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00-0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 - i Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 . Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00'O.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcut: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

i. ODCM Rev. 17 Pags 145 11/95 Table 2-2 (Continued) INDIVIDUAL DOSE-FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Cs134 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00-0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.'00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00'0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: dround T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN I Adult: 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.46E+08 Tacn: 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.46E+08. Child: 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.46E+08 Infant: '2.11E+00 2.11E+0 8 2.11E+0 8 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2. 4 6E+0 8 I-ForPathway: Vegetable T. BODY GI-TRACT-BONE LIVER KIDNEY THYROID . LUNG SKIN 6 i' Adult: 2.50E+08 5.34E+06 1.28E+08 3.05E+08 9.88E+07 0.00E+00 3.28E+07 0.00E+00 Tecn: 2.21E+08 5.93E+06 2.03E+08 4.77E+08 1.52E+08 0.00E+00 5.79E+07 0.00E+00 Child: 1.60E+08 4.10E+06 4.63E+08 7.60E+08 2.36E+08 0.00E+00 8.46E+07 0.00E+00 InfEnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.38E+07 5.10E+05.1.22E+07 2.91E+07 9.43E+06 0.00E+00 3.13E+06 0.00E+00 ! Tecn: 1.06E+07 2.35E+05 9.74E+06 2.29E+07 7.28E+06 0.00E+00 2.78E+06 0.00E+00 i Child: 5.94E+06 1.52E+05 1.72E+07 2.82E+07 8.73E+06 0.00E+00 3.13E+06 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 2.05E+08 4.38E+06 1.05E+08 2.50E+08 8.11E+07 0.00E+00 2.69E+07 0.00E+00 l Tecn: 2.00E+08 5.35E+06 1.83E+08 4.30E+08 1.37E+08 0.00E+00 5'.22E+07 0.00E+00 L Child: 1.46E+08 3.73E+06 4.22E+08 6.92E+08 2.14E+08 0.00E+00 7.69E+07 0.00E+00 l Infant: 1.28E+08 3.44E+06 6.79E+08 1.27E+09 3.26E+08 0.00E+00 1.34E+08 0.00E+00 For-Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ! Adult: 6.14E+08 1.32E+07 3.16E+08 7.51E+08 2.43E+08 0.00E+00 8.07E+07 0.00E+00 Teen: 5.99E+08 1.61E+07 5.48E+08 1.29E+09 4.10E+08 0.00E+00 1.57E+08 0.00E+00 Child: 4.38E+08 1.12E+07 1.26E+09 2.08E+09 6.43E+08 0.00E+00 2.31E+08 0.00E+00 Infant: 3.84E+08 1.03E+07 2.04E+09 3.80E+09 9.78E+08 0.00E+00 4.01E+08 0.00E+00 i I For Pathway: Inhalation i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ! Adult: 2.31E+04 3.30E+02 1.18E+04 2.69E+04 9.10E+03 0.00E+00 3.09E+03 0.00E+00 Tecn: 1.74E+04 3.09E+02 1.59E+04 3.58E+04 1.19E+04 0.00E+00 4.64E+03 0.00E+00 ) Child: 7.12E+03 1.22E+02 2.06E+04 3.21E+04 1.05E+04 0.00E+00 3.84E+03 0.00E+00 Infant: 2.36E+03 4.23E+01 1.26E+04 2.23E+04 6.04E+03 0.00E+00 2.53E+03 0.00E+00 I

ODCM Rev. 17 Page 146 11/95 Table 2-2 (Continued) IPDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xe135m For Pathway: Plume X l T.BOEY GI-TRACT BONE LIVER KINNEY THYROID LUNG SKIN Adult: 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.95E+01 1.05E+02 Tecn: 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.95E+01 1.05E+02 Child: 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.95E+01 1.05E+02 Infant: 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.95E+01 1.05E+p2 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 g Child: 0.00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00

  • Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E*00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult:

0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infart: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Fathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROIDS LUNG SKIN Adult: 0.00E+00 0.'00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0. 00E,00 0.00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0.001E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00S-00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 4 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY T~IYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E.+00 0.00E+00 Child:

0. 00E +0 0 0. 0 0E+0 0 0. 00E+0 0 0. 0 0E+0 0 0. 00E+00 0. 0 0E+00 0 ' 002'+ 0 0 0. 0 0E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 7

\\

.... _. - 7 = _. ODCM Rsv. 17 Page'147 ,11/95 Table 2-2 (Continued) INDIVID'UAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xe135 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.0CE+02 TGan: 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 Child: 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 Infant: 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 For Pcthway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0. OE+00 0.00E+00 For Pathyay: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00p+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l I ' Tecn: 0.00:3+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ! Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 t Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Ch41d: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ) For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 -Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0).00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l.TGen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation l ~ 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ! Adult: ! Teen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i i 1

i ODCM Rav. 17 Page 148 11/95 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Cs136 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00B+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tzan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infrnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+06 Tcnn: 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+05 Child: 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+06 InfCnt: 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+06 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG CKIN Adult: 1.99E+05 3.15E+05 7.01E+05 2.77E+06 1.54E+06 0.00E+00 2.11E+05 9.00E+00 TC:n: 2.14E+06 2.57E+05 8.10E+05 3.19E+06 1.74E+06 0.00E+00 2.74E+05 0.00E+00 Child: 2.88E+06 1.57E+05 1.62E+06 4.46E+06 2.37E+06 0.00E+00 3.54E+05 0.00E+00 Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.53E+05 1.03E+05 2.30E+05 9.08E+05 5.05%e05 0.00E+00 6.92E+04 0.00E+00 T cn: 4.74E+05 5.68E+04 1.79E+05 7.05E+05 3.84?&OS 0.00E+00 6.05E+04 0.00E+00 Child: 5.50E+05 2.99E+04 3.'tE+05 8.50E+05 4.53E+05 0.00E+00 6.75E+04 S.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.43E+07 2.26E+06 5.03E+06 1.99E+07 1.10E+07 0.00E+00 1.51E+06 0.00E+00 T n: 2.26E+37 2.71E+06 8.56E+06 3.37E+07 1.83E+07 0.00E+00 2.89E+06 0.00E+00 Child: 3.44E+07 1.87E+06 1.93E+07 5.31E+07 2.83E+07 0.00E+00 4.22E+06 0.00E+00 Infnnt: 4.14E+07 1.69E+06 3.77E+07 1.11E+08 4.42E+07 0.00E+00 9.05E+06 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRAUT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.29E+07 6.77E+06 1.51E+07 5.96E+07 3.31E+07 0.00E+00 4.54E+06 0.00E+00 Tacn: 6.79E+07 8.13E+06 2.57E+07 1.01E+08 5.50E+07 0.00E+00 8.67E+06 0.00E+00 Child: 1.03E+08 5.60E+06 5.80E+07 1.59E+08 8.49E+07 0.00E+00 1.27E+07 0.03E+00 Infant: 1.24E+08 5.06E+06 1.13E+08 3.33E+08 1.33E+08 0.00E+00 2.71E+07 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.50E+03 3.70E+02 1.24E+03 4.64E+03 2.71E+03 0.00E+00 3.80E+02 0.00E+00 Toen: 4.34E+03 3.45E+02 1.63E+03 6.14E+03 3.50E+03 0.00E+00 5.63E+02 0.00E+00 Child: 3.68E+03 1.33E+02 2.06E+03 5.42E+03 3.03E+03 0.00E+00 4.61E+02 0.00E+00 Infcnt: 1.68E+03 4.53E+01 1.53E+06 4.26E+03 1.79E+03 0.00E+00 3.73E+02 0.00E+00

ODCM Rev. 17 Pcga 149 11/95 i Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Cs137 l For Pathway: Plume T. BODY GI-TRACT

BONE, LIVER KIDNEY THYROID LUNG SKIN l

Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infent: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+0S 4.64E+08 i Torn: 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 4.64E+08 l Child: 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 4.64E+08 l Infcnt: 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98Et08 4.04E+08 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.88E+08 5.56E+06 2.10E+08 2.87E+08 9.75E+07 0.00E+00 3.24E+07 0.00E+00 Tsen: 1.61E+08 6.57E+06 3.47E+08 4.62E+08 1.57E+08 0.00E+00 6.11E+07 0.00E+00 ) Child: 1.17E+08 4.97E+06 8.29E+08 7.94E+08 2.59E+08 0.00E+00 9.31E+07 0.00E+00 l Ir4fcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN j Adult: 1.63E+07 4.80E+05 1.81E+07 2.48E+07 8.42E+06 0.00EFOO 2.80E+06 0.00E+00 l Teen: 6.98E+06 2.85E+05 1.51E+07 2.00E+07 6.82E+06 0.00E+00 2.65E+06 0.00E+00 l Child: 3.92E+06 3.66E+05 2.77E+07 2.66E+07 8.65E+06 0.00E+00 3.11E+06 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.38E+08 4.07E+06 1.54E+08 2.10E+08 7.13E+07 0.00E+00 2.37E+07 0.00E+00 Tarn: 1.29E+08 5.27E+06 2.78E+08 3.70E+08 1 36E+08 0.00E+00 4.90E+07 0.00E+00 Child: 9.48E+07 4.02E+06 6.71E+08 6.42E+08 2.09E+08 0.00E+00 7.53E+07 0.00E+00 { Infant: 8.88E+07 3.92E+06 1.07E+09 1.25E+09 3.36E+08 0.00E+00 1.36E+08 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i l Adult: 4.13E+08 1.22E+07 4.61E+08 6.30E+08 2.14E+08 0.00E+00 7.11E+07 0.00E+00 4 l Tsen: 3.87E+08 1.58E+07 8.35E+08 1.11E+09 3.78E+08 0.00E+00 1.47E+08 0.00E+00 ( Child: 2.84E+08 1.21E+07 2.01Ev09 1.93E+09 6.28E+08 0.00E+00 2.26E+08 0.00E+00 Infcnt: 2.66E+08 1.18E+07 3.21E+09 3.76E+09 1.01E+09 0.00E+00 4.09E+08 0.00E+00 l For Pathway: Inhalation l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.36E+04 2.66E+02 1.52E+04 1.97E+04 7.05E+03 0.00E+00 2.38E+03 0.00E+00 Tecn: 9.87E+03 2.69E+02 2.13E+04 2.69E+04 9.64E+03 0.00E+00 3.83E+03 0.00E+00 i Child: 4.07E+03 1.15E+02 2.8?E+04 2.622+04 8.95E+03 0.00E+00 3.30E+03 0.00E+00 Infant: 1.44E+03 4.23E+01 1.74E+04 1.94E+04 5.46E+03 0.00E+00 2.26E+03 0.00E+00 l l

ODCM Rav. 17 Page 150 11/95 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xe137 For Pathway: Plume 'T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ' Adult: 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.54E+01 4.24E+02 TsOn: 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.54E+01 4.24E+02 Child: 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.54E+01 4.24E+02 Infcnt: 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.54E+01 4.24E+02 For Pathway:, Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tctn: 0.00E+00'O.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 t Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk l T. BODY GI-TRACT BONE LIVER FIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tenn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 010DE+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.0CE+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk j T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tc0n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 t Tecn: 'O.00E+00,0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 t / a

. - - = ODCM Rev. 17 Paga 151 l 11/95 i e Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xe138 For Pathway: Plume ' T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02 Tccn: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02 l Child: 1.96E+02 1.96E+02 1.961+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02 l Infant: 1.9pE+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02 l i For Pathway: Ground l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i . Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 s Inftnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i For Pathway: Vegetable l T. BODY GI-TRACT' BONE LIVER KIDNEY' THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l l For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00L+00 0.00E+00 0.00E+00 . Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 'For Pathway: Cow Milk T. BODY GI-TRACi BONE LIVER KIDNEY THYROID LUNG SKIb Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.30E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY. THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen: 0.00E+00 0.00E+00 0.00E+30 0.00E+00 0.00E+00 0.00E+0D 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

ODCM Rcv. 17 Page 152 11/95 [ Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Ba140 I For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tscn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Ch'ild: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 InfEnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ForPabhway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG' SKIN Adult: 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 7.16E+05 Tecn: 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 7.16E+05 Child: 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 5.27E+05 6.27E+05 7.16E+05 Inftnt: 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 7.16E 05 7 ( For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.36E+05 4.29E+06 2.08E+06 2.62E+03 8.89E+02 0.00E+00 1.50E+03 0.00E+00 Tecn: ~1.62E+05 3.88E+06 2.52E+06 3.09E+03 1.05E+03 0.00E+00 2.07E+03 0.00E+00 Child: 3.13E+05 2.72E+06 5.36E+06 4.69E+03 1.53E+03 0.00E+00 2.80E+03 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.61E+04 1.13E+06 5.50E+05 6.91E+02 2.35E+02 0.00E+00 3.96E+02 0.00E+00 Tecn: 2.93E+04 7.02E+05 4.55E+05 5.58E+02 1.89E+02 0.0dE+00 3.75E+02 0.00E+00 l Child: 4.90E+04 4.25E+05 8.4GE+05 7.36E+02 2.40E+02 0.00E+00 4.39E+03 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 3.37E+04 1.06E+06 5.35E+05 6.47E+02 2.20E+02 0.00E+00 3.70E+02 0.00E+00 TeAn: 5.99E+04 1.4?E+06 9.29E+05 1.14E+03 3.86E+02 0.00E+00 7.66E+02 0.00E+00 Chi'ld : 1.31E+05 1.14E+06 2.24E+06 1.97E+03 6.40E+02 0.00E+00 1.17E+03 0.00E+00 inf. int : 2.38E+05 1.13E+06 4.62E+06 4.62E+03 1.10E+03 0.00E+00 2.83E+03 0.00E+00 Far Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Ad alt : 4.05E+03 1.27E+05 6.18E+04 7.76E+01 2.64E+01 0.00E+00 4.44E+01 0.00E+00 Toen: 7.18E+03 1.72E+05 1.12E+05 1.37E+02 4.63E+01 0.00E+00 9.19E+01 0.00E+00 Child: 1.57E+04 1.36E+05 2.69E+02 2.36E+02 7.68E+01 0.00E+00 1.41E+02 0.00E+00 Inlent: 2.85E+04 1.36E+05 5.54E+05 5.54E+02 1.32E+02 0.00E+00 3.40E+0; 0.00E+00 Fo:: Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 8.14E+01 6.92E+03 1.24E+03 1.55E+00 5.30E-01 0.00E+00 4.03E+04 0.00E+00 r Teen: 1.12E+02 7.29E+03 1.73E+0~ 2.13E+00 7.23E-01 0.00E+00 6.44E+04 0.00E+00 1 Child: 1.37E+02 3.23E+03 2.35E+03 2.05E+00 6.70E-01 0.00E+00 5.52E+04 0.00E+00 Infcnt: 9.19E+01 1.22E+03 1.78E+03 1.78E+00 4.26E-01 0.00E+00 5.06E+04 0.00E+00 I t

ODCM Rev. 17 Pegn 153 11/95 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Ce141 L For Pathway: Plume T. BODY GI-TRACTS BONE LIVER KIDNEY THYROID-LUNG SKIN Adult: 0.00E+00 0.00E+0040.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ! -Tccn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+0'O 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05 !.Tcon: 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05 Child: 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05 l Infcnt: 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05 l For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ! Adult: 3.55E+02 1.20E+07 4.63E+03 3.13E+03 1.45E+03 0.00E+00 0.00E+00 0.00E+00 1Totn: 5.57E+02 1.39E+07 7.26E+03 4.85E403 2.28E+03 0.00E+00 0.00E+00 0.00E+00 i ! Child: 1.29E+02 1.08E+07 1.74E+04 8.57E+03 3.80E+03 0.00E+00 0.00E+00 0.00E+00 l Infnnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ) For Pathway: Meat T. BODY GI-TRACT BONE ' LIVER KIDNEY THYROID LUNG SKIN i l Adult: 1.95E+01 6.56E+05 2.54E+02 1.72E+02 7.97E+01 0.00E+00 0.00E+00 0.00E+00 I ' Tren: 1.63E+01 4.07E+05 2.13E+02 1.42E+02 6.70E+01 0.00E+00 0.00E+00 0.00E+00 l Child: 2.97E+01 2.50E+05 4.01E+02 2.00E+02 8.77E+01 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.71E+00 2.26E+05 8.75E+01 5.92E+01 2.75E+01 0.00E+00 0.00E+00 0.00E+00 l Tsen: 1.23E+01 3.06E+05 1.60E+02 1.07E+02 5.04E+01 0.00E+00 0.00E+00 0.00E+00 Child: 2.93E+01 2.46E+05 3.95E+02 1.97E+02 8.64E+01 0.00E+00 0.00E+00 0.00E+00

Infant
5.62E+01 2.47E+05 7.83E+02 4.78E+02 1.47E+01 0.00E+00 0.00E+00 0.00E+00 L For Pathway: Goat Milk j

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 8.06E-01 2.72E+04 1.05E+01 7.10E+00 3.30E+00 0.00E+00 0.00E+00 0.00E+00 Tctn: 1.48E+00 3.68E+04 1.93E+01 1.29E+01 6.05E+00 0.00E+00 0.00E+00 0.00E+00 ' Child: 3.51E+00 2.95E+04 4.74E+01 2.37E+01 1.04E+01 0.00E+00 0.00E+00 0.00E+00 Inftnt: 6.75E+00 2.96E+05 9.40E+01 5.73E+01 1.77E+01 0.00E+00 0.00E+00 0.00E+00 For-Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.84E+01 3.80E+03 6.31E+02 4.29E+0:2 1.99E+02 0.00E+00 2.46E+05 0.00E+00 Teen: 6.87E+01 4.01E+03 9.00E+02 6.01E+02 2.81E+02 0.00E+00 4.24E+05 0.00E+00 Child: '9.13E+01 1.79E+03 1.24E+03 6.19E+02 2.71E+02 0.00E+00 3.79E+05 0.00E+00 Infant: 6.30E+01 6.83E+02 8.79E+02 5.28E+02 1.66E+02 0.00E+00 3.12E+05 0.00E+00 l l

4 ODCM Rev. 17 Page 154 11/95 Table 2-2 (Continued) INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Ce144 For Pathway:. Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.30E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00-0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt.: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.45E+06-lTscn: 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.45E+06 . Child 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.45E+06 Infant: 2.12E+06 2.12E+06 2.12E+06 2.12E+0C 2.12E+06 2.12E+06 2.12E+06.2.45E+06 For Pathway: Vegetable T. BODY GI-TRACT BONE L11ER KIDNEY THYROID LUNG SKIN Adult: 4.63E+04 2.91E+08 8.62E+05 3.60E+05 2.14E+05 0.00E+00 0.00E+00 0.00E+00 'Tasn: 7.73E+04 3.62E+08 1.44E+06 5.95E+05 3.56E+05 0.00E+00 0.00E+00 0.00E+00 Child: 1.87E+05 2.87E+08 3.51E+06 1.10E+06 6.10E+05 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN -Adult: 1.41E+03 8.90E+06 2.63E+04 1.10E+04 6.53E+03 0.00E+00 0.00E+00 0.00E+00. Toen:. *1.19E+03 5.58E+06 2.22E+04 9.18E+03 5.43E+03 0.00E+00 0.00E+00 0.00E+00 Child: 2.23E+03 3.42E+06 4.18E+04 1.31E+04 7.26E+03 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER FIDNEY THYROID LUNG SKIN Adult: 3.47E+02 2.18E+06 6.46E+03 2.70E+03 1.60E+03 0.00E+00 0.00E+00 0.00E+00 Totn: 6.39E+02 2.99E+06 1.19E+04 4.92E+03 2.94E+03 0.00E+00 0.00E+00 0.00E+00 child: 1.56E+03 2.40E+06 2.93E+04 9.19E+03 5.09E+03 0.00E+00 0.00E+00 0.00E+00 Infcnt: 2.35E+03 2.41E+06 4.20E+04 1.72E+04 6.95E+03 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.16E+01 2.62E+05 7.75E+02 3.24E+02 1.92E+02 0.00E+00 0.00E+00 0.00E+00 .Tecn: 7.67E+01 3.59E+05 1.43E+03 5.90E+02 3.53E+02 0.00E+00 0.00E+00 0.00E+00. Child: 1.88E+02 2.88E+05 3.52E+03 1.10E+03 6.11E+02 0.00E+00 0.00E+00 0.00E+00 Infant: 2.82E+02 2.89E+05 5.04E+03 2.06E+03 8.34E+p2 0.00E+00 0.00E+00 0.00E+00 .For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 5.83E+03 2.59E+04 1.09E+05 4.54E+04 2.69E404 0.00E+002i46E+050.00E+00 Tecn: 8.32E+03 2.74E+04 1.55E+05 6.42E+04 3.83E+04 0.00E+00 4/24E+05.0.00E+00 Child: 1.15E+04 1.23E+04 2.15E+05 6.71E+04 3.72E+04 0.00E+00 3.79E+05 0.00E+00 Infant: 5.59E+03.4.70E+03 1.01E+05 3.84E+04 1.70E+04 0.00E+00 3.12E+05 0.00E+00

i ODCM R v. 17 Pnga 155 11/95 TABLE 2-3 Assumptions Used in Limerick Gaseous Effluent Dose Evaluation Index Description value 1 Fraction of produce from local garden 0.76 2 Fraction of leafy vegetable from local garden 1.00 3 Soil density in plow layer (kg/m**2) 240.0 4 Fraction of deposited particulates retained on vegetation 0.20 5 Fraction of deposited iodines retained on vegetation 1.0 6 Shielding factor of residential structures 0.7 7 Period of buildup of activity in soil (hr) 175200.0 8 Period of pasture grass exposure to activity (hr) 720.0 9 Period of crop exposure to activity (hr) 1440.0 10 Transport time milkman (hr) 48.0 11 Delay time for ingestion of grass by animals (hr) 0.0 12 Delay time for ingestion of stored feed by animals (hr) 2160.0 13 Delay time for ingestion of leafy vegetable by man thr) 24.0 14 Delay time for ingestion of other vegetable by man (hr) 1440.0 15 Time between slaughter and consumption of meat animal (hr) 480.0 16 Grass yield, wet wt (kg/m**2) 0.7 17 Other vegetation yield, wet wt (kg/m**2) 2.0 18 Weathering rate constant for activity on veg (1./hr) 0.0021 19 Milk cow feed consumption rate (kg/ day wet) 50.0 20 Beef cattle consumption rate (kg/ day wet) 50.~0 21 Goat feed consumption rate (kg/ day wet) 6.0 22 Plume exposure adult (hr/yr) 8760.0 23 Plume exposure teen (hr/yr) 8760.0 24 Plume exposure child (hr/yr) 8760.0 25 Plutue exposure infant (hr/yr) 8760.0 26 Ground exposure adult (hr/yr) 8760.0 27 Ground exposure teen (hr/yr) 8760.0 28 Ground exposure child (hr/yr) 8760.0 29 Ground exposure infant (hr/yr) 8760.0 30 Inhalation exposure adult (m**3/yr) 8000.0 31 Inhalation exposure teen (m**3/yr) 8000.0 32 Inhalation exposure child (m**3/yr) 3700.0 ) 33 Inhalation exposhre infant (m**3/yr) 1400.0 i 34 Leafy veg exposure adult (kg/yr) 64.0 35 Leafy veg exposure teen (kg/yr) 42.0 30 Leafy veg exposure child (kg/yr) 26.0 37' Leafy veg exposure infant (kg/yr) 0.0 38 Non-leafy veg exposure adult (kg/yr) 520.0 39 Non-leafy veg exposure teen (kg/yr) 630.0 40 Non-leafy veg exposure child (kg/yr) 520.0 j 41 Non-leafy veg exposure infant (kg/yr) 0.0 42 Root veg consumption rate adult (kg/yr) 0.0 43 Root veg consumption rate teen (kg/yr) 0.0 i 44 Root veg consumption rate child (kg/yr) 0.0 s

ODCM Rev. 17 Page 156 11/95 TABLE 2-3 (Continued) Assumptions Used in Limerick Gaseous I Effluent Dose Evaluation -Indsx Description Value 45 Root veg consumption rate infant 1(kg/yr) 0.0 46 Cow milk consumption rate adult (1/yr) 310.0 47 Cow milk consumption rate teen (1/yr) 400.0 48 Cow milk consumption rate child (1/yr) 330.0 49 Cow milk consumption rate infant (1/yr) 330.0 50 Goat milk consumption rate adult (1/yr) 23.0 51 Goat milk consumption rate teen (1/yr) 29.0 52 Goat milk consumption rate child (1/yr) 0.0 53 Goat milk censumption rate infant (1/yr) 0.0 54 Meat consumption rate adult (kg/yr) 110.0 55 Meat consumption rate teen (kg/yr) 65.0 56 Meat consumption rate child (kg/yr) 41.0 l 57 Meat consumption rate infant (kg/yr) 0.0 58 Fraction of year mals on pasture 0.75 'd l59 Fraction of feed frv..z pasture when on pasture 0.39 60 Fraction of year leafy veg grown 0.42. 61 Atmosphere hydrogen concentration (gm/md:* 3 ) 8.0? 4 t i 9 i [ a l ) e \\

ODCM Rev. 17 Pega 157 11/95 TABLE 2-4 Nearest Gaseous Effluent Dose Receptor Distances (Meters) Plume Ground Inhalation Vegetation Meat Cow Goat Direction Pathways Pathway Pathway Pathway Pathway N 965 2574 3414 7562 0 NNE 805 805 4 1585 0 0 NE 1287 2414 1097 0 0 ENE 965 2896 3871 0 0 E 965 1770 1890 0 0 ESE 805 1931 4511 1770 1770 SE 1609 1770 7241 0 0 SSE 1609 1931 7224 7562 0 S 1287 1931 3018 3701 0 SSW 1609 2253 1433 2896 0 SW 965 965 2835 4827 0 WSW 1287 1287 2134 4505 0 W 965 3540 4084 0 0 WNW 1126 1126 0 0 0 NW 2092 2574 6660 0 0 NNW 1448 1931 6325 0 0 i h

ODCM Rnv. 17 Pags 158 11/95 l l t 4 l ) i e i 1 \\ I i 1 APPENDIX A a 1 h ? I a t 4 i

l l: ODCM Rev. 17 Paga 159 11/95 TABLE A-1 Technical Specification /ODCM Matrix ODCM ODCM Technical Section I Equation Soecification* Recuirement Section II i i 3.3.7.11 3.2.1 1-1 i 1-2 1-3 1-4 3.3.7.12 3.3.1 2-1'(or 2-9) 2-2 (or 2-9) 2 (or 2-10) 2-5 (or 2-10) ( 3.11.1.1 3.2.2-1-1 l 1-2 t 1-3 l 1-4 i 3.11.1.2 3.2.3 1-5 1-6 1-7 3.11.1.3 3.2.4 1-8 ( 1-9 3.11.2.1 3.3.2 2-2't 2-23 3.'11.2.3 3.3.4 2-26 2-27 2-28 3.11.-2.2 3.3.3 2-24 2-25 3.11.2.4 3.3.5. 2-33 3.11.2.7 3.3.6 2-4 2-5 b'

  • Transferred to ODCM via T.S.

amendment # 48 for Unit 1 and 11 for Unit 2. ~ f I'

ODCM Rsv. 17 8 Page 160 11/95 TABLE A-1 Technical Specification /ODCM Matrix ODCM ODCM Tcchnical Section I Equation Sp;cification* Requirement Section II 6.9.1.8 3.6 1-5 1-6 1-7 2-24 2-25 2-26 2-27 2-28 3.11.4 3.3.7 3-1 3.12.1 3.4.1 Section II App. B 6.9.1.7 3.5 1-5 3.12.3 3.4.3 1-6 1-7 2-29 !2-30 2-31 2-32 3-2

  • Transferred to ODCM via T.S.

amendment # 48 for Unit 1 and 11 for Unit 2.

.. _ - _. ~., -OD0f4.Rav. 17 I Pzga 161 l e 11/95 i I P s i t i r 'i l i l APPENDIX B i i P RADIOLOGICAL ENVIRONMENTAL MONITORING ~ PROGRAM - SAMPLE. TYPE, LOCATION,- AND ANALYSIS i I ( I k l I r +t I I 1 t ii I I i i t' i i i I i s i p. -. r 7 4

ODCM Rev. 17 Page 162 11/95 TABLE B-1 ODCM - Limerick Generating Station Radiological Environmental Monitoring Program r Pathway Station Code Location Collection Method Analyses I. Direct 36S2 3,183 feet N of site 1 set of four (4) TLDs Gamma dose quarterly Site Boundary 3S1 2,301 feet NNE of site from each location'at SS1 2,350 feet NE of site least quarterly 7S1 3,099 feet ENE of site 10S3 2,648 feet E of site 11S1 2,017 feet ESE of site 13S2 2,149 feet SE of site 14S1 3,319 feet SSE of site 18S2 1,390 feet S of site 21S2 977 feet ~SSW of site 23S2. 2,793 feet SW of site 25S2 2,445 feet WSW of site 26S3 2,088 feet W of site 29S1 2,886 feet WNW of site 31S1 1,395 feet NW of site 34S2 3,071 feet NNW of site Intermediate 36D1 18,527 feet N of site Distance 2E1 25,112 feet NNE of site 4E1 25,221 feet NE of site 7El 22,489 feet ENE of site,. 10E1 20,826 feet E of site 10F3 29,442 feet ESE of site 13E1 22,772 feet.SE of site 16F1 26,608 feet SSE of site 19D1 18,439 feet-S of site i 20F1 27,648 feet SSW of site 24D1 20,972 feet SW of site 25D1 21,044 feet WSW of site i 28D2 20,231 feet W of site 29El 26,110 feet WNW of site 31D2 20,446 feet NW of site

ODCM Rev. 17 Page 163 11/95 TABLE B-1 Page 2 of 4 Pathway Station Code Location Collection Method Analyses 34E1 24,243 feet NNW of site Distant 5H1 C 130,742 feet'NE of site and 6C1 11,305 feet NE of site Special 9C1 11,377 feet E of site Interest 13C1 14,980 feet SE of site 15D1 16,877 feet SE of site 17B1 8,462 feet S of site 20D1 16,157 feet SSW of site 31D1 15,853 feet WNW of site II. Airborne Particulates 10S3 2,648 feet E of site Approximately 1 cfm Gross beta analysis 11S1 2,017 feet ESE of site continuous flow through on each weekly 14S1 3,319 feet SSE of site glass fiber filter sample. Gamma 13C1 14,980 feet SE of site which is collected spectrometry shall be 22G1 C 93,619 feet SW of site weekly. done when gross beta exceeds ten times the yearly mean of control station value. Gross beta analysis done =24 hr after sampling to allow for Radon and Thoron daughter decay. Gamma Spec on quarterly composite.

ODCM Rev. 17 Page 164 11/95 TABLE B-1 Page 3 of 4 Pathway Station Code Location Collection Method Analyses Iodine 10S3 2,648 feet E of site A TEDA impregnated Iodine 131 11S1 2,017 feet ESE of site flow-through cartridge 14S1 3,319 feet SSE of site is connected to air 13C1 14,980 feet SE of site sampler and is 22G1 C 93,619 feet SW of site collected weekly at site filter change. III. Water Surface 24S1 C 1,058 feet SSW of site Sample collected from a Gamma isotopic 13B1 9,225 feet ESE of site continuous' water analysis monthly: sampler, monthly. In event sampler is H-3 on quarterly inoperable, weekly grab composite samples will be collected until sampler returned to service. Sediment 16C4 11,510 feet ESE of site A sediment sample is Gamma isotopic taken down stream of analysis each discharge semi-annually sample IV. Incestion Milk 10B3 5,725 feet ESE of site Sample of fresh milk is Gamma isotopic and 19B1 10,317 feet SSW of site collected from each I-131 analyses on 21B1 9,263 feet SSW of site farm biweekly when cows each sample 22F1 C 50,569 feet SW of site are on pasture (April through October), monthly at other times.

ODCM Rev. 17 Page 165 11/95 TABLE B-1 Page 4 of 4 Pathway Station Code Location Collection Method Analyses Drinking 15F7 33,400 feet SSE of site Sample collected from a Gross beta and gamma 15F4 45,514 feet SE of site continuous water isotopic monthly, 16C2 14,t34 feet SSE of site sampler monthly. In 28F3 C 30,811 feet WNW of site event sampler in H-3 on quarterly inoperable, weekly grab composite samples will be collected until sampler returned to service. Fish 16C5 9,251 feet SSE of site Two species of Gamma isotopic 29C1 C 13,725 feet WNW of site recreationally'* analyses on edible important fish portions. (Predator and bottom feeder) sampled in season or semiannually if not seasonal. Food Two offsite locations of highest Samples of three (3) Gamma isotopic Products predicted annual average ground different kinds of analysis level D/Q and one location (15-broad leaf vegetation 30 km distance) in the least monthly when available prevalent wind direction as if milk samplings is not determined using the results of performed. the most recent annual Landuse Survey. C = Control Location

r-I l ODCM R v. 17 Prga 166 11/95 l l l l P l i I r 1 1 I l ) l i APPENDIX C i i l .1 h' 1 i 4 ( l l } i i a t I

l ODCM Rsv. 17 Pcga 167 11/95 ODCM Revision Process 1 I. REVISION PROCESS l a. The preparer shall ensure the ODCM contains program elements i described in Technical Specifications 6.8.4.d,e and f. b. All pages affected by the change shall contain revision bars in the margin indicating the area of the page changes and 1 the date (month and year) of the change. Revision bars from previous revision;s shall be removed. i c. The preparer of the proposed change shall assemble an ODCM revision package. This package should contain: 1. Proposed page changes. i 2. Sufficient information, appropriate analysis or evaluation to suppport the change. ] 3. A determination that the changes will maintain the level of effluent control required by 10CFR20.1301, 10CFR20.1302, 40 CFR Part.190, 10CFR50.36a and Appendix j I to 20CFR Part 50. l 4. A 10CFR50.59 review prepared in accordance with administrative procedures. 5. Other documentation as required by administrative I procedures. II. REVIEW PROCESS I a. The preparer shall obtain review of the ODCM revision package utilizing the SQR. process in accordance with administrative procedures 8 This review should include: 1. Technical Support Health Physics Supervisor. 2. Cross-disciplinary review (i.e. Chem, R/W, Nuclear Eng. Div. Programs Branch, EP), if required, and 3. Review by the Superintendent - Services Division (responsible Superintendent). b. Upon satisfactory completion of the SQR and responsible Superintendent reviews the preparer shall obtain PORC approval of the ODCM revision package. ] III. APPROVAL a. Upon satisfactory completion of PORC review and appropriate review / approval forms, the revised ODCM shall be forwarded to the Plant Manager for approval signature on the ODCM cover sheet.

ODCM Rev. 17' Page 168 11/95 j IV. ISSUANCE 2. The ODCM shall be issued as a complete document. Issuing f page changes is not permitted. l b. The ODCM shall contain a cover sheet indicating the ODCM revision number and a Table of Contents. All pages of the ODCM shall be marked with the revision number and date. 1 l c. The preparer chall forward the following to the Document Control Center: [ 1. Original ODCM for issuance. [ 2. The ODCM revision package. l 3. 10 CFR50.59 reviews. 4. All appropriate review / approval forms. t V. IMPLEMENTATION j a a. Changes to the ODCM shall become effective upon approval of the Plant Manager. i b. The Effluent Physicist shall ensure that a copy of the l complete ODCM is submitted to the NRC with the Annual Radioactive Release Report for the period of the report in which the change to the ODCM was made. j i i ~ f

-r 1

i l i i i i { l l l I

p. ODCM RI;v.17 Pcg3 169 11/95 l. l 1 1 J l FIGURES l i l i I i I 1 l l l l t 1 1 i 1 i

.n LGS DILUTION vs RIVER FLOW STATION (OUTFALL) i 1l+03 l l D i L U I 1[+02 0 ,i ' N ,/ / r F f A A C 1[+01 f AJ T O / R L tr 1[+01 1[+02 1[.og $[.o4 FLOW AT POTTSTOWN (CFS) ~ Figure 1.3.1-1 I ODCM, Rev. 17 Page 170 i l 11/95

i. LGS DILUTION vs RIVER FLOW STATION (CITIZEN'S UTILITY) 1(+04 D I e a i h 1(+03 T. / l r O . a \\ N / 1[+02 F / A / l 0 / 0 11+01 R 1[+01 1l+02 1l+03 1[+04 FLOW AT POTTSTOWN (CFS) Figure.1.3.1-2 l ODCM, Rev. 17 Page 171 l 11/95

i LGS DILUTION vs RIVER FLOW STATION (PHOENIXVILLE) I 1[+03 i D i l L U / 1 I 1[+02 l 1 O / N J } f ? F e i A / C 1[+01 e T O i r R I f l 11+00 l 1l*01 1(+02 1[+03 1[+04 i i FLOW AT POTTSTOWN (CFS) I Figure 1.3.1-3 7 I l l ODCM, Rev. 17 Page 172 l 11/95 l. I I

t LGS DILUTION vs RIVER FLOW STATION (PHILA. SUBURBAN) ^ 11+03 I D 1 L U 3 j T 1[+02 / i rV O N / F i/ A / C 11+01 f T O l R lf 11+00 1[+01 1[+02 1[+05 1[+04 FLOW AT POTTSTOWN (CFS) Figure 1.3.1-4 S l ODCM, Rev. 17 Page 173 l 11/95

c i LGS DILUTION vs RIVER FLOW STATION (CREW COURSE) 1 'l f 1[+03 \\, D ,l ' g / t L U / ' [' T 1g.02 / I / O D N ,/- / F / A C '1I'01 t ' T O R 1[+00 1l+01 11+02 1l+03' 1[+04 FLOW AT POTTSTOWN (CFS) Figure 1.3.1-5

  • NOTE: Dilution factore are reduced by o fautor of 50 to neoount for ette spoolfte usage.

l ODCM, Rev. 17 Page 174 l 11/95

+ -> L.D. TANK FE Laundry G (RE Drein (LD) L.D. ^ Suesystem _g SAMPLE I. p n TANK To Cooiing 'd Tower -) L.D. TANK M t) Blowdown Line 10 GPM (Nom.) (p,,,,,, p.g,9 FD From Chem. Weste Tank SAMPLE g) 'F , TANK #1 FD FD FD ~ FD _g F COLLECTION -Tg FILTER D DEMIN SAMPLE g 7 Subsystem I TANK #2 y I ^ J k To Condeneste FD To Weste To Weele ~ 200 GPM Storage Tank SURGE 4 Studge Tank Studge Tank - (Nom) TANK ED ._) SAMPLE I.G 1r TANK A 'P ED ED 4 _g ED b Equipment COLLECT 80M i G FILTER DEMIN Drain (ED) TANK ED Subeystem ,r 4 SAMPLE > To Weste M To Weste TANK B l Studge Tank ' Sludge Tank T l PhilodolpNa Electric Comp. To FDCT

  • FE-85-OS3 Limerick Generating Station A

CW J

    • Ml8H-93412 OK904 Me1&2 Chem Weste p

g (CW) TANK (d Liquid Efflue.H Subsystem \\/ g ODCM, Rev. 17 Page 175 g 11/95 ~ m-r a.-*+- ,-w = W

  • y*-r n

-w-w w ve-- w w

D I he Monhw North Vent Wide unne a s N Range Elet 4H' 7 Mid&H%

Accident,

/\\ rettier,iete Renee mad lodine Monitor L** Me"We O Fitter continvowe Perseviate, lodine & Noble Gee Namel g Range Monitore 7 Sample One Monitor p 3 (3) Turbine Enclosure Enhevet [ I .000 CFM Turb8no Enclosure + (2) (2) Equip. Compart Erhouet I8I Turbine Enclosure Enheust k Mechenleal Vee. Pump Turbine Enclosure (II III + M (?) Bettery Room Exhevet . Equip. Comport Enhevet P Steam Pecking Exhauster A Redweste Encl. Exhavet Steam Pack. Enheuster D/W Purge Redweste Encl. Equip. (2) [ + Compartment Exhauster 7f emeeous R.de.e-1,. ~ ent ... -,,..e Tre.,..e. unii Cond.neer on es e enew Onges Fume Hood Exhnvet + Philadelphia Electric Comp. Limerick Generating Station Control Area Enhevet Y M (2) Units 1 & 2 I Gaseous Effluents Flow Diagram North Stack ODCM, Rev. 17 unit t Chereens system Page 176 - ,M Exhaust Fan // 11/95 Vg Filter = unii n Chercoal a etem r l L/

orus t o ne .n l F' c m pto t n n mt 9 E er t e ot s. ma C S t "s 't r p 2 n o 'e p emk 775 a cu im cg t luac 179 u in& o r f r o 1/ a a q it 1 gt eh E C c a EeS t f 1 E R x or s i ve1 E et sDh Bni e n u eg t owu eiG U o o o Ra h el S P pk eF leic G M dra o l C im D hU P O l ) eds2 na( ta y aGr a lu o i A } g c eet inlibn t rad ot PloNM ) 3, t )s g ( i t s 0 5> n u 0 0, M 4 0Mn.4 0 e o V .1it 3 F 0, F i u h2 4C 4CM n 1 5 t t 4n 2 ui on o .C SUlE t s n u e o 0 0 V u 0 0, F 0 M n. M '1 n h1 it 0,F i 1 tut 4n 4 C 4CM ~ oi o 3 5 n .C 2 g g k' SUlE 3 ) 3 t g g ( i i i ed s )2 na( t aGr [ ( ( a lu o ) c eeti (2 nl it ib n rd oo aPloNM ) 2( y e ru r s o o lo lc tn F n e E m g tn in r t t ot e r s s le u cu ma t p u a ee p m feh eh iu R x Rn o E E qE C l l

.n pio mta t ot n C S em ua 785 2 l icg& mg 179 r n Ea 1/ rt i 1 i t c a 1 s ler sD et u ve1 s e Eni ow eg r e n e n e U s o Ra i G G {l e P h a pk y c leic M c dr la e C eD i m D hi P L O ~ l I mr i r s e d n r G \\ re R /_ i T E tt F {@\\ LI g F a ~ B V ~ a a e rA r iap e i R r e l o int a i r dn e oo n N e A l/M e G F ta n R o s lui S V t U ct ia A ird H aa PR XE i re) 5/ t l l a i c Fi p \\ gy at \\ B( .t s '6 l c n u1 m s 2 Ea4 f hl c Tr xE k oE 0 INt k 0 J Uct c 0 as a 7 eat RES l l

.___m. ..~ __ ~ ODCM R v. 17 l Page 179 11/95 ) I l j 0 l 'l i N mw we E Y

  • ?

T = i g\\ E .im si ,s o wm ses .?,, / lvru.,o* ~ r S :' \\ I l s / u 9 i I l Figure B-1 Environmental Sampling Locations On Site or Near the Limerick Generating Station 1 i

l l ODCM R3v. 17 Prga 180 11/95 I J I 9 N NNE NNW j 34E1' 2It I NE NW t '3c3iI I 41i 3102 / ) WNW 2eE 1 eX1 ENE \\ 3101 [ 50 i \\I!' N f W '"'? %'a E l \\ . toe 1 13C1 hiot '*k ESE WSW 3 1501 2401 13E1 2001 !", \\ (' f% \\.** '~ SSW SSE f, S I A o 4 l Figure B-2 Airborne and TLD Environmental Sampling Locations at Intermediate Distances from the Limerick Generating Station

ODCM Rev. 17 Paga 181 11/95 N N NNW NNE g q l NW NE WNW ENE ,1 2srs sc. W 1 E S isp \\ SI 16c Ic2 L/

  • \\ '#

WSW 1 ESE ten 0 22F1 Sw - l ter. y I' \\ f SSW v i 4 1 F.igure B-3 Aquatic and Milk Environmental Sampling Locations at Intermediate Distances from the Limeri-k Generating Station

l ODCM R&v. 17' Prga 182 11/95 -*= = il t i l T ce I I / ( li i m l i c \\, t s n i g I -l s 2 ~ s-2 l i v) N. i i s l' I I ! / 3 I N \\ l \\ / / / s / i t Figu~re B-4 1 Environmental Sampling Locations at Remote Distances from the Limerick Generating Station

ODCM R;v.16 Page 183 4/95 l REFERENCES 1. Regulatory Guide 1.109, " Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I," Revision 1, U.S. Nuclear Regulatory Commission, Washington, D.C.

20555, October 1977.

2. Regulatory Guide 1.111, " Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water-Cooled Reactors," Revision 1, U.S. Nuclear Regulatory Commission, Washington, D.C. 20555, July 1977. 3. Regulatory Guide 1.112, " Calculation of Releases of Radioactive Materials in Gaseous and Liquid Effluents from Light-Water-Cooled Power Reactors," U.S. Nuclear Regulatory Commission, Washington, D.C. 20555, April 1976. 4. Regulatory Guide 1.113, " Estimating Aquatic Dispersion of Effluents from Accidental and Routine Reactor Releases for the Purpose of Implementing Appendix I," Revision 1, U.S. Nuclear Regulatory Commission, Washington, D.C. 20555, April 1977. 5. U.S. Nuclear Regulatory Commission, " Calculation of Releases of . Radioactive Materials in Gaseous and Liquid Effluents from ' Boiling Water Reactors (BWR-GALE Code), " USNRC Report NUREG-0016, Washington, D.C. 20555, April 1976. 6. U.S. Nuclear Regulatory Commission, "X00D00, Program for the Methodological Evaluation of Routine Effluent Releases at Nuclear Power Stations," USNRC Report NUREG-0324, Washington, D.C.

20555, September, 1977.

7. Title 10, " Energy," Chapter I, Code of Federal Reculations; Part, 20, Appendix B, U.S. Government Printing Office, Washington, D.C. 20402, January 1, 1977. 8. Title 10, " Energy," Chapter I, Code of Federal Reculations; Part 100, U.S. Government Printing Office, Washington, D.C.

20404, January 1, 1977.

9. Title 40, " Protection of Environment," Chapter I, Code of Federal Reculations, Part 141, U.S. Government Printing Office, Washington, D.C. 20402, January 1, 1977. 10. Regulatory Guide 1.21, " Measuring, Evaluating, and Reporting Radioactivity in Solid Wastes and Releases of Radioactive l Materials in Liquid and Gaseous Effluents from Light-Water-Cooled Nuclear Power Plants," Revision 1, U,.S. Nuclear Regulatory Commission, Washington, D.C. 20555,~ June 1974. l i i

k ODCM R2v.16 Pago 184 4/95 REFERENCES 11. Title 40, " Protection of Environment," Chapter I, Code of Federal Regulations, Part 190, Federal Register, Vol. 42, No. 9, Washington, D.C. 20402, January 13, 1977. 12. U.S. Nuclear Regulatory Commission, "Short Term Diffusion Estimates," Section 2.3.4, Standard Review Plan for the Review of Safety Analysis ReDorts for Nuclear Power P?. ants - LWR Edition, USNRC Report NUREG-75/087, Washington, D.C. 20555, November 1975. 13. U.S. Nuclear Regulatory Commission, " Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants," i USNRC Report NUREG-0133, Washington, D.C. 20555, October 1978. 14. Letter From Thomas E. Marley, Director Office of Nuclear Reactor Regulations, To Thomas E. Tipton Vice President and Director 5 Operations, Nuclear Management and Resources Council, 6/30/93. 15. ANSI N42.14-1991 (Revision of ANSI N42.14-1978) " Calibration and j Use of Germanium Spectrometers For the Measurement of Gamma-Ray Emission Rates of Radionuclides", Sect. 6.2.2 16. EML Procedures Manual, H.L. Volchok and G. dePlangue, Editors, U.S. Dept. Of Energy (Revised Annually) 17. L.A. Currie, " Limits For Qualitative Detection and Quantitative Determination - Application to Radiochemistry", Analytical Chemistry, Vol. 40, pp. 586-593 (TABLE II), 1968 j 18. NUREG/CR-4007, " Lower Limit of Detection: Definition and Elaboration of a Proposed Position for Radiological Effluent and Environmental Measurements", prepared by NRC by L.A. Currie (Chapter II, Sect. D.2; Chapter III, Sect. C.1), September 1984 19. Tech. Spec. Section 1.24 (Definitions) s 20. USNRC Generic Letter, 89-01 2*. Tech. Spec. Section 6.14. 2 22. Tech. Spec. Section 6.5.1.6m. 23. Tech. Spec. Section 6.5.3. 24. Tech. Spec. Section 6.8.4d, e and f. 25. Tech. Spec. Section 6.9.1.8/ODCM Control I.3.6. 26. Tech. Spec. Section 6.10.3m and n. 27. UFSAR, Section 11.5.6.

4 a e 5 + f i I i h 8 I i j i 1 1 1 1}}

Retrieved from "https://kanterella.com/w/index.php?title=ML20100L913&oldid=4309491"